<?xml version='1.0' encoding='utf-8' standalone='yes'?>
<collection>
  <source></source>
  <date>2025-12-25</date>
  <key></key>
  <document>
    <id>1170696 Figure_2-A</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) After 4 h of starvation in 1% K‐acetate medium in the presence of PMSF, autophagic vesicles can be visualized in vacuoles of wild‐type and pep4prb1 cells using Normaski optics. In aut2Δ and aut7Δ cells no autophagic vesicles can be seen. Bar represents 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_2-B</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Total protein breakdown of cells starved on nitrogen‐free medium is significantly reduced in aut2Δ andaut7Δ cells compared with wild‐type cells. pep4Δ (pra1Δ) cells are almost completely impaired in starvation‐induced vacuolar protein breakdown. Cells were pulse‐labeled with [35S]methionine and chased on non‐radioactive starvation medium. Aliquots were taken at the indicated times and acid soluble small peptides generated by proteolysis were determined according to Straub et al. (1997).</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_2-C</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Survival during starvation. Like pep4Δ (pra1Δ) cells, which are almost completely impaired in vacuolar proteolysis, aut2Δ and aut7Δ cells exhibit a significantly reduced survival rate during starvation on nitrogen‐free medium as compared with wild‐type cells. Aliquots of cells incubated in 1% K‐acetate were plated and growing colonies were determined according to Straub et al. (1997).</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_3-A</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Maturation of proaminopeptidase I is impaired in aut2‐1 (A), aut2Δ (B) and aut7Δ (C) cells. Further details are outlined in the text. Crude extracts were prepared from cells starved 4 h on 1% K‐acetate.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_3-B</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>Maturation of proaminopeptidase I is impaired in aut2‐1 (A), aut2Δ (B) and aut7Δ (C) cells. Further details are outlined in the text. Crude extracts were prepared from cells starved 4 h on 1% K‐acetate.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_3-C</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>Maturation of proaminopeptidase I is impaired in aut2‐1 (A), aut2Δ (B) and aut7Δ (C) cells. Further details are outlined in the text. Crude extracts were prepared from cells starved 4 h on 1% K‐acetate.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_5-A</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Detection of protein-protein interactions using the two‐hybrid system. Intense staining indicates an interaction between Aut2p and Aut7p, Aut2p and Tub1p, and Aut2p and Tub2p. AUT7, TUB1 and TUB2 are cloned in‐frame with the GAL4‐activator domain. AUT2 and AUT7 were fused to the GAL4‐binding domain (see Materials and methods).</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_5-B</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Affinity chromatography confirms protein-protein interaction between Aut2p and Aut7p. A fusion protein of Aut2p with the 26 kDa glutathione‐S‐transferase (GST) domain from Schistosoma japonicum (see Materials and methods) was bound to glutathione-Sepharose 4B. This GST-Aut2p column was incubated with a crude extract from aut7Δ cen Met25::AUT7-GFP cells. The non‐bound supernatant (S) fraction (lane 1) was taken away. Gel beads were successively washed with NaCl solutions of increasing concentrations to remove non‐specifically bound proteins. After the final 500 mM NaCl wash (W, lane 2), bound proteins were eluted with Laemmli buffer (E, lane 3). Samples were analyzed in immunoblots with monoclonal antibodies directed against GFP. Using Aut2p-GST, a clear band corresponding to Aut7p-GFP is seen in the eluate fraction (lane 3, arrowhead). As a control, GST alone was attached to the column and no band was detectable (lane 6).</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_5-C</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) As described in (B), bovine tubulin binds to GST-Aut2pglutathione-Sepharose 4B (lane 12), but not to GSTglutathione-Sepharose 4B (lane 9). Protein staining with Coomassie is shown in lanes 1-6; in lanes 7-12 tubulin was detected using monoclonal antibodies (Boehringer Mannheim). Further details are given in Materials and methods.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_5-D</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Similar to (C), bovine tubulin does not bind to GST-Aut7pglutathione-Sepharose 4B (lane 12) and to GSTglutathione-Sepharose 4B (lane 9). Lanes 1-6, protein staining with Coomassie; lanes 7-12 probed with antibodies directed against tubulin.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_6-A</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Benomyl sensitivity of wild‐type cells overexpressing AUT2 and AUT7, and of aut2Δ and aut7Δ cells is not altered. Cells were grown to stationary phase and dilution series with decreasing cell densites were dropped on CM plates without uracil containing 15 and 30 μg/ml benomyl. Plates were incubated at 30°C.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_7-A</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Autophagosome‐like vesicles (arrowhead) are accumulating in the cytoplasm of aut2Δ cells starved for 4 h on 1% K‐acetate in the presence of PMSF. Bar represents 100 nm.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_7-B</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Electron micrographs unravels the accumulation of double membrane‐layered autophagosome‐like vesicles in the cytoplasm of aut7Δ cells starved for 3 h in nitrogen‐free medium in the presence of PMSF. Arrowheads indicate the clearly distinguishable two membrane layers. Bar represents 100 nm.</text>
    </passage>
  </document>
  <document>
    <id>1170696 Figure_7-C_and_D</id>
    <infon key="sourcedata_document">371</infon>
    <infon key="doi">10.1093/emboj/17.13.3597</infon>
    <infon key="pmc_id">1170696</infon>
    <infon key="figure">Figure 7-C and D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C_and_D</infon>
    <passage>
      <offset>0</offset>
      <text>(C and D) Cytosol containing autophagosome‐like vesicles accumulating in the cytosol of aut2Δ cells (D) can be isolated with an additional 100 000 g centrifugation step yielding a P100 pellet fraction. In wild‐type cells (C), no P100 is detectable. Fatty acid synthase (Fas) was used as a cytosolic protein. Further details are given in the text.</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_2-A</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Sections from the cerebellar vermis of a 70-d-old npc1−/− mouse were stained with anti-Calbindin (green) to visualize PCs and 7AAD (red) for nuclei. Although there are scant PCs remaining in lobule II, the PCs in lobule X have not decreased.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="122" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">9</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="178" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">10</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="210" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_2-B</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of progressive anterior-to-posterior PC loss. PC densities from 30-d npc1+/+ and 30-, 50-, and 70-d npc1−/−mice were quantified from five sections from two mice each. Error bars show standard deviation.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">13</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="56" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="65" length="2"/>
        <text>PC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_2-C</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Bergmann glia visualized in 70-d npc1+/+ and npc1−/−mice using anti-S100β (green) have normal morphology. Note that the glial cell bodies near the PC layer and the radial processes extending into the molecular layer are intact in the npc1−/−mouse despite the loss of PCs.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">33</infon>
        <infon key="identifier">CL:0000644</infon>
        <location offset="4" length="13"/>
        <text>Bergmann glia</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">35</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="124" length="10"/>
        <text>glial cell</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">39</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="151" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">42</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="271" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_2-D</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Oligodendrocyte cell bodies stained with anti-CC1 (green) have a similar distribution and morphology in the cerebellarwhite matter of 70-d npc1−/− and wild-type mice. TOTO-3 (red) was used as a nuclear counterstain. Bar = 5 μm.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">45</infon>
        <infon key="identifier">CL:0000128</infon>
        <location offset="4" length="15"/>
        <text>Oligodendrocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_2-E</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Axonal spheroids in npc1−/−mice. Spheroids (arrows), seen as Calbindin-positive (red) swellings surrounded by myelin (anti-myelin basic protein; green), are numerous in the npc1−/−cerebellum (50-d-old, lobule X shown) but are not seen in the wild-type control. Bar = 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_2-F</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Sections from wild-type and npc1mice were stained with filipin to visualize free cholesterol. PCs from npc1mice show an accumulation of intracellular cholesterol at 30 d regardless of their lobular location. Images are oriented such that the PCs (arrowheads) are in the center of the field, with the molecular layer above and the inner granule cell layer below.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">67</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="98" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">72</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="246" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_3-A</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Genotyping of chimeric mice. Upper gel: PCR to amplify a fragment of the npc1 gene from npc1−/−↔GFP, npc1+/−↔GFP, and npc1+/−mice results in npc1− (1,067 bp) and npc1+ (947 bp) bands. Lower gel: The three genotypes can be distinguished by ApaLI digestion of the PCR products. The npc1− allele gives rise to 937- and 130-bp bands. The wild-type allele varies depending on the source: the BALB/c allele is digested to 477-, 340-, and 130-bp bands while the allele from the GFPmouse is digested to 817- and 130-bp bands. Note that the 477- and 340-bp bands are absent from the homozygous mutant chimera.</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_3-B</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of npc1−/−PC density in chimeric mice. For each mouse, the actual density observed (the average of the mean densities counted in each lobule) is compared to the number expected if no PC loss occurs (calculated from the density at 30 d in npc1−/−mice and the chimerism percentage). Five sections separated by at least 100 μm were analyzed for each mouse. For the three mice sacrificed at 70 d, only lobules I-IX were included in the analysis because of the lack of degeneration in lobule X in npc1−/−mice at this age. A value for the number of npc1−/−PCs expected if loss does occur (calculated from the density at 70 d in npc1−/−mice and the chimerism percentage) is also included for these three mice. No rescue of mouse−/−PCs was observed for any of the chimeric mice (p &lt; 0.0001 for each mouse comparing observed versus expected if no loss occurs).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">101</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="29" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="202" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="569" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">118</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="743" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_3-C</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of npc1−/−PC density by lobule in C1.4 at 70 d. Observed and expected densities are shown for npc1−/−PCs in each lobule. No clear rescue of npc1−/−PCs was observed in any lobule (p &gt; 0.05 for all lobules comparing observed versus expected if loss occurs, except II and III, where p-value is between 0.01 and 0.05; p &lt; 0.001 for all lobules comparing observed versus expected if no loss occurs, except lobule X, where p &gt; 0.05).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">124</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="29" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">126</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="120" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">128</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="166" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_3-D-E</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 3-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D and E) Images of lobules II and X taken from C1.4 at 70 d. GFP is green and Calbindin staining is red. In lobule II, the number of PCs is clearly reduced and of the five remaining PCs, four are wild-type (GFP-positive). In lobule X (where no degeneration occurs during the normal npc1−/− life span), PC density is normal and the majority of PCs (23 of 32; 72%) are mutant, as expected based on npc1−/− contribution to this mouse (67%).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">150</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="133" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">151</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="182" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">154</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="302" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">155</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="343" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_3-F</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Quantification of wild-type PC density in chimeric mice. Observed and expected densities are shown for wild-type PCs. For mice with more than 15% wild-type contribution, the density of wild-type PCs is similar to the number expected if these cells have not degenerated (p &gt; 0.05 for each mouse comparing observed versus expected if no loss occurs, except C5.2, where p = 0.02, and C5.6, where p = 0.0005).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">160</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="32" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">162</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="117" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">164</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="199" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_3-G</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Quantification of wild-type PC density by lobules in C1.4 at 70 d. No loss of wild-type PCs was observed in any of the lobules (p &gt; 0.05 for all lobules comparing observed versus expected if no loss occurs; p &lt; 0.001 for all lobules comparing observed versus expected if loss occurs, except for lobule X, where p &gt; 0.05).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">170</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="32" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="92" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) Microglia characteristics. Sections from 50-d-old npc1 mutants were stained with anti-Calbindin (green) to visualize PCs and anti-F4/80 (red) to mark microglia. (A) Very few microglia are present in lobule X, where no PC degeneration has yet occurred. (B) Lobule VIII demonstrates an infiltration of microglia in the granule cell layer and white matter tract. (C) In lobule II, nearly all PCs are gone and numerous microglia are present throughout the cerebellum. The dashed line indicates the edge of the granule cell layer.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">189</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="6" length="9"/>
        <text>Microglia</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">196</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="123" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">191</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="156" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">197</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="180" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">199</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="224" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">200</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="306" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">202</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="395" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">203</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="421" length="9"/>
        <text>microglia</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_4-D</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Microglia infiltration is not sufficient to induce PC degeneration. C1.4 demonstrates numerous microglia marked by anti-F4/80 (red) in all layers of the cerebellum, including immediately adjacent to wild-type (GFP-positive) PCs (arrows). Despite this close approximation, no loss of wild-type PCs was detected by cell counting. The GFP transgene is apparently poorly expressed in microglia, as all microglia appear GFP-negative regardless of their genotype.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">208</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="4" length="9"/>
        <text>Microglia</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">209</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="55" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">210</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="99" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">214</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="228" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">215</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="297" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="384" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">217</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="402" length="9"/>
        <text>microglia</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_4-E-F</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E) Mutant PCs are lost even when surrounded by wild-type Bergmann glia. A stretch of the PC layer in C4.8 is shown where no npc1−/− (GFP-positive) PCs remain despite the presence of numerous wild-type (GFP-negative) glia (arrowheads) marked by anti-S100β (red). The space occupied by two wild-type PCs is indicated (arrows) with two npc1−/− (GFP-positive) glia directly underneath. (F) Wild-type PCs do not degenerate even when surrounded by mutant Bergmann glia. Three wild-type PCs (GFP-positive; arrows) in C1.4 have not degenerated despite only mutant glia (arrowheads) being in the immediate vicinity.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">221</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="10" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">222</infon>
        <infon key="identifier">CL:0000644</infon>
        <location offset="57" length="13"/>
        <text>Bergmann glia</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">223</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="89" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">225</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="147" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">228</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="298" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">231</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="396" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">232</infon>
        <infon key="identifier">CL:0000644</infon>
        <location offset="449" length="13"/>
        <text>Bergmann glia</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">233</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="480" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_4-G</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Oligodendrocytes in chimeric mice are a mixture of wild-type and mutant cells. Oligodendrocyte cell bodies are stained with anti-CC1 (red). Wild-type (GFP-positive; arrows) and npc1−/− (GFP-negative; arrowheads) oligodendrocytes are interspersed in C1.4.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">236</infon>
        <infon key="identifier">CL:0000128</infon>
        <location offset="4" length="16"/>
        <text>Oligodendrocytes</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">240</infon>
        <infon key="identifier">CL:0000128</infon>
        <location offset="83" length="15"/>
        <text>Oligodendrocyte</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">238</infon>
        <infon key="identifier">CL:0000128</infon>
        <location offset="216" length="16"/>
        <text>oligodendrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_5-A</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Chimeric mice with more than 50% wild-type contribution do not exhibit wasting. Weekly weights for each of the mice were recorded from 4 wk until the mice were sacrificed. For wild-type and npc1−/− homozygous mice, the curve shown is the mean weight from three to four mice. A progressive decrease in weight of npc1mice begins to show around 7 wk. The chimeric mice display a delay in, or even absence of, wasting depending on the amount of wild-type contribution.</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_5-B</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Prevention of ataxia in chimeric mice. Mice were assessed for ataxia weekly during two 3-min trials on a balance beam (see Materials and Methods).</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_5-C</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Gait of chimeric mice. Front and back paws of mice were dipped in red or green paint, and mice walked across a box lined with paper. The npc1−/−mouse displays shorter stride length and a smearing of the footprints as the paws are not as well lifted between steps. Chimeric mice with high amounts of wild-type contribution (C4.8; C4.4 not shown) exhibited a gait indistinguishable from wild-type.</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_5-D</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantification of stride length. For wild-type and mutant controls, three mice were assessed. For chimeric mice, gait was measured prior to sacrifice at the ages noted. Error bars indicate the standard deviation. Comparison with the GFPmice demonstrates that npc1+/+, C1.4, C4.4, and C4.8 do not have significantly different stride lengths (p &gt; 0.05) while npc1−/−, C5.2, C5.6, C2.1, and C5.8 have significantly shorter stride lengths (p &lt; 0.001)</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_6-A</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Increased Autophagy in npc1PCs EM of npc1−/− and wild-type PCs from anterior vermis of 48-d-old mice. (A) Low-power field of a typical npc1PC. (B) Magnification of the red box in (A) showing accumulated multivesicular and multilamellar organelles. (C) Magnification of the blue box in (A) showing a large AV (arrowheads) containing ribosomes and membranes. (D) Another AV (arrowhead) with ER cisternae within the lumen. (E) An npc1PC probably in the late stages of degeneration, with many AVs, some with apparently degrading mitochondria (arrowheads). (F) Low-power field of two wild-type PCs. (G and H) Magnification of the red (G) and blue (H) boxes in (F) showing no AVs and very few multivesicular organelles (arrow). (I) Quantification of area occupied by AVs and other multivesicular/multilamellar organelles expressed as a percentage of total cytoplasmic area for seven wild-type and seven npc1−/−PCs; p = 0.0009 for comparing AV areas and p = 0.0003 for comparing other multivesicular/multilamellar areas, indicating both types of organelles occupy significantly more area in npc1−/−PCs. Bar = 5 μm for (A) and (F); for all others, bar = 1 μm.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">297</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="27" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">299</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="59" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">302</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="139" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">305</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="431" length="2"/>
        <text>PC</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">306</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="589" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">21</infon>
        <infon key="sourcedata_article_annot_id">309</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="904" length="3"/>
        <text>PCs</text>
      </annotation>
      <annotation id="24">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">24</infon>
        <infon key="sourcedata_article_annot_id">312</infon>
        <infon key="identifier">CL:0000121</infon>
        <location offset="1091" length="3"/>
        <text>PCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_7-A</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblots of 70 μg of protein resolved by 15% SDS-PAGE show increased levels of LC3-II in 50- and 67-d-old npc1cerebellar extracts. Two mice of each age and genotype were analyzed, and relative band intensities were quantified. p-Values derived from comparing wild-type and npc1−/−cerebella at each age are 0.3, 0.01, and 0.001 for 22-, 50-, and 67-d-old mice, respectively.</text>
    </passage>
  </document>
  <document>
    <id>1183526 Figure_7-B</id>
    <infon key="sourcedata_document">814</infon>
    <infon key="doi">10.1371/journal.pgen.0010007</infon>
    <infon key="pmc_id">1183526</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblots of CHO cell extracts resolved by 15% SDS-PAGE do not show increased levels of LC3-II in CT60 cells compared to wild-type CHO-KI cells or CT60 cells stably transfected with NPC1-YFP. No difference is noted with 10 μM U18666A, a drug that mimics npc1 loss of function. Rapamycin treatment (1 μM) of CHO-KI cells demonstrates robust activation of autophagy with increased LC3-II levels.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_1-A</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Chromatin immunoprecipitation (ChIP) analysis of receptor binding to the ER8 element (region 1) of the nrf2 promoter. Immunoprecipitation with nonspecific IgG and PCR amplification of an adjacent region (2) served as controls. ChIP assays were also carried out to analyse binding to ER8s in the il10, ddit3 and tyrobp genes. RAR, retinoic acid receptor; VDR, vitamin D receptor.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_1-B</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Reverse transcription-PCR analysis of 1,25‐dihydroxyvitamin D3(1,25D3)‐ or retinoic acid (RA)‐regulated expression of ddit3, il10, and tyrobp in U937, Calu‐3 and MCF‐7 cells.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_2-A</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Electrophoretic mobility shift assay (EMSA) of binding of vitamin D receptors (VDRs)/retinoid X receptors (RXRs) to thep19ink4dER8, with binding to the mouseosteopontin (mop) DR3vitamin D responsive element as a control, along with a comparison of binding to ER6 and ER8 motifs (right‐hand panel).</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_2-B</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) EMSA of retinoic acid receptor (RAR)/RXR binding to the p19ink4dER8, and the rarβDR5retinoic acid response element, as a control.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_2-C</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Chromatin immunoprecipitation (ChIP) analysis of binding of VDRs and RARs to the p19ink4dER8 (region 1) and RNA polymerase II (POLII) binding to the transcription start site.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_2-D</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) ReChIP analysis confirms the presence of VDR/RXRs and RAR/RXRs but not of VDR/RARs on thep19ink4dER8.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_2-EFG</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 2-EFG</infon>
    <infon key="sourcedata_figure_dir">Figure_2-EFG</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Cloning of p19ink4d promoter containing or lacking ER8 upstream of a luciferase reporter. 3 (1,25D3)‐ (F) and retinoic acid (RA)‐regulated (G) luciferase expression is dependent on the ER8 element in the p19ink4d promoter. Luciferase expression driven by a thymidine kinase (tk) control promoter is shown.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_3-AB</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 3-AB</infon>
    <infon key="sourcedata_figure_dir">Figure_3-AB</infon>
    <passage>
      <offset>0</offset>
      <text>3 and retinoic acid induce p19ink4d expression. Expression of p19ink4d messenger RNA by reverse transcription-PCR (A) or protein by western blotting (B) was carried out on extracts of cells treated with 3 (1,25D3) or retinoic acid (RA), as indicated.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_3-C</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Treatment with 1,25D3 or RA transiently enhances co‐immunoprecipitation (IP) of p19INK4D with cyclin‐dependent kinase CDK4 in U937 cells. Similar results were obtained in SCC25 cells (not shown). A control western blot (W) of CDK4 levels in ligand‐treated cells is shown below.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_3-D</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Treatment with 1,25D3 enhances co‐immunoprecipitation of p27KIP1 with CDK4 in U937 cells. Extracts of U937 cells were probed for p27KIP1 and CDK4, and immunoprecipitated with an anti‐CDK antibody and probed for p27KIP1co‐immunoprecipitation.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_4-A</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Short interfering RNAs (siRNA) knockdown ofp19ink4d messenger RNA and protein in SCC25 cells. SiRNAs were directed against p19ink4d, scrambled p19ink4d (Scr.) or cyclophilin (cyc.) controls.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_4-B</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Combined knockdown of p27KIP1 and p19INK4D in SCC25 cells analysed by western blotting for p27KIP1 (top) and p19INK4D (bottom).</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_4-C,D</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 4-C,D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C,D</infon>
    <passage>
      <offset>0</offset>
      <text>(C,D) Fluorescence‐activated cell sorting analysis of cell‐cycle distribution of control SCC25 cells, or cells transfected with scrambled (Scr), p19ink4d‐ or p27kip1‐directed siRNAs, individually or together (Dbl). (C) Cells were treated with vehicle or 1,25‐dihydroxyvitamin D3 (1,25D3), as indicated. (D) Cells were treated with DMSO vehicle, retinoic acid (RA) or 1,25D3, as indicated.</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_4-E</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Loss of p19INK4D enhances lysosomal β‐galactosidase activity in SCC25 cells. (Left) Histogram of numbers of cells staining for β‐galactosidase activity in the absence (−) or presence of 1,25D3 in control cells (−) or in cells transfected with scrambled (Scr) or p19INK4D siRNAs. (Right) Bright field images of untransfected cells (−/−) or p19INK4D‐depleted cells treated with 1,25D3 (p19/D3).</text>
    </passage>
  </document>
  <document>
    <id>1369248 Figure_4-F</id>
    <infon key="sourcedata_document">343</infon>
    <infon key="doi">10.1038/sj.embor.7400594</infon>
    <infon key="pmc_id">1369248</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Loss of p19INK4D induces lysosomal fusion. Analysis of lysosomal fusion (autophagosomes) in SCC25 cells treated as in (E), stained for incorporation of lysotracker red. Nuclei were counterstained with Hoechst (blue).</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_1-A</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Solubilized lysosomes cross‐linked with DSP were subjected to affinity chromatography with the antibody against the cytosolic tail of lamp2a (lanes 1 and 2). Eluted proteins were subjected to SDS-PAGE and silver stained (lane 1), or immunoblotted for lamp2a (lane 2). The sequence of the N‐terminus of the 32 kDa band is shown. Part of the solubilized lysosomes were directly subjected to non‐reducing SDS-PAGE (5%) and immunoblotted for lamp2a (lane 3) or PPCA (lane 4). Arrowheads indicate lamp2a multimeric complexes. The 600 kDa (*) and 200 kDa (**) molecular weight complexes of lamp2a were excised and subjected to reducing SDS-PAGE (12%) and silver staining (lanes 5 and 6). Molecular weight (kDa) is indicated on the left.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_1-B</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblot analysis of PPCA in ratliverlysosomes, their membranes (MB) and matrices (MTX) (100 μg of protein) incubated alone (None) or with 5 mM MgCl2. Arrowheads indicate the precursor (54 kDa) and heavy chain (32 kDa) of the mature PPCA.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_1-C</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblot analysis of hsc73 (upper) and PPCA (lower) in membranes from ratliverlysosomes incubated alone (None) or with 5 mM MgCl2, CaCl2, MnCl2 or 2 mM EDTA.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_1-D</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblot analysis of lamp2aco‐immunoprecipitated with PPCA in the absence of chemical cross‐linkers from membranes of liverlysosomes incubated as in (B). Light and heavy chains of IgG are shown. Lane 1 contains 1/10 of the total amount of lysosomalmembranes used for immunoprecipitation.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_1-E</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Membranes from lysosomes treated as in (D) were subjected to immunoprecipitation with an antibody specific for lamp2a or with a pre‐immune serum. Carboxypeptidase activity in total lysosomes and in the immunoprecipitates was measured as described under Materials and methods. Values are expressed as percentage of total carboxypeptidase activity in lysosomes present in the immunoprecipitates and are the mean ± SE of three different experiments.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_2-AB</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 2-AB</infon>
    <infon key="sourcedata_figure_dir">Figure_2-AB</infon>
    <passage>
      <offset>0</offset>
      <text>Levels of PPCA associated with the lysosomal membrane correlate with rates of CMA. Membranes of lysosomes incubated with increasing concentrations of GAPDH (A) or MgCl2 (B, top panel) as labeled, were analyzed by immunoblot for all forms of lamp2 (upper), lamp2a (middle) or PPCA (lower). The arrowhead indicates a previously identified truncated form of lamp2 lacking the cytosolic/transmembrane region ( Cuervo and Dice, 2000b). (B, bottom panel) Chart showing the effect of increasing concentrations of MgCl2, CaCl2 or EDTA on the degradation of [14C]GAPDH by intact ratliverlysosomes. Values are means ± SE of six different experiments. Differences from the control value were significant at P 0.001 (**) or P 0.01 (*).</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_2-C</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblot analysis for PPCA (upper) and cathepsin L (lower) of ratliverlysosomes (100 μg of protein) with high (H+) and low (H−) activity for CMA and of the lysosomalmembranes (L.Memb) and matrices (L.Mtx) from both groups of lysosomes (200 μg of protein).</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_2-D</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblot analysis for lamp2a, PPCA and cathepsin D, as labeled, of lysosomes (100 μg of protein) from fed or 48 h starved rats and the membranes (L. Memb) and matrices (L. Mtx) of both goups of lysosomes (200 μg of protein). Only mature forms of the cathepsins are shown</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_2-E</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Correlation between CMA activity, measured as in (B, bottom panel) and levels of PPCA at the lysosomal membrane determined by denstometric quantification of immunoblots similar to those shown in Figures 1 and 2 in lysosomes from fed or 20 h starved rats (Starv 20h), highly active (H+) or less active (H−) lysosomes, or lysosomes incubated with 1 mM CaCl2, MgCl2, EDTA, or increasing amounts (2, 5, 10 μg) of GAPDH. Values are expressed as times the value in fed rats (control) and are means ± SE of 3-6 different experiments.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_3-A</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Rates of protein degradation in skinfibroblasts from wild‐type (control) or PPCA(−/−) mice maintained in the presence (serum +) or absence of serum (serum −). Values are expressed as the percentage of initially radiolabeled proteins remaining at each time and are means ± SE of four different experiments.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">115</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="40" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_3-B</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Degradation of [14C]GAPDH after 30 min incubation with lysosomes isolated from wild‐type and PPCA(−/−) miceskinfibroblasts supplemented or deprived of serum was measured as described in Material and methods. Where indicated, 25 μg of RNase A were added. Values are means ± SE of four different experiments. Differences from the control value were significant to P 0.001 (**).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">129</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="115" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_3-C</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunofluorescent staining for lamp2a and lamp1 of skinfibroblasts from wild‐type and PPCA(−/−) mice. Gain for lamp2a images (top) was 1/8 of the one for lamp1 (bottom) to visualize the punctate pattern of lamp2a in PPCA(−/−) mice. Inset: detail of the vesicular distribution of lamp2a. The gain in wild type was eight times the gain in PPCA(−/−) mice). Bars: 100 μm (top), 50 μm (bottom), 10 μm (inset).</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">142</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="59" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_3-D</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblot analysis for lamp2a, all lamp2s, lamp1 or cathepsin D (cath D) of homogenates (75 μg of protein), lysosomes (10 μg of protein) and lysosomalmembranes (L.MB) and matrices (L.MTX) (5 μg of protein) isolated from wild‐type (WT) and PPCA(−/−) skinfibroblasts. The bottom chart shows the densitometric quantification of the membrane proteins (means + SE) from four immunoblots similar to those shown here. Differences from the control value were significant to P 0.001 (**) and P 0.05 (*).</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">161</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="258" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_4-A</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis for lamp2a, all lamp2s, lamp1, transferrin receptor (TFR) or cathepsin D (cath D) of liver homogenates (100 μg of protein) from wild‐type (WT), PPCA(−/−) and β‐galactosidase(−/−) (GM) mice. Right: densitometric quantification of three immunoblots (means + SE) similar to the ones shown here. Differences from the control value were significant to P 0.001 (**) and P 0.05 (*).</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_4-B</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunocytochemistry for lamp2a (left), lamp1 (center) or lamp2s (right) in hematoxylin and eosin‐stained sections from the same livers. Bar: 50 μm. Black arrows: hepatocytes; white arrows: Kupffer cells.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">181</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="166" length="11"/>
        <text>hepatocytes</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">182</infon>
        <infon key="identifier">CL:0000091</infon>
        <location offset="193" length="13"/>
        <text>Kupffer cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_4-C</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunofluorescence for lamp2a (top) and P‐glycoprotein (bottom) in mouseliver sections. The right panel shows merged images. Bar: 100 μm. Inset shows detailed area at higher magnification. Bar: 50 μm.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_5-A</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Autofluorography of the sequential immunoprecipitation of lamp2a first (left) and all the remaining isoforms of lamp2 second (right) from metabolically labeled wild‐type and PPCA(−/−) mouse skin fibroblasts. Values are means ± SE of three different experiments similar to the ones shown in the upper panels.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">200</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="199" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_5-B</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblot analysis for lamp2a (top) and all lamp2 isoforms (bottom) in lysosomalmembranes from wild‐type (WT) or PPCA(−/−) mouseskinfibroblasts at different times after incubation at 37°C. The open arrowhead indicates the truncated form of lamp2 lacking the cytosolic/transmembrane region ( Cuervo and Dice, 2000b). Right shows the densitometric quantification (mean ± SE) of four different experiments similar to the one shown here. Values are expressed as percentage of remaining lamp2a, and are means ± 1 SE of three different experiments.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">208</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="137" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_6-A</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Rates of total protein degradation in the presence and absence of serum of normal skinfibroblasts (CTR), GS cells (None) and GS cells supplemented with the precursor forms of native PPCA (+PPCA), a catalytic mutant of PPCA (+PPCA S/A) or cathepsin L (Cath L). Values are means ± SE of six different experiments. Differences from the control value were significant for P 0.001 (**) and P 0.05 (*).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="90" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">212</infon>
        <location offset="109" length="8"/>
        <text>GS cells</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">217</infon>
        <location offset="129" length="8"/>
        <text>GS cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>140041 Figure_6-B</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblot analysis for lamp2a at time 0 or after 40 min incubation at 37°C of lysosomes isolated from PPCA(−/−) cells (None) and PPCA(−/−) cells supplemented as in (A). At 40 minimmunoblot with the antibody against the luminal region of lamp2a is depicted to show the truncated form of lamp2a (open arrowhead). Right: densitometric quantification for lamp2a (means + range of values) of two different experiments similar to the one shown. Values are expressed as percentage of the lamp2a present in non‐supplemented cells.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_6-C</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblot analysis for lamp2a at time 0 or after 40 min incubation at 37°C of lysosomes isolated from PPCA(−/−) cells (None) and PPCA(−/−) cells supplemented as in (A). At 40 minimmunoblot with the antibody against the luminal region of lamp2a is depicted to show the truncated form of lamp2a (open arrowhead). Right: densitometric quantification for lamp2a (means + range of values) of two different experiments similar to the one shown. Values are expressed as percentage of the lamp2a present in non‐supplemented cells.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_6-D</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunocytochemistry for lamp2a of liver (top) and kidney (bottom) sections of age‐matched wild‐type (WT), PPCA(−/−) and bone marrow transplanted (BMT) mice. Bar, 50 μm (liver) or 100 μm (kidney).</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_7-A</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Left: amino acid sequences of the C‐terminal regions of lamp2a from different species and of other lamp2 isoforms and lamp1 from mouse. The proposed cleavage site for PPCA in lamp2a is highlighted. Right: immunoblot analysis for HA of lysosomalmembranes isolated from two different clones of HEK293 (mouse; upper panel) and NIH 3T3 cells (human; lower panel) stably transfected with wild‐type (FL) and mutated (GL) HA‐lamp2a. The arrowhead indicates the truncated form of lamp2 lacking the cytosolic/transmembrane region.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_7-B</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Total rates of protein degradation in the presence and absence of serum in non‐transfected HEK293 cells (WT) and in the transfected HEK293 clones described in (A). Values are expressed as the percentage of initially radiolabeled proteins remaining at each time and are means ± SE of three different experiments.</text>
    </passage>
  </document>
  <document>
    <id>140041 Figure_7-C</id>
    <infon key="sourcedata_document">377</infon>
    <infon key="doi">10.1093/emboj/cdg002</infon>
    <infon key="pmc_id">140041</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Top: immunoblot analysis with an anti‐HA antibody of purified wild‐type (FL) and mutated (GL) mouseHA‐lamp2a incubated in an acidic pH buffer alone, or with PPCA. Bottom: wild‐type HA‐lamp2a was incubated as in the top panel without additions (None) or in the presence of 2 mM EDTA, 10 μM L‐trans‐epoxysuccinyl‐leucylamide‐(4‐guanido)‐butane (E‐64), 2 μM pepstatin A (Pepst) or 10 μM ABSF. The open arrowhead indicates the truncated form of lamp2a.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_1-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Fed ratliverlysosomes were extracted with 1% of the indicated detergents and then subjected to sucrosegradient centrifugation. Aliquots collected from top to bottom were subjected to SDS-PAGE and immunoblotted for LAMP‐2A and flotillin‐1. Stars indicate the aliquots of the gradient of translucent appearance (highly enriched in lipids).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_1-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) The distribution of LAMP‐2A through the sucrose gradient after extraction with 1% Triton X‐114 was calculated from the densitometric quantification of immunoblots as the one shown here. Values are expressed as percentage of the total lysosomal levels and are mean+s.e. of four experiments.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_2-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Lysosomes from livers of fed (Fed) or 24 h starved rats (Stv) were extracted with 1% Triton X‐114 and processed as in Figure 1 or the aliquots in the translucent region were pooled together as the detergent‐resistant (DR) fraction, and anything below this fraction was pooled, as the solubilized fraction (Sol) (B). Lanes 5-6 are one‐tenth of the amount of lysosomes loaded in the gradient.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_2-C</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Distribution of LAMP‐2A (L‐2A) and flotillin‐1 (Flot‐1) in fed ratsliverlysosomes extracted with 1% Triton X‐114 at 4 or 37°C. DR fractions were pooled as in (B), and the aliquots below this region were divided in three fractions (a soluble (Sol; aliquot 15) and two intermediate fractions (light: aliquots 11-12; heavy: aliquots 13-14).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_2-D</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Fed ratliverlysosomes were incubated with MBCD or filipin, as described under Material and methods, and then processed as in (C). The mean value of the densitometric quantification of the LAMP‐ from two experiments is shown at the bottom in (C) and (D).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_3-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Lysosomalmembranes from fed ratlivers and their corresponding 1% Triton X‐114‐resistant regions, isolated as described under Material and methods, were subjected to one (left)‐ or two‐dimensional (right) electrophoresis and stained with Sypro Ruby.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_3-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblot for the indicated proteins of the detergent resistant (DR), intermediate (Int) and solubilized (Sol) fractions of lysosomal membranes obtained as in Figure 2.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_4-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>LAMP‐2A localizes in cholesterol‐ and GM‐1‐enriched intracellular membrane domains. Mouse fibroblasts grown on coverslips in the presence (+) or absence (−) of serum were fixed and labeled with filipin (red) (A) or incubated with Texas‐Red‐cholera toxin B subunit to label GM‐1‐enriched membrane regions (red) and then fixed.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_4-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Both groups of cells were then subjected to indirect immunofluorescence for LAMP‐2A (green). Where indicated, cells were treated with MBCD (25 mM) for 30 min before fixation. The merged images of both fluorophores are shown on the right. Insets show vesicles at higher magnification. Bar: 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_5-A-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) Regions of the lysosomalmembrane resistant to 1% Triton X‐114 recovered from the sucrose gradients were fixed and processed for electron microscopy (A) or visualized without fixation by electron microscopy (B). Arrows point to the membrane bilayer.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_5-C</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Intact ratliverlysosomes (top) and DR regions of the lysosomal membranes (bottom) were fixed and subjected to immunogold labeling for LAMP‐2A and LAMP‐2B, and a gold‐conjugated secondary antibody as described under Material and methods. Top right panels show 'clusters' of gold particles (black arrows) in individual lysosomes at higher magnification. Graph shows the labeling density (gold particles per μm) in the indicated fractions for both proteins. Values are mean+s.e. from the quantification of 15 different micrographs.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_5-D</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Intact ratliverlysosomes were fixed and subjected to double immunogold labeling for LAMP‐2A and flotillin‐1. Representative lysosomes are shown. Far right panel: zoomed‐in image of the distribution of LAMP‐2A in regions containing (black arrows) and not containing (white arrows) flotillin‐1. Bars: 0.2 μm.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_6-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Fed ratliverlysosomes were incubated in an isotonic buffer without additions, or in the presence of ratlivercytosol (25 μg), glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) (25 μg), GST‐hsc70 (10 μg/ml), ATP (5 mM) or the indicated combinations for 15 min at 37°C. Lysosomes incubated directly with apyrase or with cytosol treated with apyrase are shown in the right bottom panel. At the end of the incubation, lysosomes were subjected to Triton X‐114 extraction, apyrase density gradient centrifugation and immunoblot as in Figure 2C. Graph shows changes in LAMP‐2A distribution expressed as times the value in untreated lysosomes and are the mean of the densitometric quantification of 3-6 experiments as the one shown here. Because all the incubations were performed in the presence of protease inhibitors, total levels of LAMP‐2A in lysosomes remained constant throughout the incubation.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_6-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Lysosomes from livers of fed rats, untreated or treated with paraquat (+PQ), were processed as in (A). Graph shows changes in LAMP‐2A distribution induced by the PQ treatment, expressed as times the value in untreated animals and are the mean of three experiments.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_6-C</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Lysosomes with high (CMA+) and low (CMA−) ability for CMA isolated from livers of fed or 48 h starved rats were processed as in (A). Top left: Levels of two CMA components (LAMP‐2A and hsc70) and of an unrelated lysosomalmembrane protein (LAMP‐1) in each of the four groups of lysosomes. Bottom left: Percentage of total lysosomalLAMP‐2A present in each fraction, determined by densitometric quantification of the immunoblots.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_7-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Degradation of long‐lived proteins in mouse fibroblasts (NIH3T3 cells) treated or not with 25 mM MBCD. Where indicated, 15 mM NH4Cl/100 μM leupeptin (NH4Cl+Leup) were added into the medium. Values are the mean+s.e. of three experiments with triplicate samples.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_7-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Effect of MBCD on total rates of protein degradation, measured as in (A), in wild‐type mouse fibroblasts and in fibroblasts stably RNA interfered for LAMP‐2A (LAMP‐2A(−)). The ratio of degradation in MBCD‐treated and untreated cells is shown for cells maintained with or without 10 mM 3‐methyladenine (3MA).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_7-C</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Proteolysis of [14C]GAPDH or a pool of [3H]labeled cytosolic proteins (pool proteins) by isolated ratliverlysosomes, treated or not with MBCD. Broken: lysosomes disrupted by a hypotonic shock before the incubation with the radiolabeled proteins. Values are expressed as percentage of the degradation by untreated lysosomes and are the mean+s.e. of three experiments with triplicate samples.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_7-D</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Lysosomal-mitochondrial fractions were isolated from mouse fibroblasts untreated or loaded with cholesterol (50 μM). Top: Distribution of LAMP‐2A after Triton X‐114 extraction and sucrose density gradient centrifugation. Bottom: Ability of intact or disrupted lysosomal-mitochondrial fractions to proteolize [14C]GAPDH. Values are expressed as percentage of the degradation in fractions from untreated cells and are the mean±s.e. of triplicate samples.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_8-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Serum from mouse fibroblasts transfected with wild‐type hLAMP‐2A and maintained in the presence (Serum+) or absence (serum−) of serum were collected by centrifugation and subjected to Triton X‐114 extraction, sucrose density gradient centrifugation and immunobloting for human (hL2A) or mouse (mL2A) LAMP‐2A. Lane 1: homogenate.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_8-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Amino-acid sequence of the transmembrane and cytosolic region of hLAMP-2A and the mutations performed. Replaced amino acids are shadowed.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_8-C</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Lysosomes from mouse fibroblasts transfected with the indicated forms of hLAMP‐2A and maintained in the presence of serum were processed as in (A).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_8-D</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) The percentage of total lysosomalhLAMP‐2A present in each fraction was determined by densitometric quantification of immunoblots as the ones shown here. Values, corrected for the amount of mLAMP‐2A in each fraction, are mean+s.e. of 3-4 experiments.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_8-E</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Changes in hLAMP‐2A distribution induced by serum removal. Values are expressed as times the values in cells maintained in the presence of serum and are the mean of two experiments. Changes in the three nonDR regions are shown together (no DR).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_8-F</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 8-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Proteolysis of a pool of 3[H]labeled cytosolic proteins by intact (left) or disrupted (right) lysosomes isolated from untransfected mouse fibroblasts (none) or fibroblasts transfected with wild‐type (WT) or the indicated mutant forms of hLAMP‐2A. Values are the mean+s.e. of two experiments with triplicate samples.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_8-G</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 8-G</infon>
    <infon key="sourcedata_figure_dir">Figure_8-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Part of the lysosomes from (F) was treated with MBCD before the incubation with the radiolabeled proteins. Values are expressed as percentage of degradation by untreated lysosomes and are the mean+s.e. of two experiments with triplicate samples.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_9-A</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The Triton X‐114‐resistant and soluble regions of the lysosomalmembrane were subjected to centrifugation through a continuous (10-80%) sucrose density gradient, SDS-PAGE and immunoblot for LAMP‐2A. The molecular weight range of each fraction is as follows: fraction 1 (100 kDa); fraction 2 (100-200 kDa); fraction 3 (200-400 kDa); fraction 4 (400-600 kDa); fraction 5 (&gt;600 kDa).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_9-B</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Fed ratliverlysosomes were incubated with 1 mM CaCl2 (+Ca2+) in an isotonic buffer in the absence or presence of a cocktail of protease inhibitors (PI). Samples were subjected to Triton X‐114 extraction, sucrose density gradients centrifugation and LAMP‐2Aimmunoblot.</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_9-C</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Fed ratliverlysosomes treated or not with 25 mM MBCD were incubated in an isotonic buffer for 30 min and then subjected to SDS-PAGE and immunobloted with antibodies against the cytosolic (Top; L‐2A) and luminal (Bottom; L‐2) regions of LAMP‐2A. Arrow: LAMP‐2A proteolytic fragment ( Cuervo and Dice, 2000a).</text>
    </passage>
  </document>
  <document>
    <id>1560360 Figure_9-D-E</id>
    <infon key="sourcedata_document">379</infon>
    <infon key="doi">10.1038/sj.emboj.7601283</infon>
    <infon key="pmc_id">1560360</infon>
    <infon key="figure">Figure 9-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D, E) Ratliverlysosomes incubated or not with 1 mM CaCl2 (+Ca2+) were subjected to Triton X‐114 extraction and sucrose density gradients centrifugation. Levels of cathepsin A (D) and carboxypeptidase A activity (E) were measured in each fraction by immunoblot or using a standardized colorimetric assay, respectively. Values in (E) are expressed as times the activity in untreated membranes and are mean+s.e. of two experiments.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_1-A</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HEK293T‐Fpn cells were incubated with FAC (10 μM Fe) for 24 h followed by incubation for 6 h in the absence or presence of 10 μM Ponasterone A. Cells were then incubated with and without 100 μM chloroquine or 10 μM leupeptin for 10 h and harvested. The ferritin content was determined by ELISA. Induction of Fpn resulted in decreased ferritin levels and this was not prevented by treatment with chloroquine or leupeptin. The data are presented as the standard deviation from three different experiments.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_1-B</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Cells treated as in (A) were incubated in the presence of 1 μg/ml EGF for 2 h. Cells were fixed and processed for immunofluorescence using mouse anti‐EGF receptor and Alexa 594 conjugated goat anti‐mouse IgG. Chloroquine and leupeptin effectively inhibit degradation of EGF receptor.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_2-A</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HEK293T‐Fpn cells were incubated with FAC (10 μM Fe) for 24 h followed by incubation for 6 h in the absence or presence of 10 μM Ponasterone A. Cells were then treated with or without 10 μM MG132 or 10 μM lactacystin in the presence of Ponasterone A for 10 h and harvested. The ferritin content was determined by ELISA. Error bars represent the standard deviation from three different experiments in duplicate.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_2-B</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Samples treated as in (A) were immunoprecipitated using anti‐ferritin antibodies and the immunoprecipitate examined for the presence of ferritin or ubiquitin by Western blot analysis. The arrows indicate the migration of H and L chains.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_2-C</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cells were incubated with 1.0 × 10−7 M Tf(59Fe)2 for 24 h followed by incubation for 6 h in the absence or presence of 10 μM Ponasterone A. Cells were then treated with or without 10 μM MG132 in the presence of Ponasterone A for 10 h and harvested and the amount of 59Fe in immunoprecipitatedferritin was determined.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_2-D</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Cells were treated as described in (A) and cell extracts were applied to size exclusion chromatography and the ferritin content, in selected fractions, was determined by ELISA. Error bars represent the standard deviation from three different experiments in duplicate.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_2-E</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Cells were treated as described in (C), ferritin was then immunoprecipitated, eluted using 100 mM glycine, pH 2.5 and measured by ELISA. The amount of ferritin‐associated 59Fe was measured and the specific activity of ferritin determined. Error bars represent the standard deviation from three different experiments in duplicate.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_2-F</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Samples were treated as in (D), and ferritin was immunoprecipitated and analyzed by Western blot analysis using an antibody to ubiquitin.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_3-A</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) FM3A (black) and ts85 (grey) cells were transiently transfected with a plasmid containing CMV‐regulated Fpn‐GFP and incubated in the presence of FAC (10 μM Fe) and 0.5 μM hepcidin for 24 h. Hepcidin was either maintained (+) or removed (−) to allow Fpn‐GFP localization at the plasma membrane. Cells were maintained at the permissive temperature (33°C) or moved to the restrictive temperature (39°C) and incubated for 6 h. Cells were harvested and ferritin content determined by ELISA. Error bars represent the standard deviation from three different experiments in duplicate.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_3-B</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) FM3A and ts85 cells were treated as in (A) but FAC was replaced with 1.0 × 10−7 M Tf(59Fe)2. Ferritin was immunoprecipitated and the specific activity of 59Fe‐ferritin determined. Error bars represent the standard deviation from three different experiments in duplicate.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_3-C</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) ts85 cells were treated as in (B) and cell extracts applied to size exclusion chromatography. Ferritin content in selected fractions was measured by ELISA. Black bars represent assembled ferritin (&gt;400 kDa), gray bars represent monomeric (50 kDa).</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_3-D</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) FM3A and ts85 cells were treated as in (A) but cells that had been incubated at the restrictive temperature (39°C) were then returned to the permissive temperature (33°C) and incubated in the presence of cycloheximide (75 μg/ml) and 10 μM FAC for 1 h. Cells were then harvested and ferritin levels determined by ELISA. Error bars represent the standard deviation from three different experiments in duplicate.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_4-A</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Cells were then incubated at the restrictive temperature (39°C) for 6 h in the presence or absence of 100 μM DFO, with or without 100 μM chloroquine or 10 μM MG132. Cells were then harvested and ferritin content determined by ELISA. Error bars represent the standard deviation from three different experiments in duplicate.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_4-B</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Cells treated as in (A) were incubated in the presence or absence of 5 mM 3‐methyladenine.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_5-A</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Δccc1/pGAL‐H+L cells were transformed with a plasmid containing a methionine regulated CCC1 (pMET3CCC1). Cells were grown in medium with galactose for 20 h, washed and incubated in galactose (•), glucose with 10 × methionine (▵), glucose (○) or glucose without methionine (▾) for 10 h. Cells were then harvested and ferritin levels determined by ELISA. Error bars represent the standard deviation from three different experiments in duplicate. The absence of methionine leads to expression of the vacuolar iron transporter Ccc1p.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_5-B</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) erg6‐2 and erg6‐2 pGAL‐H+L strains were grown in medium with galactose and 250 μM FeSO4 for 24 h. Cells were then washed and incubated in galactose or glucose in the absence or presence of 50 μM MG132 for 7 h.</text>
    </passage>
  </document>
  <document>
    <id>1636618 Figure_5-C</id>
    <infon key="sourcedata_document">380</infon>
    <infon key="doi">10.1038/sj.emboj.7601409</infon>
    <infon key="pmc_id">1636618</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cells were then harvested, ferritin levels determined by ELISA and immunoprecipitated using anti‐ferritin antibodies and the immunoprecipitate examined for the presence of ubiquitin by Western analysis. Cells with the erg6‐2 allele permit the entry of MG132 ( Lee and Goldberg, 1996).</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_1.-A-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 1.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Quantification of cell death in 293 cells24 h after transfection with luciferase, p55/TNFR1, DRP-1 Δ73 or DAPk ΔCaM, and GFP. Graphs show the percentage of GFP-positive cells with altered cell morphology. (B) Photographs of GFP-positive cells cotransfected with luciferase (1), p55/TNFR1 (2), DRP-1 Δ73 (3), or DAPk ΔCaM (4).</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_1.-C</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 1.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Photographs showing the overlay of GFP and phase-contrast images of 293 cells24 h after transfection with GFP and luciferase (1) or with GFP-DAPk (2 and 3); both a blebbing GFP-DAPk-expressing cell (2, arrows indicate blebs) and spread nontransfected cells are shown (3).</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_1.-D</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 1.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Hoechst staining (4-6) of GFP-positive 293 cells (1-3) 60 h after cotransfection with GFP and DAPk ΔCaM (1 and 4), DRP-1 Δ73 (2 and 5), or p55/TNFR1 (3 and 6). Arrows point to condensed nuclei resulting from DRP-1 Δ73 or DAPk ΔCaM transfections (4 and 5).</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_10.-A-D</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 10.-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_10.-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>DRP-1 is localized to the lumen of autophagic vesicles. Immunogold staining of 293 cells expressing HA-DRP-1 reveals a specific staining of DRP-1 in the lumen of double membrane autophagosomes containing cytoplasmic material (A and B) in autophagosomes containing organelles and vacuoles (C) and inside the body of autolysosomes containing digested matter (D). The gold particles do not overlap with the phagocytosed organelles in C or the lysosomes in D.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_2.-A</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 2.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Scoring loss of mitochondrial membrane potential (ΔΨm). 293 cells expressing luciferase (black), DRP-1 Δ73 (pink), DAPk ΔCaM (purple), and Bax (green) were assayed for loss of mitochondrial membrane potential 24 h after transfection using flow cytometric analysis of TMRM fluorescence. The fraction of TMRM-negative cells calculated from three experiments is shown in the graph below. The small increase in TMRM fluorescence in the kinase-transfected cells is not statistically significant.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_2.-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 2.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Scoring the release of cytochrome C from mitochondria. 293 cells cotransfected with luciferase (1 and 2), Bax (3 and 6), DRP-1 Δ73 (7 and 8), or DAPk ΔCaM (9 and 10) and GFP constructs were incubated for 24 h and immunostained using anti-cytochrome C antibodies. Cells were visualized for cytochrome C (left) or GFP (right) fluorescence. Bax-transfected spread (3 and 4) or blebbed (5 and 6) cells are shown. In fields that also contain nontransfected cells, arrows point to GFP-positive cytochrome C-stained cells.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_2.-C</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 2.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Assessing the effects of Bcl-2 and Bcl-XL. 293 cells were cotransfected with luciferase, DRP-1 Δ73, DAPk ΔCaM, or Bax, and either Bcl-2 or Bcl-XL together with GFP. GFP-positive cells were visualized by fluorescent microscopy and scored for the appearance of cell death morphology 24 h after transfection. Total cell death refers to the sum of all morphological changes observed.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_3.-A</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 3.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Transmission electron micrographs of 293 cells transfected with luciferase (1) p55/TNFR1 (2a-2c), DRP-1 Δ73 (3a and 3b; part of fig. 3b is magnified on its right), and DAPk ΔCaM (4). The different stages of autophagic development are depicted as follows: immature autophagic vesicles (double arrow), mature autophagic vesicles and autolysosomes (black arrow), and residual bodies (dashed arrow). Empty vacuoles (white arrow) are also shown. Arrowheads show condensed and fragmented chromatin. m, mitochondria; g, Golgi apparatus. Bar, 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_3.-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 3.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Transmission electron micrographs of MCF-7 cells transfected with luciferase (1), p55/TNFR1 (2a-2c), DRP-1 Δ73 (3a and 3b), and DAPk ΔCaM (4). Immature autophagic vesicles (double arrow), autophagic vesicles (black arrow), and residual bodies (dashed arrow) are shown. Insets in B, 2b and 2c, correspond to empty vacuoles, whereas those in B, 3a and 4, correspond to autophagic vesicles. Arrowheads show condensed and fragmented chromatin. m, mitochondria; dm, darkened mitochondria; n, nucleus; g, Golgi apparatus; v, vacuoles; ly, lysosomes; er, endoplasmic reticulum.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_4.-A</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 4.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Quantification of autophagy in 293 and MCF-7 cells. Graphs show the percentage of MDC-positive cells resulting from luciferase or DRP-1 Δ73 transfections (mean ± SD calculated from triplicates of 100 cells each; note that total cell number comprises transfected and nontransfected cells). These experiments were repeated three times with reproducible results.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_4.-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 4.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Photographs of MDC-stained MCF-7 cells from the same experiment shown in A. Arrows point to MDC-positive cells. Transfections: luciferase (1a and 1b) and DRP-1 Δ73 (2a and 2b) at low (a) and high (b) magnifications.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_5.-A</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 5.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Quantification of cell death-associated morphologies in 293 cells. Graphs show the percentage of cells harboring all spectrum of morphological changes occurring as a result of luciferase, p55/TNFR1, DRP-1 Δ73, or DAPk ΔCaM transfections in the presence or absence of the caspase inhibitors BD-fmk or z-VAD-fmk (100 μM; mean ± SD calculated from triplicates of 100 cells each). This experiment was repeated three times with reproducible results.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_5.-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 5.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of cell death-associated morphologies in MCF-7 cells. Experimental conditions were performed as in A in the presence or absence of BD-fmk (100 μM).</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_5.-C</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 5.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Graphs show the percentage of cells harboring the complete spectrum of death-associated morphological changes occurring as a result of cotransfections of luciferase, p55/TNFR1, DRP-1 Δ73, or DAPk ΔCaM with the caspase inhibitor crmA or control luciferase vector (mean ± SD calculated from triplicates of 100 cells each). Immunoblot shows the expression levels of transfected HA-tagged DAPk and DRP-1 Δ73, confirming that cotransfection with crmA did not alter expression of the death-inducing proteins.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_5.-D</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 5.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Transmission electron micrographs of 293 cells transfected with p55/TNFR1 (1) or DRP-1 Δ73 (2a and 2b; parts of these figures are magnified at the right) and treated with the caspase inhibitor BD-fmk (100 μM). Immature autophagic vesicles (double arrow), autophagic vesicles (black arrow), and autolysosomes (white arrow) are shown. m, mitochondria; g, Golgi apparatus.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_5.-E</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 5.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Western blots of cell lysates prepared from HeLa cells transfected with luciferase, p55/TNFR1, DRP-1 Δ73, or DAPk ΔCaM and GFP and incubated for 24 h. Blots were reacted with anti-PARP antibodies, anti-caspase-8 antibodies, anti-caspase-3 antibodies, anti-HA antibodies for DRP-1 Δ73 and DAPk ΔCaM detection, and anti-β-tubulin antibodies to quantitate protein loading.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_6.-A</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 6.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293 cells were cotransfected with p55/TNFR1 in combination with DAPk death domain fused to GFP or DRP-1 K42A and pEGFP-N1 vector. A control luciferase vector was also used. GFP-positive cells were visualized by fluorescent microscopy and scored for the appearance of membrane blebbing 24 h after transfection.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_6.-B-C</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 6.-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Photographs of the various categories of p55/TNFR1-transfected 293 cells: spread cells (1), blebbed cells (2), condensed cells (3), cells displaying a fragmented cytoplasm (4), and cells carrying fragmented nuclei within a noncondensed cytoplasm (5). (C) Quantification of each death morphology observed 24 h after transfection with GFP, p55/TNFR1, and either luciferase or DRP-1 K42A.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_7.-A-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 7.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B). Quantification of autophagy in MCF-7 cells. MCF-7 cells were transfected with luciferase or FLAG-DRP-1 K42A followed by steroid withdrawal (serum starvation plus 10−6 M tamoxifen treatment) (A) or by serum and amino acid starvation (B) (mean ± SD calculated from triplicates of 100 cells each). These experiments were repeated three times with reproducible results. Proteins extracted from the transfected cells were subjected to Western blot analysis with anti-FLAG and anti-β-tubulin antibodies.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_7.-C</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 7.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Photographs of the MDC-stained steroid withdrawn MCF-7 cells taken from the same experiment shown in A. Transfections: luciferase (1a and 1b) and DRP-1 K42A (2a and 2b) at low (a) and high (b) magnifications.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_8.-A</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 8.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Photographs of MDC-stained MCF-7 cells. (Top) Steroid withdrawal. Cells were either grown in complete medium (1), steroid depleted (2), or steroid depleted in the presence of the broad caspase inhibitor BD-fmk (100 μM) (3) for 3 d. (Bottom) amino acid starvation. Cells were either grown in complete medium (1-3) or under amino acid starvation condition (4-6) without (1 and 4) or with (2 and 5) the presence of the broad caspase inhibitor BD-fmk (100 μM) or the general inhibitor of autophagy 3-methyladenine (10 mM) (3 and 6) for 3 d.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_8.-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 8.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) PARP cleavage in MCF-7-starved cells. Proteins extracted from 4-d steroid-depleted (left) or 12-hTNF-α-treated (100 ng/ml) cells (right) were subjected to Western blot analysis with anti-PARP antibodies. The proteins were prepared from the same experiment shown in A.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_8.-C</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 8.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Graph showing the cumulative phase microscopy scores of dead (shrunk and detached) MCF-7 cells in tamoxifen-treated (filled) or nontreated (unfilled) cultures in the presence (▴) or absence (•) of the indicated caspase inhibitors (25 μM).</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_9.-A-B</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 9.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Quantitation of autophagy in HeLa cells. Cells were either grown in complete medium (1), treated with IFN-γ (1,000 U/ml) (2), or treated with IFN-γ in the presence of the broad caspase inhibitor BD-fmk (100 μM) (3) for 3 d. (B) Photographs of the MDC-stained HeLa cells corresponding to the experiment in A. Treatments: complete medium (1), IFN-γ (1,000 U/ml) (2), and IFN-γ (1,000 U/ml) + BD-fmk (3).</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_9.-C</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 9.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) PARP cleavage in HeLaIFN-γ-treated cells. Proteins extracted from IFN-γ-treated (left) or TNF-α-treated (100 ng/ml) cells (right) were subjected to Western blot analysis with anti-PARP antibodies. The proteins were prepared from the same experiment shown in A.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_9.-D</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 9.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Transmission electron micrographs of nontreated (top) and IFN-γ-treated (bottom) HeLa cells. Arrows point to autophagic vesicles.</text>
    </passage>
  </document>
  <document>
    <id>2173279 Figure_9.-E</id>
    <infon key="sourcedata_document">837</infon>
    <infon key="doi">10.1083/jcb.200109094</infon>
    <infon key="pmc_id">2173279</infon>
    <infon key="figure">Figure 9.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) DAPk antisense-transfected and control DHFR-transfected polyclonal populations of HeLa cells were incubated with hygromycin B (200 μg/ml) in the presence or absence of IFN-γ (1,000 U/ml) and BD-fmk (50 μM). Detection of autophagic vesicles was performed 2 d later using the MDC dye. Graphs represent mean ± SD of MDC-positive cells calculated from triplicates of 100 cells each.</text>
    </passage>
  </document>
  <document>
    <id>2196185 Figure_1.-A</id>
    <infon key="sourcedata_document">836</infon>
    <infon key="doi">10.1083/jcb.200105096</infon>
    <infon key="pmc_id">2196185</infon>
    <infon key="figure">Figure 1.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Changes with time in amounts of SH-EP, α-amylase, and VmPE-1 in cotyledons of V. mungo seedlings (Attached cotyledons) or embryo axis-removed cotyledons of V. mungoseeds (Detached cotyledons). Attached or detached cotyledons were prepared as described in Materials and methods. 10 pairs of cotyledons were homogenized with 3 ml of 50 mM Tris-Cl (pH 7.4), and the homogenates were centrifuged at 15,000 g for 10 min. Supernatants (10 μl each) were analyzed by SDS-PAGE immunoblotting with anti-SH-EP, α-amylase, or VmPE-1 antibody.</text>
    </passage>
  </document>
  <document>
    <id>2196185 Figure_2.-A</id>
    <infon key="sourcedata_document">836</infon>
    <infon key="doi">10.1083/jcb.200105096</infon>
    <infon key="pmc_id">2196185</infon>
    <infon key="figure">Figure 2.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Subcellular distribution of α-amylase in V. mungocotyledon cells. Microsome and PSV fractions were prepared from cotyledons of day 3 seedlings as described in Materials and methods. Extracts from dry seeds and day 3 cotyledons, microsomes, and PSV fractions (20 μg protein each) were separated by SDS-PAGE. Proteins in the gel were analyzed by Coomassie Brilliant blue staining (A), or by immunoblotting with anti-SH-EP antibody (B) or anti- α-amylase antibody (C). Bracket indicates the polypeptides derived from storage globulins. Arrowhead indicates α-amylase.</text>
    </passage>
  </document>
  <document>
    <id>2196185 Figure_3.-A</id>
    <infon key="sourcedata_document">836</infon>
    <infon key="doi">10.1083/jcb.200105096</infon>
    <infon key="pmc_id">2196185</infon>
    <infon key="figure">Figure 3.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Electron micrographs showing the immunogold localization of α-amylase in attached cotyledons cells (A-E), detached cotyledons cells (F), or control for immunogold labeling (G). (A) Anti-α-amylase antibody immunogold-stained PSV, but not SG. (B and C) Golgi complex and PSVs were both immunogold-labeled with anti- α-amylase antibody. (D) Immunogold localization of α-amylase (15-nm particles) and SH-EP (10-nm particles). α-Amylase and SH-EP were localized in PSVs and KVs, respectively. (E) Gold particles from anti-α-amylase antibody were detected in LVs as well as PSVs. (F) PSVs in detached cotyledons were immunogold labeled with anti- α-amylase antibody. (G) Immunogold staining of detached cotyledon cells without first antibody (anti-α-amylase antibody). No gold particles were observed in the cell. CW, cell wall; G, Golgi complex; KV, KDEL-tailed cysteine proteinase-accumulating vesicle; LV, lytic vacuole; Mt, mitochondrion; PSV, protein storage vacuole; SG, starch granule. Bars, 200 nm.</text>
    </passage>
  </document>
  <document>
    <id>2196185 Figure_4.-A</id>
    <infon key="sourcedata_document">836</infon>
    <infon key="doi">10.1083/jcb.200105096</infon>
    <infon key="pmc_id">2196185</infon>
    <infon key="figure">Figure 4.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Electron micrographs showing ultrastructures of cotyledon cells of germinatedV. mungoseeds (A-G), immunogold localization of α-amylase in cotyledon cells (H), and ultrastructure of cells of detached cotyledons (I). Toluidine blue (TB) staining of sections from cotyledons of day 3 V. mungoseedlings. Conversion from TB-stained cells (region I) to TB-stainless cells (region III) was accompanied with that of the PSV to LV. (B) SGs and PSVs in TB-stained cells (A, region I). The PSV was filled with storage proteins. Arrowheads indicate border between SGs and the cytoplasm. (C) SGs and PSVs in cotyledons at region II in A. Electron density of PSVs became low. SGs were surrounded with membranous structure (arrows). LED areas were found between SGs and the cytoplasm. (D) SG and LV in TB-stainless cells (region III in A). The PSV was converted to the LV in the cells. The areas around SG with LED were enlarged. (E) Ultrastructure of TB- stainless cells. SGs wrapped with a LED area contacted with LVs (arrowheads). Vesicles with similar density to LVs were observed. (F) LED membranes around the SGs fused with the LV membranes (arrow). (G) SGs were observed in LVs. The shape of SGs were largely different from those in B-E. (H) An Immunogold image representing degradation of SGs by α-amylase localized in LVs. Gold particles from anti-α-amylase antibody were densely detected in the peripheral region of SGs, which is inserted into the inside of the LV. (I) PSVs were not converted to LVs, and SGs were not taken up into PSVs in the cells of detached cotyledons. Neither low density areas around SGs nor vesicles with similar density to LV was observed in the cells. LV, lytic vacuole; Mt, mitochondrion; PSV, protein storage vacuole; SG, starch granule. Bars: (A) 50 μm; (E and G) 2 μm; (D, F, and I) 1 μm; (B, C, and H) 200 nm.</text>
    </passage>
  </document>
  <document>
    <id>2196185 Figure_5.-A</id>
    <infon key="sourcedata_document">836</infon>
    <infon key="doi">10.1083/jcb.200105096</infon>
    <infon key="pmc_id">2196185</infon>
    <infon key="figure">Figure 5.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-A</infon>
    <passage>
      <offset>0</offset>
      <text>LysoTracker red staining of partially broken cotyledon cells, SGs, or cotyledon sections. Cotyledon cells, SGs, and sections were prepared from day 3 attached or detached cotyledons and stained with LysoTracker red as described in Materials and methods. (A) Differential interface-contrast image of a broken cell. (B) Fluorescent image of A. (C) Differential interface-contrast image of a broken cell. (D) Fluorescent image of C. (E) Differential interface-contrast image of cells of a section from attached cotyledons. (F) Fluorescent image of E. (G) Magnified image of E. (H) Magnified image of F. (I) Differential interface-contrast image of an SG. (J) Fluorescent image of I. (K) Differential interface-contrast image of an SG. (L) Fluorescent image of K. (M) Differential interface-contrast image of cells of a section from detached cotyledons. (N) Fluorescent image of M. (O) Magnified image of M. (P) Magnified image of O. Bars: (A-D, G-L, O, and P) 20 μm; (E, F, M, and N) 50 μm.</text>
    </passage>
  </document>
  <document>
    <id>2196185 Figure_6.-A</id>
    <infon key="sourcedata_document">836</infon>
    <infon key="doi">10.1083/jcb.200105096</infon>
    <infon key="pmc_id">2196185</infon>
    <infon key="figure">Figure 6.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Electron micrographs showing autophagosome-mediated autophagy in attached (A-C) and detached (D and E) cotyledon cells. (A) Two autophagosomes containing cytoplasm were observed. Mitochondria and the cytoplasm appeared to be enclosed with an ER-like double membrane. (B) An autophagosome containing mitochondria and cytoplasm was fused with LV (arrowheads). (C) Autophagic body containing mitochondria was found in LV. (D) An autophagosome containing mitochondria and cytoplasm was observed. The PSV was not converted into the LV. (E) Autophagic body was observed in the PSV of detached cotyledon cells. AB, autophagic body; AP, autophagosome; ER, endoplasmic reticulum; LV, lytic vacuole; Mt, mitochondrion; PSV, protein storage vacuole; SG, starch granule. Bars, 200 nm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_1-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) INS1 cells were transduced with mtPA‐GFP (green) and stained with TMRE (red). mtPA‐GFP distribution is shown immediately (within 2 min) after photoactivation (area indicated by a dashed square) and in the plateau phase of mtPA‐GFP spreading (45 min). Mitochondria that did not exhibit GFP FI decay (less than 5%) are marked by arrows. Upper scale bar, 10 μm; lower scale bar 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_1-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Fusion events result in the spread of mtPA‐GFP across the mitochondrial population, leading to its dilution and a decay in GFP FI value (n=16).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_1-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) The relative difference in TMRE FI between non‐fusing mitochondria and fusing mitochondria, calibrated against the whole‐cell average.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_1-D</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Primary β‐cells expressing mtPA‐GFP were photoactivated in seven different regions (squares) and imaged after 2 min and again after 2 h of incubation. Scale bar, 10 μm. *P0.001.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">29</infon>
        <infon key="identifier">CL:0000001</infon>
        <location offset="12" length="7"/>
        <text>β‐cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_2-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) An INS1 cell expressing mtPA‐GFP and co‐labeled with TMRE. The two mitochondria fused 20 s after photoactivation (arrow in '20 s'). Then, a voltage difference was established between the two poles (60-120 s) and they were later physically separated (120 s). The pattern is qualitatively similar to that shown in Figure 3Bi. Scale bar, 2 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_2-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Fusion and fission time chart for individual mitochondria. Individual mitochondria tagged with mtPA‐GFP were monitored for a period of 1 h and the occurrence of fusion and fission was recorded. Mitochondria in INS1 and COS7 cells spend 77s (±71 s) and 87 s (±78 s), respectively, in the post‐fusion, connected state, and an average of 1434s and 1172 s, respectively, in the solitary, post‐fission state.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_2-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Fusion triggers fission. Cumulative probability of the occurrence of fission events at different intervals after fusion events occur (fraction of all fission events occurring after the given time interval). The data are fit to a hyperbolic function representing linkage between the two events (INS1, R2=0.98; COS7, R2=0.96). The straight line shows the predicted linear growth rate in fission event probability over time that would be expected if the fission had occurred independently from the fusion events (dashed lines INS1, R2=0.77; COS7, R2=0.84; see Supplementary data).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_3-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Mitochondrial fission in a COS7 cell yields two daughter mitochondria with a ∼28% difference in TMRE/GFP FI ratio (∼Δ=9 mV). The relative GFP FI change was minimal (Δ=3.4%). For clarity the pseudocolored ratios before fission at 60 and 160 s after fission are shown. Scale bar, 2 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_3-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Chart of Δψm over time for typical fission events; (i) fission results in temporary depolarization of one unit, (ii) fission results in permanent depolarization of one unit, (iii) fission results in the generation of a hyperpolarized daughter mitochondrion and a mitochondrion of the pre‐fission potential.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_3-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Average Δψm before (left, gray) and after fission (right, filled and empty circles denote depolarized and hyperpolarized mitochondria respectively). Only fission events where Δψm of both mitochondria could be continuously tracked are included (n=7).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_4-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Schematic illustrations of mitochondrial tracking in four different experiments (i-iv) and corresponding Δψm traces (iv). Colored arrows indicate generation of hyperpolarizing (red) and depolarizing (green) daughters during fission. Note that after a fission event, fusion (black arrows) preferably occurred in the hyperpolarized daughter mitochondrion.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_4-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Depolarized mitochondria are selectively targeted for autophagy after a multi‐hour time lag. APs are labeled with LC3:GFP, which translocates from the cytosol to the AP's isolation membrane. MTR, a membrane potential dye that stains mitochondria irreversibly and is retained during depolarization, is used to pulse label mitochondria in INS1 cells (14 min, 50 nM) at different time points before detection of APs content. At the time set for detection, cells were treated with pepstatin A (10 μM) and E64d (10 μM) for 30 min to arrest digestion inside the APs, and then subjected to confocal microscopy (see schematic illustration of the Materials and methods). MTR pulse is used here to report on Δψm during the staining period. While mitochondria outside APs show bright MTR fluorescence, those localized in APs varied in fluorescence based on the time at which they were pulsed with MTR. Note that mitochondria inside APs have dim MTR FI if they were pulsed with MTR1 h before autophagy was detected (circle, top panel), but bright MTR FI if pulsed 24 h before detection of autophagy (circle, bottom panel). Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_4-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Distribution of MTR FI (given in Δψm) of AP‐localized mitochondria at different times before autophagy. Values are relative to cell's average MTR FI. In the x‐axis, a zero value represents the average Δψm and positive values represent depolarized mitochondria.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_5-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Relative immunofluorescence of OPA1 in INS1 cellmitochondria correlates to their fusion capacity. Cells (n=6) were photoactivated (∼10-15% of cell mitochondrial mass) and then returned to the incubator for 2 h before fixation. Based on their ability to share and thereby dilute the photoconverted mtPA‐GFP, mitochondria were classified as fused (n=54) in which GFP FI was lower than 2 times the average and non‐fused (n=10) in which GFP FI was at least 200% above the average (in the same manner as described for Figure 1). In each cell, OPA1 FI of non‐fused mitochondria was normalized to that of mitochondria that had diluted mtPA‐GFP through fusion. OPA1 FI is reduced in non‐fusing mitochondria (P=0.003). A set of FI‐coded images of mtPA‐GFP, mtDsRed and OPA1 immunostaining are shown. Scale bar, 2 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_5-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) OPA1 FI, but not mtDsRed FI, is reduced in mitochondria undergoing autophagy. INS1 cells expressing mtDsRed and LC3:GFP were treated with 0.2 μM bafilomycin (45 min) or a cocktail of pepstatin A and E64d (90 min) and fixed. Mitochondria inside APs were defined by colocalization of mtDsRed and LC3:GFP. OPA1 FI in APs was normalized to its FI in mitochondria that were located outside APs (organelles positive for mtDsRed with subthreshold GFP FI). OPA1 FI within APs was 50% (*P0.001) and 54% (**P=0.003) upon treatment with bafilomycin or a cocktail of pepstatin A and E64d, respectively. Mitochondria inside APs had similar (96%) mtDsRed FI to those located outside APs (P=0.47). Scale bar, 2 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_5-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) The effect of OPA1 overexpression on the number of AP‐containing mitochondria. Imaging of INS1 cells already expressing LC3:GFP and mtDsRed was performed 48-72 h after adenoviral transduction with either OPA1 overexpression or control (mitoPA‐GFP). The number of AP‐containing mitochondria in the OPA1 overexpression (OE, n=6) was normalized to the control (*P=0.001). Images show representative cells from each group. Red, mtDsRed; green, LC3:GFP. In the control cell, note the colocalization of APs with mitochondria. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_6-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Confocal images of FIS1 RNAi, DRP1‐DN and control cells coexpressing the AP marker LC3:GFP (green), and stained with MTR (red, control and FIS1 RNAi group) or mtDsRed (red, DRP1‐DN) and treated with pepstatin A and E64d to arrest digestion in late APs. A magnified area within a FIS1 RNAi cell shows APs with and without mitochondria (white and blue circles respectively). Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_6-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantitative analysis of AP‐containing mitochondria in INS1 cells expressing FIS1 RNAi or DRP1‐DN. In each group the number of AP‐containing mitochondria was normalized to its control and found to be significantly different (*P0.001; **P0.001).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_6-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Altering fission does not impair ER autophagy and AP or lysosomal mass. INS1 cells expressing LC3:GFP were stained with ER Tracker to assess AP‐containing ER. The number of AP‐containing ER was not significantly different between control and FIS1 RNAi cells (P=0.51; n=11). Lysosensor stain (75 nM, 30 min) reveals no difference between control and FIS1 RNAi cells (P=0.21). The total AP number in DRP1‐DN cells is similar to that of the control (n=11, P=0.53).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_7-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Level of oxidized mitochondrial protein in mitochondria purified from FIS1 RNAi (n=3), DRP1‐DN (n=4) and their respective control cells. The blot detects carbonyl groups on amino‐acid side chains (Oxiblot analysis, see Materials and methods). Loading control CIII, mitochondrialComplexIII Core I (*P0.03, **P0.04).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_7-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B)COS7 cells coexpressing DRP1‐DN and mtDsRed (red) were fixed, permeabilized and stained with a monoclonal antibody against nitrotyrosine (green). Control cells were infected with mtPA‐GFP lentivirus. DRP1‐DN cells show increased nitrotyrosine immunoreactivity in mitochondria, particularly in the distal and enlarged ends. Scale bar, 15 μm (see also Supplementary Figure S9).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_7-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Knockdown of FIS1 does not increase ROS production. ROS production in FIS1 RNAi and control cells as measured by DHE FI under different glucose levels. Cells were loaded with dye and FI was measured before and 10 min after changing of glucose concentration (NS, non‐significant; P=0.5; *P0.001).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_7-D</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Inhibition of autophagy results in increased protein oxidative damage. Treatment of INS1 cells with bafilomycin (blocking autophagy by preventing fusion with lysosomes, 0.1 μM for 3 h) results in the accumulation of oxidized proteins in mitochondria, which is shown by increased level of carbonylated amino acids in isolated mitochondria.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_7-E</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Inhibition of autophagy generates Δψm heterogeneity. INS1 cells were treated with 3‐MA (2 mM for 5 days) and then stained with TMRE and mitotracker green. Ratio image of red/green represents Δψm and is shown in pseudocolor where depolarized mitochondria appear blue. Note the increase in subcellular Δψm heterogeneity and the appearance of depolarized units with low TMRE (see also Supplementary Figure S4A-C). Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_8-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A)FIS1 and DRP1 knockdown reduced maximal respiratory chain capacity in FIS1 RNAi and DRP1‐DN compared with their control (n=4 in each group; glucose=11 mM). Inhibition of autophagy by 3‐MA in INS1 cells (2 mM, 5 days, n=4) and C2C12 cells (1 mM, 5 days, n=4) showed significant decrease in respiratory capacity. ATG5‐deficient MEF cells (n=4) had significantly decreased respiratory capacity compared with control MEF cells. Maximal respiration was tested using 5 μM FCCP or 100 μM DNP (*P0.001, **P0.04).</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_8-B</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Expression of mtDNA‐encoded subunit I of cytochrome oxidase (COX I) in INS1 cells infected with FIS1 RNAi and control RNAi lentiviruses and tested after 1 week.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_8-C</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) GSIS in FIS1 RNAi and control RNAi cells (n=5 for each column, *P0.05). Values are normalized to number of cells in each well and represent 30 min stimulation.</text>
    </passage>
  </document>
  <document>
    <id>2234339 Figure_9-A</id>
    <infon key="sourcedata_document">516</infon>
    <infon key="doi">10.1038/sj.emboj.7601963</infon>
    <infon key="pmc_id">2234339</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>A model of the mitochondrion's life cycle that integrates mitochondrial dynamics and turnover. The mitochondrion cyclically shifts between a post fusion state (network) and a post fission state (solitary). Fusion is brief and triggers fission. Following a fission event, the daughter mitochondrion may either maintain intact membrane potential (red line) or depolarize (green line). If it depolarizes, it is unlikely to proceed to a subsequent fusion, unless it re‐polarizes. After being depolarized and solitary for a few hours, the mitochondrion is removed by autophagy.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_1-A</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HeLa cells expressing GFP‐tagged UBQLN1 or UBQLN2 (or GFP for controls) were transferred to starvation medium (PBS) for the indicated time. Where specified, only serum was removed from the culture medium. Viability of transfected cells was assessed by PI staining and analysed by flow cytometry. The graph represents the mean of three experiments±s.e.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_1-B</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HeLa cells were depleted of UBQLN1 or UBQLN2 by siRNA transfection; depletion was verified by Western blot. Cells were starved for increasing periods of time, and their viability was analysed as in (A). The graph represents the mean of three experiments±s.e; *P0.05 between control and UBQLN2‐KD at 6 h (paired Student's t‐test). GAPDH, glyceraldehyde‐3‐phosphate dehydrogenase; GFP, green fluorescent protein; KD, knockdown; PI, propidium iodide; siRNA, short interfering RNA; UBQLN, ubiquilin.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_2-A</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HeLa cells were transfected with siRNAs for autophagy-related gene ATG5 (siATG5) or with a non-silencing siRNA (siC). Depletion of ATG5, which decreased the levels of the ATG5-ATG12 covalent complex, was confirmed by Western blot. Loading control: transferrin receptor (TfR).</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_2-B</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Control or ATG5‐KD cells transfected with UBQLN1 were starved, and the cell viability was assessed as in Fig 1; the graph represents the mean of three experiments±s.e.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_2-C</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HeLa cells were stably transfected with control (shC) or ATG7 (shATG7) shRNA; depletion was verified by Western blot (loading control: GAPDH).</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_2-D</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Control or ATG7‐KD cells transfected with UBQLN1 were starved for 3 or 6 h and assessed for their viability. The graph represents the mean of three experiments±s.e. GAPDH, glyceraldehyde‐3‐phosphate dehydrogenase; KD, knockdown; Pl, propidium iodide; shRNA, short hairpin RNA; siRNA, short interfering RNA; UBQLN, ubiquilin.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_3-A</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunolocalization of transfected Myc‐UBQLN (1 or 2) and GFP‐tagged microtubule‐associated protein 1 light chain 3 (GFP‐LC3) was analysed by microscopy. Inset: magnification of UBQLN1vesicular staining (arrow), which, after acquisition of Z‐stacks, was found in all UBQLN structures analysed.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_3-B</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Cells were starved for 2 h, with (top row) or without BAF A1 (bottom row). Cells were stained for endogenous UBQLN2 (magenta) and LC3 (green).</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_3-C</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Control cells (untransfected, right panel) or cells overexpressing Myc‐UBQLN2 and GFP‐LC3 (left panel) were transferred into starvation medium for 2 h. Localization of Myc‐UBQLN2 and GFP‐LC3 was analysed by immunoelectron microscopy using Myc (arrow) and GFP (arrowhead) antibodies coupled to 10 and 15 nm gold particles, respectively. Double‐membrane vacuoles (autophagosomes) in transfected cells (left panel) show increased staining by both antibodies compared with autophagosomes in untransfected cells (right panel). Scale bar, 0.5 μm. BAF A, bafilomycin A1; GFP, green fluorescent protein; UBQLN, ubiquilin.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_4-B</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Each mutant was co‐transfected with GFP‐tagged microtubule‐associated protein 1 light chain 3 (GFP‐LC3) and the localization of each protein was analysed by microscopy.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_4-C</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Starvation‐induced cell death was assessed in cells expressing UBQLN1 or UBQLN1ΔUBA. The graph represents the mean of three experiments±s.e., with *P⩽0.05 (P=0.0017 by one‐way ANOVA test, comparing control, UBQLN1 and UBQLN1ΔUBA). No difference was found between control and UBQLN1ΔUBA at any time point. ANOVA, analysis of variance; GFP, green fluorescent protein; Pl, propidium iodide; UBA, ubiquitin‐associated; UBQLN, ubiquilin.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_5-A</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Autophagosome subcellular localization during starvation was analysed by microscopy in UBQLN‐ or autophagy‐related gene ATG5‐KD cells expressing GFP‐tagged microtubule associated protein 1 light chain 3 (GFP‐LC3).</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_5-B</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Autophagosome spatial distribution was quantified by measuring the distance of each LC3vesicle from the nucleus (in pixels) and by analysing the frequency distribution.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_5-C</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Control or UBQLN‐KD cells expressing GFP‐LC3 were starved and stained with the mitochondria dye Mitotracker™. Dual staining of LC3 (green) with Mitotracker (magenta) was analysed by microscopy.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_5-D</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Control and UBQLN‐KD cells stained with Mitotracker were starved for 6 h; BAF A was added where indicated. Mitotracker fluorescence was measured by flow cytometry. Unless specified otherwise, values for UBQLN‐KD and control+BAF A were compared with that of controls at the same time points, with ***P0.001, **P0.01 and *P0.05 (paired Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_5-E</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Cells were transfected with pShooter™ together with control or UBQLN (1+2) siRNA. Expression of pShooter was comparable in control and UBQLN‐KD cells (top). Cells were starved for3 or 6 h, and the intensity of GFP was quantified by flow cytometry (bottom). The fluorescence value obtained with controls (no starvation) was considered as 100%, and the value obtained for the 3‐ and 6‐h time points was normalized to controls. The graph represents the mean±s.e. of four assessments.</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_5-F</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Cells expressing a chimaeric LC3 fused to both GFP and mCherry were transfected with control or UBQLN siRNA, and starvation was induced for the indicated times. Puncta from 25 cells were scored and analysed by microscopy for their fluorescence colour. The graph represents the mean of three experiments±s.e. The number of mCherry single‐positive puncta in UBQLN‐KD cells was compared with that of controls for each time point; **P0.01 and *P0.05 (paired Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2637314 Figure_5-G</id>
    <infon key="sourcedata_document">346</infon>
    <infon key="doi">10.1038/embor.2008.238</infon>
    <infon key="pmc_id">2637314</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Control or UBQLN‐KD cells were starved for increasing periods. Where indicated, BAF A was added to the starvation medium (+B). Cell lysates were analysed by Western blot for their content in LC3‐II. Loading control: transferrin receptor (TfR). BAF A, bafilomycin A1; GFP, green fluorescent protein; KD, knockdown; siRNA, short interfering RNA; UBQLN, ubiquilin.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_1-A</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis of BAG1, BAG3, Hsc/Hsp70 and Hsp90 in young and old I90 cells. For detection of BAG proteins, an antibody directed against the conserved BAG domain was used.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_1-B</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Real‐time PCR analysis of human BAG family members and Hsc70 and Hsp90 in young and old I90 cells. Depicted is the expression ratio (log2) of target genes in old cells relative to young cells. *P0.05 and **P0.01 versus young, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_1-C</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Co‐IP analysis of Hsc/Hsp70 interaction with BAG1 and BAG3 in young (Y) and old (O) I90 cells. Upper panel shows relative amounts of proteins in cell lysates used for Co‐IP (Input). Middle panel shows levels of BAG1 and BAG3 found in Hsc/Hsp70 immunoprecipitates. Lower panel shows levels of Hsc/Hsp70 co‐sedimented upon immunoprecipitation of BAG3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_1-D-E</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D, E) 293 cells were treated with the indicated agents for 8 h followed by immunoblot analysis of indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_2-A</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293 cells were transfected with bag1, bag3 or nonsense (nons) siRNAs, as indicated. After 48 h, cells were transfected with d2GFP expression plasmid together with half the amounts of the indicated siRNAs. After additional 24 h, levels of indicated proteins were detected by immunoblot analysis.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_2-B</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) 293 cells were transfected with indicated siRNAs for 48 h followed by real‐time PCR analysis of BAG1 and BAG3 mRNA levels. Depicted is the mean relative expression ratio (log2) ±s.e.m. *P0.05 and ***P0.001 versus nons, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_2-C</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) BAG1 knockdown was performed in 293 cells for 48 h. Thereafter, cells were transfected with GFP or GFP‐based UPS reporter genes as indicated. After additional 24 h, levels of GFP‐positive proteins were detected by western‐blot analysis using a GFP antibody.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_2-D-E</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 2-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D, E) Immunoblot analysis of indicated proteins from d2HEK cells treated with different concentrations of MG132 for 5 h (D) or transfected with indicated amounts of BAG1S plasmid for 24 h (E).</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_3-A</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293 cells were transfected with nonsense (nons), bag1 or bag3 siRNAs for 48 h and then treated for 2 h with the lysosomal inhibitors pepstatinA and E64 (both 10 μg/ml; Pep.A/E64) or DMSO as control, followed by immunoblot analysis of the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_3-B</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) 293 cells were transfected for 48 h with the indicated siRNAs and BAG3 expression plasmid (BAG3‐N1) or vector control (N1) followed by the same analysis as in (A).</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_3-C</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Diagram shows the autophagic flux of 293 cells with differently modulated BAG1 and BAG3 levels as described in (A) and (B). Autophagic flux was determined by the strength of LC3‐II accumulation in a 2‐h treatment period with Pep.A/E64. Therefore, normalised LC3‐II levels in the absence of inhibitors were subtracted from corresponding levels obtained in the presence of Pep.A/E64. Values are expressed as mean±s.e.m. *P0.05 versus control‐transfected cells, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_3-D</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) I90 cells were transfected with GFP fused to LC3 (pGFP.LC3) and co‐transfected either with BAG3‐N1 or N1. After transfection for 48 h, cells were treated as in (A) and levels of indicated proteins were detected by immunoblot analysis.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_3-E</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) I90 cells, transfected as in (D) for 24 h, were microscopically analysed for GFP‐LC3 fluorescence. Representative pictures are shown. Bar: 20 μm. Values expressed in diagram are mean±s.e.m. from three independent experiments (50 cells were counted per experiment). *P0.05 versus N1, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_4-A</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) I90 cells were transfected with BAG3 (BAG3‐N1) or vector control. After transfection for 48 h, levels of indicated proteins were detected by western‐blot analysis.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_4-B</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Transcript levels of SQSTM1 in I90 cells transfected as in (A) were compared by real‐time PCR analysis. Depicted is the fold‐increase of SQSTM1 mRNA levels in BAG3‐N1‐transfected cells relative to control (N1)‐transfected cells. Values are expressed as mean±s.e.m. **P0.01 versus N1 cells, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_4-C</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) I90 cells were transfected with a BAG3‐GFP fusion plasmid for 48 h followed by indirect immunofluorescence staining of endogenous SQSTM1. (a) Direct fluorescence of BAG3‐GFP (green), (b) indirect immunofluorescence of SQSTM1 (red) and (c) the stainings of (a) and (b) overlapped. DAPI (blue) was used to stain DNA. Representative pictures are shown. Bar: 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_4-D</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Co‐IP studies testing the interaction of SQSTM1 and BAG3. I90 cells were transfected as in (A). After 24 h, SQSTM1 and BAG3 were immunoprecipitated followed by analysis of co‐sedimented proteins, as indicated. As negative control purified rabbit (rb) and mouse (ms) IgG was used. Left panel shows relative amounts of proteins in lysates used for Co‐IP (Input).</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-A</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Proteasomal chymotrypsin and cathepsin activity in lysates from young (Y) and old (O) I90 cells was determined using specific fluorescence probes, as described in the Material and methods section. Values are expressed are mean±s.e.m. *P0.05 and **P0.01 versus young, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-B</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Real‐time PCR analysis of LC3, WIPI1 and SQSTM1 mRNA levels in young and old I90 cells. Depicted is the mean expression ratio (log2) ±s.e.m. of target genes in old cells relative to young cells. **P0.01 and ***P0.001 versus young, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-C</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblot analysis of LC3 and SQSTM1 in young and old I90 cells.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-D</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Young and old I90 cells were treated for 2 h with bafilomycin A1 (BafA1, 2 μM) or DMSO as control followed by immunoblot analysis of indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-E</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Immunoblot analysis of WIPI1 expression in young and old I90 cells.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-F</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Indirect immunofluorescence staining of endogenous LC3 (green), SQSTM1 (red) and WIPI1 (white) in I90 cells of young and old age. DAPI (blue) was used to stain DNA. Representative pictures are shown. Bar: 20 μm. Diagrams show percentage of cells with indicated characteristics counted as in Figure 3E.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-G</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Old and young I90 cells were treated for 1 h with DMSO as control (C), lactacystin (L, 2 μM) or NH4Cl (20 mM) plus leupeptin (Leu, 5 μM) (N, NH4Cl/Leu). Western‐blot analyses were performed for detection of indicated proteins. In the diagram (right panel), levels of polyUb‐proteins and SQSTM1 are depicted after normalisation to corresponding Tubulin levels. Values are expressed as mean±s.e.m. *P0.05 versus old control, #P0.05 versus young control, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-H</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) I90 cells of old (upper panel) and young (lower panel) age were transfected with atg7 or nonsense (nons) siRNA. After transfection for 4 days , the cells were treated with NH4Cl/Leu or DMSO for 1 h followed by fractioning of cell lysates in TritonX‐100 (TX‐100) soluble and insoluble material. Equal protein amounts of both fractions were directed to immunoblot analysis for analysis of indicated proteins. Gapdh and Histone H3 were used as loading controls of soluble and insoluble fractions, respectively.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_5-I</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) Transmission electron microscopic analysis of young (a) and old (b) I90 cells. Magnifications of marked areas in (a) and (b) are shown in (c) and (d), respectively. An arrow indicates an autolysosome, and arrow heads indicate autophagosomes. M, mitochondrion. N, nucleus.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_6-A</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis of indicated proteins of young (Y) and old (O) I90 cells upon fractionation as described in Figure 5H.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_6-B-C</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 6-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) After transfection for 96 h of old I90 cells with bag3 or nonsense (nons) siRNA, BAG1 and BAG3 protein and mRNA levels were analysed by immunoblot (B) and real‐time PCR (C) analysis, respectively. Transcript levels in bag3 siRNA cells are depicted as the mean log2 expression ratio ±s.e.m. relative to nons siRNA cells. *P0.05 and ***P0.001 versus nons, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_6-D</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Indirect immunofluorescence analysis of endogenous LC3 (green) and WIPI1(white) in old I90 cells transfected with nons (a, b) and bag3 siRNA (c, d) for 96 h. DAPI (blue) was used as a nuclear marker. Representative pictures are shown. Bar: 20 μm. Diagrams show percentage of cells counted as in Figure 3E.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_6-F</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Same analysis as in Figure 5G but old I90 cells transfected as in (A) were used. C, control; L, lactacystin, N, NH4Cl/Leu. Values are expressed as mean±s.e.m. *P0.05 versus nons control, or as indicated, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_6-G-H</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 6-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G, H) Same analysis as in (F) but young I90 cells 48 h after transfection with a BAG3 expression plasmid (BAG3‐N1) or vector control (N1) together with nons or sqstm1 siRNA (G) and nons or atg7 siRNA (H), as indicated, were used. *, #, ∼ and +, P0.05 versus C N1, C BAG3‐N1, C BAG3‐N1 sqstm1 or atg7 and C N1 sqstm1 or atg7, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_7-A</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Protein extracts from cerebellum (CER) of young (Y, 3 months) and old (O, 24 months) mice were analysed for BAG1 and BAG3 expression by immunoblot analysis.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_7-B</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Real‐time PCR analysis of indicated mRNA levels in cerebellum of young and old mice. Depicted is the log2 expression ratio of target genes in old mice relative to young mice. Values are expressed as mean±s.e.m. *P0.05 and **P0.01 versus young, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_7-C</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblot analysis as in (A) but in cortex (CTX), hippocampus (HIP) and mid‐brain (MB).</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_7-D</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Western‐blot analysis of indicated proteins in different brain regions of young and old mice.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_7-E</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Total cathepsin and specific cathepsin B activity in brain extracts from young and old mice was determined using fluorescence probes Z‐FR‐AMC and Z‐RR‐AMC, respectively, as described in the Material and methods section. Values are expressed as mean±s.e.m. *P0.05 versus young, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2647772 Figure_7-F</id>
    <infon key="sourcedata_document">387</infon>
    <infon key="doi">10.1038/emboj.2009.29</infon>
    <infon key="pmc_id">2647772</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Expression analysis of indicated proteins in primary hippocampal astrocytic and neuronal cell cultures from young (2 months) and old (24 months) rats. Detection of GLT1 and NeuN served as astrocyte and neuron markers, respectively. Note the NeuN signals in astrocytic cultures. We attributed these signals to the presence of resting nuclei of dead neurons, which we observed under the microscope.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">453</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="192" length="9"/>
        <text>astrocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_1-A</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) MCF10A-eGFP-LC3 cells were left untreated (Control) or treated with 5 μM rapamycin (Rapa), 500 ng/ml TRAIL or 10 ng/ml TNF for 24 h. When indicated, 10 mM 3‐MA or 5 μg/ml TRAIL‐R2 antagonist antibody was added 1 h before the drugs. Representative confocal images (20 μm scale bars) and the percentages of cells with LC3 translocation are shown.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_1-B</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) MCF10A-eGFP-LC3 cells were transfected with the indicated siRNAs for 48 h and analysed by immunoblotting (left), or stimulated with 500 ng/ml TRAIL for 24 h and analysed for LC3 translocation (right).</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_1-C</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) MCF10A cells left untreated (Control) or treated with 500 ng/ml TRAIL or 5 μM rapamycin (Rapa) for 24 h were analysed for LC3‐I, LC3‐II and tubulin by immunoblotting. Pepstatin A and E64d were added to the cells 4 h before harvesting. Similar results were obtained in two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_1-D</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) MCF10A cells were treated with 5 μM rapamycin (Rapa) or indicated concentrations of TRAIL for 24 h, and the increase in the degradation of long‐lived proteins as compared with the untreated cultures (Control) was measured.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_1-E</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) MCF10A-eGFP-LC3 cells transfected with the indicated siRNAs were left untreated 48 h later (Control) or treated with 500 ng/ml TRAIL for 24 h and analysed for the DNA content by flow cytometry. The percentage of apoptotic cells with sub‐G1 DNA content is shown. The values represent mean±s.d. for three (A, D) or four (B, E) independent experiments. *P‐value 0.05, **P‐value 0.01 and ***P‐value 0.001 as compared with control sample (A-left panel and D), with TRAIL‐treated cells without anti‐TRAIL‐R2 (A-right panel) or with TRAIL‐treated cells without siRNA (B, E).</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_2-A</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Protein lysates from MCF10A cells left untreated or treated with 500 ng/ml TRAIL or 5 μM rapamycin (Rapa, positive control) for 24 h were analysed by immunoblotting for phosphorylated p70S6K (P‐p70S6K), total p70S6K and GAPDH (loading control).</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_2-B</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblot analysis of the levels of P‐ACC and tubulin (loading control) in lysates from MCF10A cells left untreated or treated with 500 ng/ml TRAIL for 24 h, 1 mM AICAR for 4 h (positive control) or 5 μM rapamycin for 24 h (negative control).</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_2-C</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblot analysis of the level of P‐ACC and GAPDH (loading control) in lysates from MCF10A cells treated with 500 ng/ml TRAIL for the indicated times.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_2-D</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) MCF10A cells were transfected with indicated siRNAs for 48 h and analysed by immunoblotting for the indicated proteins immediately (upper panel) or after additional 24 h (middle panel) or 2 h (lower panel) incubation with (+) or without (−) 500 ng/ml TRAIL.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_2-E</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) MCF10A-eGFP-LC3 cells transfected with indicated siRNAs for 48 h and incubated for an additional 24 h with or without 500 ng/ml TRAIL were analysed for LC3 translocation (top) and the DNA content (bottom). The values represent mean±s.d. for four independent experiments. *P‐value 0.05 and ***P‐value 0.001 as compared with TRAIL‐treated cells without siRNA. Similar results were obtained in two (A, B and D) or three (C, D) independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_3-A</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) MCF10A-eGFP-LC3 cells were transfected with indicated siRNAs for 48 h and analysed for the indicated mRNAs (top) and proteins (bottom by RT-PCR and immunoblotting, respectively. Similar results were obtained in three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_3-B</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) MCF10A-eGFP-LC3 cells transfected with indicated siRNAs for 48 h, and left untreated or treated with 500 ng/ml TRAIL for 2 h, 10 μM ionomycin for 24 h or starved for amino acids and glucose for 24 h (starvation) were analysed for P‐ACC and tubulin (loading control) expression by immunoblotting. Similar results were obtained in two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_3-C</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cells transfected as in (B) and left untreated or treated with 500 ng/ml TRAIL, 10 μM ionomycin or starved for amino acids and glucose for 24 h were analysed for LC3 translocation. The values represent mean±s.d. of three independent experiments. ***P‐value 0.001 as compared with cells treated in a same way, but transfected without siRNA.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_4-A</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The lysates of MCF10A cells treated with 500 ng/ml TRAIL for the indicated times were analysed by immunoblotting. The control lane (0 min TRAIL) originates from the same blot and has been treated and exposed identically. Similar results were obtained in three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_4-B-C</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 4-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) The lysates of MCF10A-eGFP-LC3 cells transfected with indicated siRNAs for 48 h and left untreated (−) or treated with 500 ng/ml TRAIL for 2 h were analysed by immunoblotting. (C, lower panel) MCF10A-eGFP-LC3 cells were transfected with indicated siRNAs for 48 h and analysed for the indicated mRNAs by RT-PCR. Similar results were obtained in two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_4-D-E</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 4-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D, E) MCF10A-eGFP-LC3 cells were transfected with indicated siRNAs for 48 h, treated as in Figure 3C and analysed for LC3 translocation (left) and sub‐G1 DNA content (right). The values represent mean±s.d. of a minimum of three independent experiments except for the right panel in E (two experiments). *P‐value 0.05 and **P‐value 0.01 as compared with cells treated in a same way, but transfected without siRNA.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_5-A</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Protein lysates from MCF10A cells left untreated (0) or treated with 50 ng/ml TNF, 500 ng/ml TRAIL (positive control) or 10 ng/ml IL‐1β for indicated times were analysed by immunoblotting for phosphorylated ACC (P‐ACC), phosphorylated IκB (P‐IκB) and GAPDH (loading control). The values show the P‐ACC/GAPDH and P‐IkB/GAPDH ratios as percentages of the ratios in untreated cells (left lanes) and are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_5-B-C</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 5-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) MCF10A-eGFP-LC3 cells left untreated or treated with 500 ng/ml TRAIL, 50 ng/ml TNF or 10 ng/ml IL‐1β for 24 h were analysed for LC3 translocation (B) and the DNA content (C). The values represent mean±s.d. for two independent experiments. **P‐value 0.01 and ***P‐value 0.001 as compared with untreated cells.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_6-A</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The lysates of hTERT-RPE1 cells transfected with indicated siRNAs for 48 h and left untreated or treated with 500 ng/ml TRAIL for 2 h were analysed by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_6-B</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) hTERT-RPE1-eGFP-LC3 cells transfected with indicated siRNAs for 48 h were left untreated or treated with 500 ng/ml TRAIL for 24 h and analysed for LC3 translocation (left) and sub‐G1 DNA content (middle) and AMPKα expression (right).</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_6-C</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) hTERT-RPE1-eGFP-LC3 cells were transfected with indicated siRNAs for 48 h and analysed for the indicated mRNAs (top). After 48 h, cells were left untreated or treated with 500 ng/ml TRAIL for 2 h, and analysed for P‐ACC and GAPDH (loading control) expression by immunoblotting. Similar results were obtained in two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_6-D</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Cells transfected as described in (C) and left untreated or treated with 500 ng/ml TRAIL, 10 μM ionomycin or starved for amino acids and glucose for 24 h were analysed for LC3 translocation.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_6-E</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Lysates of wild‐type (WT) MEFs and MEFs with an inactive TAK1 knock‐in (TAK1Δ) treated with 500 ng/ml TRAIL were analysed by immunoblotting. Similar results were obtained in two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2666037 Figure_6-F</id>
    <infon key="sourcedata_document">386</infon>
    <infon key="doi">10.1038/emboj.2009.8</infon>
    <infon key="pmc_id">2666037</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) WT and TAK1Δ MEFs left untreated and treated with 250 or 500 ng/ml TRAIL were analysed for cell death by the LDH release assay. Similar results were obtained in two independent experiments (A, C and E). The values represent mean±s.d. for two (D) or a minimum of three independent experiments (B, F). *P‐value 0.05, **P‐value 0.01 and ***P‐value 0.001 as compared with cells treated in the same way, but transfected without siRNA (B, D) or the wild‐type cells (F).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_1-A</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The AH109 strain was co‐transformed with pGBKT7 containing the C‐terminal (CT) domain of mAtg9 (bait) and pGADT7, or pACT2, containing the CT domain of p38IP (prey). The interaction was then visualized by growth of co‐transformed yeast on SD‐Trp/Leu/His plates for 3 days at 30°C.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_1-C</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HEK293A cells were transfected with RFP-mAtg9 and HA-p38IP. HA-p38IP was immunoprecipitated with an anti‐HA antibody and the co‐immunoprecipitatedRFP-mAtg9 was detected with an anti‐mAtg9 antibody. HA-p38IP was detected with an anti‐HA antibody. Asterisk indicates a non‐specific band.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_1-DEF</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 1-DEF</infon>
    <infon key="sourcedata_figure_dir">Figure_1-DEF</infon>
    <passage>
      <offset>0</offset>
      <text>Indirect immunofluorescence analysis of mAtg9 with (D)HA-full‐length p38IP (HA-FL), (E)HA-C‐terminal p38IP (HA-CT), and (F) HA-N‐terminal p38IP (HA-NT). Bars=5 μm. The co‐localization seen in (D) and (E) was not because of overlap of randomly distributed vesicles. Cross‐correlation function (CCF) analysis ( van Steensel et al, 1996) showed a peak and maximum Rp value around ΔX=0, indicating that co‐localization between mAtg9 and p38IP is positively correlated and non random ( Supplementary Figure S1).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_2-A</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HEK293A cells were transfected with HA-p38IP alone or co‐transfected with HA-p38IP and RFP-mAtg9, homogenized and subjected to centrifugation, and the resulting post‐nuclear supernatant (PNS) was fractionated by centrifugation at 100 000 g into membrane pellet and cytosol. Equal protein amounts were resolved by SDS-PAGE and immunoblotted with anti‐mannose‐6‐phosphate receptor (MPR) antibody as a control for membrane‐associated proteins, anti‐superoxide dismutase (SOD) antibody as a control for cytosolic proteins, anti‐mAtg9 antibody, and anti‐HA antibody. HA-p38IP levels were quantified using ImageJ software and plotted relative to HA-p38IP in the PNS (n=4) (**P=0.0051).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_2-B</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HEK293 cells were depleted of mAtg9 using siRNA, then transfected with HA-p38IP and incubated in full medium or EBSS (data not shown). The asterisk indicates mAtg9‐depleted cells. Bar is 5 μM. The intensity of the nuclear versus cytosolic fluorescence in control and cells depleted of mAtg9 under fed and starvation conditions was analysed using ImageJ software (***P=0.0001, Students t‐test)</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_2-C</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HEK293A cells were transfected with HA-p38IP and processed for indirect immunofluorescence. HA-p38IP was detected with an anti‐HA antibody and endogenous mAtg9 was detected with an anti‐mAtg9 antibody. HA-p38IP localizes to the nucleus and cytoplasmic puncta in full medium or EBSS. HA-p38IP co‐localizes with mAtg9 in the periphery of the cell (arrowheads). Bars (upper panels) 5 μM, (lower panels) 1 μM.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_2-D</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Anti‐mAtg9 antibody was used to immunoprecipitatemAtg9 from HEK293 cells transfected with HA-p38IP alone or with RFP-mAtg9 and HA-p38IP. A total of 5% of lysates or immunoprecipitates were probed with anti‐HA or anti‐mAtg9 antibodies. The left and right hand bottom panels were obtained from the same immunoblot, but exposed for different times to allow the endogenous mAtg9 to be visualized better.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_2-E</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) HEK293 cells were transfected with control or p38IP siRNA. At 72 h after transfection, cells were incubated in either full medium or EBSS for 2 h, then fixed and immunostained to detect endogenous mAtg9 localization. mAtg9 localization was quantified by visually scoring cells for either a juxta‐nuclear or dispersed phenotype. Bars=5 μm (data are represented as mean±s.e.m. of 200 cells, *P=0.0413, Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_3-A</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293/GFP-LC3 cells were transfected with control or p38IP siRNA. At 72 h after transfection, cells were incubated in either full medium (FM), full medium with leupeptin (FM Leu), EBSS (ES), or EBSS with leupeptin (ES Leu) for 2 h. FM Leu (data not shown) is identical to FM alone. Quantification of GFP-LC3‐positive autophagosome number was performed by counting in a blinded experiment. Bars=5 μm (data are represented as mean±s.e.m. of 60 cells, ***P=0.0002, Students t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_3-B</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HEK293A cells were transfected with siRNA control, siRNA for p38IP, and siRNA for ULK1. Cell lysates were analysed by SDS-PAGE for endogenous LC3 lipidation using an anti‐LC3 antibody, or immunoblotted with anti‐ULK1 antibody.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_3-C</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HeLa cells were transfected with siRNA control, and siRNA for p38IP. After incubation for 2 h as in (A), samples were immunoblotted with anti‐LC3 and anti‐actin antibodies. Endogenous LC3II/LC3I levels were quantified and the ratio presented as arbitrary units. In (B), n=4, ***P=0.0001 and *P=0.0324, Students t‐test. In (C), data are representative of two experiments.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_3-D</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) 293/GFP-LC3 cells were transfected with siRNA control or siRNA p38IP, and incubated in full medium, or for 2 and 4 h in EBSS. Samples were immunoblotted with anti‐p62 antibodies, and actin as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_3-E</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) HEK293A cells were transfected with HA-p38IP or myc-ULK1 C‐terminal domain (CTD). After 24 h, cells were labelled with [14C]valine as described in Material and Methods section, and incubated in either full medium or EBSS for 2 h. Cells were then collected and analysed for long‐lived protein degradation (data are represented as mean±s.e.m. of triplicates, representative of two experiments, EBSS mock versus EBSSHA-p38IP (***P=0.036); EBSS mock versus ULK1 CTD (***P=0.0001); Students t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_4-A</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293/GFP-LC3 cells were treated with 10 μM anisomycin for 30 min, or exposed to UV irradiation for 3 min followed by a 40‐min recovery and incubation in full medium, full medium with leupeptin, EBSS, or EBSS with leupeptin for 2 h. Cells were then fixed and visualized by confocal microscopy. GFP-LC3‐positive structures per cell were quantified as in Figure 3A. Bars=5 μm. Data are represented as mean±s.e.m. n=60 cells, mock versus anisomycinEBSS (***P=0.0001); mock versus UV EBSS (***P=0.0001); mock versus anisomycinEBSS with leupeptin (***P=0.0001); mock versus EBSS with leupeptin UV (***P=0.0001). All analysed using Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_4-B</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HEK293A cells were pretreated with 10 μM anisomycin for 30 min, or UV irradiation for 3 min followed by a 40‐min recovery, before incubation in EBSS for 2 h. Images were analysed as in Figure 2E. Bars=5 μm. Data are represented as mean±s.e.m. of 60 cells, EBSS mock versus EBSSanisomycin (*P=0.0142); EBSS mock versus EBSS UV (*P=0.0150); Student's t‐test.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_5-A</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293/GFP-LC3 cells were pre‐treated with 10 μM anisomycin for 30 min before incubation in either full medium or EBSS. Cell lysates were analysed by SDS-PAGE for GFP-LC3 lipidation using an anti‐LC3 antibody. The membrane was also probed with anti‐β tubulin. The GFP-LC3 lipidation was quantified as the amount of GFP-LC3II/GFP-LC3I (data are represented as mean±s.e.m. of triplicates, P=0.0091, Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_5-B</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HEK293A cells labelled with [14C]valine, as described in Material and Methods section, were pretreated with 10 μM anisomycin for 30 min before incubation in either full medium, EBSS, or EBSS with leupeptin for 2 h. Cells were then analysed for long‐lived protein degradation (data are represented as mean±s.e.m. of triplicates, representative of two experiments, EBSS untreated versus anisomycin treated (P=0.0363); EBSS untreated versus leupeptin treated (P=0.0001), Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_5-C</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HEK293 cells were transfected with control siRNA or siRNA for p38IP. After 24‐h incubation, control or p38IP‐depleted cells were pre‐treated with anisomycin, followed by a 2‐h incubation with full medium, full medium with leupeptin, EBSS, or EBSS with leupeptin. Cell lysates were analysed with anti‐p38α or anti‐LC3 antibodies. LC3II/LC3I levels were quantified and presented normalized to control, untreated cells incubated in EBSS. Data are representative of two experiments.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_5-D</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) HEK293A cells transiently transfected with HA‐p38IP and RFP‐mAtg9 were treated with anisomycin for 30 min and mAtg9 was immunoprecipitated. 5% of the lysates or the immunoprecipitates were probed with anti‐HA and anti‐mAtg9 antibodies (data is representative of 3 experiments, *P=0.0332).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_6-A</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HEK293A cells were transfected with RFP-mAtg9 and Flag-p38 (lanes 2 and 7), RFP-mAtg9, Flag-p38 and HA-p38IP (lanes 3 and 8), or RFP-mAtg9 and HA-p38IP (lanes 4 and 9). RFP-mAtg9 was immunoprecipitated with an anti‐mAtg9 antibody, the co‐immunoprecipitatedHA-p38IP was detected with an anti‐HA antibody, and co‐immunoprecipitatedFlag-p38 was detected with an anti‐Flag antibody. RFP-mAtg9 was detected with an anti‐Atg9 antibody.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_6-B</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HEK293A cells were transfected with RFP-Atg9 and HA-p38IP (lanes 1 and 5), Flag-Flag, Flag-p38, and HA-p38IP (lanes 2 and 6), or Flag-p38 and HA-p38IP (lanes 3 and 7). HA-p38IP was immunoprecipitated with an anti‐HA antibody, the co‐immunoprecipitatedRFP-Atg9 was detected with an anti‐Atg9 antibody, and co‐immunoprecipitatedFlag-p38 was detected with an anti‐p38α antibody. HA-p38IP was detected with an anti‐HA antibody.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_6-C</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HEK293A cells were transfected with Flag-p38α for 24 h. Cells were incubated in either full medium, EBSS, or EBSS plus leupeptin for 2 h, lysed, and analysed for endogenous LC3 lipidation using an anti‐LC3 antibody, and immunoblotted with anti‐Flag antibody. LC3 lipidation was quantified as the amount of LC3II/LC3I (data are represented as mean±s.e.m. of triplicates, n=2 experiments, EBSS control versus EBSS with Flag‐p38α, ***P=0.0026).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_7-A</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293/GFP-LC3 cells were transfected with control or p38α siRNA. At 72 h after transfection, cells were incubated in either full medium, EBSS, or EBSS with leupeptin for 2 h, then fixed and visualized by confocal microscopy. Bars=5 μm (data are represented as mean±s.e.m. n=60 cells, EBSS control versus p38α siRNA (***P=0.0001); EBSS with leupeptin control versus p38α siRNA (***P=0.0001), Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_7-B</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HEK293A cells were transfected with control or p38α siRNA. At 72 h after transfection, cells were incubated in either full medium, EBSS, or EBSS containing leupeptin for 2 h. Cells lysates were analysed for LC3 lipidation using an anti‐LC3 antibody. The membrane was also probed with anti‐actin and anti‐p38αantibodies. LC3 lipidation was quantified as the amount of LC3II/LC3I (data are represented as mean ±s.e.m. n=5, full medium control versus p38α siRNA (**P=0.0056); EBSS control versus p38α siRNA (**P=0.048); EBSS with Leu control versus p38αsiRNA (**P=0.04), Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_7-C</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HEK293A cells were transfected with control or p38αsiRNA. At 72 h after transfection, cells were incubated in either full medium or EBSS for 2 h, then fixed and immunostained to detect endogenous mAtg9 localization. The percentage of cells with dispersed mAtg9 was quantified as in Figure 2E (data are represented as mean±s.e.m. n=200 cells, full medium control versus p38α siRNA (**P=0.0027); EBSS control versus p38α siRNA (*P=0.0459); Student's t‐test). Bars=5 μm</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_7-D</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) HEK293A cells were transfected with siRNA forp38α, homogenized and subjected to centrifugation, and the resulting post‐nuclear supernatant (PNS) was fractionated by centrifugation at 100 000 g into membrane pellet and cytosol as in Figure 2A. Equal protein amounts were resolved by SDS-PAGE and immunoblotted with anti‐MPR, anti‐HA, and anti‐p38α antibodies. Data are representative of four experiments.</text>
    </passage>
  </document>
  <document>
    <id>2808369 Figure_7-E</id>
    <infon key="sourcedata_document">391</infon>
    <infon key="doi">10.1038/emboj.2009.321</infon>
    <infon key="pmc_id">2808369</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) 72 h cells were transfected with control, p38α siRNA or both p38α siRNA, and p38IP siRNA. At 72 h after transfection, cells were incubated in either full medium, full medium with leupeptin, EBSS, or EBSS with leupeptin for 2 h. Cells lysates were analysed for LC3 lipidation using an anti‐LC3 antibody. The membrane was also probed with anti‐p38α. LC3 lipidation was quantified as the amount of LC3II/LC3I. Data are representative of two experiments.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_1-A</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) BH3‐only BIK displaces a subset of BCL‐2 complexes at the ER. Purified LM from H1299HA‐BCL‐2b5 cells either mock infected or infected with Ad‐BIKb5 was subjected to cross‐linking with BMH and visualized by immunoblot. Asterisks (*) denote BCL‐2 cross‐linked products, which are displaced by BIK. Bold arrow denotes region containing cross‐linked NAF‐1/BCL‐2.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_1-D</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Endogenous NAF‐1 cross‐links with BCL‐2 at the ER. LM purified from H1299 neo and HA‐BCL‐2b5 cells were subjected to cross‐linking by BMH and immunoprecipitation with anti‐NAF‐1 antibody. Precipitates were analysed by immunoblot with anti‐BCL‐2.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_1-E</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E)NAF‐1 is displaced from BCL‐2 by BH3‐only BIK. H1299HA‐BCL‐2b5 cells were either mock infected or infected with Ad‐BIK. Purified LM was treated as in (D).</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_2-A</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Co‐immunoprecipitation of endogenous NAF‐1 and BCL‐2. Lysates from SK‐Mel5 cells were collected and immunoprecipitation was performed with anti‐NAF‐1 antibody. The precipitate was subjected to immunoblotting with anti‐BCL‐2 and anti‐NAF‐1.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_2-B</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B)H1299 cells were fixed and double stained with anti‐NAF‐1 and anti‐Calnexin or anti‐Cytochrome c antibodies. Scale bar represents 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_2-C</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Co‐immunoprecipitation of NAF‐1‐Flag and HA‐BCL‐2b5. Lysates from H1299HA‐BCL‐2b5 cells infected with Ad‐NAF‐1‐Flag were collected and treated as in (A).</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_2-D</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Mutations in the CDGSH iron‐binding domain of NAF‐1 interfere with NAF‐1 binding to BCL‐2. H1299HA‐BCL‐2b5 cells were infected with either Ad‐rtTA, Ad‐NAF‐1‐Flag, or Ad‐NAF‐1‐mut‐Flag (C99S C101S C110S H114Q). Lysates were treated as in (A). Densitometric analysis was performed using Scion Image software to quantify expression and co‐precipitated levels of NAF‐1‐Flag and NAF‐1‐mut‐Flag. Graph depicts the ratio of co‐precipitated protein to expression level.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_2-E</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) A functional CDGSH iron‐binding domain is necessary, but not sufficient for the interaction between the cytosolic domains of NAF‐1 and BCL‐2. HA‐BCL‐2 ΔTM was in vitro translated in rabbit reticulocyte lysate and equivalent aliquots were added to each GST pull‐down reaction. GST‐fusion proteins used were GST alone, GST‐NAF1‐C, GST‐NAF1‐C‐mut (C99S C101S C110S H114Q), and GST‐MitoNEET‐C. The proteins were detected using anti‐HA and anti‐GST</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_3-A</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A)H1299neo and HA‐BCL‐2b5 cells treated with control (CTRL) or NAF‐1 shRNA were either mock infected or infected with Ad‐BIK in the absence or presence of 50 μM zVAD‐fmk. Cell lysates were analysed by immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_3-B</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Caspase activity was measured using the fluorescent substrate DEVD‐AMC. The results represent the average±s.d. of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_3-C</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Prolonged BIK expression and caspase inhibition induces autophagy, which is enhanced by knockdown of NAF‐1. H1299neo and HA‐BCL‐2b5 cells treated with CTRL or NAF‐1 shRNA were infected with Ad‐BIK in the presence of zVAD‐fmk for the indicated periods of time. Cell lysates were analysed by immunoblot. Levels of LC3 II were normalized to actin levels by densitometry analysis. Graph depicts normalized LC3 II levels of each lane.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_4-A</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Effect of NAF‐1 knockdown on starvation‐induced autophagy. H1299 cells infected with CTRL or NAF‐1 shRNA were starved for 4 h in EBSS with DMSO (vehicle) or Baf A1 (100 nM). Cell lysates were analysed by immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_4-B</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative images of GFP‐LC3 staining in H1299GFP‐LC3 cells transfected with LUC or NAF‐1 siRNA, untreated and starved. Scale bar represents 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_4-C</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of autophagy is expressed as the percentage of GFP‐LC3‐expressing cells displaying punctate GFP‐LC3. A minimum of 100 cells per sample were counted; results represent the average±s.d. of three independent experiments. Cell lysates were analysed by immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_5-A</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A)NAF‐1 contributes to the interaction between BCL‐2 and Beclin 1. H1299HA‐BCL‐2b5 cells were transfected with Flag‐Beclin 1 and either LUC or NAF‐1 siRNA. Cells were lysed and subjected to immunoprecipitation with anti‐BCL‐2 antibody. Precipitates were subjected to analysis by immunoblot using anti‐Beclin 1 and anti‐BCL‐2. All lanes are derived from the same gel and of the same exposure. Thin white lines indicate where lanes have been removed.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_5-B</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Loss of NAF‐1 prevents BCL‐2b5 from antagonizing starvation‐induced autophagy. H1299 GFP‐LC3 and BCL‐2b5/GFP‐LC3 cells were transfected with either LUC or NAF‐1 siRNA and starved for 4 h. Cells were analysed as in Figure 4C.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_5-CDE</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 5-CDE</infon>
    <infon key="sourcedata_figure_dir">Figure_5-CDE</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Representative electron micrographs of H1299neo and HA‐BCL‐2b5 cells treated with either LUC or NAF‐1 siRNA, with or without subsequent starvation. Scale bar represents 10 μm. Cell lysates were analysed by immunoblot. All lanes are derived from the same gel and of the same exposure. Thin white line indicates where lanes have been removed. Autophagy levels observed by electron microscopy (C) were quantified and expressed as either the percentage of cells containing autophagic vacuoles (D) or the number of autophagosomes per cell (E). A minimum of 100 cells per sample were counted; results represent the average±s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_6-A</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A)H1299 neo and HA‐BCL‐2b5 cells treated with either CTRL or NAF‐1 shRNA were loaded with Fura‐2AM, and ER Ca2+ stores were measured as the difference in cytoplasmic Ca2+ concentration before and after addition of TG (2 μM). Shown are representative traces of Fura‐2AM fluorescence measured at 340/380 nm excitation wavelength ratio at 510 nm wavelength emission. Arrow indicates time at which TG was added, delta values indicate TG‐sensitive ERCa2+ stores.</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_6-B</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Differences in ERCa2+ stores are shown as the average±s.e.m. of three independent experiments as described in (A).</text>
    </passage>
  </document>
  <document>
    <id>2830692 Figure_6-C</id>
    <infon key="sourcedata_document">508</infon>
    <infon key="doi">10.1038/emboj.2009.369</infon>
    <infon key="pmc_id">2830692</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C)Co‐immunoprecipitation of endogenous NAF‐1 and endogenous IP3 receptor type I. Lysate from H1299HA‐BCL‐2b5 cells was collected and immunoprecipitation was performed with anti‐IP3R1 antibody. The resulting precipitate was analysed by immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_1-B</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) qRT-PCR analysis using primers overlapping exons 15 and 16 permitted to quantify the non‐skipped α1S form: 18±6% (**P⩽0.001, n=19) and 10±7% (**P⩽0.001 n=19) (black bars) of the total α1S mRNA (grey bars) at 2 and 6 months post injection in TA of AAV1‐(U7‐ESE) and AAV1‐(U7‐SA):ΔDHPR or AAV1‐(U7‐Ctrl): c as a control, respectively.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_1-C</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Six months post injection, lysates from TAΔDHPR (ΔDHPR) and TACtrl (c) were immuno‐blotted for α1S or α-actin for four mice. Graph depicts mean±s.e.m. of relative expression of α1S subunit determined by densitrometry and nomalized to the α-actin expression for each muscle. Results were expressed in protein levels of α1S subunit in TAΔDHPR normalized to TACtrl for each mice, **P⩽0.001, n=4.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_1-D</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Longitudinal cryo‐sections from TAΔDHPR (ΔDHPR) and TACtrl (c) were stained with anti‐α1S subunit (red) and anti‐laminin (green) antibodies, nuclei were visualized by Dapi (blue) and imaged by confocal microscopy. Bars represent 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_2-A</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Six months post injection, TAs from eight mice were dissected and weighed.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_2-B</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) The internal diameters (shortest diameter) from all fibres throughout the total muscle section were recorded and analysed. Muscles from five different animals were examined. The bar graph presents mean±s.e.m. of the number of myofibres by fibre diameter class for TAΔDHPR (black) and TACtrl(grey).</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_2-C</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Transversal sections of TAΔDHPR (ΔDHPR) and TACtrl (c) were stained with haematoxylin and eosin, bars represent 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_2-D-E</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 2-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D) To quantify fibrosis, transversal sections of total muscle were stained with Red Sirius and quantified using Histolab Software (marked in blue), data were normalized with total surface of each muscle (orange line surrounding the sections), bars represent 500 μm. (E) Quantification is presented in bar graph and showed 4.1±0.1 fold increase of fibrosis in TAΔDHPR (ΔDHPR) compared to TACtrl (c) (**P0.001, n=4).</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_3-A</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) mRNA from TAΔDHPR and TACtrl tissues were extracted and nNOS expression was quantified by qRT-PCR. Results are expressed as mean±s.e.m., **P0.001, n=4.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_3-B</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Transversal cryo‐sections of TAΔDHPR (ΔDHPR) and TACtrl (c) were stained with anti‐nNOS (red), anti‐laminin (green) antibodies, nuclei with Dapi (blue) and imaged by confocal microscopy. Bars represent 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_3-C</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) The tissues from extracts were analysed by western blot with FoxO3a‐P antibody and normalized with α‐actin antibody. Graph depicts mean±s.e.m. of relative expression of FoxO3a‐P determined by densitometry and nomalized to the α‐actin expression for each muscle, *P⩽0.005, n=3.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_3-D</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Longitudinal cryo‐sections of TAΔDHPR (ΔDHPR) and TACtrl (c) were stained with anti‐FoxO3a (red), anti‐laminin (green) antibodies, nuclei with Dapi (blue) and imaged by confocal microscopy. Bars represent 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_3-E</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) mRNA from TAΔDHPR and TACtrl tissues were extracted and regulation of autophagy genes expression was followed by qRT-PCR. Bnip3, CathepsinL, LC3 and PI3KIII expression (noted in red) were significantly increased in TAΔDHPR compared with the controlateral TACtrl, **P0.001, n=4.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_4-A</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Ultrathin sections were imaged by electron microscopy, M, mitochondria; C, collagen fibres; T, T‐tubule. Arrows show double‐membrane vesicules called auphagosomes.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_4-B</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Transversal cryo‐sections were stained with anti‐LC3b (red), anti‐dystrophin (green) antibodies, nuclei with Dapi (blue) and imaged by confocal microscopy. Upper panel: TACtrl (Ctrl) and lower panel: TAΔDHPR (ΔDHPR). Bars represent 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_4-C</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Myofibres isolated from control (Ctrl) or 6 months post‐injected FDB (ΔDHPR) muscles were processed for immuno‐fluorescent labelling for P62 (green) and LC3b (red) and imaged by confocal microscopy. Scale bars, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_5-A</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Ultrathin sections of TAΔDHPR (ΔDHPR) and TACtrl (c) were imaged by electron microscopy. Cis, terminal cisternae; T, tubule; SR, sarcoplasmic reticulum. Bars: 500 nm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_5-B</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Myofibres isolated from Ctrl or ΔDHPRFDB muscles 6 months post injection were processed for immuno‐fluorescent labelling for RyR1 (green), SERCA (red), Dapi (blue) and imaged by confocal microscopy. Scale bars, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_6-A</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Lysates from TAΔDHPR (ΔDHPR) and TACtrl (c) were immuno‐blotted for RyR1 or α‐actin. (n=4). Graph depicts mean±s.e.m. of relative expression of null determined by densitometry and nomalized to the α‐actin expression for each muscle. Results were expressed in protein levels of ΔDHPR in TAΔDHPR normalized to TACtrl for each mice, *P⩽0.005, n=4.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_6-B</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Longitudinal cryo‐sections of TAΔDHPR (ΔDHPR) and TACtrl (c) were stained with anti‐α1S subunit (red), anti‐RyR1 (green) antibodies and imaged by confocal microscopy. Bars=20 μm.</text>
    </passage>
  </document>
  <document>
    <id>2830706 Figure_7-A-H</id>
    <infon key="sourcedata_document">499</infon>
    <infon key="doi">10.1038/emboj.2009.366</infon>
    <infon key="pmc_id">2830706</infon>
    <infon key="figure">Figure 7-A-H</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-H</infon>
    <passage>
      <offset>0</offset>
      <text>Localization of α 1S subunit. Whole skeletal muscle fibres enzymatically isolated from Ctrl (A-D) or ΔDHPR (E-H) FDB muscles 6 months post injection were processed for immuno‐fluorescent labelling for α1 S subunit (red) and laminin (green). Scale bars, 10 μm; Arrows indicate α1 S subunit expression on sarcolemma; antibody labelling was visualized by serial confocal microscopy and represented as movies of the optical sections (Supplementary Movies S5A and S5B). (D, H) Present projections of confocal Z‐series (step between each frame is 1 μm) along XZ and YZ planes as indicated.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_1.-A</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 1.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Accumulation of Ub in autophagy-deficient brain. Ub profile from the 1% Triton X-100-soluble and -insoluble fraction of autophagy-deficient brain homogenates captured with P2UBA resin. (A) Age-matched control Atg7 littermates (Atg7flox/+;nestin-Cre:p62+/−; denoted +) at 6 wk (open circles; n = 4) or Atg7 KO (Atg7flox/flox;nestin-Cre:p62+/−; denoted −) at 6 wk (closed diamonds; n = 3) are shown.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_1.-B</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 1.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-B</infon>
    <passage>
      <offset>0</offset>
      <text>Accumulation of Ub in autophagy-deficient brain. Ub profile from the 1% Triton X-100-soluble and -insoluble fraction of autophagy-deficient brain homogenates captured with P2UBA resin. (B) Control Atg5 littermates (Atg5flox/+;nestin-Cre; denoted +) at 16 (open circles; n = 4) and 26 wk (open diamonds; n = 3) or Atg5 KO (Atg5flox/flox;nestin-Cre; denoted −) at 16 (closed circles; n = 4) and 26 wk (closed diamonds; n = 3) are shown. Each symbol represents one animal. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_2.-A-B</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 2.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Suppressed accumulation of Ub in Atg7-/p62-deficient brains. (A and B) Quantitative mass spectrometry analysis of P2UBA captured total (A) and isopeptide-linked (B) Ub from the soluble and insoluble fractions of autophagy-deficient brains. Age-matched control Atg7 littermates (Atg7flox/+:nestin-Cre:p62+/−; denoted +) at 6 wk (open circles; n = 4), p62 KO (Atg7flox/flox:p62−/−; denoted −) at 6 wk (closed circles; n = 3), Atg7 KO (Atg7flox/flox:nestin-Cre:p62+/−; denoted −) at 6 wk (closed diamonds; n = 3), or Atg7-/p62-DKO (Atg7flox/flox:nestin-Cre:p62−/−) at 6 wk (closed triangles; n = 3) are shown. Each symbol represents one animal. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_3.-A-B</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 3.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Suppressed accumulation of Ub in Atg7-/Nrf2-deficient livers. (A and B) Quantitative mass spectrometry analysis of P2UBA captured p62 (A), total (A), and isopeptide-linked (B) Ub from the soluble and insoluble fraction of autophagy-deficient livers (28 d after pIpC injection). Control littermates (F/F or F/F:Nrf2+/−; denoted +; open circles; n = 4), Nrf2 KO (F/F:Nrf2−/−; denoted −; closed circles; n = 4), Atg7 KO (F/F:Mx1 or F/F:Mx1:Nrf2+/−; denoted −; closed diamonds; n = 6), or Atg7-/Nrf2-DKO (F/F:Mx1:Nrf2−/−; closed triangles; n = 6) are shown. Each symbol represents one animal. **, P ≤ 0.01; ***, P ≤ 0.005.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_4.-B</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 4.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Elevated Ub mRNA levels from Atg5-deficient brains. Total RNA was extracted from control Atg5 littermates (Atg5flox/+;nestin-Cre) at 16 wk or Atg5 KO (Atg5flox/flox;nestin-Cre) at 16 wk (n = 4 for each genotype; **, P ≤ 0.01) and the amount of transcript from Ubc, Ubb, Uba52, and Uba80 genes was quantified using real-time RT-PCR and normalized to actin. Error bars indicate SEM. au, arbitrary unit.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_6.-B</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 6.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) The addition of dox for 96 h decreased autophagy in the bicistronic stably expressing cell lines similar to the parental line, m5-7, as measured by the decreased levels of phosphatidylethanolamine-modified LC3 (LC3-II).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">106</infon>
        <infon key="identifier">CL:2000042</infon>
        <location offset="131" length="4"/>
        <text>m5-7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_6.-C</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 6.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Western blot (WB) analysis of the accumulation of htt(Q)-GFP after autophagy shutoff. At steady-state (t = 0 h), the levels of both htt(Q25)-GFP and htt(Q47)-GFP were virtually undetectable. After autophagy shutoff, there was a robust increase in the level of htt(Q47)-GFP, as detected by GFPWestern blot, whereas there was very little or no detectable increase in htt(Q25)-GFP, GAPDH, LDH, or chFP.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_6.-D</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 6.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantitative flow cytometrytime course analysis measuring selective autophagy in live cells. The ASI is the ratio of the relative increase in green and red fluorescence, as assessed by two-color flow cytometry, in response to dox. In control experiments, the ASI of two soluble, nonaggregating proteins, htt(Q25)-GFP and chFP, was 1. In contrast, the ASI of the aggregation-prone protein, htt(Q47)-GFP, compared with chFP after autophagy shutoff (+dox; 100 h) was 2. Data represent three independent experiments performed on different days. **, P ≤ 0.01; ***, P ≤ 0.005.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_6.-E</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 6.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Flow cytometrytime course analysis of cell death at different time points after autophagy shutoff (+dox). The degree of cell death correlated directly with increased htt(Q47)-GFP levels after autophagy shutoff and was significantly enhanced in cells expressing htt(Q47)-GFP compared with htt(Q25)-GFP (***, P ≤ 0.005). Data represent three independent experiments performed on different days.</text>
    </passage>
  </document>
  <document>
    <id>3003313 Figure_6.-F</id>
    <infon key="sourcedata_document">854</infon>
    <infon key="doi">10.1083/jcb.201005012</infon>
    <infon key="pmc_id">3003313</infon>
    <infon key="figure">Figure 6.-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) AQUA using heavy isotope-labeled GFP standard in addition to the routine Ub standards after P2UBA pull-down of soluble and insoluble lysates from htt(Q)-GFP-IRES-chFP bicistronic expressing cells before (−dox) and after autophagy shutoff (+dox). The experimental GFP peptide was only detected in two of the four experiments, and the data shown are representative of these. In the other two experiments, the experimental GFP peptide was below the threshold of detection.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_1.-A-B</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 1.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>SIRT1 activity is required for resveratrol-induced autophagy but not for spermidine-mediated autophagy induction in mammalian cultured cells. (A-C) Human colon carcinoma HCT 116 cells were left untransfected (Co, control) or transfected with an irrelevant siRNA (UNR, unrelated) or siRNAs specific for ATG5, ATG7, or SIRT1 and then retransfected with a GFP-LC3-encoding plasmid, cultured in complete medium for 24 h, and left untreated or treated for 4 h with 100-µM resveratrol (Resv) or spermidine (Spd). The same experiment was performed in the presence of bafilomycin A1 (BafA1), which inhibits the fusion between lysosomes and autophagosomes, to evaluate the autophagic flux. (A) Representative images. (B) Quantitative data.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_1.-C</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 1.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-C</infon>
    <passage>
      <offset>0</offset>
      <text>SIRT1 activity is required for resveratrol-induced autophagy but not for spermidine-mediated autophagy induction in mammalian cultured cells. (A-C) Human colon carcinoma HCT 116 cells were left untransfected (Co, control) or transfected with an irrelevant siRNA (UNR, unrelated) or siRNAs specific for ATG5, ATG7, or SIRT1 and then retransfected with a GFP-LC3-encoding plasmid, cultured in complete medium for 24 h, and left untreated or treated for 4 h with 100-µM resveratrol (Resv) or spermidine (Spd). The same experiment was performed in the presence of bafilomycin A1 (BafA1), which inhibits the fusion between lysosomes and autophagosomes, to evaluate the autophagic flux. (A) Representative images. (B) Quantitative data. (C) Representative immunoblots of HCT 116 cells transfected either with an unrelated siRNA or with a SIRT1-specific siRNA showing LC3 lipidation after treatment with 100-µM spermidine in the presence or absence of bafilomycin A1.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_1.-D-E-F</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 1.-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) HCT 116 cells were left transfected with a GFP-LC3 plasmid, cultured in complete medium for 24 h, and treated with either vehicle (Co), 100-µM resveratrol, or 100-µM spermidine in the presence or absence of the SIRT1 inhibitor EX527 for 4 h. (D) Representative images. (E) Quantitative data. (B and E) Bars depict the percentages of cells showing accumulation of GFP-LC3 in puncta (GFP-LC3vac; means ± SEM; n = 3; *, P &lt; 0.05). (F) Representative immunoblots showing LC3 lipidation in HCT 116 cells treated with 100-µM spermidine in the presence or absence of EX527. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_2.-A</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 2.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-A</infon>
    <passage>
      <offset>0</offset>
      <text>The lifespan-extending and autophagy-inducing effects of spermidine in yeast are not mediated by Sir2. (A-E) EGFP-Atg8p was ectopically expressed in wild-type (WT) or Δsir2S. cerevisiae undergoing chronological aging on small synthetic 2% glucose media with or without (Co, control) supplementation of 4-mM spermidine (Spd). (A) Representative images. EGFP-Atg8p localization (bottom) was visualized by fluorescence microscopy. Yeast cells undergoing autophagy (in which EGFP-Atg8p exhibits a prominent vacuolar localization) are indicated by arrows. Yeast morphology was monitored by differential interference contrast (DIC; top).</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_2.-B</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 2.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative immunoblots against EGFP. Free EGFP indicates the vacuolar degradation of EGFP-Atg8p fusion, thereby representing the autophagic flux. Notice that both WT and Δsir2yeast cells show similar free EGFP levels after spermidine-mediated autophagy induction.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_2.-C</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 2.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Relative alkaline phosphatase (ALP) activity indicative of autophagy. n = 3.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_2.-D</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 2.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Survival data. n = 4.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_2.-E</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 2.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Quantification of reactive oxygen species. Bars indicate the percentages of cells exhibiting the reactive oxygen species-mediated conversion of dihydroethidine (DHE) into ethidium (Eth; n = 4). Data represent means ± SEM; *, P &lt; 0.001 as compared with untreated cells of the same genotype. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. RFU, relative fluorescence unit.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_3.-A-B</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 3.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>The life-extending and autophagy-inducing effects of spermidine in C. elegans are not mediated by Sir2. (A) Fluorescence microscopy of C. elegans transgenic embryos expressing a full-length plgg-1DsRed::LGG-1 fusion protein indicative of autophagic activity. Two representative pictures of wild-type (WT) and sir-2.1embryos untreated (Co, control) or treated with 0.2-mM spermidine (Spd) supplementation of food are shown. (B) Quantification of autophagic activity through the measurement of DsRed::LGG-1 pixel intensity from images of WT animals shown in A. Data represent means ± SEM (n = 3) with ≥25 images processed for each trial.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_3.-C-D</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 3.-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C) Survival of WT C. elegans during aging with and without (control) supplementation of food (UV-killed E. coli) with 0.2-mM spermidine (n = 110; P &lt; 0.005). (D) Survival of sir-2.1C. elegans (ok434 phenotype) during aging with and without (control) supplementation of food (UV-killed E. coli) with 0.2-mM spermidine (n = 110; P &lt; 0.01). P-values were calculated using the log-rank test as described in Materials and methods.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_4.-A</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 4.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Convergent alterations in the phosphoproteome status after resveratrol and/or spermidine treatment. (A-C) Human colon carcinoma HCT 116 cells were treated for 2 h with vehicle (Co, control), 100-µM resveratrol (Resv), and 100-µM spermidine (Spd), alone or in combination (Resv + Spd). (A) Representative phosphoprotein arrays are shown.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_4.-C</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 4.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Representative immunoblots of selected kinases whose phosphorylation status was unaffected (PRKAA1, RPS6KB1, and acetyl-CoA carboxylase a [ACACA]) or affected by resveratrol or/and spermidine treatment (PTKB, AKT1, MAPK8, and CDKN1B), validating phosphoprotein array data.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_4.-D</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 4.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Human colorectal carcinoma HCT 116 cells were transfected with a GFP-LC3-encoding plasmid, cultured in complete medium for 24 h, and then treated with either vehicle or the indicated dose of resveratrol or spermidine, alone or in combination, for 2 h. Quantitative data. Bars depict the percentages (means ± SD; n = 3; *, P &lt; 0.05) of cells showing the accumulation of GFP-LC3 in puncta (GFP-LC3vac). GAPDH, glyceraldehyde 3-phosphate dehydrogenase.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_5.-A</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 5.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Convergent acetylproteome modification after resveratrol or spermidine treatment. (A-C) Colon carcinoma HCT 116 cells were cultured for 2 wk in three different SILAC media containing different arginine and lysine isotopes. Cells were treated with 100-µM resveratrol (Resv) or spermidine (Spd) for 2 h, fractioned into cytoplasmic, nuclear, and mitochondrial extracts, processed for acetyl lysine peptide enrichment, and analyzed by MS. (A) Hierarchical clustering of drug-specific organellar distributions of all acetylated sites quantified in at least one fraction. Fold changes are calculated relative to untreated cells. Only sites regulated &gt;1.5-fold were included in statistical analyses. (B) Graphical representation of peptides whose acetylation status was affected in a convergent or divergent way. n = 560.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_6.-A</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 6.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Significant motifs among sites undergoing acetylation. (A) Hierarchical clustering of the organellar distributions of sites whose acetylation was increased by &gt;1.5-fold in response to resveratrol or spermidine, at least in one organellar fraction. (B) Consensus acetylation motifs identified upon resveratrol (left) or spermidine (right) treatment are depicted using the MotifX algorithm (Schwartz and Gygi, 2005). Among sites that were hyperacetylated in response to both agents, the K(F/Y) motif is significantly enriched when tested against the whole proteome (P &lt; 0.00001). (C) When testing against the largest acetylation site dataset from Choudhary et al. (2009) (acetylation background dataset [ABD]), the SxK motif is significant (P &lt; 0.0001) for sites whose acetylation increased upon spermidine treatment. No general consensus motifs were found for sites whose acetylation increased in response to both agents.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_7.-A</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 7.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Significant motifs among sites undergoing deacetylation. (A) Hierarchical clustering of the organellar distributions of sites whose deacetylation was increased by &gt;1.5-fold in response to resveratrol or spermidine, at least in one organellar fraction. (B) Among sites that were hypoacetylated in response to both agents, the KP motif is significantly enriched when tested against ABD (P &lt; 0.001). (C and D) When tested against the ABD (C) or the whole proteome (D), the KP motif is significant for sites undergoing hypoacetylation upon spermidine treatment (P &lt; 0.0001). No general consensus motifs were found for sites whose acetylation decreased in response to both agents.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_8.-A-B</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 8.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Autophagy can be efficiently regulated by cytoplasmic (de)acetylation reactions. (A and B) HCT 116 cells were transfected with a GFP-LC3-encoding plasmid, cultured in complete medium for 24 h, and enucleated to obtain cytoplasts. The cytoplasts were treated with either vehicle (Co, control), 100-µM resveratrol (Resv), or 100-µM spermidine (Spd) for 4 h. 1-µM rapamycin (Rapa) was used as a positive control. (A) Representative images of cytoplasts indicative of autophagic activity. Arrows indicate GFP-LC3-transfected cytoplasts, whereas insets show nonenucleated transfected cells. (B) Quantitative data. Bars show the percentages of cells or cytoplasts showing the accumulation of GFP-LC3 in puncta (GFP-LC3vac).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">261</infon>
        <infon key="identifier">CL:0000225</infon>
        <location offset="218" length="10"/>
        <text>cytoplasts</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">266</infon>
        <infon key="identifier">CL:0000225</infon>
        <location offset="234" length="10"/>
        <text>cytoplasts</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">269</infon>
        <infon key="identifier">CL:0000225</infon>
        <location offset="439" length="10"/>
        <text>cytoplasts</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">272</infon>
        <infon key="identifier">CL:0000225</infon>
        <location offset="521" length="10"/>
        <text>cytoplasts</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">273</infon>
        <infon key="identifier">CL:0000225</infon>
        <location offset="647" length="10"/>
        <text>cytoplasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_8.-C</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 8.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) HCT 116 cells were cotransfected with a plasmid for the expression of RFP-LC3 together with an empty vector (pcDNA3) or plasmids encoding wild-type (WT) SIRT1 or a SIRT1 variant with a mutation in the nuclear localization signal fused to GFP (WT GFP-SIRT1 and mtNLS GFP-SIRT1, respectively) for 12 or 24 h, fixed, and analyzed by fluorescence microscopy. (C) Representative images indicative of 24-h autophagic activity.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_8.-D</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 8.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantitative data. Bars depict the percentages of cells exhibiting the accumulation of RFP-LC3 in puncta (RFP-LC3vac). (B and D) Means ± SEM; n = 3; *, P &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_8.-E</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 8.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Representative immunoblots for 24-h endogenous LC3 lipidation. The asterisk stands for a nonspecific band. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_9.-A</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 9.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-A</infon>
    <passage>
      <offset>0</offset>
      <text>Low doses of resveratrol and spermidine synergistically induce autophagy in vitro and in vivo. (A) Human colorectal carcinoma HCT 116 cells were transfected with a GFP-LC3-encoding plasmid, cultured in complete medium for 24 h, and then treated with either vehicle (Co, control) or the indicated dose of resveratrol (Resv) or spermidine (Spd), alone or in combination, for 2 h. (top) Quantitative data. Bars depict the percentages (means ± SD; n = 3; **, P &lt; 0.05) of cells showing the accumulation of GFP-LC3 in puncta (GFP-LC3vac). (bottom) Representative immunoblots showing endogenous LC3 lipidation.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_9.-B</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 9.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Representative immunoblots showing endogenous LC3 lipidation in the presence of bafilomycin A1 (BafA1). (C-E) Transgenic C57BL/6 mice expressing a GFP-LC3 fusion protein were injected with resveratrol and spermidine at the indicated concentrations. 3 h later, mice were killed, and tissues were processed for immunofluorescence microscopy determinations of GFP-LC3vac.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_9.-D</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 9.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantitative results. Bars represent the percentages (means ± SEM; n = 3; *, P &lt; 0.05; and **, P &lt; 0.01 as compared with the same tissue from untreated animals) of cells exhibiting GFP-LC3vac.</text>
    </passage>
  </document>
  <document>
    <id>3044119 Figure_9.-E</id>
    <infon key="sourcedata_document">856</infon>
    <infon key="doi">10.1083/jcb.201008167</infon>
    <infon key="pmc_id">3044119</infon>
    <infon key="figure">Figure 9.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Representative immunoblots showing endogenous LC3 lipidation and p62 protein content in WT C57BL/6 mouse tissues. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf1-A-C</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf1-A-C</infon>
    <infon key="sourcedata_figure_dir">figf1-A-C</infon>
    <passage>
      <offset>0</offset>
      <text>(a-c) HeLa cells were either left untreated, amino-acid (aa)/FBS starved for 5 h, or starved and then recovered in amino-acid/FBS-containing medium, then immunostained, or immunoblotted using antibodies as shown. Co-localization panels show an overlap between mTOR and LAMP1 signals. Note that changes in the positioning of lysosomalmTOR (quantified as the percentage of cells with predominantly peripheral localization of LAMP1-positive vesicles; a,c) correlate with mTORC1 activity (levels of phosphorylated S6K relative to the total S6K; b).</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf1-D</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf1-D</infon>
    <infon key="sourcedata_figure_dir">figf1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Visualization of Akt activated in response to recovery after serum starvation. After nutrient recovery, LAMP1-positive vesicles localize to peripheral regions with higher concentrations of phospho-Akt. DAPI, 4,6−diamidino−2−phenylindole. For all panels, values are means ± s.e.m. of three independent experiments carried out in triplicate. *P0.05, **P0.01, ***P0.005 Student's t-test; other comparisons are not significant (n.s.). Representative maximum-intensity projections of serial confocal optical sections are shown. Uncropped images of blots are shown in Supplementary Fig. S7.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf2-A-B</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf2-A-B</infon>
    <infon key="sourcedata_figure_dir">figf2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a,b) Nocodazole flattens the differences in lysosomalmTOR localization and dampens mTORC1 signalling in response to changes in nutrient availability. Cells were treated as in Fig. 1a followed by incubation with dimethylsulphoxide (vehicle) or with nocodazole during the last 2 h before fixation/lysis. Samples were analysed by immunofluorescence (a) or immunoblotting (b). Quantification of phopho-S6K levels is shown in (b).</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf2-C-E</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf2-C-E</infon>
    <infon key="sourcedata_figure_dir">figf2-C-E</infon>
    <passage>
      <offset>0</offset>
      <text>(c-e) Changes in lysosomal positioning induced by kinesin- or small GTPase-family members (c,d) correlate with changes in mTORC1 activity (e). HeLa cells were transfected with overexpression constructs (OE) or with siRNA as shown, followed by immunofluorescence (c,d) or by immunoblotting (e) analyses. Values are means ± s.e.m. of three independent experiments carried out in triplicate. All comparisons are with the control within each treatment condition, *P0.05, ***P0.005 Student's t-test; n.s. not significant. Uncropped images of blots are shown in Supplementary Fig. S7.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf3-A-C</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf3-A-C</infon>
    <infon key="sourcedata_figure_dir">figf3-A-C</infon>
    <passage>
      <offset>0</offset>
      <text>(a-c) HeLa cells transfected with ARL8B or KIF2 siRNA, or with ARL8B overexpression construct (non-targeting siRNA and empty pcDNA vector used as transfection controls), were either left untreated, serum/amino-acid starved for 5 h, or starved and then recovered in amino-acid- and FBS-containing medium for 30 min. Cells were immunostained using LAMP1 antibody (a) and the percentage of cells with predominantly peripheral localization of LAMP1-positive vesicles was quantified (b) or subjected to immunoblotting (c) using antibodies as shown. Quantification of phospho-S6K levels relative to the total S6K is shown in (c). Values are means ± s.e.m. of three independent experiments carried out in triplicate. All comparisons are with the control within each treatment condition, *P0.05, **P0.01, ***P0.005 Student's t-test; n.s. not significant. Uncropped images of blots are shown in Supplementary Fig. S7.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf4-A</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf4-A</infon>
    <infon key="sourcedata_figure_dir">figf4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Starvation increases pHi in HeLa cells allowed to starve using three different protocols (see Methods) with or without subsequent recovery.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf4-B-D</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf4-B-D</infon>
    <infon key="sourcedata_figure_dir">figf4-B-D</infon>
    <passage>
      <offset>0</offset>
      <text>(b-d) Changing pHi from 7.1 to 7.7 is sufficient to affect localization of lysosomes and mTORC1 activity. pHi was titrated in full tissue-culture medium containing nigericin, which enables changes in pHi to be forced by altering pH in the medium, followed by immunostaining (b,c) or western blotting (d) using antibodies as shown.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf4-E</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf4-E</infon>
    <infon key="sourcedata_figure_dir">figf4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Changes in lysosomal localization have no effect on pHi. ARL8B and KIF2 were overexpressed or knocked down in HeLa cells followed by pHi measurement.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf4-F-G</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf4-F-G</infon>
    <infon key="sourcedata_figure_dir">figf4-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(f,g) Nutrients and pHi affect levels of ARL8 and KIF2 in lysosomal fractions. Protein levels and their quantification in total cellular lysates or in isolated lysosomal fractions from HeLa cells subjected to 1 hnutrient deprivation-recovery (f) or to 1 h changes of pHi in full tissue-culture medium containing nigericin (g) are shown.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf4-H-I</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf4-H-I</infon>
    <infon key="sourcedata_figure_dir">figf4-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>(h,i) Effect of nutrients and pHi on binding of ARL8 and KIF2 to polymerized microtubules. HeLa cells treated as in (f) and (g), followed by isolation of polymerized microtubule fraction and western blotting. The asterisk indicates a nonspecific band. For all panels values are means ± s.e.m. of three independent experiments carried out in triplicate. All comparisons are with the control within each treatment condition, *P0.05, **P0.01, ***P0.005 Student's t-test; n.s. not significant. Uncropped images of blots are shown in Supplementary Fig. S7.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf5-B</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf5-B</infon>
    <infon key="sourcedata_figure_dir">figf5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Serum and amino-acid starvation of HeLa cells for 5 h reduces LC3-II levels (above), but increases autolysosome numbers detected using tfLC3 (below). With tfLC3, GFP- and RFP-positive puncta represent autophagosomes before lysosomal fusion, whereas RFP-positive/GFP-negative puncta represent autolysosomes-GFP is more rapidly quenched by low lysosomal pH (see Methods). Increased autolysosomes indicate enhanced starvation-induced flux of LC3 to lysosomes.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf5-C</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf5-C</infon>
    <infon key="sourcedata_figure_dir">figf5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) ARL8B knockdown increases autophagosomal synthesis. siRNA-transfected HeLa cells were incubated for 48 h, then left untreated or incubated with bafilomycin A1. LC3-II levels versus actin were quantified (bottom graphs). Asterisk: nonspecific band.</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf5-D</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf5-D</infon>
    <infon key="sourcedata_figure_dir">figf5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) ARL8B overexpression inhibits autophagosome synthesis and degradation. HeLa cells overexpressing ARL8B or empty vector were analysed as in (c).</text>
    </passage>
  </document>
  <document>
    <id>3071334 figf5-E-I</id>
    <infon key="sourcedata_document">598</infon>
    <infon key="doi">10.1038/ncb2204</infon>
    <infon key="pmc_id">3071334</infon>
    <infon key="figure">figf5-E-I</infon>
    <infon key="sourcedata_figure_dir">figf5-E-I</infon>
    <passage>
      <offset>0</offset>
      <text>(e) HeLa cells were co-transfected with either ARL8B overexpression construct or siRNA (non-targeting siRNA and empty peGFP vector were transfection controls) together with mCherry-LC3 for 48 h. After fixation, cells were stained for endogenous LAMP1 and DNA (DAPI). Representative maximum-intensity projections of serial confocal optical sections are shown. Co-localization panels show overlapping mCherry-LC3 and LAMP1 signals. (f-h) Quantification of autophagosome-lysosome fusion in HeLa cells. Percentages of autolysosomes (positive for both mCherry-LC3 and LAMP1) to autophagosomes (positive for mCherry-LC3 and negative for LAMP1) were quantified. In (h), we analysed cells treated for 2 h with nocodazole before fixation, which dispersed the perinuclear lysosomal cluster (see Fig. 2a). (i) Autophagosomal and autolysosomal numbers in tfLC3-expressing cells after ARL8B overexpression and knockdown (Supplementary Fig. S5o shows representative cells.). In (f-i) we analysed 20 cells per group in three independent experiments. Values are means ± s.e.m of three independent experiments carried out in triplicate. *P0.05, **P0.01, ***P0.005 Student's t-test; other comparisons not significant (n.s.). Uncropped images of blots are shown in Supplementary Fig. S7.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_1-A</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis with anti-LC3 antibody shows that NO donors reduced LC3-II levels in rat primary cortical neurons and decreased autophagosome synthesis in bafilomycin A1-treated rat primary cortical neurons and HeLa cells.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="97" length="24"/>
        <text>primary cortical neurons</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">10</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="190" length="24"/>
        <text>primary cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_1-B-E</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 1-B-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-E</infon>
    <passage>
      <offset>0</offset>
      <text>(B-E) Confocal microscopy images and analysis of autophagic flux by automated Cellomics microscopy show that NO donors reduced autolysosome numbers in mRFP-GFP-LC3HeLa cells grown in full medium (FM) (B and D) or starved with HBSS (C and E). Cells in HBSS had more autolysosomes compared to FM (C). Autolysosome number in untreated cells in FM is set at 100%.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_1-F</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) NO donors increased EGFP-HDQ74 aggregates in a dose-dependent manner in EGFP-HDQ74-transfected Atg5+/+, but not in Atg5−/−, MEFs. Atg5−/− MEFs had more EGFP-HDQ74 aggregates than Atg5+/+ MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_1-G-H</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 1-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G and H) Confocal microscopy images (H) and immunofluorescence analysis with anti-Atg16 antibody (G) show that NO donors reduced the percentage of HeLa cells with Atg16-positive structures (arrows) under starvation. Graphical data denote mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_2-A</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NO donors reduced JNK1 phosphorylation in HeLa cells, as analyzed by immunoprecipitation with anti-JNK1 agarose-conjugated beads and immunoblotting with anti-phospho-JNK antibody.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_2-B</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) NO donors reduced Bcl-2 phosphorylation in HeLa cells, as analyzed by immunoblotting with anti-phospho-Bcl-2 antibody.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_2-C</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Immunoblot analysis with anti-phospho-Bcl-2 antibody shows that DETA NONOate could not reduce phospho-Bcl-2 in Flag-CA JNK1-transfected HeLa cells, where phospho-Bcl-2 was higher compared to mock-transfected cells.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_2-D-E</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 2-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D and E) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblotting with anti-Myc antibody shows that NO donors increased the interaction of Flag-Beclin 1 with WT Myc-Bcl-2 (D), but not with AAA Myc-Bcl-2 (E), in HeLa cells transfected with WT Myc-Bcl-2 (D) or AAA Myc-Bcl-2 (E) along with either empty Flag or Flag-Beclin 1. Asterisk denotes IgG band (E).</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_2-F</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblotting with anti-Vps34 antibody shows that NO donors decreased Flag-Beclin 1-hVps34 interaction in HeLa cells transfected with hVps34 along with either empty Flag or Flag-Beclin 1.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_2-G</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblotting with anti-Vps34 antibody shows that AAA Myc-Bcl-2 decreased Flag-Beclin 1-hVps34 interaction in the presence (right panel) or absence (left panel) of DETA NONOate in HeLa cells transfected with hVps34 along with either empty Flag or Flag-Beclin 1, and with pcDNA3.1 or AAA Myc-Bcl-2. Graphical data denote mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-A</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A1-treated WT Bcl-2 and AAA Bcl-2MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-B-C</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B and C) NO donors decreased EGFP-LC3 vesicles in EGFP-LC3-transfected WT Bcl-2 and AAA Bcl-2MEFs (C). Images were acquired by a confocal microscope (B). WT Bcl-2 and AAA Bcl-2MEFs were analyzed separately.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-D</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) NO donors increased EGFP-HDQ74 aggregates in EGFP-HDQ74-transfected WT Bcl-2 and AAA Bcl-2MEFs. WT Bcl-2 and AAA Bcl-2MEFs were analyzed separately.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-E</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A1-treated WT Jnk, Jnk1−/−, and Jnk2−/−MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-F</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORC1 in HeLa cells.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-G</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Confocal microscope images of immunofluorescence with anti-phospho-S6 antibody show that DETA NONOate increased S6 phosphorylation; arrowhead shows a cell where this effect was not observed.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-H</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORC1 in WT Bcl-2 and AAA Bcl-2MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_3-I</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 3-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) Confocal microscope images of immunofluorescence with anti-phospho-mTOR and anti-LAMP1 antibodies in HeLa cells show that DETA NONOate increased phospho-mTOR but did not alter its distribution with lysosomes. Graphical data denote mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_4-A</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORC1 in Tsc2+/+MEFs, but not in Tsc2−/−, MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_4-B</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) NO donors reduced phosphorylation of IKKα/β and AMPKα in MEFs, as analyzed by immunoblotting with anti-phospho-IKKα/β and anti-phospho-AMPKα antibodies, respectively.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_4-C</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORC1 in Ikkβ+/+MEFs, but not in Ikkβ−/−MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_4-D</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A1-treated Tsc2+/+ and Tsc2−/−MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_4-E</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) DETA NONOate decreased EGFP-LC3 vesicles in Tsc2+/+ and Tsc2−/−MEFs transfected with EGFP-LC3, along with either pcDNA3.1 or AAA Myc-Bcl-2. Although it further reduced EGFP-LC3 vesicles in Tsc2+/+MEFs expressing AAA Myc-Bcl-2 compared to mock-transfected Tsc2+/+MEFs, this effect was not seen in Tsc2−/−MEFs. Tsc2+/+ and Tsc2−/−MEFs were analyzed separately. Graphical data denote mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_5-A-D</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 5-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) Immunoblot analyses with anti-LC3, along with anti-nNOS, anti-iNOS, and anti-eNOS antibodies, show decreased LC3-II levels in stable HEK293 cell lines overexpressing nNOS (A and D), iNOS-GFP (B and D), or eNOS (C and D) compared to HEK293 control cells in the presence or absence of bafilomycin A1.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_5-E-F</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) mCherry-LC3 vesicles were reduced in mCherry-LC3-transfected stable HEK293 NOS cell lines compared to HEK293 control cells cultured in HBSS, an effect that was restored in the NOS cells by L-NAME (F). Images were acquired by a confocal microscope (E).</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_5-G-H</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 5-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G and H) Confocal microscopy images (G) and immunofluorescence analysis with anti-Atg16 antibody show that stable HEK293 NOS cell lines had fewer Atg16-positive structures under starvation, compared to HEK293 control cells (H). Graphical data denote mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_6-A-F</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 6-A-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-F</infon>
    <passage>
      <offset>0</offset>
      <text>(A-F) Immunoblot analyses with anti-nNOS, anti-iNOS, anti-eNOS, anti-phospho-JNK1, anti-phospho-Bcl-2, anti-phospho-S6K, and anti-phospho-S6 antibodies show that stable HEK293 cell lines overexpressing nNOS (A and D), iNOS-GFP (B and E), or eNOS (C and F) inhibited both the JNK1-Bcl-2 and mTORC1 pathways compared to the HEK293 control cells under basal (FM) (A-C) or starvation (HBSS) (D-F) conditions. Graphical data denote mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_7-A</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analyses with anti-LC3 antibody show that rapamycin (8 hr) and L-NAME (24 hr) increased autophagosome synthesis in bafilomycin A1-treated mouseprimary cortical neurons and HeLa cells.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">336</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="158" length="24"/>
        <text>primary cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_7-B-C</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 7-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B and C) Confocal microscopy images (B) and analysis of autophagic flux by automated Cellomics microscope (C) show that L-NAME increased autolysosomes in mRFP-GFP-LC3HeLa cells.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_7-D</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) L-NAME reduced EGFP-HDQ74 aggregates in EGFP-HDQ74-transfected Atg5+/+, but not in Atg5−/−, MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_7-E</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Drosophila expressing mutant huntingtin exon 1 (Q120) shows a significant decrease in neurodegeneration (p &lt; 0.001, paired t test) upon L-NAME treatment compared to DMSO.</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_7-F</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Expression of an endogenous negative regulator of NOS activity (NOS4) significantly attenuates neurodegeneration (p &lt; 0.05, paired t test) in Drosophila expressing mutant huntingtin exon 1 (Q120).</text>
    </passage>
  </document>
  <document>
    <id>3149661 Figure_7-G-I</id>
    <infon key="sourcedata_document">830</infon>
    <infon key="doi">10.1016/j.molcel.2011.04.029</infon>
    <infon key="pmc_id">3149661</infon>
    <infon key="figure">Figure 7-G-I</infon>
    <infon key="sourcedata_figure_dir">Figure_7-G-I</infon>
    <passage>
      <offset>0</offset>
      <text>(G-I) Images from the retina of transgenic HDzebrafish show mutant huntingtin aggregates (arrows) (G). Treatment with rapamycin or L-NAME reduced the number of aggregates (H). L-NAME did not reduce aggregates in the presence of NH4Cl, which increased aggregate count (I).</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_1-B</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Kaplan-Meier curve represents the survival of BALB/cmice over time. Four BALB/cmice in each experimental group were infected i.v with 104L. monocytogenes wild-type (EGD-e) or ΔinlK mutant.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_1-C</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. The L. monocytogenes EGD-e wild-type strain (WT), the ΔinlK mutant (ΔinlK) and the complemented strain (ΔinlK+pPL2 inlK) 104 CFU were inoculated i.v into BALB/cmice. Animals were euthanized 24 h, 48 h, 72 h or 96 h after infection and organs were recovered, homogenized, and homogenates serially plated on BHI. The number of bacteria able to colonize liver (left panel) and spleen (right panel) is expressed as log10 CFU. Four animals per bacterial strain, per time points and per experiment were used. Statistical analyses were performed on the results of 3 independent experiments using the Student t test. P values of &lt;0.05 were considered statistically different and are labeled here as *.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_2-A</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. InlK amino acid sequence. The signal sequence is underlined and the different regions of leucine rich repeats (LRRs) are outlined. The consensus pentapeptide LPXTG at the C-terminal end is boxed.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_2-B</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Detection by immunofluorescence microscopy of InlK over-expressing in L. monocytogenes EGD-e (WT), ΔinlK, WT+pADc-inlK, ΔinlK+pPRT-inlK and the ΔsrtA mutant over-expressing inlK (ΔsrtA+pPRT-inlK) grown in BHI medium using the rabbit polyclonal anti-InlK antibody. InlK was detected at the surface of InlK over-expressing bacteria (WT+pADc-inlK and ΔinlK+pPRT-inlK), whereas it was undetectable at the surface WT bacteria or at the surface of the ΔstrA mutant over-expressing inlK.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_2-C</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Detection of InlK by Western blot on total lysates of L. monocytogenes EGD-e (WT), ΔinlK and ΔinlK+pPRT-inlK grown in BHI using the rabbit polyclonal anti-InlK antibody. Decreased concentrations of recombinant purified InlK were used as a positive control.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_2-D</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Detection of secreted InlK in the supernatant of ΔsrtA mutants over-expressing InlK. Western blotting was carried out on trichloroacetic acid precipitates of ΔsrtA and ΔsrtA+pPRT-inlK culture (OD600 = 1) supernatants using the rabbit polyclonal anti-InlK antibody.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_2-E</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Detection of purified recombinant InlK protein with rabbit polyclonal anti-live Listeria antibody, rabbit polyclonal anti-killed Listeria antibody, rabbit polyclonal anti-InlK and a rabbit pre-immune serum. InlK was detected only with the rabbit polyclonal anti-live Listeria antibody indicating that it is expressed during the in vivo infectious process. BSA was used as control protein. Two different amounts of proteins were tested (500 ng and 200 ng) to access signal specificity.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_3-A</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Bacterial pull-down of purified GST-MVP with the L. monocytogenes strains WT+pPRT-empty, ΔinlK+pPRT-empty, ΔinlK+pPRT-inlK and WT+pPRT-inlJ. GST-MVP bound to InlK over-expressing bacteria (ΔinlK+pPRT-inlK) but not to other bacteria. GST-ScarA was used as control of the specificity of the MVP precipitation by InlK over-expressing bacteria.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_3-B</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Bacterial pull-down of MVP-GFP from transfected HeLa cell lysates with the L. monocytogenes strains WT+pPRT-empty, ΔinlK+pPRT-empty, ΔinlK+pPRT-inlK and WT+pPRT-inlJ. MVP-GFP bound to InlK over-expressing bacteria (ΔinlK+pPRT-inlK) but not to other bacteria.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_3-C</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Co-immunoprecipitation (Co-IP) of purified InlK (20 µg) with endogenous MVP of HT29 cells. The right panel shows anti-MVP co-IP performed on HT29 cell lysates. The left panel shows the control anti-MVP co-IP performed on lysis buffer.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_3-D</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Detection of MVP recruitment at the surface of InlK over-expressing bacteria. HeLa cells were transfected with MVP-GFP (green), infected with L. monocytogenes EGD-e wild-type (WT), ΔinlK or ΔinlK+pPRT-inlK for 4 h, fixed for fluorescence light microscopy, and stained with anti-Listeria antibodies (red). Inset regions are magnified. The scale bar represents 1 µm.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_4-A</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Detection of MVP recruitment at the surface of intracellular InlK over-expressing bacteria. HeLa cells were transfected with MVP-GFP (red), infected with InlK expressing Listeria (ΔinlK+pPRT-inlK) for 4 h, fixed for fluorescence light microscopy. Intra- (only green) and extracellular (cyan = green+blue) bacteria were differentially stained with anti- Listeria antibody (cf Material and Methods). Inset regions are magnified. Arrows indicate another intracellular bacterium which recruit MVP-GFP. The scale bar represents 1 µm. The right panel represents the quantification of the intracellular bacteria that recruit MVP (mean%±SEM%) shown in the left panel. Statistical analyses were performed on the results of 3 independent experiments using the Student's t test. No significant difference was found between the 4 time points.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_4-B</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Detection of MVP recruitment at the surface of intracytosolicInlK over-expressing bacteria. HeLa cells were transfected with MVP-tomato (red) and YFP-CBD (green), infected with InlK over-expressing Listeria (ΔinlK+pPRT-inlK) for 4 h, fixed for fluorescence light microscopy and stained with phalloidin (blue). MVP positive bacteria were also labeled with YFP-CBD revealing that MVP was recruited by intracytosolic bacteria after the lysis of the internalization vacuole. Inset regions are magnified. The scale bar represents 1 µm.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_4-C</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Kinetics of MVP and actin recruitment at the surface of InlK over-expressing bacteria. HeLa cells were transfected with MVP-tomato (red) and actin-GFP (green), infected with InlK over-expressing Listeria (ΔinlK+pPRT-inlK) for 4 h, and prepared for real-time video microscopy. Image series were collected every 15 min for 2 h. The left part shows an MVP positive bacterium that never recruits actin. The right part shows MVP replacement by actin around the bacterium. No colocalization of MVP-Tomato and actin-GFP was detected. Time is indicated along the Y axis. The entire image sequence can be viewed as Video S1.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_5-A</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Impaired recruitment of p62 to MVP positive Listeria. HeLa cells were transfected with MVP-GFP (green), infected with InlK over-expressing Listeria (ΔinlK+pPRT-inlK) for 4 h, fixed for fluorescence light microscopy, and stained with phalloidin (blue) and anti-p62 antibody (red). Inset regions are magnified. Arrows indicate independent bacteria The scale bar represents 1 µm. The vast majority of MVP-positive bacteria were completely devoid of anti-p62 labeling (95.1±2.0%; mean ± SEM from n = 3 experiments) but 4.9±2.0% (mean ± SEM from n = 3 experiments) were stained at one pole with MVP and at the other pole with p62.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_5-B</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Impaired recruitment of GFP-LC3 on MVP positive Listeria. HeLa cells were transfected with MVP-tomato (red) and GFP-LC3 (green), infected with InlK over-expressing Listeria (ΔinlK+pPRT-inlK) for 4 h, fixed for fluorescence light microscopy, and stained with phalloidin (blue). Inset regions are magnified. The scale bar represents 1 µm. MVP and/or actin positive bacteria were never recognized by GFP-LC3. Arrows point to bacteria at different steps of the infection process: 1) InlK over-expressing bacterium is totally covered by MVP; 2) bacterium is partially labeled with MVP (at the poles) and actin (at the center); 3) bacterium is completely covered by actin; 4) bacterium is enclosed in an GFP-LC3 positive autophagosome.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_5-C</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Kinetics of autophagy escape for MVP positive Listeria. Jeg3 cells were transfected with MVP-tomato (red) and GFP-LC3 (green), infected with InlK over-expressing Listeria (ΔinlK+pPRT-inlK) for 4 h, and prepared for real-time video microscopy. Image series were collected every 5 min for 2 h. Time is indicated along the Y axis. The left panel shows that the GFP-LC3 membranous aggregate detaches from the MVP positive Listeria. The entire image sequence can be viewed as Video S2. The right panel shows that the GFP-LC3 membranous aggregate on MVP positive bacteria does not lead to an autophagosome formation, whereas those bacteria efficiently divided. The entire image sequence can be viewed as Video S3.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_5-D</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Impaired recruitment of GFP-LC3 and ubiquitin to MVP positive ΔactAListeria. HeLa cells were transfected with MVP-tomato (red) and GFP-LC3 (green), infected with InlK over-expressing ΔactA (ΔactA+pADc-inlK) for 4 h, fixed for fluorescence light microscopy, and stained with anti-ubiquitin antibody (blue) and DAPI (white). Inset regions are magnified. The scale bar represents 1 µm.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_5-E</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. LC3 levels in infected RAW 267.4 macrophages. Left panel: RAW 267.4 macrophages were infected with L. monocytogenes EGD (WT), ΔactA or ΔactA+InlK for 6 h. Cell total lysates were immunobloted for LC3 and actin. Western blot is representative from 3 independent experiments. Right panel: Quantification of the relative LC3-II level (mean ± SEM) shown in the left panel. Statistical analyses were performed on the results of 3 independent experiments using the Student's t test. P values of &lt;0.05 were considered statistically different.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_6-A</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. InlK and ActA expression in Listeria strains used for survival assays. Total lysates of L. monocytogenes EGD-(pADc-GFP), EGD-(pADc-inlK), ΔactA-(pADc-GFP) and ΔactA-(pADc-inlK) grown in BHI were immunoblotted using anti-ActA and anti-InlK antibodies.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_6-B</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Intracellular survival of EGD-(pADc-GFP), EGD-(pADc-inlK), ΔactA-(pADc-GFP) and ΔactA-(pADc-inlK) in RAW 267.4 macrophages. Statistical analyses were performed on the results of 3 independent experiments using the Student t test. P values of &lt;0.05 were considered statistically different and are labeled here as *.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_6-C</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Intracellular survival of ΔactA-(pADc-GFP) and ΔactA-(pADc-inlK) in MVP-GFP transfected Jeg3 cells. Statistical analyses were performed on the results of 3 independent experiments using the Student's t test. P values of &lt;0.05 were considered statistically different and are labeled here as *.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_6-D</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Intracellular survival of ΔactA-(pADc-GFP) and ΔactA-(pADc-inlK) in MVP-GFP transfected HeLa cells. Statistical analyses were performed on the results of 3 independent experiments using the Student's t test. P values of &lt;0.05 were considered statistically different and are labeled here as *.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_6-E</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. MVP levels in RAW 267.4 macrophages treated with MVP-siRNA. Western blot is representative from 3 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3150275 Figure_6-F</id>
    <infon key="sourcedata_document">788</infon>
    <infon key="doi">10.1371/journal.ppat.1002168</infon>
    <infon key="pmc_id">3150275</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Intracellular survival of ΔactA-(pADc-GFP) and ΔactA-(pADc-inlK) in MVP knock-down RAW 267.4 macrophages. Statistical analyses were performed on the results of 3 independent experiments using the Student t test. P values of &lt;0.05 were considered statistically different and are labeled here as *.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_1-A</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) BI‐1 WT and KO MEFs cells were stably transduced with retroviruses expressing cytochrome b5-GFP to visualize the ER (green). Then cells were stained with lysotracker (red) and observed with a confocal microscope. Nucleus was stained with Hoechst (blue). Scale bar: 30 μm.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_1-B</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) BI‐1 WT and KO MEFs cells stimulated with EBSS for 3 h to induce autophagy. Acidic vesicles were visualized with a confocal microscope after lysotracker staining. Data represent the results of three independent experiments. Scale bar: 50 μm.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_1-C</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) (a) Epifluorescence imaging of BI‐1 KO cells stained with lysotracker; (b) electron micrograph of the same field of cells shown in (a); (c-e), magnification of lysotracker‐positive vesicles in BI‐1 KO cells exposed to EBSS for 3 h and visualized with a fluorescent microscope (c) and the same field subsequently imaged by EM (d). Overlapping images are presented (e). Left panel: analysis of vesicular structures by EM with morphologies resembling early (f), intermediate (g) and late (h) autophagy vesicles.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_1-D</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Left panel: the distribution of endogenous LC3 was monitored by immunofluorescence and confocal microscopy in BI‐1 WT and KO MEFs cells at basal conditions (NT) or after exposure to EBSS for 3 h. Scale bar: left 15 μm and right 10 μm. Right panel: quantification of the number cells containing three or more LC3‐positive vesicles (N=160 cells). Mean and standard deviation are presented (N=4). Student's t‐test was used to analyse statistical significance, **P0.001 and *P0.01.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_1-E</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) BI‐1 WT and KO cells were transiently transfected with an expression vector for a monomeric‐tandem LC3-RFP-GFP construct. After 24 h, cells were exposed to EBSS for 3 h. Autophagy fluxes were monitored in living cells by visualizing the distribution of LC3‐positive dots in the red and green channels using a confocal microscope. Scale bar: 10 μm. Right panel: quantification of the ratio between red and yellow dots per cell is presented. Mean and standard error of the analysis of 15 cells are shown.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_2-A</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) BI‐1 WT and KO MEFs were treated with EBSS (left panel) or glucose/serum‐free RPMI media (right panel) for the indicated time points. Then, levels of LC3 were determined by western blot analysis. LC3‐I and LC3‐II forms are indicated. Hsp90 levels were assessed as loading control.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_2-B</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of LC3‐II levels relative to Hsp90 expression was performed in several experiments performed as presented in (A).</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_2-CD</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 2-CD</infon>
    <infon key="sourcedata_figure_dir">Figure_2-CD</infon>
    <passage>
      <offset>0</offset>
      <text>(C)Cells were pre‐treated with a cocktail of lysosomal inhibitors (200 nM bafilomycin A1, 10 μg/ml pepstatin, and E64d; left panel) or 10 mM 3‐methyladenine (3‐MA; right panel) for 12 h and then exposed to starvation. LC3 levels monitored by western blot (D) and quantification of LC3‐II levels relative to Hsp90 were performed in the experimental conditions described in (C).</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_2-F</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) BI‐1 KO cells were stably transduced with retroviruses expressing BI‐1-GFP or empty vector, and then levels of LC3‐II were assessed over time by western blot after exposure to EBSS. Right panel: as control, the levels of BI‐1-GFP were monitored by western blot. Hsp90 levels were used as loading control. In (B, D and E) mean and standard deviation are presented. Two‐way ANOVA was applied to analyse statistical significance. In parenthesis, the number of independent experiments for each time point is indicated. Student's t‐test was also used in (E) to analyse the statistical significance between each time point (*P0.001). In (B, D and E), normalization was performed as a ratio with the LC3‐II/Hsp90 normalized levels from non‐treated BI‐1 WT cells.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_3-A</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Left panel: BI‐1 WT and KO MEFs cells were incubated in EBSS, and then cell viability was monitored using the MTS assay. Right panel: a similar experiment was performed after treating cells with the indicated concentration of tunicamycin for 24 h. Mean and standard deviation are presented of triplicates representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_3-B</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) BI‐1 WT and KO cells were treated with three different starvation stimuli for 6 and 24 h. Cell death was determined after propidium iodide (PI) staining and FACS analysis. In addition, cells were treated with 100 ng/ml tunicamycin (Tm) for 24 h. Mean and standard deviation are presented of one experiment performed in triplicates.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_3-C</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cells were exposed to EBSS for 6 h or 1 μg/ml Tm for 2 h, and then replated in normal cell culture media. After 5 days, cell viability was monitored by staining with crystal violet. Data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_3-D</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) BI‐1 WT MEFs were stably transduced with lentiviral expression vectors to deliver an shRNA against bi‐1 mRNA or control mRNA (luciferase shRNA). Cell survival was measured after treatment of cells as described in (B). Mean and standard deviation of an experiment made by triplicate, representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_3-E</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) BI‐1 KO cells were stably transduced with retroviruses expressing BI‐1-GFP or empty vector, and then exposed to EBSS for indicated time points. Cell viability was monitored after PI staining by FACS. Mean and standard deviation are presented of triplicates representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_4-A</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) BI‐1 WT and KO MEFs were treated with EBSS for 2 h, and the levels of phospho‐p70S6k were determined by western blot analysis. Total p70S6k is also shown.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_4-B</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) LC3 was monitored by immunofluorescence in cells treated with EBSS for 3 h in the presence or absence of 10 μM JNK inhibitor SP600125. Mean and standard deviation are presented (N=3). Student's t‐test was used to analyse statistical significance, *P0.001 and **P0.0001.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_4-C</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) BI‐1 WT and KO cells were treated with EBSS for indicated time points, in the presence or absence of 10 μM of the JNK inhibitor SP600125. Levels of phosphorylation of JNK (pJNK) and LC3‐II were determined by western blot. The levels of total JNK and Hsp90 are shown as control (N=4). Image was assembled from cropped lanes of the same western blot analysis of the same gel.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_4-D</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) BI‐1 WT and KO cells were treated with EBSS for indicated time points in the presence or absence of 10 μM SP600125, and the electrophoretic shift associated with BCL‐2 phosphorylation was monitored by western blot.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_4-E</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) BI‐1 WT and KO cells were co‐transfected with expression vectors for Beclin‐1-MYC, BI‐1-HA, and BCL‐XL-FLAG. After 24 h, cells were treated with EBSS for 2 h or left untreated. The association of MYC‐tagged expressed Beclin‐1 and BCL‐XL-FLAG was assessed by immunoprecipitation of Beclin‐1 followed by western blot analysis.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_4-F</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) 293T cells were co‐transfected with expression vectors for Beclin‐1-MYC, BI‐1-HA, and BCL‐XL-FLAG. Cell extracts were prepared in CHAPS buffer and Beclin‐1-MYCimmunoprecipitated, and the possible co‐precipitation of BI‐1-HA, and BCL‐XL-FLAG was assessed by western blot analysis (N=3). Asterisks indicate BI‐1 oligomers.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_4-G</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) (G) 293T cells were co‐transfected as described in (F) and BI‐1-HA was immunoprecipitated, and the possible co‐precipitation of Beclin‐1-MYC, and BCL‐XL-FLAG determined by western blot analysis (N=3). Figure source data can be found with the Supplementary Information.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_5-A</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) BI‐1 KO MEFs were stably transduced with lentiviral vectors expressing an shRNA against beclin‐1 (shBeclin‐1) or ire1α (shIRE1α) mRNA or luciferase (shLuc) as control. The levels of LC3, Beclin‐1, IRE1α and Hsp90 were monitored by western blot.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_5-B</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) BI‐1 KO MEFs were stably transduced with lentiviral vectors as described in A. Cells were exposed to EBSS for 3 h, and then LC3 levels were analysed by western blot. Image was assembled from cropped lanes of the same western blot analysis.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_5-C</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Endogenous LC3 distribution was visualized using immunofluorescence and confocal microscopy in BI‐1 KO/shLuc and BI‐1 KO/shBeclin‐1 cells. Quantification represents the visualization of at least 180 cells. Student's t‐test was used to analyse statistical significance. Mean and standard deviation are presented, *P0.001, NS: non‐significant.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_5-D</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) LC3 was visualized and quantified in BI‐1 KO/shLuc and BI‐1 KO/shIRE1α cells described in (B) by immunofluorescence and confocal microscopy analysis.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_5-E</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) BI‐1 KO cells were transiently transfected with a TRAF2 dominant‐negative (TRAF2‐DN) construct or empty vector (mock), and after 48 h cells were stimulated with EBSS and the levels of LC3‐II and Hsp90 were monitored by western blot. Right panel: quantification of relative LC3‐II levels normalized with Hsp90 and non‐treated cells. Mean and standard deviation are presented.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_5-F</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) 293T cells were co‐transfected with expression vectors for HA‐tagged IRE1α (IRE1-HA), TRAF2-FLAG, and MYC‐tagged BI‐1 (BI1-MYC). After 48 h of transfection, HA‐tagged proteins were immunoprecipitated and the possible interaction with TRAF2 was analysed by western blot. Right panel: the percentage of TRAF2 dissociation from IRE1α by the presence or absence of BI‐1 was quantified and normalized with the expression levels observed in the inputs. For comparison, the co‐IP signal observed in the absence of BI‐1 was normalized as 100% co‐IP in each independent experiment (N=3). Mean and standard deviation are presented, *P0.05. Figure source data can be found with the Supplementary Information.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_6-A</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The expression of dBI‐1 was knocked down in Drosophila melanogaster. Then, relative expression levels of dBI‐1 mRNA were monitored by semiquantitative PCR. Actin levels were monitored as control.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_6-B</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) (B) LC3 levels were monitored in control (Da‐Gal4&gt;huLC3:GFP) or dBI‐1 RNAi larvae (Da‐Gal4&gt;huLC3:GFP, Dcr2, dBI‐1i) under basal or fasting conditions. Then, huLC3-GFP levels were analysed by western blot. In addition, dBI‐1i larvae were treated with 100 μM SP600125 (added in the growing media).</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_6-C</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Left panel: the presence of LC3‐positive vesicles (white arrowheads) was monitored by confocal microscopy in control (Da‐Gal4&gt;huLC3&gt;GFP) and dBI‐1 knockdown pupae (Da‐Gal4&gt;huLC3:GFP, Dcr2, dBI‐1i) after 6 h of puparium formation. The organization of actin cytoskeleton was monitored by staining with phalloidin (Ph, red). Nucleus was stained with Topro (blue). Scale bar: left 20 μm and right 11 μm. Right panel: overexpression of dBI‐1 (dBI‐1EY03662) delays salivary gland degradation. Overexpression of dBI‐1 was confirmed by semiquantitative RT-PCR. Actin levels were monitored as loading control. Right panel: wild‐type control and dBI‐1EY03662pupae were analysed at 14 h after puparium formation. Superficial and internal confocal planes of the cells are presented. Scale bar: 40 μm.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_6-D</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Wild‐type control and dBI‐1EY03662larvae were cultured in fasting conditions for different periods of time and fat body stained with lysotracker (red) and Hoechst (blue). Then, lysosomal content in the fat body was visualized by epifluorescence microscopy. The percentage of cells presenting lysotracker‐positive stain is indicated. Scale bar: 50 μm.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_6-E</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Control or dBI‐1 knockdown adult flies were exposed to nutrient starvation and then animal viability was monitored over time for several days. In all, 100 individuals were monitored in each condition. Data represent mean and standard error (N=3). Two‐way ANOVA was used to analyse statistical significance between groups.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_6-F</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Second instar dBI‐1 RNAi or control larvae were grown in food supplemented with 25 μg/ml Tm dissolved in DMSO or 0.5% DMSO as control. The number of individual reaching the adult fly stage was evaluated. Mean and standard error are presented (N=3), **P0.01.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_7-A</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The levels of LC3, Atg5/Atg12 complex, Beclin‐1, Bcl‐2, Bcl‐XL, IRE1α and Hsp90 were monitored in liver protein extracts of bi‐1+/+ and bi‐1−/− at 6‐month‐old mice. Each well represents independent mice.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_7-B</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) A similar analysis was performed for indicated markers in kidney protein extracts as described in liver.</text>
    </passage>
  </document>
  <document>
    <id>3230375 Figure_7-C</id>
    <infon key="sourcedata_document">410</infon>
    <infon key="doi">10.1038/emboj.2011.318</infon>
    <infon key="pmc_id">3230375</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) bi‐1+/+ and bi‐1−/−mice were injected with 50 ng/ml of tunicamycin by intraperitoneal injection (N=3) and then LC3 levels were monitored in liver protein extracts by western blot analysis. Right panel: quantification of relative LC3‐II levels, **P0.005.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_1-A</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NIH-3T3 cells were transduced with retroviral vectors expressing M45 or GFP. Two days after transduction cells were stimulated with the TLR4 agonist LPS (10 µg/ml), the TLR2 agonist LTA-SA (10 µg/ml), or IL-1β (20 ng/ml). IκBα levels were determined by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_1-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) NIH-3T3 cells were transduced with an M45-expressing or an empty retroviral vector. 30 min after stimulation with IL-1β (10 ng/ml) cells were fixed, and subcellular localization of the NF-κB p65 subunit was analyzed by immunofluorescence.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_1-C</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) NIH-3T3 cells expressing an NF-κB-dependent secreted alkaline phosphatase (SEAP) reporter were transduced with retroviral vectors expressing M45 or GFP and stimulated 78 h later with the TLR2 agonist Pam3CSK4 (Pam.,1 µg/ml), the TLR4 agonist LPS (0.1 µg/ml), or IL-1β (5 ng/ml). SEAP activity in the supernatant was quantified 15 h after stimulation and is shown as fold induction of SEAP activity of stimulated cells compared to non-stimulated cells (mean ± SD)</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_1-D</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) NIH-3T3 cells transduced with retroviral vectors expressing M45 or GFP were stimulated with IL-1β (20 ng/ml, 15 min) or TNFα (10 ng/ml, 5 min). Phosphorylated and total p38 in cell lysates was detected by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_2-A</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NIH-3T3 cells were infected with wt MCMV-GFP, an M45 deletion mutant (ΔM45) or a revertant virus (RM45) at an MOI of 10 and treated 5 h postinfection with the TLR2 agonist Pam3CSK4 (Pam., 0.1 µg/ml), the TLR4 agonist LPS (10 µg/ml), or IL-1β (20 ng/ml) for the indicated times. Levels of the indicated proteins were analyzed by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_2-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) BMDMs were infected with wt MCMV-GFP, ΔM45, or RM45 at an MOI of 3 and stimulated 8 h postinfection for 16 h with the TLR7 agonist R848 (0.1 µM). TNFα and IL-6 levels in the supernatant were determined by ELISA (mean ± SD).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="4" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_2-C</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) RAW264.7 macrophages were infected with wt MCMV-GFP or ΔM45 at an MOI of 0.1, stimulated 24 h postinfection for 4 hours with TLR agonists Pam3CSK4 (Pam.) or Malp-2 (TLR2), LPS (TLR4), R837 (TLR7), or CpG (TLR9), in the presence of brefeldin A. Cells were fixed, permeabilized, and stained with a TNFα-specific antibody. The percentages of TNFα-positive cells within infected (GFP-positive) cell populations were determined by FACS analysis (mean ± SD).</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_3-A</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) 293A cells were transfected with plasmids expressing HA-tagged M45 or an unrelated MCMV control protein (m143) and Flag-tagged IKK subunits. Lysates were subjected to immunoprecipitation (IP) using an anti-HA antibody. Immunoprecipitates were analyzed by immunoblotting (IB) using anti-Flag antibody. Whole cell lysates (WCL) were immunoblotted using Flag-, HA-, and actin-specific antibodies, respectively.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_3-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Nemo−/−MEFs were transfected with HA-tagged IKK subunits and HA-tagged M45 or an unrelated MCMV control protein (m142), respectively. IP and IB were performed using anti-HA and anti-Flag antibodies, respectively. WCL were immunoblotted with anti-NEMO antibody and as described for panel A.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_3-C</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) rip1−/−MEFs were transfected with HA-tagged M45 or an unrelated MCMV control protein (m142) and Flag-tagged NEMO. IP was done with an anti-HA antibody. Immunoprecipitates and WCL were analyzed by immunoblotting using the indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_3-D</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) 293A cells were transfected with plasmids expressing HA-tagged M45 or m143 (as a control). Lysates were subjected to anti-HAimmunoprecipitation. Immunoblotting of precipitates and the WCL was done with antibodies as indicated.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_3-E</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) NIH-3T3 cells were infected for 4 hours with RM45 (MCMV expressing HA-tagged M45), ΔM45, or Rm142 (MCMV expressing HA-tagged m142) at an MOI of 5. Cell lysates were subjected to IP and IB with antibodies as indicated.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_4-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) NIH-3T3 cells were transduced with retroviruses expressing full length M45, truncated M45 proteins, or GFP. After stimulation with IL-1β (20 ng/ml, 15 min), IκBα levels were determined by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_4-C</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) 293A cells were transfected with plasmids encoding Flag-tagged NEMO and HA-tagged full-length M45, truncated M45, or an unrelated MCMV control protein (m142), respectively. Lysates were subjected to immunoprecipitation (IP) with an anti-HA antibody. Immunoprecipitates and the whole cell lysates (WCL) were analyzed by immunoblotting (IB) with the indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_4-D</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Primary BMDMs were mock infected or infected with GFP-expressing wt MCMV (wt), ΔM45 mutant (ΔM45), M45 revertant (RM45), or MCMVs expressing Ct or Nt3 (RCt and RNt3) at an MOI of 1. 17 h postinfection cells were stimulated for 4 hours with TLR9 agonist CpG (0.5 µM) or TLR7 agonist R838 (0.1 µM) in the presence of brefeldin A. Cells were fixed, permeabilized, and stained with a TNFα-specific antibody. The percentages of TNFα-positive cells within infected (GFP-positive) cell populations were determined by FACS analysis (mean ± SEM).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="12" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_5-A</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NIH-3T3 cells were infected with MCMV ΔM45 or the revertant virus, RM45, at an MOI of 3. Cells were harvested at indicated time points postinfection, and the levels of IKK subunits, M45, IE1, and actin in lysates were analyzed by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_5-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Murine fibroblasts (NIH-3T3, 10.1) or human embryonic kidney 293A cells were transduced with retroviral vectors expressing M45 or GFP, harvested 72 hours later, and analyzed by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_5-C</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) ts20 cells harboring a immunoblotting-sensitive E1 enzyme were incubated for 14 h at a permissive (35°C) or a restrictive (40.5°C) temperature. Cells were then mock-infected or infected with RM45, and analyzed 10 h postinfection by immunoblotting</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_5-D</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) NIH-3T3 cells were mock infected or infected with RM45 (MOI of 5) and treated 2 hpi with 10 mM ammonium chloride (NH4Cl) or a mix of lysosomal protease inhibitors (PI-mix). 9 hpi, levels of IKK subunits, M45, IE1, and actin were determined by immunoblotting. (</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_5-E</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) NIH-3T3 cells were stably transduced with retroviral vectors expressing M45 or GFP, and treated for the indicated times with PI-mix, 10 mM NH4Cl, or 5 µM lactacystin, respectively. Levels of the indicated proteins were analyzed by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_6-A</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NIH-3T3 cells stably expressing Flag-tagged NEMO were mock infected or infected with wt MCMV-GFP or MCMV-GFP-ΔM45 at an MOI of 6. Cells were fixed 6 hpi, and NEMO distribution was analyzed by immunofluorescence. The arrow indicates the region which is shown in higher magnification in the right corner of the picture.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_6-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) NIH-3T3 cells were transfected with Flag-NEMO and M45-HA expressing plasmids as indicated. 24 h later, cells were fixed and double immunofluorescence staining was performed using antibodies against the HA and Flag tags. Regions shown in higher magnification in the left corner of the pictures are indicated by arrows.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_6-C</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) NIH-3T3 cells stably expressing Flag-NEMO were mock infected or infected with MCMV-M45-HA or MCMV-ΔM45 at an MOI of 7. Seven hpi, cells were fixed and analyzed as described for panel B.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_6-D</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) NIH-3T3 cells were transfected with expression plasmids for Flag-NEMO and M45-HA or empty vector as indicated. Plasmids encoding GFP-tagged LC3, Rab5, or Rab7 were cotransfected. 24 hours posttransfection cells were fixed and used for anti-Flagimmunofluorescence staining.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_7-A</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) atg5−/− and atg5+/+MEFs were mock infected or infected with MCMVΔM45 or the revertant virus, RM45, at an MOI of 10. Eight hpi cells were harvested and levels of the indicated proteins were analyzed by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_7-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) 10.1 fibroblasts were mock infected or infected with wt MCMV or ΔM45 at an MOI of 5. Cells were left untreated or treated 30 min after infection with 10 mM NH4Cl to block lysosomal degradation of LC3-II. Cells were harvested at the indicated time points, and LC3-II levels in cell lysates were analyzed by immunoblotting using an LC3-II-specific antibody. LC3-II levels were quantified by densitometric analysis and normalized using the corresponding actin levels. Fold increases are shown relative to mock-infected cells.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_8-A</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NIH-3T3 cells stably expressing GFP-LC3 were transduced with retroviral vectors expressing M45 or Ct3. Three days later, cells were analyzed by confocal laser scanning microscopy. GFP-LC3 dots were counted in 50 cells per sample. Results are shown as box and whisker plots. The bottom and top of the box represent the first and third quartile, respectively. The horizontal line within the box represents the median. The minima and maxima within 1.5-fold interquartile range are shown as whiskers. Dots represent outliers. Significance was determined using ANOVA (***, p&lt;0.001). M45 and Ct3 were detected by immunoblot</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_8-B</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Fluorescence images of cells described above. Large GFP-LC3 aggregates are indicated by arrow heads.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_8-C</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Electron micrograph of a double-membrane autophagosome in an M45-expressing cell.</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_8-D</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Autophagosomes were counted in 10 randomly selected M45- and Ct3-expressing cells (2-3 TEM sections per cell). Results are shown in box and whisker plots as described for panel A. Significance was determined using the student's t-test (***, p&lt;0.001).</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_8-E</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Epifluorescence image of an M45-expressing cell with large GFP-LC3 structures</text>
    </passage>
  </document>
  <document>
    <id>3271075 Figure_8-F-G-H</id>
    <infon key="sourcedata_document">791</infon>
    <infon key="doi">10.1371/journal.ppat.1002517</infon>
    <infon key="pmc_id">3271075</infon>
    <infon key="figure">Figure 8-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(F) TEM image of the same cell reveals large aggregates marked with 'A'. (G, H) Successive enlargement of the region marked in panel F shows an example of an aggregate-associated autophagosome.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f1-A</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f1-A</infon>
    <infon key="sourcedata_figure_dir">f1-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, b, Analysis of HeLa cells stably expressing YFP fused to the indicated galectins and infected with S. Typhimurium for 1 h. a, Percentage of bacteria coated by the indicated galectins. YFP-positive bacteria were counted by microscopy. Mean and standard deviation (s.d.) of triplicate HeLa cultures, n &gt; 100 bacteria per coverslip. b, Confocal microscopy. Arrowheads, bacteria shown in insets. DAPI, 4′,6-diamidino-2-phenylindole.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f1-B</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f1-B</infon>
    <infon key="sourcedata_figure_dir">f1-B</infon>
    <passage>
      <offset>0</offset>
      <text>c, Kinetics of fold replication for S. Typhimurium in HeLa cells transfected with the indicated siRNAs. Bacteria were counted on the basis of their ability to form colonies on agar plates. Mean and s.d. of triplicate HeLa cultures and duplicate colony counts. siRNAs are further characterized in Supplementary Fig. 2a-c. **P  0.01, Student's t-test. Scale bar, 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f2-A</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f2-A</infon>
    <infon key="sourcedata_figure_dir">f2-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, LUMIER binding assay: normalized ratio between luciferase activity bound to beads and present in lysates. Lysates of 293ET cells expressing NDP52, p62 or optineurin each fused to luciferase, and the indicated Flag-tagged galectins were incubated with anti-Flag beads. Flag-tagged proteins are further characterized in Supplementary Fig. 4a</text>
    </passage>
  </document>
  <document>
    <id>3343631 f2-B</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f2-B</infon>
    <infon key="sourcedata_figure_dir">f2-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Lysates of 293ET cells, expressing Flag-tagged proteins as indicated, were immunoprecipitated with anti-Flag beads. Lysates and immunoprecipitates (IP) were blotted for the presence of Flag-tagged proteins and endogenous NDP52.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f2-C</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f2-C</infon>
    <infon key="sourcedata_figure_dir">f2-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Confocal images of HeLa cells infected with S. Typhimurium for 1 h and stained with antisera against NDP52 and galectin 8. Arrowheads, bacteria shown in insets.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f2-D</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f2-D</infon>
    <infon key="sourcedata_figure_dir">f2-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, Co-localization of NDP52 with galectin-positive bacteria in HeLa cells stably expressing YFP fused to the indicated galectins, infected with S. Typhimurium and stained with NDP52 antiserum 1 h after infection. Mean and s.d. of duplicate HeLa cultures, n &gt; 100 bacteria per coverslip, representative of two independent experiments. Scale bar, 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f3-A</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f3-A</infon>
    <infon key="sourcedata_figure_dir">f3-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Percentage of S. Typhimurium coated by the indicated galectins. HeLa cells stably expressing YFP-tagged galectins were treated with the indicated siRNAs. YFP-positive bacteria were counted by microscopy at 1 h p.i. siRNAs are further characterized in Supplementary Fig. 2.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f3-B</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f3-B</infon>
    <infon key="sourcedata_figure_dir">f3-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Analysis of HeLa cells treated with the indicated siRNAs and stained with NDP52 antiserum. NDP52-positive bacteria were counted by microscopy 1 h after infection with S. Typhimurium. siRNAs are further characterized in Supplementary Fig. 2.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f3-C</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f3-C</infon>
    <infon key="sourcedata_figure_dir">f3-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Percentage of bacteria coated by the indicated galectin 8 alleles. HeLa cells stably expressing the indicated galectin 8 alleles fused to YFP were infected with S. Typhimurium. YFP-positive S. Typhimurium were counted by microscopy at 75 min p.i. WT, wild type.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f3-D</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f3-D</infon>
    <infon key="sourcedata_figure_dir">f3-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, Binding of galectin 8 to bacteria and HeLa cells. The indicated bacteria and HeLa cells were incubated with His-GST-ubiquitin (Ub), His-GST-galectin 8 or buffer as indicated, followed by murine anti-His antibody and PE-labelled anti-mouse serum.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f3-E</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f3-E</infon>
    <infon key="sourcedata_figure_dir">f3-E</infon>
    <passage>
      <offset>0</offset>
      <text>e, Percentage of S. Typhimurium coated by the indicated galectins. Wild-type CHO cells and mutant Lec3.2.8.1 cells stably expressing YFP-tagged galectins were infected with S. Typhimurium. YFP-positive bacteria were counted by microscopy at 1 h p.i.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f3-F</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f3-F</infon>
    <infon key="sourcedata_figure_dir">f3-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, Confocal images of HeLa cells expressing the indicated YFP-tagged galectins. Cells were left untreated or were exposed to hypertonic conditions, with or without (w/o) PEG as indicated, followed by hypotonic shock.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f3-G</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f3-G</infon>
    <infon key="sourcedata_figure_dir">f3-G</infon>
    <passage>
      <offset>0</offset>
      <text>g, Fold replication of S. Typhimurium in HeLa cells expressing the indicated galectin 3 variants and transfected with the indicated siRNAs. At 2 h and 6 h after infection, cells were lysed and bacteria counted on the basis of their ability to form colonies on agar plates. Galectin 3 proteins are further characterized in Supplementary Fig. 4b. Mean and s.d. of duplicate coverslips&gt;100 bacteria counted per coverslip. Data are representative of at least two repeats. *P&lt; 0.05, Student's t-test. Scale bar, 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f4-A</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f4-A</infon>
    <infon key="sourcedata_figure_dir">f4-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Confocal micrograph of HeLa cells expressing GFP-LC3 and mCherry-galectin-8, stained for NDP521 h after infection with S. Typhimurium. The lower right panel contains a fluorescence line scan along the yellow line in the merge inset. Arrowheads, bacteria shown in insets.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f4-B</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f4-B</infon>
    <infon key="sourcedata_figure_dir">f4-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Percentage of GFP-LC3-positive S. Typhimurium at 1 h p.i. in HeLa cells treated with the indicated siRNAs.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f4-C</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f4-C</infon>
    <infon key="sourcedata_figure_dir">f4-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Percentage of bacteria positive for NDP52. HeLa cells expressing the indicated NDP52 variants fused to YFP were infected with S. Typhimurium.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f4-D</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f4-D</infon>
    <infon key="sourcedata_figure_dir">f4-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, Percentage of bacteria positive for the indicated markers. HeLa cells, either wild type or expressing YFP-galectin-8 as indicated, were infected with S. Typhimurium. Ubiquitin was detected by antibody staining.</text>
    </passage>
  </document>
  <document>
    <id>3343631 f4-E</id>
    <infon key="sourcedata_document">544</infon>
    <infon key="doi">10.1038/nature10744</infon>
    <infon key="pmc_id">3343631</infon>
    <infon key="figure">f4-E</infon>
    <infon key="sourcedata_figure_dir">f4-E</infon>
    <passage>
      <offset>0</offset>
      <text>e, HeLa cells treated with the indicated siRNAs were infected with S. Typhimurium and stained for NDP52 at the indicated time points. Fluorescent bacteria were counted by microscopy at the indicated time points. Graphs, representing at least two independent repeats, show mean and s.d. of duplicate coverslips for which &gt;200 bacteria were counted. *P  0.05, Student's t-test. Scale bar, 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_1-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) GFP-LC3CHO cells were preincubated with 1 mM dybutiryl cAMP (+dbcAMP, panels d, e, and f) for 30 min and then were treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv) in the continuous presence of dbcAMP. Cells without any treatment were used as control (−dbcAMP, panels a, b, and c). Cells were immediately analyzed by confocal microscopy. A quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions is shown in the right panel (n = 100 cells/condition, * p&lt;0.05 paired Student's t-test). These data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_1-B-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 1-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) GFP-LC3CHO cells were incubated with complete medium in the absence (−dbcAMP) or presence of dbcAMP (+dbcAMP) and treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv) with (lower panel) or without (upper panel) bafilomycin A1 to block lysosomal degradation. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of three independent experiments. (C) The band intensities of two independent experiments were quantificated with the Adobe Photoshop program, and normalized against tubulin. * p&lt;0.05 (paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_10-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 10-A</infon>
    <infon key="sourcedata_figure_dir">Figure_10-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b wt (upper panel) or GFP-Rap2b ΔAAX (lower panel). Twenty-four hours after transfection, they were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and immediately visualized by confocal microscopy. These data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_10-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 10-B</infon>
    <infon key="sourcedata_figure_dir">Figure_10-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of the percentage of infected cells presenting LC3 puncta upon the infection. * p&lt;0.05, *** p&lt;0.001 (paired Student's t-test, n = 50 cells/condition). These data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_10-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 10-C</infon>
    <infon key="sourcedata_figure_dir">Figure_10-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of the percentage of bacteria decorated with Rap2b wt upon the infection. ** p&lt;0.01 (paired Student's t-test, n = 30 cells/condition). These data are representative of three independent experim</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_11-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 11-A</infon>
    <infon key="sourcedata_figure_dir">Figure_11-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HeLa cells were incubated for 4 h with complete medium in the presence (Hla) or absence (Ctr) of 10 µg/ml α-hemolysin or they were infected for 4 h with the wt strain of S. aureus (wt) or the α-hemolysin deficient mutant (Hla−). Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-Rap2b and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. A quantification of the bands intensities with the Adobe Photoshop program is shown in the lower panel. These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_11-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 11-B</infon>
    <infon key="sourcedata_figure_dir">Figure_11-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) HeLa cells were incubated for 4 h with complete medium in the presence (Hla) or absence (Ctr) of 10 µg/ml α-hemolysin or they were infected for 4 h with the wt strain of S. aureus (wt) or the α-hemolysin deficient mutant (Hla−). Cells were disrupted and whole cell lysates were subjected to pull-down assays using GST-Ral-GDS-RBD-sepharose. The levels of GTP-bound Rap2b were determined as was described in Materials and Methods by Western blot analysis using a rabbit anti-Rap2b and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. The band intensities were quantificated with the Adobe Photoshop program is shown in the lower panel. * p&lt;0.05 (paired Student's t-test). These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_2-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) GFP-LC3 CHO cells were preincubated for 30 min with 10 µM H89, a PKA inhibitor, in the presence (panels a, b, and c) or absence (panels d, e, and f) of 1 mM dbcAMP. Subsequently, they were incubated for 2 h in starvation medium (Stv, panels b and e) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla, panels c and f) in full nutrient media. Cells without any treatment were used as control (Ctr, panels a and d). Cells were finally analyzed by confocal microscopy. Images are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_2-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. ** p&lt;0.01 (paired Student's t-test, n = 100 cells/condition). These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_2-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) GFP-LC3CHO cells were preincubated for 30 min in the presence or absence of 10 µM H89, and then they were incubated for 2 h with 1 mM dbcAMP to verify the activity of H89. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-phosphoCREB and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. The band intensities were quantified with the Adobe Photoshop program (lower panel). These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_3-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) GFP-LC3CHO cells were preincubated with 10 µM 8-pCPT-2′-O-Me-cAMP (8-pCPT) for 30 min and then they were treated for 4 h with 10 µg/ml of α-hemolysin (Hla) or subjected to starvation conditions (Stv). Cells without any treatment were used as control. Cells were immediately analyzed by confocal microscopy. Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions is shown in the right panel (n = 50 cells/condition). These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_3-B-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) CHO cells were cotransfected with GFP-LC3 and myc-EPAC wt (left panel) or myc-ΔEPAC (right panel). Twenty-four hours after transfection they were incubated for 2 h in starvation medium (Stv) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (C) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions (n = 20 cells/condition). These data are representative of two independent experiments</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_4-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b wt (left panel) or GFP-Rap2b ΔAAX (right panel). Twenty-four hours after transfection, they were incubated for 2 h in starvation medium (Stv), with 50 ng/µl of rapamycin (Rapa) in full nutrient media, or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_4-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions is shown. * p&lt;0.05, ** p&lt;0.01 (paired Student's t-test, n = 50 cells/condition). These data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_4-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) CHO cells were transfected with GFP-Rap2b wt or GFP-Rap2b ΔAAX and incubated with complete medium without (Ctr) or with 10 µg/ml of α-hemolysin (Hla) for 4 h, with 50 ng/µl of rapamycin (Rapa) or subjected to starvation conditions (Stv) for 2 h in the absence or presence of bafilomycin A1. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_4-D</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantification of the Western blot bands intensities of two independent experiments with the Adobe Photoshop program.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_5-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HeLa cells were cotransfected with Rap2b siRNA and GFP-LC3 (right panel) or irrelevant siRNA and GFP-LC3 (left panel). Forty-eight hours after transfection, they were incubated for 2 h in starvation medium (Stv), with 50 ng/µl of rapamycin (Rapa) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_5-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of the percentage of cells presenting LC3 puncta upon incubation under the different conditions. Data correspond to two independent experiments (n = 50 cells/condition).</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_5-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Upper panel: The knockdown of Rap2b was determined by Western blot as indicated in Materials and Methods. Lower panel: The band intensities of two independent experiments were quantified with the Adobe Photoshop program, and normalized against tubulin. * p&lt;0.05 (paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_5-D</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) HeLa cells were cotransfected with GFP-LC3 and Rap2b siRNA or an irrelevant siRNA and incubated for 4 h with complete medium in the absence (Ctr) or presence of 10 µg/ml of α-hemolysin (Hla), with 50 ng/µl of rapamycin (Rapa) or subjected to starvation conditions (Stv) for 2 h. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody, and subsequently developed with an enhanced chemiluminescence detection kit. These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_5-E</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) The band intensities of two independent experiments were quantified with the Adobe Photoshop program, and normalized against tubulin. * p&lt;0.05 (paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_6-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>cAMP cannot inhibit the autophagy induced by the toxin in cells overexpressing the Rap2b negative mutant. (A) CHO cells were cotransfected with RFP-LC3 and GFP-Rap2b ΔAAX. Twenty-four hours after transfection they were incubated for 2 h in starvation medium (Stv) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla) in the presence (right panels) or absence of 1 mM dbcAMP (left panels). Cells without any treatment were used as control (Ctr). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_7-A-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) GFP-LC3CHO cells were preincubated for 30 min with 10 µM of calpeptin (a calpain inhibitor, panels b, f, and j), with 1 mM dbcAMP (panels d, h and l), or with Calpeptin+dbcAMP (panels c, g, and k). Afterwards, they were incubated for 2 h in starvation medium (Stv, panels e, f, g, and h) or treated for 4 h with 10 µg/ml of α-hemolysin (Hla, panels i, j, k, and l). Cells without any treatment were used as control (Ctr, panels a, b, c and d). Cells were analyzed by confocal microscopy. Images are representative of two independent experiments. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation with the different conditions. * p&lt;0.05 (paired Student's t-test, n = 100 cells/condition). These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_7-C-D</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Upper panel: CHO cells were preincubated for 30 min with 10 µM of calpeptin, with 1 mM dbcAMP, or with calpeptin+dbcAMP, and then they were incubated for 4 h in complete medium in the presence (Hla) or absence (Ctr) of α-hemolysin. Afterwards, cells were lysed with sample buffer and the samples were subjected to Western blot analysis using a rabbit anti-LC3 and the corresponding HRP-labeled secondary antibody. The bands were subsequently developed with an enhanced chemiluminescence detection kit. Lower panel: Quantification of the band intensities with the Adobe Photoshop program. * p&lt;0.05 (paired Student's t-test). These data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_8-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) GFP-LC3CHO cells were preincubated with 1 mM dybutiryl cAMP (+dbcAMP) for 30 min and then were infected for 4 h in the presence of db cAMP with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−) +pHla). Cells without any treatment were used as control (−dbcAMP). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods, and immediately visualized by confocal microscopy. Images are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_8-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>. (B) Quantification of the percentage of cells presenting LC3 puncta (i.e., stimulated cells) upon incubation in the different conditions. * p&lt;0.05, ** p&lt;0.01 (paired Student's t-test, n = 50 cells/condition). These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_8-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of the number of CFU/ml of CHO cells infected for 3 h with the wt strain of S. aureus, the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid in the absence or presence of cAMP. * p&lt;0.05 (paired Student's t-test). These data are representative of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_9-A</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>CHO cells were cotransfected with GFP-LC3 and myc-EPAC wt (upper panel) or myc-ΔEPAC (lower panel). Twenty-four hours after transfection, they were infected for 4 h with the wt strain of S. aureus (wt), the mutant deficient for α-hemolysin (Hla−), or the Hla(−) mutant expressing an α-hemolysin plasmid (Hla(−)+pHla). The nucleus and the bacteria were labeled with TOPRO as indicated in Materials and Methods and immediately visualized by confocal microscopy. Images are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_9-B</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Quantification of the percentage of cells presenting LC3 puncta upon the infection. These data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3359991 Figure_9-C</id>
    <infon key="sourcedata_document">794</infon>
    <infon key="doi">10.1371/journal.ppat.1002664</infon>
    <infon key="pmc_id">3359991</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of the percentage of bacteria decorated with EPAC in cells infected with S. aureus. ** p&lt;0.01 (paired Student's t-test, n = 20 cells/condition). These data are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-A-B</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-A-B</infon>
    <infon key="sourcedata_figure_dir">figf1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Western blot analysis of myosin-VI-depleted HeLa cells untreated or treated with 100 nM bafilomycin A1. (b) Quantification of western blotLC3-II intensity (±s.d.; n = 3). **P0.01, ***P0.001</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-C-D</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-C-D</infon>
    <infon key="sourcedata_figure_dir">figf1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Confocal immunofluorescence microscopy of LC3 punctae (green) in HeLa cells following knockdown of myosin VI. Hoechst labels the nuclei (blue). The insets show higher magnifications of the areas outlined in the main images (d) Quantification of LC3- and p62-positive punctae was performed and the results are represented as the average punctae fluorescence intensity per cell (±s.d.; n = 3) from &gt;1,500 cells per experiment.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-E</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-E</infon>
    <infon key="sourcedata_figure_dir">figf1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Western blot analysis of parental HeLa cells or HeLa cells stably expressing siRNA-resistant GFP-myosin VI transiently transfected with a single myosin VI siRNA oligonucleotide following treatment with 1 μM MG132.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-F</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-F</infon>
    <infon key="sourcedata_figure_dir">figf1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Western blot analysis of MEFs cultured from wild-type and Snell's waltzer (SV)mice treated with 1 μM MG132 or 100 nM bafilomycin A1.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-G-H</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-G-H</infon>
    <infon key="sourcedata_figure_dir">figf1-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Quantification of western blotLC3-II intensity (±s.d.; n = 3). **P0.01. (h) To evaluate the effects on autophagosome biogenesis, the results are shown as the fold increase in normalized LC3-II intensity with bafilomycin A1 compared with the untreated control. (±s.d.; n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-I-K</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-I-K</infon>
    <infon key="sourcedata_figure_dir">figf1-I-K</infon>
    <passage>
      <offset>0</offset>
      <text>(i) Western blot analysis of cortical neurons from wild-type and SV mice treated with 1 μM MG132 in the absence or presence of 100 nM bafilomycin A1. (j) Quantification of western blotLC3-II intensity was performed (n = 2). (k) To evaluate the effects on autophagosome biogenesis, the results are shown as the fold increase in normalized LC3-II intensity with bafilomycin A1 compared with the untreated control (n = 2).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">45</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="29" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-L-M</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-L-M</infon>
    <infon key="sourcedata_figure_dir">figf1-L-M</infon>
    <passage>
      <offset>0</offset>
      <text>(l) Western blot (top) and confocal immunofluorescence microscopy (bottom) of mock- or myosin-VI-siRNA-treated HeLa cells stably expressing the RFP-GFP-LC3 reporter. Hoechst labels the nuclei (blue). (m) Quantitative data of RFP and GFP signal overlap from confocal images of mock- or myosin-VI-siRNA-treated HeLa cells expressing RFP-GFP-LC3. The data are represented as the Pearson's coefficient of the RFP and GFP signal correlation from &gt;100cells per experiment (±s.d.; n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf1-N</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf1-N</infon>
    <infon key="sourcedata_figure_dir">figf1-N</infon>
    <passage>
      <offset>0</offset>
      <text>n) Confocal immunofluorescence microscopy of myosin-VI-depleted RPE cells stably expressing GFP-LC3 immunostained against GFP (green) and cathepsin D (red). Hoechst labels the nuclei (blue). The insets show higher magnifications of the areas outlined in the main images. Scale bars, 20 μm. Uncropped images of blots are shown in Supplementary Fig. S9.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf2-A</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf2-A</infon>
    <infon key="sourcedata_figure_dir">figf2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) RPE cells transiently transfected with siRNA against myosin VI and Atg5 were treated with 1 μM MG132 for 16 h. Cells were processed for immunofluorescence microscopy following 16 hMG132 treatment (zero time point) and 8 h post-washout of inhibitor. Immunolabelling for p62 was performed to visualize aggregates (red) and Hoechst was used to identify nuclei (blue).</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf2-B</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf2-B</infon>
    <infon key="sourcedata_figure_dir">figf2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Top, western blot analysis confirming siRNA depletion. Bottom, quantification of immunofluorescent p62-positive aggregates was evaluated using an automated Cellomics VTi microscope. The results were calculated as the average p62 fluorescence intensity at 8 h post-MG132 washout normalized to the zero time point and are represented as the percentage of the control (±s.d.; n = 3). *P0.05, ***P0.001. See Methods and Supplementary Table S1 for details of the SMARTpool (SP) and single (07) oligonucleotides.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf2-C</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf2-C</infon>
    <infon key="sourcedata_figure_dir">figf2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Parental HeLa cells or HeLa cells stable expressing siRNA-resistant GFP-myosin VI were transiently transfected with a single siRNA oligonucleotide targeting myosin VI and were subsequently treated with 1 μM MG132 for 16 h. Cells were processed for immunofluorescence microscopy at 16 h post-MG132 treatment (t = 0) or allowed to recover following washout of MG132 for 8 h (t = 8). Cells were processed for quantification with the automated Cellomics VTi microscope to evaluate the p62 fluorescence intensity. The results represent the fold increase in p62 fluorescence intensity of myosin VI siRNA compared with mock control cells following recovery from MG132 washout (t = 8; ±s.d.; n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf2-D-E</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf2-D-E</infon>
    <infon key="sourcedata_figure_dir">figf2-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(d) HeLa cells with stable expression of HttQ72-GFP were transiently transfected with siRNA against myosin VI followed by saponin extraction and processing for immunofluorescence microscopy. Immunolabelling was performed for GFP (green) and p62 (red). Nuclei are labelled with Hoechst (blue). (e) Quantification of HttQ72-GFP aggregates was performed on myosin-VI-siRNA-transfected HeLa cells. The results were calculated as the percentage of GFP-expressing cells with greater than 15 GFP-positive spots per cell. The results represent the mean (±s.d.) from n = 3independent experiments, ***P0.001. The insets show higher magnifications of the areas outlined in the main images. Scale bars, 20 μm. Uncropped images of blots are shown in Supplementary Fig. S9.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf3-A</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf3-A</infon>
    <infon key="sourcedata_figure_dir">figf3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) RPE cells transiently co-transfected with GFP-myosin VI and cherry-LC3 and either left untreated (top row) or treated with 250 nM Torin1 for 2 h (bottom row) were processed for immunofluorescence microscopy. The arrows highlight areas of co-localization and the insets show higher magnifications of the areas outlined in the main images.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf3-B</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf3-B</infon>
    <infon key="sourcedata_figure_dir">figf3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) RPE cells treated with 100 nM bafilomycin A1 were processed for immunofluorescence microscopy to evaluate endogenous myosin VI and endogenous LC3 co-localization. The arrows highlight areas of co-localization and the insets show higher magnifications of the areas outlined in the main images.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf3-C</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf3-C</infon>
    <infon key="sourcedata_figure_dir">figf3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Image stills acquired from spinning-disc time-lapse video microscopy of RPE cells transiently co-transfected with cherry-LC3 and GFP-myosin VI. The outlined regions highlight areas of interest within the cell that are shown to the right (i-iii) as video image stills captured at 1-min intervals. The arrowheads highlight myosin-VI-positive vesicles (green) coming into contact and co-localizing with LC3-positive vesicles (red).</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf3-D</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf3-D</infon>
    <infon key="sourcedata_figure_dir">figf3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Confocal immunofluorescence microscopy of RPE cells stably expressing cherry-LC3 following transient transfection with GFP-myosin VI. Immunostaining for GFP (green) and cherry (red) was performed and actin was visualized with phalloidin (white). Nuclei were labelled with Hoechst (blue). The arrowheads indicate areas of actin-rich myosin-VI/LC3-positive autophagosomes. Scale bars, 20 μm (a,b,d); 10 μm (c, whole-cell image); 2 μm (c, cropped images).</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf4-B-C</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf4-B-C</infon>
    <infon key="sourcedata_figure_dir">figf4-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(b) RPE cells with stable expression of cherry-LC3 were transiently transfected with the GFP-myosin VI cargo-binding tail domain containing various mutations in the protein-interaction (ΔWWY and ΔRRL) and ubiquitin-binding motifs (A1013G), followed by treatment with 250 nM Torin1 for 3 h to induce autophagy. Immunofluorescence microscopy was performed either in the absence or presence of saponin extraction. The arrowheads indicate areas of co-localization. Scale bar, 20 μm. (c) A Pearson's coefficient was calculated on the basis of the degree of co-localization between the different GFP-myosin VI mutant tails and cherry-LC3 from confocal immunofluorescence micrographs. The graph represents data from more than 20 transfected cells from n = 2 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf5-A</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf5-A</infon>
    <infon key="sourcedata_figure_dir">figf5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Left, immunofluorescence microscopy was performed on RPE cells following treatment with 100 nM bafilomycin A1 for 2 h. Immunolabelling was performed against the indicated endogenous proteins optineurin, T6BP and NDP52 (red), and LC3 (green). The insets show higher magnifications of the areas outlined in the main images. Right, from the confocal images, a Pearson's coefficient was calculated to estimate the degree of co-localization of the different autophagy adaptors with LC3. As a negative control, a Pearson's coefficient was calculated after rotation of one colour image by 90°. The results represent &gt;20 cells from n = 2 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf5-B</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf5-B</infon>
    <infon key="sourcedata_figure_dir">figf5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Left, stable cherry-LC3-expressing RPE cells were transiently transfected with GFP-myosin VI, treated with Torin1 for 3 h to induce autophagy, and subsequently processed for confocal immunofluorescence microscopy. Areas of co-localization are white in the merged three-colour images and the insets show higher magnifications of the areas outlined in the main images. Right, a Pearson's coefficient was calculated for the degree of co-localization between the three colours. As a negative control, a Pearson's coefficient was calculated after rotating one colour image by 90°. Results represent &gt;10 cells from n = 2 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf5-C-D</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf5-C-D</infon>
    <infon key="sourcedata_figure_dir">figf5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c) HeLa cells were either mock transfected or co-transfected with siRNA targeted against TNO. Cells were either left untreated or treated with100 nM bafilomycin A1 (BfnA1) for 4 h. Western blot analysis was performed against the indicated proteins. (d) Quantification of LC3-II intensity (±s.d.) was performed from western blot data of TNO-siRNA treated HeLa cells. The results represent n = 3independent experiments. **P0.01, ***P0.001</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf5-E</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf5-E</infon>
    <infon key="sourcedata_figure_dir">figf5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Immunofluorescence microscopy of RFP-GFP-LC3-expressing HeLa cells transfected with TNO siRNA was performed and confocal images were evaluated for the correlation in GFP and RFP punctae signal overlap using the Image JACoP plugin. The results are calculated from &gt;100 cells from n = 2 independent experiments represented as the Pearson's coefficient of GFP/RFP signal overlap. Scale bars, 20 μm. Uncropped images of blots are shown in Supplementary Fig. S9.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf6-A</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf6-A</infon>
    <infon key="sourcedata_figure_dir">figf6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Myosin VI and Tom1/Tom1L2co-immunoprecipitate from LNCAP cell lysates. Immunoprecipitation of myosin VI with three separate affinity-purified rabbit polyclonal antibodies (B4, B7, 2401) was performed alongside an IgG control immunoprecipitation. The immunoprecipitates were analysed by western blotting with antibodies against Tom1/Tom1L2.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf6-B</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf6-B</infon>
    <infon key="sourcedata_figure_dir">figf6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Binding of myosin VI to Tom1 requires the WWY motif. Bottom, the mammalian two-hybrid assay was used to test binding of full-length Tom1 and Tom1L2 or various truncated versions of Tom1, annotated by amino acid numbers, against wild-type myosin VI tail or the myosin VI ΔWWY or ΔRRL tail. The graph shows the mean values from n = 2 independent experiments. Top, Tom1 domain structure and truncation mutants. VHS, Vps-27, Hrs and STAM; GAT, GGA and Tom1.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf6-C</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf6-C</infon>
    <infon key="sourcedata_figure_dir">figf6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) RPE cells stably expressing GFP-myosin VI were processed for immunofluorescence microscopy to evaluate GFP-myosin VI and endogenous Tom1/Tom1L2 or Rab5 co-localization. The insets show higher magnifications of the areas outlined in the main panels. The arrows indicate areas of co-localization.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf6-D</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf6-D</infon>
    <infon key="sourcedata_figure_dir">figf6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) RPE cells with stable expression of GFP-myosin VI tail were subjected to mock or Tom1 siRNA transfection followed by western blot analysis (left) and immunofluorescence microscopy (middle) to evaluate GFP-myosin VI tail localization. Cells were either fixed directly or saponin-extracted before fixation. Quantification (right) was performed on RPE cells stably expressing GFP-myosin VI tail and transfected with mock, Tom1 or TNO siRNA. Cells were processed for immunocytochemistry, immunolabelled for GFP and nuclei labelled with Hoechst followed by quantification of GFP-myosin VI tail punctae per cell using an automated Cellomics VTi microscope. More than 600 cells per group from n = 3 independent experiments were analysed and are represented as the mean number of GFP-myosin VI tail punctae per cell (±s.d.). Scale bars, 20 μm. Uncropped images of blots are shown in Supplementary Fig. S9.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf7-A-B</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf7-A-B</infon>
    <infon key="sourcedata_figure_dir">figf7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a) HeLa cells transiently transfected with siRNA against Tom1 were left untreated or treated with 100 nM bafilomycin A1 for 4 h. Western blot analysis was performed on whole-cell lysates against the indicated proteins. (b) Quantification of LC3-II intensity of western blots was performed by an infrared imaging system. (±s.d.; n = 3). *P0.05, **P0.01.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf7-C</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf7-C</infon>
    <infon key="sourcedata_figure_dir">figf7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c, left) Confocal immunofluorescence microscopy was performed on HeLa cells transfected with Tom1 siRNA to evaluate LC3 punctae formation (green). The insets show higher magnifications of the areas outlined in the main images. Nuclei are labelled with Hoechst (blue). (c,right,d) Quantification of LC3-positive punctae (c, right) and p62-positive punctae (d) was performed in a 96-well format on an Arrayscan VTi HCS microscope. Cells were identified by Hoechst staining of nuclei (blue). The results are represented as the average punctae fluorescence intensity per cell (±s.d.) from n = 3 independent experiments each performed in triplicate wells, each with &gt;500 cells.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf7-D</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf7-D</infon>
    <infon key="sourcedata_figure_dir">figf7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c, left) Confocal immunofluorescence microscopy was performed on HeLa cells transfected with Tom1 siRNA to evaluate LC3 punctae formation (green). The insets show higher magnifications of the areas outlined in the main images. Nuclei are labelled with Hoechst (blue). (c,right,d) Quantification of LC3-positive punctae (c, right) and p62-positive punctae (d) was performed in a 96-well format on an Arrayscan VTi HCS microscope. Cells were identified by Hoechst staining of nuclei (blue). The results are represented as the average punctae fluorescence intensity per cell (±s.d.) from n = 3 independent experiments each performed in triplicate wells, each with &gt;500 cells.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf7-E</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf7-E</infon>
    <infon key="sourcedata_figure_dir">figf7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) HeLa cells with stable expression of the RFP-GFP-LC3 reporter construct were subjected to mock or Tom1 siRNA mediated knockdown (left). Confocal immunofluorescence microscopy (middle) was performed and images were subsequently quantified for the correlation between the GFP and RFP signals using the ImageJ JACoP plugin (right). The results are for at least 100 individual cells from n = 3 independent experiments and are represented as the Pearson's coefficient of GFP/RFP overlap (±s.d.). A higher Pearson's coefficient of GFP/RFP signal overlap represents a greater number of autophagosomes when compared with autolysosomes.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf7-F</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf7-F</infon>
    <infon key="sourcedata_figure_dir">figf7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Confocal immunofluorescence microscopy of Tom1-depleted RPE cells stably expressing GFP-LC3 immunostained against GFP (green) and cathepsin D (red). Hoechst labels the nuclei (blue). The insets show higher magnifications of the areas outlined in the main images.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf7-G</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf7-G</infon>
    <infon key="sourcedata_figure_dir">figf7-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) HeLa cells with stable expression of HttQ72-GFP were transiently transfected with Tom1 siRNA (top right), saponin-extracted, and processed for immunofluorescence microscopy (left) to quantify HttQ72-GFP punctae (bottom right). Immunolabelling against GFP (green) and p62 (red) was performed. Nuclei (blue) were labelled with Hoechst. The results are represented as the number of GFP-expressing cells with greater than 15 GFP-positive spots per cell (±s.d.; n = 3). Scale bars, 20 μm. Uncropped images of blots are shown in Supplementary Fig. S9.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf8-A</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf8-A</infon>
    <infon key="sourcedata_figure_dir">figf8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Left, RPE cells with stable expression of GFP-LC3 following mock- or myosin-VI-siRNA transfection were processed for confocal immunofluorescence microscopy and immunolabelled for Tom1/Tom1L2 (red). Nuclei (blue) were labelled with Hoechst. The insets show higher magnifications of the areas outlined in the main panels and the arrows highlight areas of complete overlapping co-localization and arrowheads highlight adjacent localization of Tom1 relative to LC3. Right, quantification was performed on &gt;75 cells for the relative position (adjacent or complete overlap) of Tom1-positive vesicles in relation to LC3-positive vesicles. The results are represented as the average number of Tom1-positive vesicles per cell categorized by their relative position to LC3 (±s.d.; n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf8-B-C</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf8-B-C</infon>
    <infon key="sourcedata_figure_dir">figf8-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(b) GFP-LC3-expressing RPE cells were depleted of myosin VI by siRNA. Cells were pulse labelled with Texas-red-dextran (red) for 4 h, before chase into fresh medium containing 1 μM MG132 for 2 h. Cells were processed for immunofluorescence microscopy and immunostained for GFP (green). Nuclei were labelled with Hoechst (blue). The insets represent higher magnifications of the areas outlined in the main panels. (c) Mander's overlap coefficients for the degree of LC3 signal co-localizing with dextran were calculated using Volocity software. The results represent &gt;20 cells from n = 3 independent experiments and are illustrated as a box and whisker plot. The box represents the median, 25th and 75th percentiles and whiskers represent the maximum and minimum.</text>
    </passage>
  </document>
  <document>
    <id>3472162 figf8-D</id>
    <infon key="sourcedata_document">606</infon>
    <infon key="doi">10.1038/ncb2589</infon>
    <infon key="pmc_id">3472162</infon>
    <infon key="figure">figf8-D</infon>
    <infon key="sourcedata_figure_dir">figf8-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) RPE cells stably expressing GFP-LC3 were depleted of myosin VI and Tom1 by siRNA. Cells were pulse-labelled with Texas-red (TR)-dextran for 16 h followed by a chase period of 4 h. Cells were processed for immunoelectron microscopy and labelled with 15 nm gold particles against GFP-LC3 and 5 nm gold particles against Texas-red-dextran. Scale bars, 20 μm (a,b); 200 nm (d).</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_1-A</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Western blot of Beclin‐1 and FACS profiles following siRNA treatment in HeLa cells and cells stably expressing a HA‐Beclin‐1 construct resistant to the siRNA targeting endogenous Beclin‐1.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_1-B</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) FACS profiles of cells treated with indicated siRNA following nocodazole blockage and release.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_1-C,D</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 1-C,D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C,D</infon>
    <passage>
      <offset>0</offset>
      <text>(C,D) Quantification of cells in mitosis (C) and quantification of each step of mitosis (D) by H3Ser10P staining for Control and Beclin‐1siRNA‐treated cells. Error bars represent standard deviations (s.d.) (n=number of counted cells) calculated on three independent experiments. Two and three asterisks indicate significant results (P=0.0028 and P=0.0006, respectively).</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_1-E</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Knockdown of Beclin‐1 increases the number of mitotic cells with misaligned chromosomes. siRNA‐treated HeLa cells were fixed in PFA, immunolabelled for α‐tubulin (green) and stained with DAPI (blue). White arrows indicate misaligned chromosomes. Quantification of cells with misaligned chromosomes is shown at the right (n=number of counted cells). Three asterisks indicate significant results (P=0.0001). Scale bar, 10 μm. DAPI, 4′,6‐diamidino‐2‐phenylindole; HA, haemagglutinin; PFA, paraformaldehyde; siRNA, small interfering RNA.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_2-A-B-C-D-E</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 2-A-B-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>Beclin‐1 depletion prolongs prometaphase by delaying chromosome congression. (A-H) Time‐lapse films of HeLa cells stably expressing YFP‐α‐tubulin and H2B‐Cherry and treated with the indicated siRNA. The pictures are acquired every 10 min. Time lapse starts at nuclear envelope breakdown. (A) Mitosis in control cells. (B) Western blot of whole‐cell lysates from Control, Beclin‐1 and Beclin‐1+Mad2 siRNA‐treated cells. (C-E) Three different classes of mitotic progression were observed upon Beclin‐1 depletion. Higher magnification of lagging chromatids in the anaphase of Beclin‐1‐depleted cells is shown on the right of (D).</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_2-F-G</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 2-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F) The prometaphase delay is dependent on MAD2 and the spindle checkpoint. Cells treated simultaneously with siRNA targeting MAD2 and Beclin‐1 rapidly exit mitosis. (G) Average duration of mitosis in different classes of Beclin‐1‐depleted cells, compared to control and MAD2 depletions. n=number of counted cells in three independent experiments. Error bars on graphs represent s.d.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_2-H</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) The frequency of the different Beclin‐1 phenotypes depended on the efficiency of Beclin‐1 knockdown. Mitotic progression in cells treated with increasing concentrations of Beclin‐1 siRNA was followed by video‐microscopy. Left panel: western blot of Beclin‐1 upon RNAi treatment; right panel: quantification of the appearance of the three different mitotic progression patterns, that is, prolonged mitosis with normal anaphase (as C), with lagging chromatids (as D) and mitotic exit without clear anaphase (as E) upon increased Beclin‐1 knockdown experiments. NEB, nuclear envelop breakdown; RNAi, RNA interference; siRNA, small interfering RNA; YFP, yellow fluorescent protein.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_3-A</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Inter‐kinetochore distance is reduced in unaligned chromosomes of Beclin‐1‐depleted cells. The distance between each kinetochore pair was quantified in siRNA‐treated and control cells treated with nocodazole for 3 h before fixation. Cells were stained with anti‐CREST antibody and DAPI. Quantification of the distance between kinetochore pairs (indicated by coloured bars) is reported at the bottom and done on sister kinetochores present in the same focal plane. One asterisk indicates significant result (P=0.0365). Graphs represent three independent experiments (error bars=s.d.).</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_3-B</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Depletion of Beclin‐1 leads to defects in K‐MT attachment. siRNA‐treated cells were cooled on ice before fixation to reveal stable k‐fibres and then stained with anti‐α‐tubulin (red) and anti‐CREST (green) antibodies. Numbers point to magnified areas and indicate the mode of attachment of k‐fibres to kinetochores (1, bi‐oriented; 2, unattached; 3, mono‐oriented kinetochores). Scale bar, 10 μm. DAPI, 4′,6‐diamidino‐2‐phenylindole; NS, not significant; siRNA, small interfering RNA.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_4-A</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) CENP‐E and CREST. Two asterisks indicate significant results, P=0.0053.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_4-B</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) CENP‐F and CREST. Three asterisks indicate significant results, P=0.0006.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_4-C</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) ZW10 and CREST. Three asterisks indicate significant results, P=0.0007.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_4-D</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) MAD2 and CREST. Two asterisks indicate significant results, P=0.0032.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_4-E</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) HEC1 and CREST.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_4-F</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) KNL‐1 and CREST. On the right, magnified areas and quantification of the fluorescence intensity of the protein of interest normalized to the fluorescence intensity of CREST staining are shown. Graphs represent three independent experiments (error bars=s.d.). Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_4-G</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Western blot of whole‐cell lysates from control and Beclin‐1 siRNA‐treated cells. siRNA, small interfering RNA.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-A</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoprecipitation of endogenous Zwint‐1 in HeLa cell extracts expressing HA‐Beclin‐1 or HA‐GFP. Input is 3.5% of the immunoprecipitated material.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-B</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) GST‐Zwint‐1 or GST‐beads were used to pull down recombinant purified His6‐Beclin‐1. (Left) Coomassie‐blue‐stained gel of the purified recombinant proteins (1 μg). (Right) A western blot of GST proteins and His6‐Beclin‐1 in the input and bound fractions. His6‐Beclin‐1 in the input represents 4% of the amount used for the pull‐down.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-C</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Zwint‐1 levels do not change in Beclin‐1‐depleted cells. Cells were treated with nocodazole before fixation. On the right, magnified individual kinetochore pairs stained for Zwint‐1 (red) and CREST (green), and quantification of Zwint‐1 levels normalized to CREST signal from three independent experiments (error bars=s.d.).</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-D</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Beclin‐1 is associated with both the centrosome and the mitotic spindle during mitosis. HeLa cells were permeabilized before fixation and immunostained for Beclin‐1 (green), α‐tubulin (red) and DNA (DAPI, blue).</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-E</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Beclin‐1 is retained on the k‐fibres. HeLa cells were cooled on ice before permeabilization and fixation, and stained with anti‐α‐tubulin (red) and anti‐Beclin‐1 (green) antibodies.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-F</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Beclin‐1 forms discrete foci in the vicinity of the outer kinetochore in a microtubule‐dependent manner. Untreated cells (left) and nocodazole‐treated cells (right) were pre‐extracted and fixed before labelling with Beclin‐1 (green) and Zwint‐1 (red) antibodies.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-G</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) The fluorescent‐tagged Cherry‐Beclin‐1 forms foci in the vicinity of the outer kinetochore. HeLa cells transfected with indicated constructs were pre‐extracted and fixed before labelling with Zwint‐1 (green) antibody. Magnified areas are shown on the right.</text>
    </passage>
  </document>
  <document>
    <id>3615652 Figure_5-H</id>
    <infon key="sourcedata_document">358</infon>
    <infon key="doi">10.1038/embor.2013.23</infon>
    <infon key="pmc_id">3615652</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Beclin‐1 localization close to the kinetochore does not depend on the ZW10 protein. Cells treated with Control, Beclin‐1 and ZW10 siRNA were pre‐extracted and fixed before labelling with Beclin‐1 (green), CREST (blue) and ZW10 (red) antibodies. DNA was visualized with DAPI. (C-H) Scale bar, 10 μm. DAPI, 4′,6‐diamidino‐2‐phenylindole; DNA, deoxyribonucleic acid; GFP, green fluorescent protein; GST, glutathione S‐transferase; HA, haemagglutinin.</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf1-A</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf1-A</infon>
    <infon key="sourcedata_figure_dir">figf1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Survival rate of wild-type mice (WT) and indicated knockout mice after intranasal infection with 750 plaque forming units (PFU) of the PR8 virus.</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf1-B-D</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf1-B-D</infon>
    <infon key="sourcedata_figure_dir">figf1-B-D</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Hematoxylin and eosin (H&amp;E)-stained lung sections from mice infected with PR8 virus on day 2. Arrows indicate cellular infiltrates and necrotic debris occluding the airways. Original magnification, ×40. (c) Disease severity ('lung score') and extent of cell death (necrosis score) on day 2 after infection based on analysis of H&amp;E-stained lung sections. (d) Necrosis score on day 7, estimated visually from H&amp;E-stained lung sections, and flow cytometry analysis for annexin V-stained lung cell populations.</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf1-E</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf1-E</infon>
    <infon key="sourcedata_figure_dir">figf1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Immunohistochemistry staining of neutrophils occluding the airways of PR8-infected mice. Original magnification, ×20.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">24</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="37" length="11"/>
        <text>neutrophils</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf1-F-G</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf1-F-G</infon>
    <infon key="sourcedata_figure_dir">figf1-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(f,g) Flow cytometry analysis of neutrophil, dendritic cell (DC) and macrophage cell numbers on days 2 and 7.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">30</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="33" length="10"/>
        <text>neutrophil</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">31</infon>
        <infon key="identifier">CL:0000451</infon>
        <location offset="45" length="14"/>
        <text>dendritic cell</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">32</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="69" length="10"/>
        <text>macrophage</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf1-H</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf1-H</infon>
    <infon key="sourcedata_figure_dir">figf1-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h) Pulmonary viral titers on days 2 and 7 after infection in Ripk2−/− and WT mice. *P 0.05, **P 0.01, ***P 0.001 (log-rank test (a) and unpaired two-sided Student's t-test (c,d,f,g). Data are pooled from three experiments (a,f-h; mean ± s.e.m. in f-h; n = 10-12 mice total) or are representative of three experiments (b-e; mean ± s.e.m.; n = 3-5 mice per experiment).</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf2-A-C</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf2-A-C</infon>
    <infon key="sourcedata_figure_dir">figf2-A-C</infon>
    <passage>
      <offset>0</offset>
      <text>(a-c) Supernatants of whole lung homogenates taken on days 2 and 7 after infection of wild-type mice (WT) and Ripk2 −/− mice with the PR8 virus were analyzed for IL-6 and TNF (day 2; a), IL-18 and IFN-γ (b), and indicated chemokines (c). *P 0.05, **P 0.01 (unpaired two-sided Student's t-test). Data were normalized for total protein (t.p.) from lung homogenates. Data are pooled from three experiments (mean ± s.e.m.; n = 10-12 mice total).</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf3-A-C</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf3-A-C</infon>
    <infon key="sourcedata_figure_dir">figf3-A-C</infon>
    <passage>
      <offset>0</offset>
      <text>(a-c) Analysis on day 2 after infection with PR8 virus of wild-type mice (WT) or Ripk2−/− mice injected intraperitoneally with control rabbit serum and Ripk2−/− mice injected intraperitoneally with anti-IL-18 neutralizing antiserum (αIL-18Ab) 3 h before infection, for IL-18, IFN-γ and CCL2 amounts in whole lung homogenates (a; t.p., total protein), and for neutrophil numbers by immunohistochemistry (b) and by flow cytometry (c). Original magnification, ×20.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">79</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="359" length="10"/>
        <text>neutrophil</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf3-D</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf3-D</infon>
    <infon key="sourcedata_figure_dir">figf3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Analysis of survival of indicated mice.</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf3-E</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf3-E</infon>
    <infon key="sourcedata_figure_dir">figf3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Neutrophil numbers in WT, Ripk2−/− and Ripk2−/−Il18−/− mice on day 2 after PR8 infection.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">93</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="4" length="10"/>
        <text>Neutrophil</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf3-F</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf3-F</infon>
    <infon key="sourcedata_figure_dir">figf3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Survival of Ripk2−/−Il18−/−, Ripk2−/− and WT mice. *P 0.05, **P 0.01, ***P 0.001 (one-way ANOVA with Tukey's post-hoc test (a,c,e) and log-rank test (d,f)). Data are representative of two independent experiments (mean ± s.e.m.; n = 6-8 mice per experiment).</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf4-A-B</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf4-A-B</infon>
    <infon key="sourcedata_figure_dir">figf4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a,b) RIPK2bone marrow chimeras were analyzed at day 2 after PR8 infection for contribution to elevated IL-18 production by using IL-18immunohistochemistry (a) and IL-18ELISA (b) of whole lung homogenates. WT, wild type; t.p., total protein. In a, blue arrows denote IL-18+ macrophages, and red arrows denote IL-18+ bronchial epithelium. Original magnification, ×200.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="274" length="11"/>
        <text>macrophages</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf4-C</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf4-C</infon>
    <infon key="sourcedata_figure_dir">figf4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Flow cytometry analysis of NK cell counts in Ripk2−/− and wild-type mice.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">121</infon>
        <infon key="identifier">CL:0000824</infon>
        <location offset="31" length="7"/>
        <text>NK cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf4-D</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf4-D</infon>
    <infon key="sourcedata_figure_dir">figf4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Analysis of wild-type and Ripk2−/− NK cells for IFN-γ production on a per cell basis.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">125</infon>
        <infon key="identifier">CL:0000814</infon>
        <location offset="39" length="8"/>
        <text>NK cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf4-E</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf4-E</infon>
    <infon key="sourcedata_figure_dir">figf4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Accumulation of T and B cells in lungs.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">130</infon>
        <infon key="identifier">CL:0000236</infon>
        <location offset="26" length="7"/>
        <text>B cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf4-F</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf4-F</infon>
    <infon key="sourcedata_figure_dir">figf4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Analysis of CD8+ T cells for IFN-γ and CD44 expression in wild-type and Ripk2−/− mice. *P 0.05, **P 0.01 (one-way ANOVA with Tukey's post-hoc test (b) and unpaired two-sided Student's t-test (d,f)). Data are representative of two experiments (a,b,f) or three experiments (c-e) (mean ± s.e.m.; n = 6-8 mice per experiment).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">139</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="21" length="7"/>
        <text>T cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf5-A</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf5-A</infon>
    <infon key="sourcedata_figure_dir">figf5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Immunoblots showing active caspase-1 (casp-1) p20 compared to GAPDH loading controls in wild-type (WT), Ripk2−/− and Nod2−/− BMDCs after PR8 infection.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">152</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="129" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf5-B</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf5-B</infon>
    <infon key="sourcedata_figure_dir">figf5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) IL-18 release in PR8-infected WT, Ripk2−/− and Nod2−/− BMDCs.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">159</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="59" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf5-C-D</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf5-C-D</infon>
    <infon key="sourcedata_figure_dir">figf5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c,d) Immunoblot analysis showing active casp-1 p20 (c) and IL-18 production (d) in BMDCs infected for 4 h with Listeria monocytogenes at multiplicity of infection of 10.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">167</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="84" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf5-E</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf5-E</infon>
    <infon key="sourcedata_figure_dir">figf5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e,f) IL-18 and casp-1 activation in Ripk2−/− BMDCs treated with the NLRP3 inflammasome-specific inhibitor glyburide (glyb.) during PR8 infection.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">177</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="46" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf5-F</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf5-F</infon>
    <infon key="sourcedata_figure_dir">figf5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(e,f) IL-18 and casp-1 activation in Ripk2−/− BMDCs treated with the NLRP3 inflammasome-specific inhibitor glyburide (glyb.) during PR8 infection.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">184</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="46" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf5-G</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf5-G</infon>
    <infon key="sourcedata_figure_dir">figf5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Immunoblot analysis of casp-1p20 during Listeria infection of WT and Aim2−/− BMDCs. *P 0.01, **P 0.001 (one-way ANOVA with Tukey's post-hoc test). Data are representative of six experiments (a,b) or three experiments (c-g) (mean ± s.d.; n = 2-3 replicates per experiment).</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">195</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="81" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf6-A</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf6-A</infon>
    <infon key="sourcedata_figure_dir">figf6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Immunoblot analysis of wild-type (WT), Ripk2−/− and Nod2−/− BMDCs for LC3-II (marker for autophagy) after 18 h of PR8 infection.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">202</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="64" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf6-B-C</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf6-B-C</infon>
    <infon key="sourcedata_figure_dir">figf6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(b,c) Numbers of LC3-II+ puncta (b), counted in at least 100 cells from five random fields from confocal images (c) of BMDCs after PR8 infection and/or chloroquine treatment. Original magnification, ×400.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">208</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="119" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf6-D-E</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf6-D-E</infon>
    <infon key="sourcedata_figure_dir">figf6-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(d,e) Immunoblots of LC3-II and caspase-1 (casp-1; e) and IL-18 production (d) in wild-type and Ripk2−/− BMDCs after treatment with rapamycin (Rap).</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">219</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="105" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf6-F</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf6-F</infon>
    <infon key="sourcedata_figure_dir">figf6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Immunoblot analysis for LC3-II in lung lysates of PR8-infected wild-type and Ripk2−/− mice (1-5 indicate individual mice).</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf6-G</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf6-G</infon>
    <infon key="sourcedata_figure_dir">figf6-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g,h) Lungneutrophil infiltration (g) in IAV-infected Ripk2−/− mice treated with rapamycin, Ripk2−/− mice and WT mice (t.p., total protein). *P 0.05, **P 0.01, ***P 0.001 (Mann-Whitney test (b); one-way ANOVA with Tukey's post-hoc test (d,g,h)).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">234</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="10" length="10"/>
        <text>neutrophil</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf6-H</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf6-H</infon>
    <infon key="sourcedata_figure_dir">figf6-H</infon>
    <passage>
      <offset>0</offset>
      <text>(g,h) IL-18 and IFN-γ amounts (h) in IAV-infected Ripk2−/− mice treated with rapamycin, Ripk2−/− mice and WT mice (t.p., total protein). *P 0.05, **P 0.01, ***P 0.001 (Mann-Whitney test (b); one-way ANOVA with Tukey's post-hoc test (d,g,h)).</text>
    </passage>
  </document>
  <document>
    <id>3631456 figf7-A-C</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf7-A-C</infon>
    <infon key="sourcedata_figure_dir">figf7-A-C</infon>
    <passage>
      <offset>0</offset>
      <text>(a-c) Flow cytometry analysis of wild-type (WT) and Ripk2−/− BMDCs stained with the mitochondrial superoxide-specific stain MitoSOX during IAV or Listeria infection (a,b) and with the general mitochondrial stain MitoTracker Green during IAV infection (c).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">258</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="61" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf7-D-E</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf7-D-E</infon>
    <infon key="sourcedata_figure_dir">figf7-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(d,e) Analysis of IL-18 production and immunoblotting to analyze caspase-1 (casp-1) p20 activation in IAV-infected BMDCs that had been pretreated with the ROS inhibitor NAC.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">271</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="115" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf7-F</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf7-F</infon>
    <infon key="sourcedata_figure_dir">figf7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Immunoblot of casp-1p20 in cell lysates of IAV-infected BMDCs pretreated with the mitochondrial superoxide inhibitor mitoTEMPO.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">281</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="60" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf7-G</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf7-G</infon>
    <infon key="sourcedata_figure_dir">figf7-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Confocal microscopy analysis of BMDCs stained for mitochondria (red) and LC3 (green) for colocalization as an indicator of mitophagy. Original magnification, ×400; inset (red boxed region) was digitally enlarged ×10. *P 0.01 (one-way ANOVA with Tukey's post-hoc test (d) and unpaired two-sided Student's t-test (g)). Data are representative of nine experiments (a), three experiments (b,d-g) or six experiments (c) (mean ± s.d.; n = 2-3 replicates per experiment).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">285</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="36" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf8-A-B</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf8-A-B</infon>
    <infon key="sourcedata_figure_dir">figf8-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a,b) IL-18 amounts (a), and caspase-1 (casp-1) p20 and LC3-II immunoblots (b) in PR8-infected wild-type (WT) BMDCs treated with the p38 and RIPK2 kinase inhibitor SB203580.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">299</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="110" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf8-C</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf8-C</infon>
    <infon key="sourcedata_figure_dir">figf8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Immunoblots for phosphorylation of ULK1 at Ser555 in WT and Ripk2−/− BMDCs after PR8 infection.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">305</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="73" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf8-D</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf8-D</infon>
    <infon key="sourcedata_figure_dir">figf8-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Immunoblots for casp-1p20 in untreated or NAC-treated WT and Ulk1−/− BMDCs after PR8 infection.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">314</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="73" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf8-E</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf8-E</infon>
    <infon key="sourcedata_figure_dir">figf8-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Flow cytometry analysis of MitoSOX staining in PR8-infected WT and Ulk1−/− BMDCs.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">321</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="79" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3631456 figf8-F</id>
    <infon key="sourcedata_document">698</infon>
    <infon key="doi">10.1038/ni.2563</infon>
    <infon key="pmc_id">3631456</infon>
    <infon key="figure">figf8-F</infon>
    <infon key="sourcedata_figure_dir">figf8-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) MitoTracker Green staining of PR8-infected WT and Ulk1−/− BMDCs.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">328</infon>
        <infon key="identifier">CL:0000841</infon>
        <location offset="62" length="5"/>
        <text>BMDCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3641819 f1-B</id>
    <infon key="sourcedata_document">553</infon>
    <infon key="doi">10.1038/nature12043</infon>
    <infon key="pmc_id">3641819</infon>
    <infon key="figure">f1-B</infon>
    <infon key="sourcedata_figure_dir">f1-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, diGly sites identified and quantified across 73 experiments. FDR, false discovery rate.</text>
    </passage>
  </document>
  <document>
    <id>3641819 f1-C</id>
    <infon key="sourcedata_document">553</infon>
    <infon key="doi">10.1038/nature12043</infon>
    <infon key="pmc_id">3641819</infon>
    <infon key="figure">f1-C</infon>
    <infon key="sourcedata_figure_dir">f1-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Log2(H:L) plots for quantified diGly peptides for HCT116PARKIN (experiment 17) or HeLaPARKIN (experiment 57) cells (Supplementary Table 2).</text>
    </passage>
  </document>
  <document>
    <id>3641819 f1-D</id>
    <infon key="sourcedata_document">553</infon>
    <infon key="doi">10.1038/nature12043</infon>
    <infon key="pmc_id">3641819</infon>
    <infon key="figure">f1-D</infon>
    <infon key="sourcedata_figure_dir">f1-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, Overlap of ubiquitylation sites in HeLaPARKIN biological triplicates (1 hCCCP + Btz) (Supplementary Tables 1, 2). Ex, experiment. e, Ubiquitylation site and protein overlap between all HCT116PARKIN and HeLaPARKIN experiments treated with CCCP and Btz for 1 h. f, log2(H:L) ratios for selected diGly sites from HCT116PARKIN (Ex17) and HeLaPARKIN (Ex57) (1 hCCCP + Btz).</text>
    </passage>
  </document>
  <document>
    <id>3641819 f2-A</id>
    <infon key="sourcedata_document">553</infon>
    <infon key="doi">10.1038/nature12043</infon>
    <infon key="pmc_id">3641819</infon>
    <infon key="figure">f2-A</infon>
    <infon key="sourcedata_figure_dir">f2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Class 1 sites are in black font. Additional sites found in Class 1 proteins are in red (HCT116PARKIN) or blue font (HeLaPARKIN). Site overlap in HCT116 and/or SH-SY5Y: magenta, orange, and green octagons. Dotted lines: interacting proteins. Rectangles represent Class 2 substrates. Red or blue boxes refer to additional sites identified in either HCT116PARKIN and HeLaPARKIN cells (Supplementary Table 2). MIM, mitochondrial inner membrane. * and ∧, protein levels decrease or increase, respectively, upon depolarization.</text>
    </passage>
  </document>
  <document>
    <id>3641819 f3-A</id>
    <infon key="sourcedata_document">553</infon>
    <infon key="doi">10.1038/nature12043</infon>
    <infon key="pmc_id">3641819</infon>
    <infon key="figure">f3-A</infon>
    <infon key="sourcedata_figure_dir">f3-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Heat map of HCIPs (represented by APSMs) for HA-Flag-PARKIN and mutants in response to depolarization in 293T cells, with or without Btz or BafA. Proteins indicated had weighted and normalized D-scores ≥ 1.0, Z-score ≥ 5, and APSMs ≥ 2 unless otherwise noted (see Methods). b, Summary of PARKIN-interacting proteins in 293T and HeLa and integration with diGly sites.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_1-A</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Autophagic markers from mixed midbraingba+/+, gba+/−, and gba−/− cultures were analyzed via western blotting using antibodies as indicated.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_1-B-C</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 1-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Autophagic flux was analyzed in gba+/+ and gba−/−midbrainneurons. Neurons were treated with 100 nM bafilomycin A1 and 1 μM rapamycin and flux assayed by comparing LC3I and LC3II levels via western blotting. β-actin was used as a loading control. (C) Densitometry analyzes of autophagy of (B) expressed as a ratio of LC3II/LC3I. Error bars, ± SEM. *p &lt; 0.05.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">11</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="61" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">16</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="70" length="7"/>
        <text>Neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_1-D</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Accumulation of p62/SQSTM1 was analyzed via immunoblotting. β-actin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_1-E</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Midbrainneurons were treated with either 10 μM MG132 or vehicle control DMSO. Proteins were extracted and analyzed via western blotting and stained with anti-ubiquitin antibodies.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">36</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="12" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_1-F</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Ubiquitin linkage of isolated midbrain analyzed using western blotting with antibodies as indicated. β-actin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_1-G</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Proteasomal activity (chymotrypsin activity) was measured using the Proteasome Glo assay where activity is proportional to the released luciferase. RFU, relative luciferase units. Data represent the mean ± SEM (n = 3, each experiment contained triplicates for each genotype). *p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_2-A</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Levels of soluble and insoluble α-synuclein from midbrain of P1 gba+/+ and gba−/−mice. TX-100 soluble and insoluble (SDS/Urea) factions were isolated and analyzed via western blotting with α-synuclein antibodies. β-actin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_2-B</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Sagittal brain stem sections from gba+/+, gba+/−, and gba−/−mice were stained with α-synuclein antibodies. Scale bar, 1,000 μm.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_3-A</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Neurons and astrocytes from gba+/+, gba+/−, and gba−/−mice were stained with TMRM. The mean florescence intensity in mitochondria was analyzed via confocal microscopy (n = 3, &gt;32 cells analyzed/experiment).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">77</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="4" length="7"/>
        <text>Neurons</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">73</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="16" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_3-B</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Neurons from gba+/+ and gba−/− bathed in TMRM containing recording solution and fluorescence intensity analyzed via confocal microscopy. After 1 min, 1 μM oligomycin was added followed by 1 μM FCCP (n = 5, three cells analyzed/experiment).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">91</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="4" length="7"/>
        <text>Neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_3-C</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Neurons from gba+/+ and gba−/− incubated with 5 mM methyl pyruvate 5 min prior to imaging. Cells bathed in 25 nM TMRM and 5 mM methyl pyruvate containing recording solution and fluorescence intensity analyzed via confocal microscopy. After 90 s, 1 μM oligomycin was added, followed by 1 μM FCCP (n = 3, three cells analyzed/experiment).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">97</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="4" length="7"/>
        <text>Neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_3-D</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) As in (C), except cells were bathed in 10 mM methyl succinate, (n = 3, four cells/experiment). All data in this figure represent the mean ± SEM, *p &lt; 0.05. Neurons from gba+/+ and gba−/− incubated with 5 mM methyl pyruvate 5 min prior to imaging. Cells bathed in 25 nM TMRM and 5 mM methyl pyruvate containing recording solution and fluorescence intensity analyzed via confocal microscopy. After 90 s, 1 μM oligomycin was added, followed by 1 μM FCCP (n = 3, three cells analyzed/experiment).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">109</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="160" length="7"/>
        <text>Neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_4-A</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Oxygen consumption rates of gba+/+, gba+/−, and gba−/− mixed midbrain cultures. Basal oxygen consumption was measured over 3 min. The maximal (uncoupled) rate was measured via the addition of FCCP and the nonmitochondrialoxygen consumption analyzed via the addition of antimycin A (n = 3, three runs/experiment).</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_4-B</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Complex I-NADH: Ubiquinone reductase activity from gba+/+, gba+/−, and gba−/−brains expressed as a ratio to citrate synthase (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_4-C</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Complex II-III: Succinate dehydeogenase, cytochome c reductase activity from gba+/+, gba+/−, and gba−/−brains expressed as a ratio to citrate synthase (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_4-D</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Complex IV activity from gba+/+, gba+/−, and gba−/−brains expressed as a ratio to citrate synthase (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_4-E</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Neurons were treated with 3 nM decylTPP and MitoQ10 for 48 hr and stained with TMRM and fluorescence intensity analyzed via confocal microscopy (n = 3, &gt;16 cells/experiment).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">168</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="4" length="7"/>
        <text>Neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_4-F</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) gba+/+and gba−/− cells treated with 3 nM decylTPP and MitoQ10 for 48 hr were subjected to immunoblotting using the indicted antibodies. All data in this figure represent the mean ± SEM, *p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_5-A-B</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Neurons and astrocytes were immunostained for cytochrome c and stained with Hoechst. Far left panels were additionally immunostained for GFAP and MAP2 to mark neurons and astrocytes. "A" in nucleus denotes astrocytes. Scale bar, 20 μm. (B) Mitochondrial morphology was blind counted from cells in (A) with neurons scored as MAP2 positive and astrocytes as GFAP positive. A "normal" morphology is classified as a mixture of fused and fragmented mitochondria that comprise a wild-type network. (n = 3; 100 cells counted/experiment).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">187</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="4" length="7"/>
        <text>Neurons</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">188</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="16" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">190</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="163" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">191</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="175" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">192</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="210" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="310" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">195</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="346" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_5-C</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Levels of morphology proteins from gba+/+, gba+/−, and gba−/− isolated mitochondria were analyzed via immunoblotting with the indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_5-D</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Midbraingba+/+, gba+/−, and gba−/−astrocytes expressing GFP-DRP1K38A were immunostained for cytochrome c and mitochondrial morphologies analyzed; concurrently cells were stained with TMRM and fluorescence intensity analyzed via confocal microscopy. Scale bar, 20 μm (n = 3, &gt;15 cells/experiment). All data in this figure represent the mean ± SEM.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">218</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="38" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_6-A</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Midbrainastrocytes were transfected with GFP-LC3, treated with 100 nM bafilomycin A1, and stained with MitoTracker Red and imaged using confocal microscopy.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">227</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="12" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_6-B-C</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 6-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Midbraingba+/+ and gba−/−neurons and astrocytes were transfected with YFP-Parkin. Half the transfected cells were treated for 1 hr with 10 μM FCCP and all bathed in TMRM containing recording solution and imaged using confocal microscopy. Scale bar, 20 μm. (C) TMRM fluorescence intensity of cells from (B) was analyzed via confocal microscopy. Data represent the mean ± SEM, (n = 3, &gt;4 cells analyzed per experiment).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">240</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="29" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">241</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="41" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3678026 Figure_6-D</id>
    <infon key="sourcedata_document">871</infon>
    <infon key="doi">10.1016/j.cmet.2013.04.014</infon>
    <infon key="pmc_id">3678026</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Mitochondria within midbrainneurons were uncoupled by the addition of 10 μM FCCP for 1 and 6 hr. PINK1 expression analyzed via immunoblotting on isolated mitochondria from gba+/+ and gba−/−neurons. Mitochondrial CI subunit NDUFS4 was used as a loading control.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">255</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="32" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">261</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="193" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-A</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative images of GFP‐LC3 staining in HCT116XIAP WT and XIAP KO cells with stable expression of GFP‐LC3. Quantification of LC3 punctate cells was shown on the right. The data are represented as means±s.d. of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-B</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Endogenous LC3 expression in HCT116XIAP WT and XIAP KO cells was analysed by western blotting with anti‐LC3 antibody. The data are representative of three biological replicates. The ratio of LC3II/LC3I to actin is presented in Supplementary Figure S1A.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-C</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Lysates from XIAP+/+ and XIAP−/−mouse embryonic fibroblasts were analysed by western blotting with the indicated antibodies. The data are representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-D</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Autophagic vesicles in HCT116XIAP WT and XIAP KO cells were evaluated by electron microscopy. The images are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-E</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) HCT116 cells were treated with Embelin as indicated. LC3‐II accumulation was determined by western blot analysis with anti‐LC3 antibody. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S1B.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-F</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) HCT116XIAP KO cells were treated with Embelin as indicated. LC3‐II accumulation was determined by western blot analysis with anti‐LC3 antibody. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-G</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) HCT116 cells were treated with Leupeptin and Embelin in the indicated combinations. Cell lysates were analysed by western blotting. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S1D.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-H</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) MEFATG5 WT and ATG5 KO cells were individually transfected with XIAP‐specific or control siRNAs. Forty‐eight hours after transfection, cell lysates were analysed by western blotting with the indicated antibodies. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S1E.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-I</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) HCT116XIAP WT and XIAP KO cells were treated with 20 ‐μM Z‐VAD‐FMK or DMSO for 2 h. Cell lysates were then analysed by western blotting. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S1F.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_1-J</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 1-J</infon>
    <infon key="sourcedata_figure_dir">Figure_1-J</infon>
    <passage>
      <offset>0</offset>
      <text>(J) HCT116XIAP KO cells were transfected with either Flag‐XIAP (D148A/W310A) or control plasmid. Twenty‐four hours after transfection, cell lysates were subjected to western blot analysis with the indicated antibodies. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S1G.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_2-A</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) A549 and IMR90 cells were transfected with XIAP‐specific or control siRNAs. Cell lysates were subjected to western blot analysis with the indicated antibodies. The data are representative of two biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S2A.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_2-B</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HCT116 cells expressing XIAP‐specific or control siRNAs, HCT116XIAP WT and XIAP KO cells were individually transfected with Flag‐XIAP or control vector. Cell lysates were analysed by western blotting. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S2D.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_2-C</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HCT116XIAP WT and XIAP KO cells were individually transfected with Flag‐XIAP or control vector. Cytoplasmic/nuclear fractionation was performed to analyse cellular localization of Mdm2 and p53. PARP and GAPDH were used as nuclear (N) and cytoplasmic (C) fraction markers, respectively. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_2-D</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) HCT116p53+/+ and p53−/− cells were individually transfected with XIAP‐specific or control siRNAs. LC3 conversion was detected by western blot analysis. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S2E.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_2-E</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) HCT116p53+/+ and p53−/− cells were individually transfected with Flag‐XIAP or control vector. LC3 conversion was detected by western blot analysis. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S2F.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_2-F</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) HCT116XIAP WT and XIAP KO cells treated with 10 μM Nutlin3 for 6 h. LC3 conversion was evaluated by western blot analysis. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S2H.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_2-G</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) HCT116XIAP KO cells were treated with the indicated amounts of Nutlin for 8 h. Cell lysates were analysed by western blotting with anti‐LC3 antibody. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-A</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Lysates from HCT116 cells were immunoprecipitated separately with anti‐XIAP antibody and an isotype‐matched control IgG. Immunoprecipitates and input were analysed by western blotting. The data are representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-B</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Recombinant His‐XIAP protein was incubated separately with purified GST and GST‐Mdm2 fusion proteins on glutathione beads for 4 h followed by western blot analysis using anti‐His antibody. GST and GST‐Mdm2 were analysed by Coomassie blue staining. The data are representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-C</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HCT116 cells were treated with XIAP‐specific or control siRNAs. Twenty‐four hours later, cells were cultured in the presence of 50 μg ml−1cycloheximide for the indicated periods of time, and subsequently analysed by western blotting. We should mention that amounts of cell lysates were adjusted to achieve similar expression levels of Mdm2 at time 0, while the same amounts of cell lysates were used to examine levels of XIAP and actin. The data are representative of three biological replicates. The ratio of Mdm2 to actin is presented in Supplementary Figure S3B.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-D</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) p53−/−Mdm2−/−MEF cells were co‐transfected with the indicated Mdm2, XIAP, and p53 constructs. Cell lysates were analysed by western blotting with the indicated antibodies. We should mention that XIAP H467A expressing plasmid was always used less than XIAP expressing plasmid to ensure expression levels of XIAP and XIAP H467A were similar. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-E</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) p53−/−Mdm2−/−MEF cells were transfected with the indicated plasmids. Twenty‐four hours after transfection, cells were treated with 20 μM MG‐132 for additional 4 h. Cell lysates were denatured before proteins conjugated to His‐ubiquitin were pulled down by Ni2+‐NTA beads. The bead‐bound proteins and total cell lysates (TCLs) were analysed by western blot with anti‐Mdm2 antibody. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-F</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) In all, 2 μM Mdm2 or its C464A mutant and 1 μM XIAP or its H467A mutant proteins were incubated with 100 nM E1, 2 μM E2 and 200 μM Ub in a total 20 μlin vitro ubiquitination reaction buffer at 37°C for 1 h. The reaction mixtures were analysed by western blotting with anti‐Mdm2 antibody. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-G</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) p53−/−Mdm2−/−MEF cells were transfected with the indicated plasmids. Cell lysates were analysed by western blotting. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_3-H</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) p53−/−Mdm2−/−MEF cells were transfected with the indicated plasmids. Twenty‐four hours after transfection, cells were treated with 20 μM MG‐132 for additional 4 h. Cell lysates were denatured before proteins conjugated to His‐ubiquitin were pulled down by Ni2+‐NTA beads. The bead‐bound proteins were analysed by western blotting with anti‐p53 antibody. The data are representative of three biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_4-A</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HCT116XIAP WT and XIAP KO cells were treated with EBSS for the indicated periods of time. GFP‐LC3 puncta formation was observed by a microscope. Quantification of LC3 punctate cells was shown on the right. The data are represented as means±s.d. of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_4-B</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) HCT116XIAP WT and XIAP KO cells were treated with EBSS for 4 h followed by western blot analysis with the indicated antibodies. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S6B.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_4-C</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HCT116XIAP WT and XIAP KO cells were treated with 1 μM API‐2 for 6 h. Cell lysates were analysed by western blotting. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S6C.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_4-D</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) HCT116 cells were treated with or without EBSS for 4 h. Cell lysates were subjected to immunoprecipitation with anti‐XIAP antibody followed by western blot analysis. The data are representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_4-E</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Lysates from HCT116 cells were immunoprecipitated with anti‐Mdm2 antibody. Immunoprecipitates and cell lysates were analysed by western blotting with anti‐p‐XIAP antibody. The data are representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_4-F</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) HCT116XIAP KO cells were transfected with Flag‐XIAP, Flag‐XIAP S87A, Flag‐XIAP S87D or control vector. Twenty‐four hours after transfection, cells were harvested. LC3 conversion was evaluated by western blot analysis. The data are representative of three biological replicates. The ratio of LCII/LC3I to actin is presented in Supplementary Figure S6D.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_4-G</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) p53−/−Mdm2−/−MEF cells were transfected with HA‐Mdm2 plus Flag‐XIAP, Flag‐XIAP S87A or Flag‐XIAP S87D. Twenty‐four hours later, cells were treated with 20 μM MG-132 for another 4h. Cell lysates were subjected to immunoprecipitation with anti‐HA antibody. Immunoprecipitates were analysed by western blotting. The data are representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_5-A-C</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 5-A-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) 1 × 106HCT116XIAP WT and 1 × 106XIAP KO cells (group 1), 1 × 106HCT116XIAP KO cells (KO‐Ctrl) and 1 × 106HCT116XIAP KO cells stably expressing wild‐type XIAP (KO‐XIAP) (group 2), 1 × 106HCT116XIAP KO cells (KO‐Ctrl) and 1 × 106HCT116XIAP KO cells stably expressing XIAP S87A mutant (KO‐XIAP SA) (group 3), or 1 × 106HCT116XIAP KO cells (KO‐Ctrl) and 1 × 106HCT116XIAP KO cells stably expressing XIAP S87D mutant (KO‐XIAP SD) (group 4) were individually injected to the left flank (Left) and right flank (Right) of nude mice as indicated. Five weeks after injection, the mice were sacrificed and photographed (A). The volumes of all flank tumours excised from six mice in each group were compared (n=6) (B). Tumour weights were represented as means±s.d. from six mice in each group (C).</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_5-D-F</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 5-D-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) 1 × 106HCT116XIAP KO cells or 1 × 106HCT116XIAP KO cells stably expressing XIAP D148A/310A were injected to the right flank of nude mice as indicated (n=3). Five weeks after injection, the mice were sacrificed and photographed (D). The volumes of excised tumours were shown (E). Tumour weights were represented as means±s.d. from three mice in each group (F).</text>
    </passage>
  </document>
  <document>
    <id>3746193 Figure_5-G-H</id>
    <infon key="sourcedata_document">421</infon>
    <infon key="doi">10.1038/emboj.2013.133</infon>
    <infon key="pmc_id">3746193</infon>
    <infon key="figure">Figure 5-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G, H) The humantumour tissues (T) from Oesophagus (G) and Colon (H) and their adjacent normal tissues (N) were homogenized for protein extraction. Protein extracts were analysed by western blotting with the indicated antibodies. The data are representative of three biological replicates. The blots in (G, H) were qualified and the ratio of LC3II/LC3I to actin was then calculated and shown in Supplementary Figure 9A and B.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-A</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-A</infon>
    <infon key="sourcedata_figure_dir">figf1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Western blot analysis of HeLa cells treated with siRNA for 84 h.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-B</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-B</infon>
    <infon key="sourcedata_figure_dir">figf1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Western blot analysis of HeLa cells treated with a second independent siRNA targeting ATG5, ATG7 or NDP52. GAPDH and total protein stained with Coomassie blue serve as loading controls.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-C</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-C</infon>
    <infon key="sourcedata_figure_dir">figf1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Western blot analysis of HeLa cells cultured in Hank's buffered salt solution (Starved) or DMEM+ 10% FBS (Serum).</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-D</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-D</infon>
    <infon key="sourcedata_figure_dir">figf1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Western blot analysis of HeLa cells treated (48 h) with an inhibitor of mTORC1 (RAP, 20 nM) or control (DMSO).</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-E</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-E</infon>
    <infon key="sourcedata_figure_dir">figf1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Western blot analysis comparing the levels of DICER in MDA-231, T47D and MDA-435 cells.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-F</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-F</infon>
    <infon key="sourcedata_figure_dir">figf1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Western blot analysis of MDA-231, T47D and MDA-435 cells treated (48 h) with inhibitors of mTORC1 (RAP, 20 nM), mTORC1 and 2 (PP242, 100 nM), or DMSO (control).</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-G</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-G</infon>
    <infon key="sourcedata_figure_dir">figf1-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Western blot analysis of HeLa cells treated with CQ or DMSO for 12 h.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-H</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-H</infon>
    <infon key="sourcedata_figure_dir">figf1-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h) Western blot analysis of HeLa cells treated with BAF (200 nM, 12 h), RAP (20 nM, 24 h), or RAP and BAF. The results in a-h are representative of three experiments and use α-tubulin (TUBA) as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-I</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-I</infon>
    <infon key="sourcedata_figure_dir">figf1-I</infon>
    <passage>
      <offset>0</offset>
      <text>(i) Western blot analysis of DICER (monoclonal antibody 13D6) or control (EEF1A1) in HeLa cells treated with control siRNA or siRNA targeting DICER.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-J</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-J</infon>
    <infon key="sourcedata_figure_dir">figf1-J</infon>
    <passage>
      <offset>0</offset>
      <text>(j) Confocal analysis of the signal from an anti-DICER monoclonal antibody (clone 13D6) or an isotype control monoclonal antibody in HeLa cells. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf1-K-L</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf1-K-L</infon>
    <infon key="sourcedata_figure_dir">figf1-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>(k,l) RT-qPCR analysis of AGO1, AGO2 and DICER mRNA in HeLa cells treated for 12 h with DMSO, BAF or CQ (k) or siRNA for 84 h (l). Error bars show s.e.m. Uncropped images of blots are shown in Supplementary Fig. S3.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf2-A-B</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf2-A-B</infon>
    <infon key="sourcedata_figure_dir">figf2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Localization using confocal microscopy of endogenous DICER (monoclonal antibody 13D6) and NDP52 in HeLa cells treated with RAP or control. The arrows highlight some examples of co-localization. The lower left insets show higher magnifications of the areas outlined in the main panel. Scale bars, 5 μm. (b) Quantification of DICER co-localization with NDP52. Total fluorescence intensity of DICER co-localized with punctae (&gt;0.2 μm3) of NDP52 was quantified with Volocity software in RAP-treated cells/control-treated cells over several Z-stacked microscope fields per experiment (n = 4, error bars s.e.m.).</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf2-C-D</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf2-C-D</infon>
    <infon key="sourcedata_figure_dir">figf2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Localization using confocal microscopy of endogenous DICER (monoclonal antibody 13D6) and HcRed-LC3 in HeLa cells treated with BAF or control. The arrows highlight some examples of co-localization. Insets as in a. Scale bar, 5 μm. (d) Quantification of DICER co-localization with HcRed-LC3 was performed as for NDP52 in b.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf2-E</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf2-E</infon>
    <infon key="sourcedata_figure_dir">figf2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Confocal microscopy analysis of GFP-DCP1A and HcRed-LC3wt in HeLa cells. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf2-F-I</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf2-F-I</infon>
    <infon key="sourcedata_figure_dir">figf2-F-I</infon>
    <passage>
      <offset>0</offset>
      <text>(f-i) Localization of DICER (monoclonal antibody 13D6) detected with anti-mouse IgG (10 nm gold beads) by electron microscopy in CQ- (20 μM, 12 h) treated HeLa cells. Mito, mitochondria; MVB, multivesicular body. The black arrows highlight all gold beads.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf2-J</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf2-J</infon>
    <infon key="sourcedata_figure_dir">figf2-J</infon>
    <passage>
      <offset>0</offset>
      <text>(j) Western blot analysis of fractions from a discontinuous gradient of Histodenz (15%, 20%, 24%, 26%) described to enrich autophagosomes (light AV) and autophagolysosomes (heavy AV; ref. ). HEK293T cells were treated with CQ (20 μM, 16 h). Fractions enriched in multivesicular body and lysosomal markers are indicated. Material that was pelleted by centrifugation at 100,000g (100 K pellet) or that remained in solution after the 100,000g spin (soluble) was not added to the gradient.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf2-K</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf2-K</infon>
    <infon key="sourcedata_figure_dir">figf2-K</infon>
    <passage>
      <offset>0</offset>
      <text>(k) Western blot analysis of UB and p62 in discontinuous Histodenz gradients (as in j) of HEK293T cells treated with control (DMSO) or CQ. Uncropped images of blots are shown in Supplementary Fig. S3.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-A</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-A</infon>
    <infon key="sourcedata_figure_dir">figf3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Western blot analysis of GEMIN4 in fractions from a discontinuous gradient of Histodenz (15%, 20%, 24%, 26%) described to enrich autophagosomes (light AV) and autophagolysosomes (heavy AV). HEK293T cells were treated with CQ (20 μM, 16 h). Fractions enriched in multivesicular body (MVB) and lysosomal markers are indicated.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-B</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-B</infon>
    <infon key="sourcedata_figure_dir">figf3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Western blot of GEMIN4 or loading control (TUBA) in HeLa cells treated with control siRNA or siRNA targeting ATG5, ATG6 or ATG7.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-C</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-C</infon>
    <infon key="sourcedata_figure_dir">figf3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Western blot analysis of GEMIN4 or control (TUBA) in HeLa cells cultured in DMEM 10% FBS (Serum), Hank's buffered salt solution (Starve) for 2 h, or treated for 16 h with control (DMSO), BAF (200 nM), RAP (20 nM), RAP+BAF, or PP242 (100 nM).</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-D</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-D</infon>
    <infon key="sourcedata_figure_dir">figf3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Top, western blot of GEMIN4immunoprecipitates (IP) from HeLa cells. Bottom, western blot analysis of GEMIN4 in immunoprecipitates of anti-NDP52, -p62 or control antibody from HeLa cells.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-E</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-E</infon>
    <infon key="sourcedata_figure_dir">figf3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Western blot of DICER immunoprecipitates from HeLa cells.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-F</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-F</infon>
    <infon key="sourcedata_figure_dir">figf3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Western blot of AGO2 immunoprecipitates from HeLa cells.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-G</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-G</infon>
    <infon key="sourcedata_figure_dir">figf3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Western blot analysis of GEMIN4, compared with loading controls (DCP1A, CLN3) in HeLa cells treated with control siRNA or siRNA targeting GEMIN3 and GEMIN4.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-H</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-H</infon>
    <infon key="sourcedata_figure_dir">figf3-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h) Western blot analysis of HeLa cells treated with indicated combinations of control siRNA or siRNA targeting GEMIN3, GEMIN4 and ATG5. Western blot analysis of CLN3 and DCP1A are used to demonstrate equal loading of wells.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-I</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-I</infon>
    <infon key="sourcedata_figure_dir">figf3-I</infon>
    <passage>
      <offset>0</offset>
      <text>(i) Western blot analysis with anti-UB monoclonal antibody (mono- and polyubiquitylated proteins, FK2 clone) in Flagimmunoprecipitates performed under stringent denaturing conditions. Flag-AGO2 was induced for 24 h with tetracycline in HEK293T cells with Tet-inducible Flag-AGO2 stably integrated that had been treated 24 h before with the indicated siRNAs.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-J</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-J</infon>
    <infon key="sourcedata_figure_dir">figf3-J</infon>
    <passage>
      <offset>0</offset>
      <text>(j) Western blot analysis of HeLa cells treated with control siRNA or siRNA targeting ATG5 for 24 h. TUBA, α-tubulin loading control.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf3-K</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf3-K</infon>
    <infon key="sourcedata_figure_dir">figf3-K</infon>
    <passage>
      <offset>0</offset>
      <text>(k) Top, RT-qPCR analysis of miR-16 or let-7a levels in AGO2 immunoprecipitates from DMSO- and BAF-treated HeLa cells. Error bars represent s.e.m. Bottom, a representative western blot of AGO2 immunoprecipitates used in one replicate of these experiments. Uncropped images of blots are shown in Supplementary Fig. S3.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf4-A</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf4-A</infon>
    <infon key="sourcedata_figure_dir">figf4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Northern blot of miR-16 and let-7a in HeLa cells treated with siRNA for 84 h. Levels of U6, ethidium-bromide-stained total RNA on northern membrane (loading) and 28S and 18S ribosomal RNA on 1% agarose gel are shown as controls for equal loading.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf4-B-D</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf4-B-D</infon>
    <infon key="sourcedata_figure_dir">figf4-B-D</infon>
    <passage>
      <offset>0</offset>
      <text>(b-d) RT-qPCR analysis of let-7a and miR-16 (b), pre-let-7a and pre-miR-16 (c) and let-7a* and miR-16* (d) in HeLa cells depleted of NDP52 or ATG5 with siRNA (84 h). n = 3 independent experiments; error bars represent s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf4-E</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf4-E</infon>
    <infon key="sourcedata_figure_dir">figf4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Quantification of fluorescence signal in AGO2 immunoprecipitates from HeLa cell extracts incubated with duplexes of let-7a-let-7a* labelled on the 3′ end of either let-7 or let-7a* with FITC. Cells were treated 16 h before with DMSO (control), BAF (200 nm) or geldanamycin (10 μM). Representative results of one experiment are shown.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf4-F</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf4-F</infon>
    <infon key="sourcedata_figure_dir">figf4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Western blot analysis of AGO2 immunoprecipitates (IP) used in e.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf5-A</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf5-A</infon>
    <infon key="sourcedata_figure_dir">figf5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Renilla luciferase expression controlled by an exogenous siRNA-siRNA* duplex targeting two partially complementary sites in HeLa cells depleted of ATG5 or ATG7 with siRNA (black and grey bars correspond to two independent siRNAs). Results are normalized to firefly luciferase and Renilla luciferase expression in cells treated with a nonspecific siRNA-siRNA* duplex. n = 2 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf5-B</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf5-B</infon>
    <infon key="sourcedata_figure_dir">figf5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Renilla luciferase expression controlled by let-7 in HeLa cells depleted of NDP52 or ATG5 with siRNA (black and grey bars are independent siRNAs). Results are normalized to firefly luciferase and a version of the Renilla luciferase construct with mutated let-7 binding sites. n = 3 independent experiments. The asterisks denote mutations in the let-7 target sites of the reporter.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf5-C</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf5-C</infon>
    <infon key="sourcedata_figure_dir">figf5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Western blot analysis of endogenous miRNA-repressed proteins (RAS, HMGA2 and CDK6 are repressed by let-7; CDK6 is also repressed by miR-16 (bottom panel)) or control (TUBA, α-tubulin) in HeLa cells treated with control siRNA or either of two independent siRNAs targeting ATG7. Cells were treated in parallel with nonspecific antagomir or let-7 targeting antagomir.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf5-D</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf5-D</infon>
    <infon key="sourcedata_figure_dir">figf5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Renilla luciferase expression controlled by the DICER 3′UTR in HeLa cells treated with control antagomir or anti-let-7 antagomir.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf5-E</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf5-E</infon>
    <infon key="sourcedata_figure_dir">figf5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Western blot analysis of DICER in HeLa cells treated with control siRNA or either of two independent siRNAs targeting ATG7. Cells were also treated with nonspecific antagomir or let-7 targeting antagomir.</text>
    </passage>
  </document>
  <document>
    <id>3771578 figf5-F</id>
    <infon key="sourcedata_document">607</infon>
    <infon key="doi">10.1038/ncb2611</infon>
    <infon key="pmc_id">3771578</infon>
    <infon key="figure">figf5-F</infon>
    <infon key="sourcedata_figure_dir">figf5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Renilla luciferase expression controlled by the DICER 3′UTR in HeLa cells treated with either of two independent siRNAs targeting ATG5 or a control siRNA. All error bars are s.e.m. Uncropped images of blots are shown in Supplementary Fig. S3.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_1-A</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) miR-155 expression levels were examined in the lungs of normal uninfected or H37Rv infected BALB/c mice 6 weeks postinfection</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_1-B</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Murine bone marrow-derived macrophages (BMDMs) were infected with BCG at an MOI of 5 for the indicated times, and the expression levels of miR-155 were measured by real-time PCR.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">6</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="11" length="31"/>
        <text>bone marrow-derived macrophages</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">7</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="44" length="4"/>
        <text>BMDM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_1-C-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C and D) RAW264.7 cells were infected with BCG at an MOI of 5 for the indicated time points (C) or at indicated MOIs for 24 h (D). The expression levels of miR-155 were examined by real-time PCR.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_1-E</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) RAW264.7 cells were infected with H37Ra at an MOI of 5 for the indicated time (E) or at indicated MOI for 24 h (F). The expression levels of miR-155 were examined by real-time PCR. Data are shown as the mean ± SEM of three independent experiments. *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_2-A-B-C</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 2-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) RAW264.7 cells were transfected with control or miR-155 mimic for 24 h followed by BCG (A), H37Ra (B) or H37Rv (C) infection at an MOI of 10 for 1 h, and intracellular mycobacterial viability was determined by CFU assay at the indicated timepoints.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_2-D-E-F</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 2-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) RAW264.7 cells were transfected with control or miR-155 inhibitor for 24 h followed by BCG (D), H37Ra (E) or H37Rv (F) infection at an MOI of 10 for 1 h, and intracellular mycobacterial viability was determined by CFU assay at the indicated timepoints.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_2-G-H</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 2-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G and H) RAW264.7 cells were transfected with miR-155 mimic (G) or inhibitor (H) for 24 h followed by Texas Red-labeled BCG infection at an MOI of 10 for 1 h. Phagocytosis of mycobacteria was determined by flow cytometry. Data are shown as the mean ± SEM of three independent experiments. *, p&lt;0.05; **, p&lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_3-A-B</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>RAW 264.7 cells were transiently transfected with control or miR-155 mimic for 24 h and then infected with Texas Red-labeled BCG for 1 h. Lysosomes were immunolabeled with CD63 antibody followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody (A)The colocalization of BCG with lysosome was detected by confocal microscopy. The percentage of co-localization of BCG with CD63-positive (B)</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_3-C-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>RAW 264.7 cells were transiently transfected with control or miR-155 mimic for 24 h and then infected with Texas Red-labeled BCG for 1 h. Lysosomes were immunolabeled with CD63 antibody followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG antibody (A), or labeled with a fluorogenic substrate for proteases, DQ-Green (C). The colocalization of BCG with lysosome was detected by confocal microscopy. The percentage of co-localization of BCG with CD63-positive (B) or DQ-Green labeled (D) lysosomes was quantified, respectively. Cells treated with rapamycin were used as a positive control. Arrows indicate the co-localization of BCG with lysosomes; scale bar = 5 µm. Quantification of data are shown as the mean ± SEM of three independent experiments (n = 100 phagosomes). **, p&lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_4-A-B</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) RAW264.7 cells were transfected with miR-155 mimic (A and C) or inhibitor (B and D) for 24 h and then either left uninfected or infected with BCG. Expression levels of miR-155 were detected by real-time PCR (A and B).</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_4-C-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) RAW264.7 cells were transfected with miR-155 mimic (A and C) or inhibitor (B and D) for 24 h and then either left uninfected or infected with BCG. Expression levels of miR-155 were detected by real-time PCR (A and B). The LC3 levels were detected by Western-blot, and the ratios of LC3-II/β-actin were calculated as shown below the representative blot (C and D)</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_4-E-F</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) RAW264.7 cells transfected with miR-155 mimic (E) or inhibitor (F) was incubated with DMSO or bafilomycin A1 (BafA.) at a concentration of 100 nM for 2 h, and then LC3 levels were detected by Western-blot. The ratios of LC3-II/β-actin were calculated as shown below the representative blot. ***, p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_5-A-B</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) RAW264.7 cells stably expressing GFP-LC3 were transiently transfected with control or miR-155 mimic for 24 h, and GFP-LC3 puncta (&gt;1 µm) were detected by confocal microscopy (A) and quantified (B).</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_5-C-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 5-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>RAW264.7 cells were transiently transfected with control or miR-155 mimic for 24 h. Endogenous LC3 was stained with LC3 antibody followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG (Green), and LC3 puncta (&gt;1 µm) were detected by confocal microscopy (C) and quantified (D).</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_5-E</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) RAW264.7 cells were transiently transfected with control or miR-155 mimic for 24 h, and then incubated with a specific fluorescent dye MDC (50 µM). The MDC-labeled autophagic vacuoles were detected by confocal microscopy (E) and cells with MDC-positive autophagic vacuoles were quantified (F). Cells treated with rapamycin were used as a positive control. Arrows indicate the GFP-LC3 puncta or autophagic vacuoles labeled with MDC; scale bar = 5 µm. Data are shown as the mean ± SEM of three independent experiments (n = 300 cells). **, p&lt;0.01; ***, p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_6-A-B</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 6-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) RAW264.7 cells stably expressing GFP-LC3 were transiently transfected with control or miR-155 mimic and then infected with Texas Red-labeled BCG for 1 h. The co-localization of BCG with LC3 was detected by confocal microscopy. (B) Quantification of the co-localization of BCG with LC3-positive autophagosomes is shown.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_6-C-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) RAW264.7 cells were transiently transfected with control or miR-155 mimic, and then infected with Texas Red-labeled BCG for 1 h. Endogenous LC3 was stained with LC3 antibody followed by Alexa Fluor 488-conjugated goat anti-rabbit IgG (Green). The co-localization of BCG with endogenous LC3 was detected by confocal microscopy. (D) Quantification of the co-localization of BCG with LC3-positive autophagosomes is shown.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_6-E-F</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 6-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E) After transient transfection with control or miR-155 mimic, RAW264.7 cells were infected with Texas Red-labeled BCG for 1 h, and then were labeled with a specific fluorescent dye MDC (50 µM) for autophagic vacuoles. The co-localization of BCG with MDC-positive autophagic vacuoles was detected by confocal microscopy. (F) Quantification of the co-localization of BCG with MDC-positive autophagosomes is shown. Cells treated with rapamycin were used as a positive control. Arrows indicate the co-localization of BCG with autophagosomes; scale bar = 5 µm. Data are shown as the mean ± SEM of three independent experiments (n = 100 phagosomes). **, p&lt;0.01; ***, p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_7-A</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) RAW 264.7 cells were transiently transfected with control or miR-155 mimic for 24 h, and then incubated with DMSO or 3-MA for 2 h. Protein levels of LC3 were detected by Western-blot in uninfected cells (A)</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_7-B</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>Intracellular mycobacterial viability was determined at the indicated timepoints by CFU assay after BCG challenge for 1 h (B)</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_7-C</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C and D) RAW 264.7 cells were transiently co-transfected with control or miR-155 mimic together with a control siRNA or Atg7 siRNA. The expression levels of Atg7 and LC3 were detected by Western-blot (C).</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_7-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>Intracellular mycobacterial viability was determined by CFU assay at the indicated time after challenging with BCG for 1 h (D). Values of LC3-II/β-actin ratios are indicated below the representative blot. Data are shown as the mean ± SEM of three independent experiments. *, p&lt;0.05; **, p&lt;0.01; NS, not significant.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_8-A</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Sequences of mouse and human miR-155 and their predicted interactions with conserved 7-mer 1A miR-155 seeds found within the Rheb 3′UTRs of different species are shown. The sequence of the Rheb 3′UTR seed mutant used for the reporter assays and the predicted disruption of the miR-155 interaction are also shown.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_8-B</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) RAW264.7 cells were co-transfected with control or miR-155 mimic and a wild-type (WT-Rheb) or mutated Rheb 3′UTR (mut-Rheb) luciferase reporter plasmid and assessed for luciferase activity at 24 h after transfection. Data are shown as the mean ± SEM of three independent experiments. ***, p&lt;0.001; NS, not significant.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_8-C-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 8-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C-F) RAW264.7 cells were transfected with miR-155 mimic (C and E) or inhibitor (D and F) for 24 h and either left uninfected or infected with BCG. Protein expression levels of Rheb were detected by Western-blot. Values of Rheb/β-actin ratios are indicated below the representative blot (C and D)</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_8-E-F</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 8-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(C-F) RAW264.7 cells were transfected with miR-155 mimic (C and E) or inhibitor (D and F) for 24 h and either left uninfected or infected with BCG. Protein expression levels of Rheb were detected by Western-blot. Values of Rheb/β-actin ratios are indicated below the representative blot (C and D), and expression levels of Rheb mRNA were detected by RT-PCR (E and F).</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_9-A</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) RAW264.7 cells were transfected with a plasmid expressing Rheb for 24 h, and then incubated with DMSO or BafA. for 2 h. The expression levels of Rheb and LC3 were detected by Western-blot. Values of LC3-II/β-actin ratios are indicated below the representative blot.</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_9-B-C</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 9-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B and C) RAW264.7 cells were co-transfected with control or miR-155 mimic together with a control plasmid or a plasmid expressing Rheb for 24 h, and then infected with Texas Red-labeled BCG for 1 h. The co-localization of BCG and MDC-labeled autophagosome was detected by confocal microscopy. Arrows indicate Quantification of BCG co-localization with autophagosomes described in B is shown (C).</text>
    </passage>
  </document>
  <document>
    <id>3795043 Figure_9-D</id>
    <infon key="sourcedata_document">804</infon>
    <infon key="doi">10.1371/journal.ppat.1003697</infon>
    <infon key="pmc_id">3795043</infon>
    <infon key="figure">Figure 9-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) RAW264.7 cells were co-transfected with control or miR-155 mimic together with a control plasmid or a plasmid expressing Rheb for 24 h. Cells were infected with BCG for 1 h, and washed for three times to remove extracellular mycobacteria. Intracellular mycobacterial viability was determined by CFU assay at the indicated timepoints. Data are shown as the mean ± SEM of three independent experiments. *, p&lt;0.05; **, p&lt;0.01; NS, not significant.</text>
    </passage>
  </document>
  <document>
    <id>3818075 Figure_1-A</id>
    <infon key="sourcedata_document">364</infon>
    <infon key="doi">10.1038/embor.2013.151</infon>
    <infon key="pmc_id">3818075</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>Domain architecture and structure of Miro. (A) Bar diagram of Miro domain structure. Numbering corresponds to dMiro isoform D, domain names are described in the text (B) Ribbon diagram of the MiroS structure in the 'side view'. Note three distinct domains: ELM1 (blue), ELM2 (green), cGTPase (grey/yellow), joined by two linkers: Lnk1 (orange), and Lnk2 (red). The structure shown is MgGDP‐MiroS, with the 2+ ion from the Ca‐MiroS structure overlaid for orientation (Ca2+/Mg2+/GDP as yellow/purple/multicoloured spheres). cGTPase, C‐terminal GTPase; dMiro, Drosophila Miro; ELM, EF hand pair with ligand mimic.</text>
    </passage>
  </document>
  <document>
    <id>3818075 Figure_2-A</id>
    <infon key="sourcedata_document">364</infon>
    <infon key="doi">10.1038/embor.2013.151</infon>
    <infon key="pmc_id">3818075</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Top, MiroS shown in the 'top view'. ELM1 and ELM2 are related by pseudo twofold symmetry, represented by the dyad between them. Bottom, overlay of the two ELM domains (rmsd of 1.8 Å over 84 Cα positions). ELM1 (blue), ELM2 (green) and identical or similar conserved residues in identical positions are shown as sticks.</text>
    </passage>
  </document>
  <document>
    <id>3818075 Figure_3-A</id>
    <infon key="sourcedata_document">364</infon>
    <infon key="doi">10.1038/embor.2013.151</infon>
    <infon key="pmc_id">3818075</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Details of the EF hand loops. All loops are shown in approximately the same orientation, with entering and exiting helices ghosted for clarity. Residues of note are coloured in orange. cEF1 is shown in its apo state. cEF2 is shown in its apo, Ca2+‐bound and Mg2+‐bound states. In the cEF2 apo state, E354 is stabilized by nearby loop residue R344. In the Ca2+‐bound state, cEF2 loop residues coordinate Ca2+ in a pentagonal, bipyramidal arrangement, with E354 as a bidentate ligand. An ordered water molecule at the apex of one of the pyramids is represented as a small red sphere. In the Mg2+‐bound state, the coordination is octahedral with E354 as a monodentate ligand. The hEF1 and hEF2 loops adopt a conformation quite different from the cEF hands, and also lack the acidic residues that typically coordinate cations. Note the conserved hEF1 272VTL274 and hEF2 386VTL388 residues, which overlay identically in Fig 2A. cEF, canonical EF hand; hEF, hidden EF hand.</text>
    </passage>
  </document>
  <document>
    <id>3818075 Figure_4-A</id>
    <infon key="sourcedata_document">364</infon>
    <infon key="doi">10.1038/embor.2013.151</infon>
    <infon key="pmc_id">3818075</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) The ELM2/cGTPase interface can be divided into three regions (insets 1-3). Select residues are shown as sticks, polar contacts as dashed lines, and Mg2+ and MgGDP as spheres. Region 1: αC2 and the hEF2 loop form both backbone and side‐chain contacts with αG1 and Switch I in the cGTPase, including the Switch I threonine T481. Region 2: αD2 in hEF2 packs against the twisting cGTPase β‐strands Gβ1‐3. Region 3: the candidate Pink1 phosphorylation site residue S324 in Lnk1 hydrogen bonds with R444 in Lnk2, which also forms a salt bridge with D521, at the end of the Switch II loop.</text>
    </passage>
  </document>
  <document>
    <id>3818075 Figure_4-B</id>
    <infon key="sourcedata_document">364</infon>
    <infon key="doi">10.1038/embor.2013.151</infon>
    <infon key="pmc_id">3818075</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) cGTPase rearrangements in MgGDP binding. Displayed is the MiroS‐MgGDP structure, with select residues from the aligned apo‐MiroS structure shown in orange. GDP is shown as sticks (2Fo‐Fc map, 1.2σ), and Mg2+ as a purple sphere. In the apo state, D505 in the Switch II 503DIDV506 motif is far from the nucleotide‐binding pocket and is hydrogen bonded to R507, which is also stabilized by interactions with P512. In the MgGDP‐bound state, the D505 side‐chain rotates ∼7 Å to interact with the β‐phosphate (arrow), locking the Switch II loop in a β‐strand conformation and extending Gβ3. V506 rotates away from the nucleotide‐binding pocket, and both R507 and Y537 become solvent exposed. cGTPase, C‐terminal GTPase; Sw I/II, Switch I/II; P loop, phosphate‐binding loop.</text>
    </passage>
  </document>
  <document>
    <id>3818075 Figure_5-A</id>
    <infon key="sourcedata_document">364</infon>
    <infon key="doi">10.1038/embor.2013.151</infon>
    <infon key="pmc_id">3818075</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Location of known Parkin ubiquitination sites within the Miro structure. MiroS is shown in a 180°‐rotated top view (relative to Fig 2). Four residues in dMiro correspond in sequence and structure to residues that are ubiquitinated by Parkin in human Miro1 (hMiro1) or human Miro2 (hMiro2) [22]. These are shown as spheres (K220, R240, K439 and K600; labelled with dMiro numbering). An alignment of a 10‐aa segment of dMiro, hMiro1 and hMiro2 flanking each ubiquitinated site is shown. The large blue 'K' within each sequence alignment indicates the ubiquitinated residue in hMiro1 or hMiro2, and a smaller, underlined K indicates that dMiro has a lysine in the same position. Residue S324, a candidate Pink1 phosphorylation site, is also shown in spheres. Note the side‐chain of K439 is disordered in the MiroS structure, so it is modelled as an alanine. dMiro/Dm Miro, Drosophila Miro; Hs Miro 1/2, human Miro1/2.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f1-A</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f1-A</infon>
    <infon key="sourcedata_figure_dir">f1-A</infon>
    <passage>
      <offset>0</offset>
      <text>a) EGF enhances colocalization of phosphorylated (P)-bRAF, P-MEK and P-ERK with LC3. Immunofluorescence (IF) showing colocalization of P-bRAF (green), P-MEK (green) and P-ERK (green) with LC3 (red) in NIH/3T3 cells in presence or absence of EGF (10 min as shown in scheme). The bars represent mean±s.e.m. **P0.01, ***P0.001; Student's t-test, 60 cells analysed from two experiments. Scale bars, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f1-B</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f1-B</infon>
    <infon key="sourcedata_figure_dir">f1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) P-ERK colocalizes with pre-autophagosomal and autophagosomal structures. IF depicting colocalization of P-ERK (green or red) with LC3 (red), ATG5-ATG12 (red), ATG16 (green), vps34 (red), WIPI1 (red), WIPI2 (red) and P-ULK1 (red) in EGF-treated NIH/3T3 cells. Scale bars, 10 μm. The bars represent mean±s.e.m. 50 cells analysed from two experiments. (c) Growth factors in serum maintain P-ERK/LC3 colocalization. IF depicting colocalization of P-ERK (green) with LC3 (red) in 2 hserum-fed NIH/3T3 cells.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f1-C</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f1-C</infon>
    <infon key="sourcedata_figure_dir">f1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(a-c) Native merged images or images with colocalization highlighted in white pixels are shown. Nuclei are blue (DAPI). Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f2-A</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f2-A</infon>
    <infon key="sourcedata_figure_dir">f2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) P- and total MEK and ERK are enriched in APhin vivo. Immunoblots for indicated proteins in homogenate (Hom), APh, APL and Lys fractions from livers of fed mice, n=4.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f2-B</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f2-B</infon>
    <infon key="sourcedata_figure_dir">f2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) EGF enhances enrichment of P-MEK and ERK in APh fractions in vitro. Immunoblots for indicated proteins in Hom, APh and APL fractions from NIH/3T3 cells in presence or absence of EGF (10 min). The bars represent mean±s.e.m. *P0.05, **P0.01; Student's t-test, n=3.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f2-C</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f2-C</infon>
    <infon key="sourcedata_figure_dir">f2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) P- and total MEK and ERK localize on to the cytoplasmic/extra-luminal face of APhin vivo. Left; model depicting localization of MEK and ERK on the extra-luminal face of autophagic vesicles and the ability of trypsin to degrade extra-luminalMEK and ERK, and right; immunoblots for indicated proteins in APh fractions from micelivers untreated (−) or treated with increasing amounts of trypsin for 15 min. The bars represent mean±s.e.m. *P0.05, **P0.01, ***P0.001 compared with corresponding trypsin-untreated value; ANOVA-Bonferroni post hoc test, n=3. The p44, p42 forms of ERK, LC3-I and membrane-associated LC3-II, and 37 kDa and 25 kDa forms of cathepsin (Cath) B are indicated.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f3-A</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-A</infon>
    <infon key="sourcedata_figure_dir">f3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) EGF enhances nuclearLC3-II content in hepatocytes. Immunofluorescence (IF) depicting nuclearLC3-II in RALAhepatocytes in presence or absence of EGF (10 min). Native/inverted images are shown. Scale bar, 5 μm. Bars represent mean±s.e.m. ***P0.001 compared with control (Con); Student's t-test, 50 cells from two experiments.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">99</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="42" length="11"/>
        <text>hepatocytes</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">101</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="106" length="4"/>
        <text>RALA</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="110" length="11"/>
        <text>hepatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3868163 f3-B</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-B</infon>
    <infon key="sourcedata_figure_dir">f3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) EGF enhances nuclear P-ERK/LC3-II colocalization. IF depicting P-ERK (green)/LC3-II (red) colocalization in untreated (Con) or EGF-treated NIH/3T3 cells. Native images (top)/images with colocalization in white pixels (bottom) are shown. Scale bar, 5 μm. Bars represent mean±s.e.m. ***P0.001 compared with Con; Student's t-test, 50 cells from two experiments.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f3-C</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-C</infon>
    <infon key="sourcedata_figure_dir">f3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Adipogenic differentiation increases nuclearLC3-II. Images depict nuclearLC3-II in 3T3-L1preadipocytes in maintenance or differentiation medium (2 h). Scale bar, 5 μm. Bars represent mean±s.e.m. **P0.01 compared with Con; Student's t-test, 50 cells from two experiments.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">118</infon>
        <infon key="identifier">CL:0002334</infon>
        <location offset="93" length="13"/>
        <text>preadipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3868163 f3-D</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-D</infon>
    <infon key="sourcedata_figure_dir">f3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Nuclear P-ERK/LC3-II colocalization in serum-fed cells. IF showing P-ERK (green)/LC3 (red) colocalization in 2 hserum-fed NIH/3T3 cells. Native images (top)/images with colocalization in white pixels (bottom) are shown. Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f3-E</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-E</infon>
    <infon key="sourcedata_figure_dir">f3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) LC3 interacts with ERKin vivo. Immunoblots showing co-immunoprecipitation of LC3 with ERK, MEK and bRAF in homogenate (Hom) (e, top), and of LC3 with P- and total ERK in nuclear fractions from mouselivers (e, bottom).</text>
    </passage>
  </document>
  <document>
    <id>3868163 f3-F</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-F</infon>
    <infon key="sourcedata_figure_dir">f3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Blocking nuclear transport decreases EGF-induced increase in nuclear LC3-II. LC3 IF (red) in EGF-treated NIH/3T3 cells pre-exposed (30 min) or not to WGA. Bars represent mean±s.e.m. ***P0.001 compared to with; Student's t-test, 60 cells from n=3. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f3-G</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-G</infon>
    <infon key="sourcedata_figure_dir">f3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Blocking nuclear transport decreases nuclearERK content. ERK IF (green) in EGF-treated NIH/3T3 cells pre-exposed (30 min) or not to WGA. Bars represent mean±s.e.m. ***P0.001 compared with Con; Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f3-H</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f3-H</infon>
    <infon key="sourcedata_figure_dir">f3-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h) Blocking nuclear transport does not modify P-ERK/LC3-II colocalization. IF depicting nuclear P-ERK (green)/LC3 (red) colocalization in EGF-treated NIH/3T3 cells pre-exposed or not to WGA. For (g) and (h): Scale bar, 10 μm, bars are mean±s.e.m. 50 cells from n=2. Nuclei are blue (DAPI). Arrows indicate LC3 puncta, ERK or colocalization.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f4-A</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f4-A</infon>
    <infon key="sourcedata_figure_dir">f4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Atg7−/− livers display decreased ERK phosphorylation. Immunoblots for the indicated proteins in liver homogenate (Hom) and cytosolic (Cyt) fractions of control (Con) and liver-specific Atg7−/− mice are shown. The bars represent mean±s.e.m. *P0.05, **P0.01, ***P0.001 compared with Con; Student's t-test, n=4.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f4-B</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f4-B</infon>
    <infon key="sourcedata_figure_dir">f4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Atg7−/− livers display decreased ERK2 dimers. Immunoblots show the indicated proteins in Hom from Con and Atg7−/− livers. The bars represent mean±s.e.m. *P0.05, ***P0.001 compared to Con; Student's t-test, n=4-5. Arrows indicate p42 monomers and dimers.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f4-C</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f4-C</infon>
    <infon key="sourcedata_figure_dir">f4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Atg7−/− brown adipose tissues (BAT) display decreased ERK phosphorylation. Immunoblots for indicated proteins in Hom from Con and Atg7−/−BAT. The bars represent mean±s.e.m. **P0.01 compared with Con; Student's t-test, n=4-6.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f4-D</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f4-D</infon>
    <infon key="sourcedata_figure_dir">f4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Atg7−/− livers exhibit decreased nuclear ERK phosphorylation. Immunoblots show the indicated proteins in homogenate (Hom, lane 1) and nuclear fractions (lanes 2-5) from Con and Atg7−/− livers. The bars represent mean±s.e.m. ***P0.001 compared with Con; Student's t-test, n=4-5.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f4-E</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f4-E</infon>
    <infon key="sourcedata_figure_dir">f4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) LC3 C terminus glycine-deleted (ΔG) mutants exhibit decreased ERK phosphorylation. Immunoblots for indicated proteins in total lysates from CFP-LC3- and CFP-LC3ΔG-transfected NIH/3T3 cells exposed or not to EGF (10 min). The bars represent mean±s.e.m. ***P0.001 compared with Con; Student's t-test, n=8.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f5-A</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f5-A</infon>
    <infon key="sourcedata_figure_dir">f5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Atg5−/− MEFs display reduced ERK phosphorylation during nutrient deprivation. Quantification of P-ERK levels normalized to total ERK (detected by immunoblotting) in WT and Atg5−/− MEFs cultured in the absence of serum for indicated times. The bars represent mean±s.e.m. *P0.05 compared with corresponding WT value; ***P0.001, ****P0.0001 compared with 10 min serum-starved Atg5−/− MEFs; ANOVA-Bonferroni post hoc test, n=3.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f5-B</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f5-B</infon>
    <infon key="sourcedata_figure_dir">f5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Serum-deprived Atg5−/− MEFs display decreased ERK and p90RSK phosphorylation. Immunoblots for the indicated proteins in total lysates from 2 hserum-deprived WT and Atg5−/− MEFs. The bars represent mean±s.e.m. *P0.05, ***P0.001 compared with Con; Student's t-test, n=3.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f5-C</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f5-C</infon>
    <infon key="sourcedata_figure_dir">f5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Atg5−/− MEFs display decreased nuclear ERK activity. Immunoblots for phosphorylated HA (haemagglutinin)-tagged Elk1 in total lysates from 2 h serum-deprived WT and Atg5−/− MEFs cells exposed or not to EGF (10 min).</text>
    </passage>
  </document>
  <document>
    <id>3868163 f5-D</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f5-D</infon>
    <infon key="sourcedata_figure_dir">f5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Atg5−/− MEFs display decreased Elk1-driven gene expression. Elk1-driven ZFP36 mRNA levels from 2 hserum-deprived WT and Atg5−/− MEFs cells exposed or not to EGF (10 min). The bars represent mean±s.e.m. ***P0.001 compared with Con; Student's t-test, n=3. (</text>
    </passage>
  </document>
  <document>
    <id>3868163 f5-E</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f5-E</infon>
    <infon key="sourcedata_figure_dir">f5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Decreased ERK phosphorylation in Atg5−/− MEFs occurs independently of changes in ERK phosphatases. Immunoblots for the indicated proteins in 2 hserum-deprived WT MEFs transfected with scrambled siRNA (scr), and Atg5−/− MEFs transfected with scr or siRNAs against MKP3 or PP2A in the presence or absence of EGF. The bars represent mean±s.e.m., n=3.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f6-A</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f6-A</infon>
    <infon key="sourcedata_figure_dir">f6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Mutations in FRS on ERK2 decrease colocalization of ERK2 with ATG5-ATG12, LC3 and WIPI1. Immunofluorescence (IF) showing colocalization (depicted as white pixels by 'colocalization finder application') of WT-ERK2-HA, FRS ERK2 mutants (L198A-, L232A-, L198A/L232A-, Y261A-ERK2-HA) or common docking (CD) mutant (D319N-ERK2-HA) with ATG5-ATG12 (panels 1-6), LC3 (panels 7-12) or WIPI1 (panels 13-18) in EGF-treated NIH/3T3 cells. ERK2 is stained in red, and autophagy proteins are stained in green. Scale bar, 10 μm. The bars represent mean±s.e.m. **P0.01, ****P0.0001 compared with WT-ERK2-transfected cells; Student's t-test, 50 cells analysed from n=2. (</text>
    </passage>
  </document>
  <document>
    <id>3868163 f6-B</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f6-B</infon>
    <infon key="sourcedata_figure_dir">f6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Mutations in FRS on ERK2 decrease colocalization of ERK2 with nuclearATG5-ATG12 or LC3. IF showing colocalization (white pixels) of WT-ERK2-HA (red), FRS ERK2 mutants (L198A-, L232A-, L198A/L232A-, Y261A-ERK2-HA) or common docking (CD) mutant (D319N-ERK2-HA) with ATG5-ATG12 (panels 1-6) or LC3-II (panels 7-12) in EGF-treated NIH/3T3 cells. Scale bar, 5 μm. The bars represent mean±s.e.m. **P0.01, ***P0.001, ****P0.0001 compared with WT-ERK2-transfected cells; Student's t-test, 50 cells analysed from n=2. Arrows depict colocalization.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f6-C</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f6-C</infon>
    <infon key="sourcedata_figure_dir">f6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) ATG5-ATG12 conjugation is required for ERK phosphorylation. Immunoblots for P-ERK, total ERK and β-actin in NIH/3T3 cells transfected with WT ATG5 or the conjugation-defective ATG5 K130R mutant and treated with EGF (10 min). The bars represent mean±s.e.m. *P0.05 compared with WT ATG5-transfected cells; Student's t-test, n=3.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-A</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-A</infon>
    <infon key="sourcedata_figure_dir">f7-A</infon>
    <passage>
      <offset>0</offset>
      <text>a) ATG4B depletion increases steady-state LC3-II levels. Immunoblots for indicated proteins in NIH/3T3 cells transfected with scrambled siRNAs (scr) or siRNAs against ATG4B (siATG4B) in presence/absence of EGF. Bars represent mean±s.e.m. *P0.05, ***P0.001 compared with scr; Student's t-test, n=4.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-B</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-B</infon>
    <infon key="sourcedata_figure_dir">f7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) siATG4B cells exhibit increased autophagic vesicles. Representative electron micrographs depicting autophagic vesicles (indicated by black arrows) in scr and siATG4BNIH/3T3 cells.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-C</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-C</infon>
    <infon key="sourcedata_figure_dir">f7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) ATG4B depletion does not increase autophagic flux in serum-fed cells. Immunoblots for indicated proteins in lysates from scr or siATG4BNIH/3T3 cells in presence/absence of lysosomal inhibitors, ammonium chloride and leupeptin (Inh) for 2 h. Scale bars, 1 μm. Bars represent mean±s.e.m., n=3.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-D</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-D</infon>
    <infon key="sourcedata_figure_dir">f7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) siATG4B cells display increased nuclear LC3-II. Images for LC3-II (red) in scr or siATG4B NIH/3T3 cells in presence/absence of EGF (10 min). Scale bar, 5 μm. Bars represent mean±s.e.m. ***P0.001 compared with scr; Student's t-test, 60 cells from n=2.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-E</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-E</infon>
    <infon key="sourcedata_figure_dir">f7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) ATG4B deficiency increases P-ERK/LC3-II colocalization. Immunofluorescence (IF) for P-ERK (green)/LC3 (red) colocalization in scr or siATG4BNIH/3T3 cells in presence/absence of EGF (10 min). Scale bars, 10 μm. Bars represent mean±s.e.m. **P0.01, ***P0.001 compared with scr; Student's t-test, 60 cells from n=2.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-F</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-F</infon>
    <infon key="sourcedata_figure_dir">f7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) ATG4B-deficient cells display increased nuclear P-ERK/LC3 colocalization. IF depicting P-ERK (green)/LC3 (red) colocalization in nuclei of scr or siATG4BNIH/3T3 cells in presence/absence of EGF. Scale bars, 5 μm. Bars represent mean±s.e.m. **P0.01, ***P0.001 compared with scr; Student's t-test, 60 cells from n=2.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-G</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-G</infon>
    <infon key="sourcedata_figure_dir">f7-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) ATG4B deficiency augments EGF-induced MEK and ERK phosphorylation. Immunoblots for P- and total MEK and ERK, LC3 and GAPDH in total lysates from scr or siATG4BNIH/3T3 cells in presence/absence of EGF. Bars represent mean±s.e.m., n=3.</text>
    </passage>
  </document>
  <document>
    <id>3868163 f7-H</id>
    <infon key="sourcedata_document">653</infon>
    <infon key="doi">10.1038/ncomms3799</infon>
    <infon key="pmc_id">3868163</infon>
    <infon key="figure">f7-H</infon>
    <infon key="sourcedata_figure_dir">f7-H</infon>
    <passage>
      <offset>0</offset>
      <text>h) ATG4B deficiency increases nuclear P-ERK levels. Native (top)/inverted images (bottom) showing nuclear P-ERK content. P-ERK fluorescence in untreated (Con)/EGF-treated scr or siATG4BNIH/3T3 cells is shown. Scale bars, 5 μm. Bars represent mean±s.e.m. **P0.01, ***P0.001 compared with scr; Student's t-test, 60 cells from n=2. Nuclei are blue (DAPI).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f1-A</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f1-A</infon>
    <infon key="sourcedata_figure_dir">f1-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Wild-type (WT) and Park2-/- BMDMs were infected with mCherry-expressing M. tuberculosis (Mtb) for 4 h and immunostained using anti-parkin antibodies.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">2</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="31" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f1-B</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f1-B</infon>
    <infon key="sourcedata_figure_dir">f1-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Wild-type BMDMs were infected with mCherry-expressing M. tuberculosis for 4 h and immunostained for polyubiquitin.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">11</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="13" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f1-C</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f1-C</infon>
    <infon key="sourcedata_figure_dir">f1-C</infon>
    <passage>
      <offset>0</offset>
      <text>b, Wild-type BMDMs were infected with mCherry-expressing M. tuberculosis for 4 h and immunostained for polyubiquitin. c, Quantification of ubiquitin-positive M. tuberculosis from b. Results are means ± s.e.m. of three independent experiments (**P &lt; 0.001, paired Student's t-test).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="13" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f1-D</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f1-D</infon>
    <infon key="sourcedata_figure_dir">f1-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, U937human macrophages expressing a scrambled shRNA (Control) or one of two different shRNAs targeting PARK2 (shRNA no. 1, shRNA no. 2) were infected with mCherry-expressing M. tuberculosis for 12 h and immunostained for polyubiquitin.</text>
    </passage>
  </document>
  <document>
    <id>3886920 f1-E-F</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f1-E-F</infon>
    <infon key="sourcedata_figure_dir">f1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>d, U937human macrophages expressing a scrambled shRNA (Control) or one of two different shRNAs targeting PARK2 (shRNA no. 1, shRNA no. 2) were infected with mCherry-expressing M. tuberculosis for 12 h and immunostained for polyubiquitin. e, Quantification of ubiquitin positive M. tuberculosis from d, results are means ± s.e.m. of three independent experiments (**P  0.005, Student's t-test). f, The parkin and actin expression in cells from e was determined by western blotting.</text>
    </passage>
  </document>
  <document>
    <id>3886920 f1-G-H</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f1-G-H</infon>
    <infon key="sourcedata_figure_dir">f1-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>g, Park2−/− BMDMs were transduced with lentivirus expressing BFP (−), wild-type parkin, or two separate mutant parkin alleles (T240R, P437L). Cells were infected with M. tuberculosis for 4 h and ubiquitin and M. tuberculosis co-localization was quantified and expressed relative to control BMDMs. Results are means ± s.e.m. of three independent experiments (**P  0.005, paired Student's t-test). h, The parkin and actin expression in cells from g was determined by western blotting.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">49</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="12" length="5"/>
        <text>BMDMs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">55</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="290" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f2-A-B</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f2-A-B</infon>
    <infon key="sourcedata_figure_dir">f2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>a, BMDMs were infected with mCherry-expressing M. tuberculosis for 4 h and immunostained using linkage-specific ubiquitin antibodies. b, Quantification of K63 and K48 ubiquitin-positive M. tuberculosis from a.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">62</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="3" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f2-C</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f2-C</infon>
    <infon key="sourcedata_figure_dir">f2-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, BMDMs were infected with mCherry-expressing M. tuberculosis for 4 h and immunostained for NDP52, p62, phospho-TBK1 or NBR1. d, Quantification of co-localization from c (n = 3 per group, **P  0.001). All errors, s.e.m.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">70</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="3" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f3-A-C</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f3-A-C</infon>
    <infon key="sourcedata_figure_dir">f3-A-C</infon>
    <passage>
      <offset>0</offset>
      <text>a, BMDMs were infected with mCherry-expressing M. tuberculosis (arrows) for 4 h and immunostained for LC3 (LC3B antibody) or ATG12. b, Quantification of results from a (n = 3 per group, **P  0.001). c, Western blot analysis of LC3 (LC3B antibody) from cell lysates from a.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">84</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="3" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f3-D</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f3-D</infon>
    <infon key="sourcedata_figure_dir">f3-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, BMDMs were infected with mCherry-expressing M. tuberculosis (arrows) for 6 h and immunostained for LAMP1.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">95</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="3" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f3-E</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f3-E</infon>
    <infon key="sourcedata_figure_dir">f3-E</infon>
    <passage>
      <offset>0</offset>
      <text>d, BMDMs were infected with mCherry-expressing M. tuberculosis (arrows) for 6 h and immunostained for LAMP1. e, Quantification of results from d expressed relative to control BMDMs (n = 3 per group, **P  0.001).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="3" length="5"/>
        <text>BMDMs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="175" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f3-F</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f3-F</infon>
    <infon key="sourcedata_figure_dir">f3-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, BMDMs were infected with M. tuberculosis and colony-forming units (c.f.u.) at t = 0 and t = 16 h were determined by plating. Results were normalized to t = 0 (n = 3 per group, *P &lt; 0.02).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">113</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="3" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3886920 f3-G</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f3-G</infon>
    <infon key="sourcedata_figure_dir">f3-G</infon>
    <passage>
      <offset>0</offset>
      <text>g, RAW264.7 macrophages transduced with lentivirus expressing green fluorescent protein (GFP) or parkin were infected with M. tuberculosis and c.f.u. were determined after 16 h. Results were normalized to GFP-expressing cells (n = 3 per group, **P &lt; 0.0076).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f3-H</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f3-H</infon>
    <infon key="sourcedata_figure_dir">f3-H</infon>
    <passage>
      <offset>0</offset>
      <text>h, U937 human macrophages expressing either scrambled or PARK2 shRNAs were infected with M. tuberculosis for 36 h and c.f.u were determined. Results were normalized to t = 0 (N = 3 per group, *P&lt; 0.02). All errors, s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>3886920 f4-A</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f4-A</infon>
    <infon key="sourcedata_figure_dir">f4-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, WT and Park2-/- mice were infected with wild-type M. tuberculosis by aerosol and lung bacterial burdens were determined by plating (means ± s.d., n = 5 per group, *P &lt; 0.02 by Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f4-B</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f4-B</infon>
    <infon key="sourcedata_figure_dir">f4-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Enumeration of liver and spleenc.f.u. from mice infected in a, 21 days post-infection (means ± s.d, n = 5 per group, *P &lt; 0.03 by Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f4-C</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f4-C</infon>
    <infon key="sourcedata_figure_dir">f4-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Survival of M. tuberculosis-infected wild-type and Park2-/- mice (n = 10, **P &lt; 0.001 by log-rank test).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f4-D</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f4-D</infon>
    <infon key="sourcedata_figure_dir">f4-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, Immunohistochemistry staining of lung sections from infected mice21 days post-infection, scale bar, 50 µm.</text>
    </passage>
  </document>
  <document>
    <id>3886920 f4-E</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f4-E</infon>
    <infon key="sourcedata_figure_dir">f4-E</infon>
    <passage>
      <offset>0</offset>
      <text>e, Immunohistochemistry staining of lung sections from a human patient with active tuberculosis. Scale bars, 500 µm (×4), 50 µm (×40).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f4-F</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f4-F</infon>
    <infon key="sourcedata_figure_dir">f4-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, Confocal microscopy images of humanlung sections from e immunostained for M. tuberculosis and parkin; DNA was visualized using DAPI (4′,6-diamidino-2-phenylindole). Scale bars, 25 µm.</text>
    </passage>
  </document>
  <document>
    <id>3886920 f4-G</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f4-G</infon>
    <infon key="sourcedata_figure_dir">f4-G</infon>
    <passage>
      <offset>0</offset>
      <text>g, Mice were infected with wild-type L. monocytogenes by i.p. injection and bacterial burdens in livers and spleens were determined by plating (means ± s.d., n = 7 per group, *P &lt; 0.04 by Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f5-A</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f5-A</infon>
    <infon key="sourcedata_figure_dir">f5-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Wild-type and two independent parkin-deficient D. melanogaster lines (parkc00062, parkf01950) were infected with L. monocytogenes by anterior abdomen injection. Atg8 processing was monitored in whole-fly protein lysates by western blotting.</text>
    </passage>
  </document>
  <document>
    <id>3886920 f5-B</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f5-B</infon>
    <infon key="sourcedata_figure_dir">f5-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, L. monocytogenes c.f.u. from a were determined by plating (means ± s.d., n = 3-5, **P &lt; 0.001 by Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f5-C</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f5-C</infon>
    <infon key="sourcedata_figure_dir">f5-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Survival of D. melanogaster was determined (n = 33, **P &lt; 0.001 by log-rank test).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f5-D-E</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f5-D-E</infon>
    <infon key="sourcedata_figure_dir">f5-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>d, e, Flies were infected with S. enterica serovar Typhimurium and bacterial c.f.u. (d) (means ± s.d., n = 3-5 per group, **P  0.009 by Student's t-test) and flysurvival (e) were determined (n = 59, **P  0.001 by log-rank test).</text>
    </passage>
  </document>
  <document>
    <id>3886920 f5-F</id>
    <infon key="sourcedata_document">556</infon>
    <infon key="doi">10.1038/nature12566</infon>
    <infon key="pmc_id">3886920</infon>
    <infon key="figure">f5-F</infon>
    <infon key="sourcedata_figure_dir">f5-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, Survival of flies infected with M. marinum (n = 37, **P  0.0045 by log-rank test).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f1-A</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f1-A</infon>
    <infon key="sourcedata_figure_dir">f1-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Percentage of ciliated cells in control (Ctrl) and IFT20− MEFs (*P = 0.030, n = 3) and wild-type (WT) and Ift88−/− KECs (**P = 0.003, 25 cells each, n = 3) after 24 h of serum removal. Arrows, cilia.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="118" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f1-B</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f1-B</infon>
    <infon key="sourcedata_figure_dir">f1-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, LC3immunoblot (left) for autophagic flux quantification (right) in Ctrl and IFT20− MEFs (top, **P = 0.0003, n = 7), and in WT and Ift88−/− KECs (bottom, *P = 0.035, n = 9). PI, protease inhibitors; S, serum. c</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">16</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="142" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f1-C</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f1-C</infon>
    <infon key="sourcedata_figure_dir">f1-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Autophagic flux in WT and Ift88−/−KECs by mCherry-GFP-LC3 puncta quantification. Puncta: yellow, autophagosomes; red only, autophagolysosomes; total, both together (**P = 0.008, *P = 0.025).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">26</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="37" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f1-D</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f1-D</infon>
    <infon key="sourcedata_figure_dir">f1-D</infon>
    <passage>
      <offset>0</offset>
      <text>. d, LC3immunoblot (left) for quantification of autophagosome formation (right). (*P = 0.048, n = 4).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f1-E</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f1-E</infon>
    <infon key="sourcedata_figure_dir">f1-E</infon>
    <passage>
      <offset>0</offset>
      <text>e, Electron microscopy images (left) and morphometric quantification of autophagic vacuoles (AV, right) in Ctrl and IFT20− MEFs (top, **P = 0.001, 10 fields in 2 experiments) and KECs WT and Ift88−/− (bottom, *P = 0.037, 5 fields). Arrows, autophagic vacuoles (AV, black) and endosomal compartments (yellow).</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">44</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="179" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f1-F</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f1-F</infon>
    <infon key="sourcedata_figure_dir">f1-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, Percentage of ciliated MEFs after induction of cilia resorption with 50 ng ml−1 platelet-derived growth factor (PDGF) treatment. (**P = 0.001, ***P = 0.0009, 121, 230 and 162 cells, n = 5).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f1-G</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f1-G</infon>
    <infon key="sourcedata_figure_dir">f1-G</infon>
    <passage>
      <offset>0</offset>
      <text>g, LC3immunoblot (top) for autophagic flux quantification (bottom) upon PDGF treatment (*P = 0.005, n = 3). Scale bars in a, 10 µm. n.s., statistically non-significant. Mean ± s.d. in b, d and mean ± s.e.m. in other panels.</text>
    </passage>
  </document>
  <document>
    <id>3896125 f2-A</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f2-A</infon>
    <infon key="sourcedata_figure_dir">f2-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, GFP-LC3puncta pattern (left) and quantification (right) in MEFs treated with purmorphamine (Purmo; top, *P = 0.028, n = 4), in Ptc−/− MEFs (middle, *P = 0.015, n = 4) and after myc-GLI1 overexpression (bottom, *P = 0.012, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f2-B</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f2-B</infon>
    <infon key="sourcedata_figure_dir">f2-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Autophagic flux by mCherry-GFP-LC3puncta quantification upon purmorphamine treatment in MEFs in the presence of serum. Yellow, autophagosomes; red only, autophagolysosomes; total, both compartments. (*P = 0.0323, 40 fields).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f2-C</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f2-C</infon>
    <infon key="sourcedata_figure_dir">f2-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, LC3immunoblot (left) for autophagic flux quantification (right) in Ctrl (**P = 0.001) and MEFs knocked down for SMO (SMO−) (**P = 0.0001) upon purmorphamine treatment (*P = 0.009, n = 4).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f2-D</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f2-D</infon>
    <infon key="sourcedata_figure_dir">f2-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, Autophagic flux by mCherry-GFP-LC3puncta quantification in WT and Ift88−/− KECs upon purmorphamine treatment (*P = 0.046, **P = 0.008, 40 fields).</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">97</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="78" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f2-E</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f2-E</infon>
    <infon key="sourcedata_figure_dir">f2-E</infon>
    <passage>
      <offset>0</offset>
      <text>. e, LC3immunoblot (left) for autophagic flux quantification (right) in Ift88−/− KECs overexpressing myc-GLI1 (**P = 0.00006, n = 3).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">107</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="81" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f2-F</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f2-F</infon>
    <infon key="sourcedata_figure_dir">f2-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, Autophagic flux by mCherry-GFP-LC3puncta quantification in MEFs treated with cyclopamine upon serum removal (*P = 0.011, **P = 0.013, 25 fields). Scale bars, 10 µm. Mean ± s.d. in c, f and mean ± s.e.m. in other panels.</text>
    </passage>
  </document>
  <document>
    <id>3896125 f3-A</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f3-A</infon>
    <infon key="sourcedata_figure_dir">f3-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Co-immunostaining (top) and 3D reconstruction (middle and bottom) for the indicated autophagy-related proteins (ATGs, green) and acetylated tubulin (red, ciliary axoneme marker) in KECs maintained in the absence of serum for 24 h. Yellow arrows, colocalization.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">126</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="184" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f3-B</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f3-B</infon>
    <infon key="sourcedata_figure_dir">f3-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Schematic representation of the ATGs associated with the axoneme (top left). Co-immunostaining for ATGs and acetylated tubulin in cilia isolated by peeling off. Individual channels and merged images are shown.</text>
    </passage>
  </document>
  <document>
    <id>3896125 f3-C</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f3-C</infon>
    <infon key="sourcedata_figure_dir">f3-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Co-immunostaining (bottom) and 3D reconstruction (top) for ATGs (green) and gamma-tubulin (red, basal body marker) in the same cells and conditions. Arrows, colocalization (yellow), no colocalization (white).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f3-D</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f3-D</infon>
    <infon key="sourcedata_figure_dir">f3-D</infon>
    <passage>
      <offset>0</offset>
      <text>d-f, Percentage of cells with colocalizing ATGs in the basal body (BB) in WT and Ift88−/− KECs in the presence or absence of serum. d, Serum- and IFT-dependent association of ATGs with the BB (VPS34, †P = 0.04, **P = 0.002, n = 4; ATG16L, ††P = 0.0003, **P = 0.0009, 15 cells each per experiment, n = 7). e, IFT-dependent but serum-independent association of ATGs with the BB (**P = 0.001, ***P = 9.33768 × 10−6, n = 4; *P = 0.018, 15 cells each per experiment, n = 5). f, BB association of ATGs independent on serum or IFT (ATG5, n = 5; LC3, n = 8; 15 cells each per experiment). Scale bars, 10 &amp;mgr;m. Mean ± s.e.m.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">185</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="90" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f4-A-B</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f4-A-B</infon>
    <infon key="sourcedata_figure_dir">f4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>a, b, Immunoblot for the indicated proteins of WT and Ift88−/− KECs subjected to co-immunoprecipitation of IFT20 (a) and ATG16L (b). Inp, 1/10 input; IP, immunoprecipitate; FT, 1/10 flow-through.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">196</infon>
        <infon key="identifier">CL:0002518</infon>
        <location offset="63" length="4"/>
        <text>KECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3896125 f4-C</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f4-C</infon>
    <infon key="sourcedata_figure_dir">f4-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Immunoblot for ATG16L and clathrin in MEF homogenate (Hom), and the pellets from 1 h centrifugation at 100,000g (organelles (Org)), 300,000g (300k) and 500,000g (vesicles, 500k).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f4-D</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f4-D</infon>
    <infon key="sourcedata_figure_dir">f4-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, Immunoblot for IFT20 and ATG16L in the same fractions isolated from Ctrl, IFT20− and IFT88− MEFs in the presence (top) and absence (bottom) of serum.</text>
    </passage>
  </document>
  <document>
    <id>3896125 f4-E</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f4-E</infon>
    <infon key="sourcedata_figure_dir">f4-E</infon>
    <passage>
      <offset>0</offset>
      <text>e, Immunogold electron microscopy for ATG16L (15-nm particles) and IFT20 (10-nm particles) in vesicles from MEFs isolated by the same method as in c. Right, quantification of IFT20 and ATG16L presence in the vesicles (11 fields). Mean ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>3896125 f5-A-B</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f5-A-B</infon>
    <infon key="sourcedata_figure_dir">f5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>a, b, Ciliated Atg5−/− MEFs in serum+ (*P = 0.038, 25 cells each per experiment, n = 3) (a) or serum− (*P = 0.006, nonlinear fit regression, 25 cells each per experiment, n = 3) (b).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f5-C</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f5-C</infon>
    <infon key="sourcedata_figure_dir">f5-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Scanning electron microscopy (SEM) of primary cilia. Arrows, cilia-associated vesicles; arrowheads, ciliary pocket.</text>
    </passage>
  </document>
  <document>
    <id>3896125 f5-D</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f5-D</infon>
    <infon key="sourcedata_figure_dir">f5-D</infon>
    <passage>
      <offset>0</offset>
      <text>. d, Cilia length quantification from SEM (*P = 0.027 n = 28; **P = 0.001, ††P = 0.0001, n = 23).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f5-E-F</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f5-E-F</infon>
    <infon key="sourcedata_figure_dir">f5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>e, f, GLI1 (*P = 0.04, n = 3) (e) and GLI2 (***P = 0.0005, **P = 0.0046, †P = 0.0132, n = 3) (f) messenger RNA expression in Atg5−/− MEFs.</text>
    </passage>
  </document>
  <document>
    <id>3896125 f5-G-H</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f5-G-H</infon>
    <infon key="sourcedata_figure_dir">f5-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>g, h, IFT20immunoblot in Atg5−/− (g) and WT MEFs with lysosomal inhibitors (NL) (h).</text>
    </passage>
  </document>
  <document>
    <id>3896125 f5-I</id>
    <infon key="sourcedata_document">559</infon>
    <infon key="doi">10.1038/nature12639</infon>
    <infon key="pmc_id">3896125</infon>
    <infon key="figure">f5-I</infon>
    <infon key="sourcedata_figure_dir">f5-I</infon>
    <passage>
      <offset>0</offset>
      <text>i, IFT20immunoblot in cytosol (Cyt), homogenate (Hom) and autophagosomes (APG). j, IFT20 protein levels in Atg5−/− MEFs (*P = 0.038, n = 6). k, IFT20immunoblot in Atg5−/− MEFs. n.s., statistically non-significant. Mean ± s.d. in d and j and mean ± s.e.m. in other panels.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf1-B</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf1-B</infon>
    <infon key="sourcedata_figure_dir">figf1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Quantification of CTM-GFP and mCTM-GFP relative to WT-GFP in HEK cells 24 h after individual transfections with WT-GFP, mCTM-GFP (n = 6) or CTM-GFP. Cells transfected with WT-GFP or CTM-GFP were treated without (no treatment; n = 13) or with serum deprivation (+ SD; n = 5; to enhance CMA activity) or with macroautophagy inhibitor 3-methyladenine (+ 3-MA; 10 mM; n = 5), proteasome inhibitor (+ MG132; 5 μM; n = 6), lysosome inhibitor (+ NH4Cl; 20 mM; n = 6) or pepstatin A (+ Pep A; 10 μM; n = 5). Top, representative immunoblots of cell lysates for GFP. Membranes reprobed for β-actin were used as a loading control. Bottom, means ± s.e.m. of relative protein levels, normalized to WT-GFP (arbitrarily set as 1; white bar); n represents the number of independent experiments from at least 4 separate cultures. One-way ANOVA with Fisher least significant difference test, F(12,73) = 20.939. ***P 0.001 versus WT-GFP (white bar); ΔΔΔP 0.001 relative to untreated CTM-GFP levels (gray bar). Full-length blots are presented in Supplementary Figure 9.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf1-C</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf1-C</infon>
    <infon key="sourcedata_figure_dir">figf1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Representative confocal images of colocalization of GFP with the lysosome marker LAMP-1 in COS-7 cells transfected with either WT-GFP (n = 17) or CTM-GFP (n = 16). Scale bar, 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf2-B</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf2-B</infon>
    <infon key="sourcedata_figure_dir">figf2-B</infon>
    <passage>
      <offset>0</offset>
      <text>b) Reciprocal coimmunoprecipitation (IP) followed by immunoblotting revealed that GluN2Bct specifically interacted with cDAPK1 but not wtDAPK1. Flag-tagged inactive wtDAPK1 or constitutively active cDAPK1 was expressed with either HA-GluN2Bct-CTM or HA-GluN2Bct-CTMm at various ratios in HEK cells, and coimmunoprecipitation and/or immunoblotting were performed 24 h thereafter. Anti-HA was used to detect HA-GluN2Bct-CTM and HA-GluN2Bct-CTMm, anti-FLAG to detect wtDAPK1 and cDAPK1.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf2-C</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf2-C</infon>
    <infon key="sourcedata_figure_dir">figf2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) HA-GluN2Bct-CTM specifically and dose-dependently decreased the level of cDAPK1 (n = 4 independent experiments from 4 separate cell cultures and transfections; P 0.001; F(5,18) = 18.27) but not wtDAPK1</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf2-D</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf2-D</infon>
    <infon key="sourcedata_figure_dir">figf2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d; n = 3 independent experiments from 3 separate cell cultures and transfections; P = 0.933; F(5,12) = 0.249). HA-GluN2Bct-CTM-mediated cDAPK1 knockdown was significantly reduced by NH4Cl (c; 20 mM; n = 4; ΔΔΔP 0.001 compared to HA-GluN2Bct-CTM:cDAPK1 8:1 group) and by mutational inactivation of CTM</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf2-E</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf2-E</infon>
    <infon key="sourcedata_figure_dir">figf2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e; HA-GluN2Bct-CTMm; P = 0.785 compared to control (white bar); F(4,35) = 0.432, 8 independent experiments from 8 separate cell cultures and transfections). Levels of cDAPK1 or wtDAPK1 cotransfected with pcDNA3.0 vector (0:1, white bar) represent the control values, arbitrarily set as 1. *P 0.05, **P 0.01, ***P 0.001, compared with the control; n.s., not significant. Bars represent relative means ± s.e.m. Full-length blots are presented in Supplementary Figure 9. Membranes reprobed for β-actin were used as loading controls. One-way ANOVA with Fisher least significant difference test.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf3-A</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf3-A</infon>
    <infon key="sourcedata_figure_dir">figf3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Left, NMDA (50 μM; 30 min) activated DAPK1, resulting in a time-dependent decrease in its phosphorylation levels (pDAPK1, n = 4). Right, coimmunoprecipitation (IP) with anti-GluN2B and sequential immunoblotting for DAPK1 and GluN2B showed an NMDA-induced association between DAPK1 and GluN2B (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf3-B</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf3-B</infon>
    <infon key="sourcedata_figure_dir">figf3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Design and production of TAT-GluN2Bct-CTM and TAT-GluN2Bct peptides (left) using an E. coli expression system. Coomassie blue staining after SDS-PAGE assessed their purity (right); left lane, size marker.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf3-C-D-E-F</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf3-C-D-E-F</infon>
    <infon key="sourcedata_figure_dir">figf3-C-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Bath application of TAT-GluN2Bct-CTM (200 μM; n = 9), but not TAT-GluN2Bct (200 μM; n = 6), knocked down activated DAPK1, and this was prevented by NH4Cl (20 mM; n = 5; one-way ANOVA; P 0.001, F(5,36) = 10.891) and dose- (d, doses in μM; n = 4; P 0.001; F(6,21) = 18.14) and time-dependent (e; P 0.001; F(8,44) = 12.074). (f) A single pretreatment of TAT-GluN2Bct-CTM (sing; 200 μM, 60 min before and during the 30-minNMDA stimulation) produced a transient reduction of DAPK1, returning to baseline within 7 h (n = 4; P = 0.888), and an additional dose of the peptide after NMDA washout resulted in a persistent decrease in DAPK1 up to 7 h (mult; n = 4; ΔΔP = 0.002). One-way ANOVA; P 0.001, F(4,15) = 10.389.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf3-G</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf3-G</infon>
    <infon key="sourcedata_figure_dir">figf3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Synthetic peptides TAT-GluN2B and TAT-GluN2BCTM.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf3-H</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf3-H</infon>
    <infon key="sourcedata_figure_dir">figf3-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h) TAT-GluN2BCTM (25 μM; n = 5; P = 0.001), but not control TAT-GluN2B (25 μM; n = 4; P = 0.223), decreased native DAPK1, and this was prevented by NH4Cl (20 mM; n = 5; P = 0.302). One-way ANOVA, P 0.001, F(5,24) = 13.591. Relative levels of DAPK1 were normalized to those in the saline control group and compared to the saline control (white bar; *P 0.05, **P 0.01 and ***P 0.001) or NMDA-treated group (gray bar; ΔP 0.05, ΔΔP 0.01 and ΔΔΔP 0.001). Membranes reprobed for β-actin were used as a loading control. Bars represent relative means ± s.e.m. Sample sizes represent number of individual experiments. Full-length blots are presented in Supplementary Figure 9.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf4-A</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf4-A</infon>
    <infon key="sourcedata_figure_dir">figf4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Top, the synthetic cell-penetrating α-synuclein targeting peptide TAT-βsynCTM and its control TAT-βsyn. Middle, immunoblots demonstrate that TAT-βsynCTM (25 μM; n = 5), but not the CTM-lacking control peptide TAT-βsyn (25 μM; n = 5), specifically decreased the targeted endogenous α-synuclein (one-way ANOVA, Tukey post hoc, P 0.001, F(3,16) = 12.435), without affecting the level of unrelated control protein PSD-95 at 4 h (bottom), and this reduction was prevented in the presence of NH4Cl (20 mM; n = 5). Sample sizes represent individual experiments from at least 3 separate primary cultures. (</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf4-B</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf4-B</infon>
    <infon key="sourcedata_figure_dir">figf4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Top, PSD-95 targeting peptide TAT-GluN2B9cCTM and control TAT-GluN2B9c. Middle, TAT-GluN2B9cCTM (25 μM; n = 4), but not Tat-GluN2B9c (25 μM; n = 4), effectively degraded endogenous PSD-95 (one-way ANOVA, Tukey post hoc, P 0.001, F(3,12) = 18.154) without perturbing untargeted protein α-synuclein (bottom). NH4Cl rescued PSD-95 degradation. Sample sizes represent individual experiments from at least 2 separate primary cultures. Membrane reprobing for β-actin was used as an additional specificity and loading control. ΔP 0.05, **,ΔΔP 0.01 and ***P 0.001; bars represent relative mean values ± s.e.m. normalized to the saline control (arbitrarily set as 1). Full-length blots are presented in Supplementary Figure 9.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf5-A</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf5-A</infon>
    <infon key="sourcedata_figure_dir">figf5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Immunoblotting for phosphorylated DAPK1 (pDAPK1) revealed a time-dependent activation (dephosphorylation) of DAPK1 by H2O2 treatment (300 μM; 30 min; n = 4).</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf5-B</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf5-B</infon>
    <infon key="sourcedata_figure_dir">figf5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Bath application of 100 μM TAT-GluN2Bct-CTM (36.54 ± 7.1% of control; n = 8; P = 0.001), but not TAT-GluN2Bct (89.13 ± 10.78%; n = 7; P = 0.311), 60 min before and during H2O2 treatment (300 μM; 30 min) knocked down DAPK1 at 2 h after washout, and this effect was rescued by NH4Cl (20 mM; n = 8; **P = 0.003 to control; P = 0.106 to H2O2-treated). One-way ANOVA, F(4,34) = 11.628, P 0.001. Bars represent DAPK1 levels relative to saline control group. β-actin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf5-C</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf5-C</infon>
    <infon key="sourcedata_figure_dir">figf5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) LDH assay revealed that H2O2 treatment (300 μM; 30 min) resulted in a significant increase in neuronal death 12 h after treatment (n = 8; 2.50 ± 0.12; P 0.001 to control), which was rescued by breaking down H2O2 with catalase (100 U in 10 μl phosphate-buffered saline; n = 4; 1.17 ± 0.02; P = 0.001 to H2O2 group). H2O2-induced neurotoxicity was significantly reduced by TAT-GluN2Bct-CTM (50 μM; applied 60 min before and maintained throughout the experiments; n = 9; 1.56 ± 0.08; P = 0.001 to H2O2 group), but not by TAT-GluN2Bct (50 μM; n = 9; 2.63 ± 0.10; P = 0.105 to H2O2 group) or the NMDAR antagonist APV (1 μM; n = 4; 2.16 ± 0.14; P = 0.169 to H2O2 group). NH4Cl abolished the neuroprotective effect of TAT-GluN2Bct-CTM (n = 4; 2.39 ± 0.27; P = 0.538 compared to H2O2 group). One-way ANOVA, P 0.001, F(6,41) = 26.842. ***,ΔΔΔP 0.001; bars represent relative mean values ± s.e.m. normalized to the saline control (white bar, arbitrarily set as 1). n represents individual experiments from at least 3 separate primary cultures. Full-length blots are presented in Supplementary Figure 9.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf6-B-C</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf6-B-C</infon>
    <infon key="sourcedata_figure_dir">figf6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(b) 2,3,5-Triphenyltetrazolium chloride staining of a series of transverse brain sections showed reliable damage in the ipsilateral side following unilateral MCAo. (c) Black dashed lines on a section stained as in b represent brain areas removed for immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf6-D</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf6-D</infon>
    <infon key="sourcedata_figure_dir">figf6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Immunoblots demonstrated specific DAPK1 knockdown in the infarct (Ipsi) but not contralateral (Contra) side following application of TAT-GluN2BCTM (10 mg per kilogram, i.v.; n = 3; t(4) = 14.459, P 0.001) but not TAT-GluN2B (10 mg per kilogram, i.v.; n = 3; t(4) = 0.739, P = 0.501). β-actin was used as a loading control; two-tailed Student's t-test ***P 0.001; n.s., not significant.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf6-E</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf6-E</infon>
    <infon key="sourcedata_figure_dir">figf6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) HE (left) and immunohistochemicalDAPK1 (right) staining of adjacent brain sections. Compared with those in saline (top) and TAT-GluN2B-treated (middle) controls, TAT-GluN2BCTM treatment (bottom) selectively reduced infarct area (left) and DAPK1 levels (right) ipsilaterally. Black outlining delineates infarct areas as visualized with HE staining.</text>
    </passage>
  </document>
  <document>
    <id>3937121 figf6-F</id>
    <infon key="sourcedata_document">709</infon>
    <infon key="doi">10.1038/nn.3637</infon>
    <infon key="pmc_id">3937121</infon>
    <infon key="figure">figf6-F</infon>
    <infon key="sourcedata_figure_dir">figf6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Left, brain sections stained with Fluorojade B in rats injected with saline (n = 6), TAT-GluN2B (n = 5) or TAT-GluN2BCTM (n = 5) after treatment as shown in a. Right, quantification of cellular damage by counting the number of Fluorojade B-positive cells in each 640 × 640 pixel image at 10× magnification. TAT-GluN2BCTM (10 mg per kilogram) displayed more prominent neuroprotection in the cortex (P 0.001) and striatum (P 0.001) as compared to TAT-GluN2B (10 mg per kilogram). Cortex: H(2) = 41.235; P 0.001; striatum: H(2) = 38.808; P 0.001. Kruskal-Wallis ANOVA on ranks with Dunn's post hoc; bars represent relative means ± s.e.m., ***,ΔΔΔP 0.001. n values represent tissue from 3 animals collected from at least 2 litters. Scale bars 1 mm in b,c,e, 20 μm in f. Full-length blots are presented in Supplementary Figure 9.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_1-A</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Alcian blue‐stained sections of descending colons from control and Atg5VC mice. The area between the two black dashed lines indicates the crypt base where epithelial progenitors and nascent goblet cells reside. Bars=200 μm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <location offset="159" length="22"/>
        <text>epithelial progenitors</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">348</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="186" length="20"/>
        <text>nascent goblet cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_1-B</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of average mucin area/goblet cell in control and Atg5VC mice (n=5-7 mice/group from 3 independent experiments; 100 goblet cells measured/mouse). **P0.01 as determined by the Student's t‐test. This analysis was performed on upper crypt goblet cells (above the upper dashed line in A).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">327</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="41" length="11"/>
        <text>goblet cell</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">12</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="134" length="12"/>
        <text>goblet cells</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">29</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="248" length="18"/>
        <text>crypt goblet cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_1-C</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of the average number of goblet cells per crypt (n=3 mice/group; over 100 crypts measured/mouse).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">15</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="44" length="12"/>
        <text>goblet cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_1-D</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) TEM images of upper crypt goblet cells from control and Atg5VC transverse colons. The yellow dashed lines outline the mucin granules in the apex of the cells. Bars=2 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">28</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="24" length="18"/>
        <text>crypt goblet cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_1-E-F</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E, F) Quantification of (E) the average granule density and (F) the average number of mucin granules/goblet cell (n=3 mice/group and 20 goblet cells evaluated/mouse). ***P0.001 as determined by the Student's t‐test.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">32</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="102" length="11"/>
        <text>goblet cell</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">333</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="137" length="12"/>
        <text>goblet cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_1-G-H</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 1-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G, H) Whole‐mount images of the mucosal surface from control and Atg5VC transverse colons. Whole‐mount colonic samples were either stained with Ulex europaeus agglutinin‐1 (UEA) that labelled mucus (G) or analysed by the scanning electron microscopy (H). Yellow arrows indicate the crypt opening orifices. Green arrowheads indicate goblet cells protruding from the surface epithelium of Atg5VC mice (insets in H show higher power image of the latter). Bars=100 μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">49</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="333" length="12"/>
        <text>goblet cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_2-B</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative whole‐mount images of single spheroids cultured in either 50% conditioned media (CM) or 5% CM+5 μM DAPT and stained for Muc2 (green) to visualize goblet cells. Bars=20 μm.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">57</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="165" length="12"/>
        <text>goblet cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_2-C-D</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C, D) Graph of relative expression (as measured by qRT‐PCR) of Atoh1 (C) and Muc2 (D) mRNAs comparing spheroids grown in either 5% CM or 5% CM+ DAPT to spheroids grown in 50% CM (n=4-5 samples/group). Error bars indicate s.e.m. *P0.05; **P0.01 as determined by a two‐tailed Student's t‐test.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_2-E-F</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 2-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E, F) Images of colonic epithelial spheroids isolated from control and Atg5VC mice grown in 5% CM+DAPT and stained for Muc2 (green: E) or with the lectin, UEA (red: F). Bars=20 μm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_2-G</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Quantification of average mucin area/goblet cell. Error bars indicate s.e.m. (n=6 samples/group; 100 cells were quantified/sample; **P0.01 as determined by a two‐tailed Student's t‐test).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">86</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="41" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_2-H</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Relative expression of Muc2 mRNA in differentiated spheroids from control and Atg5VC mice as measured by qRT-PCR (n=4-5 samples/group). No statistically significant differences were found in Muc2 expression as determined by the Student's t‐test.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_2-I-K</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 2-I-K</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I-K</infon>
    <passage>
      <offset>0</offset>
      <text>(I, K) Images of FIP200f/f (I) and Atg14f/f (K) colonic epithelialspheroids treated with recombinant Tat‐Cre and stained with UEA (red).</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_2-J-L</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 2-J-L</infon>
    <infon key="sourcedata_figure_dir">Figure_2-J-L</infon>
    <passage>
      <offset>0</offset>
      <text>(J, L) Quantification of average mucin area/goblet cell. Error bars indicate s.e.m. (n=6 samples/group; 100 cells were quantified/sample; **P0.01 and ***P0.001 as determined by a two‐tailed Student's t‐test).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="44" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_3-A</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Images of colonic sections stained for LC3β (green) from control and Atg5VC mice. The white‐dashed lines indicate the border between the basal surface of the crypt epitheliumand the mesenchyme. White asterisks denote non‐specific plasma cell staining from the mouse monoclonal anti‐LC3β antibody. Bars=50 μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">352</infon>
        <infon key="identifier">CL:0000786</infon>
        <location offset="234" length="11"/>
        <text>plasma cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_3-B</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunogold transmission electron microscopic image for LC3β in a colonic goblet cell from a wild‐type mouse. The inset is a low power image of the entire goblet cell. The black box within the inset indicates the area shown in this panel. Note this area is not associated with mucin granules. Bar=500 nm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">132</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="77" length="11"/>
        <text>goblet cell</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">133</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="158" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_3-C</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Enriched KEGG pathways for Atg5‐deficient epithelial cells obtained from a microarray comparing control and Atg5VC colonic crypt base epithelium. P‐values were determined by modified Fisher's exact test.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_3-D-G</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 3-D-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-G</infon>
    <passage>
      <offset>0</offset>
      <text>(D-G) Double label immunogold transmission electron microscopic images from wild‐type mice for LC3β (12 nm particles) and EEA1 (D), Rab7 (E), Rab11 (F), or Lamp1 (G) (18 nm particles). Bars=200 nm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_4-B</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Colonic epithelial monolayers from wild‐type mice treated with either vehicle or 100 μM Dynasore and stained for LC3β (green) and EEA1 (red). Bars=5 μm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_4-C-D</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C, D) Quantification of average number of LC3β dots per cell (C) and the percentage of LC3β dots that co‐localized with EEA1 per cell (D) (n=3 experiments/group; 25-30 cells/experiment).</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_4-E</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) LC3immunoblots of epithelial spheroids treated with 100 μM Dynasore and 100 nM BafA1 as indicated. GAPDH is a loading control. Representative image is shown from n=3 experiments.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_4-F</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Images of wild‐type colonic epithelial spheroids labelled with TRITC‐UEA (red) after treatment with either vehicle or 100 μM Dynasore. Bars=20 μm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_4-G</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Quantification of average mucin area/goblet cell (n=6 samples/group; 150 cells were quantified/sample). Error bars indicate s.e.m. ***P0.001 as determined by the Student's t‐test.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">173</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="41" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_5-A</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Colonic epithelial monolayers from a wild‐type and p22 mut mouse stained with LC3β (green) and EEA1 (red). Bar=5 μm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_5-B-C</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 5-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) Quantification of average number of LC3βdots per cell (B) and the percentage of LC3βdots that co‐localized with EEA1 per cell (C) (n=3 experiments/group; 25-30 cells/experiment).</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_5-D</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) LC3 immunoblots of either wild‐type or p22 mut epithelial spheroids treated with 100 nM BafA1 as indicated. Representative image is shown from n=3 experiments.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_5-E</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Double label immunogold transmission electron microscopic images for LC3β (12μnm particles) and p22phox (18 nm particles) showing a p22phox‐positive single membrane cytoplasmic vesicle (D) and a p22phox‐, LC3β‐positive vacuole (E). Bars=200μnm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_5-F</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Colonic epithelial monolayers from a wild‐type mouse stained for LC3β(green) and p22phox (red) and quantification of percent LC3β dots co‐localized with p22phox per cell, Bar=5 μm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_5-G</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Colonic epithelial cellspheroids from control and p22 mut mice stained with TRITC‐UEA to label goblet cellmucin. Bars=50 μm.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">366</infon>
        <infon key="identifier">CL:0011108</infon>
        <location offset="4" length="23"/>
        <text>Colonic epithelial cell</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">222</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="99" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_5-H</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Quantification of average mucin area/goblet cell (n=6 samples/group; 150 cells were quantified/sample). Error bars indicate s.e.m. **P0.01; ****P0.0001 as determined by the Student's t‐test.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">226</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="41" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_6-A</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Colonic epithelial cell spheroids from p22phox−/−, Atg5VC and wild‐type mice. Wild‐type spheroids were treated with vehicle (control), 10 μM DPI (NADPH oxidase inhibitor) or 100 μM Dynasore. Intracellular ROS in live cells were labelled by 5 μM DCF. Bars=100 μm.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">460</infon>
        <infon key="identifier">CL:0011108</infon>
        <location offset="4" length="23"/>
        <text>Colonic epithelial cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_6-B</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of fluorescent DCF normalized to control (n=3 independent experiments/group; 30 spheroids quantified/experiment).</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_6-C</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of average area of cytoplasmic mucin from wild‐type mice treated with 3% NAC as compared to controls (n=6-7 mice/group). Error bars indicate s.e.m. *P0.05; **P0.01; ****P0.0001 as determined by the Student's t‐test.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_6-D</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) TEM images of colonic epithelial monolayers treated with cerium chloride. The presence of electron dense precipitate is indicative of ROS production. Bar=500 nm.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_7-A</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Exogeneous ROS can restore mucingranule accumulation defects. (A) Quantification of fluorescent DCF normalized to controls (n=3 independent experiments/group; 10-30 spheroids quantified/culture). *P0.05 as determined by ANOVA with Tukey's multiple post‐test comparisons</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_7-B</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Images of control and Atg5VC colonic epithelialspheroids labelled with TRITC‐UEA (red) after treatment with either vehicle or 300 μM H2O2. Bars=20 μm. (C) Quantification of average mucin area/goblet cell (n=6 samples/group; 150 cells were quantified/sample). ***P0.001, ****P.0001 as determined by ANOVA with Tukey's multiple post‐test comparisons.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">455</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="196" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_7-C</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Relative expression of Muc2 mRNA in differentiated spheroids from control and Atg5VC mice treated with either vehicle or 300 μM H2O2 as measured by qRT-PCR. No statistically significant differences were found in either group as determined by ANOVA.</text>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_7-D</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(E, G) Images of p22 mut or Dynasore‐treated colonic epithelial spheroids (mucin is labelled with TRITC‐UEA; red) after treatment with either vehicle or 300 μM H2O2. Bars=20 μm. (F, H) Quantification of average mucin area/goblet cell (n=6 sample/group; 30-60 cells were quantified/sample) corresponding to experiments performed using p22 mut (E) and Dynasore‐treated wild‐type spheroids (G)</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">298</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="222" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3981139 Figure_7-E</id>
    <infon key="sourcedata_document">426</infon>
    <infon key="doi">10.1038/emboj.2013.233</infon>
    <infon key="pmc_id">3981139</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>Atg5VC and p22 mut spheroids were treated with 300 μM H2O2 plus or minus 100 μM BAPTA‐AM (I) or PMA/ionomycin (J). (I, J) Quantification of average mucin area/goblet cell (n=5 sample/group; 150 cells were quantified/sample). Error bars indicate s.e.m. ****P0.0001 as determined by the Student's t‐test (I) or ANOVA with Tukey's multiple post‐test comparisons (J).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">308</infon>
        <infon key="identifier">CL:1000317</infon>
        <location offset="159" length="11"/>
        <text>goblet cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 1-B</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure 1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative immunoblot of GFP-Atg8p expressing yeast. Wild-type cells (tet-WT) were compared to strains carrying a doxycycline-repressible tet-O7 promoter controlling ACS2 transcription (tet-ACS2). Cells were grown in SC 2% glucose medium for 24 hr (day 1 of aging) in the presence (+Doxy) or absence (−Doxy) of 1 ng/ml doxycycline to induce knockdown of ACS2 (see also Figure S1).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 1-C-D-E</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 1-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure 1-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Fluorescence microscopy of GFP-Atg8p expressing (under control of its natural pATG8 promoter) wild-type (tet-WT) and ACS2 knockdown (tet-ACS) cells grown in the presence of 1 ng/ml doxycycline (as shown in A) and chronologically aged for 3 days. Propidium iodide (PI) counterstaining served to visualize dead cells. Scale bars represent 5 μm. (D) Quantification of cells depicted in (C) (day 3) and of young (day 1) cells with 150-300 counts (blinded) for each replicate. Autophagic cells were defined as cells with clear vacuolar GFP fluorescence. Data represent means ± SEM (n = 4). ∗∗p &lt; 0.01. (E) Representative immunoblot analysis of day 1 (young controls) and day 3 (aged) cells shown in (C) and (D) using anti-GFP and anti-GAPDH (loading control) antibodies to detect "free-GFP" indicative of autophagic flux.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 1-F-G-H</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 1-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure 1-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(F-H) Representative micrographs (F), respective quantification (G), and immunoblot analysis (H) of wild-type (WT) and ACS1-deleted (Δacs1) yeast aged to day 3 compared to young (day 1) cells expressing GFP-Atg8p chimera as in (C)-(E). Data represent means ± SEM (n = 4).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 2-A-B-C</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 2-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure 2-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Fluorescence microscopy of GFP-Atg8p expressing wild-type (WT) and ACH1-deleted (Δach1) yeast grown to day 1 (young) and aged for 3 days in SC 2% glucose medium; propidium iodide (PI) counterstaining served to visualize dead cells. Scale bars represent 5 μm. (B) Quantification of cells depicted in (A) with 150-300 counts (blinded) for each replicate. Autophagic cells were defined as cells with clear vacuolar GFP fluorescence. Data represent means ± SEM (n = 4). ∗∗∗p &lt; 0.001. (C) Representative immunoblot analysis of cells shown in (A) and further aged to day 5 using anti-GFP and anti-GAPDH (loading control) antibodies to detect "free-GFP" indicative of autophagic flux (see also Figure S2).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 2-D-E-F</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 2-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure 2-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Representative micrographs (D), respective quantification (E), and immunoblot analysis (F) of wild-type (WT) and MPC1 deleted (Δmpc1) yeast expressing GFP-Atg8p chimera as in (A)-(C) and aged to indicated time points. Data represent means ± SEM (n = 4). ∗∗∗p &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 3-A-D-G</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 3-A-D-G</infon>
    <infon key="sourcedata_figure_dir">Figure 3-A-D-G</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) Chronological lifespan (CLS) analyses in SC 2% glucose medium of wild-type (WT) cells compared to Δacs1 (A), Δmpc1 (B), or Δach1 (C) cells (see also Figure S3). Survival was determined by colony-forming capacity (clonogenicity). Data represent means ± SEM (n = 4) of a representative aging experiment. (D-F) Propidium iodide (PI)-positive cells analyzed by flow cytometry to quantify age-induced cell death of experiments shown in (A)-(C). Data represent means ± SEM (n = 4) (see also Figure S4). (G-I) Extracellular acetate assessed from crude culture supernatants obtained at indicated time points of experiments shown in (A)-(C). Data represent means ± SEM (n = 4). ∗p &lt; 0.05 and ∗∗∗p &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 3-B-E-H</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 3-B-E-H</infon>
    <infon key="sourcedata_figure_dir">Figure 3-B-E-H</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) Chronological lifespan (CLS) analyses in SC 2% glucose medium of wild-type (WT) cells compared to Δmpc1 (B) cells (see also Figure S3). Survival was determined by colony-forming capacity (clonogenicity). Data represent means ± SEM (n = 4) of a representative aging experiment. (D-F) Propidium iodide (PI)-positive cells analyzed by flow cytometry to quantify age-induced cell death of experiments shown in (A)-(C). Data represent means ± SEM (n = 4) (see also Figure S4). (G-I) Extracellular acetate assessed from crude culture supernatants obtained at indicated time points of experiments shown in (A)-(C). Data represent means ± SEM (n = 4). ∗p &lt; 0.05 and ∗∗∗p &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 3-C-F-I</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 3-C-F-I</infon>
    <infon key="sourcedata_figure_dir">Figure 3-C-F-I</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) Chronological lifespan (CLS) analyses in SC 2% glucose medium of wild-type (WT) cells compared to Δach1 (C) cells (see also Figure S3). Survival was determined by colony-forming capacity (clonogenicity). Data represent means ± SEM (n = 4) of a representative aging experiment. (D-F) Propidium iodide (PI)-positive cells analyzed by flow cytometry to quantify age-induced cell death of experiments shown in (A)-(C). Data represent means ± SEM (n = 4) (see also Figure S4). (G-I) Extracellular acetate assessed from crude culture supernatants obtained at indicated time points of experiments shown in (A)-(C). Data represent means ± SEM (n = 4). ∗p &lt; 0.05 and ∗∗∗p &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 4-A-B-C</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure 4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) Representative immunoblot (A) and densitometric quantification expressed as normalized Acs2p/GAPDH ratios (B) of protein extracts from wild-type (WT) and Δach1yeast chronologically aged to indicated time points in SC 2% glucose medium (see also Figure S4). (C) Representative immunoblot analysis of 3-day-old WT and Δach1 cells similar to (A) using pan-acetyl-lysine antibodies. Crude protein extracts (Input) obtained in the presence of histone deacetylase and sirtuin inhibitors (see Supplemental Experimental Procedures) were subjected to immunoprecipitation (IP) at indicated protein concentrations using pan-acetyl-lysine antibodies to enrich acetylated proteins (Ac-Lys IP). GAPDH served as loading control.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 4-D</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure 4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Heatmap of protein ratios (Δach1 versus WT, log2 scale) corresponding to indicated genes. Data were obtained from mass spectrometric analyses of acetylated proteins enriched by IP similar to (C, 1 mg/ml protein). Extracts from stable-isotope (SILAC)-labeled cells were mixed prior to IP (prelysate), and mean SILAC-protein ratios after IP were normalized to ratios of prelysates to correct for changes in general protein abundance. Two biological replicates were performed (Rep. 1 and Rep. 2) with a regression coefficient of 0.76 of observed protein ratios. Heatmap represents identified proteins with reproducible 1.5-fold upregulation (red color) or downregulation (green color).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 4-E-F</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure 4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) Representative immunoblots of whole cell acid extracts of wild-type (WT) and Δach1 (E) cells chronologically aged to designated time points. Blots were probed with antibodies against total histone H3 (loading control) or H3 acetylated lysines (K9Ac, K14Ac, K18Ac). Densitometric quantification (F) of relative acetylation was calculated as Ac-K/total H3 ratios normalized to ratios of WT at day 1. Data represent means ± SEM (n = 7-8) (see also Figure S5).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 4-G-H</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 4-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure 4-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G and H) Survival analyses in SC 1.25% galactose/0.75% glucose medium of wild-type cells ectopically overexpressing ACS2 (ACS2 overexp.) compared to vector control cells (Vector control). Survival (I) was determined by colony-forming capacity (clonogenicity) and cell death (J) assessed by propidium iodide (PI)-positive cells analyzed by flow cytometry. Data represent means ± SEM (n = 4) of a representative aging experiment.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 4-I-J</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 4-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure 4-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(I and J) Autophagic flux determination by vacuolar protease-dependent GFP liberation after ACS2 overexpression compared to empty vector controls (Control) similar to (G) and (H). Representative immunoblots at indicated time points (G) and quantification by densitometry of free-GFP/GFP-Atg8p signal ratios (H) are shown. Data represent means ± SEM (n = 4).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 5-A-B</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure 5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) ATG7 mRNA levels by quantitative reverse-transcriptase PCR (RT-qPCR) of wild-type and Δach1 cells aged to day 3 (see also Figure S5). Rel. mRNA levels are expressed as ratios of 18S rRNA normalized to wild-type cells by ΔΔCt-method. Data represent means ± SEM (n = 8). (B) Representative immunoblot analysis from wild-type (WT) and ACH1-deleted (Δach1) yeast expressing chromosomally tagged ATG7 by C-terminal 6HA fusion aged to indicated time points. Blots were probed with anti-HA and anti-GAPDH (loading control) antibodies.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 5-C</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure 5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C and D) Representative immunoblots (C) and densitometric quantification (D) of whole-cell acid extracts of wild-type and Δach1 cells combined with or without knockdown of ACS2 (tet-ACS2). Cells were chronologically aged to day 3 in the presence of 1 ng/ml doxycycline. Blots were probed with antibodies against total histone H3 (loading control) or H3 acetylated lysines (K9Ac, K14Ac, K18Ac). Data represent means ± SEM (n = 8).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 5-D</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure 5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C and D) Representative immunoblots (C) and densitometric quantification (D) of whole-cell acid extracts of wild-type and Δach1 cells combined with or without knockdown of ACS2 (tet-ACS2). Cells were chronologically aged to day 3 in the presence of 1 ng/ml doxycycline. Blots were probed with antibodies against total Histone H3 (loading control) or H3 acetylated lysines (K9Ac, K14Ac, K18Ac). Data represent means ± SEM (n = 8).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 5-E</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure 5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) ATG7 mRNA levels (E) by RT-qPCR and representative immunoblot analysis (F) of wild-type and Δach1 cells with or without knockdown of ACS2 (tet-ACS2) as in (C) and (E) aged to day 3. Rel. mRNA levels (E) are expressed as ratios to 18S rRNA normalized to wild-type cells by ΔΔCt method. Data represent means ± SEM (n = 7-8).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 5-F</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure 5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) ATG7 mRNA levels (E) by RT-qPCR and representative immunoblot analysis (F) of wild-type and Δach1 cells with or without knockdown of ACS2 (tet-ACS2) as in (C) and (E) aged to day 3. Rel. mRNA levels (E) are expressed as ratios to 18S rRNA normalized to wild-type cells by ΔΔCt method. Data represent means ± SEM (n = 7-8).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 5-G-H</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 5-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure 5-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G and H) Representative immunoblot (H) and densitometric quantification (G) of histone H3 wild-type (H3-wt/wt) and H3 mutated (H3-K14,18Q/-K14,18R) strains carrying the GFP-Atg8p fusion to calculate "free-GFP/GFP-Atg8p Ratio" indicative of autophagic flux.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 6-A-B</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 6-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure 6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) Representative micrographs (A) and respective quantification (B) of wild-type and Δach1 cells expressing GFP-Atg8p chimera combined with or without knockdown of ACS2 (tet-ACS2). Cells were chronologically aged to day 3 in the presence of 1 ng/ml doxycycline and PI counterstained prior to epifluorescence microscopy (see also Figure S6).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 6-C</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure 6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) Representative micrographs (A) and respective quantification (B) of wild-type and Δach1 cells expressing GFP-Atg8p chimera combined with or without knockdown of ACS2 (tet-ACS2). Cells were chronologically aged to day 3 in the presence of 1 ng/ml doxycycline and PI counterstained prior to epifluorescence microscopy (see also Figure S6).   (C) Representative immunoblot analysis of cells shown in (A) aged until days 1, 2, and 3 to detect "free-GFP" indicative of autophagic flux (see Figure S6A for quantification).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 6-D</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure 6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D and E) Representative immunoblot analyses of GFP-Atg8p expressing wild-type (WT) and Δach1 cells either combined with deletion of SCH9 (D) and aged until indicated time points. Blots were probed with anti-GFP and anti-GAPDH (loading control) antibodies to detect "free-GFP" indicative of autophagic flux (see Figures S6B and S6C for quantification).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 6-E</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure 6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D and E) Representative immunoblot analyses of GFP-Atg8p expressing wild-type (WT) and Δach1 cells either combined with deletion of SCH9 (D) or supplemented with or without 20 nM rapamycin (Rapa) (E) and aged until indicated time points. Blots were probed with anti-GFP and anti-GAPDH (loading control) antibodies to detect "free-GFP" indicative of autophagic flux (see Figures S6B and S6C for quantification).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 6-F-G-H</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 6-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure 6-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(F and G) Representative micrographs (F) and respective quantification (G) of GFP-Atg8p expressing yeast cells ectopically overexpressing ACS2 (ACS2 overexp.) or carrying the empty vector (wild-type) during nutrient depletion (starved) compared to SC 2% galactose control conditions (control). Counterstaining of cells with propidium iodide was used to visualize dead cells. (H) Representative immunoblot analyses of the experiment shown in (F) to detect "free-GFP" indicative of autophagic flux.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 7-A-B</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure 7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) Chronological aging in SC 2% glucose medium supplemented with 1 ng/ml doxycycline of wild-type and Δach1 cells combined with or without knockdown of ACS2 (tet-ACS2). Survival (A) was determined by colony-forming capacity (clonogenicity). Age-associated cell death (B) was assessed through propidium iodide (PI) staining analyzed by flow cytometry. Data represent day 1 normalized means ± SEM (n = 4).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 7-C-D</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure 7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) Chronological aging in SC 2% glucose medium supplemented with 1 ng/ml doxycycline of wild-type and Δach1 cells combined with or without knockdown of ACS2 (tet-ACS2). Survival (A) was determined by colony-forming capacity (clonogenicity). Age-associated cell death (B) was assessed through propidium iodide (PI) staining analyzed by flow cytometry. Data represent day 1 normalized means ± SEM (n = 4). (C and D) Survival (C) and cell death (D) of chronological aging experiment similar to (A) and (B) but in the background of ATG7-deleted autophagy-incompetent cells (Δatg7). Data represent day 1 normalized means ± SEM (n = 4).</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 7-E-F</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 7-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure 7-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) Drosophila lifespan analyses of male (E) and female (F) flies depleted for acetyl-CoA synthetase (AcCoAS) using RNAi-mediated knockdown (AcCoAS RNAi) compared to isogenized controls (Control (EGFP RNAi)). Log rank tests revealed p &lt; 0.0001 for both sexes.</text>
    </passage>
  </document>
  <document>
    <id>3988959 Figure 7-G-H</id>
    <infon key="sourcedata_document">277</infon>
    <infon key="doi">10.1016/j.cmet.2014.02.010</infon>
    <infon key="pmc_id">3988959</infon>
    <infon key="figure">Figure 7-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure 7-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Immunofluorescence specific to p62-homolog ref(2)p of adult brain sections from 10-day-old flies compared to 30-day-old flies as depicted in (E). Representative confocal micrographs are shown with scale bars representing 25 μm. (H) Quantification of total ref(2)P intensity in the central brain region normalized to 10-day-old control flies (Control (EGFP RNAi)). Standard box plot represents data from seven to eight independent brains (whiskers indicate minimum and maximum values).</text>
    </passage>
  </document>
  <document>
    <id>4024763 f1-B</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f1-B</infon>
    <infon key="sourcedata_figure_dir">f1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Cells stably expressing WT or D620NGFP-VPS35 or otherwise transiently transfected with a panel of GFP-VPS35 constructs were lysed and the respective GFP-tagged protein recovered by immunoprecipitation (IP).</text>
    </passage>
  </document>
  <document>
    <id>4024763 f1-C</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f1-C</infon>
    <infon key="sourcedata_figure_dir">f1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Untransfected HeLa cells or cells stably expressing VPS29-GFP, GFP-VPS35 wild-type or GFP-VPS35D620N were lysed and the lysates incubated with anti-VPS26 to IP the retromer CSC.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f1-D</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f1-D</infon>
    <infon key="sourcedata_figure_dir">f1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Cells stably expressing the VPS29-GFP V90D mutant that cannot assemble with VPS35 were transiently transfected with mCherry-tagged WT VPS35, D620N and H675R constructs, along with an additional control of mCherry-FAM21 tail. Cells were lysed 48 h post transfection, and VPS29-GFP V90D and associated proteins were recovered by anti-GFP native IP. Blots shown are representative of experiments replicated at least twice.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f2-A</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f2-A</infon>
    <infon key="sourcedata_figure_dir">f2-A</infon>
    <passage>
      <offset>0</offset>
      <text>a) Cells expressing either WT GFP-VPS35 or the D620N mutant were treated with siRNA to abolish expression of endogenous VPS35. Each dish of cells was lysed in either HEPES lysis buffer (H) or PBS lysis buffer (P). Following centrifugation, equal portions of each lysate were combined to generate a mixed lysate (H/P). Each lysate was incubated with anti-GFP to recover the respective GFP-tagged VPS35 protein.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f2-B</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f2-B</infon>
    <infon key="sourcedata_figure_dir">f2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Similar to (a), but only cells expressing GFP-VPS35 wild type were analysed, either mock treated or treated with siRNA to silence FKBP15 expression.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f2-C</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f2-C</infon>
    <infon key="sourcedata_figure_dir">f2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Cells stably expressing WT or D620NGFP-VPS35 were treated with indicated siRNAs, lysed and immunoprecipitated as in (a).</text>
    </passage>
  </document>
  <document>
    <id>4024763 f3-A-B</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f3-A-B</infon>
    <infon key="sourcedata_figure_dir">f3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a,b) Cells expressing either WT or D620NGFP-VPS35 were treated with siRNA to silence expression of endogenous VPS35, fixed and labelled for GFP and FKBP15 (a) or FAM21 (b). Cells were imaged by fluorescence microscopy. Scale bar, 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f3-C</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f3-C</infon>
    <infon key="sourcedata_figure_dir">f3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Cells stably expressing WT or D620NGFP-tagged VPS35 were treated with siRNA to abolish expression of endogenous VPS35 and subsequently fixed and labelled for GFP and either VPS26, FKBP15 or FAM21. The cells were imaged using Cellomics automated fluorescence microscopy. Approximately 250 cells per well in four wells were analysed for each cell line. The data for FKBP15 and FAM21 spot intensity were normalized to GFP-VPS35 and VPS26 signals. P0.0002 for both FKBP15 and FAM21 spot intensity in D620N compared with WT. Error bars indicate s.d.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f3-D</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f3-D</infon>
    <infon key="sourcedata_figure_dir">f3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Cells stably expressing either WT GFP-VPS35 or the D620N mutant were treated with siRNA to silence the expression of endogenous VPS35. Cells were permeabilized by flash freezing followed by rapid thawing and centrifuged to separate supernatant (S) and membrane pellet (P) fractions.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f3-E</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f3-E</infon>
    <infon key="sourcedata_figure_dir">f3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) The graph shows the percentage of membrane-associated FKBP15 and strumpellin and is the mean of three experiments. The error bars indicate s.e.m. A representative blot of three experiments is shown, indicating the efficacy of the knockdown of endogenous VPS35 and also further showing that membrane proteins such as the CIMPR are detected only in the pellet fraction.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f4-A-B</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f4-A-B</infon>
    <infon key="sourcedata_figure_dir">f4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>a) HeLa cells stably expressing GFP-VPS35 WT and D620N were treated with bafilomycin A1 or DMSO vehicle control. Endogenous LC3-II and tubulin levels were examined by western blot. A representative experiment of six experiments is shown. (b) Quantification of the representative experiment in triplicate shown in a, in which endogenous LC3-II levels are normalized to tubulin and expressed as a ratio of levels in WT. ***P=7.86 × 10−6 (DMSO) and 3.81 × 10−5 (Baf) by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f4-C</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f4-C</infon>
    <infon key="sourcedata_figure_dir">f4-C</infon>
    <passage>
      <offset>0</offset>
      <text>c) HeLa cells stably expressing GFP-VPS35 WT and D620N were transfected with mRFP-LC3. The number of LC3vesicles was quantified by Cellomics automated fluorescence microscopy. A representative experiment of three independent experiments is shown, with 344 (WT) and 401 (D620N) cells analysed. ***P0.0001 by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f4-D</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f4-D</infon>
    <infon key="sourcedata_figure_dir">f4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) GFP-VPS35 WT and D620N-expressing cells were transfected with HA-Q74 and immunostained for HA. The percentage of transfected cells with aggregates was counted by a blinded experimenter. The quantification shows the mean of three experiments in triplicate with minimum 200 cells per replicate. ***P=0.00086 by 1-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f4-F</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f4-F</infon>
    <infon key="sourcedata_figure_dir">f4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) Cells stably expressing WT and D620NGFP-VPS35 were transfected with GFP-α-synuclein A53T and GFP for 48 h and analyzed by western blotting.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f4-G</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f4-G</infon>
    <infon key="sourcedata_figure_dir">f4-G</infon>
    <passage>
      <offset>0</offset>
      <text>g) Quantification of the representative experiment in triplicate in f, in which the level of α-synuclein was expressed as a ratio to GFP. A representative experiment of two independent experiments is shown. **P=0.0047 by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f4-H</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f4-H</infon>
    <infon key="sourcedata_figure_dir">f4-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h) VPS35 was knocked down with two individual siRNA nucleotides in HeLa cells, and cells were treated with bafilomycin A1 and lysed as in a. A representative experiment is shown in triplicate</text>
    </passage>
  </document>
  <document>
    <id>4024763 f4-J</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f4-J</infon>
    <infon key="sourcedata_figure_dir">f4-J</infon>
    <passage>
      <offset>0</offset>
      <text>(j) Protein levels of CSC, including VPS35, VPS26 and VPS29), were assessed upon VPS35 knockdown, confirming previous results that knockdown of one component destabilizes the CSC. All error bars indicate s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f5-A-B</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f5-A-B</infon>
    <infon key="sourcedata_figure_dir">f5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a) HeLa cells were transfected with pEGFP vector or GFP-FAM21 tail for 48 h and subsequently treated with bafilomycin A1 as in Fig. 4. Endogenous LC3-II and tubulin levels were assessed by western blot. (b) Quantification of the representative experiment in triplicate shown in a, of two independent experiments. *P=0.02 (DMSO) and 0.08 (Baf) by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f5-C-D</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f5-C-D</infon>
    <infon key="sourcedata_figure_dir">f5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c) HeLa cells stably expressing GFP-VPS35 WT and D620N were transfected with pEGFP vector or GFP-FAM21, and subsequently treated with bafilomycin A1, lysed and subjected to western blot as in a. (d) Quantification of the representative experiment in triplicate shown in c, of two independent experiments. **P=0.008 by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f5-E-F</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f5-E-F</infon>
    <infon key="sourcedata_figure_dir">f5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Cells were depleted of WASH1, treated with bafilomycin A1 and examined for endogenous LC3-II, tubulin, WASH1 and GAPDH levels. A representative experiment of six independent experiments is shown. (f) Quantification of the representative experiment shown in e. **P=0.002 (DMSO) and P=0.0028 (Baf) by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f5-G</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f5-G</infon>
    <infon key="sourcedata_figure_dir">f5-G</infon>
    <passage>
      <offset>0</offset>
      <text>g) HeLa cells depleted of WASH1 by siRNA were transfected with GFP-LC3 for 24 h. The number of LC3vesicles was quantified by Cellomics automated fluorescence microscopy. A representative experiment of two independent experiments is shown, with 757 (control) and 695 (knockdown) cells analysed. ***P0.0001 by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f5-H</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f5-H</infon>
    <infon key="sourcedata_figure_dir">f5-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h) HeLa cells depleted of FKBP15 were transfected with GFP-LC3 and vesicles were quantified as in g. A representative experiment of two independent experiments in triplicate is shown, with 579 (control) and 815 (knockdown) cells analysed in total.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f5-I</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f5-I</infon>
    <infon key="sourcedata_figure_dir">f5-I</infon>
    <passage>
      <offset>0</offset>
      <text>(i) HeLa cells depleted of FKBP15 were subsequently transfected with a GFP-Q74 construct for 24 h and fixed in PFA. The percentage of transfected cells with aggregates was counted by a blinded experimenter. The quantification shows the mean of two experiments, each in triplicate with min 220 cells counted per replicate</text>
    </passage>
  </document>
  <document>
    <id>4024763 f5-J</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f5-J</infon>
    <infon key="sourcedata_figure_dir">f5-J</infon>
    <passage>
      <offset>0</offset>
      <text>(j) FKBP15 was depleted in HeLa cells as in e. A representative blot from three independent experiments in triplicate is shown. Error bars indicate s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f6-A-B-C</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f6-A-B-C</infon>
    <infon key="sourcedata_figure_dir">f6-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(a) HeLa cells were immunostained for endogenous ATG9A and VPS35 and subjected to confocal microscopy. Magnified areas are shown on the right of the pictures. (b) HeLa cells were transfected with ATG9A-GFP for 24 h, and subsequently fixed, immunostained for endogenous WASH1 and subjected to confocal microscopy. (c) HeLa cells were transfected with ATG9A-GFP as in b, but immunostained instead for endogenous FAM21.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f6-D-E</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f6-D-E</infon>
    <infon key="sourcedata_figure_dir">f6-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(d) HeLa cells stably expressing GFP-VPS35 WT and D620N were depleted of endogenous VPS35 using 40 nM of siRNA, and subsequently immunostained for TGN46 and endogenous ATG9A and subjected to confocal microscopy. (e) Colocalization between TGN and ATG9A is expressed in terms of the Pearson's Coefficient. n=25 cells (WT) and 33 cells (D620N). Error bars represent s.e.m. and **P=0.01 by 2-tailed Student's t-test. Scale bars in (a-d), 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f7-A</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f7-A</infon>
    <infon key="sourcedata_figure_dir">f7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) HeLa cells depleted of WASH1 with two successive siRNA treatments were either starved in Hank's balanced salt solution for 1 h or kept in full medium. Following fixation, cells were immunostained for TGN46, ATG9A and VPS35 and subjected to confocal microscopy. Representative pictures with magnified areas are shown. Scale bar, 10 μm. (b) Colocalization between TGN and ATG9A is expressed in terms of the Pearson's coefficient. Number of cells analysed: 38 (control basal), 46 (knockdown basal), 36 (control starved), 53 (knockdown starved). Error bars represent s.e.m. and ***P=0.0005 (basal) and P=0.0004 (starved) by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f8-A</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f8-A</infon>
    <infon key="sourcedata_figure_dir">f8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) HeLa cells stably expressing GFP-VPS35 WT and D620N were transfected with mRFP-LC3 for 24 h, immunostained for endogenous ATG9A, and imaged by confocal microscopy.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f8-B</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f8-B</infon>
    <infon key="sourcedata_figure_dir">f8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Colocalization is expressed in terms of Mander's coefficient M1 to indicate the proportion of LC3 intensities that also contain ATG9A intensities. A representative experiment of three independent experiments is shown, in which at least 33 cells were analysed per condition. Error bars indicate s.e.m., and ***P0.001 by 2-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f8-C</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f8-C</infon>
    <infon key="sourcedata_figure_dir">f8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) HeLa cells depleted of WASH1 were transfected with GFP-LC3 for 24 h, immunostained for endogenous ATG9A, and imaged by confocal microscopy.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f8-D</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f8-D</infon>
    <infon key="sourcedata_figure_dir">f8-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Colocalization expressed as M1, as in b. A representative experiment of two independent experiments is shown, in which at least 24 cells were analysed per condition. Error bars indicate s.e.m., and ***P0.001 by 2-tailed Student's t-test. Scale bars in (a,c), 10 μm. In b,d, colocalization was measured for the entire area of the cell slice in each image. In order to ensure that results were not confounded by diffuse nuclear staining often observed in the LC3 channel, the analyses were repeated with the nuclei excluded, and all of the results remained statistically significant.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f9-A-B</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f9-A-B</infon>
    <infon key="sourcedata_figure_dir">f9-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a) SH-SY5Y cells were depleted of WASH1, treated with bafilomycin A1 and examined for LC3-II, tubulin, WASH1 and GAPDH levels. Blots shown are representative of two independent experiments in triplicate. (b) Quantification of the representative experiment in triplicate shown in (a), of two independent experiments. Error bars indicate s.e.m. **P=0.0058 by 1-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4024763 f9-C</id>
    <infon key="sourcedata_document">661</infon>
    <infon key="doi">10.1038/ncomms4828</infon>
    <infon key="pmc_id">4024763</infon>
    <infon key="figure">f9-C</infon>
    <infon key="sourcedata_figure_dir">f9-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) WASH1-depleted SH-SY5Y cells were trypsinized, stained with propidium iodide and analysed by flow cytometry. Living cells, not stained with propidium iodide, are shown as a percentage of total cells. The graph depicts a representative experiment in triplicate out of two independent experiments, in which at least 10,000 cells were analysed in each replicate. Error bars indicate s.e.m. *P=0.045 by 1-tailed Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_1.-A-E</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 1.-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A) UASp-GFP-mCherry-DrAtg8a/+;nosGAL4/+ flies conditioned on yeast paste had diffuse GFP-mCherry-DrAtg8a staining in midstage egg chambers. (B) Nondegenerating midstage egg chambers from starved flies contained autophagosomes (yellow) and autolysosomes (red). (C and D) Egg chambers early in the degeneration process showed follicle cells that take up portions of the nurse cellcytoplasm (C) followed by condensation and fragmentation of the nurse cellnuclei and further uptake of the nurse cellcytoplasm into follicle cells (D). (E) Late stage degenerating egg chambers lose all GFP staining and fluoresce red.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">10</infon>
        <infon key="identifier">CL:0000477</infon>
        <location offset="325" length="14"/>
        <text>follicle cells</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">11</infon>
        <infon key="identifier">CL:0000026</infon>
        <location offset="369" length="10"/>
        <text>nurse cell</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <infon key="identifier">CL:0000026</infon>
        <location offset="443" length="10"/>
        <text>nurse cell</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <infon key="identifier">CL:0000026</infon>
        <location offset="486" length="10"/>
        <text>nurse cell</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">20</infon>
        <infon key="identifier">CL:0000477</infon>
        <location offset="511" length="14"/>
        <text>follicle cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_1.-F-K</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 1.-F-K</infon>
    <infon key="sourcedata_figure_dir">Figure_1.-F-K</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Fed Dcp-1Prev1/Dcp-1Prev1;UASp-GFP-mCherry-DrAtg8a/nosGAL4 flies showed diffuse GFP-mCherry-DrAtg8a staining in the germline. (G) Starved Dcp-1Prev1/Dcp-1Prev1;UASp-GFP-mCherry-DrAtg8a/nosGAL4 flies showed reduced autolysosomes in degenerating midstage egg chambers. (H and I) Fed flies overexpressing truncated Dcp-1 (tDcp-1) in the germline showed increased autophagosomes and autolysosomes in nondegenerating midstage egg chambers (H) and also contained degenerating midstage egg chambers that lose all GFP fluorescence and fluoresce red (I). Bars: (main images) 25 µm; (insets) 12.5 µm. Insets in A-I show diffuse cytoplasmic staining of Atg8a or autophagosomes and autolysosomes. (J and K) The percentages of autolysosomes (autolysosomes/total autophagic structures) were manually calculated in at least eight egg chambers for each genotype as indicated. Error bars represent the means ± SD. Statistical testing was performed using one-way ANOVA with a Dunnet post test (****, P &lt; 0.0001) or a two-tailed Student's t test (**, P &lt; 0.005).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_2.-A-B</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 2.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) DrosophilaS2 cells stably expressing GFP-RFP-Atg8a showed an increase in the percentage of cells containing two or more autolysosomes after starvation, which was blocked after Bafilomycin A1 (BafA1) treatment. At least 50 cells were manually quantitated in three independent experiments (n = 3). Statistical significance was determined using one-way ANOVA with a Dunnett post test (**, P &lt; 0.01). (B) Representative images of S2-GFP-RFP-Atg8a cells after the indicated treatments.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_2.-C-D</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 2.-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2.-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) S2-GFP-RFP-Atg8a cells were treated with dsRNAs and subjected to fed or starvation conditions as indicated. At least 50 cells were manually quantitated in three independent experiments (n = 3). Statistical significance was determined using one-way ANOVA with a Dunnett post test (**, P &lt; 0.01; ***, P &lt; 0.001; ****, P &lt; 0.0001). (D) Representative images of S2-GFP-RFP-Atg8a cells after the indicated RNAi treatments. Error bars represent the means ± SD. Bars, 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_3.-A-B-D-E</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 3.-A-B-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-A-B-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Nondegenerating midstage egg chambers from fed w1118flies showed Ref(2)P staining in follicle cells and nurse cells. (B) Starved w1118flies contained degenerating midstage egg chambers with reduced Ref(2)P.(D) Starved Atg7flies showed an accumulation of Ref(2)P in the follicle cells and nurse cells of degenerating midstage egg chambers. (E) Starved Dcp-1Prev1flies contained increased levels of Ref(2)P in degenerating midstage egg chambers.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">122</infon>
        <infon key="identifier">CL:0000477</infon>
        <location offset="89" length="14"/>
        <text>follicle cells</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">115</infon>
        <infon key="identifier">CL:0000026</infon>
        <location offset="108" length="11"/>
        <text>nurse cells</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">131</infon>
        <infon key="identifier">CL:0000477</infon>
        <location offset="273" length="14"/>
        <text>follicle cells</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">126</infon>
        <infon key="identifier">CL:0000026</infon>
        <location offset="292" length="11"/>
        <text>nurse cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_3.-C</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 3.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) A representative Western blot of ovaries from w1118 and Atg7d77/d14flies subjected to fed or starvation conditions for 4 d. Ref(2)P was detected by immunoblotting. Actin served as a loading control. Densitometry was performed to quantitate Ref(2)P protein levels relative to actin. Graph represents ± SD from five independent experiments (n = 5). Statistical significance was determined using a two-tailed Student's t test. *, P = 0.004 for fed samples; *, P = 0.008 for starved samples.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_3.-F</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 3.-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3.-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) A representative Western blot of ovaries from w1118 and Dcp-1Prev1flies that were subjected to fed or starvation conditions for 4 d. Ref(2)P was detected by immunoblotting. Actin served as a loading control. Densitometry was performed to quantitate Ref(2)P protein levels relative to actin. Graph represents ± SD from five independent experiments (n = 5)</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_4.-A-B</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 4.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) l(2)mbn cells were labeled with antibodies to Dcp-1 and ATPsyn-α (A) or MitoTracker red (MTR; B). Merged images show colocalization between Dcp-1 and the mitochondria. Boxes represent zoomed images. Bars: (main images) 5 µm; (zoomed images) 1.25 µm.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_4.-C</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 4.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Western blot from l(2)mbn cells subjected to nutrient-rich or starvation conditions for 6 h. Cells were separated into cytosolic (C) and mitochondrial enriched (M) fractions.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_4.-D</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 4.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Ovaries from fed w1118flies were separated into cytosolic and membrane-enriched fractions and probed with antibodies to VDAC, Tubulin, ATPsyn-α, and Dcp-1.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_4.-E</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 4.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) Intact and lysed mitochondria (E) or intact mitochondria isolated from l(2)mbn cells (F) were treated with proteinase K (PK). The effects of proteinase K treatment were assessed by antibodies to VDAC, ATPsyn-α, Pink1, and Dcp-1.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_4.-F</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 4.-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E and F) Intact and lysed mitochondria (E) or intact mitochondria isolated from l(2)mbn cells (F) were treated with proteinase K (PK). The effects of proteinase K treatment were assessed by antibodies to VDAC, ATPsyn-α, Pink1, and Dcp-1.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_4.-G</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 4.-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4.-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Control and Dcp-1 RNAi-treated cells were subjected to nutrient-rich or starvation conditions and stained with NAO. Mean fluorescence was measured by flow cytometry. Graph represents ± SEM of three independent experiments (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_5.-A-B</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 5.-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) l(2)mbn cells were labeled with the ATPsyn-α, and mitochondrial morphology was scored as fragmented, normal, or elongated. (B) Cells were treated with control or Dcp-1 dsRNA and subjected to nutrient-rich media or 1 h of starvation. Quantifications represent the percentage of cells with elongated mitochondria divided by the total number of cells examined. At least 100 cells were examined manually in three independent experiments (n = 3). Error bars represent the mean ± SD. Statistical significance was determined using one-way ANOVA with a Bonferroni post test (*, P &lt; 0.05; **, P &lt; 0.01).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_5.-C-F</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 5.-C-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5.-C-F</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Mitochondrial targeted GFP (mitoGFP) was expressed in the germline using the nosGAL4 driver. Staining shows mitoGFP, Armadillo, and DNA. (D) Mitochondria were scored as healthy (H), clustered (C), or elongated and overly connected (E). All of mitochondria from fed UASp-mitoGFP/+;nosGAL4/+ flies were scored as healthy. n = 15 egg chambers manually scored. (E) mitoGFP was expressed in Dcp-1Prev1flies using the nosGAL4 driver. (F) 54% of egg chambers from UASp-mitoGFP/+;Dcp-1Prev1/Dcp-1Prev1;nosGAL4/+ flies contained elongated mitochondria, 39% contained mitochondria that were scored as healthy, and 7% contained clustered mitochondria. n = 28 egg chambers manually scored.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_6.-A</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 6.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Total cellular ATP levels were measured in l(2)mbn cells treated with control or Dcp-1 dsRNA. Data represent ± SEM of three independent experiments (n = 3). Statistical significance was determined using a two-tailed Students t test (*, P = 0.02).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_6.-B</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 6.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Total cellular ATP levels were measured in ovaries from fed or starved w1118 and Dcp-1Prev1flies. Data represent ± SEM of five independent experiments (n = 5). Statistical significance was determined using a two-tailed Student's t test (**, P = 0.014; ***, P &lt; 0.001).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_6.-C</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 6.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Fed or starved w1118 and Dcp-1Prev1flies were treated with DMSO or 25 µg/ml oligomycin A, and Ref(2)P levels were assessed by immunoblot analysis. Actin served as a loading control. Densitometry was performed to quantitate protein levels relative to actin. Graph represents ± SD from three independent experiments (n = 3). Statistical significance was determined using a two-tailed Student's t test (*, P = 0.02).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_6.-D-E</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 6.-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6.-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D and E) Control UASp-GFP-mCherry-DrAtg8a/+;nosGAL4/+ flies (D) and Dcp-1Prev1/Dcp-1Prev1;UASp-GFP-mCherry-DrAtg8a/nosGAL4 flies (E) were subjected to starvation conditions supplemented with DMSO or 25 µg/ml oligomycin A. Bars, 25 µm. Quantifications show percentage of autolysosomes (autolysosomes/total autophagic structures). At least eight egg chambers were manually quantitated per genotype per condition (n = 8). Statistical testing was determined using a two-tailed Student's t test. ***, P = 0.0002.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_7.-A</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 7.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) A representative Western blot showing SesB and ATPsyn-α levels from fed or starved l(2)mbn cells treated with control or Dcp-1 RNAi. Actin served as a loading control. Densitometry was performed to quantitate protein levels relative to actin. Graphs represent ± SD from three independent experiments (n = 3). Statistical significance was determined using a two-tailed Student's t test (*, P &lt; 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_7.-B</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 7.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) A representative Western blot of ovaries from fed or starved w1118 or Dcp-1Prev1flies. SesB and ATPsyn-α were detected by immunoblotting. Actin served as a loading control. Densitometry was performed to quantitate protein levels relative to actin. Graphs represent ± SD from three independent experiments (n = 3). Statistical significance was determined using a two-tailed Student's t test (*, P &lt; 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_7.-C</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 7.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Purified catalytically active Dcp-1FL, but not catalytically inactive Dcp-1C&lt;A, cleaved in vitro translated Drice. Cleavage of in vitro translated SesB was not detected.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_7.-D</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 7.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) V5-tagged Dcp-1C&lt;A or V5 vector only control was expressed in l(2)mbn cells and subjected to nutrient-full or starvation conditions for 2 h. After IP with anti-V5 antibodies, lysates were separated by SDS-PAGE. Proteins were visualized with colloidal Coomassie stain.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_7.-E</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 7.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) FLAG-SesB or a vector only control was expressed in l(2)mbn cells and was immunoprecipitated with FLAG-agarose. Immunoblots show the interaction between FLAG-SesB and endogenous pro-Dcp-1. The asterisk represents a nonspecific band.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_8.-A</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 8.-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Ovaries from fed SesBOrgflies show reduced Ref(2)P staining in degenerating midstage egg chamber (arrow).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_8.-B</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 8.-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Ovaries from fed w1118 and SesBOrg were analyzed by Western blotting using Ref(2)P. Actin served as a loading control. Results are representative of three independent experiments (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_8.-C</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 8.-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) SesBOrgflies expressing GFP-mCherry-DrAtg8a in the germline showed increased autophagosomes and autolysosomes in nondegenerating (left) and degenerating (right) midstage egg chambers. Insets show autophagosomes and autolysosomes (left) and autolysosomes (right) in SesBOrg midstage egg chambers.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_8.-D</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 8.-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantitation of percentages of autolysosomes (autolysosomes/total autophagic structures) in nondegenerating ovaries from fed w1118 and SesBOrgflies. 10 egg chambers were manually examined per genotype. Error bars represent the means ± SD. Statistical significance was determined using a two-tailed Student's t test (***, P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_8.-E</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 8.-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Degenerating midstage egg chambers (arrows) from fed SesBOrgflies are TUNEL positive.</text>
    </passage>
  </document>
  <document>
    <id>4033768 Figure_8.-F-G</id>
    <infon key="sourcedata_document">865</infon>
    <infon key="doi">10.1083/jcb.201303144</infon>
    <infon key="pmc_id">4033768</infon>
    <infon key="figure">Figure 8.-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_8.-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Degenerating midstage egg chambers from starved control SesBOrg/FM7a;Dcp-1Prev1/Dcp-1Prev1flies contained persisting nurse cellnuclei and increased Ref(2)P. n = 117 ovarioles examined. Box represents zoomed image. (G) Degenerating midstage egg chambers from fed SesBOrg;Dcp-1Prev1flies contained condensed and fragmented nurse cellnuclei and low levels of Ref(2)P. Box represents zoomed image. n = 156 ovarioles examined.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">396</infon>
        <infon key="identifier">CL:0000026</infon>
        <location offset="121" length="10"/>
        <text>nurse cell</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">402</infon>
        <infon key="identifier">CL:0000026</infon>
        <location offset="325" length="10"/>
        <text>nurse cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4075283 f1-A</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f1-A</infon>
    <infon key="sourcedata_figure_dir">f1-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Silver staining of LC3 complexes purified from U2OS cells expressing ZZ-Flag-LC3 in normal medium or Earle's balanced salt solution (EBSS) for 2 h. Asterisks mark centriolar satellite proteins.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f1-B-D</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f1-B-D</infon>
    <infon key="sourcedata_figure_dir">f1-B-D</infon>
    <passage>
      <offset>0</offset>
      <text>b-d, Co-immunoprecipitation (IP) of OFD1 with LC3, LC3 with PCM1, or OFD1 with PCM1 in HEK293T cells. HA, haemagglutinin.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f1-E</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f1-E</infon>
    <infon key="sourcedata_figure_dir">f1-E</infon>
    <passage>
      <offset>0</offset>
      <text>e, Western blotting analysis of PCM1 and OFD1 protein levels in control or PCM1 knockdown (KD) HEK293T cells.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f1-F</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f1-F</infon>
    <infon key="sourcedata_figure_dir">f1-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, Co-immunoprecipitation of OFD1 with LC3 in control or PCM1 KD HEK293T cells. IP efficiency is calculated as the ratio of immunoprecipitated OFD1/LC3.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f1-G</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f1-G</infon>
    <infon key="sourcedata_figure_dir">f1-G</infon>
    <passage>
      <offset>0</offset>
      <text>g, h, Western blotting analysis of protein levels of indicated proteins in MEFs with indicated genotypes in normal medium or subjected to 24 hserum starvation (SS). Quantified OFD1 level was normalized with alpha-tubulin. Similar results were observed in three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f1-H</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f1-H</infon>
    <infon key="sourcedata_figure_dir">f1-H</infon>
    <passage>
      <offset>0</offset>
      <text>g, h, Western blotting analysis of protein levels of indicated proteins in MEFs with indicated genotypes in normal medium or subjected to 24 hserum starvation (SS), 50 nM bafilomycin A1 (Baf), 20 µM chloroquine (CQ) or 1 µM MG132. Quantified OFD1 level was normalized with alpha-tubulin. Similar results were observed in three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f2-A</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f2-A</infon>
    <infon key="sourcedata_figure_dir">f2-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Representative confocal images of endogenous OFD1 puncta with cilium marker acetylated tubulin (Ac-tubulin), or centriole marker γ-tubulin in hTERT-RPE1 cells in normal medium (Un) or subjected to 24 hserum starvation (SS).</text>
    </passage>
  </document>
  <document>
    <id>4075283 f2-B</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f2-B</infon>
    <infon key="sourcedata_figure_dir">f2-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Representative confocal images of endogenous OFD1 and acetylated tubulin in Atg5+/+ and Atg5−/− MEFs subjected to 24 hserum starvation. a, b, Data shown represent mean ± s.d. percentage of cells with centriolar satelliteOFD1 for 100 cells per well in triplicate samples. ***P 0.001, two-tailed unpaired student's t-test. Similar results were observed in three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f3-A-B</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f3-A-B</infon>
    <infon key="sourcedata_figure_dir">f3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>a, b, Representative confocal images of cilium marker acetylated tubulin from MEFs with indicated genotype subjected to 24 hserum starvation. Data shown represent mean ± s.d. percentage of cells with primary cilia or length of the cilia for 500 cells or 100 cells per well, respectively, in triplicate samples. ***P  0.001, two-tailed unpaired student's t-test. Similar results were observed in three independent experiments. Un, untreated; SS, serum-starved.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f4-A</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f4-A</infon>
    <infon key="sourcedata_figure_dir">f4-A</infon>
    <passage>
      <offset>0</offset>
      <text>a, Western blotting analysis of OFD1 protein levels in control or OFD1 knockdown MCF7 (C-19) cells, quantified OFD1 level was normalized with alpha-tubulin.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f4-B</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f4-B</infon>
    <infon key="sourcedata_figure_dir">f4-B</infon>
    <passage>
      <offset>0</offset>
      <text>b, Quantification of percentage of cells with primary cilia in MCF7 or C19 cells subjected to 72 h serum starvation. Data shown represent mean ± s.d. percentage of cells with primary cilia for 500 cells per well in triplicate samples. ***P 0.001, two-tailed unpaired student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f4-C</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f4-C</infon>
    <infon key="sourcedata_figure_dir">f4-C</infon>
    <passage>
      <offset>0</offset>
      <text>c, Quantification of length of primary cilia in C19 cells subject to 48 h or 72 hserum starvation.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f4-D</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f4-D</infon>
    <infon key="sourcedata_figure_dir">f4-D</infon>
    <passage>
      <offset>0</offset>
      <text>d, e, Representative confocal images of primary cilia with variable length formed in MCF7 or C19 cells subject to 72 hserum starvation. Data shown represent 100 cells per well in triplicate samples.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f4-E</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f4-E</infon>
    <infon key="sourcedata_figure_dir">f4-E</infon>
    <passage>
      <offset>0</offset>
      <text>d, e, Representative confocal images of primary cilia with variable length formed in C19 cells subject to 72 hserum starvation. Data shown represent 100 cells per well in triplicate samples.</text>
    </passage>
  </document>
  <document>
    <id>4075283 f4-F</id>
    <infon key="sourcedata_document">558</infon>
    <infon key="doi">10.1038/nature12606</infon>
    <infon key="pmc_id">4075283</infon>
    <infon key="figure">f4-F</infon>
    <infon key="sourcedata_figure_dir">f4-F</infon>
    <passage>
      <offset>0</offset>
      <text>f, Scanning electron microscope analysis of primary cilia (marked by arrows) formed in C-19 cells subject to 72 hserum starvation and cycling Atg5+/+ MEFs in normal medium for 24 h. Similar results were observed in three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f1-A</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f1-A</infon>
    <infon key="sourcedata_figure_dir">f1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a-f) HepG2 cells were treated with bovine serum albumin (Con), 500 μM PA or 100 nM rapamycin (Rap) for 9 h and subjected to following analyses. (a,c-f) Cells were stained with ubiquitin (Ub), p62, LC3 and LAMP1 antibodies and DAPI (blue). Boxed areas are magnified in right-most panels (c,d). Co-localization between LAMP1 and LC3 staining (e) was quantified (f; n=3).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f1-B</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f1-B</infon>
    <infon key="sourcedata_figure_dir">f1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Cells were subjected to serial protein extraction (solubility fractionation) with indicated concentration of Triton X-100 (TX100) or sodium dodecyl sulphate (SDS) and analysed by immunoblotting with indicated antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f1-C-D</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f1-C-D</infon>
    <infon key="sourcedata_figure_dir">f1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(a-f) HepG2 cells were treated with bovine serum albumin (Con), 500 μM PA or 100 nM rapamycin (Rap) for 9 h and subjected to following analyses. (a,c-f) Cells were stained with ubiquitin (Ub), p62, LC3 and LAMP1 antibodies and DAPI (blue). Boxed areas are magnified in right-most panels (c,d). Co-localization between LAMP1 and LC3 staining (e) was quantified (f; n=3).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f1-E-F</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f1-E-F</infon>
    <infon key="sourcedata_figure_dir">f1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(a-f) HepG2 cells were treated with bovine serum albumin (Con), 500 μM PA or 100 nM rapamycin (Rap) for 9 h and subjected to following analyses. (a,c-f) Cells were stained with ubiquitin (Ub), p62, LC3 and LAMP1 antibodies and DAPI (blue). Boxed areas are magnified in right-most panels (c,d). Co-localization between LAMP1 and LC3 staining (e) was quantified (f; n=3).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f1-G-H</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f1-G-H</infon>
    <infon key="sourcedata_figure_dir">f1-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(g,h) HepG2 cells stably transduced with mCherry (mCh)-GFP-LC3-expressing retroviruses were treated with Con, Rap or PA for 9 h and examined under a live confocal microscope (g). Yellow dots represent autophagosomes while red dots indicate autolysosomes in which GFP signal was faded out. Number of autolysosomes was quantified (h; n=7). Scale bar, 5 μm. All data are shown as mean±s.e.m. ***P0.001 (Student's t-test). Molecular weight markers are indicated in kDa.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f2-A-D</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f2-A-D</infon>
    <infon key="sourcedata_figure_dir">f2-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>HepG2 cells were treated with bovine serum albumin (Con or (−)), PA (500 μM), PA+verapamil (Ver, 50 μM) or PA+nicardipine (Nic, 100 μM) for 9 h. (a-d) After each treatment, cells were loaded with a calcium indicator X-Rhod-1-AM (a,b) or Fura-2-AM (c,d). Calcium levels were visualized by laser confocal microscopy (a) or by dual fluorescent microscopy (c, 340/380 nm ratio image) and quantified (b,d; n=8 and 30, respectively).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f2-E-H</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f2-E-H</infon>
    <infon key="sourcedata_figure_dir">f2-E-H</infon>
    <passage>
      <offset>0</offset>
      <text>(e-h) Cells with indicated treatments were subjected to solubility fractionation. 1% Triton X-100-insoluble fractions were dissolved in 2% SDS, analysed by immunoblotting (e,f) and quantified (g,h; n=3).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f2-I-L</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f2-I-L</infon>
    <infon key="sourcedata_figure_dir">f2-I-L</infon>
    <passage>
      <offset>0</offset>
      <text>(i-l) Cells with indicated treatments were subjected to immunostaining with indicated antibodies (i,k). DNA was stained with DAPI (blue). Amount of aggregated proteins was quantified (j; n=10). Co-localization between LAMP1 and LC3 was quantified (l; n=4). Boxed areas in fluorescence images are magnified in right-most panels (i,k). Scale bar, 10 μm (a), 20 μm (c), 5 μm (i,k). All data are shown as mean±s.e.m. *P0.05, **P0.01, ***P0.001 (Student's t-test). Molecular weight markers are indicated in kDa.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f3-A-B</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f3-A-B</infon>
    <infon key="sourcedata_figure_dir">f3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Four-month-oldC57BL/6 male mice kept on HFD for 2 months were subjected to daily administration of phosphate-buffered saline (Con, n=4) or verapamil (Ver, 25 mg per kg body weight, i.p., n=3) for 10 days. Low-fat diet (LFD)-kept mice (n=5) of same age were used as a negative control. (a) Body weight was daily monitored during injection period. (b) Daily food consumption was measured during injection period.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f3-C-D</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f3-C-D</infon>
    <infon key="sourcedata_figure_dir">f3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Livers were collected from indicated mice and photographed. (d,e) Total liver mass (d) were measured from indicated mice.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f3-E</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f3-E</infon>
    <infon key="sourcedata_figure_dir">f3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Livers were collected from indicated mice and photographed. (d,e) Total liver mass (d) and total epididymal white adipose tissue (eWAT) mass (e) were measured from indicated mice.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f3-F-H</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f3-F-H</infon>
    <infon key="sourcedata_figure_dir">f3-F-H</infon>
    <passage>
      <offset>0</offset>
      <text>(f-h) Relative mRNA expression was analysed from eWAT of indicated mice through quantitative reverse transcription-PCR.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f3-I-J</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f3-I-J</infon>
    <infon key="sourcedata_figure_dir">f3-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(i,j) Liver sections were analysed by hematoxylin and eosin (HE, upper panels) and Oil Red O (ORO, lower panels) staining (i). ORO densities were quantified (j).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f3-K-L</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f3-K-L</infon>
    <infon key="sourcedata_figure_dir">f3-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>(k,l) Calcium-induced CaMKII autophosphorylation in livers was analysed by immunoblotting (k) and quantified (l).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f3-M</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f3-M</infon>
    <infon key="sourcedata_figure_dir">f3-M</infon>
    <passage>
      <offset>0</offset>
      <text>(m) Primary hepatocytes from 2-month-oldC57BL/6mice kept on LFD were treated with bovine serum albumin (Con), PA (500 μM), PA+verapamil (Ver, 50 μM) or PA+nicardipine (Nic, 100 μM) for 12 h. After each treatment, cells were loaded with a calcium indicator Fura-2-AM. Calcium levels were visualized by dual fluorescent microscopy at 340/380 nm, and ratio of fluorescence intensities of Fura-2-AM at 340 nm over 380 nm was quantified (n=17). Scale bar, 1 cm (c), 200 μm (i). All data are shown as mean±s.e.m. *P0.05, **P0.01, ***P0.001 (Student's t-test). Molecular weight markers are indicated in kDa.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">140</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="4" length="19"/>
        <text>Primary hepatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4157315 f4-A-D</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f4-A-D</infon>
    <infon key="sourcedata_figure_dir">f4-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>Four-month-old C57BL/6 male mice kept on HFD for 2 months were subjected to daily administration of phosphate-buffered saline (Con, n=4) or verapamil (Ver, 25 mg per kg body weight, i.p., n=3) for 10 days. Low-fat diet-kept mice (n=5) of same age were used as a negative control. (a-d) Livers were subjected to solubility fractionation. 1% Triton X-100-soluble (a) and -insoluble (b) fractions were analysed by immunoblotting (a,b) and quantified (c,d).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f4-E</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f4-E</infon>
    <infon key="sourcedata_figure_dir">f4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e,f) Paraffin sections of indicated livers were subjected to p62immunostaining and hematoxylin counterstaining (e). p62-positive areas were quantified (f). Scale bar, 200 μm (e). All data are shown as mean±s.e.m. *P0.05, **P0.01, ***P0.001 (Student's t-test). Molecular weight markers are indicated in kDa.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f5-A-B</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f5-A-B</infon>
    <infon key="sourcedata_figure_dir">f5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Four-month-oldC57BL/6 male mice kept on HFD for 2 months were subjected to daily administration of phosphate-buffered saline (Con, n=4) or verapamil (Ver, 25 mg per kg body weight, i.p., n=3) for 10 days. Low-fat diet-kept mice (n=5) of same age were used as a negative control. (a,b) Levels of LC3-II from 1% Triton X-100-insoluble fraction of livers were analysed by immunoblotting (a) and quantified (b).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f5-C-D</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f5-C-D</infon>
    <infon key="sourcedata_figure_dir">f5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c,d) Frozen sections of indicated livers were subjected to LC3/LAMP1immunostaining and DAPI counterstaining (c). Co-localization between LC3 and LAMP1 was quantified (d). Boxed areas in fluorescence images are magnified in right-most panels (c). Scale bar, 5 μm (c). All data are shown as mean±s.e.m. ***P0.001 (Student's t-test). Molecular weight markers are indicated in kDa.</text>
    </passage>
  </document>
  <document>
    <id>4157315 f6-A-B</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f6-A-B</infon>
    <infon key="sourcedata_figure_dir">f6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Four-month-oldC57BL/6 male mice kept on HFD for 2 months were subjected to daily administration of phosphate-buffered saline (Con, n=4) or verapamil (Ver, 25 mg per kg body weight, i.p., n=3) for 10 days. Low-fat diet-kept mice of same age (n=5) were used as a negative control. (a,b) Liver sections were subjected to F4/80immunostaining, which visualizes macrophage infiltration and hematoxylin counterstaining (a). F4/80-positive areas were quantified (b).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">204</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="356" length="10"/>
        <text>macrophage</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4157315 f6-C-F</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f6-C-F</infon>
    <infon key="sourcedata_figure_dir">f6-C-F</infon>
    <passage>
      <offset>0</offset>
      <text>(c-f) Glucose tolerance tests (GTT, c,d) and insulin tolerance tests (ITT, e,f) were conducted using indicated mice (c,e). Area under the curve (AUC) was quantified from GTT and ITT data (d,f).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f6-G</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f6-G</infon>
    <infon key="sourcedata_figure_dir">f6-G</infon>
    <passage>
      <offset>0</offset>
      <text>(g) Seruminsulin levels were measured from indicated mice before (Basal) and 10 min after (Glucose stimulated) glucose injection (n=4).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f6-H</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f6-H</infon>
    <infon key="sourcedata_figure_dir">f6-H</infon>
    <passage>
      <offset>0</offset>
      <text>(h,i) Pancreas sections were analysed by hematoxylin and eosin (HE) staining (h). Islet areas were quantified (i; n=4). Scale bar, 200 μm (a), 100 μm (h). All data are shown as mean±s.e.m. *P0.05, **P0.01, ***P0.001 (Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4157315 f7-A-G</id>
    <infon key="sourcedata_document">669</infon>
    <infon key="doi">10.1038/ncomms5834</infon>
    <infon key="pmc_id">4157315</infon>
    <infon key="figure">f7-A-G</infon>
    <infon key="sourcedata_figure_dir">f7-A-G</infon>
    <passage>
      <offset>0</offset>
      <text>(a-g) Four-month-oldC57BL/6 male mice kept on HFD for 2 months were subjected to daily administration of phosphate-buffered saline (Con, n=4) or verapamil (Ver, 25 mg per kg body weight, i.p., n=4) for 10 days. Systolic blood pressure (a), LV wall mass (b), diastolic LV volume (c), systolic LV volume (d), ejection fraction (e, % EF), stroke volume (f, SV) and cardiac output (g, CO) were analysed by tail-cuff method (a) or echocardiography (b-g). All data are shown as mean±s.e.m. *P0.05 (Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_1-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunofluorescence staining of cortex of 4‐month‐old rTg4510 mice either untreated (Tau) or injected with TFEB (Tau + TFEB) at P0 using phospho‐Tau antibodies AT8 (S202/T205) and PHF1 (S396/S404) or conformation‐specific antibody MC1 and counter‐stained with DAPI. AAV‐TFEB was injected at P0 and mice were analyzed at 4 months. Scale bar: 200 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_1-B</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Quantification of staining intensities. Student's t‐test was performed to analyze the significance. n = 5 mice/genotype/treatment group. **P = 0.0011, ***P = 6.85 × 10−5, and ***P = 9.33 × 10−5 for AT8, PHF1 and MC1, respectively. Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_1-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Western blot analysis of detergent‐extracted brain lysates using anti‐total Tau, Tau1, AT8 or MC1 antibodies. WT: wild‐type; WT + TFEB: wide‐type mice injected with TFEB; Tau: rTg4510 transgenic mice; Tau + TFEB: rTg4510 transgenic mice injected with TFEB. Two exposures were displayed for total : the short exposure was used for quantification of Tau transgenic samples; the long exposure was used for side‐by‐side comparisons of the total levels in WT and Taumice and for quantification of WT total Tau. γ‐tubulin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_1-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Western blot analysis of TFEB expression in 4‐month‐old WT or Taumice with (+TFEB) or without AAV‐TFEB P0 injection (the same as in A and C but from another independent batch of experiments). PHF1 and total Tau antibodies were used to blot the Tau transgenic lysates for correlation with TFEB levels.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_1-E-F</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Quantification of relative band intensities in WT (E) or mice (F) mice. Student's t−test shows that TFEB protein levels are significantly increased in WT + TFEB vs WT (**P = 0.0026) and in Tau + TFEB vs Tau (*P = 0.047). AT8, PHF1 and MC1 levels are significantly reduced in Tau + TFEB vs Tau (*P = 0.032, 0.041, 0.040, respectively). &amp;, significant correlation between TFEB protein levels and PHF−1 was determined using Pearson Product Moment Correlation test (P = 0.0044). n = 3/group/experiment. Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_2-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>AWestern blot analysis of detergent−free (Soluble) and sarkosyl−insoluble (Insoluble) preparations of total (total ), unphosphorylated (Tau1) or CP13− (S202/T205) and PHF1−positive pTau species in 4−month−old Tau or Tau + TFEBmice with P0 injection. γ−tubulin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_2-B-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Quantification of relative band intensities in soluble (B) and insoluble (C) fractions. n = 3 mice/genotype/treatment group. CP13 and PHF1 are significantly reduced in both soluble and insoluble fractions (Student's t−test, ***P = 0.00072 and **P = 0.004, for B; and **P = 0.007 and **P = 0.009 for C).</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_2-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Western blot analysis of total Tau, unphosphorylated Tau (Tau1) and CP13‐ or PHF1‐positive pTau levels in response to doxycycline induction (Tau) and/or TFEB‐FLAG transfection (TFEB) in T40PL cell line. Ctrl: untreated; Tau: 0.5 μg/ml doxycycline treated for 48 h; TFEB: TFEB transfected for 48 h; Tau + TFEB: combined TFEB transfection and DOX treatment. FLAG: anti‐FLAG antibody blotting for TFEB expression. γ‐tubulin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_2-E</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Quantification of relative band intensities. CP13, PHF1 and total Tau are significantly reduced by TFEB transfection (Student's t−test, n = 3, **P = 0.0012, 0.0040, and 0.0019, respectively). Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_3-B</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Fluorescence images of GFP and immunofluorescence images of anti‐FLAG compared with immunofluorescence images of anti‐PHF1 in GFP or TFEB transfected and doxycycline induced T40PL cell line at 8, 16 or 40 h post‐transfection. Merge: Overlay of GFP or TFEB‐FLAG with PHF1. Insets are higher resolution images documenting that whereas overlapping GFP and PHF1 immunoreactivity can be observed at all the time points, TFEB‐ and PHF1‐double‐positive cells can only be detected at 8 h but not later times. Scale bar: 200 μm; in inset: 50 μM.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_3-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Pearson correlation coefficients (Pearson R−values) showing no correlation between GFP and PHF1 (PHF1/GFP) at any time points, but negative correlation between TFEB and PHF1 (PHF1/TFEB) starting at 16 h and persisting to 40 h (Student's t−test, n = 4, *P = 0.026 and **P = 0.008 for 16 and 40 h, respectively, comparing R−values for GFP/PHF1 with TFEB/PHF1). The whole view field of eight confocal projection slices per view field, four view fields per time point per transfection was used for analysis. Bar graph represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_4-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunofluorescence staining of untreated or TFEB‐treated (+TFEB) hippocampus of wild‐type (WT) and rTg4510 (Tau) mice using the anti‐NeuN antibody. Scale bar: 1000 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_4-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Unbiased stereological quantification of NeuN−positive neurons in area CA1 of wild−type (WT) or Tau transgenic mice injected with GFP or TFEB. n = 4 sections/mice, 5 mice/group. Student's t−test, **P = 0.0063.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">824</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="57" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_4-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Wet brain weight measurement of WT or Taumice with (+TFEB) or without TFEB injection. n = 14 mice/group. ***P &lt; 0.001 (2 way ANOVA with Bonferroni post hoc). Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_4-E-F</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Representative immunofluorescence images of cortex (CTX) or hippocampus (HPC) of untreated or TFEB‐treated (+TFEB) rTg4510 (Tau) mice stained with anti‐Iba1 (E) or anti‐GFAP (F) antibodies antibody. Scale bar in E: 200 μm; in F. 400 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_5-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Morris water maze test of groups of 4−month−old WT or Taumice without or with TFEB (+TFEB) treatment, showing longer latency (time to find hidden platform) in Taumice compared to WT controls at any given day of training. TFEB has no effect on WT mice, but significantly reduced the latency in Taumice. n = 14/group. ***P &lt; 0.001 (2 way ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_5-B</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Number of platform crossings in non‐target quadrants (NTQ) vs. the target quadrant (TQ). Values of the three NTQs were combined and averaged. n.s.: non‐significant. *P = 0.047 and ***P = 0.0005 for TQ of WT vs Tau and Tau vs Tau + TFEB, respectively (Student's t‐test). Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_5-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Slope of field excitatory postsynaptic potential (fEPSP) in response to theta-burst stimulation delivered to the Schaffer collateral pathway from WT mice (n = 10 recordings from 6 mice), Taumice (n = 19 recordings from 6 mice) or Taumice with TFEB injection (Tau + TFEB; n = 8 recordings from 6 mice). Insets: example fEPSP traces taken before (upper) or after (lower) stimulation from WT, Tau or Tau + TFEBmice. Calibration: 1 mV, 5 msec.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_5-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Quantification of average fEPSP slope in the last 10 minutes demonstrating severely impaired LTP in Taumice (WT vs. Tau) and significant improvement by TFEB treatment (Tau vs. Tau + TFEB). Each bar represents average ± s.e.m. **P &lt; 0.01 (2 way ANOVA with Bonferroni post hoc).</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_6-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Gene set enrichment analysis (GSEA) of transcriptome changes in TFEB−injected vs. uninjected wild−type (WT + TFEB vs. WT) mice. GSEA of genes annotated as participating in the lysosomal function are reported. The upper panel shows the enrichment generated by GSEA of ranked gene expression data (left in upper panel and red in middle panel: upregulated; right in upper panel and blue in middle panel: downregulated). Peak value corresponds to the point (along the ranked microarray) where the enrichment score (ES) meets its highest value, while the zero value indicates the boundary (along the ranked microarray) between positive fold change and negative fold change. In the middle panel, vertical blue bars indicate the position of lysosomal genes within the ranked list. Lower panel shows the cumulative distribution of lysosomal genes within the ranked lists. The ranking positions that include 50% of lysosomal genes are indicated. The analysis shows that lysosomal genes have a significant global shift toward upregulated genes in TFEB−injected mice compared with uninjected littermates (ES = 0.56, P = 0.0029). n = 4 mice/group.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_6-B</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Representative image of Taumice coinjected with TFEB‐FLAG/GFP and immunostained with anti‐FLAG and LAMP1 antibodies. Merge image highlights that nuclear TFEB‐FLAG is correlated with higher LAMP1. Scale bar: 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_6-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Western blot analysis of TFEB, LAMP1 and CTSD expression in Taumice with (+TFEB) or without AAV‐TFEB adult injection.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_6-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Quantification of relative band intensities of (C). n = 3 and 4 per group. TFEB protein levels are significantly increased in Tg + TFEB vs Tg (***P = 0.00013) along with LAMP1 protein levels (*P = 0.013) and CTSD protein levels (*P = 0.028), Student's t‐test. Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_7-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Western blot analysis of Lamp1 and LC3‐I and LC3‐II levels in T40PL cells transfected with TFEB‐FLAG and harvested at times indicated. γ‐tubulin was used as a loading control. Ctrl: untransfected.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_7-B</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Fluorescent images of T40PL cells transfected with TFEB and RFP‐GFP‐LC3. Thick white arrows indicate cells with significant LC3 puncta and lower PHF1 compared with nearby cells. Images on the upper and right are higher magnification views of the bracketed area of the LC3‐GFP and LC3‐RFP or Merge panels, respectively. RFP‐only autolysosomes are marked by red arrows; GFP/RFP double‐positive puncta representing an autophagosome is shown in yellow (upper inset). Right insets highlight a cell with colocalization of GFP/RFP‐positive autophagosome with PHF1. Scale bar: 10 μm; in inset: 2.5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_7-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunofluorescence images of T40PL cells transfected with TFEB and stained with anti‐LAMP1/MC1 (top) or PHF1 (bottom). Arrow marks cells with nuclear TFEB and its correlation with higher LAMP1 and lower MC1 (top) or PHF1 (bottom) stainings. Arrowhead indicates nearby cells with cytoplasmicTFEB and opposite LAMP1 and MC1/PHF1 patterns. Scale bar: 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_7-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Western blot analysis of T40PL cells transfected with either pCMV or TFEB, allowed to recover for 24 h, and then treated with 0.5 µg/ml doxycycline and either DMSO or 50-µM Leupeptin for 48 h prior to lysis. Black line denotes cropped lanes from a single immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_7-E</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Quantization of the autophagy markers LC3-I, LC3-II (pCMV vs pCMV+Leupeptin P = 0.032, TFEB vs TFEB+Leupeptin P = 0.014), and p62 (pCMV vs pCMV+Leupeptin P = 0.019, TFEB vs TFEB+Leupeptin P = 0.024), and Tau species markers Tau1, PHF1 (pCMV vs pCMV+Leupeptin P = 0.00082, TFEB vs TFEB+Leupeptin P = 0.022), and total Tau normalized for loading to y-tubulin from (D). P-values determined by t-test, n = 4. (*P &lt; 0.05) Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_8-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A qRT‐PCR analysis of PTEN levels as a function of TFEB treatment in WT or Taumice. n = 3 mice/genotype/treatment group in triplicates. *P = 0.027 and **P = 0.01 for WT vs WT + TFEB and Tau vs Tau + TFEB, respectively (Student's t‐test).</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_8-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C ChIP analysis of FLAG binding. HPRT and APRT: negative controls; MCOLN1: positive control. Open bar: IgG control; filled bar: FLAG‐FLAG IP. The experiment was done two times each in triplicates.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_8-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Normalized luciferase activity by transfecting 300 ng of each PTEN−luciferase reporter. Open bar: vector transfection control; filled bar: TFEB transfected. Student's t−test, n = 4; *P = 0.01; **P = 0.005</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_8-E</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Dose-dependent luciferase activities in response to increasing concentrations of TFEB using the (−1344 to +1) PTEN−luciferase reporter. The experiment was done three times each in triplicates.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_8-F</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 8-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Western blot analysis of PTEN and LC3 expression in T40PL cells transfected with either pCMV or TFEB.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_8-G</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 8-G</infon>
    <infon key="sourcedata_figure_dir">Figure_8-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Quantization of blots in F and normalized for loading to γ-tubulin. PTEN and LC3-II are significantly increased in cells transfected with TFEB with *P = 0.032 and 0.036, respectively (Student's t-test, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_8-H</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 8-H</infon>
    <infon key="sourcedata_figure_dir">Figure_8-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Representative immunofluorescent images of T40PL cells transfected with TFEB and triple staining for TFEB (FLAG), PTEN and PHF1. Arrow marks cell with higher TFEB and PTEN is correlated with lower PHF1. Arrowhead indicates nearby cell with opposite TFEB/PTEN/PHF1 patterns. Scale bar: 10 μm. Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_9-A</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Western blot analysis of total Tau and PHF1‐positive pTau levels as a function of wild‐type or the C124S or G129E mutant PTEN expression. Empty vector (Ctrl)‐ or TFEB‐transfected cells were used as negative and positive controls, respectively. γ‐tubulin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_9-B</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Quantization of blots in A and normalized for loading to γ-tubulin. TFEB and PTEN transfection significantly reduced pTau as probed by PHF1 (P = 0.0095 and 0.0092, respectively), as well as total Tau (P = 0.0052 and 0.034, respectively), n = 3, Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_9-C</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Representative immunofluorescence imaging showing that cells with wild‐type PTEN (WT), but not the C124S or G129E mutants, were correlated with reduced PHF1‐positive Tau. Scale bar: 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_9-D</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 9-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Western blot analysis of total Tau, PHF1‐positive pTau and LC3 levels in response to TFEB or TFEB and PTEN shRNA expression. Transfection of a scramble PTEN shRNA was used as negative controls. γ‐tubulin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4197862 Figure_9-E</id>
    <infon key="sourcedata_document">260</infon>
    <infon key="doi">10.15252/emmm.201303671</infon>
    <infon key="pmc_id">4197862</infon>
    <infon key="figure">Figure 9-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Quantization of blots in D and normalized for loading to γ-tubulin. Comparing with cells transfected with scramble+pEGFP, scramble+TFEB transfection reduces PHF1 and total Tau intensity (P = 0.038 and 0.035, respectively) and increases PTEN and LC3II (P = 0.04 and 0.0076, respectively) (white slashed bars). shRNA significantly reduce PTEN when transfected with either pEGFP or TFEB (P = 0.0089 and 0.043, respectively), but TFEB's effect in reducing pTau drops from 60% reduction in the presence of scramble sequence to 30% reduction when combined with shRNA of PTEN. All statistics here are Student's t-test, n = 3. Each bar represents average ± s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_1-A-D</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 1-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-D SQST‐1::GFP is very weakly expressed and diffusely localized in the cytoplasm in wild‐type larval intestine, but is expressed at much higher levels and accumulates into numerous aggregates in the intestine in bp399 mutant larvae. (A) and (C) represent DIC images of the animals in (B) and (D), respectively.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_1-E</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Compared to wild‐type, SQST‐1::GFP levels are much higher in bp399 and bp412 mutant larvae as shown by immunoblotting assay. SQST‐1::GFP levels in bp399 mutants are greatly reduced after 12 h of starvation. 200 young adult animals for each genotype were collected for analysis.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_1-H-I</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 1-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>H, I SQST‐1::GFP aggregates in rpl‐43(bp399) mutants are separable from LAAT‐1::Cherry‐labeled lysosomes under normal conditions, but are delivered to lysosomes upon starvation. Some aggregates are enclosed by lysosomes (inserts). Scale bar: 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_1-J-Q</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 1-J-Q</infon>
    <infon key="sourcedata_figure_dir">Figure_1-J-Q</infon>
    <passage>
      <offset>0</offset>
      <text>J-Q RNAi inactivation of let‐363, rpn‐2, cogc‐1, or hgrs‐1 suppresses the accumulation of SQST‐1::GFP aggregates in rpl‐43(bp399) mutants. (J), (L), (N), and (P): DIC images of the animals in (K), (M), (O), and (Q). Scale bar: 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_1-R</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 1-R</infon>
    <infon key="sourcedata_figure_dir">Figure_1-R</infon>
    <passage>
      <offset>0</offset>
      <text>R SQST‐1::GFP levels in rpl‐43(bp399) mutants are greatly reduced by inactivation of rpt‐3 and rpn‐2. 200 young adult animals for each genotype were collected for analysis.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-A-B</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B SQST‐1::GFP aggregates are absent in the rpl‐43(bp399); sma‐3(wk20) mutant intestine.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-C</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Percentage of the indicated animals with different levels of SQST‐1::GFP aggregates. S: many SQST‐1::GFP aggregates in all intestinal cells, as in rpl‐43(bp399) mutants; M: fewer SQST‐1::GFP aggregates in some but not all intestinal cells; N: no or very few SQST‐1::GFP aggregates in intestinal cells. For each genotype, &gt; 30 animals were examined.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-D</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D SQST‐1::GFP levels in rpl‐43(bp399) mutants are dramatically decreased in a Western blot when sma‐3, lin‐35, or daf‐2 is simultaneously depleted. Loss of function of daf‐16 partially restores SQST‐1 levels in rpl‐43(bp399); daf‐2(RNAi) mutants.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-E</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Endogenous LGG‐1 is elevated in a Western blot in dbl‐1(wk70), sma‐2(e502), and sma‐3(wk20) mutants.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-F</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F mRNA levels of bec‐1, epg‐8, lgg‐1, and atg‐7 are upregulated in dbl‐1(wk70), sma‐2(e502), and sma‐3(wk20) mutants. **P  0.01. 500 young adult animals were collected for analysis. Error bars indicate s.d. from three experiments.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-G-H</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G, H No SQST‐1::GFP aggregates are observed in the lin‐35(n745); rpl‐43(bp399) mutant intestine.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-I-J</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>I, J Numerous SQST‐1::GFP aggregates are formed in rpl‐43(bp399); lin‐15A(n767) mutants.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-K</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-K</infon>
    <infon key="sourcedata_figure_dir">Figure_2-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Endogenous LGG‐1 levels are increased in lin‐9(n112), lin‐15B(n744), and lin‐35(n745) mutants.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-L</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-L</infon>
    <infon key="sourcedata_figure_dir">Figure_2-L</infon>
    <passage>
      <offset>0</offset>
      <text>L mRNA levels of bec‐1, epg‐8, lgg‐1, and atg‐7 are upregulated in lin‐9(n112), lin‐15B(n744), and lin‐35(n745) mutants. **P  0.01. 500 young adult animals were collected for analysis. Error bars indicate s.d. from three experiments.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-M-N</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-M-N</infon>
    <infon key="sourcedata_figure_dir">Figure_2-M-N</infon>
    <passage>
      <offset>0</offset>
      <text>M, N rpl‐43(bp399); daf‐2(RNAi) mutant larvae contain no intestinal SQST‐1::GFP aggregates.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_2-O-P</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 2-O-P</infon>
    <infon key="sourcedata_figure_dir">Figure_2-O-P</infon>
    <passage>
      <offset>0</offset>
      <text>O, P SQST‐1::GFP aggregates are partially restored in daf‐16(mu86); rpl‐43(bp399); daf‐2(RNAi) animals.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_3-A-D</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 3-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>A, B hsp‐4::GFP is very weakly expressed in wild‐type animals.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_3-C</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Percentage of indicated animals with different levels of SQST‐1::GFP aggregates. S: strong. M: medium. N: none. &gt;30 animals were examined for each genotype.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_3-D-E</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 3-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Phsp‐4::GFP expression is much higher in rpt‐3(RNAi) animals.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_3-F-G</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 3-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F, G Upregulation of Phsp‐4::GFP expression in rpt‐3(RNAi) animals is suppressed by the xbp‐1(zc12) mutation.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_3-H-I</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 3-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>H, I SQST‐1::GFP aggregates are absent in rpl‐43(bp399); rpt‐3(RNAi) animals.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_3-J-K</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 3-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_3-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>J, K Loss of function of xbp‐1 restores SQST‐1::GFP aggregates in rpl‐43(bp399); rpt‐3(RNAi) animals.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_3-M</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 3-M</infon>
    <infon key="sourcedata_figure_dir">Figure_3-M</infon>
    <passage>
      <offset>0</offset>
      <text>M The increase in bec‐1, epg‐8, lgg‐1, and atg‐7mRNA levels in npl‐4.1, rpt‐3, and pep‐2RNAi animals is dependent on xbp‐1. *P  0.05, **P  0.01. 500 young adult animals were collected for analysis. Error bars indicate s.d. from three experiments.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_4-A</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Phsp‐60::GFP is weakly expressed in wild‐type animals.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_4-B</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B egl‐46(RNAi) causes upregulation of Phsp‐60::GFP.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_4-C</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Percentage of indicated mutant animals with different levels of SQST‐1::GFP aggregates. S: strong. M: medium. N: none. &gt;30 animals were examined in each group.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_4-D</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Levels of SQST‐1::GFP in various genetic mutants. 200 young adult animals for each genotype were collected for analysis.</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_4-E-F</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Loss of function of atfs‐1 suppresses the upregulation of Phsp‐60::GFP in egl‐46(n1126) mutants. (E): DIC image of (F).</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_4-G-H</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 4-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G, H The dramatic decrease in the number of SQST‐1::GFP aggregates in the intestine in rpl‐43(bp399); egl‐46(RNAi) mutants (G) is restored by simultaneous loss of function of atfs‐1(gk3094) (H).</text>
    </passage>
  </document>
  <document>
    <id>4197881 Figure_4-I-J</id>
    <infon key="sourcedata_document">513</infon>
    <infon key="doi">10.1002/embr.201338310</infon>
    <infon key="pmc_id">4197881</infon>
    <infon key="figure">Figure 4-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>I, J GFP::LGG‐1 forms numerous puncta in the intestine in egl‐46(RNAi) (I), gfi‐1(RNAi) (J) animals.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_1-A</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A cdc14‐3 temperature‐sensitive cells reconstituted with CDC14 or CDC14‐NLS were released from a G1 arrest at the restrictive temperature and stained for Cdc14 and the spindle (Tub1) once cells had reached late anaphase.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_1-B</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Wild‐type, cdc14‐3, +CDC14 and +CDC14‐NLS cells were released from an α‐factor‐induced G1 arrest and re‐arrested in the next G1. Samples were harvested at the indicated time points and stained with DAPI and for the nucleolar protein Nop1 (n &gt; 100). Photographs of examples of cells without (top) and with (bottom) rDNA segregation defects at 80 min after release are shown together with quantification over time.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_1-C</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Cells from the experiment in (B) were stained for the spindle (n &gt; 100). Cells without (top) and with (bottom) anaphase spindles at 100 min after release are shown together with their quantification over time.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_1-D</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D FACS analysis of DNA content and Western blot analysis of cell cycle markers of the samples from (B). Tub1 served as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_2-A</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A +CDC14 and +CDC14‐NLS cells were grown at 35.5°C for 5 h and sonicated, and differential interference contrast (DIC) images were acquired.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_2-B</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Cells from a synchronous culture (as in Fig B) were treated with zymolyase to remove the cell wall. The fraction of remaining budded cells is shown over time (n = 100).</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_2-C-D</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Cells expressing the plasma membrane marker GFP‐Spo2051-91, exemplifying the indicated bud neck phenotypes and stages of cytokinesis. D Bud neck phenotypes of synchronized GFP‐Spo2051-91‐expressing +CDC14 or +CDC14‐NLS cells during the progression of a cell cycle (n &gt; 75).</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_2-E</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E +CDC14 or +CDC14‐NLS cells expressing Spc42‐YFP and GFP fusions with the indicated cytokinetic protein were synchronized in G1 using α‐factor. Upon release at 35.5°C, cells were imaged every 2 min and the time from anaphase onset to the indicated events was recorded. Error bars represent SD; Student's t‐test was applied to analyze differences between the indicated conditions; **P ≤ 0.01; ****P ≤ 0.0001. For representative image sequences, see Supplementary Fig S2C.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_3-A</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A MET3pr‐CDC20cdc15‐as1 cells were arrested in metaphase by Cdc20 depletion and subsequently treated with 1NM‐PP1 to inhibit Cdc15‐as1. Cells were released from the metaphase arrest by Cdc20 re‐induction (left graph), or Cdc14 and/or Sic1 expression were induced from the GAL1 promoter while cells remained arrested (right graph). The fraction of large‐budded cells after spheroplastation (n = 100) was quantified. Representative photographs 120 min after galactose addition are shown. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_3-B</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B As (A), the plasma membrane marker GFP‐Spo2051-91 was visualized following Cdc14 induction (n = 100).</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_3-C</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Samples from the experiment in (B) were processed for Western blot analysis of the indicated cell cycle proteins. Arrowheads indicate endogenous and exogenous forms of Cdc14. Tub1 served as a loading control. A schematic of downstream processing for the phosphoproteome analysis is shown on the right.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_4-A-F</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 4-A-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-F</infon>
    <passage>
      <offset>0</offset>
      <text>A Phospho‐peptide abundance during Cdc14‐induced mitotic exit. Examples of phospho‐peptides that disappear with early (red), intermediate (orange) and late (green) timing or that remain stable (black) are shown. This color coding is used throughout all panels of this figure. B Numbers of unique peptides and corresponding proteins that do or do not contain a minimal Cdk consensus motif are shown, categorized according to timing of disappearance as described in (A). C Protein stability data for proteins corresponding to disappearing phospho‐peptides (blue) and for all other proteins (black). D The fractions of peptides that contain a minimal Cdk consensus motif ([S/T]‐P) within the timing categories shown in (B) were calculated. The ratio and P‐value of enrichment of each category relative to the combined stable/rest category (gray) are shown. E Similar to (D), the enrichment for reported physical Cdc14 interactors is assessed within [S/T]‐P‐containing phospho‐peptides. F Peptides that contain the indicated Cdk consensus sequence motifs and that have disappeared over time are represented as a fraction of all phospho‐peptides containing that motif.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_4-G</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Unique phospho‐peptides of Spa2, as an example, are categorized based on their dephosphorylation timing (graph). Enrichment of clustered timing for all proteins covered by phospho‐peptides was compared to random for Cdk or non‐Cdk consensus site‐containing peptides (table). Fisher's exact tests were used to determine significance.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_5-B</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Western blot analysis of cells expressing conditional Clb2m (+) or Clb2mΔCdk (Δ) fusions to the indicated proteins, before (−) and 5 h after (+) β‐estradiol treatment. Tub1 served as a loading control. c, control cells.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_5-C</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C FACS analysis of DNA content after conditional Clb2m or Clb2mΔCdk fusion to the indicated proteins. Quantification of the fraction of cells with &gt; 2C DNA content is shown in the bar graph for two independent biological replicates, with red dots representing individual and bars representing average values. Bnr1 fusions were included as controls for cytokinetic defects. Student's t‐test was applied to compare matched Clb2m versus Clb2mΔCdk fusion strains. ‐P &gt; 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_5-D</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Serial dilutions of cells from (C) were plated 6 h following β‐estradiol treatment and grown for 1 day at 36°C.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_5-E</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E The length of cell chains containing a common cytoplasm was scored 6 h after β‐estradiol treatment using the GFP‐Spo2051-91 plasma membrane marker (n &gt; 150). c, control cells; scale bars, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_6-A</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Genes corresponding to the indicated proteins were replaced by wild‐type (wt) or Cdk phospho‐site mutant (xA) sequences and then conditionally fused to Clb2m or Clb2mΔCdk. Cytokinetic defects were scored by FACS analysis of DNA content as in Fig C. The individual values from two independent clones (red dots) as well as their average (bars) are shown. Student's t‐test was applied to compare matched wt and xA strains. c, control cells.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_6-C</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C The indicated strains were spotted in serial dilutions onto auxin‐containing plates and grown for 2 days.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_6-D</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Auxin was added to cultures of the indicated strains, and after 6 h, cells were sonicated and the number of attached cell bodies was counted (n &gt; 200). Significance was calculated using a Wilcoxon rank‐sum test.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_6-E</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E The fraction of cells in asynchronously proliferating cultures of the indicated strains with a DNA content of &gt; 2C was determined by FACS analysis (n = 3). Error bars represent SD.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_7-A</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Cyk3‐GFP signal intensity at the GFP relative to the onset of actomyosin ring contraction (t = 0). The mean and SEM from at least 20 cells are shown.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_7-B</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Inn1‐Clb2m, Inn1‐Clb2mΔCdk and control cells before Clb2m fusion were arrested in G1 using α‐factor, released and harvested 90-100 min later at the time of cytokinesis. Indirect immunofluorescence microscopy was used to determine Inn1bud neck staining and the spindle status. Representative images of full spindles and partially and fully disassembled spindles are shown. nr, non‐recombined cells. Scale bars, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_7-C</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C The time from anaphase onset until the GFP appearance of Inn1 was determined by filming synchronized Inn1‐Clb2m‐GFP and Inn1‐Clb2mΔCdk‐GFP cells containing Spc42‐YFP‐labeled spindle pole bodies. Error bars represent SD.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_7-D</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D As in (C), now the persistence of a full actomyosin ring was measured in cells expressing Inn1‐Clb2m, Inn1‐Clb2mΔCdk or their respective non‐phosphorylatable mutants together with Myo1‐GFP and Spc42‐YFP. Error bars represent SD.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_7-E-F</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 7-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E Montage of medial view projections of actomyosin rings in Inn1‐Clb2m and Inn1‐Clb2mΔCdk cells. Frames are shown in 2‐min intervals. F Actomyosin ring contraction phenotypes from at least 21 cells filmed as in (E) were blindly scored as having a normal ("constriction") or aberrant ("disintegration") cytokinetic phenotype.</text>
    </passage>
  </document>
  <document>
    <id>4291482 Figure_7-G</id>
    <infon key="sourcedata_document">1628</infon>
    <infon key="doi">10.15252/embj.201488958</infon>
    <infon key="pmc_id">4291482</infon>
    <infon key="figure">Figure 7-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Cytokinetic defect and cell viability of Inn1‐Clb2m or Inn1‐Clb2mΔCdk cells in the absence or presence of Chs2V377I. In the bar graph, red dots represent values of duplicate biological replicates with bars representing the average. Significance is calculated using Student's t‐test. 10‐fold spot dilution assays are represented, together with the Western blotting analysis for Inn1 before and after its fusion to Clb2m. Tub1 served as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_1-A</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Equal aliquots (2 mg) of a Triton X-100 solubilized lysate from ratbrain were incubated with GST or GST-ROC. Specifically bound proteins were detected by Western blot with antibodies recognizing the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_1-B</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Brain lysate as in (A) was incubated with GST or GST-nCLCb. Specifically bound proteins were detected by Western blot with antibodies recognizing the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_1-C</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Full-length GST-nCLCb (1-228) and various truncation mutants were purified from bacteria. Equal aliquots of purified protein were incubated with GST or GST-ROC. Specifically bound proteins were detected by Western blot with antibody against CLCs.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_1-D</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Brain lysate as in (A) was incubated with GST or GST-nCLCb proteins with boundaries as indicated. Specifically bound proteins were detected by Western blot with antibody against CLCs.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_1-F</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Highly enriched triskelia were stripped from purified CCVs. The triskelia were incubated with GST or GST-ROC. Specifically bound proteins were detected by Western blot with antibodies recognizing the indicated proteins. For A-D/F, aliquots of the starting material (SM) equal to 10% of that added to the beads, was analyzed in parallel.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_2-A</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>PCR results of LRRK2-WT from clone E1 (1) using primers that detect endogenous LRRK2. Clone E1 is positive for 3xHA-LRRK2 (2) using a primer pair with the antisense in the 3xHA insert and the sense primer in endogenous LRRK2. (3) Control unedited COS-7 cells using the same primer combination as in (2). (4) 1Kb marker.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_2-C</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>COS-7 clone E1 cells were serum starved followed by 20 min incubation with Alexa488-EGF, after which the cells were fixed and processed for immunofluorescence using HA antibody. Scale bar = 10 m for bottom 6 panels and 25 m for top 3 panels.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_2-D</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>COS-7 clone E1 cells were fixed and processed for immunofluorescence using HA and CLC antibodies. Scale bar = 10 m.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_2-E</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>COS-7 clone E1 cells were fixed an processed for immunofluorescence using HA and EEA1 antibodies. Scale bar = 10 m for bottom 6 panels and 25 m for top 3 panels.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_3-A-B</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Lysates from COS-7 cells transfected with siRNA as indicated were processed for Western blot with antibodies recognizing the indicated proteins. Band intensities of blots as in A are presented as % control siRNA. Two-tailed Student t-test, Mann-Whiteney post hoc test, ***p &lt; 0.001, N = 3.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_3-C</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>NP-40 soluble lysates were prepared from COS-7 cells transfected with siRNA as indicated and equal protein aliquots (1.5 mg) were incubated with GST-PAK-CRIB domain. Specifically bound proteins were detected by Western blot with antibody recognizing Rac1. An aliquot of the starting material (SM) equal to 5% of that added to GST-PAK-CRIB was analyzed in parallel.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_3-E</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>COS-7 cells transfected with siRNA as indicated were fixed and processed for immunofluorescence using Phalloidin-647 and antibody recognizing CLCs. Scale bar = 10 m.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_3-G</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>Lysates from 21 day in vitro cultured hippocampal neurons transduced with lentivirus (at 7 days in vitro) driving expression of control shRNAmiR or shRNAmiRs specific for CLCa, CLCb, or both viruses in combination. The lysates were processed for Western blot with antibody that recognizes all forms of CLCs.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="38" length="19"/>
        <text>hippocampal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_3-H</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>Hippocampal neurons transduced as in G were fixed at 21 days in vitro and processed for immunofluorescence with polyclonal antibody specific for the pre-synaptic protein synapsin and monoclonal antibody specific for the post-synaptic protein PSD95. The lentivirus drives expression of GFP. The areas indicated by white boxes in the low power images (squares) are shown enlarged immediately below. The scale bars = 10 µm for the low mag and 2.5 µm for the high mag.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="0" length="19"/>
        <text>Hippocampal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_4-A</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Ai-x. Lateral view of the adult flyhead. Scale bar = 100 μm. i. longGMR,UAS-Rac1W/TM6B, Hu, Tb causes a mild rough eye phenotype with fused (arrows) and disorganized but still separated ommatidia (arrowheads). ii/iii. Rac1 overexpression with KD of dlrrk (UAS-dlrrk-RNAi (v22139 or v22140)/longGMR-GAL4, UAS-Rac1W), results in smaller eyes where most ommatidia are fused. iv/v. Rac1 overexpression with KD of Clc (UAS-Clc-RNAi (v22318 or v106632)/+;longGMR-GAL4,UAS-Rac1W/+), results in smaller eyes with some ommatidia fused. vi. Rac1 overexpression with KD of the inwardly rectifying potassium channel 3 (irk3), a non-relevant RNAi control (UAS-irk3-RNAi(v101174)/+; longGMR-GAL4,UAS-Rac1W/+), has no effect. vii/viii. KD of dlrrk with GMR-GAL4/+; UAS-dlrrk-RNAi(v22139 or 22140)/+, respectively as control have no effect on eye morphology. ix/x. KD of Clc with GMR-GAL4/UAS-Clc-RNAi (v22318 or v106632), respectively as control have no effect on eye morphology.</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_4-B</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Bi-ii. Lateral view of the adult flyhead. Scale bar: 100 μm. i. Rac1 overexpression with removing one copy of dlrrk (dlrrke03680/longGMR-GAL4,UAS-Rac1W), results in smaller eyes where most ommatidia are fused together. ii. Removing one copy of dlrrke03680 in GMR-GAL4 background, as control has no effect on eye morphology (GMR-GAL4/+;dlrrke03680/+).</text>
    </passage>
  </document>
  <document>
    <id>4304731 Figure_4-C</id>
    <infon key="sourcedata_document">1279</infon>
    <infon key="doi">10.15252/embr.201438714</infon>
    <infon key="pmc_id">4304731</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>Ci-viii. Lateral view of the adult flyhead. Scale bar: 100 μm. i. longGMR,UAS-Rac1W/TM6B, Hu, Tb causes a mild rough eye phenotype with fused and disorganized but still separated ommatidia (as explained in Ai). ii. Rac1 co-expression with dlrrk-WT using UAS-dlrrk-WT/+;longGMR-GAL4,UAS-Rac1W/+, results in rescued eye morphology. iii. Rac1 co-expression with Clc using UAS-GFP-Clc/+;longGMR-GAL4,UAS-Rac1W/+, results in rescued eye morphology. iv. Rac1 co-expression with dlrrk-WT-3KD using UAS-dlrrk-3KD/+;longGMR-GAL4,UAS-Rac1W/+, results in rescued eye morphology. v. A wild-type eye of the longGMR-GAL4 promoter as a control. vi-viii. Overexpression of dlrrk-WT, dlrrk-3KD, or Clc alone with GMR-GAL4 as control, have no effect on eye morphology.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_1-A</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Live cell imaging reveals that expression of GFP‐KSHV‐TK, but not GFP induces contraction of HeLa cells (see Supplementary Movies S1 and S2). The time from the start of imaging is indicated above each panel, and the scale bars represent 18 μm. Quantification of GFP‐KSHV‐TK‐induced cell contraction. The graphs show cell area (μm2) of cells expressing the indicated protein, and error bars represent SEM from three independent experiments in which n = 224 for GFP and n = 203 for GFP‐KSHV‐TK. ***P 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_1-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Phase images taken from Supplementary Movie S3 illustrating GFP‐KSHV‐TK induced blebbing of contracted cells. The time from the start of imaging is indicated above each panel, and the scale bars represent 18 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_1-C</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Scanning electron microscopy of HeLa cells expressing GFP or GFP‐KSHV‐TK.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_1-D</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Immunofluorescence microscopy images illustrating the association of GFP‐KSHV‐TK, but not GFP, with actinstress fibres. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_2-A</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Co‐expression of GFP‐RhoN19 but not GFP inhibits RFP‐KSHV‐TK‐induced cell contraction. Graphs represent cell area (μm2) of KSHV‐TK, RhoN19 or KSHV‐TK and RhoN19 expressing cells. Error bars represent SEM from 3 independent experiments, n = 204 for KSHV‐TK, n = 223 for RhoN19 and n = 189 for KSHV‐TK and RhoN19.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_2-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B GFP‐KSHV‐TK‐induced cell contraction does not occur in cells treated with the ROCK and myosin II inhibitors Y‐27632 and blebbistatin, respectively. Error bars represent SEM from three independent experiments, n = 213 for DMSO, n = 189 for Y‐27632 and n = 245. ***P 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_2-C</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunoblot analysis of rhotekinpull‐down (P.D.) assays reveals that GFP‐KSHV‐TK increases the level of GTP‐bound RhoA (GTP‐RhoA). Actin is included as a loading control, and the input lysates are indicated.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_2-D</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D GFP‐KSHV‐TK but not GFP induces the loss of phosphotyrosine, phospho‐FAK Y925 and phospho‐paxillin Y31 epitopes from focal adhesions.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_3-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Immunoblot analysis of BHK cells infected with MuHV‐4 and MuHV‐4 [g‐KSHV‐TK] or uninfected cells using antibodies against phosphotyrosine (p‐Tyr), GFP, MuHV‐4 TK, ORF17 (capsid) and glycoprotein N.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_3-C</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunofluorescence microscopy analysis of MuHV‐4‐ and MuHV‐4 [g‐KSHV‐TK]‐infected cells with the indicated antibodies reveals GFP‐KSHV‐TK expressed in the context of lytic infection (MuHV‐4 [g‐KSHV‐TK]) induces the loss of phospho‐FAK Y925 and paxillin Y31 from focal adhesions. White arrowheads indicate examples of infected cells expressing GFP‐KSHV‐TK or GFP (indicating WT MuHV‐4 infection, BAC+ virus).</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_3-D</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Immunofluorescence microscopy analysis reveals that GFP‐KSHV‐TK expressed in the context of lytic infection (MuHV‐4 [g‐KSHV‐TK]) does not alter focal adhesion integrity (paxillin) in the presence of the ROCK inhibitor Y‐27632.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_3-E</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Immunofluorescence microscopy analysis of paxillin in the lytically induced rKSHV.219/Vero cell line in the presence or absence of Y‐27632.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_4-A</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Cellular localisation and immunoblot analysis of phosphotyrosine (upper panel) and GFP (lower panel) in cells expressing wild‐type or kinase‐dead GFP‐KSHV‐TK.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_4-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Scanning electron microscopy of HeLa cells expressing GFP or GFP‐KSHV‐TK‐DEAD.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_4-C</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunofluorescence microscopy analysis of HeLa cells expressing GFP‐KSHV‐TK‐DEAD (white arrowheads) with the indicated phospho antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_4-D</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Immunofluorescence microscopy images of the localisation of FAK and zyxin in HeLa cells expressing GFP‐KSHV‐TK‐DEAD (white arrowheads).</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_4-E</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Purified recombinant GST‐EBV‐TK, GST‐MuHV‐4-TK and GST‐KSHV‐TKimmunoblotted for phosphotyrosine and GST following a sequential dephosphorylation and kinase reaction.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_4-F</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Purified recombinant GST‐KSHV‐TK and GST‐KSHV‐TK‐KINASE‐DEAD immunoblotted for phosphotyrosine and GST.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_4-G</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Immunoblot analysis demonstrating that the N‐terminus of KSHV‐TK is only auto‐phosphorylated by the kinase domain in cis.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_5-A</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunoblot analysis of N‐terminal deletions of KSHV‐TK demonstrates that the first 100 amino acids are required for tyrosine phosphorylation.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_5-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Immunoblot analysis reveals that mutation of tyrosines 65, 85 and 120 ablates tyrosine phosphorylation of the KSHV‐TK.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_5-C-D</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 5-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C-E Immunofluorescence microscopy analysis with the indicated antibodies reveals that mutation of tyrosines 65, 85 and 120 to phenylalanine abrogates the ability of GFP‐KSHV‐TK to induce loss of phosphotyrosine epitopes, phospho‐paxillin and phospho‐FAK from focal adhesions.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_5-E</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>C-E Immunofluorescence microscopy analysis with the indicated antibodies reveals that mutation of tyrosines 65, 85 and 120 to phenylalanine abrogates the ability of GFP‐KSHV‐TK to induce loss of phosphotyrosine epitopes, phospho‐paxillin and phospho‐FAK from focal adhesions.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_5-F</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Immunoblot analysis of level of GTP‐bound and total RhoA in cells expressing the indicated GFP‐tagged KSHV‐TK proteins.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_5-G</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Immunofluorescence microscopy analysis reveals that localisation of paxillin at focal adhesions is unaffected by KSHV‐TK‐Y3F expressed in the context of lytic infection.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_6-A</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunoblot analysis reveals that GFP‐KSHV‐TK WT, Y2F and Y3F but not GFP‐KSHV‐TK‐DEAD associate with FAK.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_6-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B GFP‐KSHV‐TK does not displace paxillin or zyxin from focal adhesions (white arrowheads) or induce contraction in the absence of FAK. Scale bar, 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_6-C</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C GFP‐KSHV‐TK does not induce loss of zyxin and p‐Tyr from focal adhesions or contraction of HeLa cells depleted of paxillin. Error bars represent SEM from three independent experiments, n = 196 for mock siRNA and n = 229 for paxillin siRNA; ***P 0.001. Scale bar, 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_7-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Immunoblot analysis of GFP antibody immunoprecipitates reveals that GFP‐KSHV‐TK but not Y2F or GFP associates with CrkI, II and L.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_7-C</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunofluorescence microscopy analysis reveals CrkII associates with GFP‐KSHV‐TK but not the Y2F mutant. Scale bars, 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_7-D</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Immunoblot analysis of RFP antibody immunoprecipitates reveals that RFP‐KSHV‐TK specifically associates with the SH2 domain of CrkII and CrkL.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_7-E</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Immunofluorescence microscopy analysis of phosphotyrosine epitopes in cells expressing GFP‐CrkII SH2, GFP‐CrkL SH2, RFP‐KSHV‐TK or a combination of CrkII/LSH2 and RFP‐KSHV‐TK. Arrowheads represent contracted KSHV‐TK‐expressing cells. The SH2 domains of CrkII or L block KSHV‐TK‐induced cell rounding. Scale bars, 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_8-B</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Immunoblot analysis reveals that GFP‐KSHV‐TK WT and Y2F but not Y120F associate with p85 of PI3‐Kinase.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_8-C</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunoblot analysis of p85PI3‐Kinase antibody immunoprecipitates reveals that GFP‐KSHV‐TK and its Y2F mutant but not Y120F associate with p85 of PI3‐Kinase.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_8-D</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Immunoblot analysis of CrkII and CrkL antibody immunoprecipitates reveals that GFP‐KSHV‐TK and the p85PI3‐Kinase associate with CrkII and CrkL. No association is observed with the Y2F, Y3F or kinase‐dead TK.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_8-E</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Tyrosine phosphorylation of CrkII and CrkL is only upregulated in cells expressing GFP‐KSHV‐TK.</text>
    </passage>
  </document>
  <document>
    <id>4331000 Figure_8-F</id>
    <infon key="sourcedata_document">1816</infon>
    <infon key="doi">10.15252/embj.201490358</infon>
    <infon key="pmc_id">4331000</infon>
    <infon key="figure">Figure 8-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Immunoblot analysis reveals that recombinant His‐CrkII binds to and is phosphorylated by KSHV‐TK but not the Y2F or Y3F mutants.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_1-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>Heat map showing two distinct types of AR binding locations. Agonist (DHT) induced AR binding in 34,442 agonist‐responsive regions. Antagonist (bicalutamide and enzalutamide)‐enhanced AR recruitment in 3,292 antagonist‐responsive loci. The normalized average signal density of reads 2 is also shown for each condition.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_2-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A ARChIP‐exo defines four types of high‐confidence agonist‐liganded ARBEs. Numbers indicate motif counts. The first two columns of each ARBE panel show normalized tags distribution over ARBEs on the forward (blue) and reverse (red) strands, separately. Forward strand refers to the motif‐containing strand. The aggregated tag density is shown at the top of the raw signal plots. The third column of each ARBE panel represents the bound motif sequences ordered as in the left two columns.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B ARBE reporter constructs were transiently transfected into LNCaP cells. Cells were stimulated with DHT (100 nM), a synthetic androgen R1881 (10 nM), or vehicle for 16-24 h, and luciferase activities were measured. The results were presented as the mean ± SD of the quadruplicate transfections. The genomic positions of ARBEs are also shown.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-C</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C UCSC genome browser showing signals on ChIP‐exo defined TMPRSS2 −13.5 kb enhancer ARBE.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Enhancer activity was compared between literature‐based ARE and Exo‐defined ARBE in TMPRSS2 locus by reporter gene assay.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E ARBE2 and ARBE4 were validated in TMPRSS2 enhancer through WT or Mut construct transfections. The results were presented as the mean ± SD of the quadruplicate transfections.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_3-F</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Two ARBE1 regions were changed to ARBE2, ARBE3, or ARBE4 through mutations at nucleotide 5 and/or 6. Cells were stimulated with DHT (100 nM), R1881 (10 nM), or vehicle for 16-24 h, and luciferase activities were measured. The results were presented as the mean ± SD of the quadruplicate transfections. The genomic positions of ARBEs are also shown.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_4-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Aggregated sequencing tag distribution of ARChIP‐exo and H3K4me2 MNaseChIP‐seq around the four precisely defined ARBEs. ChIP‐exo density plot is shown as forward (blue) and reverse (red) strands, respectively. H3K4me2 signal is shown in green. The window indicates ± 500 bp regions from the ARBE motif (0).</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_4-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Partitional clustering of the 4 types of ARBE locations based on dynamic signal shifting of H3K4me2 affected by DHT treatment.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_4-F</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F SNP frequency comparison between each type of ARBE and whole‐genome control. **P  1E‐8, *P  1E‐5.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Heat map showing raw tags distribution over the four types of agonist‐responsive ARBEs in LNCaP cells treated with vehicle, bicalutamide (10 μM), bicalutamide plus DHT (10 nM), enzalutamide (10 μM), or enzalutamide plus DHT (10 nM). The order of sequences in each type of ARBE is the same as the order of sequences shown in Fig A.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B UCSC genome browser views of sequencing data at KLK3 locus under different conditions.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-C</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Regular ChIP analysis of AR on KLK3 enhancer. LNCaP cells were treated with or without agonist and antagonist for 4 h. The data are presented as the fold enrichment over IgG (mean ± SD, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Quantitative RT‐PCR was performed to assess KLK3 mRNA levels under agonist or antagonist treatments. The data are the mean of triplicates ± SD.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_5-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Eight agonist‐responsive ARBE reporter constructs used in Fig B were transiently transfected into LNCaP cells. Cells were stimulated with vehicle, DHT (100 nM), bicalutamide (10 μM), bicalutamide plus DHT, enzalutamide (10 μM), or enzalutamide plus DHT for 16-24 h, and luciferase activities were measured. The results are presented as the mean ± SD of the quadruplicate transfections.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Heat map showing the signal intensity of AR binding in LNCaP cells treated with DHT, bicalutamide, and enzalutamide, respectively. Numbers indicate the antagonist‐responsive AR locations in each category.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Clustering of the antagonist‐responsive AR locations based on dynamic signal shifting of H3K4me2 affected by DHT treatment.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-C</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C The aggregated tag density is shown on the forward (blue) and reverse (red) strands, separately. The bottom panel represents the bound motif sequences found in the antagonist‐responsive AR locations. Antagonist‐liganded ARBE is also shown.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D EMSA was performed to validate specific AR binding to antagonist‐liganded ARBEs. Biotin‐labeled wild‐type (WT) or mutated (Mut) probes were incubated with same amounts of nuclear extract from LNCaP cells treated with bicalutamide or enzalutamide. Arrow indicates the position of the shifted specific probe. Four probes (M1-M4) were randomly selected. Quantification of EMSA gel bands shows that antagonists increase the in vitro binding to 1.7-3.8‐fold compared to the vehicle.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Top panel represents overlap between genes within 20 kb of the bicalutamide‐responsive AR locations and enzalutamide‐responsive AR locations. Bottom panel indicates microarray analysis of genes around enzalutamide‐responsive AR locations following treatment with DHT or enzalutamide in LNCaP cells.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-F</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F UCSC genome browser views of sequencing data at CPEB4 locus under different conditions. The blue region represents antagonist‐responsive AR location, while the two pink regions indicate agonist‐responsive AR locations.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-G</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>G ARChIP‐exo library validation on antagonist‐responsive and agonist‐responsive AR locations referred to (F). The data are the mean of triplicates ± SD.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-H</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>H mRNA levels of CPEB4 were examined in cells treated with or without DHT and enzalutamide. The data are the mean of triplicates ± SD.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_6-I</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 6-I</infon>
    <infon key="sourcedata_figure_dir">Figure_6-I</infon>
    <passage>
      <offset>0</offset>
      <text>I Silencing of CPEB4 enhanced the inhibitory effects of enzalutamide in LNCaP cells. LNCaP cells were transfected with a control siRNA or siCPEB4. Cells were then treated with vehicle or 1 μM enzalutamide, and cell numbers were determined on day 3 with a direct viable cell count assay. The data are the mean of triplicates ± SD.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-A</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunohistochemistry (IHC) detection of AR in four malignant prostatetumors and two paired NATs. Representative microphotographs of HE staining showed normal prostatic gland (NATs) and poorly differentiated adenocarcinoma cells. IHC analysis indicated heterogeneous AR expression among patients. Magnification, 40×. N1a and M3a were collected from the same patient ((Supplementary Table S5). N2b and M4b were gathered from another patient ((Supplementary Table S5).</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-B</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Tissue ARChIP‐exo raw signal intensity showing 1,715 enhanced AR binding locations in malignant prostatetumors (M) compared to NATs (N). ChIP‐exo data of LNCaP (+DHT) is plotted around the same locations.</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-D</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Oncomine analysis showing median rank for genes in the PROSTATIC NEOPLASMS network across 16 analyses of overexpression in prostate cancer (PCa) versus normal. The right column represents fold change in gene expression detected by RNA‐seq in the LNCaP cell line after DHT treatment (Log2 FC DHT/Vehicle, P  0.01).</text>
    </passage>
  </document>
  <document>
    <id>4331004 Figure_7-E</id>
    <infon key="sourcedata_document">1815</infon>
    <infon key="doi">10.15252/embj.201490306</infon>
    <infon key="pmc_id">4331004</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Survival curves were generated based on Kaplan-Meier analysis. For each of the four clinical datasets, up to one‐third of genes in the PROSTATIC NEOPLASMS network was selected based on gene expression level. These genes were then used to stratify patients. The P‐values were calculated by log‐rank test.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_1-A</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Statistical analysis of NFATc1 expression with respect to tumor grading in KPCmice tissues.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_1-B</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Immunohistochemistry detection of NFATc1 and p53, illustrating G1‐G2 and G3 in human PDAC tissues. Scale bars, 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_1-C</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Statistical illustration of TMA analysis demonstrating NFATc1 strong nuclear positive tumors (n = 161 patients) with respect to functional status of p53 expression in human PDAC tissues.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_1-D-E</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D Representative H&amp;E‐stained sections as well as immunohistochemistry detection of HA‐NFATc1 and p53 in well‐ and poorly differentiated pancreatic tissues of KNCmice. Scale bars, 100 μm. E Quantification of p53 expression with respect to the tumor grading by evaluating both the intensity of immunostaining and the number of cells with overexpression by means of an immunoreactivity score (IRS) in KNCmice (every dot represents one mouse).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_1-F</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Incidence of livermetastases in KNCmice (mean values ± SD).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_2-A</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Genome‐wide expression and GSEA analysis show p53‐enriched signatures with "EMT" and "stem cell transcript" in KNCtumor cells.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_2-B</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Heat map showing p53‐dependent regulation of "EMT"‐ and "stemness"‐related genes in KNCtumor cells. Fold change relative to control cells is displayed in a green red color scheme for selected genes with FClog2 1.0 or FClog2 &gt; −1.0.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_2-C</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Statistical analysis of wound healing assay performed in primary KNCtumor cells following p53 depletion. Time‐lapse analyzer software was used to quantify the wound closure rate. Means ± SD are shown from one out of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_2-D</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Western blot analysis revealing protein expression levels upon p53 depletion in KNCtumor cells.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_2-E</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E X‐fold mRNA expression of EMT‐related marker genes after p53 depletion in KNCtumor cells. Means ± SD from at least three independent experiments are shown. Asterisks display significance (*P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_2-F</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Representative protein expression of EMT inducers in pancreatic lysates prepared from KNCmice with different tumor gradings.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_3-A</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Kaplan-Meier curves showing survival of KNC, KPNC, and KPΔNC mice under the control of p48‐Cre pancreas‐specific promoters (P 0.0001 for KPNC or KPΔNC cohorts versus KNC, log‐rank test, for pairwise combination).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_3-B</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Pathological features of KPNC and KP∆NC mice before tumor extraction. Pancreatic tissue is encircled.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_3-C-D</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D HE and corresponding immunohistochemistry stainings of (C) KPNC and (D) KP∆NCmousetumors. Scale bars, 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_3-E</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Tumor grading of PDAC from KPNCmice (n = 10).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_4-A</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Quantitative RT‐PCR analysis of EMT‐related markers obtained from tumors derived from mice of the indicated genotypes (n = 3, means ± SD).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_4-B</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Relative mRNA expression of NFATc1‐ and EMT‐related marker genes on administration of CsA (1 μM) in KPNC cells. Data represents means ± SD from at least three independent experiments. Asterisks show significance (*P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_4-C</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Western blot analysis revealing protein expression levels in KPNC cells from the indicated proteins following transfection of siRNA control or siRNA toward NFATc1, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-A</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Sox2mRNA expression of pancreatic lysates from KNC, KPNC, and KPCmice, analyzed by real‐time PCR in three independent experiments (means ± SD).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-B-C</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Western blot analysis shows Sox2 expression in pancreatic lysates of (B) KNCmice with indicated tumor grading and in (C) KPNC and KPCmice.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-D</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Protein expression levels after siRNA‐mediated p53 depletion in KNCtumor cells.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-E-F</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F NFATc1 and Sox2 protein expression after (E) NFATc1 depletion or (F) upon CsA (1 μM, 24 h) treatment in Panc1 cells.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-G</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Sox2 and E‐cadherinmRNA expression after NFATc1 depletion in L3.6 cells.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-I</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>I, J ChIP assays show NFATc1 binding to Sox2 enhancer and promoter in KNCtumor cells (I)</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-J</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J</infon>
    <passage>
      <offset>0</offset>
      <text>I, J ChIP assays show RNA polymerase II binding to Sox2 promoter upon CsA (1 μM, 24 h) treatment in L3.6 cells (J).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-K</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-K</infon>
    <infon key="sourcedata_figure_dir">Figure_5-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Co‐immunoprecipitation of endogenous HA‐NFATc1 and Sox2 was performed in KPNC cells.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-L</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-L</infon>
    <infon key="sourcedata_figure_dir">Figure_5-L</infon>
    <passage>
      <offset>0</offset>
      <text>L ChIP experiments show NFATc1 binding along with H3K27 acetylation (H3K27ac) mark at the selected Snai1 enhancer region and RNA polymerase II binding at Snai1 promoter in the presence or absence of Sox2 in KPNCtumor cells. Representative results from at least three independent experiments are shown (means ± SD; P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-M</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-M</infon>
    <infon key="sourcedata_figure_dir">Figure_5-M</infon>
    <passage>
      <offset>0</offset>
      <text>M Relative mRNA expression levels of EMT‐related marker genes upon Sox2 depletion in KPNCtumor cells (P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_5-N</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 5-N</infon>
    <infon key="sourcedata_figure_dir">Figure_5-N</infon>
    <passage>
      <offset>0</offset>
      <text>N Zeb1 and SnailmRNA levels in L3.6 cells after shRNA‐mediated depletion of Sox2 and transient overexpression of NFATc1 shows that loss of Sox2 significantly rescues NFATc1‐mediated induction of EMT genes (*P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_6-A</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A NFATc1 and Sox2 protein expression in L3.6 cells (adherent versus spheres).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_6-B</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Relative mRNA expression of NFATc1 and Sox2 in L3.6 cells as well as in KPNCmicetumor cells (adherent versus spheres). Graph represents data from three independent experiments (means ± SD). Asterisks display significance (*P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_6-C</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Cell sorting was performed to collect CD44 high and low populations in KPNC spheres (left panel), which were analyzed for NFATc1 and Sox2 mRNA expression (right panel).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_6-D</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Sox2 mRNA expression upon CsA (1 μM) treatment in L3.6 cells (adherent versus spheres) (*P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_6-E</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Bright‐field light microscopy images as well as quantification of KPNC spheres after transient NFATc1 depletion.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-A</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Expression analysis of indicated miRNAs upon adenoviral re‐expression of p53 in KPΔNC tumor cells, detected by real‐time PCR (P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-B</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Protein expression of EMT marker genes after adenoviral re‐expression of GFP‐tagged p53 in KPΔNC tumor cells.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-C</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Protein (C) expression levels of EMT and stemness marker genes upon miRNA‐34a and miRNA‐200c overexpression using specific mimics in KPNCtumor cells. Representative results from at least three independent experiments are shown (means ± SD; P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-D</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D mRNA (D) expression levels of EMT and stemness marker genes upon miRNA‐34a and miRNA‐200c overexpression using specific mimics in KPNCtumor cells. Representative results from at least three independent experiments are shown (means ± SD; P 0.05).</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-E</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Western blot analysis of EMT marker expression in KNC cells following depletion of miR‐200c.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-F</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>F ChIP experiments showing NFATc1 binding along with H3K27 acetylation mark at the selected Snai1 enhancer region as well as Sox2 and RNA polymerase II binding at Snai1 promoter after miR‐200c overexpression in KPNCtumor cells. Means ± SD are shown from one out of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-G</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-G</infon>
    <passage>
      <offset>0</offset>
      <text>G ChIP analysis in KP∆NCtumor cells after adenoviralGFP‐tagged p53 overexpression. NFATc1 and H3K27ac binding are illustrated on Snai1 enhancer, and Sox2 and RNA polymerase II binding are demonstrated on Snai1 promoter. Means ± SD are shown from one out of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4331005 Figure_7-H</id>
    <infon key="sourcedata_document">1809</infon>
    <infon key="doi">10.15252/embj.201489574</infon>
    <infon key="pmc_id">4331005</infon>
    <infon key="figure">Figure 7-H</infon>
    <infon key="sourcedata_figure_dir">Figure_7-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Quantification of KP∆NC tumour cell-derived spheres after adenoviralGFP‐tagged p53 overexpression.</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_2-B</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>Experimental validation for CCA1 regulation of the flowering pathway. ChIP data showing CCA1 enrichment in regions containing CCA1 elements (CBS or EE; white bars) in GI, FKF1 and CDF1 promoters, compared to regions of their respective exons (dark bars). Locations of primers for GI (GI-a, GI-N), FKF1 (FKF1-a, FKF1-N) and CDF1 (CDF1-a, CDF1-N) are shown in Supplementary Fig S3. Seedlings were grown for 14 days 12L:12D cycles at 22°C and harvested at ZT2. Statistical analysis performed using Welch tests, *P &lt; 0.005. Error bars represent standard error of technical replicates.</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_2-C-D</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>CDF1 mRNA in LDs (C) and FKF1 mRNA in SDs (D), from WT (data: black lines, filled squares; simulation: black lines), and the cca1;lhy mutant (data: green lines, open circles; simulation: dashed green lines) (data sets used for parameter optimisation).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_2-E-F</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 2-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>CDF1 (E) and FKF1 (F) mRNA data in LDs, from WT (as in C, D) and the prr9;7 mutant (blue-green line, open circles).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_2-G-H</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 2-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>CDF1 (G) and FKF1 (H) mRNA simulations in LDs, from WT (as in C, D) and the prr9;7 mutant (dashed blue-green line).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_3-B</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>CDF1 protein data and simulations in a 35S:3HA-CDF1 line (CDF1ox; black lines, open squares) and 35S:HA-CDF1;fkf1 mutant (CDF1ox;fkf1; blue lines, open squares) in LDs. Data from Imaizumi et al (2005).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_3-C</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>CDF1 protein data and simulations in a 35S:HA-CDF1 line (CDF1ox; as in B) and 35S:HA-CDF1;gi-2 mutant (CDF1ox;gi; red lines, open squares) in LDs. Plants were grown for 10 days in 16L:8D cycles.</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_3-D-E</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 3-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>CO data and simulations in 16L:8D in WT (data: black lines, filled squares; simulation: black lines), the gi-2 mutant (data: red lines, open circles; simulation: dashed red lines) and fkf1 mutants (data: blue lines, open circles; simulation: dashed blue lines). Data from Sawa et al (2007).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_3-F-G</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 3-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>CO and FT mRNA data and simulations in LDs in WT (as in D, E) and the prr9;7 mutant (data: blue-green lines, open circles; simulation: dashed blue-green lines). Data from Nakamichi et al (2007).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_3-H-I</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 3-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>CO and FT mRNA data and simulations in 10L:14D in WT (as in D) and the cca1;lhy mutant (data: green lines, open circles; simulation: dashed green lines). Data from Nakamichi et al (2007).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_4-B-D</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 4-B-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-D</infon>
    <passage>
      <offset>0</offset>
      <text>PIF4, IAA29 and ATHB2 mRNA levels in SDs in WT (data: black lines, filled squares; simulation: black lines).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_4-H</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>ATHB2 mRNA at dawn (ZT0) across a range of photoperiods. Data from Kunihiro et al (2011).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_4-I-L</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 4-I-L</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I-L</infon>
    <passage>
      <offset>0</offset>
      <text>Comparison of model simulations with microarray time course data from the two largest clusters of PIF-induced targets (Cluster 1: 107 genes, Cluster 2: 84 genes), in SDs (I, K) and LDs (J, L) [data from Michael et al (2008b)].</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_5-C</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>Using FTAREA values, the number of days to flower was calculated and compared to data from Corbesier et al (1996) (see Supplementary Information). Error bars represent standard deviation. Simulated flowering: solid black line, filled squares; data: dashed black lines, empty squares.</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_5-D</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>Same as in (C) using ATHB2AREA to calculate hypocotyl length. Data taken from Kunihiro et al (2011) (error bars were unavailable).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_6-B-E</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 6-B-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-E</infon>
    <passage>
      <offset>0</offset>
      <text>Comparison of data and model simulations for temperature response of PIF4 (B, C) and ATHB2 (D, E) mRNA in LDs (16L:8D) in the WT. Data from Nomoto et al (2012a) were normalised such that data and simulation have equal peaks at 28°C (22°C data: black lines, filled squares; 22°C simulation: black lines; 28°C data: red lines, filled squares; 28°C simulation: red lines).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_6-F</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>CO mRNA data in LDs in WT and the pif4;pif5 mutant at 22 and 27°C (WT 22°C data/simulation: as in (B-E); pif4;pif5 22°C data: dashed black lines, open squares; WT 27°C data: red lines, filled circles; pif4;pif5 27°C data: dashed red lines, open circles).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_6-G</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>CO protein data in LDs (16L:8D) in WT at 22 and 27°C (as in F).</text>
    </passage>
  </document>
  <document>
    <id>4332151 Figure_6-H</id>
    <infon key="sourcedata_document">1475</infon>
    <infon key="doi">10.15252/msb.20145766</infon>
    <infon key="pmc_id">4332151</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>FT mRNA data in LDs in WT and the pif4;pif5 mutant at 22 and 27°C (as in F)</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_1-D</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>Colony formation assay of miRNA mimic transfected-Dgcr8-/- ESCs. There were 17 miRNAs that decreased the colony forming ability, 15 miRNAs that did not affect colony formation and 8 miRNAs enhanced colony formation of ESCs. Representative pictures are shown. Full data are shown in Supplementary Fig S1.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="59" length="4"/>
        <text>ESCs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="218" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_2-A</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Alkaline phosphatase staining of ESCs after miRNA mimic transfection. There were 21 miRNAs that decreased the AP activity, 11 miRNAs that mildly affected the AP activity and 8 miRNAs boosted the AP activity of ESCs. Representative pictures are shown. Full data are shown in Supplementary Fig S2.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">7</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="33" length="4"/>
        <text>ESCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">11</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="210" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_2-B</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>Cell cycle distribution in representative miRNAs evoking G1 phase accumulation in miRNA mimic transfected Dgcr8-/- ESCs. Error bars indicate s. d. (n=3). Full data are shown in Supplementary Fig S3A, B.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">14</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="115" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_2-D</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>Immunofluorescence staining of Oct4 in miRNA mimic transfected ESCs. 20 miRNAs decreased Oct4 expression and produced small and grossly differentiated cell colonies, 12 miRNAs mildly affected Oct4 expression, and 8 miRNAs improved Oct4 expression and yielded compact and undifferentiated cell colonies. Representative pictures are shown. Full data are shown in Supplementary Fig S3C.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="63" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_2-F</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>AP staining of V6.5ESCs after mimic transfection (Full data are shown in Supplementary Fig S4B).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">24</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="19" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_3-B-C</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B,C. Northern blot analysis of the expression of miR-23a, miR-27a and miR-24 during EB formation (B) and RA induced differentiation of V6.5ESCs (C). The heatmap was representive of the results of quantitative analysis.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">40</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="139" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_3-D</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D,E. The expression of primary miR-23a~27a~24-2 transcript during EB formation (D) and RA induced differentiation (E). Error bars indicate s.d. (n=3).</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_3-E</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>D,E. The expression of primary miR-23a~27a~24-2 transcript during EB formation (D) and RA induced differentiation (E). Error bars indicate s.d. (n=3).</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_3-F</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Q-PCR analysis of miR-23a, miR-27a and miR-24 expression in ESCs (JM8A3) and a variety of C57BL/6J adult tissues. Data are shown as mean + s.d. (n=3).</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">73</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="63" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_3-G</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Relative protein levels of Oct4, Sox2 and Nanog in miRNA mimic transfected Dgcr8-/- ESCs and wild- type ESCs.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">93</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="87" length="4"/>
        <text>ESCs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">94</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="107" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_3-H-I</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 3-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>H,I. Oct4, Nanog, Foxa2, Gata2 and Nestinimmunofluorescence staining of mimic transfected Dgcr8-/- (H) and wild- type ESCs (I).</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="118" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-B</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis of the expression of target genes in miR-27a or miR-24 over-expressed V6.5ESCs. Candidate target genes whose expression was decreased were framed.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">117</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="96" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-C</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>The relative luciferase activity of the reporter constructs co-transfected with scramble or miR-27a and miR-24 mimics. Error bars indicate s.d. (n=3); * indicates P-value &lt; 0.05. Candidate target genes whose luciferase activity was decreased were framed. PC group was positive reporter control which harbored reverse complementary sequence of miR-27a or miR-24.</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-D</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>The relative luciferase activity of the wild-type 3′ UTR or mutated 3′ UTR reporter co-transfected with scramble or miR-27a and miR-24 mimics. Data are shown as mean + s.d. (n=3); * indicates P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-F-G</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F,G RT-PCR and qRT-PCR analysis of in vivo binding of the miRNAs with their targets. Error bars indicate s.d. (n=3); * indicates P-value &lt; 0.05; ** indicates P-value &lt; 0.01; *** indicates P-value &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-H</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. Western blot analysis of c-Myc expression in siRNA treated V6.5ESCs.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">177</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="66" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-I</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I</infon>
    <passage>
      <offset>0</offset>
      <text>I. Q-PCR analysis of primary-23a~27a~24-2, miR-23a, miR-27a and miR-24 expression in c-Myc knocked down ESCs. Error bars indicate s.d. (n=3); * indicates P-value &lt; 0.05; ** indicates P-value &lt; 0.01; *** indicates P-value &lt; 0.001.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">185</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="104" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-K</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-K</infon>
    <infon key="sourcedata_figure_dir">Figure_4-K</infon>
    <passage>
      <offset>0</offset>
      <text>K. ChIP-PCR and ChIP-q-PCR analysis of c-Myc binding to the putative sites in the promoter. Error bars indicate s.d. (n=3); *** indicates P-value &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-L</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-L</infon>
    <infon key="sourcedata_figure_dir">Figure_4-L</infon>
    <passage>
      <offset>0</offset>
      <text>L. Relative luciferase activity of the wild-type and -15 binding site mutated promoter in NIH3T3 cells co-transfected with c-Myc or the blank vector (NC). Error bars indicate s.d. (n=3); * indicates P-value &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_4-M</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 4-M</infon>
    <infon key="sourcedata_figure_dir">Figure_4-M</infon>
    <passage>
      <offset>0</offset>
      <text>M. Relative luciferase activity of wild-type and -15 binding site mutated promoter in V6.5ESCs. Error bars indicate s.d. (n=3); * indicates P-value &lt; 0.05.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">204</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="90" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-B</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>Validation of the effect of miRNA inhibition in MEFs by q-PCR. Error bars indicate s.d. (n=3).</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-C</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>AP staining of the iPSC colonies in reprogramming with OSK combined with scramble control, inhibitors of miR-23a, miR-27a, miR-24 and let-7c respectively.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">223</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="19" length="4"/>
        <text>iPSC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-D</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>Fold increase in Oct4-GFP-positive cell colonies in the above cells. Data are shown as mean + s.d. (n=5); ** indicates P-value &lt; 0.01; *** indicates P-value &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-E</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>Morphology of typical Oct4-GFP-positive iPSC colonies that were reprogrammed by OSK combined with miRNA inhibitors.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">263</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="40" length="4"/>
        <text>iPSC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-F</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>Detection of endogenous and exogenous Oct4, Sox2, Klf4 and Nanog expression in iPSCs, ESCs and MEFs by RT-PCR.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">280</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="79" length="5"/>
        <text>iPSCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">278</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="86" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-H</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>Immunofluorescencestaining of Oct4, Nanog and SSEA1 of the iPSC colonies.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">285</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="59" length="4"/>
        <text>iPSC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-I</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>Q-PCR analysis of the expression of self-renewal (Oct4, Sox2, Nanog) and differentiation (Cdx2, Foxa2, Brachyury, Hand1, Nestin, FGF5) relative markers in EBs derived from the iPSCs. Error bars indicate s.d. (n=3).</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">300</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="176" length="5"/>
        <text>iPSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_5-J</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 5-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J</infon>
    <passage>
      <offset>0</offset>
      <text>Hematoxylin and eosin staining of teratoma derived from the iPSC colonies. Neuronal rosette(Ectoderm), Cartilage (Mesoderm) and respiratory epithelium (Endoderm) are marked with black arrows.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">311</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="60" length="4"/>
        <text>iPSC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_6-C</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>Genomic PCR of the specific fragments spanning miR-23~27~24 clusters. WT indicate wild-type ESCs; DKO indicate miR-23a~27a~24-2-/-, miR-23b~27b~24-1-/- ESCs; KO indicate miR-23a~27a~24-2-/- ESCs.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">316</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="92" length="4"/>
        <text>ESCs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">318</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="152" length="4"/>
        <text>ESCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">320</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="190" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_6-D</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR analysis of mature miR-23a/b, miR-27a/b and miR-24 expression in wild-type, DKO and KO ESCs. Data are shown as mean + s.d. (n=3).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">330</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="101" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_6-E</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>AP staining of wild-type and miR-23~27~24 cluster knockout ESCs.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">336</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="59" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_6-F</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR analysis of Oct4, Sox2 and Nanog expression in wild-type and miR-23~27~24 cluster knockout ESCs. Data are shown as mean + s.d. (n=3).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">349</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="105" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_6-G</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>Oct4, Sox2 and Nanogimmunofluorescencestaining of wild-type and the knockout ESCs.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">359</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="77" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-A</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR analysis of Oct4 and several lineage differentiation markers expression during EB formation of wild-type and knockout ESCs. Data are shown as mean ± s.d. (n=3).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">371</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="132" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-B</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>Beating EB incidence during cardiac differentiation of wild-type and knockout ESCs. Data are shown as mean + s.d. (n=3). * indicates P-value &lt; 0.05; ** indicates P-value &lt; 0.01; *** indicates P-value &lt; 0.001.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">391</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="78" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-C</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR analysis of several cardiac markers expression during cardiac differentiation of wild-type and knockout ESCs. Data are shown as mean ± s.d. (n=3).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">401</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="118" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-D</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>Actinin, ANP and Troponin Iimmunofluorescence staining of differentiation cultures derived from wild-type and knockout ESCs.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">419</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="119" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-E</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>Volumes of teratomas at different days after injection. Data are shown as mean + s.d. (n=4). * indicates P-value &lt; 0.05; ** indicates P-value &lt; 0.01; *** indicates P-value &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-F</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>Weight of teratomas derived from wild-type and knockout ESCs. Data are shown as mean ± s.d. ** indicates P-value &lt; 0.01.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">438</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="56" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-G</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-G</infon>
    <passage>
      <offset>0</offset>
      <text>Oct4immunohistochemistrystaining of teratomas derived from wild-type and knockout ESCs. Representative Oct4 positive regions are shown.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">449</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="82" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339122 Figure_7-H</id>
    <infon key="sourcedata_document">1676</infon>
    <infon key="doi">10.15252/embj.201489957</infon>
    <infon key="pmc_id">4339122</infon>
    <infon key="figure">Figure 7-H</infon>
    <infon key="sourcedata_figure_dir">Figure_7-H</infon>
    <passage>
      <offset>0</offset>
      <text>Hematoxylin and eosin staining of teratomas derived from wild-type and knockout ESCs. Ectoderm, Mesoderm and Endoderm are marked with different color arrows.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">458</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="80" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_1-A</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immortalized Brca1F/−MEFs were infected with retroviruses expressing the indicated shRNAs and/or Cre recombinase, followed by selection with puromycin for 72 h. Cell extracts were prepared 48 h later and analysed by Western blotting as indicated. SMC1 and tubulin were used as loading controls. *non‐specific band.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_1-B-C</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 1-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B Cells treated as in (A) were fixed 48 h after selection and stained with an anti‐53BP1 antibody (green). Telomeres were visualized with a Cy3‐conjugated (CCCTAA)3‐PNA probe (red). Yellow arrowheads point to 53BP1 foci that co‐localize with telomeres. C Quantification of TIFs in cells treated as in (B). A minimum of 200 nuclei were scored for each sample. Error bars represent SD of two independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. *P ≤ 0.05; NS, P &gt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_2-A</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immortalized Brca1F/−MEFs were infected with retroviruses expressing the indicated shRNAs and/or Cre recombinase, followed by selection with puromycin for 72 h. Cells were arrested in mitosis with colcemid and mitotic chromosomes were processed for CO‐FISH analysis. Metaphase chromosome spreads were stained with Cy3‐conjugated leading strand telomeric PNA probe (red) and FITC‐conjugated lagging strand telomeric PNA probe (green). DNA was counter‐stained with DAPI (blue). B The frequency of chromosome‐type telomeric fusions in cells treated as in (A) was quantified as a percentage of total number of chromosomes (illustrated in Supplementary Fig S2A). A minimum of 2,000 chromosomes were scored for each treatment. Error bars represent SD of at least two independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. *P ≤ 0.05; **P ≤ 0.01; NS, P &gt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_3-A</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immortalized Brca1F/−MEFs were infected with retroviruses expressing the indicated shRNAs and/or Cre recombinase, followed by selection with puromycin for 72 h. Mitotic chromosomes isolated 48 h later were fixed and stained with a Cy3‐conjugated (CCCTAA)3‐PNA probe. The frequency of end‐to‐end chromosome‐type fusions is represented as a percentage of fusions observed after TRF2 depletion. A minimum of 2,000 chromosomes were scored for each sample. Error bars represent SD of three independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. NS, P &gt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_3-B</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Immortalized Brca1F/C61GMEFs were infected with retroviruses expressing the indicated shRNAs and/or Cre recombinase, followed by selection with puromycin for 72 h. The frequency of end‐to‐end chromosome‐type fusions was analysed as in (A).</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_3-C</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C-F MEFs of the indicated genotypes were infected with retroviruses expressing TRF2 and/or CtIP shRNAs, followed by selection with puromycin for 72 h. Cell extracts were prepared 48 h later and analysed by Western blotting as indicated. GAPDH was used as a loading control. *non‐specific band.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_3-D</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>C-F MEFs of the indicated genotypes were infected with retroviruses expressing TRF2 and/or CtIP shRNAs, followed by selection with puromycin for 72 h. Cells treated as in (C) and (E) were arrested in mitosis with colcemid, and mitotic chromosomes isolated 48 h later were fixed and stained with a Cy3‐conjugated (CCCTAA)3‐PNA probe (D, F). The frequency of end‐to‐end chromosome‐type fusions is represented as a percentage of fusions observed after TRF2 depletion. Error bars represent SD of two independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. *P ≤ 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_3-E</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>C-F MEFs of the indicated genotypes were infected with retroviruses expressing TRF2 and/or CtIP shRNAs, followed by selection with puromycin for 72 h. Cell extracts were prepared 48 h later and analysed by Western blotting as indicated. GAPDH was used as a loading control. *non‐specific band.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_3-F</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>C-F MEFs of the indicated genotypes were infected with retroviruses expressing TRF2 and/or CtIP shRNAs, followed by selection with puromycin for 72 h. Cells treated as in (C) and (E) were arrested in mitosis with colcemid, and mitotic chromosomes isolated 48 h later were fixed and stained with a Cy3‐conjugated (CCCTAA)3‐PNA probe (D, F). The frequency of end‐to‐end chromosome‐type fusions is represented as a percentage of fusions observed after TRF2 depletion. Error bars represent SD of two independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. *P ≤ 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_4-A-B</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Immortalized MEFs were infected with retroviruses expressing the indicated shRNAs, followed by selection with puromycin for 72 h. Cell extracts were prepared 48 h later and analysed by Western blotting as indicated. SMC1 was used as a loading control. *non‐specific band. B Quantification of the frequency of end‐to‐end chromosome‐type fusions of cells treated as in (A) represented as a percentage of fusions observed after TRF2 depletion. A minimum of 2,000 chromosomes were scored for each sample. Error bars represent SD of three independent experiments. The P‐value was calculated using an unpaired two‐tailed t‐test. NS, P &gt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_4-C</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>Immortalized Brca1F/− MEFs were infected with retroviruses expressing the indicated shRNAs and/or Cre recombinase. Mitotic chromosomes isolated 48 h later were fixed and stained with a Cy3‐conjugated (CCCTAA)3‐PNA probe. The frequency of end‐to‐end chromosome‐type fusions is represented as a percentage of fusions observed after TRF2 depletion. A minimum of 2,000 chromosomes were scored for each sample. Error bars represent SD of three independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. NS, P &gt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_4-D-E</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 4-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D Immortalized Brca1F/−MEFs were infected with retroviruses expressing TRF2 shRNAs and/or Cre recombinase, together with a lentivirus expressing PARP1 shRNA, followed by selection with puromycin for 72 h. Cell extracts were prepared 48 h later and analysed by Western blotting as indicated. SMC1 was used as a loading control. *non‐specific band. E Quantification of the frequency of end‐to‐end chromosome‐type fusions of cells treated as in (D) represented as a percentage of fusions observed after TRF2 depletion. A minimum of 1,500 chromosomes were scored for each sample. Error bars represent SD of three independent experiments. The P‐value was calculated using an unpaired two‐tailed t‐test. NS, P &gt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_5-A</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Immortalized MEFs were infected with retroviruses expressing the indicated shRNAs, followed by selection with puromycin for 72 h. Cell extracts were prepared 48 h later and analysed by Western blotting as indicated. SMC1 and GAPDH were used as loading controls. *non‐specific band.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_5-B</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B MboI‐ and AluI‐digested DNA from cells treated as in (A) was resolved by pulsed‐field gel electrophoresis and probed with end‐labelled (AACCCT)4 probe. Representative pulsed‐field gel samples run under native and denatured conditions are shown.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_5-C</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Quantification of the 3′ overhang in cells treated as in (B). For each sample, the ss/total DNA ratios were expressed relative to the GFP shRNA‐treated control. Error bars represent SD of two independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_6-A</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A-C MEFs of the indicated genotypes were infected with retroviruses expressing the indicated shRNAs, followed by selection with puromycin for 72 h. Mitotic chromosomes isolated 48 h later were fixed and stained with a Cy3‐conjugated (CCCTAA)3‐PNA probe. The frequency of end‐to‐end chromosome‐type fusions is represented as a percentage of fusions observed after TRF2 depletion in each experiment. A minimum of 1,200 chromosomes were scored for each sample. Error bars represent SD of two independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. *P ≤ 0.05; NS, P &gt; 0.05. Each graph represents a separate set of experiments.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_6-B</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>A-C MEFs of the indicated genotypes were infected with retroviruses expressing the indicated shRNAs, followed by selection with puromycin for 72 h. Mitotic chromosomes isolated 48 h later were fixed and stained with a Cy3‐conjugated (CCCTAA)3‐PNA probe. The frequency of end‐to‐end chromosome‐type fusions is represented as a percentage of fusions observed after TRF2 depletion in each experiment. A minimum of 1,200 chromosomes were scored for each sample. Error bars represent SD of two independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. *P ≤ 0.05; NS, P &gt; 0.05. Each graph represents a separate set of experiments.</text>
    </passage>
  </document>
  <document>
    <id>4339125 Figure_6-C</id>
    <infon key="sourcedata_document">1680</infon>
    <infon key="doi">10.15252/embj.201488947</infon>
    <infon key="pmc_id">4339125</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C MEFs of the indicated genotypes were infected with retroviruses expressing the indicated shRNAs, followed by selection with puromycin for 72 h. Mitotic chromosomes isolated 48 h later were fixed and stained with a Cy3‐conjugated (CCCTAA)3‐PNA probe. The frequency of end‐to‐end chromosome‐type fusions is represented as a percentage of fusions observed after TRF2 depletion in each experiment. A minimum of 1,200 chromosomes were scored for each sample. Error bars represent SD of two independent experiments. P‐values were calculated using an unpaired two‐tailed t‐test. *P ≤ 0.05; NS, P &gt; 0.05. Each graph represents a separate set of experiments.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_1-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A C57BL/6 WT or Rag2−/−mice were immunosuppressed with hydrocortisone +/− FK506 and infected with 105 AF CEA10 conidia intranasally. Mortality was assessed using a 20% weight loss endpoint. Mortality was significantly increased in FK506 immunosuppressed mice reaching 100% by day 10 p.i. (P = 0.003 for HC versus HC+FK506 in Rag2−/− using log-rank test, n = 10 per group).</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_1-B-C</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 1-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C PAS-stained lung sections of Rag2−/−mice were scanned and inflammation quantified by pixel intensity threshold analysis in ImageJ. FK506-treated animals had increased inflammation at day 2 p.i. compared to control. P = 0.0126 (using Student's t-test), n = 3-5 per group. (C) Close-up of an infectious focus showing increased inflammation and fungal growth in the FK506-treated group. Scale bar: 400 μm.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_1-D-E</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Murine macrophages (J774A.1) were pre-treated with hydrocortisone, and the effects of FK506 on nuclear shuttling of the glucocorticoid receptor were assessed by confocal immunofluorescence microscopy. The nuclei are indicated in red, and the GR is indicated in green. Scale bar: 50 μm. FK506 did not cause increased translocation of the glucocorticoid receptor. Data represent mean + SEM calculated from 10 fields of vision. One out of 2 experiments is shown.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_2-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Immunocompetent (IC) or FK506-treated (5 mg/kg/day) C57BL/6 WT mice were infected with AF CEA10 (1 × 107conidia/mouse) i.n. A Weight was monitored daily for 7 days p.i. Immunosuppressed mice showed increased weight loss through days 1-3 p.i. Data points represent mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_2-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>Immunocompetent (IC) or FK506-treated (5 mg/kg/day) C57BL/6 WT mice were infected with AF CEA10 (1 × 107conidia/mouse) i.n. B BALs were performed over a 3-day period p.i. and fungal killing assessed by enumerating CFUs. Fungal killing was significantly impaired in immunosuppressed mice. Error bars indicate SEM.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_2-C-D</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>Immunocompetent (IC) or FK506-treated (5 mg/kg/day) C57BL/6 WT mice were infected with AF CEA10 (1 × 107conidia/mouse) i.n. C, D Flow cytometry analysis of the CD45+leucocyte populations in BAL. Representative dot plots for CD45+ cells (C) and percentages of Ly-6G-positive neutrophils infiltrating the infected lungs over a 48-h p.i. time course (D). The bars indicate the mean percentage (± SEM) of neutrophils of total CD45+leucocytes (n = 5 mice per group). Neutrophil influx was significantly impaired in immunosuppressed mice at 6 h p.i.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">56</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="165" length="9"/>
        <text>leucocyte</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">58</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="274" length="11"/>
        <text>neutrophils</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">63</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="401" length="11"/>
        <text>neutrophils</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">60</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="427" length="10"/>
        <text>leucocytes</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">61</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="462" length="10"/>
        <text>Neutrophil</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_2-E</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>Immunocompetent (IC) or FK506-treated (5 mg/kg/day) C57BL/6 WT mice were infected with AF CEA10 (1 × 107conidia/mouse) i.n. E PAS-stained lung sections of immunocompetent and FK506-treated animals at 6 h p.i. Scale bar: 50 μm. IC animals showed inflammatory cell infiltrates around conidia (black arrows), whereas in FK506-treated animals, only uptake of conidia by the resident macrophage population could be seen.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">76</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="379" length="10"/>
        <text>macrophage</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_2-F</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>Immunocompetent (IC) or FK506-treated (5 mg/kg/day) C57BL/6 WT mice were infected with AF CEA10 (1 × 107conidia/mouse) i.n. F Tissue density of whole lung sections was quantified by pixel intensity analysis using ImageJ. Bars represent mean percentages (± SEM), n = 3.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_2-G</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>Immunocompetent (IC) or FK506-treated (5 mg/kg/day) C57BL/6 WT mice were infected with AF CEA10 (1 × 107conidia/mouse) i.n. G Luminex multiplex cytokine analysis of BAL SNs at 6 h p.i. Bars represent mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_3-A-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>At 2 days post-fertilization (dpf),Lyz:dsRed or mpx:GFPlarvae were transferred into DMSO ctrl or FK506 (1 μg/ml) containing 0.5 × E2. At 3 dpf, zebrafishlarvae were microinjected with AFeGFPconidia into the hindbrain and mortality, and fungal burden and neutrophil recruitment were assessed. A, B Absolute neutrophil numbers in treated and untreated mpx:GFPlarvae were quantified by direct counting of fluorescent neutrophils in non-infected whole fish (n = 11-13 per group). There were no significant differences.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">111</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="254" length="10"/>
        <text>neutrophil</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">113</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="306" length="10"/>
        <text>neutrophil</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="414" length="11"/>
        <text>neutrophils</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_3-C</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>At 2 days post-fertilization (dpf),Lyz:dsRed or mpx:GFPlarvae were transferred into DMSO ctrl or FK506 (1 μg/ml) containing 0.5 × E2. At 3 dpf, zebrafishlarvae were microinjected with AFeGFPconidia into the hindbrain and mortality, and fungal burden and neutrophil recruitment were assessed.   C For survival analysis, lyz:dsRedlarvae were microinjected with ˜10 conidia and the effects of FK506 on the outcome from invasive aspergillosis was determined by Kaplan-Meier analysis for survival over 6 days post-infection (n = 16 per group). Immunosuppression led to a significant increase in mortality.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_3-D</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>At 2 days post-fertilization (dpf),Lyz:dsRed or mpx:GFPlarvae were transferred into DMSO ctrl or FK506 (1 μg/ml) containing 0.5 × E2. At 3 dpf, zebrafishlarvae were microinjected with AFeGFPconidia into the hindbrain and mortality, and fungal burden and neutrophil recruitment were assessed. D TNF-α mRNA levels were measured in whole non-infected or infected larvae 48 h p.i. Immunosuppression led to significant and almost complete inhibition of TNF-α expression during infection.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_3-E-F-G</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 3-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>At 2 days post-fertilization (dpf),Lyz:dsRed or mpx:GFP larvae were transferred into DMSO ctrl or FK506 (1 μg/ml) containing 0.5 × E2. At 3 dpf, zebrafishlarvae were microinjected with AFeGFPconidia into the hindbrain and mortality, and fungal burden and neutrophil recruitment were assessed. E-G Lyz:dsRedlarvae were infected with ˜50 eGFP-expressing conidia of A. fumigatus and were imaged daily from 24 h p.i. (E) The effects of FK506 on neutrophil recruitment were assessed by integrated density analysis of red fluorescent neutrophils at sites of infection in ImageJ. A representative image showing impaired neutrophil recruitment to the site of infection in immunosuppressed larvae is shown (60 h p.i.). The arrows indicate infectious foci. (F) Neutrophil recruitment was minimal throughout the first 60 h p.i. in immunosuppressed larvae (n = 8 per group). (G) Fungal growth was determined by measurement of the length of individual fluorescent hyphal elements (n = 8 per group).</text>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">167</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="255" length="10"/>
        <text>neutrophil</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">176</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="441" length="10"/>
        <text>neutrophil</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">170</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="528" length="11"/>
        <text>neutrophils</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">21</infon>
        <infon key="sourcedata_article_annot_id">177</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="613" length="10"/>
        <text>neutrophil</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">172</infon>
        <infon key="identifier">CL:0000775</infon>
        <location offset="751" length="10"/>
        <text>Neutrophil</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_4-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A J774A.1 macrophages were treated with an increasing concentration of FK506 and stimulated with AF SC (MOI = 1), zymosan (50 μg/ml) or LPS (25 ng/ml) overnight. TNF-α was measured in the culture supernatant by ELISA. FK506 significantly reduced TNF-α levels at 5 and 10 ng/ml for AF. A significant reduction in TNF-α was also seen for zymosan, but not LPS.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_4-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B J774A.1 cells were treated with FK506 (10 ng/ml) and either left non-stimulated (NS) or stimulated with AF SC (MOI=1) for 6 h. TNF-α mRNA levels were quantified from whole-cell RNA extracts by RT-PCR. FK506 significantly reduced TNF-α expression.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_4-C</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C J774A.1 macrophages were treated with control (Ctrl.) or calcineurin A (CnA)-targeting siRNA (50 nM) and stimulated with either AF SC (MOI = 1), zymosan (50 μg/ml) or LPS (25 ng/ml) overnight. TNF-α was measured in the culture supernatant by ELISA. CnA siRNA led to significant reductions in both AF- and zymosan-dependent TNF-α levels, but had no significant effect on LPS responses.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_5-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A J774A.1macrophages were stimulated with live AF SC (MOI=5), and macrophage cytoplasmic and nuclear extracts were probed by Western blot for NFATc2. NFATc2 shuttling to the nucleus was observed and was maximal at 2 h p.i.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_5-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B J774A.1macrophages were stimulated with live or fixed swollen conidia (MOI = 5) or zymosan (50 μg/ml), and NFAT translocation was assessed by confocal microscopy. NFAT is indicated in green, the nuclei are indicated in red, and AFconidia can be seen in pink. Live conidia were observed to stimulate sustained nuclear translocation compared to dead conidia or zymosan. Data represent mean ± SEM. Scale bar: 50 μm. Arrows indicate A. fumigatus or zymosan-positive cells.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_5-C</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C J774A.1macrophages were stimulated with zymosan after FK506 (10 ng/ml) or control treatment, and macrophagenuclear extracts were probed by Western blot for NFATc2 and NF-κB translocation. NFATc2 and NF-κBnuclear translocation was observed, which was maximal at 1 h p.i., in stimulated macrophages. FK506 specifically inhibited NFATc2 translocation, but had no effect on NF-κB.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_5-D</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D J774A.1macrophages were pre-treated with FK506 (10 ng/ml) or vehicle and stimulated with live swollen conidia or zymosan. NFATc2 translocation was evaluated 30 min after stimulation. Box and whisker plot shows median ± maximum/minimum. Scale bar: 50 μm. FK506 completely inhibited nuclear translocation of NFATc2 in response to AF or zymosan. Statistical analysis was carried out by Student's t-test. NS, non-stimulated. Arrows indicate A. fumigatus or zymosan-positive cells.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A BMDMs from WT, Dectin-1−/− or MyD88−/−mice were infected with swollen conidia (MOI = 1), and TNF-α was measured in the SN after overnight incubation. TNF-α levels were significantly reduced in Dectin1−/− and Myd88−/−BMDMs.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">283</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="2" length="5"/>
        <text>BMDMs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">285</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="218" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B BMDMs were stimulated with swollen conidia (MOI = 5) or zymosan (50 μg/ml), and NFATc2 translocation was quantified by confocal microscopy 30 min after stimulation. Whilst almost complete abrogation of NFAT translocation was seen in Dectin1−/−macrophages stimulated with zymosan, NFAT responses to AF were unaffected.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">313</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="2" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-C</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C-E J774A.1macrophages were pre-treated with (C, D) the Syk inhibitor piceatannol or (E) a control or Syk-targeting siRNA (10 nM) before stimulation with swollen conidia (MOI = 1) or zymosan (50 μg/ml). (C) TNF-α was measured in the SN after overnight incubation. Syk inhibition significantly reduced swollen conidia-dependent or zymosan-dependent TNF-α levels.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-D</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>C-E J774A.1macrophages were pre-treated with (C, D) the Syk inhibitor piceatannol or (E) a control or Syk-targeting siRNA (10 nM) before stimulation with swollen conidia (MOI = 1) or zymosan (50 μg/ml). (D) NFATc2 translocation was quantified by confocal microscopy. Syk inhibition impaired zymosan-dependent NFAT translocation, but did not affect AF-dependent NFAT translocation.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-E</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>C-E J774A.1macrophages were pre-treated with (C, D) the Syk inhibitor piceatannol or (E) a control or Syk-targeting siRNA (10 nM) before stimulation with swollen conidia (MOI = 1) or zymosan (50 μg/ml). (E) Whole-cell lysates of Syk or Ctrl. siRNA-treated cells were separated by SDS-PAGE, followed by Western blotting, and membranes were probed with anti-Syk and anti-β-actin antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-F</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F J774A.1macrophages were pre-treated with piceatannol and infected with swollen conidia (MOI = 5). Phagocytosis was quantified by FACS 30 min after stimulation. Syk inhibition led to impaired phagocytosis of zymosan, but had no effect on phagocytosis of SC.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-G</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>G-IJ774A.1macrophages were pre-treated with cytochalasin D (CytoD, 10 μM) and infected with swollen conidia (MOI = 5) or zymosan (50 μg/ml). (G) NFATc2 translocation after 30 min of stimulation was quantified by confocal microscopy.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-H</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>G-IJ774A.1macrophages were pre-treated with cytochalasin D (CytoD, 10 μM) and infected with swollen conidia (MOI = 5) or zymosan (50 μg/ml). (H) For quantification of NF-κB translocation, nuclear extracts were separated by SDS-PAGE, followed by Western blotting. Membranes were probed with anti-NF-κB p65 and anti-HDAC1 antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_6-I</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 6-I</infon>
    <infon key="sourcedata_figure_dir">Figure_6-I</infon>
    <passage>
      <offset>0</offset>
      <text>G-I J774A.1 macrophages were pre-treated with cytochalasin D (CytoD, 10 μM) and infected with swollen conidia (MOI = 5) or zymosan (50 μg/ml). (I) After overnight stimulation, TNF-α was measured in the SN by ELISA. Inhibition of phagocytosis with cytochalasin D led to impaired NFAT translocation in response to zymosan or AF, but not ionomycin (G). In addition, inhibition of phagocytosis lead to increased translocation of NF-κB (H) and increased levels of TNF-α in response to either zymosan or AF.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_7-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A J774A.1macrophages were pre-treated with bafilomycin A1 (100 nM) and stimulated with swollen conidia (MOI = 3) for 30 min. NFATc2 translocation was assessed by confocal microscopy. Acidification was required for NFATc2 translocation.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_7-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B TLR9 recruitment was assessed in WT BMDMs 30 min after infection with eGFP-expressing swollen conidia by confocal microscopy. Scale bar: 10 μm. The arrow indicates a TLR9-positive AF-containing phagosome.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">423</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="38" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_7-C</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C BMDMs from WT or TLR9−/−mice were infected with swollen conidia (MOI = 1), and after overnight stimulation, TNF-α was measured in the SN by ELISA. TLR9−/−BMDMs had significantly lower TNF-α levels.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">427</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="2" length="5"/>
        <text>BMDMs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">432</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="156" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_7-D</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, E BMDMs from WT or TLR9−/−mice were infected with swollen conidia (MOI = 5) for 30 min, and NFATc2 translocation was quantified by (D) confocal microscopy. TLR9−/−BMDMs exhibited reduced NFATc2 translocation by both approaches.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">438</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="5" length="5"/>
        <text>BMDMs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">441</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="166" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_7-G</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 7-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-G</infon>
    <passage>
      <offset>0</offset>
      <text>G BMDMs from WT or MyD88−/−mice were pre-treated with ODN2088 (10 μM) and infected with swollen conidia (MOI = 5) for 30 min. NFATc2 translocation was quantified by confocal microscopy. In both, WT and MyD88−/−BMDMs, blocking TLR9 significantly impaired NFATc2 translocation.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">464</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="2" length="5"/>
        <text>BMDMs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">470</infon>
        <infon key="identifier">CL:0002476</infon>
        <location offset="210" length="5"/>
        <text>BMDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_8-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, B J774A.1macrophages were pre-treated with the BTK inhibitor LFM-A13 (12.5 μM) and infected with swollen conidia. (A) After overnight stimulation, TNF-α was measured in the SN by ELISA.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_8-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B J774A.1macrophages were pre-treated with the BTK inhibitor LFM-A13 (12.5 μM) and infected with swollen conidia. (B) After 30 min of stimulation, NFATc2 translocation was quantified by confocal microscopy. Both TNF-α levels and NFATc2 translocation were significantly reduced by BTK blockade.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_8-C</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C J774A.1macrophages were treated with a control or BTK-targeting siRNA (25 nM), and NFAT translocation was quantified by confocal microscopy. BTK knock-down led to a significant reduction in NFATc2 translocation in response to AF.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_8-D-E</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 8-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E J774A.1 macrophages were treated with a control, BTK (25 nM)- or TLR9 (75 nM)-targeting siRNA and additionally pre-treated with either ODN2088 (10 μM) or the BTK inhibitor LFM-A13 (12.5 μM). The cells were infected with swollen conidia (MOI = 5), and NFATc2 translocation was measured by confocal microscopy. Blocking both TLR9 and BTK signalling had no additive effect on NFAT translocation blockade.</text>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_9-A</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>Alveolar macrophages from 13 different lung transplant recipients were isolated from bronchoalveolar lavage. Cells were pre-treated for 1 h with FK506 (10 ng/ml), the NFAT inhibitor MCV1 (1 μM) or SC514 (10 μM) before stimulation with A. fumigatus swollen conidia (MOI 0.1). After 24 h of stimulation, TNF-α was measured in the cell culture supernatant by ELISA. A Representative FACS-phenotyping demonstrative of a normal alveolar macrophage phenotype is shown for three patient samples.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">515</infon>
        <infon key="identifier">CL:0000583</infon>
        <location offset="0" length="20"/>
        <text>Alveolar macrophages</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">550</infon>
        <infon key="identifier">CL:0000583</infon>
        <location offset="423" length="19"/>
        <text>alveolar macrophage</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364943 Figure_9-B</id>
    <infon key="sourcedata_document">1364</infon>
    <infon key="doi">10.15252/emmm.201404556</infon>
    <infon key="pmc_id">4364943</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>Alveolar macrophages from 13 different lung transplant recipients were isolated from bronchoalveolar lavage. Cells were pre-treated for 1 h with FK506 (10 ng/ml), the NFAT inhibitor MCV1 (1 μM) or SC514 (10 μM) before stimulation with A. fumigatus swollen conidia (MOI 0.1). After 24 h of stimulation, TNF-α was measured in the cell culture supernatant by ELISA.B Inhibition of alveolar macrophage responses to AF with FK506, MCV1 or SC514 led to a significant reduction in TNF-α levels.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">531</infon>
        <infon key="identifier">CL:0000583</infon>
        <location offset="0" length="20"/>
        <text>Alveolar macrophages</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">546</infon>
        <infon key="identifier">CL:0000583</infon>
        <location offset="378" length="19"/>
        <text>alveolar macrophage</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_1-A-B-C</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 1-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C Five-day treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (A) body weight and (B, C) body composition. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_2-A-B</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A-G Five-day treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (A, B) energy expenditure. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_2-C</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-G Five-day treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (C) respiratory exchange ratio (RER). Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_2-D</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-G Five-day treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (D) locomotor activity. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_2-E-F-G</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 2-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>A-G Five-day treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (E) cumulative food intake, (F) meal number and (G) meal size. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_3-A-B</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B Treatment-induced changes in hypothalamic gene expression in DIOmice treated for 2 (A) or 5 (B) days with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Compounds were administered by daily subcutaneous injections, and the last injection was provided 2 h prior to tissues sampling. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, §P &lt; 0,001, comparison between treatment and vehicle control. #P &lt; 0.05, ##P &lt; 0.01, ###P &lt; 0.001, comparison to liraglutide. +P &lt; 0.05, comparison to RM-493.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_4-A</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Glucose metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (A) Fasted bloodglucose levels. Data represent means ± SEM;n = 8 in (A-H); *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_4-B-C</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 4-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Glucose metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered).(B, C) glucose tolerance. Data represent means ± SEM;n = 8 in (A-H); *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_4-D</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Glucose metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (D) fasted insulin levels,. Data represent means ± SEM;n = 8 in (A-H); *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_4-E-F</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Glucose metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (E, F) glucose-induced insulin secretion. Data represent means ± SEM;n = 8 in (A-H); *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_4-G</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Glucose metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (G) HOMA-IR. Data represent means ± SEM;n = 8 in (A-H); *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_4-H</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Glucose metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (H) insulin sensitivity. Data represent means ± SEM;n = 8 in (A-H); *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_4-I</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 4-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Glucose metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (I) hepatic phosphorylation of AKT (p-AKTSer473) were analyzed. Compounds were administered by daily subcutaneous injections. To assess insulin-stimulated p-AKTSer473, insulin (n = 5) or saline (n = 3) was injected 10 min prior to liver sampling. Data represent means ± SEM;n = 8 in (A-H); *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_5-A</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A-D Cholesterol metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (A) Plasma lipoprotein fractions. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_5-B</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>A-D Cholesterol metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (B) livercholesterol levels. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_5-C</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-D Cholesterol metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (C) expression of genes implicated in hepatic cholesterol and lipoprotein uptake. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_5-D</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-D Cholesterol metabolic parameters were assessed following 5 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). (D) expression of genes implicated in cholesterol and bile acid metabolism and excretion were analyzed. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_6-A</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A-F 22 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (A) body weight. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_6-B</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>A-F 22 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (B) cumulative food intake. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_6-C-D</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-F 22 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (C, D) body composition. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4364946 Figure_6-E-F</id>
    <infon key="sourcedata_document">1355</infon>
    <infon key="doi">10.15252/emmm.201404508</infon>
    <infon key="pmc_id">4364946</infon>
    <infon key="figure">Figure 6-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>A-F 22 days of treatment of DIO male mice with vehicle (white), liraglutide (10 nmol/kg) (gray), RM-493 (3.6 μmol/kg) (black), or liraglutide (10 nmol/kg) and RM-493 (3.6 μmol/kg) (checkered). Effects on (E, F) glucose tolerance. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM;n = 8; *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_1-A</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>MPK4‐HA is detected in PAT1‐Mycimmunoprecipitates from double transgenic Arabidopsis plants. Immunoblots of input and anti‐Myc IPs probed with anti‐HA and anti‐Myc antibodies. Left panel, input; right panel, anti‐MycIP.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_1-B</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>Yeastpat1Δ mutants are unable to grow at 37°C while wild‐type (B4742) strain grows at 30°C (left panel) and 37°C (right). Growth at 37°C is restored in pat1Δ expressing AtPAT1. Serial dilutions of each yeast strain were plated on YPAD agar plates and grown at the indicated temperatures.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_1-C</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>Co‐IP between PAT1‐HA and LSM1‐GFP. Proteins were transiently co‐expressed in N. benthamiana and tissue harvested 3 days post‐infiltration. Immunoblots of GFP IPs (top panel) and inputs (20 μg each, bottom panel). Immunoblots were cut in half and probed with anti‐HA antibodies and anti‐GFP antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_1-D</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>Agarose gel electrophoresis of 5′ RACE PCR to detect capped transcripts of EIF4A1, UGT87A2 and EXPL1 in 14‐day‐old Col‐0 and pat1‐1.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_2-B</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>MPK4 and MPK6 were immunoprecipitated from extracts of Col‐0seedlings treated with 200 nM flg22 for 10 min. For the negative control (−), extracts were incubated with agarose beads without antibodies. IPs were incubated with His6‐PAT1, His6‐PAT1 S208A or MBP for 60 min at 37°C before boiling and SDS‐PAGE. Autoradiogram (top panel), Coomassie‐stained gel for loading control (bottom).</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_3-A</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>pat1 mutants have a serrated leaf, semi‐dwarf phenotype  Plants photographed at 4 weeks of growth in short day conditions, genotypes as indicated. Col‐0 and eds1‐2 plants and pat1‐1 and pat1‐1/eds1‐2, respectively, were placed in the middle of the same pots before the pictures were taken.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_4-A</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>PR gene expression is elevated in mpk4‐2 and pat1‐1 mutants. Four‐week‐old plants were used for RNA extraction, followed by qRT‐PCR. Fold‐change in PR1 (gray bars) and PR2 (black) expression is relative to Col‐0, normalized to UBQ10. Standard error of the mean is indicated by errors bars (n = 3). Statistical significance between the mean values was determined by ANOVA followed by Fisher's LSD test, P‐values are only shown for mean values significantly different from Col‐0.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_4-B</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>pat1 is more resistant to colonization by P. syringae pv. tomato DC3000. Bacteria were syringe‐infiltrated and samples taken 3 days post‐infiltration. Data are shown as log10‐transformed colony‐forming units/cm2leaf tissue (cfu/cm2). Standard error of the mean is indicated by errors bars (n = 4). Statistical significance between the mean values was determined by ANOVA followed by Fisher′s LSD test.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_5-A</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Confocalmicroscopy with root elongation zones. Five‐day‐old Col‐0/PAT1‐GFPseedlings were treated with 1 μM flg22 on glass slides for 20 min (second panel) followed by treatment with 100 μg/ml cycloheximide for 60 min (bottom panel). The scale bar corresponds to 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_5-B</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>Confocalmicroscopy with 5‐day‐old VCS‐GFPseedlings treated as in (A). The scale bar corresponds to 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_5-C</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>PAT1protein is induced by PAMP treatment. Immunoblot detection of equal amounts of protein from Col‐0seedlings at times in minutes as indicated following vacuum infiltration with 1 μM flg22 or water (180 min after infiltration). Immunoblots were probed with anti‐PAT1 antibodies. Negative control pat1‐1 was loaded for comparison. Coomassie brilliant blue protein loading control is indicated by CBB.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_5-D</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>Anti‐GFPimmunoblotting of proteins extracted from Col‐0/PAT1‐GFPseedlings treated over a time course with flg22 (top panel) and Coomassie brilliant blue (CBB)‐stained PVDF loading control is shown (bottom panel). No PAT1‐GFP was detected in negative control Col‐0.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_6-A</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Elevated PR gene expression in pat1 mutants is suppressed by summ2‐8. Four‐week‐old plants were used for RNA extraction, followed by qRT‐PCR. Fold‐change in PR1 (gray bars) and PR2 (black bars) expression is relative to Col‐0, normalized to UBQ10. Standard error of the mean is indicated by errors bars (n = 3).</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_6-B</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>pat1 resistance to P. syringae pv. tomato DC3000 is suppressed by summ2‐8. Bacteria were syringe‐infiltrated and samples taken 3 days post‐infiltration. Data are log10‐transformed colony‐forming units/cm2leaf tissue (cfu/cm2). Standard error of the mean is indicated by errors bars (n = 4).</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_6-C</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>14‐day‐old seedlings grown on ms plates were used for RNA extraction. Next, 1 μg of RNA from each sample was treated with XRN1 (NEB) or mock treated before RT‐qPCR. Data were normalized to ACT2, and transcript levels were compared between XRN1 and mock‐treated RNA for each genotype. Standard error of the mean is indicated by error bars (n = 4). Statistical significance between the mean values was determined by ANOVA followed by Fisher's LSD test.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_6-D</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>Phosphorylation of the PAT1 peptide SSFVSYPPPGSISPDQR, which include Ser208, in Col‐0 and mkk1/1‐summ2 before and after flg22 treatment. The phosphorylation stoichiometry is illustrated relative to Col PAT1 without flg22 treatment. The ratios were obtained using quantitative iTRAQ mass spectrometry.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_7-A</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Proteins were transiently co‐expressed (PAT1‐GFP + MPK4‐HA or SUMM2‐HA) in N. benthamiana and tissue harvested 2 days post‐infiltration. Anti‐HAimmunoblots of inputs (20 μg each) are shown in the bottom panel. Immunoblots of GFP IPs were probed with anti‐HA antibodies, then stripped and probed with anti‐GFP antibodies. Molecular weights are shown in kDa on the right.</text>
    </passage>
  </document>
  <document>
    <id>4365030 Figure_7-B</id>
    <infon key="sourcedata_document">1830</infon>
    <infon key="doi">10.15252/embj.201488645</infon>
    <infon key="pmc_id">4365030</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>Confocalimages of yellow fluorescent protein complementation. PAT1‐Nc was transiently co‐expressed with either SUMM2‐Nn or At4g12010 in N. benthamiana. Confocalmicroscopy on leaf disks was conducted 2 days post‐infiltration. Merged pictures show overlay of brightfield, chlorophyll and eYFP. The scale bar corresponds to 25 μm.</text>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_1-A</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A IF for PRMT5 (green) and OCT4+PGCs (arrows) at E10.5, and MVH+PGCs (arrows) at E11.5 (red).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="32" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">6</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="64" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_1-B</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B PRMT5 (green) in male gonads at E13.5, E16.5 and P1‐2. MVH (red) marks germ cells, with PRMT5 foci (white arrow heads) or MVH foci (red arrow heads).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">10</infon>
        <infon key="identifier">CL:0000586</infon>
        <location offset="73" length="10"/>
        <text>germ cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_1-C</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C PRMT5 (green) expression in female gonads at E13.5, E16.5 and P1‐2. MVH (red) marks germ cells.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">19</infon>
        <infon key="identifier">CL:0000586</infon>
        <location offset="86" length="10"/>
        <text>germ cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_2-B</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Recombination rate of Blimp1‐Cre (BC). BC was crossed to YFP lox‐stop‐lox mice, and recombination rate was calculated based on the fraction of YFP+ cells in the STELLA+ (E9.0) or MVH+ (E13.5) fraction.</text>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_2-C-D</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D P1‐2 male gonad (C) and P1‐2 female gonad (D) in control (Ctrl) and PCKO embryos. Arrows indicate germ cells. Scale bar, 100 μm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">34</infon>
        <infon key="identifier">CL:0000586</infon>
        <location offset="103" length="10"/>
        <text>germ cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_2-E-F</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 2-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F IF for PRMT5 (green) and MVH (red) in (E) P1‐2 male and (F) P1‐2 female gonads. L, Leydig cell. Arrows indicate germ cells. Scale bar, 20 μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">44</infon>
        <infon key="identifier">CL:0000178</infon>
        <location offset="88" length="11"/>
        <text>Leydig cell</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">42</infon>
        <infon key="identifier">CL:0000586</infon>
        <location offset="117" length="10"/>
        <text>germ cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-A-B</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B IF for MVH+germline cells (red) in (A) male, and (B) female gonads at E13.5. In males, sertoli cells are also marked with SOX9 (green). Dashed circle indicates a testis cord. Scale bar, 50 μm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <infon key="identifier">CL:0000586</infon>
        <location offset="16" length="14"/>
        <text>germline cells</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">53</infon>
        <infon key="identifier">CL:0000216</infon>
        <location offset="92" length="13"/>
        <text>sertoli cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-C</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Higher power image of (A) at E13.5. Dashed circle indicates a cross section through a testis cord. Arrows point to PGCs, which were identified by MVH+staining. Scale bar, 20 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">59</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="117" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-D</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D IF of the indifferent gonads at E11.5 with PGCs identified by staining for STELLA (green) and MVH (red). Arrows indicate a small PGC cluster in the PCKO mutants. Scale bar, 100 μm. Note that PCKO mutant PGCs are STELLA‐positive but not MVH‐positive at this magnification.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">67</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="45" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">65</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="131" length="3"/>
        <text>PGC</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">70</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="205" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-E</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E IF at E9.5 with PGCs identified by co‐staining for STELLA (green) and OCT4 (red). Scale bar, 100 μm.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">76</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="18" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-F</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Higher power image of (E) at E9.5. Arrows indicate OCT4 and STELLA double‐positive PGCs. Scale bar, 20 μm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">83</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="85" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-G</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Quantification of germ cell number between control and PCKO at different gestational stages.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">89</infon>
        <infon key="identifier">CL:0000586</infon>
        <location offset="20" length="9"/>
        <text>germ cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-H</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>H E9.5 embryos from control and PCKO. Scale bar, 1 mm.</text>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_3-I</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 3-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-I</infon>
    <passage>
      <offset>0</offset>
      <text>I E11.5 embryos of control and PCKO. The majority of PCKO embryos are equivalent size to the control at E11.5. Scale bar, 1 mm.</text>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_4-A-B</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A IF of E10.5 embryos showing OCT4+ (red) PGCs with cPARP (green). Arrows indicate apoptotic PGCs. Scale bar, 20 μm. B Quantification of apoptotic OCT4+PGCs in control and PCKO embryos at E10.5. Data are shown as mean ± SEM. Standard error is across visual fields containing 10 PGCs. In total, about 4-5 fields were used for the quantification for each genotype.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">110</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="42" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="93" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">114</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="152" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">116</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="278" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_4-C-D</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C IF of E9.5 embryos for Ki67 showing OCT4+PGCs (arrows). Scale bar, 10 μm. D Quantification of Ki67 negative OCT4+PGCs at E9.5. Data are shown as mean ± SEM.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">122</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="43" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">124</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="115" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_4-E</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E IF at E10.5 for OCT4+PGCs and H3K9me2. White arrows mark OCT4+PGCs. Both Ctrl and PCKO PGCs show the absence of H3K9me2 (green) staining. Scale bar, 20 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">131</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="23" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">133</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="64" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">134</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="89" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_4-F</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F IF at E11.5 for STELLA+PGCs and 5mC. White arrows mark STELLA+PGCs. Both Ctrl and PCKO PGCs show the absence of global 5mC (green) staining. Note that STELLA+ PCKO PGCs are not MVH positive at this age. Scale bar, 20 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">143</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="25" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">145</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="64" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">146</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="89" length="4"/>
        <text>PGCs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">148</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="166" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_4-G</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G IF at E11.5 for PGCs (arrows) with MVH (red) and STELLA (green). Scale bar, 20 μm.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">157</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="18" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-B</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Western blot of iPHet and iPKO ESCs 5 days after treatment with 4‐OHT. Nu, nuclear fraction. Cyto, cytoplasmic fraction. ACTIN and H2A are used for loading control of nuclear and cytoplasmic fraction, respectively.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">165</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="33" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-C</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C IF for Ki67 (green) in iPHet and iPKO ESCs 5 days after treatment with 4‐OHT. White arrows mark Ki67‐positive ESCs. Red arrows mark Ki67‐negative ESCs. Scale bar, 20 μm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="40" length="4"/>
        <text>ESCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">182</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="112" length="4"/>
        <text>ESCs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">184</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="148" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-D</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Growth curve of iPHet and iPKO ESCs at days 2, 3 and 5 after 4‐OHT treatment. n = 2 replicates. The original seeding on day 0 is 50,000 (50K) cells per well of a 6‐well plate.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">190</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="33" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-E</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Western blot for SYM10 antibody of iPHet and iPKO ESCcytoplasmic lysates 5 days after treatment with 4‐OHT. Cyto, cytoplasmic fraction. ACTIN is used as a loading control. The absence of PRMT5 is shown in iPKO ESCs.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">198</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="52" length="3"/>
        <text>ESC</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">200</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="212" length="4"/>
        <text>ESCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-I</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>I (Reverse transcript) RT-PCR validation of aberrant splicing events in Mdm4 and Ehmt2. SE, skipped exon. PCR is performed among at least three replicates for each locus. Electrophoresis image was quantified using ImageJ software. **P = 0.0046, ***P = 0.0006.</text>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-J</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J</infon>
    <passage>
      <offset>0</offset>
      <text>J Representative flow plot of sorting cKIT+/SSEA1+PGCs (red box) at E10.5 using FACS (shown is an embryo with genotype Prmt5fl/fl;creER with 4‐OHT injection at E6.5).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">214</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="50" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-K</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-K</infon>
    <infon key="sourcedata_figure_dir">Figure_5-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Sorted PGC numbers among control iPHet (Prmt5fl/+;creER) and mutant iPKO (Prmt5fl/fl;creER). *P = 0.0486.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">223</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="9" length="3"/>
        <text>PGC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4369312 Figure_5-L</id>
    <infon key="sourcedata_document">1942</infon>
    <infon key="doi">10.15252/embj.201489319</infon>
    <infon key="pmc_id">4369312</infon>
    <infon key="figure">Figure 5-L</infon>
    <infon key="sourcedata_figure_dir">Figure_5-L</infon>
    <passage>
      <offset>0</offset>
      <text>L PCR validation of aberrant splicing events in Mdm4 and Ehmt2 using cDNA reverse‐transcribed and amplified from FACS‐sorted PGCs (individual embryos) using the NuGEN Ovation RNA Amp System V2. SE, skipped exon. PCR was performed among one control (Prmt5fl/+;creER) and two mutants (Prmt5fl/fl;creER).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">232</infon>
        <infon key="identifier">CL:0000670</infon>
        <location offset="125" length="4"/>
        <text>PGCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_1-A</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 1-A</infon>
    <infon key="sourcedata_figure_dir">Fig_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Western-blot analysis of HCV-infected cells at various time-points post-infection (p.i.) (m.o.i. = 1). Numbers under Rubicon and UVRAG panels indicate their protein levels at different time points relative to their levels in mock-infected cells (i.e., 0 hour p.i.).</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_1-B-C</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 1-B-C</infon>
    <infon key="sourcedata_figure_dir">Fig_1-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Fluorescence imaging of HCV infected cells. Stable Huh7.5 cells that expressed mRFP-GFP-LC3 were infected with HCV and fixed at the time points indicated for the analysis of RFP and GFP puncta. Nuclei were stained with DAPI. The boxed areas were enlarged and shown to the right. (C) Upper panel, levels of RFP and GFP puncta after HCV infection relative to those in mock-infected cells, which were arbitrarily defined as 1. Lower panel, percentages of RFP puncta that were positive for GFP (i.e., Yellow/Red ratio). The results represent the average of &gt;50 cells that were analyzed.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_1-D</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 1-D</infon>
    <infon key="sourcedata_figure_dir">Fig_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Fluorescence imaging of RFP, GFP and LAMP1 in HCV-infected cells expressing mRFP-GFP-LC3. The lysosomal marker LAMP1 was stained in blue color. DAPI was not used to stain the nuclei. The colocalization of RFP and GFP will generate the yellow color, and the colocalization of RFP with LAMP without GFP will generate the purple color. The boxed areas were enlarged and shown to the right.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_2-A</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 2-A</infon>
    <infon key="sourcedata_figure_dir">Fig_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Huh7.5 cells were transfected with the negative control siRNA (NC) or the Rubicon (Rb) siRNA for 48 hours and then infected with 1 m.o.i. of HCV. Western-blot analysis of cell lysates at different time points after HCV infection. Actin served as the loading control.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_2-B</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 2-B</infon>
    <infon key="sourcedata_figure_dir">Fig_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Huh7.5 cells were transfected with the negative control siRNA (NC) or the Rubicon (Rb) siRNA for 48 hours and then infected with 1 m.o.i. of HCV. Real-time RT-PCR analysis of HCV RNA at 24 and 48 hours post-infection. *, p &lt; 0.05. siNC, negative control siRNA; siRb, Rubicon siRNA.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_2-C-D</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Fig_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>Huh7.5 cells were transfected with the negative control siRNA (NC) or the Rubicon (Rb) siRNA for 48 hours and then infected with 1 m.o.i. of HCV. (C) Fluorescence imaging of RFP and GFP puncta in cells transfected with the control siRNA (top two panels) or the Rubicon siRNA (bottom two panels). Cells were fixed at 24 and 48 hours after HCV infection for the analysis. Boxed areas in merged images are enlarged and shown to the right. (D) Percentages of RFP puncta that were also positive for GFP in Huh7.5 cells treated with either the control siRNA or the Rubicon siRNA. The results represent the average of &gt;50 cells.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_3-A</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 3-A</infon>
    <infon key="sourcedata_figure_dir">Fig_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Huh7.5 cells were transfected with the control vector or the Flag-tagged Rubicon expression plasmid for 24 hours followed by infection with HCV. Western-blot analysis of cell lysates at different time points after infection. Mock-infected cells were lysed at 48 hours post-transfection.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_3-B</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 3-B</infon>
    <infon key="sourcedata_figure_dir">Fig_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Huh7.5 cells were transfected with the control vector or the Flag-tagged Rubicon expression plasmid for 24 hours followed by infection with HCV. Real-time RT-PCR analysis of HCV RNA at 24 and 48 hours post-infection. *, p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_3-C-D</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Fig_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>Huh7.5 cells were transfected with the control vector or the Flag-tagged Rubicon expression plasmid for 24 hours followed by infection with HCV. (C) RFP and GFP puncta in cells with the over-expression of Rubicon at different time points after HCV infection. Merged images are shown to the right. (D) Percentages of RFP puncta that were also positive for GFP in Huh7.5 cells transfected with either the control vector or the Rubicon expression plasmid. The results represent the average of &gt;50 cells.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_4-A</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 4-A</infon>
    <infon key="sourcedata_figure_dir">Fig_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Huh7.5 cells were transfected with the control vector or the Flag-tagged UVRAG expression plasmid for 24 hours followed by infection with HCV. (A) Western-blot analysis of cell lysates at different time points after infection. Mock-infected cells were lysed at 48 hours post-transfection.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_4-B</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 4-B</infon>
    <infon key="sourcedata_figure_dir">Fig_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Huh7.5 cells were transfected with the control vector or the Flag-tagged UVRAG expression plasmid for 24 hours followed by infection with HCV. (B) Real-time RT-PCR analysis of HCV RNA at 24 and 48 hours post-infection. *, p &lt; 0.05.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_4-C-D</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Fig_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>Huh7.5 cells were transfected with the control vector or the Flag-tagged UVRAG expression plasmid for 24 hours followed by infection with HCV. (C) RFP and GFP puncta in cells with the over-expression of UVRAG at different time points after HCV infection. Merged images are shown to the right. (D) Percentages of RFP puncta that were also positive for GFP in Huh7.5 cells transfected with either the control vector or the UVRAG expression plasmid. The results represent the average of &gt;50 cells.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_5-A</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 5-A</infon>
    <infon key="sourcedata_figure_dir">Fig_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Cells transfected with the control siRNA (siNC), the Rubicon siRNA (siRb), the Rubicon expression plasmid (pRubicon) or the UVRAG expression plasmid (pUVRAG) were infected with HCV (m.o.i. = 1). The incubation media were harvested at 24 and 48 hours post-infection and used to infect naïve Huh7.5 cells. Cells were either fixed and stained for the HCVcore protein for the determination of viral titers (A)</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_5-B</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 5-B</infon>
    <infon key="sourcedata_figure_dir">Fig_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>Cells transfected with the control siRNA (siNC), the Rubicon siRNA (siRb), the Rubicon expression plasmid (pRubicon) or the UVRAG expression plasmid (pUVRAG) were infected with HCV (m.o.i. = 1). The incubation media were harvested at 24 and 48 hours post-infection and used to infect naïve Huh7.5 cells. Cells were lysed for Western-blot analysis of the HCVcore protein (B) two days after infection. Actin served as the loading control in (B).</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_6-A</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 6-A</infon>
    <infon key="sourcedata_figure_dir">Fig_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Increase of Rubicon, UVRAG, p62 and LC3-II in HCV subgenomic RNA replicon cells. Actin served as the loading control. Numbers under Rubicon and UVRAG indicate the protein levels of Rubicon and UVRAG in replicon cells relative to their levels in control Huh7 cells.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_6-B</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 6-B</infon>
    <infon key="sourcedata_figure_dir">Fig_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Effects of nutrient starvation on Rubicon, p62 and LC3 in Huh7 cells. Huh7 cells were nutrient-starved for 2 or 6 hours as indicated and lysed for Western-blot analysis. The replicon cells were used as the control for comparison.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_6-C-D</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Fig_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Colocalization analysis of GFP-LC3 puncta and lysosomes. Stable Huh7 cells that expressed GFP-LC3 were nutrient-starved for 2 hours and stained with Lysotracker-red for lysosomes. The HCV replicon cells were also stained with Lysotracker-red for comparison. (D) Colocalization efficiency of GFP puncta with Lysotracker-red shown in (C). The results represent the average of &gt;30 cells.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_6-E</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 6-E</infon>
    <infon key="sourcedata_figure_dir">Fig_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Effect of Rubicon knockdown on parental Huh7 cells and HCV replicon cells. Huh7 cells and HCV replicon cells were treated with the control siRNA or the Rubicon siRNA for two days. Cells were then lysed for Western-blot analysis.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_6-F</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 6-F</infon>
    <infon key="sourcedata_figure_dir">Fig_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Relative HCV RNA levels as measured by real-time RT-PCR. HCV replicon cells treated with either the control siRNA or the Rubicon siRNA for two days were lysed for quantification of HCV RNA by real-time RT-PCR.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_6-G</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 6-G</infon>
    <infon key="sourcedata_figure_dir">Fig_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Effect of UVRAG overexpression on HCV replicon cells. HCV replicon cells were transfected with the control vector or flag-UVRAG plasmid for two days. Cells were then lysed for Western-blot analysis.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_6-H</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 6-H</infon>
    <infon key="sourcedata_figure_dir">Fig_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Relative HCV RNA levels as measured by real-time RT-PCR. HCV replicon cells transfected with either the control vector or the flag-UVRAG plasmid for two days were lysed for quantification of HCV RNA by real-time RT-PCR. In (F) and (H), *, p&lt;0.05.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_7-A</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 7-A</infon>
    <infon key="sourcedata_figure_dir">Fig_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Western-blot analysis of Huh7 cells transfected with the expression plasmids of HA-tagged GST and various HCV nonstructural proteins. Cells were lysed 48 hours after transfection for analysis. The localizations of molecular weight markers are indicated. The asterisk denotes a nonspecific protein band.</text>
    </passage>
  </document>
  <document>
    <id>4373777 Fig_7-B-C</id>
    <infon key="sourcedata_document">813</infon>
    <infon key="doi">10.1371/journal.ppat.1004764</infon>
    <infon key="pmc_id">4373777</infon>
    <infon key="figure">Fig 7-B-C</infon>
    <infon key="sourcedata_figure_dir">Fig_7-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Analysis of GFP-LC3 puncta in stable Huh7 cells that expressed GFP-LC3. Cells were transfected with various expression plasmids for 48 hours and immunostained with the anti-HA antibody (red color). GFP-LC3 puncta were apparent in cells that expressed HCV NS4B. (C) The average number of GFP-LC3 puncta per cell shown in (B). The results represent the mean of &gt;30 cells.</text>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_1-B</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B GFP+ EBs derived from CT and RA cultures at day 10; scale bar: 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_1-C</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Representative FC plots depicting percentage of GFP+ cells obtained at day 15, from CT and RA cultures in a typical experiment.</text>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_1-D</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Heat map demonstrating enrichment of cardiac genes in GFP+ fractions (CT+, RA+) compared to GFP− fractions (CT−, RA−) at day 31.</text>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_1-E-F</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Heat map of a select list of genes (E) upregulated and (F) downregulated in RA+ compared to CT+ at day 31. Fold change &gt; 2.</text>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_2-A-B-C</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 2-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C qPCR of selected transcripts at day 31 to validate (A) enrichment of cardiac markers in GFP+ fractions against GFP− fractions, (B) upregulation of atrial and (C) downregulation of ventricular genes in RA+ compared to CT+ (n = 3). Data information: Data are presented as mean ± SEM. In (A-C), *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001 by unpaired t-test. In (A), for TNNT2, P = 0.0001 for CT− against CT+ and P = 0.0002 for RA− against RA+; for NKX2.5, P = 0.00005 for CT− against CT+ and P = 0.00007 for RA− against RA+. In (B), P = 0.0006 for NPPA and P = 0.0002 for PITX2. In (C), P = 0.02 for HEY2 and P = 0.007 for IRX4.</text>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_3-B</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Representative APs of day 31 CMs from control (CT) and RA-treated (RA) groups at 1 Hz.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">74</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="31" length="3"/>
        <text>CMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_3-C-D-E-F</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 3-C-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>C-E RMP, APAmax and APAplat (C), dV/dtmax (D) and APD20, APD50 and APD90 of CT and RACMs (E). F Plot showing all measured APAplat values of CT and RACMs.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">79</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="85" length="3"/>
        <text>CMs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">81</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="149" length="3"/>
        <text>CMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_3-G-H</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 3-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G Representative APs of CT and RACMs at 0.5-4 Hz. H Average APAplat at 0.5-4 Hz. Please note that the AP differences in morphology are present at all measured frequencies.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">84</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="33" length="3"/>
        <text>CMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_4-A-B</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B Line plot illustrating relative mRNA levels of (A) COUP-TFI and (B) COUP-TFII in VM and AM differentiations from day 5 through day 9 (left) and in GFP+CMs at day 31 (right); n = 3. Data information: Data are presented as mean ± SEM. In (A, B), *P &lt; 0.05, **P &lt; 0.01, ***P &lt; 0.001 by unpaired t-test. In (A), left panel, P = 0.03, 0.02, 0.03, 0.005 and 0.0004 for comparison of COUP-TFI expression between AM and VM at days 5, 6, 7, 8 and 9 of differentiation. In (A), right panel, P = 0.0002 for comparison of COUP-TFI expression at day 31 between AM and VM. In (B), left panel, P = 0.02, 0.03, 0.006, 0.004 and 0.003 for comparison of COUP-TFII expression between AM and VM at days 5, 6, 7, 8 and 9 of differentiation. In (B), right panel, P = 0.0001 for comparison of COUP-TFII expression at day 31 between AM and VM. CT = control differentiation; hESC-atrial (AM); hESC-ventricular (VM).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="86" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">89</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="93" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">93</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="156" length="3"/>
        <text>CMs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">95</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="410" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">96</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="417" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">98</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="553" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">99</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="560" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">101</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="670" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="677" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="814" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">105</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="821" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">21</infon>
        <infon key="sourcedata_article_annot_id">214</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="855" length="4"/>
        <text>hESC</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">106</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="868" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="24">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">24</infon>
        <infon key="sourcedata_article_annot_id">217</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="873" length="4"/>
        <text>hESC</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">107</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="891" length="2"/>
        <text>VM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_4-C-D</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D COUP-TFI (C) and COUP-TFII (D) immunofluorescence at day 31 in AM (top) and VM (bottom). Scale bars: 40 μm.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">114</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="68" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">115</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="81" length="2"/>
        <text>VM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_5-A-B</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B mRNA expression of COUP-TFI and COUP-TFII following shRNA-mediated knockdown of (A) COUP-TFI or (B) COUP-TFII in hESC-atrialcardiomyocytes (AM) at day 30.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">218</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="118" length="4"/>
        <text>hESC</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">123</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="129" length="14"/>
        <text>cardiomyocytes</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">129</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="145" length="2"/>
        <text>AM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_5-C-D</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 5-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D mRNA expression of ion channel genes KCNA5, KCNJ3 and KCNJ5 after knockdown of (C) COUP-TFI or (D) COUP-TFII in AM at day 30.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">136</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="117" length="2"/>
        <text>AM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_5-E-F-G-H</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 5-E-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Schematic of NR2F binding sites in (E) KCNA5 and (F) KCNJ3 promoters. G, H ChIP-qPCR analysis at day 30 shows enriched binding of COUP-TFI and COUP-TFII to the promoter region of (G) KCNA5 and (H) KCNJ3, compared to IgG in AM.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">146</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="228" length="2"/>
        <text>AM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_6-A</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Expression of KCNA5 (left) and KCNJ3 (right) in GFP+ pools of VM and AMCMs at day 31, as well as in ventricles and atria of humanheart.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">154</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="64" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">155</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="71" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">156</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="73" length="3"/>
        <text>CMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_6-B-C</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 6-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Typical examples (left) and current-voltage relationships (right) of (B) IKur and (C) IK,ACh in VM and AMCMs. Data information: Data are presented as mean ± SEM. In (A), *P &lt; 0.05 by unpaired t-test. In (B, C), *P &lt; 0.05 by two-way repeated measures ANOVA followed by pairwise comparison using the Student-Newman-Keuls test for (B) and Mann-Whitney rank-sum test for (C). In (B), P = 0.778, 0.350, 0.03, 0.02, 0.002, 0.001, &lt; 0.001 and &lt; 0.001, respectively, for comparison between VM and AM within membrane potentials of −20, −10, 0, 10, 20, 30, 40 and 50 mV. In (C), P = 0.01, 0.01, 0.01, 0.01, 0.03, 0.397, 0.397, 0.397, 0.671, 0.207, 0.207, 0.09, 0.01, 0.039 and 0.015, respectively, for comparison between VM and AM within membrane potentials of −120, −110, −100, −90, −80, −70, −60, −50, −40, −30, −20, −10, 0, 10 and 20 mV. CMs = cardiomyocytes; hESC-atrial (AM) and hESC-ventricular (VM) CMs; IK,ACh = acetylcholine-activated potassium current; IKur = potassium ultra-rapid delayed rectifier current. 4-AP = 4-aminopyridine; CCh = carbachol.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">167</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="101" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">168</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="108" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">169</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="110" length="3"/>
        <text>CMs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">170</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="487" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="494" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">172</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="716" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">173</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="723" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">175</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="836" length="3"/>
        <text>CMs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">166</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="842" length="14"/>
        <text>cardiomyocytes</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">220</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="858" length="4"/>
        <text>hESC</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">176</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="871" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">21</infon>
        <infon key="sourcedata_article_annot_id">222</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="879" length="4"/>
        <text>hESC</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">177</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="897" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">178</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="901" length="3"/>
        <text>CMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_6-D-E</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 6-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Representative APs of VM and AM at 1 Hz in response to (D) IKur block by 4-AP and (E) IK,ACh activation by CCh. AP parameters are shown in Supplementary Table S5.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="27" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">181</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="34" length="2"/>
        <text>AM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_7-A-B-C</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 7-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative APs at 1 Hz of VM and AMCMs in response to vernakalant. Inset shows dV/dtmax. B, C Average APAplat (B) and dV/dtmax (C)in the absence and presence of vernakalant at 1-4 Hz. AP parameters are shown in Supplementary Table S6. Abbreviations as in Figs3 and 6. Data information: Data are presented as mean ± SEM. *P &lt; 0.05 by Mann-Whitney rank-sum test for (B). P = 0.01, 0.008, 0.008 and 0.007, respectively, for comparison of APAplat between VM and AM groups at frequencies of 1.0, 2.0, 3.0 and 4.0 Hz. Two-way repeated measures ANOVA followed by pairwise comparison using the Student-Newman-Keuls test for (C). P = 0.686 between VM and AM groups and hence not statistically significant. For VM, P = 0.06 for 1 versus 2 Hz; P &lt; 0.001 for 1 versus 3 Hz; P &lt; 0.001 for 1 versus 4 Hz; P = 0.001 for 2 versus 3 Hz; P = 0.002 for 2 versus 4 Hz; and P = 0.857 for 3 versus 4 Hz. For AM, P = 0.03 for 1 versus 2 Hz; P &lt; 0.001 for 1 versus 3 Hz; P &lt; 0.001 for 1 versus 4 Hz; P = 0.02 for 2 versus 3 Hz; P = 0.02 for 2 versus 4 Hz; and P = 0.621 for 3 versus 4 Hz.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">186</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="32" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">187</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="39" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">188</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="41" length="3"/>
        <text>CMs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">190</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="457" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">191</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="464" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">192</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="645" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="652" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">194</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="707" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">195</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="892" length="2"/>
        <text>AM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_8-A</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative APs of VM and AMCMs in the absence, presence and following washout of 3 μmol/l XEN-D0101. AP parameters are shown in Supplementary Table S7.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">198</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="24" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">199</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="31" length="2"/>
        <text>AM</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">200</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="33" length="3"/>
        <text>CMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_8-B</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Representative APs (1 Hz) of VM and AM in the CCh, to activate IK,ACh and subsequent addition of XEN-R0703. AP parameters are shown in Supplementary Table S9.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">203</infon>
        <infon key="identifier">CL:0002131</infon>
        <location offset="31" length="2"/>
        <text>VM</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">204</infon>
        <infon key="identifier">CL:0002129</infon>
        <location offset="38" length="2"/>
        <text>AM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403042 Figure_8-C-D</id>
    <infon key="sourcedata_document">1380</infon>
    <infon key="doi">10.15252/emmm.201404757</infon>
    <infon key="pmc_id">4403042</infon>
    <infon key="figure">Figure 8-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Experiments performed in RAP conscious dogs in the presence of vehicle or following 1, 3 and 10 mg/kg XEN-R0703 show (C) mean right AERP values (left), mean Van de Water's QTc (right) and (D) AF inducibility plotted as a function of dose. Data information: For RAP dog experiments, n = 5; statistical significance tested with paired t-test. Data are presented as mean ± SEM. AERP = atrial effective refractory period; AF = atrial fibrillation; RAP = rapid atrial pacing; N.S. = not significant. Other abbreviations as in Figs3, 6 and 7.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_1-A</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Phase contrastimages of Mabs cultured into PF hydrogels (5 days): cells formed a thick three-dimensional myotube network with numerous thick myofibres (arrows). Scale bar: 50 μm.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">2</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="26" length="4"/>
        <text>Mabs</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">3</infon>
        <infon key="identifier">CL:0002372</infon>
        <location offset="107" length="7"/>
        <text>myotube</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_1-B</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Confocalimmunofluorescence analysis with an antibody against myosin heavy chain (MyHC) (red) and SYTOX green which labels nuclei (green), showing multi-nucleated, mature musclefibres (arrows) developed from Mabs in PF (5 days). Scale bar: 50 μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">12</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="209" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_1-C-D</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Western blot and densitometry analysis of different protein extracts of Mabs differentiated inside PF constructs (PF) showing expression levels comparable to adult TA (Ctrl). Group of n = 6 of Mabs differentiated inside PF and host TA has been tested, densitometric analysis from n = 3 different Western blots gauging the level of expression of muscle markers is presented as means ± standard error.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="77" length="4"/>
        <text>Mabs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">21</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="198" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-A-B-C-D</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A Gross morphology of the PF implant containing Mabs-nLacZ/PlGF immediately after implantation on the surface of underlying TA (arrow). B, C Artificial muscles (arrows) developed within 8 weeks over the host TA surface (arrowheads), encapsulated by the host perimysium (B) and released after tendon resection of the TA (C). D The isolated artificial muscle from the TA surface (arrow) is comparable in size to the underlying host TA (arrowhead).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">35</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="48" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-E</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Stereomicroscopy images revealing blood vessel formation in the artificial muscle. Scale bar: 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-F</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F X-Gal and H&amp;E staining on artificial muscle section revealing vessel connection with host vasculature by Indian ink, injected into the femoral artery immediately before sacrifice. Scale bar: 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-G-H</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G Western blot analysis of protein extracts from artificial muscles (PF) and host TA (Ctrl) reveals remarkable expression of muscle- and vessel-specific proteins (n = 5).</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-I-J-K-L</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-I-J-K-L</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I-J-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>I-L X-Gal and H&amp;E staining of artificial muscle sections at 4 (I, K) and 8 weeks (J, L) after implantation, showing donor origin of muscle cells (nLacZ+ nuclei) and correlation between implant duration and myofibre maturation (I, J images are the results of the collage of several photos). Scale bar: (I, J) 200 μm, (K, L) 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-M-N-O-P</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-M-N-O-P</infon>
    <infon key="sourcedata_figure_dir">Figure_2-M-N-O-P</infon>
    <passage>
      <offset>0</offset>
      <text>M-P Immunofluorescence analysis on adjacent sections revealing laminin organization (green) and myosin heavy chain (MyHC) expression (red) at 4 weeks (M) and 8 weeks (N) after grafting (M, N displayed items are obtained from a multi-photo collage); DAPI staining (blue) shows centrally located nuclei in developing fibres (O) and peripheral nuclei in mature myofibres (P). Scale bar: (M, N) 200 μm, (O, P) 50 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-Q</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-Q</infon>
    <infon key="sourcedata_figure_dir">Figure_2-Q</infon>
    <passage>
      <offset>0</offset>
      <text>Q Confocal isosurface image of neurofilament (green) and bungarotoxin (red) immunofluorescence in the artificial muscle section shows a mature neuromuscular plaque. Scale bar: 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-R</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-R</infon>
    <infon key="sourcedata_figure_dir">Figure_2-R</infon>
    <passage>
      <offset>0</offset>
      <text>R Immunofluorescence against smooth muscle actin (blue), laminin (green) and VE-Cad (red) superimposed on phase contrast image shows blood vessels (arrows) adjacent to the myofibres in the artificial muscle section. Scale bar: 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_2-S</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 2-S</infon>
    <infon key="sourcedata_figure_dir">Figure_2-S</infon>
    <passage>
      <offset>0</offset>
      <text>S X-Gal staining on mature artificial muscle (arrowhead) and the underneath host TA (arrow) revealing no tendon development at the extremity of the artificial tissue; implanted LacZ-positive Mabs are present within the host TA. Scale bar: 200 μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">110</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="191" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-A</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Electron microscopy with Bluo-Gal staining reveals a LacZ-positive donor nucleus (arrow) peripheral to transversely sectioned sarcomeres of the artificial muscle. Scale bar: 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-B</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Longitudinal EM section of an artificial muscle showing mature sarcomeremyofibril organization. Scale bar: 0.5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-C</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C A single fibre from an artificial muscle showing a striation pattern typical of a mature myofibre. Scale bar: 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-D</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D X-Gal staining of freshly dissected artificial muscle bundle at 8 weeks showing abundant LacZ-positive donor nuclei. Scale bar: 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-E-F</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E Immunofluorescence analysis of LacZ-positive nuclei (green) and dystrophin (red) in an individual muscle fibre after functional analysis. Scale bar: 10 μm. F The same fibre shown in (E) is counterstained with DAPI to show that the interstitial nuclei (blue) are of donor origin. Scale bar: 10 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">136</infon>
        <infon key="identifier">CL:0008002</infon>
        <location offset="100" length="12"/>
        <text>muscle fibre</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-G-H-I</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-G-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>G-I Specific force (Po/CSA) (G), maximum shortening velocity (Vo) (H), and cross-sectional area (CSA) (I) of single fibres (n = 153) from artificial muscles and control (CTRL) muscles (n = 103).</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-J</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-J</infon>
    <infon key="sourcedata_figure_dir">Figure_3-J</infon>
    <passage>
      <offset>0</offset>
      <text>J Silver-stainedSDS-PAGE (8%) gel revealing myosin heavy chain (MyHC)-2B isoform expression in two single fibres of artificial muscles (lanes 1, 2) and a bulk muscle control sample from soleus muscle containing all four adult MyHC isoforms indicated in (K) (lane 3).</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_3-K</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 3-K</infon>
    <infon key="sourcedata_figure_dir">Figure_3-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Comassie blue-stained SDS-PAGE (8%) of bulk samples of two artificial muscles (lanes 1, 2) and of a bulk control muscle sample (lane 3), as in (J), showing different MyHC isoform expression.</text>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_4-A-B</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B Gross morphology of the TA injury at 6 months after massive muscle ablation, revealing the new artificial TA regeneration (arrow) when grafted with PF-embedded Mabs-PlGF (B) and absence of TAmuscle (arrow) when treated with empty PF as a control (A).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">178</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="165" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_4-C</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C PF-embedded Mabs-PlGF-derived artificial TA (right) showing comparable size to the wild-type normal TA (left).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">185</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="14" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_4-D-O</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 4-D-O</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-O</infon>
    <passage>
      <offset>0</offset>
      <text>D-O Immunofluorescence against myosin heavy chain (MyHC) (red) and laminin (green) on miceTA cross sections at early (10 days) (D-I) and later stage (6 months) (J-O) after massive removal of the muscle (D, G, J, M are the results of a collage of several photos). TA regeneration at early stages showed very few residual myofibres after implantation of acellular PF in place of the ablated TA (white box in D), an enlarged view (E), and DAPI-counterstained view (F) reveals the infiltration of undifferentiated mono-nucleated cells. Conversely, a PF-embedded Mabs-PlGF graft (G) demonstrated early-stage regeneration with several MyHC-positive (red) regenerating myofibres surrounded by laminin (green) (H), most of these (arrows) being centre-nucleated (DAPI labelled in I). At the later stages, acellular PF implanted mice (J) showed a very small portion of muscle tissue likely derived from residual myofibres from TA removal, higher magnification (K) revealed very few mature myofibres with peripheral nuclei (DAPI labelled in L). Contrary, the PF-embedded Mabs-PlGF treatment (M) showed a complete replacement of the ablated TA with the recovered native structure of MyHC-positive myofibres surrounded by laminin (N), some of these (arrows) still being centre nucleate (DAPI labelled in O). Scale bar: (D, G, J, M) 500 μm, (E, F, H, I, K, L, N, O) 100 μm.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">202</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="558" length="4"/>
        <text>Mabs</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="1060" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_4-P-Q-R</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 4-P-Q-R</infon>
    <infon key="sourcedata_figure_dir">Figure_4-P-Q-R</infon>
    <passage>
      <offset>0</offset>
      <text>P-R Functional analysis demonstrated the effective ability of the PF and Mabs-PlGF combination to generate a complete and functional artificial TA replacing the ablated TA injury. (P) The fore-hind limb grip test diagram reveals functional grab force recovery for mice treated with PF-embedded Mabs-PlGF (TA ABL-PF+MABS) after only 4 weeks post-TA injury, being comparable with not-ablated wild-type (WT) mice and significantly higher than control ablated mice (TA ABL-CONT) or mice implanted with void PF (TA ABL-PF CONT) (n = 10 mice per group). (Q, R) The treadmill analysis of the treated mice relative to wild-type not-ablated (wt) shows both exhaustion time and distance indicative of a full recovery of motor functionality already at 3 weeks after TA ablation with an increase in time and distance run for mice treated with PF-embedded Mabs-PlGF, while control mice (TA ABL-CONT or TA ABL-PF CONT) showed a much lower resistance (n = 10 mice per group). The values shown in the diagrams are expressed as means ± standard error and statistical significance was tested using Student's t-test (P &lt; 0.05 was considered significant).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">229</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="73" length="4"/>
        <text>Mabs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">235</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="294" length="4"/>
        <text>Mabs</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">226</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="315" length="4"/>
        <text>MABS</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">252</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="843" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4403043 Figure_4-S-Z</id>
    <infon key="sourcedata_document">1382</infon>
    <infon key="doi">10.15252/emmm.201404062</infon>
    <infon key="pmc_id">4403043</infon>
    <infon key="figure">Figure 4-S-Z</infon>
    <infon key="sourcedata_figure_dir">Figure_4-S-Z</infon>
    <passage>
      <offset>0</offset>
      <text>S-Z Morphological analysis demonstrated the effective ability of the PF and Mabs-PlGF combination to generate a complete and functional artificial TA replacing the ablated TA injury. H&amp;E staining of TA injury in mice by cross section at an early (10 days) (S-V) and late (6 months) (W-Z) time point after ablation (in S, U, W, Y displayed items are obtained from a multi-photo collage). At the early time point, the acellular PF-treated mice revealed few mature muscle fibres that survive the massive ablation (box in S) signs of continued muscle degeneration (arrows in T), whereas PF-embedded Mabs implanted mice showed remarkable muscle regeneration indicated by centre-nucleated myofibres (arrows in V). At later stages, the control mice grafted with acellular PF showed an almost devoid TA (W) with very few muscle fibres (X), in contrast to PF-embedded Mabs, which exhibited a complete muscle replacement generating an artificial TA (Y), enlarged view (Z) proved the complete and mature organization of the newly formed muscle showing capillary and blood vessel around myofibres (arrows). Scale bar: (S, U, W, Y) 500 μm, (T, V, X, Z) 50 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">264</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="76" length="4"/>
        <text>Mabs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">274</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="595" length="4"/>
        <text>Mabs</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">283</infon>
        <infon key="identifier">CL:0000134</infon>
        <location offset="859" length="4"/>
        <text>Mabs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_1-A</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A CcnomRNA is expressed in the embryonic node at E8 as shown by in situ hybridization. Occasionally, additional expression is observed at the posterior tip of the embryo (asterisk). Double labelling by staining for LacZ expression from the CcnoTA allele (shown in B) and in situ hybridization for Dand5, marking crown cells at the circumference of the node. Ccno expression is restricted to ciliated, ventral pit cells of the node as detailed in the transverse section at the indicated plane.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <location offset="312" length="11"/>
        <text>crown cells</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">15</infon>
        <location offset="409" length="9"/>
        <text>pit cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_1-C</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Whole embryoX‐Gal staining of E16 CcnoTA/+ and wild‐type control embryos and indicated section planes of (D-F').</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_1-D-E-F</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 1-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>D-F' Histological sections of LacZ‐stained CcnoTA/+embryo at E16 reveal Ccno expression in the epithelium of (D) plexus choroideus and ependyme, (E) snoutepithelium, and (F, F') trachea and bronchi. pc, plexus choroideus; se, snoutepithelium; tr, trachea; and br, bronchus.</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_1-G</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Co‐expression of Ccno and Foxj1 in multiciliated cells of the trachea shown by double staining for X‐Gal and immunohistochemistry using a FOXJ1‐specific antibody.</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_2-A</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Ccno‐deficient mice develop severe hydrocephalus resulting in characteristic head deformation at P21 (arrow).</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_2-B-C</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Cranial MRI analysis (B) shows the drastically enlarged ventricular cavity (marked by V) and diminished cerebral cortex tissue, (C) also seen when brains are cut in coronal orientation.</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_2-D</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, D' Alcian‐blue staining of paranasal cavities reveals mucus congestion along the nasal epithelium (arrows).</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_2-F</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F, F' Scanning electron microscopy (SEM) of P21 adult trachea shows reduced numbers of cilia of Ccno‐deficient MCCs. Remaining cilia are found in the central regions of the cell surface, and cell margins frequently lack the ciliary decoration (arrows).</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_2-G</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Transmission electron microscopy (TEM) of wild‐type and CcnoRA/RAMCCs from adult trachea. Ccno‐deficient MCCs show reduced numbers of basal bodies and cilia that correctly docked to the apical cell surface (arrows). Ectopic electron‐dense material is found within the cytoplasm of Ccno‐deficient MCCs (arrowheads).</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">261</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="67" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">262</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="107" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">283</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="298" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_3-A</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A-H X‐Gal‐staining of (A-C) control and (D-H) CcnoTA/+ embryonic lungs at indicated stages showing onset of Ccno expression from E13 in the proximal trachea and in the main bronchi. Expression is extending to more distal regions, and from E16 staining is also found in bronchioli. I X‐Gal‐staining indicating LacZ expression from the CcnoTA/+ allele in mTEC cultures after 5 days of differentiation‐onset by switching to air-liquid interface (ALI) conditions (ALI d5).</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_3-J</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 3-J</infon>
    <infon key="sourcedata_figure_dir">Figure_3-J</infon>
    <passage>
      <offset>0</offset>
      <text>J Transcript levels of Ccno and indicated genes with known functions for the generation of multiple cilia during mTEC differentiation. mRNA levels from three independent experiments were measured by qRT-PCR and levels of expression set as 1 on day 0 of ALI cultures. Scales for Ccno and Deup1 are indicated on the left, and for Cep152, Cep63 and Ift57 on the right side.</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_3-K</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 3-K</infon>
    <infon key="sourcedata_figure_dir">Figure_3-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Relative mRNA expression levels for indicated genes were measured by qRT-PCR in wild‐type and Ccno‐deficient mTEC cultures at indicated days after differentiation‐onset. Relative values were calculated as in (J) relative to day 0 of ALI cultures.</text>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_4-A-B</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A-B' SEM of tracheae from (A, A') wild‐type and (B, B') CcnoRA/RAembryos at E17. In comparison to wild‐type MCCs, Ccno‐deficient MCCs almost completely lack formation of multiple cilia and only single, or doublet (arrow) cilia are observed at E17.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">123</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="108" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">127</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="129" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_4-C-D-E</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 4-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>C-E The lack of multiple cilia at E17 stages is reflected by the almost complete absence of acetylated α‐tubulin staining as marker for axonemes in (D) Ccno‐deficient MCCs of E17 embryonic trachea as quantified in (E). FOV, field of view.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">133</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="167" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_4-F-G-H-I</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 4-F-G-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F-G-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>F-I TEM of MCCs from E17 embryonic tracheae shows deuterosomes with forming procentrioles in (F, F', H) Ccno‐proficient and (G, G', I) Ccno‐deficient MCCs. Asterisks in (F, G) indicate microvilli that extend from the apical cell surface. (F', G') Deuterosomes in Ccno‐deficient MCCs are significantly enlarged (identical size bars in F' and G') and show irregular morphology, which is different to the annular shape of wild‐type deuterosomes as seen in (F', H). Procentrioles (arrowheads in F' and I) that are found at deuterosomes of (I) Ccno‐deficient MCCs were recurrently found being shorter and appeared less structured in comparison to (F', H) wild‐type cells.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">143</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="11" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">149</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="150" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">273</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="278" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">153</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="554" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_4-J-K</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 4-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_4-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>J The average length of procentrioles was quantified for wild‐type and Ccno‐deficient MCCs of E17 tracheae (49 procentrioles in n = 3 independent samples for wild‐types and 47 procentrioles in n = 3 independent samples for Ccno‐deficient MCCs). K The diameter of deuterosomes (41 deuterosomes in n = 3 independent samples for wild‐types; 38 deuterosomes in n = 5 independent samples for Ccno‐deficient MCCs) was measured in wild‐type and Ccno‐deficient MCCs of E17 tracheae.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">157</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="86" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">162</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="238" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">169</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="402" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">276</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="453" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_5-A</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Double IF analysis of mTEC cultures at early stage of MCC differentiation and centriole amplification (ALI day 3) using antibodies for the deuterosome protein DEUP1 and the early centriole marker SAS‐6. Deuterosome numbers are decreased and deuterosome size enlarged in Ccno‐deficient MCCs as quantified in (C). Deuterosome‐dependent centriole biogenesis is severely reduced in Ccno‐deficient MCCs as shown by reduced staining for the early centriole marker SAS‐6.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">174</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="54" length="3"/>
        <text>MCC</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">183</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="285" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">187</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="393" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_5-B</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>IFstaining for DEUP1 reveals a further size increase of deuterosomes of Ccno‐deficient MCCs at later stages of centriole biogenesis (ALI day 7). Deuterosome number and size were quantified in (C). IF using a Centrin antibody shows globally reduced presence of centrioles at ALI day 7, which stay localized below the level of deuterosomes and fail to dock to the apical cellmembrane in Ccno‐deficient MCCs as seen in z‐projection.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">198</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="87" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">204</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="400" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_5-C</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>IFstaining for DEUP1 in (A, B) was analysed by Imaris 7.7.2 software to calculate average deuterosome number of wild‐type (n = 17) and Ccno‐deficient (n = 19) MCCs at ALI day 3, and wild‐type (n = 12) and Ccno‐deficient (n = 14) MCCs at ALI day 7. Deuterosome size was measured using the spot measurement tool in n = 10 MCCs for both genotypes at ALI day 3, and in wild‐type (n = 12) and Ccno‐deficient (n = 14) MCCs at ALI day 7.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">212</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="159" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">214</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="229" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="320" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">279</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="412" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_6-A-B</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 6-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B IF analysis of mTEC cultures at ALI day 7 using antibodies against the centriole marker Centrin and CEP164, which marks maturing centrioles. At ALI day 7, centrioles of wild‐type MCCs are decorated with CEP164 and are mostly localized to the apical cellmembrane. The fewer centrioles of Ccno‐deficient MCCs do not colocalize with CEP164 and fail to reach the apical cell surface as seen in z‐projection. Lack of CEP164 indicates immature centrioles in Ccno‐deficient MCCs. (B) Total centriole numbers per MCC were counted in n = 11 MCCs for both genotypes using Imaris 7.7.2 software.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">227</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="184" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">231</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="307" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">235</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="472" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">237</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="510" length="3"/>
        <text>MCC</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">21</infon>
        <infon key="sourcedata_article_annot_id">238</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="537" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4406653 Figure_6-C-D</id>
    <infon key="sourcedata_document">1991</infon>
    <infon key="doi">10.15252/embj.201490805</infon>
    <infon key="pmc_id">4406653</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Double IFstaining using Centrin‐ and CP110‐specific antibodies shows an almost complete absence of CP110 from Centrin‐positive centrioles in the majority of wild‐type MCCs at day 7 of ALI cultures. Most Ccno‐deficient MCCs exhibit pronounced CP110 staining that colocalizes with Centrin as seen in z‐projection. (D) CP110‐positive MCCs were counted in wild‐type and Ccno‐deficient MTEC cultures and the percentages of CP110‐positive MCCs from total MCCs calculated.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">248</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="172" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">281</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="223" length="4"/>
        <text>MCCs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">252</infon>
        <infon key="identifier">CL:0000064</infon>
        <location offset="336" length="4"/>
        <text>MCCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_1-A-E</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 1-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>A-E Microvascular leak and tumor cell extravasation were modeled in vitro using modified Boyden chamber experiments where lungHMVECs (A-C) and dermalHMVECs (D-E) were grown to 100% confluence over 8-μm-pore insert membranes. ECs were first treated with Vasculotide (VT), PBS (vehicle/negative control), Ang1 (positive control), PEG-Cys (polyethylene glycol backbone), T7c (non-PEGylated CHHHRHSF peptides), or VT in the presence of 100-fold molar excess of T7c. The concentrations used, 10-20 ng/mL VT and 200-400 ng/mL Ang1, are estimated molar equivalents (0.71-1.43 nM). Thirty minutes later, ECs were stimulated with thrombin, 0.1% BSA (vehicle/negative control), or EDTA (positive control). Another 30mins later, the amount of FITC-dextran diffusion into the lower chambers (A, D) provides a measure of endothelial permeability. CMTPX-labeled tumor cells (TCs) were then dispensed into inserts, and the amount of TC fluorescence emitting from the underside of insert membranes after 20 h (B-C) or 28 h (E) reflects the efficiency of trans-endothelial TC migration. Representative fluorescent images (10×) of membrane undersides are shown in (C), where DAPI-stained nuclei of ECs/TCs are shown in blue, 'extravasated' CMTPX-labeled TCs are shown in red, and the # of CMTPX+ pixels are shown numerically in red. Means ± SEM are shown (A,B,D,E). Three experiments (twice with HMVEC-LBl and once with HMVEC-DBl) were run with n = 3-5 inserts (independent biological replicates) per group and analyzed by two-sampled unpaired t-tests.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="126" length="6"/>
        <text>HMVECs</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">24</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="149" length="6"/>
        <text>HMVECs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="225" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">21</infon>
        <infon key="sourcedata_article_annot_id">29</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="596" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="22">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">22</infon>
        <infon key="sourcedata_article_annot_id">31</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="1180" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">23</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="1378" length="5"/>
        <text>HMVEC</text>
      </annotation>
      <annotation id="23">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">23</infon>
        <infon key="sourcedata_article_annot_id">36</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="1402" length="5"/>
        <text>HMVEC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_2-A-H</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 2-A-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-H</infon>
    <passage>
      <offset>0</offset>
      <text>A-H LM2-4luctumor cells were implanted intravenously into SCIDmice, generating predominantly lung-specific metastases in one experiment (n = 5-6; A-D) and predominantly lymphatic-specific metastases in another experiment (n = 12; E-H). (C and G) Photographs of typical metastases in the lungs and caudal lymphatics, respectively. Kaplan-Meier survival analysis showed that Vasculotide (VT) significantly delayed mortality due to lungmetastases (A) but not lymphaticmetastases (E). Quantitative analysis of in vivo bioluminescent images taken at 24DPI (B) showed that concurrent VT treatment effectively reversed the sunitinib (SU)-induced acceleration of lungmetastases (D). With regard to lymphaticmetastases (F, H), SU treatment did not accelerate their progression. Geometric means ± 95%CI are depicted in (D and H); P values were derived by one-way ANOVA (D) and Kruskal-Wallis test (H). The same trends were reproduced in confirmatory experiments summarized in Supplementary Fig S5.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_3-A-D</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 3-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-D An experiment where HT29luctumor cells were implanted intravenously into YFP-SCIDmice. (A) Kaplan-Meier survival analysis. (B) Quantification of total metastatic burden in the liver and lymphatics, at 35 days post-implantation (DPI), from whole-body bioluminescent imaging (C). (D) Photograph of typical livermetastases.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_3-E-F-G</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 3-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>E-G An experiment where SN12luctumor cells were implanted intravenously into YFP-SCIDmice. (E) Kaplan-Meier survival analysis. (F) Quantification of total metastatic burden at 50DPI, mostly within the lungs, from whole-body bioluminescent imaging (G).</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A, B In modified Boyden chamber experiments, confluent dermalHMVECs were stimulated with tumor cell-conditioned media (TC-CM)-that is, media conditioned by either LM2-4luc, SN12luc, or HT29luctumor cells-and treated with 20 ng/mL Vasculotide vs. 400 ng/mL Ang1 (positive control) vs. PBS (negative control). Meta-analyses of treatment effects on dextran permeability (A) and tumor cell migration (B), where each datapoint represents the mean of an independent experiment, averaged over 2-3 biological replicates (inserts) per treatment group and normalized internally within that same experiment. Statistical significance of overall Ang1 or VT treatment effects was determined by paired t-tests, n = 11 (A) or 6 (B) experimental replicates. C Representative fluorescent images (10×) of 'extravasated' CMTPX-labeled TCs (red) fixed on membrane undersides.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">99</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="61" length="6"/>
        <text>HMVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_4-D</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D LM2-4luc produced the highest levels of VEGF and IL-8, but lower levels of IL-6, compared to other TC types; ***P &lt; 0.001 and *P &lt; 0.05 (unpaired t-tests).</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_5-A-B-C</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 5-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C Vasculotide (VT) did not alter the growth kinetics of orthotopic LM2-4luctumors; n = 8 mice per group. Sunitinib (SU) treatment significantly lowered primary tumor burden as measured by volume (B: one-way ANOVA, P &lt; 0.01) or bioluminescent activity (C: one-way ANOVA, P &lt; 0.001).</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_5-D</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D VT treatment did not alter the mean thickness of the viable peripheral regions of primary tumors, as quantified by H&amp;Ehistological staining.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_5-E</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E VT treatment did not alter the mean thickness of the CAIX+ hypoxic edge between the viable periphery and necrotic core of a primary tumor; IHC control and sample images taken at 5× are shown.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_5-F</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Ex vivo bioluminescent imaging suggests that VT treatment lowered the proportion of mice with metastatic involvement in the lungs, without the corresponding effect on lymphaticmetastases. Representative bioluminescent vs. photographic images of dissected lungs in a 24-well plate are shown.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_5-G</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G HumanLM2-4luc cells can be identified on histological sections of mouselung tissue by IHC staining of human vimentin, a cytoskeletal protein. Size distribution analysis show VT monotherapy reducing the occurence of bigger metastatic nodules.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_6-A</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Kaplan-Meier survival curves. Number of days gained in median survival due to treatments is listed in brackets. Yellow arrows mark the timepoints at which the bioluminescent images were taken.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_6-B-C-D</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 6-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B Bioluminescent images of tumor burden. C-D Total bioluminescent fluxes, at 35 days post-implantation (while the 'SU_3 wk' group was still receiving 60 mg/kg/day sunitinib treatment), were separately quantified from the thoracic (C) and abdominal (D) regions. Geometric means and P values from Mann-Whitney tests are depicted in (C and D). Percentages listed below the x-axes in panels (C and D) refer to treatment-associated changes in the geometric mean bioluminescence, relative to the vehicle group.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_7-A-F</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 7-A-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-F</infon>
    <passage>
      <offset>0</offset>
      <text>A-F Primary humanumbilical vein endothelial cells (HUVECs) or primary humandermalmicrovascular endothelial cells (HMVEC-DBls) were stimulated at 80% confluency with Vasculotide (treatment), Ang1 (positive control; ligand of Tie2), PBS (vehicle control), or VEGF (negative control; non-ligand of Tie2). Tie2 was immunoprecipitated from cell lysates and immunoblotted for total Tie2 or phosphotyrosine. Vasculotide treatment did not lead to increases in the pTie2/Tie2 ratio in HUVECs after 45-min (A-D) or 15-min (E) treatments, with (E) or without (A-D) serum/supplement starvation. Vasculotide also did not activate Tie2 receptors in HMVEC-DBls, whether in the presence or absence of serum, growth factor, and cytokine supplements (F).</text>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">211</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="51" length="6"/>
        <text>HUVECs</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">194</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="81" length="31"/>
        <text>microvascular endothelial cells</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">198</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="114" length="5"/>
        <text>HMVEC</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">218</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="476" length="6"/>
        <text>HUVECs</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">205</infon>
        <infon key="identifier">CL:2000008</infon>
        <location offset="635" length="5"/>
        <text>HMVEC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_8-A-B</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 8-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Healthy non-tumor-bearing mice (n = 8-9 per group) were treated for 1 week with vehicle (Veh); Vasculotide 250 ng/2 days IP (VT); sunitinib 60 mg/kg/day PO (SU); or VT + SU. Tie2immunoprecipitates from lung, kidney, or liver homogenates were pooled from two mice per treatment group and immunoblotted with an anti-Tie2 antibody ('Tie2') or an anti-phosphotyrosine antibody ('p-Tie2'). Densitometry analysis of immunoblots from (A). pTie2/Tie2 ratios were internally normalized to the vehicle group within each blot. Means ± SEM and P values (unpaired t-tests) are depicted.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_9-A</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>A-B Pull-down assay. Input ligands-rhAng1 (A) and VT (B)-were incubated with either protein A sepharose beads only, bead-conjugated mouseTie2-Fc (mTie2), or bead-conjugated humanTie2-Fc (hTie2). The 'bound' fraction shows the total amount pulled down by beads. The 'unbound' fraction is 7% of residual/free ligands remaining in the supernatant.</text>
    </passage>
  </document>
  <document>
    <id>4459817 Figure_9-B</id>
    <infon key="sourcedata_document">1471</infon>
    <infon key="doi">10.15252/emmm.201404193</infon>
    <infon key="pmc_id">4459817</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>C Quantitative kinetics analysis by SPR. All analytes were run at increasing concentrations of 0.625, 1.25, 2.5, 5, and 10 nM, at 37°C and pH 7.4. The positive controls-rhAng1, BowAng1, COMP-Ang1-all bound strongly to immobilized hTie2-Fc. There was no detectable binding of VT, or the negative control, rhVEGF, to immobilized hTie2-Fc.</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_1-A-F</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 1-A-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-F</infon>
    <passage>
      <offset>0</offset>
      <text>A-F (A-C) Exercise performance on a treadmill apparatus using an intense exercise (incremental speed paradigm) that relies solely on anaerobic metabolism. (D-F) Exercise performance on a treadmill apparatus using a moderate exercise (constant sub-maximal speed) that relies on the recruitment of aerobic metabolism and that is representative of endurance exercise. (A, D) Kaplan-Meier curves representing values corresponding to the percentage of mice still running at a given time point. (B, E) Median values of the time that mice ran are represented in the min to max graphical representation; 15.5 min for wild-type (WT) and 14.33 min for SOD1G86R in (B); 59.33 min for WT and 65.43 min for SOD1G86R in (E). (C, F) Mean distance run ± SEM by WT and SOD1G86Rmice in (C) and by WT and SOD1G86Rmice in (F).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_2-A</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Grip test was performed to measure mousemuscle strength at different time points during disease progression. Graph represents the mean of percentage from initial force measured at 11 weeks ± SEM. At 13 weeks, *P = 0.03; at 14 weeks, P = 0.06; at 15 weeks, *P = 0.04 (n = 8 for WT and SOD1G86R, respectively, at 11-15 weeks, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_2-B</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>Electromyography (EMG) recordings were performed weekly during disease development, starting from 9 weeks of age. Spontaneous electrical activity was considered as positive EMG only for peak-to-peak amplitudes &gt; 50 μV. Left: The percentage of mice presenting with positive EMG in each age group are represented. Right: Representative examples of negative (EMG−) and positive (EMG+) electromyography profiles (n = 10 for WT and SOD1G86R, respectively, at 9-13 weeks and n = 8 and 7 for WT and SOD1G86R, respectively, at 15 weeks).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_2-C</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>Relative mRNA levels of denervation markers AChR (subunits α and γ) and MuSK were evaluated by qPCR at the indicated ages (65 and 105 days) in tibialis anterior (upper panels) and soleus (lower panels) of WT and SOD1G86Rmice. Graphs represent mean fold change ± SEM from age-matched WT (n &gt; 5). ***P-values versus WT: &lt; 0.0001 for AChRα, AChRγ, and MuSK in tibialis anterior; and **P-values versus WT: 0.001 for AChRα, and ***P-values versus WT: 0.0007 for AChRγ, 0.0002 for MuSK in soleus (n=7 and 8 for WT and SOD1G86R, respectively, at 65 days; n = 5 and 6 for WT and SOD1G86R, respectively, at 105 days; two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_2-D</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>Relative mRNA levels of muscle atrophy markers MuRF1 and Atg-1 were measured by qPCR at the indicated ages (65 and 105 days) in tibialis anterior (upper panels) and soleus (lower panels). Graphs represent mean fold change ± SEM from age-matched WT. ***P-values versus WT: &lt; 0.0001 for MuRF1 and Atg-1 in tibialis anterior; and **P-values versus WT: 0.007 for MuRF1 and P = 0.006 for Atg-1 in soleus (n = 7 and 8 for WT and SOD1G86R, respectively, at 65 days, n = 5 and 6 for WT and SOD1G86R, respectively, at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_3-A</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Enzymatic activity of phosphofructokinase in whole tibialis anterior muscle cytosolic homogenates is expressed as mean fold change ± SEM from age-matched WT at 65 days of age *P = 0.016 (WT n = 6, SOD1G86Rn = 7) and 105 days of age ***P &lt; 0.0001 (n = 5/genotype), two-way ANOVA followed by Fisher's LSD post hoc test. Data shown are representative of two independent experiments having similar results.</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_3-B</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>Pyruvate was measured in whole tibialis anterior muscle tissue homogenates. The mean fold change ± SEM compared to age-matched WT are represented with *P = 0.019 at 65 days of age (n = 5/genotype) and *P = 0.041 at 105 days of age (n = 4/genotype), two-way ANOVA followed by Fisher's LSD post hoc test. Data shown are representative of two independent experiments having similar results.</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_3-C</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>Left: Representative Western blot showing glycogen synthase and phosphorylated glycogen synthase levels. Right: Quantification represents the mean ratio of optical densities of glycogen synthase/P-glycogen synthase ± SEM. At 65 days of age n = 6/genotype, *P = 0.0162, and at 105 days of age n = 5/genotype, *P = 0.0163, two-way ANOVA followed by Fisher's LSD post hoc test.</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_3-D</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>Left: Representative microphotographs of PAS staining from WT and SOD1G86Rtibialis anterior cross-sections at 65 and 105 days of age showing glycogen-negative (light pink) and glycogen-positive (dark pink) fibers. Scale bar: 200 μm. Right: Quantification of glycogen-negative (−) and glycogen-positive (+) fibers at 65 and 105 days of age. For (−) fibers: **P-values versus WT: 0.0026 at 65 days and 0.0074 at 105 days, for (+) fibers: ##P-values versus WT: 0.0025 at 65 days and 0.0073 at 105 days (n = 5/genotype at 65 days and n = 4/genotype at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">95</infon>
        <infon key="identifier">CL:0008002</infon>
        <location offset="206" length="6"/>
        <text>fibers</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">98</infon>
        <infon key="identifier">CL:0008002</infon>
        <location offset="306" length="6"/>
        <text>fibers</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">100</infon>
        <infon key="identifier">CL:0008002</infon>
        <location offset="348" length="6"/>
        <text>fibers</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <infon key="identifier">CL:0008002</infon>
        <location offset="428" length="6"/>
        <text>fibers</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_4-A</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Relative mRNA levels of Pdk4 and Pdk2 evaluated by qPCR at the indicated ages in tibialis anterior of WT and SOD1G86Rmice. Graphs represent mean fold change ± from age-matched WT. Pdk4: **P-values versus WT: 0.014 at 65 days and 0.018 at 105 days; Pdk2: ***P-value versus WT &lt; 0.0001 at 105 days. n = 7 and 8 for WT and SOD1G86R, respectively, at 65 days; n = 5/genotype at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test.</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_4-B</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Relative mRNA levels of genes involved in lipid handling evaluated by qPCR at the indicated ages in tibialis anterior of WT and SOD1G86Rmice. Graphs represent mean fold change ± SEM from age-matched WT. P-values versus WT: Lpl **P = 0.0009, Cd36 *P = 0.051, Acsf2 ***P &lt; 0.0001 at 65 days, **P = 0.0059 at 105 days and Cpt-1β **P = 0.01 at 65 days and *P = 0.02 at 105 days (n = 6 and 7 for WT and SOD1G86R, respectively, at 65 days; n = 10 and 8 for WT and SOD1G86R, respectively, at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_4-C</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>Relative levels of (left) ATP and (right) NADH and NAD+ measured in total tibialis anterior homogenates of WT and SOD1G86Rmice. Left: Graphs represent mean fold change ± SEM in ATP from age-matched WT. **P = 0.002 (n = 9 and 12 for WT and SOD1G86R, respectively, at 65 days; n = 10/genotype at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test). Right: The amounts of NADH and NAD+ relative to protein content in whole tibialis anterior homogenates are represented as mean ± SEM. *P = 0.027 and **P = 0.001 (n = 5, Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_5-A-B-C-D</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 5-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-D Relative mRNA levels of (A) Pparß/δ, (B) Foxo1, (C) citrate synthase, and (D) Pgc-1α were evaluated by qPCR at the indicated ages in tibialis anterior of WT and SOD1G86R mice. Graphs represent mean fold change ± SEM from age-matched WT. P-values versus WT: Pparβ/δ **P = 0.0016 at 65 days; Foxo1 ***P = 0.0001 at 105 days, citrate synthase ***P &lt; 0.0001 at 105 days, Pgc-1α *P = 0.0104 at 105 days (n = 7 and 8 for WT and SOD1G86R, respectively, at 65 days; n = 5/genotype at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_5-E</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Representative Western blot of PGC-1α and respective actin that was used for normalization. PGC-1αprotein levels in tibialis anterior muscle tissue are represented as mean fold change ± SEM from age-matched WT. **P-values versus WT: 0.02 (n = 6/genotype at 65 days; n = 5/genotype at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_5-F</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Relative mRNA levels of ERRα, Mfn2, and Nrf1 were evaluated by qPCR at the indicated ages in tibialis anterior of WT and SOD1G86Rmice. Graphs represent mean fold change ± SEM from age-matched WT. P-values versus WT: ERRα ***P &lt; 0.0001, Mfn2 **P = 0.002 and Nrf1 **P = 0.009 (n = 6-7 and 7-8 for WT and SOD1G86R, respectively, at 65 days; n = 5 and 6 for WT and SOD1G86R, respectively, at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_6-A</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Mitochondrial DNA (mtDNA) was quantified using qPCR. Relative mtDNA levels are expressed as the ratio between mitochondrial-encoded gene Cox1 and the nuclear-encoded gene cyclophilin A. Graphs represent mean fold change ± SEM from age-matched WT for tibialis anterior (left panel) and soleus (right panel) of WT and SOD1G86Rmice. ***P &lt; 0.0001 (n = 5 and 4 for WT and SOD1G86R, respectively, at 65 days; n = 6/genotype at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_6-B</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>Relative mRNA levels of Gpx1 were measured by qPCR at the indicated ages in tibialis anterior (left panel) and soleus (right panel) of WT and SOD1G86Rmice. Graphs represent mean fold change ± SEM from age-matched WT. ***P &lt; 0.0001 (n = 7 and 8 for WT and SOD1G86R, respectively, at 65 days; n = 9 and 8 for WT and SOD1G86R, respectively, at 105 days, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_7-A-I</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 7-A-I</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-I</infon>
    <passage>
      <offset>0</offset>
      <text>A-I Relative mRNA levels of (A) Pdk4, (B) Pparβ/δ, (C) Foxo1, (D) Pfk1, (E) Acsf2, (F) citrate synthase, (G) PGC-1α, (H) Mfn2, and (I) Gpx1 were evaluated by qPCR in tibialis anterior of control (CT) or DCA-treated (DCA) WT and SOD1G86Rmice. Graphs represent mean fold change ± SEM from CT WT group. P-values versus WT: Pdk4 ***P = 0.002 and ##P = 0.0039, Pparβ/δ#P = 0.0178, Foxo1 **P = 0.0033 and ##P = 0.0038, Pfk1 ***P = 0.0002 and ##P = 0.0080, Acsf2 *P = 0.0437, citrate synthase###P = 0.0004, Pgc-1α **P = 0.0084 and ###P = 0.0009, Mfn2 *P = 0.0272, $P = 0.0145 and ###P = 0.0002 and Gpx1 ***P &lt; 0.0001 and ###P &lt; 0.0001 (n = 9/genotype in CT groups, n = 9 and 8 for WT and SOD1G86R, respectively, in DCA group, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_8-A</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>Grip strength is represented as mean of percent from T0 for each experimental group ± SEM. ##P = 0.0045 and ***P = 0.0003 (n = 9/genotype in CT groups, n = 9 and 8 for WT and SOD1G86R, respectively, in DCA group, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_8-B</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>Relative mRNA levels of muscular atrophy markers Murf1 and Atg-1 were measured by qPCR in tibialis anterior of control (CT) or DCA-treated (DCA) WT and SOD1G86Rmice. Graphs represent mean fold change ± SEM from CT WT group. **P = 0.0079 and ***P = 0.0018 (n = 9/genotype in CT groups, n = 9 and 8 for WT and SOD1G86R, respectively, in DCA group, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492815 Figure_8-C</id>
    <infon key="sourcedata_document">1449</infon>
    <infon key="doi">10.15252/emmm.201404433</infon>
    <infon key="pmc_id">4492815</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>Relative mRNA levels of denervation markers AChRα, AChRγ, and MuSK were measured by qPCR in tibialis anterior of control (CT) or DCA-treated (DCA) WT and SOD1G86Rmice. Graphs represent mean fold change ± SEM from CT WT group. **P = 0.015 for AChRα, #P = 0.028 and **P = 0.074 for AChRγ, #P = 0.042 and **P = 0.0029 for MuSK (n = 9/genotype in CT groups, n = 9 and 8 for WT and SOD1G86R, respectively, in DCA group, two-way ANOVA followed by Fisher's LSD post hoc test).</text>
    </passage>
  </document>
  <document>
    <id>4492820 Figure_2-A</id>
    <infon key="sourcedata_document">1437</infon>
    <infon key="doi">10.15252/emmm.201404430</infon>
    <infon key="pmc_id">4492820</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Orthotopic MPNST xenografts at passages 1 (OT P1) and 4 (OT P4) were histopathologically similar to their corresponding primary MPNST (PT) in hematoxylin-eosin staining of paraffin-embedded tumor sections from patients MPNST-NF1-001 and MPNST-SP-002. Main panels show a general view of the tumors at low magnification (40×); inset pictures were taken at higher magnification (400×).</text>
    </passage>
  </document>
  <document>
    <id>4492820 Figure_2-B</id>
    <infon key="sourcedata_document">1437</infon>
    <infon key="doi">10.15252/emmm.201404430</infon>
    <infon key="pmc_id">4492820</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>Orthotopic xenograft and primary MPNSTs exhibited similar immunohistochemical features. A representative immunostained section of vimentin, CD34, S100, and Ki-67 is shown for primary tumors (PT) and orthotopic tumors (OT) from patientsMPNST-NF1-001 and MPNST-SP-002. Positive antibody signals are shown in brown, and the hematoxylin counterstain in blue. Main panels show pictures at high magnification (400×); inset pictures show mitotic cells present in these tumors.</text>
    </passage>
  </document>
  <document>
    <id>4492820 Figure_3-A</id>
    <infon key="sourcedata_document">1437</infon>
    <infon key="doi">10.15252/emmm.201404430</infon>
    <infon key="pmc_id">4492820</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Stromal elements of the primary tumors were labeled with anti-humanCD34 but not anti-mouseCD34; patient-derived xenografts are labeled with anti-mouseCD34 only and no anti-human marker. Representative sections (at 40× and 400× magnification) of the primary tumors (PT) and the orthoxenograft tumors at passages 1 (OT P1) and 4 (OT P4) were labeled with anti-humanCD34 (H) and anti-mouseCD34 (M).</text>
    </passage>
  </document>
  <document>
    <id>4492820 Figure_3-B</id>
    <infon key="sourcedata_document">1437</infon>
    <infon key="doi">10.15252/emmm.201404430</infon>
    <infon key="pmc_id">4492820</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>Sanger sequencing of the germline NF1 mutation c.350T&gt;A present in the patient that developed two different tumors (MPNST-NF1-001 and MPNST-NF1-002). Sequencing results from normal tissue, primary tumor (PT), and orthotopic xenografttumors (OT) are shown. The sequence of the NF1 region revealed WT NF1 alleles in primary tumor samples, and not in the corresponding derived orthoxenografts, indicating probable loss of the human stromal cells.</text>
    </passage>
  </document>
  <document>
    <id>4492820 Figure_3-C</id>
    <infon key="sourcedata_document">1437</infon>
    <infon key="doi">10.15252/emmm.201404430</infon>
    <infon key="pmc_id">4492820</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>SNP array of primary tumor (PT) and orthotopic xenograft passages 1 (OT P1) and 4 (OT P4) for MPNST-NF1-001 and MPNST-NF1-002tumors. Results correspond to chromosome 17. Images show the B-allele frequency (BAF) for the different samples as scatter plots and the copy number callings below them represented by thick horizontal lines: 2n regions are shown in gray, gained regions in orange, lost regions in green, and LOH regions are represented in blue. The vertical red line indicates the location of the NF1 locus. In addition, the percentage of tumor versus stromal cells for each sample is represented in a pie chart (blue, stromal cells; red, tumor cells).</text>
    </passage>
  </document>
  <document>
    <id>4492820 Figure_7-A</id>
    <infon key="sourcedata_document">1437</infon>
    <infon key="doi">10.15252/emmm.201404430</infon>
    <infon key="pmc_id">4492820</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Tumorgrowth effects of treatment with doxorubicin, sorafenib, rapamycin and combinations thereof in the five MPNST xenograft models. Results are plotted as an average of the log2 ratio of tumor volume at different days relative to the initial value. Statistically significant differences are shown as *P &lt; 0.05 and **P &lt; 0.001 versus control group by the Bonferroni test.</text>
    </passage>
  </document>
  <document>
    <id>4492820 Figure_7-B</id>
    <infon key="sourcedata_document">1437</infon>
    <infon key="doi">10.15252/emmm.201404430</infon>
    <infon key="pmc_id">4492820</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>For long-term studies, a subgroup of treated mice (n = 3-5 mice/group) was kept alive for a maximum period of 4 months and sacrificed over time when relapsed tumor masses grew as large solid masses (usually 1,500-2,000 mm3). The graph illustrates differences in the time delay (in days) of relapsed tumor masses for the different treatments.</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_1-A-B</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>HumanAβ exhibits a biphasic profile in CSF of APP transgenic mice A, B Aβ40 and Aβ42 concentrations in CSF of male APP23 mice (heterozygous; 3 (n = 14), 6 (n = 12), 8 (n = 10), 12 (n = 11), 19 (n = 9), and 25 (n = 6) months of age). CSFAβ40 (F(1, 56) = 22.351, P &lt; 0.001) as well as CSFAβ42 (F(1, 56) = 38.597, P &lt; 0.001) followed a significant quadratic trend.</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_1-C</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Aβ42/40 ratio in CSF of APP23 mice showed a delayed decrease with age (F(1, 56) = 53.894, P &lt; 0.001).</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_1-D-E</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Aβ40 and Aβ42 concentrations in CSF of male and female APP24 mice (homozygous; 2 (n = 13), 3-4 (n = 16), 7-8 (n = 15), 18-19 (n = 14), 24 (n = 16), and 30 (n = 18) months of age). CSFAβ40 followed a significant quadratic trend (F(1, 86) = 6.678, P = 0.011) and CSFAβ42 best fitted a cubic trend (F(1, 86) = 30.599, P &lt; 0.001).</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_1-F</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Aβ42/40 ratio in CSF of APP24 mice showed a delayed decrease with age (F(1, 86) = 64.936, P &lt; 0.001).</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_1-G-H</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 1-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G, H Aβ40 and Aβ42 in the CSF of female APP51 mice (heterozygous; 3 (n = 6), 15 (n = 8), and 24 (n = 8) months of age; 22 mice in total). CSFAβ40 (F(1, 19) = 37.349, P &lt; 0.001) as well as CSFAβ42 (F(1, 19) = 107.670, P &lt; 0.001) followed a significant quadratic trend.</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_1-I</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 1-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I</infon>
    <passage>
      <offset>0</offset>
      <text>IAβ42/40 ratio in CSF of APP51 mice showed a delayed decrease with age (F(1, 19) = 26.367, P &lt; 0.001).</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_2-A</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>HumanAβ in CSF and brain of APP transgenic mice A APP23CSFAβ40 and Aβ42 in the same animals as shown in Fig1. CSFAβ42 and Aβ40 are expressed as percentages of levels measured in the youngest age group.</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_2-B-C</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Aβ40 and Aβ42 (pmol/g wet brain) in the FA-soluble brain extract from the same APP23mice showed a robust increase with age; ANOVA revealed a significant cubic trend (F(1, 56) = 221.114, P &lt; 0.001 and F(1, 56) = 370.947, P &lt; 0.001, respectively).</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_2-D</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D APP24CSFAβ40 and Aβ42 in the same animals shown in Fig1 as percentage of the youngest age group.</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_2-G</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G APP51 CSFAβ40 and Aβ42 in the same animals shown in Fig1 as percentages of levels in the youngest age group.</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_2-H-I</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 2-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>H, IAβ40 and Aβ42 (pmol/g wet brain) in the brain from the same APP51 mice showed a robust increase with age; ANOVA revealed a significant quadratic trend (F(1, 19) = 12.960, P = 0.002 and F(1, 19) = 19.366, P &lt; 0.001, respectively).</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_3-A</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Aβplaque pathology in the brains of APP23mice Aβimmunostaining (CN3 antibody, dark blue) in 25-μm sagittal brain sections shows only sparse Aβ deposits primarily in the frontal cortex of 6- to 8-month-old APP23mice. At 12 months and thereafter, there is a progressive increase in plaque number and size and a progressive involvement of different brain regions. Insets highlight the plaque characteristics at the different ages. Scale bar, 100 μm. The mean number of Aβ plaques per section per hemibrain increased with age in 3- to 12-month-old mice. Only four mice were analyzed in the 3-month-old age group, as APP23mice do not develop plaques at this age (Sturchler-Pierrat et al, 1997). The 6-, 8-, and 12-month-old age groups included 12, 10, and 11 mice, respectively (these are the same mice that were used for CSF and brainAβ measurements). Note that the Aβ plaques became too numerous and often could no longer be individually distinguished in the age groups &gt; 12 months of age. Data are represented as group means ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>4520655 Figure_4-A</id>
    <infon key="sourcedata_document">1492</infon>
    <infon key="doi">10.15252/emmm.201505026</infon>
    <infon key="pmc_id">4520655</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Brain sAPPβ shows an age-related increase in APP23, APP24, and APP51 mice sAPPβ was measured in Triton X-100brain extracts from largely the same mice as analyzed in Figs1 and2 and is expressed as percentages of levels measured in the youngest age group. Swedish sAPPβ showed an age-dependent increase in APP23mice following a linear trend (F(1, 83) = 52.914, P &lt; 0.001); APP23 from two independent batches were included in this analysis (see Materials and Methods and Supplementary Fig S2 for details). Swedish sAPPβ showed an age-dependent increase in APP24mice following a linear trend (F(1, 84) = 11.264, P = 0.001). Human wild-type sAPPβ showed an age-dependent increase in APP51 following a quadratic trend (F(1, 18) = 68.980, P &lt; 0.001). Data information: Post hoc Dunnett's test group comparisons were always conducted between the youngest group and all other groups. All data are represented as group means ± SEM; *P &lt; 0.05; **P &lt; 0.01; and ***P &lt; 0.001. For absolute values, see Supplementary Fig S2.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_1-C</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>TRF1immunofluorescence of the lungs. Notice the absence and presence of TRF1 signal in the carcinomas and surrounding healthy tissue of Trf1Δ/Δmice, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_1-D</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>Analysis of Trf1 excision by PCR. Notice the completed excision in carcinomas of Trf1lox/loxlungs.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_1-E</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>Detection of β-galactosidase activity in the lungs as a surrogate marker of oncogenic K-RasG12V expression.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_2-A-B</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Tumor growth curve of Trf1+/+K-Ras+/G12Vp53+/+ and Trf1Δ/ΔK-Ras+/G12Vp53+/+ measured by computed tomography (CT). Quantification of the number and size of Trf1+/+K-Ras+/G12Vp53+/+ and Trf1Δ/ΔK-Ras+/G12Vp53+/+carcinomas at death point.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_2-C</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>Percentage of tumors that have deleted Trf1 quantified by TRF1immunofluorescence after mice had been sacrificed. Post-mortem analysis of Trf1 deletion in each tumor revealed that none of the Trf1lox/lox K-Ras+/G12V p53+/+ ones had excised Trf1.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_2-D</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>Tumor growth curve and tumor growth slope of Trf1+/+ K-Ras+/G12Vp53−/− and Trf1−/− K-Ras+/G12Vp53−/− measured by CT.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_2-E</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>Tumor maximal section of Trf1+/+K-Ras+/G12Vp53−/− and Trf1Δ/ΔK-Ras+/G12Vp53−/−lungs measured by histological analysis before death point by CT.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_2-F-G</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 2-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>Maximum 18F-FDG-glucose uptake by Trf1+/+K-Ras+/G12Vp53−/− and Trf1Δ/ΔK-Ras+/G12Vp53−/−tumors 22 weeks after infection by positron emission tomography (PET). Representative PET-CT image of Trf1+/+K-Ras+/G12Vp53−/− and Trf1Δ/ΔK-Ras+/G12Vp53−/−lungs.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_2-H</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>Survival curve of Trf1+/+ K-Ras+/G12Vp53−/− and Trf1−/− K-Ras+/G12Vp53−/−mice.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_3-A</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Percentage of cells showing γH2AXfoci in carcinomas of the indicated genotypes (left panel). Representative images of γH2AX immunohistochemistry (right panel).</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_3-B</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>Percentage of cells showing 3 or more γH2AX and RAP1 colocalizing foci (TIFs) (left panel). Representative images of γH2AX and RAP1 double immunofluorescence (right panel). Yellow arrowheads: colocalization of γH2AX and RAP1.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_3-C</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>Percentage of active caspase-3 (AC3)-positive cells (left panel). Representative images of AC3 immunohistochemistry (right panel).</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_4-A</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Percentage of Ki67-positive cells in the carcinomas of the indicated genotypes (left panel). Representative images of Ki67immunohistochemistry (right panel).</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_4-B</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Percentage of pH3-positive cells in the carcinomas of the indicated genotypes (left panel). Representative images of pH3immunohistochemistry (right panel). Red arrowheads: pH3-positive cells.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_4-C-D-E</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 4-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>Percentage of giant nuclei in the carcinomas of the indicated genotype. Percentage of anaphase bridges out of total anaphases in the carcinomas of the indicated genotypes. Representative images of giant nuclei, multilobulated nuclei, anaphase bridges, and multipolar mitoses. Red arrowheads indicate the corresponding mitotic aberrations indicated in the image.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-A-B-C-D</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-C The latency (A), volume (B), and weight (C) of subcutaneous tumors generated by control and Trf1-downregulated K-RasG12V-transformed lung cells in athymic mice. D Representative images of the subcutaneous tumors.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-E</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Trf1 expression levels measured by qPCR in the injected cell line and in the generated subcutaneous tumors.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-F-G-H</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>F-H Number of Ki67-positive (F), number of γH2AX-positive (G), and number of active caspase-3-positive (H) cells per field in the subcutaneous tumors.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-I</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>I Representative images of aberrant giant nuclei and anaphase bridges in the Trf1-downregulated subcutaneous tumors compared to the normal nuclei of control tumors.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-J</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J</infon>
    <passage>
      <offset>0</offset>
      <text>J TRF1immunofluorescence shows the downregulation of Trf1 in lungtumors of the mice intravenously injected with control and Trf1-downregulated cells.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-K-L</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-K-L</infon>
    <infon key="sourcedata_figure_dir">Figure_5-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>K Tumor area measured in the lungs of the mice intravenously injected with control and Trf1-downregulated cells. L Representative images of the lungs colonized by control and Trf1-downregulated cells, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-M-N-O</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-M-N-O</infon>
    <infon key="sourcedata_figure_dir">Figure_5-M-N-O</infon>
    <passage>
      <offset>0</offset>
      <text>M-O Number of Ki67-positive (M), number of γH2AX-positive (N), and number of active caspase-3-positive (O) cells per field in the lungtumors.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-P</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-P</infon>
    <infon key="sourcedata_figure_dir">Figure_5-P</infon>
    <passage>
      <offset>0</offset>
      <text>P Trf1 expression levels measured by qPCR in the A549 cell line infected either with sh-scrambled or sh-Trf1.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_5-Q</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 5-Q</infon>
    <infon key="sourcedata_figure_dir">Figure_5-Q</infon>
    <passage>
      <offset>0</offset>
      <text>Q Growth of A549-derived tumors.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_6-B</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>Trf1 expression levels in the indicated tissues of wild-type and Trf1lox/lox hUBC-CreERT2mice subjected to a tamoxifen-containing diet for 7 weeks.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_6-C</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>Representative images of TRF1immunofluorescence and quantification of the percentage of TRF1-positive cells in skin and intestine sections of wild-type and Trf1lox/lox hUBC-CreERT2mice subjected to a tamoxifen-containing diet for 7 weeks.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_6-D</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>Survival curve of wild-type and Trf1lox/lox hUBC-CreERT2mice subjected to a tamoxifen-containing diet for 7 weeks.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_6-E</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of the histological alterations observed in tamoxifen-treated Trf1lox/lox hUBC-CreERT2mice and 4 months after tamoxifen retrieval compared to their wild-type counterparts.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_6-F</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of blood cell populations in wild-type and Trf1lox/lox hUBC-CreERT2mice subjected to a tamoxifen-containing diet for 7 weeks and after 3 weeks and 4 months of tamoxifen retrieval.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">293</infon>
        <infon key="identifier">CL:0000081</infon>
        <location offset="18" length="10"/>
        <text>blood cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_6-G</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>Trf1 expression levels in blood, intestine, skin, and bone marrow of Trf1lox/lox hUBC-CreERT2mice subjected to a tamoxifen-containing diet either for 7 weeks or for 6 months and after 3 weeks tamoxifen retrieval compared to wild-type mice.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_7-A</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of TRF1 levels by immunofluorescence in lungtumor-derived cell line treated with DMSO, with 10 μM ETP-47228 (24 h), and with 10 μM ETP-47037 (48 h). Representative images are shown to the right.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_7-B</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of γH2AX levels by immunofluorescence in lungtumor-derived cell line treated with DMSO, with ETP-47228 (24 h), and with ETP-47037 (48 h). Representative images are shown to the right.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_7-C</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of telomere-induced foci (TIFs) by double immunofluorescence with anti-RAP1 and anti-γH2AX antibodies. Representative images are shown to the right. White arrowheads: colocalization of γH2AX and RAP1.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_7-D</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>Effect of different ETP-47228 and ETP-47037 concentrations during 24 h on proliferation in lungtumor-derived cell line relative to the growth of DMSO-treated cells.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_7-E</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>Tumor growth quantification in allograft model ETP-47037 or with ETP-47228.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_8-B</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of tumorgrowth relative to initial tumor size. Representative CTimages are shown to the right. The white arrowhead indicates a tumor within a highly inflammatory region.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_8-C</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>Quantification of TRF1 levels by immunofluorescence in intestine and lungtumors samples of mice treated with vehicle or with ETP-47037 for 10 days. Representative images are shown to the right (n = 4).</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_8-D</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>Number of cells showing γH2AX foci in intestine and lungtumors samples of mice treated with vehicle or with ETP-47037 for 10 days. Representative images are shown to the right (n = 4).</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_9-A-B-C-D</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 9-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-C Quantification of the number of (A) Ki67-, (B) pan-nuclear p-H3 pattern-, and (C) foci p-H3 pattern-positive cells in untreated and ETP-470037-treated lungcarcinomas. The data represent the mean values obtained for three mice in each group. Error bars represent standard errors. D Representative Ki67 and p-H3 images.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_9-E</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 9-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Representative H&amp;Eimages of intestine samples corresponding to untreated and ETP-47037-treated animals. High-magnification images are shown to the right indicating the presence of normal mitosis, giant multinucleated and aberrant mitotic figures.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_9-F</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 9-F</infon>
    <infon key="sourcedata_figure_dir">Figure_9-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Representative H&amp;Eimages of bone marrow and skin samples corresponding to untreated and ETP-47037-treated animals. High-magnification images are shown indicating the presence of necrosis, hemosiderosis, multinucleated cells, and giant nuclei. Bone marrow showed moderated aplasia.</text>
    </passage>
  </document>
  <document>
    <id>4520658 Figure_9-G</id>
    <infon key="sourcedata_document">1491</infon>
    <infon key="doi">10.15252/emmm.201404497</infon>
    <infon key="pmc_id">4520658</infon>
    <infon key="figure">Figure 9-G</infon>
    <infon key="sourcedata_figure_dir">Figure_9-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Telomere length in untreated and ETP-47037-treated lungtumor samples. Representative images are shown to the right.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_1-A</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) Wild-type (WT) (BY4741) cells expressing GFP−Atg8 were grown to mid-log-phase in YPD and were then preincubated with 50 µM cerulenin or 50 µM cerulenin + 0.1 mM palmitic/stearic/myristic acids or with DMSO (-) in the rich medium for 30 min. Cells were washed and shifted to nitrogen-starvation medium (SD-N) for 4 h in the presence of 50 µM cerulenin or 50 µM cerulenin + 0.1 mM palmitic/stearic/myristic acids or DMSO. Cells were then lysed and subjected to SDS−PAGE, followed by western blot analysis using anti-GFP and anti-Pgk1 antibodies (A),</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_1-B</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) Wild-type (WT) (BY4741) cells expressing GFP−Atg8 were grown to mid-log-phase in YPD and were then preincubated with 50 µM cerulenin or 50 µM cerulenin + 0.1 mM palmitic/stearic/myristic acids or with DMSO (-) in the rich medium for 30 min. Cells were washed and shifted to nitrogen-starvation medium (SD-N) for 4 h in the presence of 50 µM cerulenin or 50 µM cerulenin + 0.1 mM palmitic/stearic/myristic acids or DMSO. Cells were then lysed and subjected to SDS−PAGE, followed by western blot analysis using anti-GFP and anti-Pgk1 antibodies (A), or were visualized by fluorescencemicroscopy (B)</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_1-C</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cells (TOS038) expressing Atg1-GFP were grown to mid-log phase and were then preincubated in YPD with 50 µM cerulenin or with DMSO for 30 min. Cells were washed, shifted to SD-N for 4 h, and then visualized by fluorescencemicroscopy. Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_1-D</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) WT (BY4741) and pep4∆ (TOS015) strains were grown to mid-log phase and preincubated in YPD with cerulenin or DMSO for 30 min. Cells were pulse-labeled for 10 min with [35S] methionine and cysteine and chased for the indicated time periods. Cell lysates were subjected to immunoprecipitation with anti-Ape1 antibodies followed by SDS‒PAGE and X-ray film to detect radioactive signals. prApe1, premature Ape1; mApe1, mature Ape1. (</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_1-E</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Cells of the fas1∆ (TOS029) strain expressing GFP‒Atg8 were grown to mid-log phase in YPD + 0.1 mM palmitic/stearic/myristic acids and shifted either to the same medium or to YPD without fatty acids for 30 min. Cells were then shifted to SD-N for the indicated times. Cell lysates were subjected to SDS‒PAGE, followed by western blot analysis using anti-GFP antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_1-F</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) WT (BY4741) cells were grown to mid-log phase and then preincubated in YPD with 25 µM or 50 µM cerulenin (25, 50) or with DMSO (-) in rich medium for 30 min. Cells were washed and shifted to SD-N in the presence of cerulenin (25, 50) or DMSO (-). Cells were lysed and subjected to SDS‒PAGE, followed by western blot analysis using anti-GFP and anti-Pgk1 antibodies. cer, cerulenin; DIC, Differential interference contrast; FA, fatty acids; SD-N, nitrogen-starvation medium; WT, wild-type YPD, complete medium.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_2-A</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Cells (TN124 strain) were grown to mid-log phase and preincubated in YPD with 50 µM cerulenin for the indicated time periods (Cer preincubation) or incubated with DMSO without preincubation] (-). Cells were then shifted to SD-N for 3 h with the addition of DMSO or 50 µM cerulenin (cer). Autophagic activity was measured by alkaline phosphatase assay. Error bars represent the s.e.m. of three independent experiments. *P &lt; 0.05 (Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_2-B</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Cells were grown as in (A), stained with BODIPY, and visualized by fluorescencemicroscopy. Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_2-C</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) WT (SCY62) and tagΔsteΔ (H1246) cells were grown to mid-log phase in YPD and shifted to SD-N for 3 h. Cells were stained with Nile red and visualized by fluorescencemicroscopy. Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_2-D</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) WT (SCY62) and tag∆ste∆ (H1246) cells expressing GFP−Atg8 were grown to mid-log phase in YPD and shifted to SD-N for the indicated time periods. Cell lysates were subjected to SDS−PAGE, followed by western blot analysis using anti-GFP, anti-Ape1 (prApe1, premature Ape1; mApe1, mature Ape1), and anti-Fas1 and anti-Pgk1 antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_2-E</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) WT (SCY62) and tag∆ste∆ (H1246) cells were grown to mid-log phase in YPD and shifted to SD-N for 2 h. GFP−Atg8 was visualized by fluorescencemicroscopy. Scale bar, 5 μm. cer, cerulenin; DIC, Differential interference contrast; FA, fatty acids; SD-N, nitrogen-starvation medium; WT, wild-type, YPD, complete medium.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_3-A</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) GAL-DGA1GAL-ARE2lro1Δ are1Δ (FYS118 strain) was grown on SC (synthetic minimal medium without dextrose) + raffinoseovernight, diluted to OD 0.4, and grown to mid-log phase in either SC + glucose or SC + galactose medium. Cells were shifted to SD-N for 2 h, stained with BODIPY, and visualized by fluorescencemicroscopy. Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_3-B</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WT (BY4741) and GAL-DGA1GAL-ARE2lro1∆ are1∆ (FYS118) cells expressing GFP−Atg8 were grown as in A. Cells were lysed at the indicated times and subjected to SDS‒PAGE, followed by western blot analysis using anti-GFP antibodies. (</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_3-C-D</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C, D) WT (BY4741) and GAL-DGA1GAL-ARE2lro1∆ are1∆ (FYS118) cells expressing GFP−Atg8 (C) or GFP−Atg1 (D) were grown as in A and visualized by fluorescencemicroscopy after 2 h in SD-N. Scale bar, 5 μm. DIC, Differential interference contrast; SD-N, nitrogen-starvation medium; WT, wild-type.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_4-A</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) WT (SCY62), tag∆ste∆ (H1246), tag∆ (H1226) and ste∆ (H1112) cells expressing GFP−Atg8 were grown to mid-log phase in YPD and shifted to SD-N for 6 h. Cells were stained with BODIPY and visualized by fluorescencemicroscopy. Scale bar, 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_5-A-B</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) WT (SCY62), tag∆ste∆ (H1246), tag∆ (H1226) and ste∆ (H1112) cells expressing GFP−Atg8 were grown to mid-log phase in YPD and shifted to SD-N for the indicated time periods. Cells were lysed and subjected to SDS−PAGE, followed by western blot analysis using anti-GFP antibodies. (B) Quantification of the GFP/GFP−Atg8 ratio. Error bars represent the s.e.m. of three independent experiments. *P &lt; 0.05 (Student's t-test). (</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_5-C</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>. (C) WT (SCY62), tag∆ste∆ (H1246), tag∆ (H1226) and ste∆ (H1112) cells expressing GFP-Atg8 were grown to mid-log phase in YPD and shifted to SD-N for 2 h. GFP−Atg8 was visualized by fluorescencemicroscopy. Scale bar, 5 μm. (</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_5-D</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) WT (SCY62), tag∆ste∆ (H1246), tag∆ (H1226) and ste∆ (H1112) cells were grown as in (A). Lysates were subjected to SDS−PAGE in urea gel, followed by western blot analysis using anti-Atg8 and anti-Pgk1 antibodies. Atg8I, non-lipidated Atg8; Atg8 II, lipidated Atg8. DIC, Differential interference contrast; SD-N, nitrogen-starvation medium; WT, wild type.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_6-A</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Fig. 6 Lack of lipid droplets inhibits starvation-induced formation of autophagosomes. (A, H) WT pep4∆ (pep4∆) (A,B), tag∆ste∆ pep4∆ (tag∆ste∆pep4∆)(C,D), ste∆ pep4∆ (ste∆pep4∆)(E,F) and tag∆ pep4∆ (tag∆pep4∆) (G,H) cells were grown to an exponential phase in YPD before being starved in SD-N for 2 h, and were then processed for electron microscopy . H is a magnification of the box in panel G. Magnification of proliferating ER in a tag∆ste∆ (H1246) cell is shown in (I) Asterisks indicate autophagic bodies. N, nucleus; PM, plasma membrane; CW, cell wall; ER, endoplasmic reticulum; M, mitochondrion; V, vacuole; #, trehalose; F, ER proliferation. Scale bars: 1 µm (A-H) and 200 nm (I). (J) Average number of autophagic bodies per cell section was determined by counting 100 randomly selected cell profiles. Error bars represent standard deviations fromcounting of the three grids. ***P &lt; 0.001 (Student's t-test). SD-N,nitrogen-starvation medium; WT, wild type YPD, complete medium.</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_7-A</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) WT (BY4741), tgl1∆, yeh1∆ ,and yeh2∆ cells expressing GFP−Atg8 were grown to mid-log phase in YPD and shifted to SD-N for the indicated time periods. Cells were lysed and subjected to SDS−PAGE, followed by western blot analysis using anti-GFP antibodies. Quantification of the GFP/GFP−Atg8 ratio is presented on the right. Error bars represent the s.e.m. of three independent experiments. *P &lt; 0.05 (Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_7-B</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WT (BY4741) and tgl3∆tgl4∆tgl5∆ cells expressing GFP−Atg8 were grown, treated, lysed, and western blotted as in (A). Quantification of the GFP/GFP−Atg8 ratio is presented on the right. Error bars represent the s.e.m. of three independent experiments. *P &lt; 0.05 (Student's t-test). (</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_7-C</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) WT (BY4741), ayr1∆ and ldh1∆ cells expressing GFP−Atg8 were grown, treated, lysed, and western blotted as in (A). Quantification of the GFP/GFP−Atg8 ratio is presented on the right. Error bars represent the s.e.m. of three independent experiments. *P &lt; 0.05 (Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_7-D</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) WT (BY4741), ldh1∆ayr1∆ cells expressing GFP−Atg8 were grown, treated, lysed, and western blotted as in (A). Quantification of the GFP/GFP−Atg8 ratio is presented on the right. Error bars represent the s.e.m. of three independent experiments. **P &lt; 0.01 (Student's-t test).</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_7-E</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) WT (BY4741), ice2∆ and ldb16∆ cells expressing GFP−Atg8 were grown, treated, lysed, and western blotted as in (A). Quantification of the GFP/GFP−Atg8 ratio is presented on the right. Error bars represent the s.e.m. of three independent experiments. *P &lt; 0.05, **P &lt; 0.01 ***P &lt; 0.001 (Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4557665 Figure_7-F</id>
    <infon key="sourcedata_document">1798</infon>
    <infon key="doi">10.15252/embj.201490315</infon>
    <infon key="pmc_id">4557665</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) WT (BY4741), ice2∆ and yeh1∆ cells expressing GFP−Atg8 were grown to mid-log phase in YPD and shifted to SD-N for 4 h. GFP−Atg8 was visualized by fluorescencemicroscopy. Scale bar, 5 μm. DIC, Differential interference contrast; SD-N, nitrogen-starvation medium; WT, wild type.</text>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_1-B</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>Conditioned medium was collected from pericytes 48 h after adenoviral transduction. Western blotting verified the secretion of Sema3CΔ13 (81 kDa) and Sema3Cp60 (60 kDa) isoforms.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">1</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="38" length="9"/>
        <text>pericytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_1-C</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>HUVECs were suspended in conditioned medium with VEGF (25 ng/ml) and plated on Matrigel. Branch points of the capillary-like network were counted after 18 h. n = 4 independent experiments; scale bar, 200 μm. Control vs. Sema3C, *P = 0.0375 and control vs. Sema3CΔ13, *P = 0.0162.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">6</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="0" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_1-D</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>HUVEC spheroids in collagen were treated with conditioned medium with or without VEGF (25 ng/ml). After 24 h, the cumulative sprout length per spheroid was quantified. Data are representative of three independent experiments with ten spheroids per group. Scale bar, 100 μm. Control vs. Sema3C (− VEGF), *P = 0.0276; control vs. Sema3CΔ13 (− VEGF), *P = 0.0443; control vs. Sema3C (+ VEGF), *P = 0.028 and control vs. Sema3CΔ13 (+ VEGF), *P = 0.032.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">11</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="0" length="15"/>
        <text>HUVEC spheroids</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_2-B-C</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Microvessels within the plugs stained against human-specific CD34. Cell nuclei were stained with DAPI. Scale bar, 100 μm. The area of CD34-positive microvessels was quantified and normalized to the total area of plug. Results represent the means ± s.e.m of 5 plugs (control) and 7 plugs (Sema3C), *P = 0.018.</text>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_2-D-E-F</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 2-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>Vessel coverage was assessed by αSMA staining. Scale bar, 100 μm. Vessel coverage was quantified as the ratio of endothelial cell-associated mural cells to total amount of vessels (n = 5 (control) and n = 7 (Sema3C)). Vessel perfusion was evaluated by i.v. injection of FITC-lectin (0.15 mg) 30 min before mice were sacrificed. The data show the percentage of perfused vessels in the plug and normalized to total vessel area (n = 5 (control) and n = 7 (Sema3C)).</text>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="113" length="16"/>
        <text>endothelial cell</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">52</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="141" length="11"/>
        <text>mural cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_3-A-E</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 3-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>A C57BL/6Nmicepups at P3 received 1 μg of mouseSema3C-Fc (right eye) or control IgG-Fc (left eye). The retinal vasculature was examined at P5 by whole-mount CD31immunofluorescence staining. Representative images show the total retinal vasculature and sprouting tips at the vascular front (iii and iv, arrows) and the enlarged intercapillary space (ii and iv, asterisks). Scale bar, 100 μm and 20 μm (iii and iv). B,C (B) Retinal vessel outgrowth measured as the total area from the central optic disk to the vascular front normalized to control IgG-Fc treatment, ***P = 0.0009. (C) Vessel density was quantified by CD31-stained vessels and normalized to the total vessel area, ***P = 0.0002. (Mean ± s.e.m; n = 23 retinae in each group from four independent experiments; unpaired Student's t-test.) D,E (D) Number of sprouting tips per retina, *P &lt; 0.0001. (E) Branch points in the capillary plexus represented as the ratio to the control IgG-treated retinae, ***P &lt; 0.0001. (Mean ± s.e.m; n = 18 retinae in each group from three independent experiments; unpaired Student's t-test.)</text>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_3-F</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Pups received same treatment as described in (A). The astrocyte layer was examined at P5 by GFAPstaining. Scale bar, 100 μm (upper panel) and 20 μm (lower panel). Representative images of six retinae per group.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">75</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="56" length="9"/>
        <text>astrocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_3-G</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Six-week-old C57BL/6N male mice were intravitreally injected with Sema3C-Fc (right eye) or control IgG-Fc (left eye), and retinae were collected 2 days later. The retinal vessel network was examined with CD31immunostaining. Scale bar, 100 μm (upper panel) and 20 μm (lower panel). Representative images of four retinae per group.</text>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_4-A</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>HUVECs were treated with Sema3C- or GFP-conditioned medium for 24 h. Cell proliferation was quantified by BrdU incorporation (mean ± s.e.m; n = 3; n.s., non-significant).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">94</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="0" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_4-B</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Apoptosis of HUVEC was measured by caspase-3 and caspase-7 activities after 3 h of incubation with Sema3C- or control-conditioned medium (mean ± s.e.m; n = 3, *P = 0.018 using unpaired Student's t-test).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">101</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="13" length="5"/>
        <text>HUVEC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_4-C-D</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>Serum-starved HUVECs were incubated with conditioned medium or conditioned medium + VEGF (50 ng/ml) for 15 min. Cell lysates were subjected to SDS-PAGE and immunoblotted with anti-phospho-AKT antibody. Quantification of phospho-AKT normalized to total AKT levels (mean ± s.e.m; n = 4; control vs. Sema3C (− VEGF), *P = 0.034 and control vs. Sema3C (+ VEGF), *P = 0.024 using unpaired Student's t-test).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">105</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="14" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_4-E</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>HUVECs were adenovirally transduced with VE-cadherin-GFP and plated on ibidi slides (n = 4; control vs. Sema3C (− VEGF) at 20× magnification (Supplementary Movies S1 and S2)). Representative pictures are shown at time points 0 and 1 h. Arrowheads indicate gaps between endothelial cells. Scale bar, 100 μm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">118</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="0" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_4-F</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>C57BL/6Nmicepups at P5 received 1 μg of recombinant Sema3C or IgG-Fc proteins. Endothelial cell junctions were examined by whole-mount VE-cadherinimmunofluorescence staining 6 h later. Representative images show VE-cadherin at cell junctions (arrows). The linear structure (i) was disrupted in Sema3C-treated retinae (ii). Scale bar, 100 μm (upper panel) and 20 μm (lower panel).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">123</infon>
        <infon key="identifier">CL:0002585</infon>
        <location offset="79" length="16"/>
        <text>Endothelial cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_4-G-H</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 4-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>Whole-mount immunostaining of the vascular bed by CD31 and apoptotic cells by cleaved caspase-3 in the retinae at P5 8 h after intravitreal injection of Sema3C or IgG-Fc. Representative images show active caspase-3 signals that co-localize with endothelial cells (arrows). Scale bar, 100 μm. Quantification of cleaved caspase-3 normalized to area of CD31-stained vessels (mean ± s.e.m; n = 5; **P = 0.007 using paired Student's t-test).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">143</infon>
        <infon key="identifier">CL:0002585</infon>
        <location offset="245" length="17"/>
        <text>endothelial cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_5-A</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HUVECs were transduced with adenoviral vector expressing RFP-conjugated F-actin binding peptide (LifeAct). Time-lapse imaging of F-actin in HUVEC spheroids was obtained at 20× magnification (Supplementary Movies S3 and S4). Representative images are shown at 0 and 2 h. Arrowheads indicate detached cells after Sema3C treatment. Scale bar, 100 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">151</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="2" length="6"/>
        <text>HUVECs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">157</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="142" length="15"/>
        <text>HUVEC spheroids</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_5-B-C</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 5-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B Endothelial cell migration was determined using a scratch wound assay with a co-culture model. A wound was generated in a confluent HUVEC monolayer, and cells were cultured in basal medium with or without VEGF (25 ng/ml) in a 24-well plate. At the same time, the transwells containing Sema3C or GFP-expressing pericytes. Representative pictures show remaining gaps within the HUVEC monolayer. Scale bar, 200 μm. C Migration distance was measured after 24 h and normalized to control treatment (mean ± s.e.m; n = 3 independent experiments, control vs. Sema3C (− VEGF), *P = 0.021 and control vs. Sema3C (+ VEGF), *P = 0.039 using unpaired Student's t-test).</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="134" length="5"/>
        <text>HUVEC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">165</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="312" length="9"/>
        <text>pericytes</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">172</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="378" length="5"/>
        <text>HUVEC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_5-D-E</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 5-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D,E (D) Serum-starved HUVECs were treated with Sema3C- or control-conditioned medium with or without VEGF (50 ng/ml) for 10 min. Cell lysates were subjected to SDS-PAGE and probed with anti-phosphoT180/Y182 p38MAPK antibody. Quantification of p38MAPK activation was normalized to total p38MAPK and presented as the ratio to the cells with control medium without VEGF treatment. Control vs. Sema3C (− VEGF), *P = 0.046 and control vs. Sema3C (+ VEGF), *P = 0.043. (E) HUVECs were treated as described before and the activation of FAK detected by anti-phosphoY397 FAK antibody and normalized to the total amount of FAK. Control vs. Sema3C (− VEGF), *P = 0.033 and control vs. Sema3C (+ VEGF), *P = 0.047. (Mean ± s.e.m; n = 3 independent experiments; unpaired Student's t-test.)</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="22" length="6"/>
        <text>HUVECs</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">22</infon>
        <infon key="sourcedata_article_annot_id">188</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="467" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_5-F</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Serum-starved HUVECs were treated with conditioned medium for 15 min. Focal adhesion proteins were examined with anti-phosphoY397FAK and anti-vinculin antibodies. F-actin was stained with Alexa Fluor 546-conjugated phalloidin. Merged images show the coupling of stress fibers with focal adhesion complexes in the cells treated with control medium. Inset, phospho-Y397FAK and vinculin formed focal adhesions that were stained in an elongated dot-like structure (i). Lower panel (ii), Sema3C treatment induced F-actin disassembly and membrane ruffling. Phospho-Y397FAK and vinculin were randomly distributed at the peripheral membrane. Scale bars, 10 μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">203</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="16" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_6-A</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>HUVECs were transfected with siRNA against PlexinD1 or control NS (non-silence) siRNA. qPCR analyses and Western blotting were performed after 48 h (n = 3; paired Student's t-test, NS siRNA vs. PlexinD1 siRNA, ***P = 0.0004). Cell lysates were subjected to SDS-PAGE and probed with anti-PlexinD1.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="0" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_6-B</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>HUVECs were transfected with siRNA against PlexinD1 and plated on gelatin-coated coverslips. Confluent monolayers were treated with Sema3C-, Sema3Cp60- or control-conditioned medium for 30 min. Cells were fixed and stained with Alexa-Fluor 488-conjugated phalloidin to visualize F-actin. Arrows indicate Sema3C-induced cell membrane ruffling. Scale bar, 20 μm. Cell repellence was quantified as the number of cells with membrane ruffling normalized to the number of nuclei (n = 5; mean ± s.e.m., paired Student's t-test, **P = 0.001).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">221</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="0" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_6-C</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>Silencing of Nrp-1 by lentiviral particles expressing shRNA. After culturing 72 h in selection medium, RNA was harvested for qPCR analysis. NS shRNA vs. Nrp-1 shRNA: #1, *P = 0.017 and #2, *P = 0.02; n = 3; mean ± s.e.m. Cell lysates were subjected to SDS-PAGE and probed with anti-Nrp-1.</text>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_6-D</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>Depletion of Nrp-1 abolished the response to Sema3C. Sema3Cp60 had no effect on HUVEC adhesion. Arrows indicate membrane ruffling. Scale bar, 20 μm. Cell repellence was quantified as the number of cells with membrane ruffling normalized to the number of nuclei (n = 5; mean ± s.e.m.; paired Student's t-test, ***P = 0.0003).</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">245</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="80" length="5"/>
        <text>HUVEC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_6-E</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>HUVECs were treated with Sema3C-conditioned medium for 10 min and lysed, and Nrp-1 was immunoprecipitated. Bound Sema3C was detected by Western blotting.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">251</infon>
        <infon key="identifier">CL:0002618</infon>
        <location offset="0" length="6"/>
        <text>HUVECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_7-B</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>RNA scope analyses showed Sema3C and PlexinD1 expression in pre-retinal tufts (OIR model, P19). The retinae were subsequently stained against collagen IV. Sema3CmRNA was detected in peri-endothelial cells. Scale bar: 20 μm.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">259</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="182" length="22"/>
        <text>peri-endothelial cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_7-C</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>Nrp-1 expression in pre-retinal tufts (OIR model, P17). Abundant expression of Nrp1 in endothelial cells. Pericytes at vascular tufts were immunostained with anti-NG2. Scale bar, 20 μm.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">274</infon>
        <infon key="identifier">CL:0002585</infon>
        <location offset="87" length="17"/>
        <text>endothelial cells</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">269</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="106" length="9"/>
        <text>Pericytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_7-D</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>H&amp;E staining shows neovascular tufts (arrows). Representative of five retinae per group in two independent experiments. Scale bar, 50 μm.</text>
    </passage>
  </document>
  <document>
    <id>4604683 Figure_7-E-F-G</id>
    <infon key="sourcedata_document">1555</infon>
    <infon key="doi">10.15252/emmm.201404922</infon>
    <infon key="pmc_id">4604683</infon>
    <infon key="figure">Figure 7-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>Whole-mount CD31immunostaining. The white line defines the whole retinal area, and red line outlines the vaso-obliterative zone. Inset image shows large numbers of peri-retinal tufts (i, arrow heads) in control IgG-Fc-treated retinae compared to Sema3C-treated retinae (ii). Scale bar, 500 μm (upper panel) and 100 μm (lower panel). The avascular area is presented as percentage of the whole retinal area (n = 10 retinae in each group; n.s., non-significant using paired Student's t-test). The formation of pre-retinal tufts was quantified in the superficial layer of the retinal vasculature and normalized to whole retinal area (n = 6 retinae in each group; *P = 0.033 using paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_1-A-B-C</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 1-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunofluorescence staining of endothelium (CD31, in red), pericytes (NG2, in green), smooth muscle cells (α-SMA, in cyan), and nuclei (DAPI, in blue) on frozen sections of limbmuscles injected with myoblast clones expressing different VEGF levels (V Low, V Med, and V High, respectively) and treated with VEGF-Trap or saline after 10 and 17 days. Analysis was performed after 4 days of treatment (2 and 3 weeks, respectively). All normal vessels induced by low and medium VEGF doses displayed a similar coverage by normal pericytes, whereas aberrant structures induced by high VEGF were covered with α-SMA-positive smooth muscle cells. Asterisks indicate muscle fibers, which were mostly sectioned in longitudinal orientation, although some cross sections are visible depending on the orientation of muscle bundles. Scale bar = 25 μm. B, C Quantification of vessel length density (VLD) on the same samples showed that stabilization started already by 10 days for vessels induced by low VEGF, but not until 17 days for those induced by medium VEGF, despite similar pericyte coverage, while aberrant structures induced by high VEGF always regressed. Data represent the mean ± SEM of individual images (n) acquired from three muscles/group; 2 weeks (B): V Low saline, n = 9; V Med saline, n = 13; V High saline, n = 8; V Low TRAP,n = 28; V Med TRAP,n = 22; V High TRAP,n = 30; 3 weeks (C): V Low saline, n = 9; V Med saline, n = 11; V High saline, n = 19; V Low TRAP,n = 43; V Med TRAP,n = 14; V High TRAP,n = 19; *P &lt; 0.05 and ***P &lt; 0.001 (all versus Ctrl) by one-way ANOVA with Bonferroni multiple comparisons test; 2 weeks (B): V Low TRAP versus Ctrl P &lt; 0.0001; 3 weeks (C): V Low TRAP versus Ctrl P &lt; 0.0001; V Med TRAP versus Ctrl P = 0.0158.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="61" length="9"/>
        <text>pericytes</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">6</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="88" length="19"/>
        <text>smooth muscle cells</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">12</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="201" length="8"/>
        <text>myoblast</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">22</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="525" length="9"/>
        <text>pericytes</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">25</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="618" length="19"/>
        <text>smooth muscle cells</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <infon key="identifier">CL:0008002</infon>
        <location offset="658" length="13"/>
        <text>muscle fibers</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">20</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="1067" length="8"/>
        <text>pericyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_2-A</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Muscles were harvested 7 days after implantation of V Low, V Med, and V High clones or control cells (Ctrl). Gene expression of Pdgfb,Ang1,Ang2,Tgfb1, and Sema3a was quantified by qRT-PCR and expressed as fold-change versus control muscles. Data represent individual values, with mean ± SEM (n = 3 or 4, as indicated); *P &lt; 0.05 and **P &lt; 0.01 by one-way ANOVA with Bonferroni multiple comparisons test, after data normalization by logarithmic transformation. TGF-β1: V Low versus V Med P = 0.0047; V Low versus V High P = 0.0379; Sema3A: V Low versus V High P = 0.0042; V Med versus V High P = 0.0179.</text>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_2-B</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>Muscles were harvested 7 days after implantation of V Low, V Med, and V High clones or control cells (Ctrl). Immunohistochemistry for Sema3A on frozen muscle sections confirmed a decreasing protein expression in the areas implanted with myoblasts producing increasing VEGF doses (n = 4). The right panels represent higher-magnification views of the left panels, which encompass the majority of the implantation sites. Scale bar = 50 μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">52</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="237" length="9"/>
        <text>myoblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_2-C</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>Muscles were harvested 7 days after implantation of V Low, V Med, and V High clones or control cells (Ctrl). In situ hybridization for Sema3A (green) and CD31 (red) mRNA, with nuclei staining by DAPI, on frozen muscle sections. The three lower panels represent a higher-magnification of the area in the white square in the top panel, as a merged image and as individual channels: arrows indicate cells expressing both transcripts (yellow), only Sema3A (green), or only CD31 (red). Scale bar = 30 μm. Quantification of the percentage of endothelial cells (CD31+) that express Sema3A (left group) and of Sema3A-expressing cells that are endothelial (CD31+, right group). Data represent the mean ± SEM of 12 individual fields of view from three independent muscles (15-94 nuclei/image, 642 total nuclei). No statistics was applied, as data represent complementary sets.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">67</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="536" length="17"/>
        <text>endothelial cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_3-A-B</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Immunofluorescence staining of endothelial cells (CD31, in red) and NEM (CD11b, in green) on cryosections of limbmuscles 1 week after injection with V Low, V Med, and V High myoblast clones. Scale bar = 100 μm. Quantification of the number of NEM/cm of vessel length in sites of new angiogenesis by increasing VEGF doses. Data represent the mean ± SEM of individual images (n) acquired from three muscles/group: V Low, n = 48; V Med, n = 39; V High, n = 94; *P &lt; 0.05 and ***P &lt; 0.001 by one-way ANOVA with Bonferroni multiple comparisons test: V Low versus V Med P = 0.0008; V Low versus V High P &lt; 0.0001; V Med versus V High P = 0.0304.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">76</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="31" length="17"/>
        <text>endothelial cells</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">77</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="68" length="3"/>
        <text>NEM</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">83</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="243" length="3"/>
        <text>NEM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_3-C</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>Endothelial cells (CD31+ quadrant) and NEM (CD11b+ quadrant) were sorted by FACS from muscles 1 week after injection with the same myoblast clones.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">86</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="0" length="17"/>
        <text>Endothelial cells</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="39" length="3"/>
        <text>NEM</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">92</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="131" length="8"/>
        <text>myoblast</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_3-D</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>Relative gene expression was quantified in the ex vivo FACS-purified endothelial cells (CD31+) and NEM (CD11b+) and expressed as fold-change versus the V High group. Data represent individual values, with mean ± SEM (n = 3-7, as indicated); **P &lt; 0.01 by one-way ANOVA with Bonferroni multiple comparisons test, after data normalization by logarithmic transformation; Sema3A: V Low versus V High P = 0.0157.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">96</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="69" length="17"/>
        <text>endothelial cells</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">98</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="99" length="3"/>
        <text>NEM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_4-A-B</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Mice, implanted with control cells (Ctrl) or myoblasts expressing low (V Low) or medium (V Med) VEGF levels, were treated with the anti-NRP1A antibody blocking Sema3A/NRP1 binding (AbαNRP1A) or with control IgG2a. Analyses were performed after 1 week. A, B Quantification of recruited NEM in sites of new angiogenesis by increasing VEGF doses, expressed as number of CD11b+ cells/mm2 of area (A) or /cm of vessel length (B). Data represent the mean ± SEM of individual images (n) acquired from three muscles/group. (A) Ctrl IgG2a, n = 11; Ctrl AbαNRP1A, n = 17; V Low IgG2a, n = 24; V Low AbαNRP1A, n = 28; V Med IgG2a, n = 25; V Med AbαNRP1A, n = 34; *P &lt; 0.05, **P &lt; 0.01 and ***P &lt; 0.001 by Kruskal-Wallis analysis with Dunn's multiple comparisons test: V Low IgG2a versus Ctrl IgG2a P = 0.0068; V Low IgG2a versus V Low AbαNRP1A P = 0.0068; V Med IgG2a versus V Med AbαNRP1A P = 0.0460. (B) V Low IgG2a versus V Low AbαNRP1A P &lt; 0.0001; V Low IgG2a versus V Med IgG2a P = 0.0193; V Med IgG2a versus V Med AbαNRP1A P = 0.0046.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">106</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="45" length="9"/>
        <text>myoblasts</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">113</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="285" length="3"/>
        <text>NEM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_4-C</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>Mice, implanted with control cells (Ctrl) or myoblasts expressing low (V Low) or medium (V Med) VEGF levels, were treated with the anti-NRP1A antibody blocking Sema3A/NRP1 binding (AbαNRP1A) or with control IgG2a. Analyses were performed after 1 week. C Quantification of vessel length density generated by increasing VEGF doses after the different treatments. Data represent the mean ± SEM of individual images (n) acquired from three muscles/group: Ctrl IgG2a, n = 6; Ctrl AbαNRP1A, n = 6; V Low IgG2a, n = 19; V Low AbαNRP1A, n = 20; V Med IgG2a, n = 20; V Med AbαNRP1A, n = 25; *P &lt; 0.05, **P &lt; 0.01 and ***P &lt; 0.001 by Kruskal-Wallis analysis with Dunn's multiple comparisons test: V Low IgG2a versus Ctrl IgG2a P &lt; 0.0001; V Low AbαNRP1A versus Ctrl IgG2a P &lt; 0.0001; V Low IgG2a versus V Med IgG2a P = 0.0014; V Low AbαNRP1A versus V Med AbαNRP1A P = 0.0179.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">139</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="45" length="9"/>
        <text>myoblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_4-D</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>Mice, implanted with control cells (Ctrl) or myoblasts expressing low (V Low) or medium (V Med) VEGF levels, were treated with the anti-NRP1A antibody blocking Sema3A/NRP1 binding (AbαNRP1A) or with control IgG2a. Analyses were performed after 1 week. D Tgfb1 gene expression in total skeletal muscles after the different treatments, expressed as fold-change versus the Ctrl IgG2a group. Data represent individual values, with mean ± SEM (n = 3 or 4, as indicated); *P &lt; 0.05 and **P &lt; 0.01 by one-way ANOVA with Bonferroni multiple comparisons test, after data normalization by logarithmic transformation; V Low IgG2a versus Ctrl IgG2a P = 0.0083; V Low IgG2a versus V Low AbαNRP1A P = 0.0315.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">165</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="45" length="9"/>
        <text>myoblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_4-E</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>Mice, implanted with control cells (Ctrl) or myoblasts expressing low (V Low) or medium (V Med) VEGF levels, were treated with the anti-NRP1A antibody blocking Sema3A/NRP1 binding (AbαNRP1A) or with control IgG2a. Analyses were performed after 1 week. E Immunohistochemistry for Sema3A protein on frozen muscle sections with H&amp;E counterstaining. The intensity of Sema3A stain was quantified as reciprocal intensity on a scale out of 250. Scale bar = 100 μm. Data represent the mean ± SEM of individual images (n) acquired from three muscles/group: No stain, n = 3; Ctrl IgG2a, n = 23; Ctrl AbαNRP1A, n = 12; V Low IgG2a, n = 53; V Low AbαNRP1A, n = 38; *P &lt; 0.05 and ***P &lt; 0.001 by Kruskal-Wallis analysis with Dunn's multiple comparisons test: V Low IgG2a versus No stain P = 0.0007; V Low IgG2a versus Ctrl IgG2a P &lt; 0.0001; V Low AbαNRP1A versus Ctrl IgG2a P = 0.0142; V Low IgG2a versus V Low AbαNRP1A P = 0.0001.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="45" length="9"/>
        <text>myoblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_5-A</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Relative gene expression of Id1, specifically induced by activated SMAD1/5, and Pai1, specifically induced by activated SMAD2/3, in total muscle tissues 1 week after implantation with V Low-, V Med- and V High-expressing myoblast clones or control cells (Ctrl), expressed as fold-change versus the Ctrl group. Data represent individual values, with mean ± SEM (n = 3 or 4, as indicated); **P &lt; 0.01 and ***P &lt; 0.001 by one-way ANOVA with Bonferroni multiple comparisons test, after data normalization by logarithmic transformation; V Low versus Ctrl P = 0.0002; V Low versus V Med P = 0.005; V Low versus V High P = 0.0016.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">212</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="221" length="8"/>
        <text>myoblast</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_5-B</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>Immunofluorescence staining of endothelium (CD31, in red), nuclei (DAPI, in blue), and phosphorylated SMAD2/3 (in cyan) on cryosections of similarly injected muscles confirmed that endothelial SMAD2/3 activation was inhibited by increasing VEGF doses. Scale bar = 10 μm; n = 3.</text>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_6-A-B-C</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 6-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C Endothelial Sema3A expression is directly inhibited by VEGF and stimulated by TGF-β1 in vitro. Mouseaortic endothelial cells were stimulated with increasing doses of recombinant VEGF164 or TGF-β1 for 24 h. The expression of Sema3a and Tgfb1 was quantified by qRT-PCR and expressed as fold-change versus the non-stimulated cells. VEGF dose dependently inhibited Sema3a expression (A), but did not affect that of Tgfb1 (B), while TGF-β1 upregulated Sema3a expression in a dose-dependent fashion (C). Data represent individual values, with mean ± SEM (n = 4); **P &lt; 0.01 and ***P &lt; 0.001 by one-way ANOVA with Bonferroni multiple comparisons test, after data normalization by logarithmic transformation; Sema3A expression upon VEGF stimulation: 40 versus 0 P = 0.0041; TGF-β1 upon VEGF stimulation: no significant differences; Sema3A expression upon TGF-β1 stimulation: 1 versus 0 P &lt; 0.0001; 2.5 versus 0 P &lt; 0.0001; 40 versus 0 P &lt; 0.0001.</text>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">240</infon>
        <infon key="identifier">CL:0002544</infon>
        <location offset="104" length="24"/>
        <text>aortic endothelial cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_6-D</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Inhibition of TGF-β1 abolishes Sema3A production and NEM recruitment in vivo. Mice, implanted with control cells (Ctrl) or myoblasts expressing low (V Low) VEGF levels, were treated with a TGF-β1 blocking antibody. Analyses were preformed after 1 week. (D) Immunohistochemistry for Sema3A protein on frozen muscle sections with H&amp;E counterstaining. The intensity of Sema3A stain was quantified as reciprocal intensity on a scale out of 250. Scale bar = 50 μm. Data represent the mean ± SEM of individual images (n) acquired from three muscles/group: No stain, n = 10; Ctrl IgG1, n = 17; Ctrl AbαTGF-β1, n = 16; V Low IgG1, n = 23; V Low AbαTGF-β1, n = 28. **P &lt; 0.01 and ***P &lt; 0.001 by Kruskal-Wallis analysis with Dunn's multiple comparisons test: V Low IgG1 versus No stain P = 0.0069; V Low IgG1 versus Ctrl IgG1 P &lt; 0.0001; V Low AbαTGF-β1 versus V Low IgG1 P = 0.0002.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">247</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="58" length="3"/>
        <text>NEM</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">250</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="128" length="9"/>
        <text>myoblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_6-E</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Inhibition of TGF-β1 abolishes Sema3A production and NEM recruitment in vivo. Mice, implanted with control cells (Ctrl) or myoblasts expressing low (V Low) VEGF levels, were treated with a TGF-β1 blocking antibody. Analyses were preformed after 1 week. (E) Quantification of recruited NEM (number of CD11b+ cells/mm2 of area). Scale bar = 25 μm. Data represent the mean ± SEM of individual images (n) acquired from three muscles/group: Ctrl IgG1, n = 20; Ctrl AbαTGF-β1, n = 19; V Low IgG1, n = 20; V Low AbαTGF-β1, n = 27; ***P &lt; 0.001 by Kruskal-Wallis analysis with Dunn's multiple comparisons test: V Low IgG1 versus Ctrl IgG1 P = 0.0005; V Low AbαTGF-β1 versus V Low IgG1 P &lt; 0.0001.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">272</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="58" length="3"/>
        <text>NEM</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">279</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="128" length="9"/>
        <text>myoblasts</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">274</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="290" length="3"/>
        <text>NEM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_7-A-B-C</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 7-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C Mice, implanted with myoblasts expressing low (V Low) or medium (V Med) VEGF levels, were treated on days 4 and 6 after cell implantation with intramuscular injections of Sema3A-Fc (0.1 or 10 mg/kg of average muscle tissue weight), or with control Fc protein. (A) Quantification of the number of NEM/cm of vessel length in sites of new angiogenesis after 1 week. Data represent the mean ± SEM of individual images (n) acquired from 3 to 5 muscles/group: V Low Fc, n = 21; V Low 0.1 mg/kg, n = 22; V Low 10 mg/kg, n = 28; V Med Fc, n = 20; V Med 0.1 mg/kg, n = 30; V Med 10 mg/kg, n = 25; **P &lt; 0.01 and ***P &lt; 0.001 by Kruskal-Wallis analysis with Dunn's multiple comparisons test: V Low Fc versus V Low 10 mg/kg P = 0.0027; V Med Fc versus V Med 0.1 mg/kg P = 0.001; V Med Fc versus V Med 10 mg/kg P &lt; 0.0001. (B) Quantification of vessel length density (VLD) in treated muscles after 1 week. Data represent the mean ± SEM of individual images (n) acquired from 3 to 4 muscles/group: V Low Fc, n = 8; V Low 0.1 mg/kg, n = 20; V Low 10 mg/kg, n = 18; V Med Fc, n = 8; V Med 0.1 mg/kg, n = 23; and V Med 10 mg/kg, n = 27. Data were subjected to Kruskal-Wallis analysis with Dunn's multiple comparisons test, and no significant differences were detected. (C) Vascular stabilization rate was determined 2 weeks after cell implantation by measuring vessel length density after abrogation of VEGF signaling by VEGF-Trap. Treatment with 10 mg/kg Sema3A-Fc did not affect the stabilization of angiogenesis induced by low VEGF, but significantly increased the resistant fraction of vessels induced by medium VEGF. Data represent the mean ± SEM of individual images (n) acquired from 3 to 4 muscles/group: V Low Fc, n = 32; V Low Sema3A, n = 14; V Med Fc, n = 28; V Med Sema3A, n = 33; *P &lt; 0.05 by one-way ANOVA with Bonferroni multiple comparisons test: V Med Fc versus V Med Sema3A P = 0.0458.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">290</infon>
        <infon key="identifier">CL:0000056</infon>
        <location offset="25" length="9"/>
        <text>myoblasts</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">294</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="300" length="3"/>
        <text>NEM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_7-D-E-F</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 7-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>D-F Mice received intramuscular injections of adenovirus expressing VEGF (AdVIC) or CD8 control (AdCD8) and were treated on days 4 and 6 after vector delivery with intramuscular injections of Sema3A-Fc (10 mg/kg of average muscle tissue weight) or control Fc protein. (D) Immunofluorescence staining of endothelium (CD31, in red), pericytes (NG2, in green), smooth muscle cells (α-SMA, in cyan), and nuclei (DAPI, in blue), showing vessel density and morphology 1 week after injection of adenoviral vectors alone (no treatment) or after 3 weeks and with Fc or Sema3A-Fc treatment. Scale bar = 50 μm. (E) Quantification of vessel length density (VLD) on the same samples shows that treatment with Sema3A-Fc accelerated stabilization of vessels induced by transient and uncontrolled VEGF expression. Data represent the mean ± SEM of individual images (n) acquired from 3 to 4 muscles/group: Uninjected muscles, n = 72; AdCD8 1 week, n = 68; AdVIC 1 week, n = 53; AdVIC+Fc 3 weeks, n = 78; AdVIC+Sema3AFc 3 weeks, n = 91; **P &lt; 0.01 and ***P &lt; 0.001 by Kruskal-Wallis analysis with Dunn's multiple comparisons test: AdCD8 1 week versus AdVIC+Fc 3 weeks P = 0.0037; all other comparisons indicated P &lt; 0.0001.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">339</infon>
        <infon key="identifier">CL:0000669</infon>
        <location offset="331" length="9"/>
        <text>pericytes</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">340</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="358" length="19"/>
        <text>smooth muscle cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4604689 Figure_7-G</id>
    <infon key="sourcedata_document">1571</infon>
    <infon key="doi">10.15252/emmm.201405003</infon>
    <infon key="pmc_id">4604689</infon>
    <infon key="figure">Figure 7-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-G</infon>
    <passage>
      <offset>0</offset>
      <text>D-F Mice received intramuscular injections of adenovirus expressing VEGF (AdVIC) or CD8 control (AdCD8) and were treated on days 4 and 6 after vector delivery with intramuscular injections of Sema3A-Fc (10 mg/kg of average muscle tissue weight) or control Fc protein. (F) Immunofluorescence staining of endothelial cells (CD31, in red) and NEM (CD11b, in green) on frozen sections of muscles 3 weeks after injection of adenoviral vectors and with Fc or Sema3A-Fc treatment. White arrows indicate NEM. Scale bar = 50 μm.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">360</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="303" length="17"/>
        <text>endothelial cells</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">351</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="340" length="3"/>
        <text>NEM</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">367</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="496" length="3"/>
        <text>NEM</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_1-A-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative images show expression of YAP in normal cervical tissues, early-stage cervical cancer (stage I &amp; II), and advanced-stage cervical cancer (stage III &amp; IV). Note the significant increase in YAP immunosignals (brown staining) in the advanced-stage tumors. Tissue core size: 1.5 mm. B Positivity (percentage of positively stained cells relative to the total number of cells in the tissue section) of YAP immunosignals in the normal and cancerous tissues. Data were analyzed with unpaired t-test in GraphPad Prism 5 with Welch's correction. Bars represent means ± SEM (n = 10 for normal tissues; n = 69 for tumor tissues; ***P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_1-C-H</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 1-C-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-H</infon>
    <passage>
      <offset>0</offset>
      <text>C A representative image showing the expression of YAP (brown staining) in normal cervical tissue. Scale bar = 20 μm. D-F Representative images showing the expression of YAP in (D) early-stage cervical cancer tissue (stage Ib, T1N0M0); (E) medium-stage cervical cancer tissue (stage IIb, T2N0M0); and (F) advanced-stage cervical cancer tissue (stage IIIb, T3N1M0). Scale bar = 20 μm. G, H High-resolution images showing the cellular location of YAP in (G) early-stage cervical cancer tissue and (H) advanced-stage cervical cancer tissue. Scale bar = 20 μm.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_1-I</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 1-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I</infon>
    <passage>
      <offset>0</offset>
      <text>I Multidimensional cancer genomics data analysis results showing cross-cancer YAP gene alteration. The histogram showed the frequencies of YAP gene mutation, deletion, and amplification across cancers. Data were extracted from TCGA database and analyzed using cBioPortal online analyzing tools. The results indicate that the highest alteration frequency of YAP gene occurs in cervical cancer.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_10-A</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 10-A</infon>
    <infon key="sourcedata_figure_dir">Figure_10-A</infon>
    <passage>
      <offset>0</offset>
      <text>Effect of YAP mRNA levels in HT3 cells treated with or without E6 (400 nM) for 60 min in McCoy's 5A with 1% serum. Data were normalized with 18S mRNA. Bars with same letters are not significantly different from each other (P &gt; 0.05). n = 4, P = 0.9407.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_10-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 10-B</infon>
    <infon key="sourcedata_figure_dir">Figure_10-B</infon>
    <passage>
      <offset>0</offset>
      <text>YAP mRNA levels in HT3 cells treated with or without E6 (400 nM) for 48 h in McCoy's 5A with 1% serum. mRNA levels were measured with real-time PCR. Data were normalized with 18S mRNA. Each bar represents mean ± SEM (n = 5). Bars with same letters are not significantly different from each other (P &gt; 0.05) (P = 0.3233).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_10-C</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 10-C</infon>
    <infon key="sourcedata_figure_dir">Figure_10-C</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot results showing YAP and EGFR protein levels after treatment with MG132 or cycloheximide (CHX) for 4 h or 8 h. β-actin was used as a protein loading control. Confluent HT3 cells were starved for 4 h before treatment with MG132 (10 μM) or CHX (20 μg/ml) for 0, 4 or 8 h.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_10-D-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 10-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_10-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>HPV16E6 protein prevented YAP protein from degradation. Confluent HT3 cells were starved for 4 h before treatment with or without CHX (20 μg/ml), HPV16E6, or CHX combined with HPV16E6 for 8 h. Treatment of starved HT3 cells with HPV16E6 (400 nM) for 8 h suppressed degradation of YAP, but not EGFR protein. Quantitative data showing relative YAP protein levels in (D). Protein levels were normalized with β-actin and presented as ratios relative to that of control. Each bar represents mean ± SEM (n = 4). Bars with different letters are significantly different from each other (Ctrl vs. CHX, P = 0.0003; Ctrl vs. CHX+E6, P = 0.2665; Ctrl vs. E6, P = 0.0258).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_10-F</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 10-F</infon>
    <infon key="sourcedata_figure_dir">Figure_10-F</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis showing that expression of HPV16E6 in HT3 cells increased the protein level of total YAP and casein kinase Iε, but decreased the protein level of SOCS6. Importantly, HPV16E6 increased YAP phosphorylation at serine 127, but suppressed its phosphorylation at serine 397. HPV16E6 had no effect on the level of β-TrcP, LATS1/2 and MOB1 in HT3cervical cancer cells.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_10-G</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 10-G</infon>
    <infon key="sourcedata_figure_dir">Figure_10-G</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot results showing that knockdown of endogenous E6 in HeLa cells with HPV18E6 siRNA (siE6) reduced YAP protein levels, but increased SOCS6 protein levels.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_10-H</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 10-H</infon>
    <infon key="sourcedata_figure_dir">Figure_10-H</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis showing that knockdown of SOCS6 in HT3 cells with SOCS6 siRNA (siSOCS#1 and siSOCS6#2) increased total YAP protein, enhanced phosphorylation of YAP protein at serine 127, but suppressed phosphorylation of YAP at serine 397.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_11-A-F</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 11-A-F</infon>
    <infon key="sourcedata_figure_dir">Figure_11-A-F</infon>
    <passage>
      <offset>0</offset>
      <text>A-F Representative images showing expression of YAP (in red) in wild-type mousecervical tissues (n = 5) (A), HPV16E6-induced (C) and HPV16E6/E7-induced (E) mousecervicaltumor tissue (n = 4 each). Scale bars for (A), (C), and (E): 100 μm. High-resolution images showing the expression and cellular location of YAP in normal cervical tissues (B), HPV16E6-induced (D) and HPV16E6/E7-induced (F) mousecervicaltumor tissue. Scale bars for (B), (D), and (F): 25 μm.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_11-G-H-I-J</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 11-G-H-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_11-G-H-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>G, H Representative images showing expression of YAP (in red) in normal (G) and HPV16-containing humanforeskinkeratinocyte raft cultures (n = 5 each) (H). Scale bars: 100 μm. I, J High-resolution images showing the expression and cellular location of YAP in normal (I) and HPV16-containing humanforeskinkeratinocytes raft cultures (J). Scale bars: 20 μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">633</infon>
        <infon key="identifier">CL:0000312</infon>
        <location offset="110" length="12"/>
        <text>keratinocyte</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">638</infon>
        <infon key="identifier">CL:0000312</infon>
        <location offset="303" length="13"/>
        <text>keratinocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_2-A-C-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 2-A-C-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-C-E</infon>
    <passage>
      <offset>0</offset>
      <text>A, C, E Western blot analysis showing levels of YAP and phosphorylated YAP in ME180 cell lines [ME180-MXIV (control), ME180-YAP, and ME180-YAPS127A cells] (A); HT3 cell lines [HT3-MXIV (control), HT3-YAP, and HT3-YAPS127A cells] (C); and Ect1 cell lines [Ect1-MXIV (control), Ect1-YAP, and Ect1-YAPS127A cells] (E). β-Actin was used as a protein loading control.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_2-B-D-F</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 2-B-D-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-D-F</infon>
    <passage>
      <offset>0</offset>
      <text>B, D, F Growth curves of YAP-overexpressed ME180 cell lines [ME180-MXIV (control), ME180-YAP, and ME180-YAPS127A cells] (B); HT3 cell lines [HT3-MXIV (control), HT3-YAP, and HT3-YAPS127A cells] (D); and Ect1 cell lines [Ect1-MXIV (control), Ect1-YAP, and Ect1-YAPS127A cells] (F). Each point represents the mean ± SEM (n = 4). ***P &lt; 0.0001, ME180-MXIV vs. ME180-YAP cells and ME180-MXIV vs. ME180-YAPS127A cells on day 8. ***P &lt; 0.0001, HT3-MXIV vs. HT3-YAP cells and HT3-MXIV vs. HT3-YAPS127A cells on day 8. ***P &lt; 0.0001, Ect1-MXIV vs. Ect1-Ect1-YAPS127A cells on day 4. *P &lt; 0.0074, Ect1-MXIV vs. Ect1-YAP cells on day 4.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_2-G</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Western blot showing YAP levels in non-targeting control siRNA (siCtrl)- and YAP siRNA (siYAP)-transfected HT3 cells.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_2-H</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Proliferation of HT3 cells treated with control (siCtrl) or YAP siRNA (siYAP). Each point represents the mean ± SEM (n = 5). ***P &lt; 0.001 compared with siCtrl (siCtrl vs. siYAP, P = 0.0002).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_3-A-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative images showing colonies formed by Ect1-MXIV, Ect1-YAP, and Ect1-YAPS127A cells after growth in soft agar for 9 days. Scale bar: 500 μm. B Quantitative data showing colony formation in Ect1-MXIV, Ect1-YAP, and Ect1-YAPS127A cells. Each bar represents mean ± SEM of five independent experiments. Bars with different letters are significantly different from each other (Ect1-MXIV vs. Ect1-YAP, P = 0.0003; Ect1-MXIV vs. Ect1-YAPS127A, P = 0.0002).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_3-C-D-E-F</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 3-C-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>C, E Representative images showing the anchorage-independent growth of YAP-expressing HT3 (C) and ME180 (E) cervical cancer cell lines. Anchorage-independent cell growth was determined by the soft agar colony formation assay. Scale bar: 500 μm. D, F Fluorescence-based quantitative analysis showing the differences of anchorage-independent growth in HT3-MXIV, HT3-YAP, and HT3-YAPS127A (D) and ME180-MXIV, ME180-YAP, and ME180-YAPS127A cells (F). The anchorage-independent cell growth was determined using a CytoSelect 96-Well Cell Transformation Assay kit, and data are presented as relative fluorescent units (RFU). Each bar represents mean ± SEM of four independent experiments. Bars with different letters are significantly different from each other (HT3-MXIV vs. HT3-YAP, P = 0.0002; HT3-MXIV vs. HT3-YAPS127A, P &lt; 0.0001; ME-MXIV vs. ME-YAP, P = 0.0011; ME-MXIV vs. ME-YAPS127A, P = 0.0013).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A, B Representative images of tumorxenografts of ME180-MXIV (MX, right flank), ME180-YAP (A) (YAP, left flank), and ME180-YAPS127A (B) (YAPS127A, left flank) cells implanted in athymic nude mice. Red lines indicate the edge of tumors. C The growth curve of humantumorxenografts derived from control (ME-MX) and YAP-overexpressing ME180cervical cancer cell lines (ME-YAP, ME-YAPS127A) implanted in the athymic nude mice. Each point represents mean ± SEM of six tumors (control n = 10).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_4-D-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 4-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D Representative images showing the relative size of tumors from control and YAP-overexpressing ME180cervical cancer cells. E The average weight of tumorxenografts from the control and YAP-overexpressing ME180 cell lines. Data were analyzed for significance using one-way ANOVA in GraphPad Prism 5 with Tukey's post hoc tests. Each bar represents the mean ± SEM (n = 10 for control, n = 6 for YAP and YAPS127A groups). Bars with different letters are significantly different from each other (MXIV vs. YAP, P = 0.0008; MXIV vs. YAPS127A, P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_4-F</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Western blot analysis of YAP protein levels in the tumorxenografts derived from ME180-MXIV, ME180-YAP, and ME180-YAPS127A cells.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_4-G</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Expression of Ki67 in the tumorxenografts of ME180-MXIV, ME180-YAP, and ME180-YAPS127A cells implanted in athymic nude mice. Ki67 was visualized using an Alexa-488 (green)-conjugated secondary antibody. Actin was visualized using an Alexa-594 (red)-conjugated secondary antibody. Nuclei were stained with DAPI. Scale bar: 20 μm. Note the significant increase in the Ki67-positive cells in the ME180-YAP and ME180-YAPS127Atumorxenografts.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_4-H</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Western blot analysis showing YAP protein levels in ME180 cells transfected with lentiviral empty vector (shCtrl) or lentivirus-based YAP shRNAs (shYAP#1 or shYAP#2).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_4-I</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 4-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I</infon>
    <passage>
      <offset>0</offset>
      <text>I Representative images showing tumorxenografts derived from ME180-shCtrl cells (left flank) and ME180-shYAP#1 cells (right flank) (n = 6).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_4-J</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 4-J</infon>
    <infon key="sourcedata_figure_dir">Figure_4-J</infon>
    <passage>
      <offset>0</offset>
      <text>J Representative images showing the relative size of tumors derived from ME180cervical cancer cells transfected with control shRNA (left, shCtrl) or YAP shRNA#1 (right, shYAP#1) (n = 6).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_5-A</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>RT-PCR results showing that YAP stimulates the mRNA expressions of EGFR, AREG, and TGF-α in ME180cervical cancer cell. Data were analyzed for significance using one-way ANOVA in GraphPad Prism 5 with Tukey's post hoc tests. Each bar represents mean ± SEM (n = 4). Bars with different letters are significantly different from each other (YAP mRNA: MXIV vs. YAP, P = 0.0003; MXIV vs. YAPS127A, P = 0.0001; EGFR mRNA: MXIV vs. YAP, P = 0.0066; MXIV vs. YAPS127A, P = 0.0003; TGF-α mRNA: MXIV vs. YAP, P = 0.0235; MXIV vs. YAPS127A, P = 0.0040; AREG mRNA: MXIV vs. YAP, P = 0.0002; MXIV vs. YAPS127A, P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_5-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>Proliferation of ME180 cells incubated in medium containing 1% FBS in the absence (control) or presence of 10 ng/ml TGF-α. Data were analyzed with unpaired t-test in GraphPad Prism 5 with Welch's correction. Each point represents the mean ± SEM of four independent repeats. ***P &lt; 0.0001 versus control on day 5.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_5-C</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>TGF-α treatment (10 ng/ml, 24 h) promotes ME180cell cycle progression. G1, S, and G2 indicate cells in G1 phase, DNA synthesis phase, and the G2/M phase, respectively, of cell cycle. Apo: apoptotic cells.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_5-D</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>Representative images showing the morphology of ME180 cells with or without TGF-α (10 ng/ml) treatment for 24 h (scale bar: 50 μm) or 108 h (scale bar: 25 μm). Please note the elongation of ME180 cells after TGF-α treatment for 24 h (TGF-α, 24 h) and the formation of multiple layers in ME180 cells after TGF-α treatment for 108 h (TGF-α, 108 h).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_5-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>Effect of TGF-α on the migration of ME180 cells. TGF-α treatment (100 ng/ml, 10 h) drastically stimulated the migration of ME180 cells.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_6-A</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis showing effects of TGF-α on phosphorylation of EGFR, YAP, AKT, and ERK1/2. ME180 cells were starved for 6 h after reaching cell confluence, then cells were treated with TGF-α (100 ng/ml) for 0, 5, 10, 30, 60 or 120 min.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_6-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis showing effects of TGF-α on the phosphorylation of the components of the Hippo signaling pathway. ME180 cells were starved for 6 h after reaching cell confluence, then cells were treated with TGF-α (100 ng/ml) for 0, 30, 60 min.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_6-C</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR determines the action of TGF-α and YAP levels on the mRNA expression of AREG. Each bar represents the mean ± SEM (n = 5). Bars with different letters are significantly different from each other (Ctrl vs. TGF-α, P &lt; 0.0001; MXIV vs. YAP, P &lt; 0.0001; MXIV vs. YAPS127A, P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_6-D</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR analysis showing that knockdown of YAP with YAP siRNA (siYAP) significantly suppressed TGF-α-induced (FBS 10%, TGF-α: 10 ng/ml for 48 h) AREG expression in ME180 cells. siCTRL, a non-targeting siRNA, was used as a negative control. Each bar represents the mean ± SEM (n = 5). Bars with different letters are significantly different from each other (siCTRL vs. siCTRL+TGF-α, P &lt; 0.0001; siYAP+CTRL vs. siYAP+TGF-α, P &lt; 0.0001; siCTRL+TGF-α vs. siYAP+TGF-α, P = 0.0067).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_6-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>Proliferation of ME180 cells (FBS 1%) treated with control (siCTRL) or YAP (siYAP) prior to treatment with control medium or TGF-α (10 ng/ml) for 108 h. Each bar represents the mean ± SEM (n = 4). Bars with different letters are significantly different from each other (siCtrl vs. siCTRL+TGF-α, P = 0.0058; siYAP+CTRL vs. siYAP+TGF-α, P = 0.1840; siCTRL+TGF-α vs. siYAP+TGF-α, P = 0.0013).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_6-F</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>Quantitative data of the wound-healing assay showing the migration of ME180 cells that were treated with control (siCTRL) or YAP siRNA (siYAP) prior to treatment with or without TGF-α for 12 h. Each bar in bar graphs represents the mean ± SEM (n = 4). Bars with different letters are significantly different from each other (siCtrl vs. siCTRL+TGF-α, P &lt; 0.0001; siYAP+CTRL vs. siYAP+TGF-α, P &lt; 0.0001; siCTRL+TGF-α vs. siYAP+TGF-α, P = 0.0041).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_7-A</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Western blot analysis showing that AREG treatment induced dephosphorylation of LATS1, MOB1, and YAP. ME180 cells were starved for 6 h after reaching cell confluence, then cells were treated with AREG (50 ng/ml) for 0, 30, 60 min.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_7-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>AREG (50 ng/ml) treatment induced appearance of elongated cells in ME180 cells (top and middle panels) and significantly stimulated ME180 cell proliferation (lower panel). Each bar represents mean ± SEM (n = 5). Bars with different letters are significantly different from each other (P = 0.003). Scale bar: 100 μm.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_7-C</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>Wound-healing assay showing that AREG stimulates migration of ME180 cervical cancer cells within 10 h in serum-free medium. Scale bar: 200 μm.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_7-D</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR showing that treatment of ME180 cells with AREG for 24 h significantly increased AREG mRNA expression. Each bar represents mean ± SEM (n = 9). Bars with different letters are significantly different from each other (P &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_7-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>Real-time PCR showing that knockdown of YAP in ME180 cells with YAP siRNA (siYAP) significantly suppressed AREG-induced AREG mRNA expression. siCTRL (non-target siRNA) was used as a siRNA control. Each bar represents mean ± SEM (n = 4). Bars with different letters are significantly different from each other (siCTRL vs. siCTRL+AREG, P &lt; 0.0001; siYAP+CTRL vs. siYAP+AREG, P &lt; 0.0001; siCTRL+AREG vs. siYAP+AREG, P = 0.0037).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_8-A</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>Representative images showing the morphology of spheroids derived from ME180-siCtrl and ME180-siLATS1/2 cells growing in a 3D hanging-drop culture system for 10 days. Scale bar: 1.0 mm.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_8-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>Quantitative data showing changes in the volume of spheroids derived from ME180-siCTRL and ME180-siLATS1/2 cells growing in a 3D hanging-drop culture system. Each bar represents mean ± SEM (n = 5). Bars with different letters are significantly different from each other (P = 0.0004).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_8-C</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>Quantitative data showing changes in the volume of spheroids derived from ME180 cells growing in a 3D hanging-drop culture system in the absence or presence of AREG (20 ng/ml, 8 days). Each bar represents mean ± SEM (n = 5). Bars with different letters are significantly different from each other (P = 0.0030).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_8-D</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>Soft agar assay showing the effect of AG1478 and VTPF on colony formation in ME180-MXIV, ME180-YAP and ME180-YAPS127A cells. Scale bar: 500 μm.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_8-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>Representative images showing the effect of AREG, EGFR inhibitor (AG1478), and YAP antagonist verteporfin (VTPF) on the growth of ME180 cell in a 3D hanging-drop culture system. ME180 cells were incubated in the 3D hanging-drop culture system for 10 days in the absence or presence of AREG, AG1478 or verteporfin for 8 days. Scale bar: 1.0 mm.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-A</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>Effect of recombinant HPV16E6 protein on the proliferation of HT3 cells. Each point represents mean ± SEM (n = 5). ***P = 0.0001 compared with control (Ctrl) on day 4. HT3 cells were cultured in serum-reduced medium in the presence or absence of recombinant HPV16E6 (400 nM).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-B</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>Recombinant HPV16E6 protein increased YAP protein level, but had no effect on β-actin protein level in HT3 cells. Cell culture and treatment procedure are the same as described in (A).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-C</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>AREG mRNA levels in HT3 cells incubated for 48 h with or without recombinant HPVE6. Each bar represents mean ± SEM (n = 5). Bars with different letters are significantly different from each other (P = 0.0042).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-D</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D</infon>
    <passage>
      <offset>0</offset>
      <text>Western blotting analysis showing the effect of HPV16E6 (400 nM, 48 h) on YAP protein levels in HT3 cells transfected with non-targeting control siRNA (siCtrl) or YAP siRNA (siYAP).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-E</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-E</infon>
    <passage>
      <offset>0</offset>
      <text>Effect of YAP on HPV16E6 stimulation of HT3 cell proliferation. siCtrl: non-targeting control siRNA; siYAP: YAP siRNA; E6: 400 nM recombinant HPV16E6, 48 h. Each bar represents mean ± SEM (n = 4). Bars with the same letters are not significantly different from each other (siCtrl vs. siCtrl+E6, P = 0.0232; siCtrl+E6 vs. siYAP+E6, P = 0.0011).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-F</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-F</infon>
    <infon key="sourcedata_figure_dir">Figure_9-F</infon>
    <passage>
      <offset>0</offset>
      <text>Knockdown of endogenous E6 in HeLa cells with HPV18E6 siRNA (siE6) reduced YAP protein in HeLa cells, while knockdown of YAP with YAP siRNA (siYAP) in these cells had no effect on the mRNA level of HPV18E6. siCtrl: non-targeting control siRNA.</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-G</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-G</infon>
    <infon key="sourcedata_figure_dir">Figure_9-G</infon>
    <passage>
      <offset>0</offset>
      <text>Knockdown of endogenous HPV18E6 in HeLa cells with HPV18E6-specific siRNA (siE6) significantly suppressed mRNA expression of AREG. Each bar represents mean ± SEM (n = 4). Bars with different letters are significantly different from each other (siCtrl vs. siHPV18E6, P = 0.0181; siCtrl vs. siYAP, P = 0.0005).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-H</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-H</infon>
    <infon key="sourcedata_figure_dir">Figure_9-H</infon>
    <passage>
      <offset>0</offset>
      <text>Knockdown of endogenous HPV18E6 in HeLa cells with HPV18E6-specific siRNA (siE6) significantly suppressed cell growth (n = 9, siCtrl vs. siHPV18E6, P = 0.0002; siCtrl vs. siYAP, P = 0.0004).</text>
    </passage>
  </document>
  <document>
    <id>4644376 Figure_9-I</id>
    <infon key="sourcedata_document">1569</infon>
    <infon key="doi">10.15252/emmm.201404976</infon>
    <infon key="pmc_id">4644376</infon>
    <infon key="figure">Figure 9-I</infon>
    <infon key="sourcedata_figure_dir">Figure_9-I</infon>
    <passage>
      <offset>0</offset>
      <text>Concentrations of AREG in the culture medium of HeLa cells transfected with non-targeting control siRNA (siCTRL) or HPV18E6 siRNA (siHPV18E6). Each bar represents mean ± SEM (n = 6). Bars with different letters are significantly different from each other (P = 0.0461).</text>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_1-A-B-C</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 1-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-G After iPSC‐based reprogramming of fibroblasts, we generated DAn from PD patients (n = 10) and gender‐ and age‐matched healthy controls (n = 4) using a 30‐day differentiation protocol. Blind to researcher, resulting iPSC‐derived DAn showed similar properties and maturation state in PD and controls. Specifically, studied iPSC‐derived DAn encompassed 30‐day ventromedial (vm)‐DAn‐enriched cultures of morphologically mature DAn showing typical bipolar morphology, lacking PD neural phenotypes, mostly of the A9 subtype, and showing properties of tyrosine hydroxylase (TH)+ mature neurons. Representative immunocytochemistry analyses of vmDAn from PD patients and controls showed that (A) TUJ1‐positive cells expressing neural tubulin III (TUJ1) co‐expressed TH (Scale bar, 25 μm); (B) co‐expressed the A9 subtype marker of inward rectifier K+ channel GIRK2 (Scale bar, 25 μm); (C) co‐expressed the A9 subtype marker of transcription factor Forkhead Box A2 (FOXA2) (Scale bar, 12.5 μm).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">1</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="10" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">2</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="38" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">3</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="64" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">13</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="219" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">14</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="232" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">15</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="325" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">16</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="338" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="379" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="427" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">8</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="641" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_1-D</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>A-G After iPSC‐based reprogramming of fibroblasts, we generated DAn from PD patients (n = 10) and gender‐ and age‐matched healthy controls (n = 4) using a 30‐day differentiation protocol. Blind to researcher, resulting iPSC‐derived DAn showed similar properties and maturation state in PD and controls. Specifically, studied iPSC‐derived DAn encompassed 30‐day ventromedial (vm)‐DAn‐enriched cultures of morphologically mature DAn showing typical bipolar morphology, lacking PD neural phenotypes, mostly of the A9 subtype, and showing properties of tyrosine hydroxylase (TH)+ mature neurons. Representative immunocytochemistry analyses of vmDAn from PD patients and controls showed that (D) The 1‐week neural progenitor cells (NPCs) from which iPSC‐derived DAn were generated strongly expressed DAn progenitor markers such as the nuclear‐related receptor 1 NURR1 (Scale bar, 12.5 μm).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">22</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="10" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">23</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="38" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">24</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="64" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">33</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="219" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">34</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="232" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">35</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="325" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">36</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="338" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">37</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="379" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">38</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="427" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">29</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="641" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">30</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="702" length="23"/>
        <text>neural progenitor cells</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">31</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="727" length="4"/>
        <text>NPCs</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">40</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="744" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">41</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="757" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">42</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="795" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_1-E</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>A-G After iPSC‐based reprogramming of fibroblasts, we generated DAn from PD patients (n = 10) and gender‐ and age‐matched healthy controls (n = 4) using a 30‐day differentiation protocol. Blind to researcher, resulting iPSC‐derived DAn showed similar properties and maturation state in PD and controls. Specifically, studied iPSC‐derived DAn encompassed 30‐day ventromedial (vm)‐DAn‐enriched cultures of morphologically mature DAn showing typical bipolar morphology, lacking PD neural phenotypes, mostly of the A9 subtype, and showing properties of tyrosine hydroxylase (TH)+ mature neurons. (E) We observed similar and comparable cell counts of total neurons in PD and controls as quantified by TUJ‐1/DAPI and of DAn as quantified by TH/TUJ1. Selected DAn cells were generated upon 2‐6 iPSC lines per subject (See methods). Error bars indicate SEM. C, control; TUJ1, neuron‐specific class III b‐tubulin.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">44</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="10" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">45</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="38" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">46</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="64" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">48</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="219" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">49</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="232" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">50</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="325" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="338" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">52</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="379" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">53</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="427" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">58</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="714" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">61</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="753" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">62</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="787" length="4"/>
        <text>iPSC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_1-F</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>A-G After iPSC‐based reprogramming of fibroblasts, we generated DAn from PD patients (n = 10) and gender‐ and age‐matched healthy controls (n = 4) using a 30‐day differentiation protocol. Blind to researcher, resulting iPSC‐derived DAn showed similar properties and maturation state in PD and controls. Specifically, studied iPSC‐derived DAn encompassed 30‐day ventromedial (vm)‐DAn‐enriched cultures of morphologically mature DAn showing typical bipolar morphology, lacking PD neural phenotypes, mostly of the A9 subtype, and showing properties of tyrosine hydroxylase (TH)+ mature neurons. Representative immunocytochemistry analyses of vmDAn from PD patients and controls showed that (F) co‐expressed the synaptic vesicle protein synaptophysin (SYP) which was located along neurites (Scale bar, 5 μm).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">69</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="10" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">70</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="38" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">71</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="64" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">77</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="219" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="232" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">79</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="325" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">80</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="338" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">81</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="379" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">82</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="427" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">75</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="641" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_1-G</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>A-G After iPSC‐based reprogramming of fibroblasts, we generated DAn from PD patients (n = 10) and gender‐ and age‐matched healthy controls (n = 4) using a 30‐day differentiation protocol. Blind to researcher, resulting iPSC‐derived DAn showed similar properties and maturation state in PD and controls. Specifically, studied iPSC‐derived DAn encompassed 30‐day ventromedial (vm)‐DAn‐enriched cultures of morphologically mature DAn showing typical bipolar morphology, lacking PD neural phenotypes, mostly of the A9 subtype, and showing properties of tyrosine hydroxylase (TH)+ mature neurons. (G) Calcium imaging assay revealed strong spontaneous neuronal activity. %ΔF/F indicates the relative change in fluorescence of the monitored neurons. Collectively, these results indicate that the iPSC‐derived DAn used our study were sufficiently mature for the studied parameters to be functional and to spontaneously form active neural networks in a similar and comparable manner for PD and controls.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">84</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="10" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="38" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">86</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="64" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">93</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="219" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">94</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="232" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">95</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="325" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">96</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="338" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">97</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="379" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">98</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="427" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">99</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="789" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">100</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="802" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_2-A-B-C</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 2-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Principal component analysis (PCA) of methylation data from 28,363 CpG sites with variable methylation values (SD &gt; 0.1) in iPSC‐derived DAn cell lines (n = 14). This analysis shows different DNA methylation profiles between PD patients and controls, and no differences between L2PD and sPD. PC, principal component. Bar diagram showing the number of differentially methylated CpGs (DMCpGs) among iPSC‐derived DAn lines (n = 14) as detected in multiple comparisons. This analysis indicates that L2PD and sPD share similar DNA methylation changes with respect to controls. Hypermeth, hypermethylation; hypometh, hypomethylation. Relative distribution of DMCpGs in PD iPSC‐derived DAn lines (n = 10) across inter‐ and intragenic regions (left), across different gene‐related regions (middle), and within CpG islands (CGI), CGI shores, CGI shelves, or outside CGI (right). Bkg, background (methylation platform).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="124" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">105</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="137" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">106</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="397" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">107</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="410" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="666" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">109</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="679" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_3-C</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>Technical validation of 10 top DEGs in PD iPSC‐derived DAn as compared to controls (n = 14) identified by genome wide gene expression study (upper heat‐map) and validated by real‐time qPCR (lower heat‐map). Relative gene expression and statistical significances were calculated using the ΔΔCt method and GAPDH, ACTB, and PPIA as endogenous controls. Pearson correlation analysis between microarray and real‐time qPCR data showed a high degree of correlation (r 2 = 0.99, P = 7.7 × 10−7) (bottom graph). L2, LRRK2‐associated PD; s, sporadic PD.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">118</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="42" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">119</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="55" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_4-B</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Examples of genes showing significant correlation including a brief functional description: OTX2, transcription factor for midbrain DAn development which blocks LMX1A; DCT, dopachrome tautomerase, induced by OTX2, is a detoxifying enzyme of DA metabolites involved in the synthesis of neuromelanin; DRD4, DA receptor type 4; CASP8, apoptosis extrinsic pathway member inducing CASP3; ERC2, cytoskeleton organizer at nerve terminals for neurotransmission; NELL2, neural epidermal growth factor‐like 2 involved in neural differentiation.</text>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">147</infon>
        <location offset="123" length="12"/>
        <text>midbrain DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_5-A-B</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Relative enrichment of TF‐binding sites (TFBSs) overlapping with the 2,087 DMCpGs detected in PD iPSC‐derived DAn (n = 10). This analysis shows an enrichment of binding sites for 23 TFs in regions hypermethylated in PD. Bar plot showing the results of the Spearman correlation analysis between levels of TF gene expression and of average DNA methylation at the 376 enhancer sites hypermethylated in PD iPSC‐derived DAn (n = 10). Coef, coefficient.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">148</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="97" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">149</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="110" length="3"/>
        <text>DAn</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">150</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="402" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">151</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="415" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_5-D</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>Scatter plots of key TF gene expression and DNA methylation levels at enhancers in iPSC‐derived DAn (n = 14).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">153</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="83" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">154</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="96" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_6-A</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Pearson correlation coefficients and correlation P‐values were calculated evaluating TF gene expression levels in iPSC‐derived DAn from PD patients and controls (n = 14) under a 2‐tailed Student's t‐test. Among TFs showing coordinated expression, maximal correlation was observed for FOXA1, FOXA2, NR3C1, HNF4A, and FOSL2.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">167</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="114" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">168</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="127" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4693505 Figure_7-A</id>
    <infon key="sourcedata_document">1577</infon>
    <infon key="doi">10.15252/emmm.201505439</infon>
    <infon key="pmc_id">4693505</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, B Graphical representation of gene and protein expression of the key TFs FOXA1, NR3C1, HNF4A and FOSL2 (A) (see also Fig EV3B and Source data for Fig 7), or of the PD upregulated genes (B) (see also Fig EV3A and Source data for Fig 7) identified in iPSC‐derived DAn from PD patients, normalized to the expression of controls, and expressed, respectively, as log2 or lineal fold change (FC) values. (For gene expression, linear model with empirical bayes moderation of the variance similar to ANOVA with FDR‐adjusted P &lt; 0.05; for protein expression, two‐tailed Student's t‐test (**P &lt; 0.01, *P &lt; 0.05). Samples were studied at least in three independent experiments. Data are represented as group mean ± SEM).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">176</infon>
        <infon key="identifier">CL:0002248</infon>
        <location offset="252" length="4"/>
        <text>iPSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">177</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="265" length="3"/>
        <text>DAn</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_1-A-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A and B) Root length (averages ± SD, n ≥ 15) (A) and cell death staining of cotyledons and primary root tips (B) of Arabidopsis seedlings that were exposed to 100 nM Pep2 for 7 days, 2 days after germination. BAK1 (D416N) is a kinase-dead variant.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_1-D</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Pep2 induces PEPR1-FLAG association with SERK1-, SERK2-, BKK1-, and BAK1-HA in N. benthamiana. Experiments were repeated at least three times, with the same conclusions. IP and IB denote imunoprecipitation and immunoblotting with the indicated antibodies, respectively. NT indicates non-transformed plants. (*, p &lt; 0.05 in two-tailed tests compared to the differences (± Pep2) from the corresponding values of WT plants.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_2-A</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis for BIK1-HA in Arabidopsis protoplasts exposed to Pep2 or flg22 for 10 min. Arrowheads indicate phosphorylated BIK1-HA.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">70</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="51" length="11"/>
        <text>protoplasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_2-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblot analysis for Pep2-triggered MAPK activation. Ponceau S-stained loading controls are shown (bottom).</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_2-C</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Root length (averages ± SD, n ≥ 15) of Arabidopsis seedlings that were exposed to 100 nM Pep2. (*, p &lt; 0.05 in two-tailed tests compared to the differences (± Pep2) from the corresponding values of bak1-3 plants. Two independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_3-A</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Scatter plots for log2 fold changes of gene expression in WT plants versus bak1-3 plants treated with Pep2 for 2 and 10 h. The regression of these scatter plots is indicated by the red lines.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_3-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Hierarchical analysis of genes exhibiting a &gt;2-fold change in expression level in bak1-3 plants after Pep2 application for 10 h in a whole-genome microarray analysis. Using Genevestigator v3, these genes were separately cross-referenced to public databases to show their expression responses to salicylate (SA), methyl-jasmonate (JA), or ethylene (ET).</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_3-C</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C and D) qRT-PCR analysis of defense-related genes in 10-day-old seedlings exposed to 0.5 µM Pep2 for 10 h. Data are averages (±SD) of three biological replicates. (*, p &lt; 0.05 in two-tailed tests compared to the corresponding bak1-4 and bak1-3 values in C and D, respectively. Relative cycle threshold (Ct) values of two independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_4-A</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) qRT-PCR analysis of PROPEP genes in 10-day-old seedlings exposed to 0.5 µM Pep2 for 10 h. *, p &lt; 0.05 in two-tailed tests compared to the corresponding WT values. Relative Ct values of two independent experiments with three biological replicates each were combined for statistical analysis.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_4-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Anti-GFP (upper) and anti-PROPEP3 (middle) immunoblot analysis of PROPEP3-Venus in seedlings submerged in liquid medium and treated with (+) or without (-) 0.5 M Pep2 for the indicated times. The positions of the molecular weight markers are shown on the left. Arrowheads and asterisks indicate PROPEP3-Venus and cross-reactive bands, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_4-C-D-E</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 4-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(C, D and E) Immunoblot analysis of PEPR1-FLAG in 10-day-old seedlings following Pep1 or flg22 application. (C and D) Plants were exposed to 1 M Pep1 or flg22 for the indicated times. (E) Plants were pre-exposed to MG132 (50 µM), Wortmannin (Wm) (30 µM) and Tyrphostin A23 (TyrA23) (100 µM) for 1 h before being exposed to Pep1 for 10 h. The numbers below the immunoblots represent relative intensities of the PROPEP-Venus (B) and PEPR1-FLAG (C-E) bands normalized to the backgrounds in the Ponceau S-stained loading controls (bottom), with the band/background values in WT plant extracts 24 h (upper) and 0 h (middle) after Pep2 application, respectively, set as 1.0.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_5-A</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) qRT-PCR analysis of defense-related genes in 10-day-old seedlings exposed to 0.5 µM Pep2 for 10 h. (*, p &lt; 0.05 in two-tailed tests compared to the corresponding WT values. Relative Ct values of two independent experiments with three biological replicates each were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_5-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Root length (averages ± SD, n ≥ 15) of Arabidopsis seedlings exposed to 100 nM Pep2. (*, p &lt; 0.05 in two-tailed tests compared to the differences (± Pep2) from the corresponding values of WT plants. Two independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_5-D</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblot analysis for BAK1 in 10-day-old seedlings with or without 0.5 M Pep1 for 24 h. The numbers below the upper panel represent relative intensities of the BAK1 band normalized to the backgrounds in the Ponceau S-stained loading controls, with the value in non-elicited WT plants set as 1.0.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_6-A</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) qRT-PCR analysis in 4-week-old plant leaves challenged with the indicated P. syringae pv. tomato (Pst) DC3000 strains for the indicated times.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_6-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Anti-GFPimmunoblot analyses in seedlings challenged with Pst DC3000 (DC3000) and Pst DC3000 ∆hrcC(∆hrcC) for the indicated times.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_6-C</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>. (C) Anti-PROPEP3immunoblot analysis of PROPEP3-Venus (upper) in plant tissues (expressed in plants) and in the extracellular fraction (released into medium), 24 h and 48 h after the inoculation with (+) or without (-) Pst DC3000. Lower panels indicate Ponceau S-stained loading controls. The numbers below the upper panel represent relative intensities of the PROPEP3-Venus band normalized to the backgrounds in the Ponceau S-stained loading controls. NT denotes non-transgenic WT plants.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_6-D</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Trypan blue cell death staining of Arabidopsis seedlings challenged with Pst DC3000 or Pst DC3000 AvrRpm1 (AvrRpm1) for 48 h.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_6-E</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Anti-PROPEP3immunoblot analyses in the seedlings exposed to the indicated Pst DC3000 strains or 1 M Pep1 for 48 h.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_6-F</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Anti-GFPimmunoblot analysis for the extracellular fraction of the seedlings exposed to Pst DC3000 AvrRpm1for 48 h. (B, C, E and F) Arrowheads and arrows indicate an apparently full-length and processed form of PROPEP3-Venus, respectively. Asterisks indicate cross-reactive bands. The positions of the molecular weight markers are shown on the left of the immunoblots.</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_7-A</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Growth of H. arabidopsidis (Hpa) Noco2 in 2-week-old plants. Spores were counted at 6 days post inoculation (dpi). Results are averages ± SE of three biological replicates. (*, p &lt; 0.05 in two-tailed tests compared to the corresponding values of Col plants. ■, p &lt; 0.05 in two-tailed tests between the indicated values. Three independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_7-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Growth of syringe-infiltrated Pst DC3000 in rosette leaves of 4-week-old plants pretreated with water (Mock) or 1 M flg22 for 24 h. Bacterial titers were determined at 3 dpi. Results are averages ± SE of three independent replicates. (*, p &lt; 0.05, **, p &lt; 0.01 in two-tailed tests compared to the corresponding values of WT plants. ▲, p &lt; 0.01 in two-tailed tests compared to the differences (± flg22) from the corresponding values of WT plants. Three independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_7-C</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Total SA levels were determined in the rosette leaves of 4-week-old plants with or without 1 µM flg22 application for 24 h. Data are averages (±SD) of material from three independent plants. The experiments were repeated twice, with similar results. (▲, p &lt; 0.01 in two-tailed tests compared to the differences (± flg22) from the corresponding values of WT plants. Two independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_7-D</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) qRT-PCR analysis of the PR1 gene in 4-week-old plants exposed to 1 µM flg22. Data are averages (±SD) of three biological replicates. (*, p &lt; 0.05 in two-tailed tests compared to the corresponding WT values. Relative Ct values of four independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_7-E</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Growth of syringe-infiltrated Pst DC3000 in rosette leaves of 4-week-old plants pretreated with water (Mock) or 1 M flg22 for 24 h. Bacterial titers were determined at 3 dpi. Results are averages ± SE of three independent replicates. (**, p &lt; 0.01, ***, p &lt; 1.0e-10 in two-tailed tests compared to the corresponding values of WT plants. ▲, p &lt; 0.01 in two-tailed tests compared to the differences (± flg22) from the corresponding values of WT plants. Three independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_8-A</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Lesion sizes (left) were determined 5 days after C. higginsianum(Ch) inoculation. Invasion rates (right) of Ch on Arabidopsis leaves were determined 3 days after spore inoculation. An average of 3 replicates is shown (±SD) (left) and (±SE) (right). (■, p &lt; 0.05 in two-tailed tests between the indicated samples. *, p &lt; 0.05 in two-tailed tests compared to the corresponding WT values. Two independent experiments were combined for statistical analysis.)</text>
    </passage>
  </document>
  <document>
    <id>4718002 Figure_8-B</id>
    <infon key="sourcedata_document">1095</infon>
    <infon key="doi">10.15252/embj.201591807</infon>
    <infon key="pmc_id">4718002</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Immunoblot (left) and qRT-PCR (right) analyses following Ch challenge for the indicated times (dpi). The numbers below the immunoblots represent relative intensities of the indicated bands normalized to the backgrounds, with the values at 0 dpi set as 1.0. Experiments were performed three times with the same conclusions.</text>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_1-A</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 1. CHCHD10 resides in the same complex than Mitofilin, CHCHD3 and CHCHD6. A. Second dimension of the Blue-Native (BN) PAGE showing that CHCHD10 migrates with the MICOS protein subunits Mitofilin, CHCHD3 and CHCHD6 in isolated mitochondria from mousebrain</text>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_1-B</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. BN-PAGE of the MICOS and OXPHOS complexes in control (C) and patient (P1, P2) fibroblasts. Complexes I to IV of OXPHOS were detected with the 39kDa subunit antibody (CI), 70kDa subunit antibody (CII), core I antibody (CIII) and cytochrome c oxidase subunit I antibody (CIV). MICOS complex was detected with an anti-Mitofilin antibody.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="81" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_1-C</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Second dimension of the BN-PAGE showing that the steady-state levels of assembled CHCHD10 in MICOS complex are decreased in patientfibroblasts.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">31</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="134" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_1-D</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Analysis of OXPHOS supercomplexes in control and patientfibroblasts. BN-PAGE from isolated mitochondria permeabilized with 6g/g (w/v) of digitoninimmunoblotted on PVDF membrane and incubated with the indicated antibodies. SC, supercomplexes I+III2+IVn. The dividing lines correspond to gels sections visible in the raw data file.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">38</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="59" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_2-A</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 2. Interaction of CHCHD10 with components of MICOS complex. A. Co-immunonoprecipitation (IP) of endogenous mitofilin, CHCHD10 and CHCHD3 in control and patientfibroblasts (1mg of total extracts were used for each IP (left lower panel) and 200µg were used for the input (left upper panel)). The same results were found in P2 fibroblasts (not shown). Reverse co-IP experiment in HeLa cells with an antibody against CHCHD10 (right lower panel). 1mg of total extracts were used for each IP and 200µg were used for the input (right upper panel). The dividing lines correspond to gels sections visible in the raw data file.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">65</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="166" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">66</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="331" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_2-B</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Duolink proximity ligation assay between Mitofilin and CHCHD10 (upper panels) and, CHCHD10 and CHCHD6 (lower panels) in control and patientfibroblasts observed by confocal microscopy. Mitochondria were stained with Mitotracker. Duolink spots per cell were quantified for 30 randomly-selected individual cells per each studied fibroblast cell line from 2 independent experiments. Differences between the cell lines were analyzed by Student's t-test (two-sided): extremely significant (***: p=0.0001). Scale bar = 10 µm.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="142" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">72</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="329" length="10"/>
        <text>fibroblast</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_3-A</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 3. Decrease of nucleoid number without mtDNA depletion in patientfibroblasts. A. In control and patientfibroblasts, nucleoids were labeled with an antibody against DNA and mitochondria were stained with Mitotracker. Image analysis was performed by confocal microscopy. Scale bar: 10 µm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">83</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="72" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="110" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_3-B-C-D</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 3-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-C. The average number (B) and size (C) of nucleoids, labeled with antibodies against DNA shown in A, were quantified for 35 randomly-selected individual cells per each studied fibroblast cell line from 2 independent experiments. Differences between the cell lines were analyzed by Student's t-test (two-sided): extremely significant (***: p&lt;0.001). Nucleoid number (B): patient 1 versus control ***: p=0.0001, patient 2 versus control ***: p=0.001. Nucleoid size (C): patient 1 versus control ***: p=0.0001. D. Mitochondrial DNA content in control and patientfibroblasts was quantified by real-time PCR. Data were expressed as ratio between mtDNA and nuclear DNA concentration. Results represent the mean of relative PCR ± SD of 3 independent experiments. Statistical analysis were performed by Student's t-test (two-sided).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">90</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="178" length="10"/>
        <text>fibroblast</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">96</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="561" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_4-A</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 4. Decrease of nucleoid number without mtDNA depletion in HeLa cells overexpressing the CHCHD10S59L and CHCHD10P34S alleles. A. Transfections were performed with empty vector (EV) or vectors encoding wild-type CHCHD10-FLAG (WT), CHCHD10-FLAG (S59L) or CHCHD10-FLAG (P34S) mutants. Mitochondria were stained with Mitotracker. Cells overexpressing wild-type and mutant CHCHD10 were labeled with FLAG antibodies. Nucleoids were visualized with an antiserum against DNA. Image analysis was performed by confocal microscopy. Scale bar: 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_4-B-C-D</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 4-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-C. The average number (B) and size (C) of nucleoids, labeled with antibodies against DNA shown in A, were quantified for 35 randomly-selected individual cells per each studied cell line from 2 independent experiments. Differences between the cell lines were analyzed by Student's t-test (two-sided): very significant (**: p=0.0280) or extremely significant (***: p=0.0001). D. Mitochondrial DNA content was quantified by real-time PCR. Data were expressed as ratio between mtDNA and nDNA concentration. Results represent the mean of relative PCR ± SD of 3 independent experiments. Statistical analysis were performed by Student's t-test (two-sided).</text>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_5-A</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 5. Nucleoid disorganization in patientfibroblasts leading to a defect in mtDNA repair under conditions of oxidative stress. A. Total extracts from control (C) fibroblasts and intact isolated mitochondria from control and patientfibroblasts (P1, P2) were analyzed by immunoblotting using antibodies against PCNA (nuclear protein), GAPDH (cytosolic protein) or SMAC (mitochondrial intermembrane space protein) (upper panel). Mitochondria from patient and control fibroblasts were incubated with NP-40 and separated into pellets (P) and supernatants (S). The fractions of each extraction were subjected to western blot analysis. VDAC and SMAC were used to identify behaviors of well defined mitochondrial proteins that are integral membrane and soluble proteins, respectively (middle panel). Ratio of mtDNA amplified from supernatant/mtDNA amplified from pellet, by qPCR, was quantified in control and patientfibroblasts (lower panel).</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">151</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="45" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">153</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="166" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">156</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="235" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">159</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="468" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">23</infon>
        <infon key="sourcedata_article_annot_id">164</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="913" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_5-B-C</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 5-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B. Determination of the mtDNA copy number after H2O2 treatment. mtDNA/nDNA values in control, patient 1 and patient 2 fibroblasts. mtDNA : mitochondrial DNA, nDNA: nuclear DNA. C. mtDNA repair after H2O2 treatment. A long-range PCR was used to evaluate the oxidative damage, induced by H2O2 treatment, in mtDNA. The relative PCR amplification of a 15.6kb mtDNA fragment was normalized to relative PCR copy number that was evaluated by PCR amplification of a 172bp mtDNA fragment. mtDNA repair activity in control, patient 1 and patient 2 relative PCR. B-C. Cells were exposed to 150µM H2O2 for 30 min and either harvested immediately or allowed to recover in conditioned medium for the indicated times. Untreated control cultures were incubated in serum-free medium alone. Results represent the mean of relative PCR amplification ± SD of three independent experiments in which three PCRs per point were performed. Values were normalized to untreated cells and differences were analyzed by Student's t-test (two-sided): significant (*:0.05&gt;p&gt;0.01), very significant (**:0.01&gt;p&gt;0.001). Patient 1 versus control: *: p=0.015 (recovery 1h), *: p=0.022 (recovery 2h), **: p=0.003 (recovery 4h). Patient 2 versus control: *: p=0.0230 (recovery 2h), *: p=0.041 (recovery 4h). NT: cells not treated with H2O2</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">174</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="118" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_6-A-B-C</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 6-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 6. No autophagy inhibition (A-C) and no mitophagy defect (D-E) in patientfibroblasts. A. Immunoblot of LC3B-I/-II expression in fibroblasts of patient 2 (1,2), patient 1 (3,4) and control individual (5,6) in absence (-) or presence (+) of chloroquine (CLQ). B. Quantitative analysis of LC3B-II/β-tubulin ratio from immunoblots (n=3). C. Quantitative analysis of LC3B-II + CLQ/ LC3B-II - CLQ ratio from immunoblots (n=3).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">202</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="80" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">203</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="135" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_6-D-E</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 6-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D. Confocal images of fibroblasts derived from a control, patient 1 and patient 2. Boxed regions are enlarged. Scale bar: 20µm. E. Bar graph showing ratios of fluorescent intensity of mitochondria delivered to lysosomes relative to that of mitochondria present in the cytosol (FL lyso/FL mito ). Statistical analysis were performed on mean ± SEM using Student's t-test (two-sided).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">215</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="22" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_7-A</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 7. CHCHD10 mutant fibroblasts are less sensitive to apoptotic cell death compared to control fibroblasts. A. Control (C1, C2) and patient (P1, P2) fibroblasts were treated with 1 μM of staurosporine (STS) for 16 h. Cell death was determined by flow cytometry using Annexin V/DAPI staining. Three independent experiments were performed per condition with two points analyzed per experiment. Differences between the control and patientfibroblasts were analyzed by Student's t-test (two-sided): significant (*: p=0.0116) or extremely significant (***: p=0.0001).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">226</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="25" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">227</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="100" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">229</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="154" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">231</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="440" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_7-B</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B-C. Fibroblasts were treated with 1 μM STS for 4, 6 or 16 h (O/N), and caspase activation was determined either by western blot (B) assessing the cleavage of PARP and the caspase 3 (actin was used as a loading control)</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">233</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="5" length="11"/>
        <text>Fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_7-C</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>B-C. Fibroblasts were treated with 1 μM STS for 4, 6 or 16 h (O/N), and caspase activation was determined either by western blot (B) assessing the cleavage of PARP and the caspase 3 (actin was used as a loading control) or by DEVDase activity measurement (C). Two (B) or three (C) independent experiments were performed per condition. Differences between the control and patientfibroblasts were analyzed by Student's t-test (two-sided): extremely significant (***: p=0.0001).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">242</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="5" length="11"/>
        <text>Fibroblasts</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">248</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="378" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_7-D</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D-E. Mitochondrial membrane potential (ΔΨM) was measured by flow cytometry in control and patientfibroblasts after treatment of 1μM STS for 24 h (E) and quantified in D from two independent experiments. Differences between the control and patientfibroblasts were analyzed by Student's t-test (two-sided): significant (*:0.05&gt;p&gt;0.01). Patient 1 (P1) versus control (C2): *: p=0.0414 (24h). Patient 2 (P2) versus control (C2): *: p=0.0461 (24h).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">253</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="97" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">256</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="246" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_7-E</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>D-E. Mitochondrial membrane potential (ΔΨM) was measured by flow cytometry in control and patientfibroblasts after treatment of 1μM STS for 24 h (E) and quantified in D from two independent experiments. Differences between the control and patientfibroblasts were analyzed by Student's t-test (two-sided): significant (*:0.05&gt;p&gt;0.01). Patient 1 (P1) versus control (C2): *: p=0.0414 (24h). Patient 2 (P2) versus control (C2): *: p=0.0461 (24h).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">261</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="97" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">264</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="246" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_8-A</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 8. Overexpression of the CHCHD10 mutant alleles in HeLa cells leads to inhibition of apoptotic cell death. Transfections were performed with empty vector (EV) or vectors encoding either wild-type CHCHD10-FLAG (WT) or mutant CHCHD10-FLAG (P34S and S59L). A. Western blot on HeLa cells extracts using antibodies against FLAG or Hsp90.</text>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_8-B-C</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 8-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B-D. HeLa cells transiently expressing the WT or mutated forms of CHCHD10-FLAG (P34S or S59L) were treated with 1 μM Actinomycine D (ActD) for 4, 6 or 8 h with measurement of Annexin V/DAPI staining (B), DEVD-ase activity (C) from three independent experiments. Differences between the mutated and non mutated alleles were analyzed by Student's t-test (two-sided): significant (*:0.05&gt;p&gt;0.01) or very significant (**:0.01&gt;p&gt;0.001). P34S versus WT: **: p=0.0055 (4h), *: p=0.0103 (8h). S59L versus WT: *: p=0.0304 (4h), *: p=0.0129 (8h).</text>
    </passage>
  </document>
  <document>
    <id>4718158 Figure_8-D</id>
    <infon key="sourcedata_document">1179</infon>
    <infon key="doi">10.15252/emmm.201505496</infon>
    <infon key="pmc_id">4718158</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Mitochondrial outer membrane permeabilization was determined by western blot by assessing the degradation of Smac. Hsp90 was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_1-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative images of WT, iCCM1 and iCCM1/KLF4mousebrains at P12 (n=5 for each genotype). Scale bar: 500µm.</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_1-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative confocal analysis of VE-CADHERIN (green) and KLF4 (red) in vascular lesions (dotted area) and pseudo-normal cerebellar vessels (white arrowheads) of WT, iCCM1 and iCCM1/KLF4mice (n=4 in each group). VE-CADHERIN identifies ECs; DAPI visualizes nuclei. Scale bar: 50µm.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">15</infon>
        <infon key="identifier">CL:1001602,CL:0000115</infon>
        <location offset="241" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_1-C</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) qRT-PCR of both Ccm1 and Klf4 expression performed on freshly isolated brainECs derived by WT, iCCM1 and iCCM1/KLF4mice at P12. Fold difference in gene expression are relative to WT mice. Data are mean ± SD (n=4-5/group). A two-tailed unpaired t-test was performed. Ccm1: ***P=0.0004; Klf4: ***P=0.0003, ****P=1.43E-05</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">32</infon>
        <infon key="identifier">CL:0000115,CL:1001602</infon>
        <location offset="80" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_1-D</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantification of number and size of vascular lesions in the cerebellum of iCCM1 and iCCM1/KLF4mice at P12. Columns represent means ± SD (n=3 for each genotype from 2 litters). A two-tailed unpaired t-test was performed comparing iCCM1 versus iCCM1/KLF4. &lt;5000 μm2: **P=0.0018; 5-1000 μm2: *P=0.0117; &gt;10000 μm2: **P=0.0019</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_1-E</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Kaplan-Meier survival curve of WT, iCCM1 and iCCM1/KLF4mice (n=8 for each group). Mantel-Cox statistical test was performed: ***P&lt; 0.0001</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_2-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Left panel: Ccm1 and Klf4 relative mRNA levels in Ccm1 (siCCM1) and control (siCTRL) siRNA-treated hCMEC/D3. The result is shown as fold changes in gene expression in siCCM1-treated versus control. Data are presented as mean ± SD (n=3). A two-tailed unpaired t-test was performed. ****P&lt;0.00001, ####P=1.2E-05. Right panel: WB analysis of KLF4 amount in siCCM1- and siCTRL-treated hCMEC/D3. Tubulin is used as loading control. These data are representative of three independent observations.</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_2-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunohistochemical analysis performed on serial sections of brain tissue derived from a familial CCM1patient. Hematoxilin and Eosin (left panels), CLAUDIN5 (central panels) and KLF4 (right panels) stainings were performed in brain lesion and normal peri-lesion vessels as control brain tissue. Higher magnification images of KLF4 staining of the boxed regions are shown. CLAUDIN5 identifies ECs and arrowheads mark endothelial KLF4 positive nuclei. Scale bar: 100µm. These data are representative of three independent observations.</text>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <infon key="identifier">CL:1001602,CL:0000115</infon>
        <location offset="396" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_3-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) Cultured lung derived WT and CCM1 KO ECs were lentiviral transduced with shRNA directed to either Klf4 (shKLF4) or control sequence (shCTRL). (A) qRT-PCR of mesenchymal (Fsp1, Id1), stem cell-like (Sca1) and endothelial markers (VE-cadherin and Claudin5) in WT shCTRL, WT shKLF4, CCM1 KO shCTRL and CCM1 KO shKLF4ECs. Data are mean ± SD (n=3). Fold difference in gene expression are relative to WT shCTRL ECs. A two-tailed unpaired t-test was performed. Klf4: ****P&lt;0.00001, ***P= 0.0008, **P=0.007; Fsp1: ***P=0.0001, ****P=3.9E-05, ###P=0.0002; Sca1: ***P=0.0001, ****P&lt;0.00001; Id1: ***P=0.0001; Ve-cadherin: ***P=0.0001; Claudin5: ****P=1.37E-05</text>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <infon key="identifier">CL:1001567,CL:0000115</infon>
        <location offset="43" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">107</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="319" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="411" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_3-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) Cultured lung derived WT and CCM1 KO ECs were lentiviral transduced with shRNA directed to either Klf4 (shKLF4) or control sequence (shCTRL).(B) WB of EndMT markers in WT shCTRL, WT shKLF4, CCM1 KO shCTRL and CCM1 KO shKLF4ECs. Vinculin is the loading control. These data are representative of three independent observations.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">128</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="43" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">133</infon>
        <infon key="identifier">CL:1001567,CL:0000115</infon>
        <location offset="229" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_3-C</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) Cultured lung derived WT and CCM1 KO ECs were lentiviral transduced with shRNA directed to either Klf4 (shKLF4) or control sequence (shCTRL).(C) Proliferation rate of WT shCTRL, WTshKLF4, CCM1 KO shCTRL and CCM1 KO shKLF4ECs cultured for 5 days. Columns represent mean ± SD (n=8). A two-tailed unpaired t-test was performed. 3 days of culture: ***P=0.0001, **P=0.0045, ##P=0.0017; 5 days of culture: ***P=0.0001, **P=0.0029, ##P=0.0040</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">150</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="43" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">154</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="227" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_3-D</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) Cultured lung derived WT and CCM1 KO ECs were lentiviral transduced with shRNA directed to either Klf4 (shKLF4) or control sequence (shCTRL).(D) Migration rate measured in a wound assay of WT shCTRL, CCM1 KO shCTRL and CCM1 KO shKLF4ECs. Mean ± SD is graphed (n=6). A two-tailed unpaired t-test was performed. ***P=0.0004, ###P=0.0009</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">169</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="43" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">173</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="239" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_3-E</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Cultured lung derived WT ECs were lentiviral transduced with a full length murine Klf4 (LentiKLF4) or empty vector (Mock). qRT-PCR (left panel) and WB (right panel) of EndMT markers in Mock and LentiKLF4ECs. qRT-PCR data are mean ± SD (n=3) and the fold changes are relative to Mock ECs. A two-tailed unpaired t-test was performed. **P=0.002, ***P=0.0007, ###P=0.0001. WB results are representative of three independent observations. Tubulin is the loading control.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="29" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">184</infon>
        <infon key="identifier">CL:1001567,CL:0000115</infon>
        <location offset="207" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">186</infon>
        <infon key="identifier">CL:1001567,CL:0000115</infon>
        <location offset="287" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_4-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) qRT-PCR of Bmp6 expression in WT shCTRL, WT shKLF4, CCM1 KO shCTRL and CCM1 KO shKLF4 cultured ECs. Data represent the mean ± SD (n=3). Fold changes are relative to CCM1 KO shCTRL ECs. A two-tailed unpaired t-test was performed. ****P&lt;0.00001</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">203</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="99" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">205</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="184" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_4-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WB of pSMAD1 and SMAD1 in WT shCTRL, WT shKLF4, CCM1 KO shCTRL and CCM1 KO shKLF4ECs. pSMAD1/SMAD1 ratio normalized over tubulin was quantified by densitometry scan. These data are representative of three independent observations.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">220</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="85" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_4-C</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunohistochemical analysis of PECAM1 (left panels) and BMP6 (central panels) performed on serial sections of cerebellum derived from WT, iCCM1 and iCCM1/KLF4mice at P12. Higher magnification images of the boxed regions are shown in the right panels. Black arrowheads mark ECs, dotted area indicates the Purkinje cell layer used as positive control of the staining. Scale bar: 100 µm. These data are representative of three independent observations (n=3 for each genotype).</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">234</infon>
        <infon key="identifier">CL:0000115,CL:1001602</infon>
        <location offset="278" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_4-D</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) ChIP analysis of KLF4 binding to Bmp6 promoter. Putative KLF4 binding sites identified by MatInspector are indicated. The levels of DNA are normalized to input. Columns are mean ±SD of triplicates from a representative experiment out of three.</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_4-E</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Transcriptional reporter assay performed in HEK-293 cells transfected with Bmp6 promoter reporter plasmid together with an empty vector, a full lenght KLF4 or a mutant KLF4 lacking the DNA binding zinc finger domain (KLF4 ΔZnF). Red boxes in the picture indicate KLF4 binding sites validated by ChIP. Fold change in the Bmp6 promoter activity are relative to empty vector transfected cells. Data are mean ± SD (n=3). A two-tailed unpaired t-test was performed. ****P&lt;0.00001, ####P=5.8E-05</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_5-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) qRT-PCR of Bmp6 in Mock and LentiKLF4 cultured ECs. Data are mean ± SD (n=3). Fold changes are relative to Mock ECs. A two-tailed unpaired t-test was performed. **P=0.0034</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">262</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="51" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">263</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="116" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_5-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WB of pSMAD1 and SMAD1 in Mock and LentiKLF4ECs. Vinculin is the loading control. pSMAD1/SMAD1 ratio normalized over vinculin was quantified by densitometry scan. These data are representative of three independent observations.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">270</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="48" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_5-C</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) ChIP of KLF4 interaction with Bmp6 promoter in Mock and LentiKLF4ECs. Putative KLF4 binding sites identified by MatInspector are indicated. The levels of DNA are normalized to input. Columns are mean ±SD of triplicates from a representative experiment out of three.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">277</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="69" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_5-D</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Mock and LentiKLF4 cultured ECs were lentiviral transduced with shRNA directed to either Bmp6 (shBMP6) or control sequence (shCTRL). (D) qRT-PCR analysis of Bmp6 in Mock shCTRL, Mock shBMP6, LentiKLF4 shCTRL and LentiKLF4 shBMP6ECs. qRT-PCR data represent the mean ± SD (n=3) and the fold changes are relative to Mock shCTRL ECs. A two-tailed unpaired t-test was performed. ***P=0.0008, **P=0.004, ##P=0.003</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">286</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="34" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">290</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="234" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">292</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="331" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_5-E</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Mock and LentiKLF4 cultured ECs were lentiviral transduced with shRNA directed to either Bmp6 (shBMP6) or control sequence (shCTRL).(E) WB of pSMAD1 and SMAD1 in Mock shCTRL, Mock shBMP6, LentiKLF4 shCTRL and LentiKLF4 shBMP6 cultured ECs. pSMAD1/SMAD1 ratio was quantified as in B. These WB data are representative of three independent observations.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">302</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="34" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">306</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="241" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_5-F</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Mock and LentiKLF4 cultured ECs were lentiviral transduced with shRNA directed to either Bmp6 (shBMP6) or control sequence (shCTRL).(F) WB of EndMT markers in Mock shCTRL, Mock shBMP6, LentiKLF4 shCTRL and LentiKLF4 shBMP6ECs. Tubulin is the loading control. The fold changes of FSP1, SCA1 and ID1 normalized over tubulin were quantified by densitometry scan. These WB data are representative of three independent observations.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">319</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="34" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">323</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="228" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_6-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) qRT-PCR (left panel) and WB (right panel) analysis of KLF4 in cultured lung WT and KLF4 KO ECs. qRT-PCR data represent the mean ± SD (n=3) and the fold changes are relative to WT ECs. A two-tailed unpaired t-test was performed. ***P=0.0006. GAPDH is the loading control in WB. These WB data are representative of three independent observations.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">333</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="95" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">335</infon>
        <infon key="identifier">CL:1001567,CL:0000115</infon>
        <location offset="183" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_6-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WB of pSMAD1 and SMAD1 in WT and KLF4 KO ECs left untreated or treated with recombinant BMP6 for 4 h. pSMAD1/SMAD1 ratio normalized over GAPDH was quantified by densitometry scan. These WB data are representative of three independent observations.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">345</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="45" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_6-C</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) qRT-PCR of Fsp1, Sca1 and Id1 in WT and KLF4 KO ECs stimulated with BMP6 for 96 h. qRT-PCR data are mean ± SD (n=3). Fold changes in gene expression in BMP6-treated versus untreated ECs. A two-tailed unpaired t-test was performed. **P=0.0032, ***P=0.0007</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">355</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="52" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">359</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="186" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_6-D-F</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 6-D-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-E-F) ChIP analysis of KLF4 binding to the promoters of Fsp1(D), Sca1(E) and Id1(F) in WT and CCM1 KO cultured ECs. The positions of the putative KLF4 binding sites identified with MatInspector in the promoters of the genes analysed are indicated. The levels of DNA are normalized to input. Columns are mean ± SD of triplicates from a representative experiment out of three performed.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">367</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="113" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_6-G-H</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 6-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G-H) Transcriptional reporter assays performed in HEK-293 cells transfected with either Fsp1 (F) or Sca1 (G) promoter reporter plasmid together with an empty vector, KLF4 or KLF4 ΔZnF. In the pictures: red boxes indicate KLF4 binding sites validated by ChIP, while grey boxes indicate KLF4 binding sites not validated by ChIP. Fold change in the promoter activity are relative to empty vector transfected cells. Data are mean ± SD (n=3). A two-tailed unpaired t-test was performed. ****P&lt;0.00001</text>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_7-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) WB of phoshorylated ERK5 (pERK5) and total ERK5 in freshly isolated brainECs from WT (n=2) and iCCM1 (n=4) mice from 2 different litters at P12. VE-PTP measured the endothelial content and vinculin is the loading control. pERK5/ERK5 ratio normalized over vinculin and VE-PTP was quantified by densitometry scan.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">388</infon>
        <infon key="identifier">CL:1001602,CL:0000115</infon>
        <location offset="77" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_7-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WB of pERK5, ERK5 and KLF4 in cultured lung derived WT ECs either Ccm1 (siCCM1) or control (siCTRL) siRNA-treated alone or in combination with two siRNA targeting Erk5 (siERK5#1,2). pERK5/ERK5 ratio normalized over vinculin is indicated. These data are representative of three independent observations.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">406</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="59" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_7-C</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) Treatment of cultured lung derived WT and CCM1 KO ECs with either 5 µM of XMD8-92 or the vehicle (72 h). (C) WB analysis of pERK5, ERK5 and KLF4. pERK5/ERK5 ratio was quantified as in B.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">415</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="56" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_7-D</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) Treatment of cultured lung derived WT and CCM1 KO ECs with either 5 µM of XMD8-92 or the vehicle (72 h)(D) Left panel: evaluation of pSMAD1 and SMAD1 protein levels. pSMAD1/SMAD1 ratio normalized over vinculin is shown. These data are representative of three independent observations. Right panel: qRT-PCR of Bmp6. The data represent the mean ± SD (n=3). Fold changes are relative to vehicle-treated CCM1 KO ECs. A two-tailed unpaired t-test was performed. **P=0.001, *P=0.01</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">426</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="56" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">434</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="414" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_7-E</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) Treatment of cultured lung derived WT and CCM1 KO ECs with either 5 µM of XMD8-92 or the vehicle (72 h).(E) Representative WB of EndMT markers (one out of three performed). Tubulin is the loading control.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">438</infon>
        <infon key="identifier">CL:0000115,CL:1001567</infon>
        <location offset="56" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_7-F</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) qRT-PCR (left panels) analysis of Klf4, Mef2A, Mef2C and Mef2D and WB of KLF4 (right panels) in cultured WT and CCM1 KO ECs treated with either control siRNA (siCTRL) or siRNA directed to any of Mef2A (upper panels), Mef2C (central panels) or Mef2D (lower panels). qRT-PCR data represent the mean ± SD (n=3) and the fold changes are relative to WT siCTRL ECs. A two-tailed unpaired t-test was performed. Upper panels ***P=0.0002, ###P=0.0005, ****P=4.09E-05, **P=0.001; central panels ***P=0.0005 (WT siCRTL vs WT siMEF2C), ***P=0.0006 (KO siCRTL vs KO siMEF2C), ###P=0.0001, ****P&lt;0.00001, **P=0.007; lower panels ****P=5.6E-05 (WT siCRTL vs WT siMEF2D), ****P=1.53E-05 (KO siCRTL vs KO siMEF2D), ####P=3.1E-05. For WB, vinculin is used as loading control and data are representative of three independent observations.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">457</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="124" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">459</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="359" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_8-A</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Left panel: WB analysis of pERK5, ERK5, KLF4 and MEKK3 in WT and CCM1 KO ECs treated with either two different siRNAs against Mekk3 (siMEKK3 #1 and siMEKK3 #2) or a control sequence (siCTRL). Both pERK5/ERK5 ratio and KLF4 amount normalized over vinculin were quantified by densitometry scan. WB results are representative of three independent observations. Right panel: qRT-PCR of Klf4 in WT and CCM1 KO ECs treated with two different siRNAs directed to Mekk3 (siMEKK3 #1 and siMEKK3 #2) or a control sequence (siCTRL). qRT-PCR results are shown as mean ± SD (n=3) and fold changes are relative to siCTRL treated WT ECs. A two-tailed unpaired t-test was performed. ***P=0.0002, **P=0.002, ****P=2.5E-05, ####P=3.1E-05, ###P=0.0007</text>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">476</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="77" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="18">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">483</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="409" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">486</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="621" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_8-B</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) WB analysis of pERK5, ERK5, KLF4 and MEK5 (left panel) and qRT-PCR of Klf4 (right panel) in WT and CCM1 KO ECs treated with a siRNA against MEK5 or a control sequence (siCTRL) quantified as in A. **P=0.0035, ****P&lt;0.00001, ####P=3.5E-05</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">496</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="111" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718159 Figure_8-C</id>
    <infon key="sourcedata_document">1136</infon>
    <infon key="doi">10.15252/emmm.201505433</infon>
    <infon key="pmc_id">4718159</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) WB analysis of pERK5, ERK5, and KLF4 (upper panel) and qRT-PCR of Klf4 (lower panel) in WT and CCM1 KO ECs treated with BIX-02189 or vehicle for 48 h quantified as in A. Fold changes are relative to vehicle treated WT ECs. A two-tailed unpaired t-test was performed. ***P=0.0002, ****P=2.1E-05</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">506</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="107" length="3"/>
        <text>ECs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">507</infon>
        <infon key="identifier">CL:0000115</infon>
        <location offset="222" length="3"/>
        <text>ECs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_1-A</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Domain architecture of S. pombebromodomainAAA-ATPases. The D1 and D2 ATPase domains (AAA) are shaded blue and orange, respectively, and the bromodomain (BD) is grey. The percentage similarity to each other and the indicated proteins was determined by FASTA sequence comparison [74] using the scoring matrix BLOSUM50.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_1-B</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Venn diagrams showing overlap between genes up-regulated (1.5 fold) in abo1Δ mutants with genes up-regulated under the indicated condition, along with the significance of the overlaps (based on hypergeometric distribution).</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_2-A</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Normalised cumulative nucleosome (150 ± 30 bp size class) position frequency profiles for 4013 S. pombe genes aligned at the transcription start site (TSS) plotted from low MNase (biorep1) and high MNase (biorep 2) datasets. P-values (calculated using a two-tailed unpaired t-test) for the difference in means between random n = 100 subsets of the frequency values at the points indicated by the dotted lines ("-4" nucleosome and "+4" nucleosome) are shown.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_2-B</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Nucleosome position frequency values for the coding regions of 4013 S. pombe genes were k-means clustered (k = 9) using the abo1Δ data from biorep 1 (low MNase) and displayed with positive values coloured yellow and other values coloured blue (left-hand panel). The cluster order was then used to display the equivalent wild type frequency values in the right-hand panel.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_2-C</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Level of histone gene mRNAs was determined by qRT-PCR. Data are the mean of four independent biological repeats and error bars are ±SEM. Two-tailed unpaired t-tests showed no significant differences (P &gt; 0.05) between wild type and abo1Δ cells.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_2-D</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Whole cell extracts were subjected to western blotting with histone H3 (Abcam), histone H2A (Abcam) and tubulin antibodies. Examples of the primary data are shown (left) along with a quantification of histone H2A and H3 levels normalized to tubulin (right). Data are the mean of at least three independent repeats and error bars represent ±SEM. P-values were calculated using a two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_3-A-B</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Whole cell extracts (WCE) were prepared from the indicated strains, immunoprecipitated (IP) with anti-GFP antibody and subjected to western blotting with anti-V5-Pk (Serotec) and anti-GFP (Life Technologies) antibodies. Data are representative of three independent biological repeats. B As for A.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_3-C</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C RNA purified from wild type, abo1Δ and spt16-18 cells was analysed by northern blotting using a probe to the 3′ end of spbc19c7.11 (top panel). RNA (5 µg) used for northern blotting was analysed on an ethidium bromide stained 1% TAE agarose gel (bottom panel). Data are representative of two independent biological repeats.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_3-D</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D RNA purified from wild type, and abo1Δ cells was analysed by strand specific RT-PCR. RNA from hip1Δ cells was analysed as a control. One primer, complementary to either the forward or reverse transcripts, was included during the reverse transcription step the second primer was then added during PCR amplification. Control reactions omitting the reverse transcription step (-RT) were included to demonstrate the absence of contaminating genomic DNA. Data are representative of two independent biological repeats.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_3-E</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E The indicated strains were subjected to ChIP analysis with anti-GFP antibodies and the resulting DNA was analysed by qPCR for the indicated locus. Data are the mean of three independent biological repeats and error bars represent ±SEM. P-values were calculated using a two-tailed unpaired t-test. Significant (P &lt; 0.05) values are indicated.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_3-F</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F ChIP analysis of histone H3 levels at act1+ was determined by qPCR. Data are the mean of three independent biological repeats and error bars represent ±SEM. P-value was calculated using a two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_3-G</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>G The indicated strains were subjected to ChIP analysis as described for E.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_3-H</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Log phase cells were subjected to five-fold serial dilution and spotted onto rich (YE5S) agar or agar supplemented with MMS (0.006%). Plates were incubated for 3-5 days at 30°C or 7 days at 20°C. Images are representative of three independent biological repeats.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_4-A</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A The position of ura4+ reporter alleles in centromere 1 is shown in the top panel. Strains containing the imr::ura4+ allele were grown to log phase in YE5S medium, subjected to 5-fold serial dilutions and spotted onto YE5S agar or YE5S agar supplemented with 5-FOA (1 mg/ml). Data are representative of three independent biological repeats.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_4-B</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Strains carrying the otr::ura4+ were analysed as described for A.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_4-C</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C RNA was purified from the indicated strains and the level of centromeric transcripts determined by qRT-PCR. Data is the mean of three independent repeats and error bars indicate ± SEM. P-value was calculated using a two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_4-D</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D RNA was purified from the indicated strains and subjected to qRT-PCR for the subtelomeric gene, tlh1+. Data is the mean of three biological repeats and error bars indicate ± SEM. P-value was calculated using a two-tailed unpaired Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_4-E</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E The position of insertion of ade6+ reporter allele in the silent mat locus is shown in the top panel. Log phase cells containing the mat3-M::ade6+ allele were subjected to five-fold serial dilution and spotted onto YE5S agar plates lacking adenine (Low Ade) were incubated for 4 days at 30°C. Data are representative of at least three independent biological repeats. Note, microarray analysis indicates that deletion of abo1+ does not influence the expression of ade6+ (or ura4+) when these genes are present at their normal genomic loci.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_5-A</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A ChIP analysis was performed on wild type (untagged) and abo1-GFP cells and the resulting DNA analysed by qPCR for centromeric (dh, dg and imr) repeat sequences. Data are the mean of four independent biological repeats and error bars represent ±SEM. P-values calculated using a two-tailed unpaired t-test indicates that all loci are significantly enriched (P &lt; 0.05) relative the untagged control.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_5-B</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B The indicated strains expressing GFP-Swi6 were subjected to ChIP analysis. The level of centromeric (dg) repeat sequences relative to the euchromatic control locus, adh1+ was determined by qPCR and scaled to a clr4Δ (- H3 K9me control) mutant. Data are the mean of two independent ChIP experiments and error bars represent the range of the data.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_5-C</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C ChIP analysis of histone H3 levels at centromeric (dg) repeat sequences was determined by qPCR. Data are the mean of three independent ChIP experiments and error bars are ±SEM. P-values were calculated using a two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_5-D</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. ChIP analysis of Abo1-GFP at centromeric (dh and imr) repeat sequences regions in wild type and pob3Δ cells. Data are the mean of three independent experiments and error bars represent ±SEM. P-values, calculated using a two-tailed unpaired t-test, indicated no significant difference (P &gt; 0.05) for wild type and pob3Δ cells.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_5-E</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E ChIP analysis of Abo1-GFP at centromeric (dh and imr) repeat sequences in wild type and pob3Δ cells. Data are the mean of duplicate experiments and error bars represent the range of the data.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_5-F</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F ChIP analysis of Abo1-GFP over the dh and imr regions in wild type and swi6Δ cells. Data are the mean of three independent experiments and error bars represent ±SEM. P-values, calculated using a two-tailed unpaired t-test, indicated no significant differences (P &gt; 0.05) for wild type and swi6Δ cells.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_6-A</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A RNA was extracted from mid log phase cells and Tf2mRNA levels were determined by qRT-PCR, normalised to act1+ mRNA and scaled relative to the wild type level. Data are the mean of three independent biological repeats and error bars represent ±SEM.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_6-B-C</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 6-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B Mid log phase cells with the indicated integrated lacZ reporter were subjected to quantitative β-galactosidase assays. Data are the mean of three independent biological repeats and error bars represent ±SEM. C As for B</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_6-D</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D ChIPDNA samples from wild type (untagged) and abo1-GFP cells were analysed by qPCR for Tf2 LTR. Data are the mean of four independent biological repeats and error bars represent ±SEM.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_6-E</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Normalised cumulative nucleosome (150 ± 30 bp) position frequency profiles for Tf2LTR retrotransposons aligned at the ATG plotted from low MNase (biorep1) and high MNase (biorep 2) datasets. P-values were calculated using a two-tailed unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_7-A</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Log phase cells were subjected to five-fold serial dilution and spotted onto rich (YE5S) agar or agar supplemented with TBZ (15 μg/ml) and incubated for 3-5 days 30°C. Data are representative of at three independent biological repeats.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_7-B</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B The frequency of Ch16 minichromosome loss was assayed by plating cells onto adenine limiting agar and determining the frequency of half sectored (red-white) colonies. At least two independently derived strain isolates were used for each genotype and the total number of colonies counted for each genotype is indicated in parenthesis.</text>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_7-C</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Heterothallic (h90) strains were cultured on nitrogen limiting (EMMG) medium for 3 days at 25°C to induce mating and meiosis. The resulting asci were stained with DAPI and visualised by fluorescence microscopy. Data are representative of three biological repeats</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">258</infon>
        <infon key="identifier">CL:0000607</infon>
        <location offset="142" length="4"/>
        <text>asci</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718406 Figure_7-D</id>
    <infon key="sourcedata_document">1131</infon>
    <infon key="doi">10.15252/embr.201540476</infon>
    <infon key="pmc_id">4718406</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Sporeviability was measured by dissecting spores onto YE5S agar followed by incubation for 4-5 days at 30°C. Data are the mean of three independent biological repeats and error bars are ±SEM. P-value was calculated using a two-tailed unpaired t-test.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">263</infon>
        <infon key="identifier">CL:0000596</infon>
        <location offset="2" length="5"/>
        <text>Spore</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">264</infon>
        <infon key="identifier">CL:0000596</infon>
        <location offset="44" length="6"/>
        <text>spores</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_1-A</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. 293T cells were co-transfected with CMV-renilla, 8X-TBS (eight repeats of the TEAD-binding-sequence) luciferase reporter, Flag-YAP, HA-TEAD2 and wild-type (WT) or catalytically inactive (CS) USP9X-V5. One day after transfection, luciferase activity was measured and normalized with respect to renilla activity. The value for Flag-YAP/HA-TEAD-transfected cells (2nd column) was adjusted to 1. Shown below is a representative Western blot showing that the expression levels were comparable between samples (n=4). Error bars indicate the S.E.M. (*p&lt; 0.05, **p &lt; 0.01; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_1-B</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. 293T cells were transfected with control or USP9X-targeting siRNAs. One day after siRNA transfection, the cells were co-transfected with CMV-renilla, 8X-TBSluciferase, Flag-YAP and HA-TEAD2. Reporter activity was quantified as described in (A) (n=4). Error bars indicate the S.E.M. (***p &lt; 0.001; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_1-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. RPE or MCF10A cells were transfected with the indicated siRNAs for 24 hours and then re-seeded to either sparse or dense culture conditions. At 48 hours after siRNA transfection, the cells were harvested and cell extracts were analyzed by Western blotting for the indicated proteins. L.E., long exposure, S.E., short exposure.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_1-D</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Cells were treated as described in (C), the indicated mRNAs were analyzed with RT-qPCR, and the results were normalized with respect to the β-actin mRNA (n=4). Error bars indicate the S.E.M. (*p&lt; 0.05, **p &lt; 0.01; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_1-E</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. RPE cells were transfected with the indicated siRNAs for 24 hours, and then co-transfected with CMV-renilla and 8X-TBSluciferase. One day after the latter transfection, the cells were re-seeded to either sparse or dense conditions, and reporter activity was measured at 24 hours after re-seeding (n=3). Error bars indicate the S.E.M. (**p &lt; 0.01; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_2-A</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Representative anti-YAPimmunofluorescence images of sparsely cultured RPE cells transfected with the indicated siRNAs. Green, YAP. Blue, DAPI. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_2-B</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The nuclearYAP intensities of the cells shown in (A) were quantified using the Image J software. At least 70 cells from five or six random fields were analyzed. Quantified values were normalized by adjusting the average of "siControl Dense cells" to 1. We performed two independent experiments and obtained similar results. Data from one representative experiment are presented. The red bar indicates the average value. S, Sparse. D, Dense (***p &lt; 0.001; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_2-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Sparsely cultured RPE or MCF10A cells were transfected with the indicated siRNAs, fractionated into cytosolic and nuclear extracts, and analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_2-D</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Representative anti-YAPimmunofluorescence images of densely cultured RPE cells transfected with the indicated plasmids. Green, GFP or V5. Red, YAP. Blue, DAPI. Scale bar, 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_2-E</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. The nuclearYAP intensities of transfected cells in (D) were quantified using the Image J software. At least 70 cells from five to six random fields were analyzed. Quantified values were normalized by adjusting the average of "EGFP transfected cells" to 1. Similar results were obtained from two independent experiments. Data from one representative experiment are presented. The red bar indicates the average value. (***p &lt; 0.001; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_2-F</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Densely cultured stable RPE clones integrated with empty vector (Vec), USP9X-V5 WT or CS mutant were fractionated into cytosolic and nuclear extracts, and analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_2-G</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Densely cultured RPE cells transduced with CRISPR-SAM targeting USP9X were fractionated into cytosolic and nuclear extracts, and analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_3-A</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. RPE cells were analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_3-B</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Indicated stable RPE clones in densely cultured conditions were analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_3-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Densely cultured RPE cells transduced with CRISPR-SAM targeting USP9X were analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_3-D</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. RPE or MCF10A cells expressing the control or USP9X shRNA were transfected with the LATS1/2 siRNA as indicated. Cells were re-seeded to low density and harvested after one day.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_3-E</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. RPE cells transduced with Flag-YAP WT or Flag-YAP 5SA were transfected with the indicated siRNAs. Cells were re-seeded to low density and harvested after one day.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_3-F</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. RT-qPCR of CTGF mRNAs in the cells described in (E) (n=3). Error bars indicate the S.E.M. (*p&lt; 0.05, paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_4-A</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. RPE or MCF10A cells were transfected with the indicated combinations of siRNAs and re-seeded to low density, and cell extracts were analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_4-B</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The cells described in (A) were analyzed by RT-qPCR for the indicated target genes (n=4). Error bars indicate the S.E.M. (*p&lt; 0.05, **p &lt; 0.01; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_4-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Sparsely cultured RPE cells transfected with the indicated siRNAs were immunoprecipitated with an anti-AMOTL2 antibody and analyzed by Western blotting for the indicated proteins. WCL, whole cell lysates.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_5-A</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. 293T cells were transfected with the indicated siRNAs, cultured for 24 hours, and then transfected with the indicated DNAs. 48 hours after siRNA transfection, the cells were harvested and ubiquitination of Flag-AMOTL2 was examined. C, control siRNA.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_5-B</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. 293T cells were transfected with the indicated combinations of DNAs, cultured for 24 hours, and subjected to in vivo ubiquitination assays.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_5-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. RPE cells transduced with vector (control) or Flag-AMOTL2 were seeded under sparse (S) or dense (D) conditions, and an in vivo ubiquitination assay was performed.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_5-D</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. RPE cells transduced with Flag-AMOTL2 were transfected with a 1:1 mixture of the two USP9X siRNAs. One day after siRNA transfection, the cells were re-seeded to the sparse condition and an in vivo ubiquitination assay was performed after one day.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_5-E</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. 293T cells were transfected with the indicated combinations of DNAs, and a co-immunoprecipitation assay was performed.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_5-F</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Sparsely cultured RPE or MCF10A cells were immunoprecipitated with an anti-AMOTL2 antibody.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_6-A</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Flag-AMOTL2 constructs were designed to express regions spanning from the N-terminus to the coiled-coil domain (AA 1-306), the coiled-coil domain (AA 307-581), and the C-terminal portion (AA 582-781). These constructs were co-transfected into 293T cells with Myc-Ub, and an in vivo ubiquitination assay was conducted. *, non-specific band.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_6-B</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The SBP-AMOTL2 coiled-coil domain was expressed in 293T cells, subjected to tandem affinity purification, fractionated by SDS-PAGE and stained with Coomassie blue. Bands corresponding to the AMOTL2 coiled-coil domain were excised and analyzed by mass spectrometry for identification of ubiquitinated sites (K-G-G linkages). Shown are MS/MS spectra recoded using an LTQ-Orbitrap mass spectrometer for the doubly charged peptide, IEK*LESEIQR (MH+ = 1358.72, z = 2+; upper), and the triply charged peptide, LASK*TQEAQAGSQDMVAK (MH+ = 1992.96, z = 3+; lower). These peptides contain the K347 and K408 ubiquitination sites, respectively (marked by asterisks). Fragmented ions are annotated according to the nomenclature for peptide fragmentation in mass spectrometry.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_6-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. The indicated Flag-AMOTL2 WT or mutant proteins were subjected to an in vivo ubiquitination assay in 293T cells.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_6-D</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. RPE or MCF10A cells were transduced with Flag-AMOTL2 WT or Flag-AMOTL2 K347/408R, and immunoprecipitated with an anti-Flag antibody. Immunoprecipitated and WCL samples were analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_6-E</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. RPE or MCF10A cells were transduced with Flag-AMOTL2 WT or Flag-AMOTL2 Y213A, and processed as (D).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_7-A</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. MCF10A cells expressing shRNA against AMOTL2 were complemented with shRNA-resistant Flag-AMOTL2 WT or the K347/408R mutant. The indicated cells were harvested and analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_7-B</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. mRNAs isolated from cells in (A) were analyzed by RT-qPCR against indicated EMT marker genes (n=4). Error bars indicate the S.E.M. (*p&lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001; paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_7-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Transwell migration assay was performed using cells in (A) (n=8). We analyzed 5 random fields for each sample. Error bars indicate the S.E.M. (**p&lt; 0.01, paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_7-D</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Representative images of soft agar assay results using cells in (A). Scale bar, 1 mm.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_7-E</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Soft agar assay was performed using cells in (A) (n=8). Error bars indicate the S.E.M. (**p &lt; 0.01, ***p &lt; 0.001, paired Student's t-test).</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_8-B-C</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 8-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C. 293T cells were transfected with the indicated DNAs and immunoprecipitated with an anti-Flag antibody or pulled down with streptavidin-binding beads.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_8-D-E</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 8-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E. 293T cells were transfected as indicated and immunoprecipitated with an anti-HA antibody. LATS2 immune complexes were subjected to a kinase assay with His-YAP and cold ATP.</text>
    </passage>
  </document>
  <document>
    <id>4718409 Figure_8-F</id>
    <infon key="sourcedata_document">1104</infon>
    <infon key="doi">10.15252/embr.201540809</infon>
    <infon key="pmc_id">4718409</infon>
    <infon key="figure">Figure 8-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Lats1-/-; Lats2fl/fl; SV40 mouse embryonic fibroblasts complemented with vector, LATS2 WT or ΔUBA mutant were infected with empty (control) or Zeocin-Creretroviruses and selected with 400 μg/ml of Zeocin for 4 days. Harvested cells were analyzed by Western blotting for the indicated proteins.</text>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_1-B</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Phospholipid transport/synthesis, as measured by 3H-serine incorporation, in humanfibroblasts (mean±SE; n=9, with 5 replicates/experiment) and in primary mousehippocampal neurons (mean±SE; n=3, with 4 or 5 replicates/experiment). *, p&lt;0.05 vs E3.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">3</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="84" length="11"/>
        <text>fibroblasts</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="161" length="19"/>
        <text>hippocampal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_1-C</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Comparison of 3H-serine incorporation in ApoEACM-treated WT- and Mfn2-KO MEFs (mean±SE; n=3, with 3 replicates/experiment).</text>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_1-D</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Duramycin sensitivity in ApoE ACM-treated fibroblasts. Note increased sensitivity after 20 min to 5 μM duramycin in ApoE4-treated cells, which was blocked upon the addition of 15 μM exogenous PtdEtn (mean±SD; n=3, with 3 replicates/experiment).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">25</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="44" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_2-B</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Fractions from the discontinuous gradient were blotted with anti-ApoE (WUE-4) antibody; the doublet is a characteristic feature on ApoE western blots due to ApoE sialylation [16].</text>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_2-C</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C An ApoE-containing fraction (fraction 5 [+]), an ApoE-negative fraction (fraction 3 [-]), and recombinant lipid-free ApoE protein were applied to humanfibroblasts. Note increase in phospholipid synthesis using an ApoE4-containing lipoprotein fraction, but not with either an ApoE4-negative fraction or with lipoprotein-free recombinant ApoE3 or ApoE4 protein (mean ± SE; n=3, with 3 replicates/experiment).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">50</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="153" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_3-A</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Cholesteryl ester synthesis, as measured by 3H-oleate incorporation. Note increased CE in ApoE4-treated cells, whereas there was essentially no difference in triglyceride (TAG) production (mean±SE; n=3. with 3 replicates/experiment). †, p=0.06 vs E3.</text>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_3-B</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Comparison of 3H-oleate incorporation in ApoEACM-treated WT- and Mfn2-KO MEFs (mean±SE; n=3, with 5 replicates/experiment).</text>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_3-C</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C ApoEACM-treated fibroblasts were stained with LipidTox green neutral lipid stain, and lipid droplets were visualized (example at left) and counted (right). Note significantly more lipid droplets in ApoE4-treated cells (mean ± SD, n=3).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">76</infon>
        <infon key="identifier">CL:0000057</infon>
        <location offset="18" length="11"/>
        <text>fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4718413 Figure_4-A</id>
    <infon key="sourcedata_document">1096</infon>
    <infon key="doi">10.15252/embr.201540614</infon>
    <infon key="pmc_id">4718413</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>HeLa cells were transfected with plasmids to visualize ER (in green) and mitochondria (in red), and then were treated with ApoE3- and ApoE4-ACM for 24 hours. Shown is a box-and-whisker plot comparing co-localization in ApoE3 ACM (n = 15 images analyzed [gray circles, average of co-localization in ~5 cells in each image field]) compared to that in ApoE4 ACM (n = 18 images).</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_1-A</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 1. Identification of non-canonical p53 binding sites in human subtelomeres. (A and B) ChIP-seq tracks for p53 in camptothecin (CPT) treated or untreated HCT116 cells were aligned with RNAPII, CTCF, RAD21, and SMC1 for human chromosome18q (A) or 13q (B) subtelomeres. Position relative to the centromeric end of the terminal TTAGGG repeat tract are indicated in bp at the top. Subtelomeric DNA paralogy segment tracks, internal telomere-like sequence tracks (red CCCTAA), and annotated RefSeq gene tracks are indicated above the ChIP-seq tracks. (C) Alignment of human subtelomeric elements containing non-canonical p53 recognition sequences. The position of the RepeatMasker-defined LTR10c element is shown; also note the (TG)n microsatellite repeat adjacent to the p53 binding site. (D) Schematic organization of non-canonical p53 binding sites found in human subtelomeres.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_2-A</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Stress-induced p53 binding at human subtelomeres. (A) Western blot of HCT116p53-/- and p53+/+ cells treated with DMSO (D) or 50 µM etoposide (E) for 24 hrs. Cell lysates were assayed for total p53, phospho-Ser15 p53 (p-p53), γH2AX, or GAPDH.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_2-B</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) ChIP-qPCR was assayed in HCT116p53-/- or p53 +/+ cells treated with DMSO or etoposide as in panel A, and assayed by ChIP with antibodies to p53 (Ab6) or control IgG, followed by qPCR for p53 binding site in subtelomere18q (top panel) or 13q (lower panel).</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_2-C</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HCT116p53-/- and p53+/+ cells were cultured in DMEM with 10% FBS or Hank's buffered saline solution (HBSS) lacking FBS and then assayed by ChIP with either IgG control (grey) or two different p53-specific antibodies Ab6 (red) or FL(black). ChIP was assayed by qPCR with primers proximal to p53 binding sites at 18q, 13q, or p21 promoter.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_2-D</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>. (D) Doxycyclin (Dox)-inducible p53H1299 cells were treated without (-) or with (+) Dox in media containing 10% serum or in serum free HBSS, and then subject to ChIP assay with control IgG or p53-specific Ab6 antibody. ChIPDNA was assayed by qPCR using primers specific for p53 binding site at p21 (top panel), p53-negative control IGX1A (middle panel), or p21 positive control (lower panel). Error bars represent SD, and * indicates p value &lt; .05. p-values were determined by Student t-test.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_3-A</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>. Transcriptional activity of subtelomeric p53-response elements. (A) Luciferase test constructs containing either empty test vector (top), p53-response elements from 18qsubtelomere (middle) or MDM2 promoter (lower) were assayed in HCTp53-/- cells transfected with two independent preparations of empty vector or p53 WT expression vector.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_3-B</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) RT-qPCR measure of p21 (top panel) or PARD6G (lower panel) in HCT116p53-/- or p53+/+ cells after treatment with DMSO or 50 µM etoposide.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_3-C</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) RT-qPCR analysis of TERRA transcripts from subtelomere 13q (upper) or 2q (lower).</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_3-D</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) RT-qPCR analysis of TERRA transcripts from 18q using two independent primer sets pr1 (top panel) or pr2 (lower panel) from HCT116p53+/+ cells cultured with serum (grey bars) or in HBSS lacking serum (black bars). Error bars represent SD and * indicates p value</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-A</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>. p53-dependent cell viability and telomere protection in response to DNA damage. (A) Western blot of total p53, γH2AX, and GAPDH in HCT116p53-/- or p53+/+ cells treated with 1 µM or 50 µM etoposide for 24 hrs.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-B</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>s. (B) Cell cycle analysis of HCT116p53-/- or p53+/+ cells untreated or treated with 50 µM etoposide for 24 hrs. Cell cycle was determined by FACS analysis of propidium iodide stained cells.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-C</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Cell clonal survival assay for HCT116p53-/- or p53+/+ cells treated with DMSO or 1, 1.5 or 2 µM etoposide for 24 hr prior to replating.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-D</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>. (D) Quantification of clonal survival assay relative total cell numbers (top panel) or normalized to DMSO controls (lower panel).</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-E</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E) TIF assay for HCT116p53+/+ or p53-/- cells treated with 1 µM etoposide for 3 hrs. TelomereDNAFISH with TelC probe (red), γH2AX (green), Dapi (blue).</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-F</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Quantification of TIF assay for % cells with &gt; 4 TIFs per cell for p53+/+ (black) or p53-/- (red) cell.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-G</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G) Telomere length assay showing p53-/- or p53+/+ cells treated with either DMS0, 1 or 50 µM etoposide. Ethidium bromide (EtBr) stained agarose gels (left panel), Southern blot hybridized with Tel C probe (middle panel) or with α Satellite DNA promote (right panel). Quantification of telomereDNA signal relative to invariant bands in α Sat. Error bars represent SD and * indicates p values</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_4-H</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Two-dimensional agarose gel analysis of telomeric DNA from HCTp53+/+ or or p53-/- treated with 50 µM etoposide for 24 hrs. Ethidium gel (top) and Southern blot probed with TelG probe (lower panel). Single stranded telomereDNA (red arrow) and recombination/ replication-associated structures (blue arrow) are indicated.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_5-A-B</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 5. p53-dependent histone modification changes in response to DNA damage stress. HCT116p53-/- (left panels) or p53 +/+ (right panels) were treated with DMSO (black) or 50 µM etoposide (red) for 24 hrs and assayed by ChIP-qPCR at various locations relative to the TTAGGG repeats across the chromosome18qsubtelomere (panel A) or 13qsubtelomere (panel B) or for control regions (p21 promoter, GKN1/2, PARKIN) as indicated below. ChIP-qPCR for p53, H3K9Ac, H3K27Ac, γH2AX, or IgG control were quantified as % input. Error bars indicates SD and * indicates p value</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_5-C-D</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 5-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Dot blot analysis of telomere repeat or Alu repeat DNA from p53+/+ or p53-/- HCT116 cells treated with DMSO or etoposide (ETP) (as described in panel A), that were subject to ChIP with antibodies to IgG, p53, γH2AX, TRF2, or TRF1. Quantitation of three independent ChIP-assays for TRF1 and TRF2 is shown in the panel to the right. (</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_5-E</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) ChIP-qPCR for TRF2 is shown for cells treated as in panel A using primers across the subtelomeres of 18q (left) or 13q (right).</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_6-A</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) HCT116p53+/+ or p53-/- cells treated with 50 µM etoposide were assayed by Western blot with antibodies for p53, γH2AX, H3K9Ac, panH3, and GAPDH at times 0, 8, 16, or 24 hr post-treatment.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_6-B</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) ChIP-qPCR for γH2AX (upper panels) or IgG control (lower panels) for cells treated as indicated in panel A. (C-D) RT-qPCR analysis for cells treated as shown in panel A.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_6-C-D</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C-D) RT-qPCR analysis for cells treated as shown in panel A. (C) RT-PCR for the p21 (top), or PARD6G mRNA (lower). (D) RT-PCR for primer pairs spanning subtelomere18q as indicated below. Lower panel shows the No-RT control for 18qsubtelomere primers. RT-qPCR was quantified as relative to Actin with error bars indicating SD and * indicating p value</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_6-E</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Meta-data analysis of published GRO-Seq and ChIP Seq data sets. Gro-Seq Minus (red/maroon) or Plus (purple/pink) RNA strand from Control or Nutlin -3a treated MCF7 cells was mapped to human 18q subtelomere. Histone H3K27ac, H3K4me1, and H3K4me3ChIP-Seq data sets from untreated MCF7 are also shown for these subtelomeric regions. Right panel shows a zoom in of approximately 1000bp (light blue on left panel) surrounding the p53 response element within the subtelomere.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_6-F</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Summary of GRO-Seq and ChIP-Seq metadata analyses from human subtelomeres with p53 binding sites. Each p53 response element is located upstream of a region of bidirectional transcription which is modulated in a p53 dependent manner along with local bidirectional transcription at the p53 response element itself.</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_7-B</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Western blot analysis of CRISPR deleted cell lines 18q WT and 18q Δp53 treated with DMSO (D) or 50 µM etoposide (E) for 24 hr. Blots were probed with pan-p53, phospho-p53, γH2AX, or GAPDH (as loading control)</text>
    </passage>
  </document>
  <document>
    <id>4718461 Figure_7-C-D-E</id>
    <infon key="sourcedata_document">1178</infon>
    <infon key="doi">10.15252/embj.201490880</infon>
    <infon key="pmc_id">4718461</infon>
    <infon key="figure">Figure 7-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) RT-qPCR for p21 (C), PARDG6 (D), or 18q subtelomeric RNA (E) in 18q WT or18q Δp53 treated with DMSO (black) or 50 μM etoposide (red) for 24 hr. (F) ChIP-qPCR assay for γH2AX at 18qsubtelomere in 18q WT or 18q Δp53 treated as in panels B-E.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_1-A</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Tunicamycin (Tn, 2 µg/ml) increased Nox4 protein levels in H9c2 cells. Tubulin was used as a loading control. n=4-6/group. *, significant compared to baseline.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_1-B</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Thapsigargin (Tp, 1 µg/ml) increased Nox4 protein levels in H9c2 cells. n=4-6/group. *, significant compared to baseline.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_1-C-D</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C. Effect of Nox4 on the unfolded protein response. Nox4 was depleted in H9c2 cells by shRNA-mediated knockdown (Ad.shNox4) or cells were treated with a control adenovirus (Ad.Ctl). In cells with Nox4 knockdown, tunicamycin treatment resulted in lower increases in protein levels of the ER chaperones Grp94, Grp78 and calreticulin than in conrol cells. Nuclear protein levels of ATF4 were substantially lower in Nox4-depleted cells than control cells but the levels of cleaved ATF6 (ATF6c) were similar. Histone was used as a loading control. The relative mRNA levels of Xbp1-s (a readout of IRE1 signaling) were unaltered after Nox4 knockdown. Mean data are shown in Appendix Fig S1E. Similar results were obtained with an independent siRNA approach (Appendix Fig S2A). D. Effect of adenoviral-mediated overexpression of Nox4 (Ad.Nox4) or a control β-galactosidase protein (Ad.β-Gal) on tunicamycin responses of H9c2 cells. Nox4 enhanced the increase in cellular ER chaperones and nuclearATF4 levels but did not affect tunicamycin-induced changes in nuclearATF6c levels and caused minor reduction in Xbp1s mRNA levels. Mean data are shown in Appendix Fig S2B.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_1-E-F</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E,F. Effect of Nox4 knockdown or overexpression, respectively, on the tunicamycin-induced changes in mRNA levels of ATF4 target genes. n=4/group. Psat1, phosphoserine aminotransferase; Phgdh, 3-phosphoglycerate dehydrogenase; Asns, asparagine synthetase; Slc6a9, glycine transporter 1.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_1-G</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Effect of ATF4 silencing with two different siRNAs on Nox4 protein levels in tunicamycin-treated H9c2 cells. Scrambled siRNAs were used as a control (Ctl). Representative immunoblots shown to the top (captions at bottom of bar graphs refer also to the immunoblots); tubulin was used as a loading control. n=4/group. *, significant compared to baseline; #, significant comparing siATF4 versus corresponding siCtl.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_1-H</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 1-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. Effect of ATF4 overexpression on Nox4 mRNA and protein levels. n=3/group.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_2-A-B-C-D</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 2-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A. The knockdown of endogenous Nox4 resulted in a substantial inhibition of tunicamycin-induced eIF2a phosphorylation in H9c2 cells, with no change in phospho-Thr980-PERK (PERK-P) levels. GADD34 levels were significantly decreased after Nox4 knockdown while there was no change in PP1 protein levels. B. Overexpression of Nox4 in H9c2 cells caused prolongation of tunicamycin-induced eIF2a phosphorylation, with minimal change in phospho-PERK levels. C,D. Mean levels of phosphorylated eIF2a relative to total eIF2a protein in tunicamycin-treated cells after Nox4 knockdown or overexpression, respectively. n=3/group. *, significant compared to baseline; #, significant comparing Nox4 knockdown (Ad.shNox4) or overexpression (Ad.Nox4) versus corresponding controls (Ad.Ctl or Ad.β-Gal, respectively).</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_2-E-F</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 2-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E,F. Effect of Nox4 knockdown or overexpression, respectively, on okadaic acid-resistant Ser/Thr phosphatase activity in membrane fractions of tunicamycin-treated H9c2 cells. n=4/group. *p&lt;0.05, **p&lt;0.01 cf. baseline; #, p&lt;0.05, ##, p&lt;0.01 comparing Nox4 knockdown (Ad.shNox4) or overexpression (Ad.Nox4) versus corresponding controls (Ad.Ctl or Ad.β-Gal, respectively).</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_2-G-H</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 2-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G,H. Nox4 knockdown or overexpression, respectively, had no effect on the phosphorylation of glycogen synthase at Ser641 (GS-P) or Histone H3 at Ser57 (H3-P) in H9c2 cells.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_2-I</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 2-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I</infon>
    <passage>
      <offset>0</offset>
      <text>I. Nox4-/-MEF cells (KO) showed blunted tunicamycin-induced increases in levels of phospho-eIF2a, ATF4 and ER chaperones as compared to wild-type (WT) MEFs, a response that was rescued by re-introduction of Nox4 (KO+Nox4). The latter had no effect on GS-P or H3-P levels.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-A</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Sub-cellular localization of Nox4. Tunicamycin (Tn 2 µg/ml, 6h) increased Nox4 levels in H9c2 cells as assessed by spinning disk confocal microscopy (scale bar, 10 µm).3D SIM images (scale bars, 2 µm) showed localisation of Nox4 (green) to the ER, which was labeled with an anti-KDEL antibody (red). At higher magnification (right), yellow dots denote co-localization of Nox4 and KDEL signals. Cell nuclei were stained with DAPI (blue). 1 Z slice from 3D stack is shown.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-B</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Progressive enrichment of GADD34, PP1, eIF2α and Nox4 in membrane fractions of tunicamycin-treated H9c2 cells.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-C</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. After sucrose gradient fractionation of lysates of tunicamycin-treated H9c2 cells, GADD34, PP1 and Nox4 co-eluted in fractions 12 and 13 (F12, F13).</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-D</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Immunoprecipitation (IP) of pooled fractions 12/13 with an anti-GADD34 antibody revealed the presence of both PP1 and Nox4.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-E</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. The association of Nox4 with GADD34 was validated in HEK293 cells co-transfected with Nox4 and either Flag-tagged or non-tagged GADD34, followed by IP with an anti-Flag antibody.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-F</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Co-transfection of HEK293 cells with GADD34-Flag and different myc-tagged Nox4 constructs, followed by IP with an anti-myc antibody. GADD34 binds to full-length Nox4 (FL) and the Nox4 transmembrane domain (TD) but not the C-terminal domain (CD).</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-G</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Representative pseudocolor images of simultaneous ER and cytosolicROS measurement with HyPer ERand HyPerRed Cyto, respectively, in tunicamycin-treated MEF cells. Redox-insensitive mutant probes were used as negative controls and to exclude pH changes. Extracellular H2O2 (200 nM) was added as a positive control. The pseudocolor scale is shown along the left vertical edge of each image. KO = Nox4-/-. Scale bars, 2 µm.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_3-H</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. Transfection of HEK293 cells with PP1 and GADD34 increased PP1 activity (bar graph) and decreased phospho-eIF2 levels (immunoblots). Co-transfection of full-length Nox4 reduced PP1 activity and increased phospho-eIF2 levels (captions at bottom refer both to the bar graphs and immunoblots). These effects were abrogated when either Nox4 P437H or the Nox4 transmembrane domain (TD) were transfected. Nox4 did not affect phosphorylation of glycogen synthase (GS-P) or histone H3 (H3-P). All experiments were n=3/group. Values below the immunoblots are mean ± SEM levels for phospho-eIF2/total-eIF2. *, p&lt;0.05 comparing third and fourth lanes; Levels of significance for comparisons of PP1 activities are shown above the bar columns. See also Fig EV1 and Appendix Fig S4.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_4-A</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Recombinant PP1 was inhibited by H2O2 (0.2 mM) and activity was not restored by glutathione (GSH), cysteine (Cys) or dithiothreitol (DTT). A Cys127Ser/Cys273Ser PP1 mutant was inhibited by H2O2 similarly to wild-type PP1. Values above bars denote level of significance for the inhibitory effect of H2O2.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_4-B</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Ascorbate (Asc) dose-dependently restored PP1 activity. #, significant effect of Asc compared to H2O2 alone.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_4-C</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. EPR spectra of PP1 incubated with ascorbate (1 mM) alone (a) or PP1 exposed to H2O2 followed by catalase treatment, then incubation with ascorbate (b). Panel b shows a typical spectrum for the ascorbyl radical (hyperfine splitting constant, aH = 1.8G), similar to the positive control obtained by exposing ascorbate to H2O2 (c). Panel d shows that no ascorbyl radical is detected if H2O2 is degraded by catalase in the absence of PP1, prior to ascorbate addition.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_4-D</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Cartoon representation of the active site of H2O2-treated PP1 as in Fig EV2D. 2mFo-DFc electron density map at the 2.2 Å resolution is shown in yellow at the 1.1 level. H2O2-treatment causes an overall shrinkage of the PP1 coordination sphere by 0.12 Å compared to ascorbate-treated crystals consistent with the oxidation of the dinuclear center. This increases the energy barrier for the catalytic steps involving -OH- attack on the phosphorous center of the bridging phosphate and rupture of the P-O scissile bond with the assistance of H125 (black arrows). Reported coordination distances in Å are averaged over the two PP1 molecules in the crystallographic asymmetric unit. See also Appendix Table S1.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_4-E</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Effect of Nox4 on GADD34/PP1-mediated eIF2 dephosphorylation in transfected HEK293 cells. Nox4 increased eIF2 phosphorylation in cells transfected with GADD34 and WT PP1, and resulted in even higher phospho-eIF2α levels in cells transfected with N124D or D64N PP1 variants.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_4-F</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Effect of ascorbate (Asc, 0.5 mM) on phosphatase inhibition in tunicamycin-treated H9c2 cells with overexpression or knockdown of Nox4 (Ad.Nox4 and Ad.shNox4, respectively). In control cells, ascorbate enhanced tunicamycin-stimulated increases in phosphatase activity. Phosphatase activity was lower in Nox4-overexpressing than control cells but was normalized by ascorbate to the same level as in control cells. In Nox4 knockdown cells, tunicamycin-induced increases in phosphatase activity were enhanced and ascorbate had minimal additional effect.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_5-A</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. H9c2 cells treated with tunicamycin (2 µg/ml, 12h) showed significantly lower survival when endogenous Nox4 was silenced (siNox4) as compared to cells treated with a scrambled siRNA (siCtl). Cell survival was restored by treatment with either guanabenz (Gbz, 5 µM) or salubrinal (Sal, 50 µM) but was unaffected by clonidine (Cld, 5 µM). n=3/group.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_5-B</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Nox4-depleted cells had lower levels of phospho-eIF2α and ATF4 than control cells but these were restored in the presence of guanabenz (Gbz).</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_5-D</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Hearts from Nox4 knockout (KO) mice and WT controls were subjected to global ischemia followed by aerobic reperfusion (I/R). Infarct size assessed by triphenyltetrazolium chloride (TTC) staining was greater in Nox4 KO hearts compared to WT and was significantly reduced by guanabenz (Gbz). In the representative heart sections shown at the top, white denotes infarct area and red the viable area. Scale bars, 1 mm. Numbers of hearts are indicated within the bars.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_5-E</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Immunoblotting of heart homogenates after I/R showed lower levels of phospho-eIF2a, ATF4 and ER chaperones, and higher levels of cleaved caspase-12, in Nox4 KO compared to WT. Tubulin was used as a loading control. Treatment with guanabenz (Gbz) reversed these changes (blots shown to the right).</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_6-A</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Plasmaurea levels were elevated to a greater extent in tunicamycin-treated Nox4 KO mice than WT. Co-treatment with guanabenz (Gbz) reduced urea levels in both groups. Numbers of animals are indicated within bars.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_6-B</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. 48 hours after systemic tunicamycin treatment, kidneys of Nox4 KO mice showed a marked surface pallor (bottom right).</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_6-C</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. TUNEL staining revealed a significantly higher number of apoptotic cells in tunicamycin-treated Nox4 KO mice. n=4/group.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_6-D</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Immunoblotting of kidney homogenates showed significantly elevated cleaved caspase-12 and cleaved PARP levels in tunicamycin-treated Nox4 KO mice compared to WT.</text>
    </passage>
  </document>
  <document>
    <id>4741303 Figure_6-E</id>
    <infon key="sourcedata_document">1310</infon>
    <infon key="doi">10.15252/embj.201592394</infon>
    <infon key="pmc_id">4741303</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Survival curves showed that a very high proportion of Nox4 KO mice died after AKI. Guanabenz (Gbz) treatment dramatically improved survival in tunicamycin-treated KO mice. Number of animals as indicated. Levels of significance by Kaplan Meier analysis are reported to the right.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_1-A</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. RT-PCR analysis of the expression of β-actin, Trpv1, Trpv2, Trpv3 and Trpv4 using mouse differentiated brown adipocytes after 29 (upper) and 35 (lower) thermal cycles with (RT (+)) and without (RT (-)) reverse transcription (RT). Control (Ct.) lanes indicate the results with each plasmid DNA as a template.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">8</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="106" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_1-B</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Results of real-time RT-PCR analysis of Trpv1, Trpv2, Trpv3 and Trpv4 expression using mouse differentiated brown adipocytes. Expression levels of mRNA were normalized to that of the ribosomal protein gene (36B4), a housekeeping gene un-affected by adipogenesis. Data are presented as mean ± SEM, n = 6.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="111" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_1-C</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Results of real-time PCR analysis of Trpv1, Trpv2, Trpv3 and Trpv4expression using mouse interscapular brown adipose tissue (iBAT). mRNA expression levels were normalized to that of 36B4. Data are presented as mean ± SEM, n = 5.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_1-D</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Western blot results of TRPV2 and tubulin from WT and TRPV2KO brown adipocytes. Upper bands in the TRPV2 blots likely indicate glycosylated forms.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">29</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="65" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_1-E</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Averaged traces of [Ca2+]i changes in response to 500 µmol/L 2APB in differentiated brown adipocytes from WT (black) and TRPV2KO (red) mice. One µmol/L NE was used to confirm differentiation. Five µmol/L ionomycin was used to confirm cell viability. Ratio values correspond to the real [Ca2+]i of differentiated mousebrown adipocytes. Data are presented as mean ± SEM, n = 149 of WT cells, and n = 112 of TRPV2KO brown adipocytes; ** P &lt; 0.01. Unpaired Student's t-test.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">38</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="87" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">39</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="320" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">40</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="416" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_1-F-G</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 1-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F. A representative trace of whole-cell current activated by 3 mmol/L of 2APB in the presence or absence of 10 µmol/L SKF in mouse differentiated brown adipocyte. The left inset indicates a voltage ramp-pulse protocol. The right inset indicates the current-voltage curves of basal current (a, black), current in the presence of 2APB+SKF (b, blue) and current in the presence of 2APB alone (c, red) at the time points of a, b and c, respectively. G. Comparison of the mean densities of basal currents (Base, black), currents in the presence of 2APB alone (red) and currents in the presence of 2APB+SKF (blue) at -60 mV and +100 mV in mouse differentiated brown adipocytes. Data are presented as mean ± SEM, n = 10; ** P &lt; 0.01 vs. Base; ##P &lt; 0.01 vs. 2APB alone. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">50</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="146" length="15"/>
        <text>brown adipocyte</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="654" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_2-A</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Results of real-time RT-PCR analysis of Trpv1, Trpv2, Trpv3 and Trpv4 expression in mouse pre-adipocytes and differentiated brown adipocytes. Expression levels of mRNA were normalized to those of 36B4. Data are presented as mean ± SEM, n = 6. * P &lt; 0.05 vs. pre-adipocytes. Unpaired Student's t-test.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">71</infon>
        <infon key="identifier">CL:0002334</infon>
        <location offset="93" length="14"/>
        <text>pre-adipocytes</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">68</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="127" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">72</infon>
        <infon key="identifier">CL:0002334</infon>
        <location offset="261" length="14"/>
        <text>pre-adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_2-B</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The number of 6 day-differentiated mousebrown adipocytes treated with TRPV2 agonists, 100 µmol/L 2APB or 10 µmol/L LPC. Mean ± SEM, n = 6, * P &lt; 0.05 and ** P &lt; 0.01 vs. dimethyl sulfoxide (DMSO) group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">76</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="43" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_2-C-D</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C and D. Comparison of the numbers of 6 day-differentiated mousebrown adipocytes (C) and triglyceride levels (D) in the cells from WT and TRPV2KO mice with different differentiation media. 1/10 suppl. indicates differentiation medium ten-time-diluted with DMEM. Mean ± SEM, n = 8, ** P &lt; 0.01 vs. control group, ##P &lt; 0.01 vs. WT group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">84</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="64" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_3-A</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Basal mRNA expression of Ucp1, peroxisome proliferator-activated receptor gamma coactivator 1-alpha (Pgc1α), peroxisome proliferator-activated receptor  γ(Pparγ) and β3-adrenergic receptor 3 (Adrb3) in the differentiated brown adipocytes from WT and TRPV2KO mice. Data are presented as mean ± SEM, n = 5; ** P &lt; 0.01 vs. WT. Unpaired Student's t-test.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">95</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="224" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_3-B-C</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B and C. Changes in Ucp1 (B) and Pgc1α(C) mRNA expression in the differentiated brown adipocytes from WT and TRPV2KO mice with and without 10 µmol/L isoproterenol (ISO) for 4 h. Data are presented as mean ± SEM, n = 5; ** P &lt; 0.01 vs. DMSO group; # P &lt; 0.05; ## P &lt; 0.01 vs. WT group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">106</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="80" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_3-D-E</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 3-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D and E. Changes in Ucp1 mRNA expression (D) and non-esterified fatty acid (NEFA) release (E) in the differentiated brown adipocytes from WT and TRPV2KO mice with or without 10 µmol/L forskolin for 4 h. Data are presented as mean ± SEM, n = 6; * P &lt; 0.05; ** P &lt; 0.01 vs. DMSO group; ## P &lt; 0.01 vs. WT group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">111</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="116" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_3-F-G</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 3-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F and G. Changes in Ucp1 mRNA (F) and Pgc1α mRNA (G) in the differentiated brown adipocytes treated with 10 µmol/L ISO alone or 10 µmol/L ISO plus 10 µmol/L BAPTA-AM for 4 h. Data are presented as mean ± SEM, n = 6; * P &lt; 0.05; ** P &lt; 0.01 vs. DMSO group; ## P &lt; 0.01 vs. ISO group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">121</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="75" length="16"/>
        <text>brown adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_4-A</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Body weight changes from 3-weeks to 8-weeks of age between the two genotypes (n = 11). Data are presented as mean ± SEM; * P &lt; 0.05; ** P &lt; 0.01 vs. WT group. Unpaired Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_4-B-C</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 4-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B and C. Changes in food intake (B) and water intake (C) from 3-weeks to 8-weeks of ages between WT and TRPV2KO mice (n = 6).</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_4-D</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Weights of tissues related to energy metabolism normalized to their body weights in WT and TRPV2KO mice (n = 15).</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_4-E</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. The expression levels of mRNA related to energy metabolism in iBAT from WT and TRPV2KO mice. mRNA expression levels of Ucp1, Pgc1a, Ppary, Adrb3, cytochrome c oxidase subunit 4 isoform 1 (Cox4i1), PR domain containing 16 (Prdm16), Ucp2, lipoprotein lipase (Lpl) and cluster of differentiation 36 (Cd36) were examined and normalized to the levels of 36B4. Data are presented as mean ± SEM, n = 15; * P &lt; 0.05 vs. WT group; ** P &lt; 0.01 vs. WT group. Unpaired Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_5-A-B-C-D</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 5-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A. Representative morphological results of iBAT by hematoxylin and eosin staining from 8-week WT and TRPV2KO mice. Scale bars indicate 100 μm. B. Comparison of lipid droplet size histograms from 8-week-old WT (black) and TRPV2KO (red) iBAT with hematoxylin and eosin staining. Mean values are 9.5 ± 0.2 µm in 8-week-old WT adipocytes, and 14.7 ± 0.2 µm in 8-week-old TRPV2KO adipocytes (P &lt; 0.01). 1000 to 1400 droplets were counted. Data are presented as mean ± SEM, n = 4. C. Comparison of adipocyte size histograms from 8-week-old WT (black) and TRPV2KO (red) iBAT with hematoxylin and eosin staining. 800 to 1000 cells were counted. Data are presented as mean ± SEM, n = 4. D. Mean diameters of adipocytes in 8-week-old WT mice (black) and TRPV2KO mice (red). Mean values are 15.8 ± 0.4 µm in 8-week-old WT adipocytes, and 19.8 ± 0.3 µm in 8-week-old TRPV2KO adipocytes. Data are presented as mean ± SEM, n = 4; * P &lt; 0.05 vs. WT group. Unpaired Student's t-test.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">168</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="323" length="10"/>
        <text>adipocytes</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">176</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="375" length="10"/>
        <text>adipocytes</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">170</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="492" length="9"/>
        <text>adipocyte</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">179</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="699" length="10"/>
        <text>adipocytes</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="811" length="10"/>
        <text>adipocytes</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">181</infon>
        <infon key="identifier">CL:0000449</infon>
        <location offset="863" length="10"/>
        <text>adipocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_6-A-B-C-D</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 6-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A, B, C and D. Changes in mRNA expression of Ucp1(A), Pgc1α(B), Pparγ (C) and Trpv2(D) in iBAT of WT and TRPV2KO mice before (25oC), after 1 day and 3 days cold (4oC) exposure. Mean ± SEM, n = 5 - 8; * P &lt; 0.05; ** P &lt; 0.01 vs. 25oC group; # P &lt; 0.05 vs. WT group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_6-E-F</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 6-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E and F. Western blot results of UCP1 protein in iBAT from WT and TRPV2KO mice before (25oC) and after 3 days cold (4oC) exposure (E). Comparison of UCP1 protein levels before and after cold exposure in iBAT from WT and TRPV2KO mice (F). Mean ± SEM, n = 6; * P &lt; 0.05 vs. 25oC group; # P &lt; 0.05 vs. WT group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_6-G-H</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 6-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G and H. Averages of core body temperatures (G) and activities (H) of WT and TRPV2KO mice with or without cold (4oC) exposure. Data are presented as mean ± SEM, n = 5; * P &lt; 0.05 vs. WT group. Unpaired Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_7-A-B-C</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 7-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A, B and C. Changes in mRNA expression of Ucp1(A), Pgc1α(B) and Pparγ(C) from WT and TRPV2KO iBAT 4 h after intraperitoneal administration (i.p., arrows) of saline or a selective β3-adrenergic receptor agonist, BRL37344 (600 µg/kg body weight). Mean ± SEM, n = 5 - 7; * P &lt; 0.05 vs. saline group; # P &lt; 0.01 vs. WT BRL37344 administration group. One-way ANOVA followed by 2-tailed t-test with Bonferroni correction.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_7-D-E</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 7-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D and E. Average traces of changes in iBATtemperature (D) or rectalbody temperature (E) from WT and TRPV2KO mice after BRL37344 (600 µg/kg body weight) administration (i.p., arrows). Mean ± SEM, n = 5. * P &lt; 0.05 vs. WT group. Unpaired Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_7-F-G</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 7-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F and G. iBATNE turnover rates (F) and rate constants k (G) in WT and TRPV2KO mice upon cold exposure (4oC) for 4 h. Data are presented as mean ± SEM, n = 8.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_8-A</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Body weight changes between WT and TRPV2KO mice treated with high fat diet (HFD) for continuous 8 weeks from 13-week-old.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_8-B-C</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 8-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B and C. Bloodglucose level (B) and plasmainsulin level (C) of WT and TRPV2KO mice after 8-week HFD treatment.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_8-D</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Weights of tissues related to energy metabolism in WT and TRPV2KO mice after 8-week HFD treatment.</text>
    </passage>
  </document>
  <document>
    <id>4772987 Figure_8-E</id>
    <infon key="sourcedata_document">1419</infon>
    <infon key="doi">10.15252/embr.201540819</infon>
    <infon key="pmc_id">4772987</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. mRNA expression of Ucp1and Pgc1α in iBAT from WT and TRPV2KO mice after 8-week HFD treatment. All data are presented as mean ± SEM, WT mice (n = 6), TRPV2KO mice (n = 8); * P &lt; 0.05; ** P &lt; 0.01 vs. WT group. Unpaired Student's t-test.</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_1-A</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>Immunoprecipitation was performed with GFP-binding protein immobilized on magnetic beads using extracts of Arabidopsis seedlings, expressing either YFP-MKKK7 or Lti6B. Seedlings were treated with 1 μM flg22 for the indicated time. YFP-MKKK7 and Lti6B-GFP were detected with an anti-GFP antibody while FLS2 was detected with an FLS-specific antibody. Upper panel shows (co)-immunoprecipated proteins, lower panel shows input levels of protein. Arrowheads indicate the position of proteins of interest.</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_2-A-I</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 2-A-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-I</infon>
    <passage>
      <offset>0</offset>
      <text>Application of selected reaction monitoring (SRM) mass spectrometry to quantify phosphorylated peptides in cell extracts treated with 1 μM flg22. Bars represent the mean ratio of endogenous phosphopeptide versus spiked-in synthetic phosphopeptide normalized to t = 0 with error bars ± SEM (n=3.). Asterisks indicate significant difference level compared to t = 0 (student t-test, *&gt;0.05, **&gt;0.01 and ***&gt;0.001). The color of each bar corresponds to the different time points (0 minutes = dark blue, 5 minutes = red, 10 minutes = green, 20 minutes = purple, 30 minutes = light blue). Above each graph is the protein name and the phosphorylated residue (in brackets) is indicated and below the corresponding phosphopeptide is shown with the Serine (S), Threonine (T) or Tyrosine (Y) phosphorylation site indicated by "[+80]".</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_3-A</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Immunoblot analyses showing MAPK phosphorylation after flg22 induction in Col-0 and in mkkk7. Protein extracts were made from seedlings treated with 1 μM flg22 and samples were taken at t=0, 10 and 30 min post induction. The p44/42 antibody was used to detect phosphorylated MAPKs. Position of the individual phosphorylated MAPKs is indicated at the right. Equal loading of proteins is shown with an α-Actin antibody as a loading control (bottom panel). Three biological replicates were done with identical results</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_3-B</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) MPK6 phosphorylation is specifically enhanced in mkkk7. Comparison of phosphopeptide abundances from selected MAP kinases in Col-0 (blue) and mkkk7 (red) seedlings at t = 0 min and t = 10 min after 1 μM flagellin treatment by selected reaction monitoring (SRM) mass spectrometry. Phosphopeptide corresponding to MKKK7 are only detectable in Col-0 seedlings and are non-detectable (ND) in mkkk7. Bars represent means of measured peptide areas (sum of all transition areas) for three biological replicates, with error bars ± SEM (n=3). Asterisks indicate significant difference between Col-0 and mkkk7 at individual time points (student t-test, *&gt;0.05, **&gt;0.01 and ***&gt;0.001). ND indicates integration of an area without transitions significantly above background. Above each graph the protein name and the phosphorylated residue (in brackets) is indicated as well as the corresponding phosphopeptide sequence. Serine (S), Threonine (T) or Tyrosine (Y) phosphorylation is indicated by "[+80]".</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_4-A</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Transient expression analysis in Arabidopsis mesophyll protoplasts shows enhanced defense gene expression in mkkk7protoplasts after flg22 treatment. Protoplasts were isolated from 4 week old plants and transfected with pWRKY29:fLUC (WRKY29) or pFRK1:fLUC(FRK1) constructs together with 35S:rLUC, as indicated in the graph. Protoplasts were treated for 4 hrs with 10 µM flg22 or mock treated as indicated. The horizontal axis indicates the treatment while the vertical axis represents expression levels relative to the mock treated control sample, as fold induction. All measurements were normalized to the rLUC activity. Bars represent means ± STDEV (n=2). Experiment was repeated 6 times with similar results.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">59</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="58" length="11"/>
        <text>protoplasts</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">61</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="117" length="11"/>
        <text>protoplasts</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">63</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="152" length="11"/>
        <text>Protoplasts</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">55</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="326" length="11"/>
        <text>Protoplasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_4-B</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) WRKY29 transcripts measured by qRT-PCR in flg22 treated leaf material. Leaf strips of Col-0 and mkkk7 were treated with 1 µM flg22 for t=0, 1, 2, and 4h. WRKY29 transcripts were normalized against Ubiquitin transcript as described before [62]. Bars represent mean value and error bars show SE (n=3). (* p&lt;0.05, ** p&lt;0.01, student t-test).</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_4-C</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) FRK1 transcripts measured by qRT-PCR in flg22 treated leaf material. Leaf strips of Col-0 and mkkk7 were treated with 1 µM flg22 fort=0, 1, 2, and 4h. FRK1 transcripts were normalized against Ubiquitin transcript as described before [62]. Bars represent mean value and error bars show SE (n=3). (* p&lt;0.05, ** p&lt;0.01, student t-test).</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_5-A</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Transient co-expression of MKKK7 in Arabidopsis mesophyll protoplasts shows suppression of flg22-induced WRKY29 gene expression. Protoplasts were transfected with pWRKY29:fLUC, 35S:rLUC and indicated overexpression constructs of MKKK7 (OE-MKKK7, OE-MKKK7AA or OE-MKKK7DD) as indicated on the horizontal axis. Protoplasts were treated with 10 μM flg22 or mock treated for 4 hrs. All measurements were normalized to the rLUC activity and expression is relative to the mock treated control sample, shown as fold induction on the vertical axis. Results shown are means ± STDEV (n=2). At least two biological replicates were done with similar results</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">96</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="61" length="11"/>
        <text>protoplasts</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">99</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="132" length="11"/>
        <text>Protoplasts</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">105</infon>
        <infon key="identifier">CL:0000371</infon>
        <location offset="312" length="11"/>
        <text>Protoplasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_6-A</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Four-week-old seedlings were dipped into a suspension containing virulent Pst DC3000 and 72 h later the disease symptoms were scored. Data represents mean values ± SEM (n=20;***, p&lt;0.001; paired t-test). Three biological experiments were done showing similar results.</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_6-B</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Quantification of bacterial growth in Arabidopsis lines Col-0, mkkk7 and p35S:MKKK7-GFP in the mkkk7 background. Four to five-week-old plants were pressure-infiltrated with virulent Pst DC3000 and at indicated time points 6 samples were harvested and bacteria re-isolated on selective media. The number of colony forming units (cfu/cm2) was determined at t=0, 2 and 3days post inoculation (dpi). Data represents mean values ± SEM (n=6; **, p&lt;0.01; paired t-test). Experiments were done at least twice with similar results.</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_6-C</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Disease symptom development in Pst-infected lines with estradiol inducible constructs of ind-MKKK7AA L8, ind-MKKK7AA L10, ind-MKKK7DD L1 and ind-MKKK7DD L3. Two independent transgenic lines for each construct were grown under short-day conditions and disease symptoms were scored 3 dpi. Data represents mean values ± SEM (n=20; *, p&lt;0.05; **, p&lt;0.01; paired t-test). The vertical axis represents the percentage disease symptoms. Experiments were done at least twice with similar results.</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_7-A</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Effect of 100 nM flg22 treatment on ROS burst measured in 5 week old plants of Col-0 and mkkk7.</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_7-B</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Effect of 100 nM flg22 treatment on the ROS burst measured in 5 week old plants of Col-0 and two independent inducible MKKK7AA transgenic lines.</text>
    </passage>
  </document>
  <document>
    <id>4772993 Figure_7-C</id>
    <infon key="sourcedata_document">1309</infon>
    <infon key="doi">10.15252/embr.201540806</infon>
    <infon key="pmc_id">4772993</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Effect of 100 nM flg22 treatment on the ROS burst measured in 5 weeks old plants of Col-0 and two independent inducible MKKK7DD transgenic lines. Graphs represent means with error bars ± SEM (n=24). The vertical axis represents the relative increase in ROS production (photon counts) after PAMP treatment. At least three biological replicate experiments were done with similar results.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_1-A</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunofluorescence staining of Lin-Sca-1+cKit+ (LSK) cells using an antibody specific for phosphorylated STAT5 (pSTAT5) or total STAT5. Scale bars represent 5μm. Bar graphs showing the quantification of nuclear localization presented as mean fluorescence intensity (MFI). Data are shown as means ± SD of three independent experiments.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">213</infon>
        <infon key="identifier">CL:0001008</infon>
        <location offset="52" length="3"/>
        <text>LSK</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_1-C</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Western blot analysis of HPC7 cells grown in the presence of SCF demonstrates nuclear and cytoplasmic uSTAT5 in the absence pSTAT5. K562 cell lysates were used as a positive control for pSTAT5.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">13</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="29" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_1-D</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Western blot analysis of HPC7 cells after TPO stimulation (100ng/ml) at the indicated time points.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">25</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="29" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_1-E</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Western blot analysis was performed after immunoprecipitation of STAT5 from unstimulated and TPO stimulated cells using antibodies to total STAT5 or to pSTAT5 (pY694/p699). 1% (5μg) of lysate was loaded as input control.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_2-A</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Summary of ChIP-Seq results obtained using HPC7 cells and an antibody to total STAT5. For each STAT5 occupied region, the occupancy of STAT5 in unstimulated (T=0 mins) and in TPO stimulated (T=30 mins) cells is indicated within a 5-kb window centered on the total STAT5 bound region.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="47" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_2-B</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Examples of loci containing ChIP-Seq peaks from Cluster 1 (ie uSTAT5 peaks) or Cluster 2 (ie pSTAT5 peaks) showing loss of the former and appearance of the latter following TPO stimulation.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_2-C-D</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C and D) ChIP-Seq results were validated by ChIP-qPCR using antibodies against total STAT5 or pSTAT5. Data represented as means ± SD of 3 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_2-G</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) ChIP-Seq genome-browser views showing co-localization of uSTAT5 binding with CTCF.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_2-H</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Immunofluorescence analysis of STAT5 wild type and knockout MEFs with 4′,6-diamidino-2-phenylindole (DAPI) staining (blue) and anti-STAT5 antibody (red). Scale bars represent 25μm.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_2-I</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 2-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) Western blot analysis of cell lysates isolated from STAT5 wild type and knockout MEFs. **, p&lt;0.01; ***, p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_3-A</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Western blot analysis showing efficient knock-down of uSTAT5 in HPC7 cells on day 3 after infection.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">60</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="68" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_3-B</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) RNA microarray analysis following uSTAT5 depletion by shRNA_7 in HPC7 cells grown in SCF. The 40 most upregulated genes following uSTAT5 knock-down are illustrated. Genes upregulated during megakaryopoiesis are indicated in red.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">67</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="69" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_3-C</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Gene set enrichment analysis showing significant enrichment of a megakaryocyte progenitor (MKP, Lin-Sca1-Kit+Itga2b+Slamf1+) signature in STAT5 knockdown cells. CLP, common lymphoid progenitor (Lin-Sca1lowKitlowIL7r+Flk2+); preGM, pre-grenulocyte/macrophage progenitors (Lin-Sca1-Kit+Itga2b-FcgRlowSlamf1-Englow); NES, normalized enrichment score.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_3-D</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantitative RT-PCR confirmed upregulation of uSTAT5 target genes following uSTAT5 depletion. Relative RNA levels were normalized to 18S RNA. Bar graphs represent means ± SD of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_3-E-F</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 3-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E-F) Kinetics of the upregulation of uSTAT5(E) and pSTAT5(F) target genes following TPO stimulation. Each data point represents a mean ± SD. n=3; *, significant difference from time 0 (p&lt;0.05); *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_4-B</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Depletion of uSTAT5 was accompanied by the appearance of large cells that stain positively for Acetylcholinesterase (AchE). Scrambled shRNA (scr), shSTAT5_5 (sh_5) or shSTAT5_7 (sh_7).</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_4-C</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Increased percentage of polyploid cells following uSTAT5 depletion. Bars represent means ± SD from three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_4-D</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Increased percentage of cells expressing high levels of CD41 and CD61 following uSTAT5 depletion. Bars represent means ± SD from three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_4-F</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Western blot analysis of HPC7 cells expressing empty vector (EV), wild type STAT5B (WT) or mutant STAT5B (Y699F). EV and Y699F expressing cells exhibit similar levels of STAT5 phosphorylation following TPO treatment (100ng/ml for 30min).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">114</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="29" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_4-G</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Expression of the Y699F mutant repressed the appearance of large cells that stained for acetylcholinesterase (AchE). Scale bars represent 25μm.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_4-I</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 4-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) The Y699F mutant increased the percentage of cells expressing high levels of CD41 and CD61. Bars represent means ± SD from three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_4-J-K</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 4-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_4-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>(J) Quantitative RT-PCR showing that the Y699F mutant did not alter induction of pSTAT5 target genes by endogenous pSTAT5 following TPO stimulation (100ng/ml for 30 min). Bars represent means ± SDs from three independent experiments. (K) Quantitative RT-PCR showing that the Y699F mutant repressed induction of uSTAT5 target genes following TPO treatment. Bar graphs represents means ± SDs from three independent experiments. *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_5-A</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Heatmap showing hierarchical clustering of pairwise peak overlap of HPC7 ChIP-seq data, red representing positive Pearson's correlation coefficient values and blue representing negative correlation coefficients.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">150</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="72" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_5-C</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) ChIP-reChIP experiment using HPC7 cells grown in SCF containing media. An antibody to total STAT5 or control IgG was used for the first pull-down and an antibody to CTCF or ERG was used for the second pull down.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">152</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="33" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_5-D</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) ChIP-reChIP experiment using HPC7 cells grown in SCF containing media. An antibody to ERG or control IgG was used for the first pull-down and an antibody to CTCF or STAT5 was used for the second pull down.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">159</infon>
        <infon key="identifier">CL:0000037</infon>
        <location offset="33" length="4"/>
        <text>HPC7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_5-E-G</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 5-E-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-G</infon>
    <passage>
      <offset>0</offset>
      <text>(E and G) ChIP-qPCR showing increased enrichment of ERG binding sites at Mpl or F2r loci following STAT5 knock-down (E) or stimulation with TPO(G).</text>
    </passage>
  </document>
  <document>
    <id>4801948 Figure_5-F-H</id>
    <infon key="sourcedata_document">1257</infon>
    <infon key="doi">10.15252/embj.201592383</infon>
    <infon key="pmc_id">4801948</infon>
    <infon key="figure">Figure 5-F-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F-H</infon>
    <passage>
      <offset>0</offset>
      <text>(F and H) ChIP-qPCR showing decreased uSTAT5 binding at Mpl and F2r loci after STAT5 knock-down (F) or following TPO treatment (H). All bar graphs represent means ± SD; n = 3; *, p&lt;0.05; **, p&lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>4818753 Figure_1-A</id>
    <infon key="sourcedata_document">1458</infon>
    <infon key="doi">10.15252/emmm.201506106</infon>
    <infon key="pmc_id">4818753</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 1: Growth Charts and Photographs of Affected Subjects •A Family 1-Subject II.1. •B Family 1-Subject II.3. •C Family 2-Subject II.3. •D Family 2-Subject II.4. •E Family 2-Subject II.5. •F Top Row -Representative X-rays showing narrow fibulae and elongated digits in Subject II.1 of Family 1. Bottom Row - Lower extremities and foot from Subject II.5 and hand from Subject II.4, both from Family 2.</text>
    </passage>
  </document>
  <document>
    <id>4818753 Figure_2-B-C</id>
    <infon key="sourcedata_document">1458</infon>
    <infon key="doi">10.15252/emmm.201506106</infon>
    <infon key="pmc_id">4818753</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>• B Pedigree and representative Sanger sequencing trace of the mutation identified in family 1. •C Pedigree and representative Sanger sequencing trace of the mutation identified in family 2.</text>
    </passage>
  </document>
  <document>
    <id>4818753 Figure_3-A</id>
    <infon key="sourcedata_document">1458</infon>
    <infon key="doi">10.15252/emmm.201506106</infon>
    <infon key="pmc_id">4818753</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>• A Assessment of proteolytic activity present in culture media of human embryonic kidney 293T cells transfected with cDNA encoding PAPP-A2, PAPP-A2(D643fs) (family 1), or PAPP-A2(A1033V) (family 2). Radiolabeled substrates tested include IGFBP-3, IGFBP-4, and IGFBP-5. Cleavage was visualized by autoradiography following SDS-PAGE. Positions of intact IGFBPs (i) and cleavage products (c) are indicated.</text>
    </passage>
  </document>
  <document>
    <id>4818753 Figure_3-B</id>
    <infon key="sourcedata_document">1458</infon>
    <infon key="doi">10.15252/emmm.201506106</infon>
    <infon key="pmc_id">4818753</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Western blots following nonreducing or reducing SDS-PAGE of media from transfected cells, as indicated. Polyclonal antibodies raised against the N-terminal portion of PAPP-A2 were used for detection.</text>
    </passage>
  </document>
  <document>
    <id>4818753 Figure_3-C</id>
    <infon key="sourcedata_document">1458</infon>
    <infon key="doi">10.15252/emmm.201506106</infon>
    <infon key="pmc_id">4818753</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>•C Comparison of proteolytic activity similar to the experiment of panel A, except that equimolar concentrations of PAPP-A2 and PAPP-A2 (A1033V) were used. The variant from Family 1, carrying a frameshift mutation N-terminal to the proteolytic domain of PAPP-A2, did not show any detectable expression. All gels and blots are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4818753 Figure_4-A</id>
    <infon key="sourcedata_document">1458</infon>
    <infon key="doi">10.15252/emmm.201506106</infon>
    <infon key="pmc_id">4818753</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>• A Concentrations of endogenous insulin-like growth factor (IGF)-I in the different fractions obtained by neutral chromatography on a Superdex 200 column. Serum samples from the four siblings of family 1 were analyzed and compared to a non-related prepubertal control, as all siblings were prepubertal. The amount of IGF-I detected in the fractions corresponding to the ternary complex (TC) was markedly greater in the homozygous affected subjects (II·1 and II·3) compared to the unaffected siblings (II.2 and II.4) and the prepubertal control. No IGF-I was detected in the fractions corresponding to the binary complex (BC) or free IGF-I in any of the subjects. This is most likely due to the fact that under physiological conditions 80-85% of IGF-I circulates in the TC and after the separation procedure, the amount of IGF-I in the BC or free was below the level of detection of our IGF-I assay. These results clearly demonstrate that in the affected patients the amount of IGF-I circulating in the TC is markedly elevated.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_1-B</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B . Screening results of compounds competing Dvl-CXXC5 interaction. Each 2 μM of the compounds was used for competing as described in Fig 1A. [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_1-C-D</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D. Primary calvaria cells were treated with 2 μM of each compound for 2 days. The cells were subjected to immunofluorescence analyses to visualize β-catenin (C; green). The relative numbers of β-catenin-positive nuclei were counted (D). [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_1-E-F</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F . The calvariae from 4-day-old mice were cultured ex vivo for 7 days with 2 µM of each compound. Representative calvaria sections were visualized by H&amp;E staining (E). The calvaria thicknesses were measured from the images using Image Pro software (F). [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_2-B</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B . A competition curve for the Dvl-CXXC5 interaction by KY-02061.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_2-C-D-E</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 2-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>C-E. NMR titration analyses for Dvl PZD domain with KY-02061. 1H-15N-HSQC analyses were performed to analyze the interaction of 15N-labelled Dvl-PDZ domain with KY-02061. The 1H-15N-HSQC spectrum of different molar ratios (Dvl PDZ domain:KY-02061) are displayed as red (1:0), orange (1:10), purple (1:20), cyan (1:40), green (1:60) and blue (1:80) (C, residues with meaningful chemical shift change are indicated by arrows). Plot of chemical shift changes (Δδ) as a function of residue number in molecular ratio 1:80 (D, a red-colored line indicates the line for Δδ=0.05). The residues with Δδ greater than 0.05 are visualized as a stick model on the ribbon representation of the Dvl PDZ domain structure (E).</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_2-F</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Molecular docking of Dvl binding motif (DBM) or KY-02061 to Dvl PDZ domain were analyzed by in silico experiments. The superimposed structure of DBM (green) and KY-02061 (yellow) on the surface of Dvl PDZ domain (gray) was visualized.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_3-A</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A . MC3T3E1 cells were transfected with pTOPFLASH together with pCMV-β-gal. After 24 h, the cells were treated with DMSO, KY-02061 in DMSO, or 5 µM PolyR-DBM for 2 days. The luciferase activities of whole cell lysates were measured and normalized with β-galactosidase activities. [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_3-B</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B . Primary calvaria cells were isolated from the calvariae of 4-day-old mice (Manton et al, 2007), and treated with DMSO or KY-02061 in DMSO for 4 days. ALP activity levels were visualized by ALP staining.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_3-C</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Primary calvaria cells were treated with DMSO or 5 µM KY-02061 in DMSO for 14 days. The cells were subjected to immunofluorescence analyses to visualize Runx2 (green) and β-catenin (red). The cell nuclei were counterstained with DAPI (blue).</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_3-D-E</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 3-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E. Calvariae from 4-day-old mice were cultured ex vivo for 7 days with KY-02061 in DMSO (D). The calvaria thicknesses were measured from the stained sections using Image Pro software (E). [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_4-B</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. A competition curve for the Dvl-CXXC5 interaction by KY-02327.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_4-C</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Fluorescence quenching plot of Dvl PDZ domain upon addition of different amounts of KY-02327. From top to bottom final moral ratio between Dvl PDZ and KY-02327 was, 1:0, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:15, 1:20 and 1:25, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_4-D-E-F</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 4-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>D-F. 1H-15N-HSQC analyses were performed to analyze the interaction of 15N-labelled Dvl-PDZ domain with KY-02327. The 1H-15N-HSQC spectrum of different molar ratios (Dvl PDZ domain:KY-02327) are displayed as red (1:0), yellow (1:5), green (1:10), and magenta (1:20) (D, residues with meaningful chemical shift change are indicated by arrows). Plot of chemical shift changes (Δδ) as a function of residue number in molecular ratio 1:20 (E, a red-colored line indicates the line for Δδ=0.05). The residues with Δδ greater than 0.05 are visualized as a stick model on the ribbon representation of the Dvl PDZ domain structure (F).</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_4-G</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Molecular docking of KY-02061 or KY-02327 to Dvl PDZ domain were analyzed by in silico experiments. The superimposed structure of KY-02061 (yellow) and KY-02327 (cyan) on the surface of Dvl PDZ domain (gray) was visualized.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_5-A</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A . MC3T3E1 cells were transfected with pTOPFLASH together with pCMV-β-gal. After 24 h, the cells were treated with indicated dose of KY-02327 for 2 days. The luciferase activities of whole cell lysates were measured and normalized with β-galactosidase activities. [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_5-B</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B-C . MC3T3E1 cells were treated with indicated concentrations of KY-02327 for 2 days. β-Catenin and α-tubulin were detected by immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_5-C</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>B-C . MC3T3E1 cells were treated with indicated concentrations of KY-02327 for 2 days. β-Catenin and α-tubulin were detected by immunoblot (B) or immunofluorescence (C) analyses. Nuclei were counterstained with DAPI (C, blue).</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_5-D</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. MC3T3E1 cells were treated with indicated concentrations of KY-02327 for 14 days. The mRNA level of collagen 1a (Col1a) was measured by quantitative real-time qRT-PCR. [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_5-E</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. MC3T3E1 cells were treated with indicated concentrations of KY-02327 for 21 days. The mRNA level of osteocalcin (OCN) was measured by qRT-PCR. [n=3]</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_6-A-B-C</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 6-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-F. Vehicle or 20 mg of KY-02327 per kg of animal body weight (mpk) was orally administered or 0.06 mpk of the N-terminal fragment of PTH (amino acids 1-34) was subcutaneously injected into the Sham-operated (Sham) or ovariectomized (OVX) mice on 5 sequential days per week for 4 weeks [n=4]. After calcein injection, the prepared femoral sections of the OVX mice were examined under fluorescence microscope to visualize integrated calcein (A, green, arrows). Nuclei were counterstained with DAPI (A, blue). Osteoblast numbers (B) and calcein double labelled surfaces (C) were measured in the femoral sections.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">161</infon>
        <infon key="identifier">CL:0000062</infon>
        <location offset="509" length="10"/>
        <text>Osteoblast</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_6-D-E</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 6-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>A-F. Vehicle or 20 mg of KY-02327 per kg of animal body weight (mpk) was orally administered or 0.06 mpk of the N-terminal fragment of PTH (amino acids 1-34) was subcutaneously injected into the Sham-operated (Sham) or ovariectomized (OVX) mice on 5 sequential days per week for 4 weeks [n=4]. The mousefemurs were analyzed using micro-CT and BMD (D) and BV/TV (E) were calculated from the micro-CT data.</text>
    </passage>
  </document>
  <document>
    <id>4818757 Figure_6-F-G-H</id>
    <infon key="sourcedata_document">1523</infon>
    <infon key="doi">10.15252/emmm.201505714</infon>
    <infon key="pmc_id">4818757</infon>
    <infon key="figure">Figure 6-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>A-F. Vehicle or 20 mg of KY-02327 per kg of animal body weight (mpk) was orally administered or 0.06 mpk of the N-terminal fragment of PTH (amino acids 1-34) was subcutaneously injected into the Sham-operated (Sham) or ovariectomized (OVX) mice on 5 sequential days per week for 4 weeks [n=4]. The three-dimensional images of femoraltrabecular bone were reconstructed (F), and trabecular number (G) and trabecular separation (H) were calculated.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_1-A-B</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A-B. Correlation of MCU and MCUb expression levels with breast cancer clinical stages. Median-centered log2 mRNA expression levels of MCU and MCUb were collected from the TCGA breast cancer dataset (http://tcga-data.nci.nih.gov/docs/publications/brca_2012/). Data were plotted and analysed against tumor size (T1-T4) (A) and regional lymph node infiltration (N0-N3) (B), according to the AJCC Cancer Staging Manual (7th edition). Linear regression analysis with different stages was implemented. Parameters of linear regression are shown. Number of samples for each stage are shown in parentheses.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_1-C-D-E</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 1-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>C-E. MCU silencing reduces Ca2+mit uptake in TNBC cells. Cells were transfected with siMCU or siControl. After 48h, [Ca2+]mit uptake upon ATP (C, E) or Histamine (D) stimulation was measured (n=10). P-values: ***p= 0.0008, ***p&lt;0.0001, ***p= 0.0001, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_1-F-G-H</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 1-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>F-H. MCU silencing impairs TNBC cell migration. Cells were transfected with siMCU or siControl. The day after transfection, a linear scratch was obtained on the cell monolayer through a vertically held P200 tip (time- point 0h). Cell migration into the scratched area was monitored 48 hours later. The covered area was measured and expressed as a percentage relative to 0-hour time-point (n=12). P-value: ***p&lt;0.0001.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_1-I-J-K</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 1-I-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>I-K. Cell proliferation is mainly unaffected by MCU depletion. Cells were transfected with siMCU or siControl. Cell number was counted every 24 hours for 3 days (the 72-hour time point corresponds to the 48-hour time-point of wound healing assay). Results are expressed as ratio R/R0 where R0 is the number of cells at the time of transfection (0 hour time-point) (n=6). P-value: *p=0.05.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_2-A</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Re-expression of mMCU rescues cell motility of MCU-silenced cells. Cells were transfected with siMCU or siControl. Ad-mMCU was used to re-express MCU (Ad-GFP was used as control). MCU protein expression was verified by western blot. The day after transduction a linear scratch was made (time-point 0h). Cell migration into the wounded area was monitored at 48 hour time-point and the covered area was measured (n=12). P-value: ***p&lt;0.0001.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_2-B</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. MCU silencing blunts cell invasiveness. Stable shMCU and shControl-expressing spheroids were plated and let grow into collagen-I (0 hour time-point). Spheroid area was measured at 0-hour and 48-hour (n=8). Scale bar 300 μm. P-value: ***p=0.0003.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_2-C</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. MCU silencing reduces the clonogenic potential of MDA-MB-231 cells. Stable shMCU and shControl-expressing cells were plated at low confluence (2x103/well of a 6-well plate). After 7 days the number of colonies was counted (minimum 30 cells/colony, n=8). P-value: **p=0.0027.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_2-D</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. MCU depletion does not induce cell death. Cells were transfected with siMCU or siControl. 72 hours later, cell apoptosis and necrosis were measured by FITC-Annexin V and Propidium Iodide (PI) detection (Q1: PI positive, Q2: PI and FITC-Annexin V positive, Q3: PI and FITC-Annexin V negative, Q4: FITC-Annexin V positive. n=6).</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_2-E</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. MCU depletion does not alter cell cycle. Cells were transfected with siMCU or siControl. 72 hours later, cell cycle distribution was monitored by Propidium Iodide (PI) detection (n=6).</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_3-A</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Tumor mass volume was measured at specific time-points until the day of sacrifice (day 39 post-injection for control, day 46 and 56 p.i. for MCU-/- cl.1 and cl.2, respectively). P-values: ***p=0.0001, ***p&lt;0.0001.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_3-B</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. left: in vivo metastasis at the homolateral axillary area of three representative mice per group at the time of sacrifice. Right: total flux analysis. P-values: **p=0.01, *p=0.02.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_3-C</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Lymph nodesweight at the time of sacrifice. P-values: ***p=0.0010, **p=0.0014.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_3-D</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Human cytokeratin 7 (CK7) IHC staining of three representative lymph nodes per group. Scale bar= 500 µm.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_3-E</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Left: images of three representative lungs per group collected ex vivo at the time of sacrifice. Right: total flux analysis. P-values: **p=0.0031, ***p= 0.0004.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A-C. FLIM analysis of cellular NADH/NADPH levels. Fluorescence lifetimes of NAD(P)H autofluorescence in stable shControl and shMCU expressing cells were imaged. Representative images of the distribution of τbound on an intensity weighted pseudocolored scale (2.2-2.5 ns) are shown. Scale bars = 20 μm (A). Mean +/- SE of τbound (B) and relative NADH and NADPH intensities (C) calculated from equation in (Blacker et al., 2014) are shown (n=3). P-values: **p=0.01, **p=0.002, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_4-D-E</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 4-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D-E. Measurement of the redox state of the NADH/NAD+ couple. Representative measurements of NADH intensity at steady state and at minimal and maximal reduced state (D). Percentage of the steady state redox state (E) (n=3).</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_4-F</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. MCU depletion impairs the mitochondrial rate of ATP production. Cells were transfected with siMCU or siControl. 48 hours later, cells were treated with 5.5 mM 2-deoxy-D-glucose for 1 hour and cellular ATP levels were quantified (n=6). P-value: ***p=0.0009.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_5-A</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Antioxidant treatments decrease cell migration. A linear scratch was obtained on cell monolayer through a vertically held P200 tip (time-point 0h). Cells were treated for 48 hours with N-Acetylcysteine (NAC) or Dithioerythritol (DTE). Cell migration into the wounded area was monitored at 48-hour time-point and the covered area was measured (n=12). P-values: **p=0.008, ***p&lt;0.0001, **p=0.005.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_5-B</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Scavenging of mitochondrial ROS decreases cell migration. A linear scratch was obtained on a cell monolayer through a vertically held P200 tip (time-point 0h). Cells were treated for 48 hours with 50 µM MitoTEMPO. Cell migration into the wounded area was monitored at 48 hour time-point and the covered area was measured (n=12). P-value: ***p&lt;0.0001.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_5-C</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. MCU silencing does not affect matrix pH. Cell were transfected with siMCU or siControl and SypHer2 probe. 48 hours later, matrix pH was measured (n=22).</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_5-D-E</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 5-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D-E. MitochondrialH2O2 levels are critically blunted after MCU depletion. Cells were transfected with shMCU or shControl, together with the ratiometric YFP-based biosensor pHyper-dMito (D) or the mitochondrialH2O2-sensitive HyPerRed probe (E). 48 hours later, H2O2 production was measured (n=35). P-values: *p=0.02, *p=0.05, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_5-F</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Mitochondrialsuperoxide levels are critically blunted after MCU silencing. Cells were transfected with siMCU or siControl. 48 hours later, cells were loaded with the red dye MitoSOXTM and superoxide anion levels were measured (n=25). P-value: *p=0.04.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_5-G</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Mitochondrial GSSG/GSH ratio is critically reduced after MCU silencing. Cells were transfected with shMCU or shControl, together with the mitochondrial targeted mitGrx1-roGFP2 probe. 96 hours later, the glutathione redox potential (EGSH) was measured (n=46). P-value: ***p&lt;0.0001.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_6-A</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. MCU silencing reduces HIF-1α protein levels. Cells were transfected with siMCU or siControl. HIF-1α protein levels were detected 48 hours later.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_6-B</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. MCU silencing reduces MG132-mediated HIF-1α and hydroxylated HIF-1α protein accumulation. Cells were transfected with siMCU or siControl. 48 hours later, cells were treated with 10 μM of the proteasome inhibitor MG132. Left: Protein levels were revealed by western blot. Right: quantification by densitometry (n=5).</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_6-C</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. ROS increase HIF-1α transcription. Cells were treated O/N with 100 µM paraquat to induce ROS production. HIF-1α mRNA levels were measured by RealTime-PCR (n=3). P-value: **p=0.002.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_6-D-J</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 6-D-J</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-J</infon>
    <passage>
      <offset>0</offset>
      <text>D-J. MCU silencing reduces mRNA levels of HIF-1α, HIF-2α, and HIF-1α target genes. Cells were transfected with siMCU or siControl. mRNA expression was measured by RealTime-PCR (n=3). P-values: (HIF-1α) **p=0.0031, **p=0.009, (HIF-2α)**p=0.01, (LOX)***p=0.001, ***p=0.0005, (PDK1)*p=0.02, **p=0.009, (G6PI)*p=0.02, **p=0.005, (CA IX)**p=0.0026, **p=0.0022, (HK2) **p=0.0024, *p=0.03.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_6-K</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 6-K</infon>
    <infon key="sourcedata_figure_dir">Figure_6-K</infon>
    <passage>
      <offset>0</offset>
      <text>K. HIF-1α overexpression rescues siMCU-mediated migration impairment. Cells were transfected with siMCU or siControl. Wild type (wt) and constitutively active (ca) HIF-1α were expressed by retroviral infection (pBABE was used as control). The day after transduction, cells were scratched (time-point 0h). Cell migration into the wounded area was monitored at 48 hour time-point and the covered area was measured (n=12). P-values: ***p&lt;0.0001, *p=0.04.</text>
    </passage>
  </document>
  <document>
    <id>4864890 Figure_6-L-M</id>
    <infon key="sourcedata_document">1568</infon>
    <infon key="doi">10.15252/emmm.201606255</infon>
    <infon key="pmc_id">4864890</infon>
    <infon key="figure">Figure 6-L-M</infon>
    <infon key="sourcedata_figure_dir">Figure_6-L-M</infon>
    <passage>
      <offset>0</offset>
      <text>L-M. MCU expression levels correlate with HIF1α (L) and HIF1α-regulated genes (M). A linear model (lm) to test the power of MCU expression levels predicting the expression of HIF1α and HIF1α-regulated genes was calculated and plotted for each of the 532 samples of the TCGA database (see Figure 1). Equation and R2 values of the linear regression and significance indicating deviation from 0 are shown. The area of 95% prediction limit is shaded below and above the linear regression line. The HIF1α-regulated gene set was compiled from Broad Institute GSEA database (http://www.broadinstitute.org/gsea/msigdb/cards/V$HIF1_Q5.html, merged sets of V$HIF1_Q3 and V$HIF1_Q5).</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_1-A-B</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a-b) eIF4A knockdown in either S2 (a) or Kc167 (b) cells blunts the inactivation of TORC1 upon amino acid removal. Cells were treated with dsRNA targeting GFP as a negative control, or three independent, non-overlapping dsRNAs targeting eIF4A for 5 days and then incubated with complete medium or medium lacking only amino acids for 30 minutes. Representative of 3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_1-D</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Impaired inactivation of TORC1 in response to eIF4A knockdown is most apparent upon partial depletion of amino acids, caused by removal of amino acid subsets. After 5 days of knockdown, S2 cells were treated for 30 min with either complete Schneider's medium (+aa), Schneider's medium lacking all amino acids (-aa) or various subsets of amino acids, as indicated (where EAA "essential amino acids" = H,I,L,K,M,T,W,V). Error bars: std dev. n=3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_1-E</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Time course of amino-acid removal reveals that eIF4A knockdown Kc167 cells maintain elevated S6K phosphorylation up to the maximum possible timepoint of 60 minutes when the cells start dying (see drop in S6K and tubulin levels). Representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_1-F</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) eIF4A mutant larvae have impaired TORC1 inactivation upon shifting to food lacking amino acids. Control (w1118) or eIF4A1006/1013 1st instar larvae were transferred from standard food to plates containing either standard fly food or PBS/1% agarose+2%sucrose for 1h prior to lysis and immunoblot analysis. Two biological replicates are shown. Representative of 3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_2-A</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a-a') Although knockdown of eIF4A or eIF3-S2 equally blunt translation of EGFP from an inducible plasmid (a), only knockdown of eIF4A but not eIF3-S2 impairs TORC1 inactivation upon amino acid removal (a'). (a) S2 cells, treated with indicated dsRNAs for 5 days, on day 3 transfected with an inducible EGFP plasmid (pMT-EGFP) and on day 4 induced for 18h. Non-targeting LacZ dsRNA used as a negative control. (a') S2 cells treated with indicated dsRNAs for 5 days, then incubated with medium lacking amino acids for indicated time prior to lysis. Representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_2-B</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Knockdown of eIF4A, but not other translation initiation factors, blunts TORC1 inactivation upon amino acid withdrawal. Kc167 cells treated with indicated dsRNAs for 4 days and then incubated with complete Schneider's medium or Schneider's medium lacking the indicated amino acids for 30 minutes prior to lysis.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_2-C</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Inhibition of translation with cycloheximide does not block inactivation of TORC1 upon amino acid withdrawal in Kc167 cells. Kc167 cells treated with either eIF4A dsRNA for 4 days, or cycloheximide (50 µg/mL, "CHX") for 5 min prior to, as well as during removal of amino acids (-LIVASTQP). CHX treated cells still inactivate TORC1 (compare lanes 8 to 7) whereas eIF4A knockdown cells do not (lanes 14 vs 13). Quantifications of two biological replicates are shown. CHX and eIF4A samples were normalized to their respective control conditions.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_2-D</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Knockdown of eIF4A in Kc167 cells does not prevent a drop in intracellular amino acids levels when amino acids are removed from the medium for 30 min. Quantification of total intracellular amino acids, analyzed in a blinded fashion. Levels of individual amino acids shown in Figure S2D. For CHX samples, cycloheximide (50µg/mL) was added 5 minutes prior to, and during treatment with medium containing or lacking amino acids. Statistical significance tested by ANOVA2 using Scheffé's multiple comparisons method (p&lt;0.05). Error bars: std. dev. n=5.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_3-A</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Knockdown of eIF4F components (eIF-4E and eIF-4G) partially phenocopy the eIF4A knockdown, leading to elevated TORC1 activity upon amino acid removal (30 min). Knockdown of all other tested translation initiation factors do not cause elevated TORC1 upon amino acid removal (main Figures 1c, 2a' and 2b). Error bars: std. dev. n=3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_3-B</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Quantification of de novo protein synthesis rates by OPP incorporation reveals that eIF4E and eIF4G knockdowns deplete eIF4F function less efficiently than the eIF4A knockdown, explaining why the effects of eIF4E and eIF4G knockdowns on TORC1 activity (panel a) are a bit milder than the eIF4A knockdown. Kc167 cells treated with dsRNA for 4 days then incubated with 20μM Click-it OPP reagent 30min before fixation and fluorescent labeling. Quantification of OPPfluorescence per cell (nuclear count) for two independent experiments is displayed (3 independent images per condition), normalized to the no dsRNA condition. Scale bars: 25µm.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_4-A</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Binding of eIF4G to the Rag GTPases detected by co-immunoprecipitation from Kc167 cells in absence or presence of the chemical cross-linker DSP. Representative of &gt;3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_4-B</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Binding between eIF4G and the Rag GTPase complex is mainly mediated by RagC, detected by expressing and immunoprecipitating either RagA or RagC alone. Representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_4-C</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Interaction between eIF4A and Raptor detected via co-immunoprecipitation of epitope-tagged proteins. Proteins were cross-linked with DSP prior to lysis and immunoprecipitation. Representative of 3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_4-D</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d-d'') eIF4A and Raptor form a complex, detected by proximity ligation assay (PLA). Specificity of the PLA signal was controlled by knocking down either eIF4A or Raptor in Kc167. (d) Representative images. Cells outlined in white. (d') Quantification of number of PLA spots per cell. (n&gt;200. ***p&lt;0.0001, ANOVA1, Dunnett's multiple comparisons test, was performed on log-transformed data, box = +/- 1 quartile, whiskers = max/min). (d'') Immunoblotting to detect efficiency of eIF4A and Raptor knockdowns.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_4-E-F</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(e-f) The eIF4A-Raptor interaction does not take place on lysosomes (e) or the endoplasmic reticulum (ER) (f). Kc167 cells were either incubated with 100 µg/mL Dextran for 1 hour, washed and incubated for 14 hours in normal growth medium to label late endosomes and lysosomes (e), or transfected to express an ER-resident GFP (f). Amino acid removal was for 45 min. Pearson's correlation coefficients for eIF4A-RaptorPLA and Dextran in panel (e) are 0.09 and 0.08 for +aa and -LIVASTQP respectively (calculated for all cells in the acquired fields, which were chosen randomly, n=40). Scale bars: 5µm.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_5-A</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Knockdown of eIF4A and TSC2 do not elevate TORC1 activity in an additive manner, indicating they act in the same, and not parallel pathways. Whereas knockdown of eIF4A increases TORC1 activity in control Kc167 cells (lanes 1-2 and 5-6), eIF4A knockdown cannot further increase TORC1 activity in TSC2 knockdown cells (lanes 3-4 and 7-8). Error bars: std dev. n=3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_5-B</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Activation of TSC2 with the p90RSK inhibitor BI-D1870 rescues the elevated TORC1 activity caused by eIF4A knockdown in Kc167 cells, consistent with TSC2 acting downstream of eIF4A. BI-D1870 leads to inhibition of TORC1 (lanes 1-4) in a TSC2-dependent manner (see also Appendix Figure S5A). Representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_5-C</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) FLAG-eIF4A and TSC2-V5co-immunoprecipitate in Kc167 cells in the absence of chemical cross-linker. Cells were transfected with FLAG-eIF4A and TSC2-V5 expression vectors and treated with media containing or lacking amino acids for indicated timepoints prior to lysis and anti-FLAGimmunoprecipitation. The experiment was performed in absence of the chemical cross-linker DSP. Representative of 3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_5-D</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Expression of TSC2-insensitive (S15H or Q63L), but not wild-type (WT) Rheb causes TORC1 activity to remain high upon amino acid removal. Kc167 cells were transfected to express either wild-type or mutant Rheb and then incubated with Schneider's medium either containing or lacking amino acids for 30 minutes. Elevated TORC1 activity can be observed either by looking at phosphorylation of endogenous S6K, or phosphorylation of an HA-tagged S6K that was co-transfected with the Rheb constructs to assay specifically the transfected cells. Representative of two biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_6-A</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Mass spectrometry analysis of proteins co-immunoprecipitating with eIF4A reveals NAT1 as one of the top interacting proteins. eIF4Aimmunoprecipitations were performed in triplicate, from cells treated with medium either containing (+aa) or lacking amino acids (-aa), and average values are shown. Peptide counts for each protein in each replicate were normalized to eIF4A peptide counts. Raw peptide counts shown in parentheses. (a') Schematic diagram of eIF4G and NAT1 primary protein structures. Binding sites for other initiation factors are shown.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_6-B</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Binding between eIF4A and NAT1 is regulated by amino acid availability in a TORC1-independent fashion. Co-immunoprecipitation of tagged eIF4A and NAT1 in control Kc167 cells, or cells treated with medium lacking amino acids or supplemented with 20 nM rapamycin for indicated times. Representative of 3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_6-C</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Knockdown of NAT1 using 4 independent, non-overlapping dsRNAs leads to reduced TORC1 activity. Kc167 cells, treated with indicated dsRNAs for 4 days and then incubated with medium containing or lacking amino acids for 30 min. Error bars: std. dev. n=3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_6-D</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) eIF4A is epistatic to NAT1 for TORC1 regulation. In the absence of amino acids, eIF4A knockdown cells have elevated TORC1 activity, NAT1 knockdown cells have reduced TORC1 activity, and eIF4A &amp; NAT1 double-knockdown cells have elevated TORC1 activity compared to control cells. Cells were treated with indicated dsRNAs for 4 days and then treated with medium containing or lacking the indicated amino acids for 30 min. Error bars: std. dev. n=3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868951 Figure_6-E</id>
    <infon key="sourcedata_document">1537</infon>
    <infon key="doi">10.15252/embj.201593118</infon>
    <infon key="pmc_id">4868951</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) TSC2 is epistatic to NAT1 for TORC1 regulation. As in (d), knockdown of TSC2 rescues the reduced TORC1 activity caused by NAT1 knockdown.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_1-B</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative PCR genotyping results from 2 Fus+/+, 2 FusΔNLS/+ and 2 FusΔNLS/ΔNLS knock-in mice using primers designed around the distal loxP site of the FusΔNLS allele and shown as gDNA in panel A. The expected size of the PCR product of the ∆NLS allele is 240 bp; the size of wild type allele is 160 bp.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_1-C</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) RT-PCR analysis of brain from 2 Fus+/+, 2 FusΔNLS/+ and 2 FusΔNLS/ΔNLS knock-in P0 mice using primers located in the STOP cassette, and thus specific to the ΔNLS mRNA (ΔNLS, upper panel), or primers located in exon 11, i.e. upstream of the floxed cDNA insertion, and thus amplifying total Fus-derived mRNA (Total, middle panel). PCR amplification of 18S rRNA is shown as standard gene (lower panel).</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_1-D</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblot analysis of FUSprotein in cerebral cortex of 2 Fus+/+, 2 FusΔNLS/+ and 2 FusΔNLS/ΔNLS knock-in mice using a combination of two different antibodies targeting either the C-terminal (C-ter. 1 and C-ter. 2) NLS, the N-terminal part (N-ter. 1) or an internal part (N-ter. 2) of FUS. Molecular weight markers are shown on the left, and apparent MW is indicated.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_1-E</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Double immunostaining for the motor neuronal marker ChAT and Fus (N-terminal part) in the ventral horn of spinal cord.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_1-F</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Double immunostaining for nuclei (DAPI, blue) and Fus (N-terminal part) in the cerebral cortex.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_2-A-B-C</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 2-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Photographs of Fus+/+ and FusΔNLS/ΔNLS pups immediately after birth (P0 animals). (B-C) FusΔNLS/ΔNLS mice showed significantly reduced body weight (B) and length (C). Weight and length values normalized to wild type (Fus+/+) are presented. N=11 Fus+/+, N=26 FusΔNLS/+ and N=14 FusΔNLS/ΔNLS; (*) p&lt;0.05 (**) p&lt;0.01 vs Fus+/+, (#) p&lt;0.05 vs Fus∆NLS/+; One way ANOVA followed by Tukey post hoc test.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_2-D</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Representative haematoxylin and eosin stainings of lungs of Fus+/+ and FusΔNLS/ΔNLS at birth.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_3-B-C</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative immunoblot for FUS on protein extracts of E18.5 brain. Histone 3 is used as loading control. (C) Quantification of FUS protein levels from immunoblots . (**) p&lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_3-D</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Quantitative real-time PCR for Fus transcript in Fus+/+ and Fus-/- mice. (**) p&lt;0.01.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_3-E</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Immunostaining for the neuronal marker NeuN and FUS on the spinal cordventral horn of E18.5Fus+/+ and Fus-/- mice.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_3-F-G</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 3-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F-G) Body weight (F) and length (G) of Fus+/+, Fus+/- and Fus-/- pups at birth; N=14 Fus+/+, N=36 Fus+/- and N=13 Fus-/- for body weight; N=6 per genotype for body length; (**) p&lt;0.01 vs Fus+/+, (##) p&lt;0.01 vs Fus+/- ; One way ANOVA followed by Tukey post hoc test.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_4-A</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) RNA-seq reads from brain of homozygous knock-in (FusΔNLS/ΔNLS, upper panel), homozygous knock-out (Fus-/-, middle panel) and control (Fus+/+, lower panel) mice showing the absence of exon 15 (red arrow) in Fus mRNA in FusΔNLS/ΔNLS mice while the entire Fus transcript is absent in Fus-/-mice (green arrows).</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_4-B</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Heatmap with hierarchical clustering of RNA-seq data from biological replicates of FusΔNLS/ΔNLS (N=5) and control littermates (N=4), showing genes differentially regulated between both genotypes among which 237 are upregulated and 549 are downregulated in FusΔNLS/ΔNLS animals</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_4-C</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Heatmap with hierarchical clustering of RNA-seq data from biological replicates of Fus-/- (N=5) and control littermates (N=5), showing genes differentially regulated between both genotypes, among which 669 are upregulated and 889 are downregulated in Fus-/- animals as defined by P&lt;0.05 adjusted for multiple testing in B and C).</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_4-E</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Normalized expression (based on FPKM from RNA-seq) of genes identified by RNA-seq to be significantly downregulated (Ahi1, Kcnip1, Nefm, Nefl, Tuba4a, Dmpk, Rad9b, Stac3, Hist1h2bc, Hist1h1c) or upregulated (Fam193b, Pmm2, Bphl, Taf15) in both FusΔNLS/ΔNLS and Fus-/- compared to their control. Error bars represent SEM in 4-5 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_4-F</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Normalized expression (based on FPKM from RNA-seq) of genes identified by RNA-seq to be uniquely changed in FusΔNLS/ΔNLS mice (Trove2, Uhmk1, Ssh3, Vtn, Snrpb, Ephb3). Error bars represent SEM in 4-5 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_5-A</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Heatmap with hierarchical clustering of RASL-seq data from biological replicates of FusΔNLS/ΔNLS (N=4) and control littermates (N=4), showing 173 alternative splicing alterations associated with expression of cytoplasmic FUS in knock-in animals.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_5-B</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Heatmap with hierarchical clustering of RASL-seq data from biological replicates of Fus-/- (N=5) and control littermates (N=5), showing 252 alternative splicing alterations associated with loss of FUS in knock-out animals.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_5-C</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Semi-quantitative RT-PCR analyses of selected targets. Left panels show representative acrylamide gel pictures of RT-PCR products. Quantification of splicing changes from at least three biological replicates of FusΔNLS/ΔNLS (blue bars) and Fus-/- (red bars) compared to their control littermates (Fus+/+, black bars) by semi-quantitative RT-PCR (middle panel) and RASL-seq (right panel) are shown. Error bars represent SEM.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_6-A-E</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 6-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative light microscopy images of spinal cord sections of Fus+/+, FusΔNLS/+, FusΔNLS/ΔNLS and Fus-/- mice at birth stained with cresyl violet (Nissl, A1, A3 A5, A7), or anti-choline acetyl transferase (ChAT, A2, A4 A6, A8). (B-C) Quantification of ChAT+ motor neurons (B) and Nissl+ motor neurons (defined as Nissl positive cells with a soma area &gt;80µm2) (C) per spinal cordventral horn in FusΔNLS/ΔNLS mice. For Nissl+ N=8 Fus+/+, N=5 FusΔNLS/+, N=7 FusΔNLS/ΔNLS and for ChAT+ N=7 per genotype, (**) p&lt;0.01 vs Fus+/+, (##) p&lt;0.01 vs Fus∆NLS/+ ; One way ANOVA followed by Tukey post hoc test. (D-E) Quantification of ChAT+ (D) and Nissl+ (E) motor neurons per spinal cordventral horn in Fus-/- mice. N=6 per genotype, no significant differences were found, by Student's unpaired t-test.</text>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">183</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="266" length="13"/>
        <text>motor neurons</text>
      </annotation>
      <annotation id="21">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">21</infon>
        <infon key="sourcedata_article_annot_id">186</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="295" length="13"/>
        <text>motor neurons</text>
      </annotation>
      <annotation id="23">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">23</infon>
        <infon key="sourcedata_article_annot_id">190</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="654" length="13"/>
        <text>motor neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_7-A-B</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative images of TUNEL assay in spinal cord of FusΔNLS/ΔNLS mice ((panels A4-A6) and Fus+/+mice (panels A1-A3). (B) Quantification of the total number of TUNEL and DRAQ5 (blue) double-positive cells in FusΔNLS/ΔNLS and Fus+/+ per spinal cord section. N=3 per genotype, (*) p&lt;0.05, by Student's unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_7-C-D-E</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 7-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(C-D) Immunofluorescence microscopy of spinal cord of Fus+/+ (C) and FusΔNLS/ΔNLS (D) mice showing active-caspase 3 (green), ChAT (red) and DNA (cyan, DRAQ5). (E) Quantification of caspase 3 (Cas3)/ChAT/DRAQ5 triple positive cells in FusΔNLS/ΔNLS mice. N=7 per genotype, (**) p&lt;0.01, by Student's unpaired t-test.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_8-A</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>Representative images of SMN (green) immunofluorescence in spinal cord. Nuclear gems, corresponding to SMN-immunoreactive foci in nuclei are marked by arrows.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_8-B</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>HDAC1 immunoreactivity in spinal cord sections of Fus+/+ and FusΔNLS/ΔNLS mice.</text>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_8-C</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>Representative images of immunofluorescent staining of motor neurons, labelled with ChAT (red) and HDAC1 (green). Examples of HDAC1 immunoreactive foci in motor neurons are indicated by arrows.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">244</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="55" length="13"/>
        <text>motor neurons</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">245</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="155" length="13"/>
        <text>motor neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_8-D</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>Representative images of immunofluorescent staining of motor neurons labelled with ChAT (red) and phosphorylated eIF2α (green), a general translational stress response marker. DRAQ5 (cyan) was used to label nuclei.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">257</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="55" length="13"/>
        <text>motor neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_9-A</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Double-immunolabeling of spinal cordneurons with ChAT (red) and N-terminal FUS antibody (green). Nuclei were visualized with DRAQ5 (blue). Cellular localization of FUS was analyzed in the ventral spinal cord of Fus+/+/ChAT-CRE (A1-A4), FusΔNLS/ΔNLS/- (A5-A8), and FusΔNLS/ΔNLS/ChAT-CRE (A9-A12). FUS was completely nuclear in ChAT+ neurons of Fus+/+/ChAT-CRE, while cytoplasmic in FusΔNLS/ΔNLS/-, In the ventral horn of FusΔNLS/ΔNLS/ChAT-CREmice, ChAT+ neurons (motor neurons, e.g. within the dashed square) displayed nuclearFUS immunoreactivity, while ChAT negative cells retained cytoplasmicFUS immunoreactivity (arrows)</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">261</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="40" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="31">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">31</infon>
        <infon key="sourcedata_article_annot_id">291</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="336" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="33">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">33</infon>
        <infon key="sourcedata_article_annot_id">293</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="457" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">265</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="466" length="13"/>
        <text>motor neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4868956 Figure_9-B-C-D-E</id>
    <infon key="sourcedata_document">1520</infon>
    <infon key="doi">10.15252/embj.201592559</infon>
    <infon key="pmc_id">4868956</infon>
    <infon key="figure">Figure 9-B-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative light microscopy images of spinal cord sections of Fus+/+/ChAT-CRE (B1, B4), FusΔNLS/ΔNLS/- (B2, B5) and FusΔNLS/ΔNLS/ChAT-CRE (B3, B6) mice at birth stained with cresyl violet (Nissl, B1-B3) or anti-choline acetyl transferase (ChAT, B4-B6). (C-D) Quantification of Nissl+ (C) and ChAT+ (D) motor neurons per spinal cord ventral horn. N=9 Fus+/+/ChAT-CRE, N=8 FusΔNLS/ΔNLS/- and N=4 FusΔNLS/ΔNLS/ChAT-CRE; for Nissl+ and N=11 Fus+/+/ChAT-CRE, N=7 FusΔNLS/ΔNLS/- and N=8 FusΔNLS/ΔNLS/ChAT-CRE; for ChAT+ (**) p&lt;0.01 vs Fus+/+, (##) p&lt;0.01 vs Fus∆NLS/+ ; (ns) non-significant; One way ANOVA followed by Tukey post hoc test. (E) Total numbers of caspase 3 (Cas3)/ChAT/DAPI triple positive cells in Fus+/+/ChAT-CRE, FusΔNLS/ΔNLS/- and FusΔNLS/ΔNLS/ChAT-CREmice. N=9 Fus+/+/ChAT-CRE, N=7 FusΔNLS/ΔNLS/- and N=8 FusΔNLS/ΔNLS/ChAT-CRE; (**) p&lt;0.01 vs Fus+/+, (#) p&lt;0.05 vs Fus∆NLS/+ ; (ns) non-significant; One way ANOVA followed by Tukey post hoc test.</text>
      <annotation id="48">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">48</infon>
        <infon key="sourcedata_article_annot_id">353</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="310" length="13"/>
        <text>motor neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_1-A-B</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Nucleosomal array oligomers are globular. A Nucleosomal array oligomers were stained with DAPI and examined using FM (fluorescence microscopy) as described in the Materials and Methods section. Shown are representative images obtained in 4.5 mM and 10mM MgCl2. B Control FM images obtained in 0, 1 and 2.5 mM MgCl2.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_1-C</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Nucleosomal array oligomers were negatively stained and visualized by TEM as described under Materials and Methods. Shown in the left panels are representative images obtained in 4.5 mM, and 10 mM MgCl2. Shown in the right panels are images of the interior of the oligomers (white arrows, left panels) after cropping and re-scaling.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_2-A</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 2 Sedimentation velocity analysis of the salt-dependent assembly of nucleosomal array oligomers. A Representative experiment showing the second moment sedimentation coefficients of the oligomeric nucleosomal arrays as a function of MgCl2. The second moment sedimentation coefficient is equivalent to the mass average sedimentation coefficient for the entire sample (see Materials and Methods). The inset shows the mean second moment sedimentation coefficient the standard error for three replicated experiments. B Analysis of the same raw data as in panel (A) by the time derivative method to yield the sedimentation coefficient distribution, g(s*).</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_3-A-B</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B SAXS profiles of the nuclesomal arrays in 0 (TE), 1, 2.5 mM MgCl2(A) and 5, 10 mM MgCl2(B) are shown as plots of log(I × S2) vs. 1/S (I, intensity; S, scattering vector (1/nm)).</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_4-A</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A 601-nucleosomal arrays were incubated in 0.5, 5 mM MgCl2, 5 mM MgCl2+ MNase, and analyzed by the differential centrifugation assay to determine the fraction oligomeric. The amounts of DNA in the supernatant fraction were measured. Note that for the MNase-digested oligomers the supernatant fraction also includes the digested free linker DNA. Each value is the mean of three measurements and the error bars represent the standard deviation.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_4-B</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Verification of complete MNase digestion. DNA was purified from the nucleosomal arrays incubated in 5 mM MgCl2 or 5 mM MgCl2+ MNase, and then electrophoresed on agarose gel. The position of mono nucleosome is marked with a star symbol.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_4-C</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Nucleosomal array oligomers (left) or with MNase treatment (right) were stained with DAPI and examined using FM. Shown are representative images obtained. Note that the sizes of MNase-treated oligomers are much smaller than those of the control oligomers (left and Fig. 1A).</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_5-A-B</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Oligomers assembled from H1-nucleosomal arrays were stained with DAPI and examined using FM. Shown are representative images obtained in 4 mM and 5 mM MgCl2. B Control FM images obtained in 0, 1 and 3 mM MgCl2.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_5-C</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C H1-nucleosomal array oligomers were negatively stained and visualized by TEM. Shown in the left panel is a representative image obtained in 4 mM MgCl2. Shown in the right panel is an image of the interior of the oligomer (white arrow, left panel) after cropping and re-scaling.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_6-A</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 6 Sedimentation analysis of salt-dependent H1-oligomer assembly. A Representative experiment showing the second moment sedimentation coefficients of the H1-oligomers as a function of MgCl2. The dashed line indicates the upper limit of measurable sedimentation coefficients (~106 S). The white symbol is intended to show that the sedimentation coefficient of the H1-oligomers in 5 mM MgCl2 is beyond the detectable limit. B Analysis of the same raw data as in panel (A) by the time derivative method to yield the sedimentation coefficient distribution, g(s*). C The g(s*) profiles in 2.5 mM, 3 mM, and 3.5 mM from panel (B) are re-plotted on a smaller scale.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_7-A-B</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B SAXS profiles of the H1-nuclesomal arrays in 0 (TE), 1, 2.5 mM MgCl2(A) and 5, 10 mM MgCl2(B) are shown as plots of log(I × S2) vs. 1/S (I, intensity; S, scattering vector (1/nm)).</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_7-C-D</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D SAXS profiles of the native chickenchromatin in 0 (TE), 0.5, 1 mM MgCl2(C) and 2.5, 5 mM MgCl2(D) are shown as plots of log(I × S2) vs. 1/S (I, intensity; S, scattering vector (1/nm)).</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_8-A</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A FMimages of chromatin structure in the nuclei with 0 mM (left), 1 mM (center) and 5 mM MgCl2 (right). Insets show the intensity line profiles between the two marked arrow heads in the images.</text>
    </passage>
  </document>
  <document>
    <id>4868957 Figure_8-B</id>
    <infon key="sourcedata_document">1632</infon>
    <infon key="doi">10.15252/embj.201592660</infon>
    <infon key="pmc_id">4868957</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B SAXS profiles of the isolated HeLanuclei. SAXS profiles of the nuclei in 0 mM (left), 1 mM (center) and 5 mM MgCl2 (right) are shown in blue. For comparison, the scattering curves of H1-arrays from Figs. 7A and B were overlaid as red lines (left, 0 mM; center and right, 10 mM MgCl2).</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_1-A-B</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B X-gal staining showed NB-3/LacZ expression in the sham-operated (A) and injured (B) spinal cords from adult NB-3+/−mice.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_1-C-D</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Western blot analysis (C) and quantification (D) of NB-3 expression in the lesion area post-injury. NB-3 expression levels were normalized by b-tubulin. Data are represented as mean ± SEM. *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni's post-test. Data were analyzed from 10 independent experiments each including 2 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_1-E-F</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 1-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Single-labeling immunostaining showed NB-3 expression in the sham-operated (E) and injured (F) spinal cords from adult NB-3+/+mice.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_1-G-L</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 1-G-L</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G-L</infon>
    <passage>
      <offset>0</offset>
      <text>G-K Co-immunostaining of NB-3 (green), PDGFR-β (red), and GFAP (blue) on serial sagittal sections from the same NB-3+/+spinal cord 14 days post-injury. (G1-K1) High-magnification images of boxed areas in (G-K), respectively. L Co-immunostaining of NB-3 (green), PDGFR-β (red), and GFAP (blue) on sagittal sections from the NB-3−/− spinal cord 14 days post-injury. (L1) High-magnification image of the boxed area in (L). The arrows indicate the lesion sites.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_1-M-R</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 1-M-R</infon>
    <infon key="sourcedata_figure_dir">Figure_1-M-R</infon>
    <passage>
      <offset>0</offset>
      <text>M-Q Co-immunostaining of NB-3 (green), Fibronectin (red), and GFAP (blue) on serial sagittal sections from the same NB-3+/+spinal cord 14 days post-injury. (M1-Q1) High-magnification images of boxed areas in (M-Q), respectively. R Co-immunostaining of NB-3 (green), Fibronectin (red), and GFAP (blue) on sagittal sections from the NB-3−/− spinal cord 14 days post-injury. (R1) High-magnification image of the boxed area in (R). The arrows in (G-R) indicate the lesion sites.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_10-A-B</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 10-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_10-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Co-immunostaining of PTPσ (blue), NB-3 (green), and BDA (red) at spinal lesion sites of NB-3+/+ (A1) and NB-3−/− (A6) mice. (A2-A5 and A7-A10) High-magnification images of boxed areas in (A1 and A6) showing PTPσ expression at the terminations of BDA-labeled corticospinal axons, respectively. Images in (A2 and A7) are presented as single-channel fluorescence images in (A3-A5 and A8-A10), respectively. B Quantification of fluorescence intensity of PTPσ at BDA-labeled axonal terminations of NB-3+/+ and NB-3−/−mice after SCI. *p &lt; 0.05; one-way ANOVA followed by Bonferroni post-test. n = 12 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_10-C-D</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 10-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_10-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Co-immunostaining of PTPσ and NB-3 in the FG-labeled corticospinal neurons (arrowheads) of NB-3+/+ and NB-3−/− mice 14 days post-injury (dpi). Insets, only the signals from PTPσ and FG in NB-3+/+corticospinal neurons (red arrowheads) were visualized. D Quantification of fluorescence intensity of PTPσ in (C). *p &lt; 0.05; one-way ANOVA followed by Bonferroni post-test. The intensities of more than 300 corticospinal neurons from 3 mice in each group were quantified.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">488</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="55" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">487</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="197" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">490</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="404" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_10-E-F</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 10-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_10-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E Co-immunoprecipitation of NB-3 and PTPσ from sensorimotor cortex lysates of NB-3+/+mice after SCI. F Quantification of immunoprecipitated PTPσ by NB-3 in (E). **p &lt; 0.01; one sample t-test. Data were analyzed from 3 independent experiments each including 15 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_10-G-H</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 10-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_10-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>G PTPσ expression in NB-3+/+ and NB-3−/−pyramidal neurons when co-culturing with NB-3-expressing astrocytes (dashed lines and asterisks) or astrocytes that didn't express NB-3 (dashed lines). Upper inset, high-magnification view of the soma (white arrowhead). Lower inset, high-magnification view of the axon tip (green arrowhead). H Quantification of fluorescence intensity of PTPσ in (G). n.s., not significant, and *p &lt; 0.05; one-way ANOVA followed by Bonferroni post-test.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">512</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="40" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">513</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="97" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">516</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="140" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_10-I-J</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 10-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_10-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>I Expression of PTPσ, p-Akt, p-mTOR, and p-S6 (S240/244) in pyramidal neurons that expressed PTPσ shRNA-GFP. A control plasmid expressing GFP was transfected as the negative control (nc). J Quantification of fluorescence intensity of PTPσ, p-Akt, p-mTOR, and p-S6 (S240/244) in (I). *p &lt; 0.05; one sample t-test. The intensities of more than 300 pyramidal neurons from 4 independent experiments in each group in (H) and (J) were quantified, respectively.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">523</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="60" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">531</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="346" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_10-K-N</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 10-K-N</infon>
    <infon key="sourcedata_figure_dir">Figure_10-K-N</infon>
    <passage>
      <offset>0</offset>
      <text>K-M Sagittal sections showing the corticospinal axons in injured spinal cords following injection of LV-nc-GFP (K) and LV-PTPσ shRNA-GFP (L) into the sensorimotor cortex. High-magnification image (M) of the area in (L) (asterisk). The arrows indicate the lesion sites; the asterisk indicates the lesion epicenter. N Quantification of the intensity index of BDA-labeled axons at certain distances from the lesion border in (K and L). *p &lt; 0.01; two-way ANOVA followed by Fisher's LSD. n = 8 mice in (K), and n = 10 mice in (L).</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_2-B-C</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B NB-3 expression in corticospinal neurons 14 and 28 days post-injury (dpi). FG (blue) was applied to retrogradely label corticospinal neurons. C Quantification of the fluorescence intensity of NB-3 in (B). **p &lt; 0.01; one-way ANOVA followed by Bonferroni's post-test. The intensities of more than 300 corticospinal neurons from 3 mice in each group were quantified.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">49</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="21" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">52</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="121" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">54</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="302" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_2-D-E</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 2-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Western blot analysis (D) and quantification (E) of NB-3 expression in the sensorimotor cortex after SCI. NB-3 expression levels were normalized by b-tubulin. *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni's post-test. Data were analyzed from 3 independent experiments each including 3 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_2-F-K</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 2-F-K</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F-K</infon>
    <passage>
      <offset>0</offset>
      <text>F-K Induced NB-3 expression at the distal terminations of post-traumatic corticospinal axons and in reactive astrocytes at the lesion border 14 (H and I) and 28 days post-injury (dpi) (J and K). BDA (red) was applied to anterogradely label corticospinal axons. GFAP (blue) was used to label reactive astrocytes. (G) High-magnification image of the boxed area in (F). (I and K) High-magnification and x-y-z reconstruction images of boxed areas in (H and J), respectively, show co-localization of NB-3 and GFAP in astrocytes at the lesion border and co-localization of NB-3 in BDA-labeled axons and GFAP-positive astrocytes at the contact surface of corticospinal axons and astrocytes (arrowheads). The arrows in (H and J) indicate the lesion sites. The asterisks in (H and J) indicate the terminations of the BDA-labeled projecting axons.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">74</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="109" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="300" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">81</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="512" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">82</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="611" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">84</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="672" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_3-B-L</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 3-B-L</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-L</infon>
    <passage>
      <offset>0</offset>
      <text>B-K Representative images of serial sagittal sections showing the main BDA-labeled corticospinal axons in NB-3+/+ (B-D) and NB-3−/− (E-G) mice 14 weeks after complete spinal transection. (H-J) High-magnification images of the areas in (E-G) (single asterisks), respectively. (K) High-magnification image of the area in (E) (double asterisk). The arrows indicate the lesion sites; the white dashed lines indicate the regenerative corticospinal axons extending into the distal spinal cord; the single asterisks in (E-G) indicate the lesion epicenters; the double asterisk in (E) indicates the axons extending from the caudal lesion border. Scale bars, 400 µm (B-G) and 100 µm (H-K).   L Quantification of the intensity index of BDA-labeled axons at certain distances from the lesion border in (B-G). Data are represented as mean ± SEM. *p &lt; 0.05, and **p &lt; 0.01; two-way ANOVA followed by Fisher's LSD. n= 25 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_4-A</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Time course of the change in BMS scores in NB-3+/+ and NB-3−/−mice as measured with the BMS rating scale after spinal cord complete transection. *p &lt; 0.05; two-way ANOVA followed by Bonferroni's post-test. n= 25 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_4-C</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Electrophysiology transmission across the spinal lesion site. In each group of NB-3+/+ and NB-3−/−mice, the electrophysiological responses in the caudal spinal cord were recorded in the condition of sham-operated or 12 weeks post-injury. The latencies and amplitudes of responses were analyzed and quantified in each group. n.s., not significant, *p &lt; 0.05, and **p &lt; 0.01; two-way ANOVA followed by Bonferroni's post-test. n= 10 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_4-E-F</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>E Representative images of coronal sections showing synapse formation between the glutamatergic corticospinal terminals and spinal neurons in NB-3+/+ and NB-3−/−mice. Corticospinal axons, neurons, and glutamatergic terminals of corticospinal axons were labeled with BDA (red), Tuj1 (blue) and vGlut1/2 (green), respectively. Each group showed the data from the rostral and caudal spinal cord in the condition of sham-operated or 12 weeks post-injury. Scale bar, 20 μm. F Quantification of the number of glutamatergic corticospinal synapses per neuron in each group. n.s., not significant, **p &lt; 0.01; two-way ANOVA followed by Fisher's LSD. n= 15 mice per group.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">119</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="124" length="14"/>
        <text>spinal neurons</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">132</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="188" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">136</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="544" length="6"/>
        <text>neuron</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_5-A-B</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B Western blot analysis (A) and quantification (B) of NB-3 expression in cultured pyramidal neurons infected with lentivirus encoding negative control (LV-nc-GFP) and that encoding NB-3 shRNA (LV-NB-3 shRNA-GFP). NB-3 expression levels were normalized by b-tubulin. ***p &lt; 0.001; one sample t-test. Data were analyzed from 5 independent experiments.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">144</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="85" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_5-C-F</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 5-C-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-F</infon>
    <passage>
      <offset>0</offset>
      <text>C-E Sagittal sections showing the BDA-labeled corticospinal axons in injured spinal cords following cortical injection of LV-nc-GFP (C) and LV-NB-3 shRNA-GFP (D). High-magnification image (E) of the area in (D) (asterisk). F, J Quantification of the intensity index of BDA-labeled axons at certain distances from the lesion border in (C, D, G, and H). *p &lt; 0.01; two-way ANOVA followed by Fisher's LSD. n= 19 mice per group in (F), and n= 17 mice per group in (J).</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_5-G-J</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 5-G-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G-J</infon>
    <passage>
      <offset>0</offset>
      <text>G-I Sagittal sections showing the corticospinal axons in injured spinal cords following injection of LV-nc-GFP (G) and LV-NB-3 shRNA-GFP (H) into the lesion sites. High-magnification image (I) of the area in (H) (asterisk). The arrows in (C-E and G-H) indicate the lesion sites; the asterisks in (D and H) indicate the lesion epicenters; the white dashed lines in (D and H) indicate the regenerative corticospinal axons extending into the distal spinal cord. F, J Quantification of the intensity index of BDA-labeled axons at certain distances from the lesion border in (C, D, G, and H). *p &lt; 0.01; two-way ANOVA followed by Fisher's LSD. n= 19 mice per group in (F), and n= 17 mice per group in (J).</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-A-B</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A, B NB-3-Fc-coated bead aggregation assay (A). BSA-coated beads as a negative control (B).</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-C</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Co-immunoprecipitation of NB-3-Myc with NB-3-HA from co-transfected COS1 cells.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-D-E</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D, E Cis interactions of NB-3-Myc with NB-3-HA in COS1 cells. (E) High-magnification image of the boxed area in (D). Cells were co-stained for Myc (red), HA (green), and DAPI (blue). The arrowheads indicate cell surface co-localization of NB-3-Myc and NB-3-HA.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-F-G</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F, G Trans interactions between NB-3 expressed in COS1 cells and treated NB-3-Fc. Cells were co-stained for Myc (red), Fc or NB-3-Fc (green), and DAPI (blue). The arrows indicate co-localization of NB-3-Myc and NB-3-Fc at the cell membrane (G).</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-H</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Cell membrane co-localization of NB-3-Myc and NB-3-HA separately expressed in 293T and COS1 cells. Cells were co-stained for Myc (red), HA (green), and DAPI (blue).</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-I-J</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_6-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>I, J NB-3 expression in cultured pyramidal neurons and astrocytes. Pyramidal neurons were co-stained for NB-3, Ctip2 and Tuj1 (I). Astrocytes were co-stained for NB-3, GFAP, and DAPI (J).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">239</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="33" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">240</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="55" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">241</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="67" length="17"/>
        <text>Pyramidal neurons</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">243</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="131" length="10"/>
        <text>Astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-K</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-K</infon>
    <infon key="sourcedata_figure_dir">Figure_6-K</infon>
    <passage>
      <offset>0</offset>
      <text>K Western blot analysis and quantification of NB-3 in cultured pyramidal neurons and astrocytes. NB-3 expression levels were normalized by b-tubulin and expressed relative to that of neurons. ***p &lt; 0.001; one sample t-test. Data were analyzed from 3 independent experiments.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">247</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="63" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">250</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="85" length="10"/>
        <text>astrocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_6-L-R</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 6-L-R</infon>
    <infon key="sourcedata_figure_dir">Figure_6-L-R</infon>
    <passage>
      <offset>0</offset>
      <text>L-Q NB-3+/+ (L and M) and NB-3−/− (O and P) pyramidal neurons were co-cultured with astrocytes that did not (L and O) or did (M and P) express NB-3, and immunostained for Tuj1, NB-3, and GFAP (L, M, O and P). NB-3+/+pyramidal neurons (N) and NB-3−/−pyramidal neurons that overexpressed NB-3ΔECD-Myc (Q) were co-cultured with astrocytes that overexpressed NB-3ΔECD-Myc, and immunostained for Tuj1, Myc, and GFAP (N and Q). R The length of neurites on astrocytes relative to total neurite length. n.s., not significant, and *p &lt; 0.05; one-way ANOVA followed by Bonferroni post-test. The neurite lengths of more than 150 pyramidal neurons from 4 independent experiments in each group were quantified.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">254</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="44" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">255</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="84" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">266</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="216" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="15">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">268</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="249" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">270</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="325" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="23">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">23</infon>
        <infon key="sourcedata_article_annot_id">277</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="450" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="25">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">25</infon>
        <infon key="sourcedata_article_annot_id">279</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="618" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_7-A-B</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Layer V cortex explants from E18.5 NB-3+/+ and NB-3−/−mice were cultured in medium supplemented with either Fc or NB-3-Fc (50 μg/ml). B Quantification of neurite outgrowth in (A). n.s., not significant, **p &lt; 0.01; one-way ANOVA followed by Bonferroni post-test. Data were analyzed from more than 50 layer V cortical explants from 5 independent experiments in each group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_7-C-D</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Pyramidal neurons of NB-3+/+ and NB-3−/−mice were cultured in medium supplemented with either Fc or NB-3-Fc (50 μg/ml). The neurons were co-stained for Ctip2, NB-3, and Rhodaminephalloidin. (C1-C4) High-magnification images of the growth cones (white arrowheads) of the neurons in (C), respectively. D Quantification of neurite length in (C), and the percentage of collapsed growth cones in (C). n.s., not significant, *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni post-test. Data were analyzed from more than 300 corticospinal neurons from 6 independent experiments in each group.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">290</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="2" length="17"/>
        <text>Pyramidal neurons</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">300</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="534" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_8-A-B</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 8-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Images of coronal sections of layer Vsensorimotor cortex from NB-3+/+ and NB-3−/−mice after SCI. Corticospinal neurons were retrogradely labeled with Fluorogold (FG), and coronal sections were co-stained with p-mTOR (A) (arrowheads). B Quantification of fluorescence intensity of p-mTOR in FG-labeled corticospinal neurons in (A). *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni post-test. The intensities of more than 300 corticospinal neurons from 3 mice in each group were quantified.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">309</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="99" length="21"/>
        <text>Corticospinal neurons</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">313</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="303" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">317</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="441" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_8-C-D</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 8-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Images of coronal sections of layer Vsensorimotor cortex from NB-3+/+ and NB-3−/−mice after SCI. Corticospinal neurons were retrogradely labeled with Fluorogold (FG), and coronal sections were co-stained with p-S6 (S240/244) (C) (arrowheads). D Quantification of fluorescence intensity of p-S6 (S240/244) in FG-labeled corticospinal neurons in (C). *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni post-test. The intensities of more than 300 corticospinal neurons from 3 mice in each group were quantified.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">328</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="99" length="21"/>
        <text>Corticospinal neurons</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">332</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="321" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">336</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="459" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_8-E-H</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 8-E-H</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E-H</infon>
    <passage>
      <offset>0</offset>
      <text>E-H Western blot analysis and quantification of the expression of p-Akt/Akt (E and F) and p-S6 (S240/244) (G and H) in sensorimotor cortex from NB-3+/+ and NB-3−/−mice after SCI. *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni post-test. Data were analyzed from 3 independent experiments each including 3 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_8-I-P</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 8-I-P</infon>
    <infon key="sourcedata_figure_dir">Figure_8-I-P</infon>
    <passage>
      <offset>0</offset>
      <text>I, K, M, O Expression of Akt (I), p-Akt (K), p-mTOR (M), and p-S6 (S240/244) (O) in NB-3+/+pyramidal neuron-astrocyte co-cultures. The astrocytes were transfected either with NB-3-Myc or a control vector. The dashed lines outline the astrocytes. The asterisks indicate the NB-3-expressing astrocytes. J, L, N, P Quantification of fluorescence intensity of Akt (J), p-Akt (L), p-mTOR (N), and p-S6 (S240/244) (P), respectively, in pyramidal neurons of the co-cultures in (I, K, M, and O). n.s., not significant, and *p &lt; 0.05; one sample t-test. The intensities of more than 300 pyramidal neurons from 6 independent experiments in each group were quantified.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">354</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="91" length="16"/>
        <text>pyramidal neuron</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">355</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="108" length="9"/>
        <text>astrocyte</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">356</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="135" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">361</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="234" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">18</infon>
        <infon key="sourcedata_article_annot_id">363</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="289" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">358</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="430" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">27</infon>
        <infon key="sourcedata_article_annot_id">368</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="578" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_9-A-B</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 9-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Co-immunostaining of CHL1 (blue), NB-3 (green), and BDA (red) in injured spinal cords of NB-3+/+ (A1) and NB-3−/− (A5) mice. (A2-A4 and A6-A8) High-magnification images of boxed areas in (A1 and A5), respectively. Images in (A2 and A6) are presented as single-channel fluorescence images in (A3-A4 and A7-A8), respectively. B Quantification of fluorescence intensity of CHL1 at the spinal lesion sites of NB-3+/+ and NB-3−/− mice after SCI. *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni post-test. n = 11 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_9-C-D</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 9-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Western blot analysis (C) and quantification (D) of CHL1 expression in spinal lesion areas of NB-3+/+ and NB-3−/−mice after SCI. *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001; one-way ANOVA followed by Bonferroni post-test. Data were analyzed from 3 independent experiments each including 2 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_9-E</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 9-E</infon>
    <infon key="sourcedata_figure_dir">Figure_9-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Co-immunoprecipitation of NB-3 and CHL1 from spinal cord lesion areas of NB-3+/+ and NB-3−/−mice.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_9-F-G</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 9-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_9-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F Co-immunostaining of CHL1 and NB-3 in FG-labeled corticospinal neurons (arrowheads) of NB-3+/+ and NB-3−/−mice 14 days post-injury (dpi). G Quantification of the fluorescence intensity of CHL1 in (F). *p &lt; 0.05, and **p &lt; 0.01; one-way ANOVA followed by Bonferroni post-test. The intensities of more than 300 corticospinal neurons from 3 mice in each group were quantified.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">403</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="51" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">408</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="311" length="21"/>
        <text>corticospinal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_9-H-I</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 9-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_9-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>H, I Western blot analysis (H) and quantification (I) of CHL1 expression in sensorimotor cortices of NB-3+/+ and NB-3−/−mice after SCI. *p &lt; 0.05; one-way ANOVA followed by Bonferroni post-test. Data were analyzed from 3 independent experiments each including 3 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_9-J-K</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 9-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_9-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>J CHL1 expression in the somas and axons of NB-3+/+ and NB-3−/−pyramidal neurons when co-culturing with NB-3-expressing astrocytes (dashed lines and asterisks) or astrocytes that didn't express NB-3 (dashed lines). Co-localization of CHL1 and NB-3 in astrocytes overexpressed NB-3 (asterisks). Co-localization of CHL1 and NB-3 in the somas and axons of co-cultured NB-3+/+pyramidal neurons (arrowheads). Left inset, high-magnification view of the soma (white arrowhead). Right inset, high-magnification view of the axon tip (green arrowhead). K Quantification of fluorescence intensity of CHL1 in (J). *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001; one-way ANOVA followed by Bonferroni post-test. The intensities of more than 300 astrocytes or pyramidal neurons from 3 independent experiments in each group were quantified.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">423</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="63" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">424</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="120" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">429</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="163" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">432</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="251" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">439</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="372" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="22">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">22</infon>
        <infon key="sourcedata_article_annot_id">441</infon>
        <infon key="identifier">CL:0000127</infon>
        <location offset="724" length="10"/>
        <text>astrocytes</text>
      </annotation>
      <annotation id="23">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">23</infon>
        <infon key="sourcedata_article_annot_id">442</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="738" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4875577 Figure_9-L-O</id>
    <infon key="sourcedata_document">1836</infon>
    <infon key="doi">10.15252/embj.201593460</infon>
    <infon key="pmc_id">4875577</infon>
    <infon key="figure">Figure 9-L-O</infon>
    <infon key="sourcedata_figure_dir">Figure_9-L-O</infon>
    <passage>
      <offset>0</offset>
      <text>L-N Sagittal sections showing the corticospinal axons in injured spinal cords following injection of LV-nc-GFP (L) and LV-CHL1 shRNA-GFP (M) into both the sensorimotor cortex and lesion sites. High-magnification image (N) of the area in (M) (asterisk). The arrows indicate the lesion sites; the asterisk indicates the lesion epicenter. O Quantification of intensity index of BDA-labeled axons at certain distances from the lesion border in (L and M). *p &lt; 0.05 and **p &lt; 0.01; two-way ANOVA followed by Fisher's LSD. n= 9 mice in (L), and n= 10 mice in (M).</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_2-B-C-D-E</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 2-B-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(B) In vitro degradation of UbLRad23-GFP-95 by purified S. cerevisiae proteasome. The graph plots the amount of substrate over time, estimated by fluorescence intensity monitored by plate-reader (green) or electronic autoradiography of SDS-PAGE gel bands (red), normalized to the initial substrate amount as described in Methods. (C) Michaelis-Menten analysis of UbLRad23-GFP-95 degradation by different concentrations of purified S. cerevisiae proteasome (green, 10 nM; red, 40 nM). (D) UbLRad23 inhibits UbLRad23-GFP-95 degradation. The initial degradation rates of UbLRad23-GFP-95 at different concentrations of purified UbLRad23 domain are plotted and fitted to the equation describing competitive inhibition. (E) The UbLDsk2 domain is a competitive inhibitor of UbLRad23-GFP-95 degradation. Lineweaver-Burk plot of UbLRad23GFP95 degradation with different concentrations of purified UbLDsk2 domain. (C-E) Proteasomal degradation of UbLRad23-GFP-95 monitored by fluorescence intensity in a Tecan plate reader as described in Methods.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_3-A</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) In vitro degradation of model proteins by purified S. cerevisiae proteasome. The model proteins (UbL-DHFR-95) consisted of an N-terminal UbL domain, followed by an E. coli DHFR domain and a 95 aminoacid tail derived from S. cerevisiae cytochrome b2. UbL-DHFR-95 proteins were degraded by proteasome (red solid circle) and can be stabilized by removing the UbL domain (no UbL, black triangles), by removing the 95-amino-acid tail (no tail, blue diamonds) or by proteasome inhibitor (MG132, green squares). (A) Degradation of model proteins containing the UbL domain of S. cerevisiae Rad23.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_3-B</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) In vitro degradation of model proteins by purified S. cerevisiae proteasome. The model proteins (UbL-DHFR-95) consisted of an N-terminal UbL domain, followed by an E. coli DHFR domain and a 95 aminoacid tail derived from S. cerevisiae cytochrome b2. UbL-DHFR-95 proteins were degraded by proteasome (red solid circle) and can be stabilized by removing the UbL domain (no UbL, black triangles), by removing the 95-amino-acid tail (no tail, blue diamonds) or by proteasome inhibitor (MG132, green squares). (A) Degradation of model proteins containing the UbL domain of S. cerevisiae Rad23. (B) Degradation of model proteins containing other UbL domains or ubiquitin. The graphs plot the amount of substrate estimated by electronic autoradiography in SDS-PAGE gel bands over time as normalized to the initial substrate amount as described in Methods. Data points represent mean values determined from at least three repeat experiments; error bars indicate s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_4-B</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) UbL domains mediated degradation of His3 fusion proteins with a Su9 tail, and affected yeastgrowth under selective condition (+3-AT, -his). Replacing UbL domains with DHFR domains rescued the growth defect. Cells expressing His3 fusion proteins in late log phase were serially diluted and stamped on selective plates. Plates were incubated at 30 ˚C for 3 days for imaging.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_5-B</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Fluorescence profiles of cells expressing different substrates monitored by flow cytometry. UbLRad23 targeted YFP-Su9protein for degradation. Removing the Su9 tail or replacing UbLRad23 with a DHFR domain stabilizes YFPprotein in cells.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_5-C</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) UbL domains targeted YFP substrates to degradation in the presence of an initiation region. The Y-axis plots abundance of the UbL-YFP-tail proteins normalized by a translation control, which is the same UbL-YFPprotein without the tail. The ratio is equal to one for domains that are not recognized by the proteasome, and smaller than one if the UbL is recognized by the proteasome and the UbL-YFP-tail protein is degraded. YFPfluorescence is also corrected for plasmid copy number using RFPfluorescence. The median of YFP/RFP ratio for each construct was calculated from 10,000 cells collected in one flow cytometry run and reflected the abundance of YFP substrates in yeast cells as described in Methods. Data points represent mean values determined from at least three repeat experiments; error bars indicate s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_6-B</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) In vitro degradation of Mdy2 proteins by purified S. cerevisiae proteasome. Mdy2 (red solid circles), Mdy2ΔN-95 (blue solid circles) and Mdy2-95 (green solid circles) were degraded. Removing the N-terminal domain of Mdy2 (Mdy2ΔN, black solid circles) or adding its binding partner Get4 (red open squares, dash line) or the proteasome-binding competitor UbLMdy2 (red open diamonds, dotted line) stabilized Mdy2Get4. When Mdy2 binding buried the N-terminal domain, addition of a 95 amino-acid tail derived from S. cerevisiae cytochrome b2 at the Cterminus restored degradation of Mdy2 (green open squares, dotted line). The graph plots the amount of substrate estimated by electronic autoradiography in SDS-PAGE gel bands over time as normalized to the initial substrate amount as described in Methods. Data points represent mean values determined from at least three repeat experiments; error bars indicate s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_6-C</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Degradation of Mdy2in vivo. The steady-state accumulation of overexpressed C-terminally HA-tagged full-length Mdy2 and a mutant in which the N-terminal domain was deleted (Mdy2ΔN) in S. cerevisiae, in the absence of Get4, the presence of endogenously expressed Get4 or overexpressed Get4. Overexpressed Get4 was detected through an N-terminal Flag-tag.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_6-D</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Steady-state accumulation of endogenous Mdy2 in S. cerevisiae, with deleted (get4∆) or endogenous (wt) Get4 in the presence or absence of the proteasome inhibitor bortezomib. Protein levels were determined by western blotting for the HA-tag, Flag-tag, Mdy2 or Scs2 of SDS-PAGE gels of S. cerevisiae protein extracts. Protein loading levels in each lane were estimated in all lysates by western blotting for the integral endoplasmic reticulum membraneprotein Scs2.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_7-B</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) In vitro degradation of Ubp6 proteins by purified S. cerevisiae proteasome. Full-length Ubp6 (Ubp6, black open circles) and a UbL deletion mutant (Ubp6ΔN, green open circles) escaped proteasome degradation. Attachment of a Cterminal 95 amino-acid tail derived from S. cerevisiae cytochrome b2 allowed the proteasome to degrade the Ubp6 proteins (Ubp6-95, black solid circles and Ubp6ΔN-95, green solid circles). The graph plots the amount of substrate estimated by electronic autoradiography in SDS-PAGE gel bands over time as normalized to the initial substrate amount as described in Methods. Data points represent mean values determined from at least three repeat experiments; error bars indicate s.e.m.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_7-C</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Degradation of Ubp6 proteinsin vivo. The steady-state accumulation of N-terminally HA-tagged Ubp6 and mutants in S. cerevisiae. Ubp6 and Ubp6ΔN are stable in yeast and not further stabilized by bortezomib. Attachment of a Su9 tail to the Cterminus lead to the degradation of Ubp6 and Ubp6ΔNproteins and the proteins were stabilized by bortezomib treatment.</text>
    </passage>
  </document>
  <document>
    <id>4884787 Figure_7-D</id>
    <infon key="sourcedata_document">1939</infon>
    <infon key="doi">10.15252/embj.201593147</infon>
    <infon key="pmc_id">4884787</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) The steady-state accumulation of endogenous Ubp6 and Ubp6 derivatives with short (19 amino acid) or long (54 amino acid) tails at their C-termini. The 19 amino-acid tail destabilized Ubp6 and the 54-amino-acid tail lead to complete depletion of Ubp6. Protein levels were determined by western blotting for the HA-tag, Ubp6 or Scs2 in SDS-PAGE gels of S. cerevisiae protein extracts. The proteasome was inhibited by 100 µM bortezomib as indicated. Protein loading levels in each lane were normalized in all lysates by western blotting for the integral endoplasmic reticulum membrane proteinScs2.</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_1-A</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Yeast two-hybrid assays to test for interaction between Munc18-1 and ERK1/2. pGAL4-Munc18-1 (M18) and pGAL4-Empty (control) were used as baits and ERK1 and ERK2 as prey. Both ERK1 and ERK2 bind Munc18-1 and allow growth on selection plates (minus Histidine (-HIS) and minus Histidine and Adenosine (-ADE)).</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_1-B-C</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 1-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) In vitro kinase assays showing Munc18-1 phosphorylation by ERK. Radioactive phosphoblot (32P) and immunoblot (IB) of in vitro ERK kinase assay using immunoprecipitatedMunc18WT, Munc184A (M18T78A,S158A,S241A,T574A), Munc183A (M18S158A,S241A,T574A), and Munc18AA (M18S241A,T574A) from HEK293T cells incubated with recombinant ERK2. The phosphoblot shows phosphorylated Munc18-1 (pMunc18-1) and auto-phosphorylated ERK2 (pERK2). (C) Quantification of phospho-Munc18-1 intensity in wild-type and Munc18AA mutant expressed as the amount of 32P incorporation in Munc18-1 normalized to total Munc18-1 levels. Phosphorylation of Munc18WT was set to 100%. (Munc18WT: 100±3%; Munc18AA: 24±2%, n=3, * p = 0.01).</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_1-D</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) ERK1in vitro kinase assay showing ERK-dependent 32P-incorporation in Munc18WT immuno-precipitated from HEK293T cells. Western Blot stained with Munc18-1 antibody shows total precipitated Munc18-1 levels were identical in all conditions.</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_2-A-B</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Experimental setup of fear conditioning paradigm. Mice placed in a fear- conditioning box received no shock (NS), an immediate shock (IS) or delayed shock (DS) and were decapitated 30 min after returning to the home cage. Dorsal and ventral hippocampi were subjected to cellular fractionation (P2). DS and IS significantly increased the levels of phosphorylated ERK1/2, a hallmark of ERK activation. (B) Activity values across three different training paradigms to ascertain that footshock was received in the IS and DS group.</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_2-D-H</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 2-D-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-H</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Western Blot analysis of P2 synaptosomal fractions of ventral hippocampi from the fear conditioning paradigm stained for pM18S241, total Munc18-1, pSynapsin, total synapsin, pERK and GAPDH as loading control. (E) Quantification Munc18-1 phosphorylation in dorsal hippocampus expressed as ratio pM18S241 over total Munc18-1 levels. No shock was set to 1 (NS: 1.0±0.19, n=5; DS: 4.01±0.39, n=5; IS: 2.88±0.37, n=5; **p&lt;0.01; ***p&lt;0.001). (F) Quantification of Munc18-1 phosphorylation in ventral hippocampus expressed as ratio pM18S241 divided by total Munc18-1 levels. (NS: 1.0±0.32, n=5; DS: 4.39±0.55, n=5; IS: 3.62±0.50, n=5; **p&lt;0.01; ***p&lt;0.001). (G) Quantification of synapsin phosphorylation in dorsal hippocampus expressed as ratio pSynapsin divided by total synapsin levels. (NS: 1.0±0.31, n=5; DS: 1.88±0.43, n=5; IS: 1.18±0.34, n=5; n.s.). Inset shows quantification of ERK2 phosphorylation in dorsal hippocampus expressed as ratio pERK2 divided by total ERK2 levels. (NS: 1.0±0.11, n=5; DS: 3.51±0.41, n=5; IS: 3.98±0.24, n=5; **p&lt;0.01). (H) Quantification of synapsin phosphorylation in ventral hippocampus expressed as ratio pSynapsin divided by total synapsin levels. (NS: 1.0±0.20, n=5; DS: 3.32±0.46, n=5; IS: 3.30±0.60, n=5; **p&lt;0.01).</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_3-A-B</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Western Blot of whole cell lysate of adult mousebrain slices treated with the proteasome inhibitor MG132 (10 M) and DMSO, the GABAA receptor blocker GABAzine (GBZ, 10 M) or the voltage-gated sodium channel blocker TTX (2 M) for 4 h. Blots were stained for pMunc18S241, Munc18-1 and tubulin as loading control. (B) Quantification of (A). ERK phosphorylation of Munc18-1 in adult mousebrain slices expressed as ratio pM18S241 divided by total Munc18-1 levels. Vehicle (DMSO) was set to 1 (DMSO: 100 ± 0.4%; GBZ: 1.73 ± 0.12; TTX: 0.052 ± 0.002, n = 4, * p&lt;0.05, ** p&lt;0.01).</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_3-C-D</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 3-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Western Blot of whole cell lysate of adult mousebrain slices treated with proteasome inhibitor MG132 (10 M) and MEK inhibitor PD98059 (10 M) for 4 h. Proteasome block increases the levels of phosphorylated Munc18-1 and ERK1/2, which can be prevented by MEK inhibition. Blots were stained for pMunc18S241, Munc18, pERK1/2 and ERK1/2. (D) Quantification of (C). ERK phosphorylation of Munc18-1 in adult mousebrain slices expressed as ratio pM18S241 divided by total Munc18-1 levels. Vehicle (DMSO) was set to 1 (DMSO: 100 ± 0.8%; MG132: 375 ± 14.2%; MG132 + PD98059: 24 ± 3%, n = 3, ** p&lt;0.01).</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_3-E</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) DIV14 ratcortical cultures treated with type 2 mGluR agonist LY379268 (1 M) for 5 min or BDNF (100ng/ml) for 48 h in the presence of 2 M TTX and stained for pMunc18S241, Munc18, pERK and tubulin as loading control.</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_4-A</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Hippocampal autaptic neurons of munc18-1null mutant mice were rescued with lentiviruses expressing M18WT, M18S241A or M18S241D. Electrophysiology recordings were performed between DIV14-17. (A) Amplitude of excitatory synaptic response (EPSC) (M18WT: 1.37±0.21 nA, n=35; M18S241A: 2.53±0.31 nA, n=45; M18S241D: 0.24±0.05 nA, n=17, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">150</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="0" length="28"/>
        <text>Hippocampal autaptic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_4-B</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Hippocampal autaptic neurons of munc18-1null mutant mice were rescued with lentiviruses expressing M18WT, M18S241A or M18S241D. Electrophysiology recordings were performed between DIV14-17.   (B) Percentage of cells that do not respond to electrical stimulation (M18WT: 15.5%; M18S241A: 0%; M18S241D: 56.9%). These cells are not included in (A). Insert: representative recording of single EPSCs. Scale bar represents 10 ms and 0.5 nA.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">153</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="0" length="28"/>
        <text>Hippocampal autaptic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_4-C-D-E</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 4-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>Hippocampal autaptic neurons of munc18-1null mutant mice were rescued with lentiviruses expressing M18WT, M18S241A or M18S241D. Electrophysiology recordings were performed between DIV14-17.   (C) Typical examples of spontaneous vesicle release. Scale bar represents 0.1 s and 25 pA. (D) Spontaneous release frequency (M18WT: 7.05 ± 1.28 Hz, n=32; M18S241A: 14.26 ± 2.04 Hz, n=37; M18S241D: 0.64 ± 0.29 Hz, n=11; ***p&lt;0.001, **p&lt;0.01). (E) Amplitude of spontaneous release events (M18WT: 15.40 ± 1.06 pA, n=17; M18S241A: 15.03 ± 0.61 pA, n=20; M18S241D: 10.98 ± 0.72 pA, n=10; **p&lt;0.01).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">161</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="0" length="28"/>
        <text>Hippocampal autaptic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_4-F</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>Hippocampal autaptic neurons of munc18-1null mutant mice were rescued with lentiviruses expressing M18WT, M18S241A or M18S241D. Electrophysiology recordings were performed between DIV14-17.   (F) Size of the readily releasable pool (RRP) assessed with single hyperosmotic sucrose application (500 mM, 3.5 s, M18WT: 0.74 ± 0.15 nC, n=7; M18S241A: 1.6 ± 0.33 nC, n=10; M18S241D: could not be determined; * p &lt; 0.05).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">166</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="0" length="28"/>
        <text>Hippocampal autaptic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_4-G</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>Hippocampal autaptic neurons of munc18-1null mutant mice were rescued with lentiviruses expressing M18WT, M18S241A or M18S241D. Electrophysiology recordings were performed between DIV14-17.   (G) Neurons were stimulated with two consecutive pulses with varying inter-stimulus interval to assess release probability. Paired pulse ratio calculated as ratio of the second to the first synaptic response is plotted as function of inter-stimulus interval (M18WT, n=25; M18S241A, n=19; M18S241D, n=17); * p &lt; 0.05, ** p &lt; 0.01). All data are expressed as mean ± SEM. See also Figure EV2 and EV3.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">169</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="0" length="28"/>
        <text>Hippocampal autaptic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_5-A-D</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 5-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-F) Munc18-1 protein levels were measured in glia free cultures of munc18-1null mutant neurons expressing M18WT, M18S241A or M18S241D. (A) Typical examples showing Munc18-1 protein localization and intensity in neurites of M18WT, M18S241A or M18S241Dneurons. MAP2 in blue, VAMP2 in red and Munc18-1 in green. Scale bar represents 2 m. (B) Mean somatic Munc18-1 intensity (M18WT: 1682 ± 206 a.u., n = 46; M18S241A: 1719 ± 238 a.u., n = 36; M18S241D: 582 ± 98 a.u., n = 33; *** p &lt; 0.001). (C) Mean synapticMunc18-1 intensity (M18WT: 1281 ± 161 a.u.; M18S241A: 1390 ± 180 a.u.; M18S241D: 210 ± 30 a.u.; *** p &lt; 0.001). (D) Mean synapticMunc18-1 intensity as a function of radial distance from the soma.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">178</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="47" length="4"/>
        <text>glia</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="89" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">186</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="252" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_5-E</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A-F) Munc18-1 protein levels were measured in glia free cultures of munc18-1null mutant neurons expressing M18WT, M18S241A or M18S241D.  (E) Mean synapticMunc18-1 intensity in cultures with 3 times the standard number of neurons to increase network activity (M18WT: 1072 ± 123 a.u., n = 36; M18S241A: 1480 ± 170 a.u., n = 32; M18S241D: 251 ± 70 a.u., n = 34; * p &lt; 0.05, *** p &lt; 0.001).</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">196</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="47" length="4"/>
        <text>glia</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">197</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="89" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">198</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="222" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_5-F</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(A-F) Munc18-1 protein levels were measured in glia free cultures of munc18-1null mutant neurons expressing M18WT, M18S241A or M18S241D. (F) Mean synapticMunc18-1 intensity in cultures treated with GABAA receptor antagonist Bicuculline (40 μM, 48 h). (M18WT: 761 ± 121 a.u., n = 26; M18S241A: 1482 ± 150 a.u., n = 31, ** p &lt; 0.01).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">209</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="47" length="4"/>
        <text>glia</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">321</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="89" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_5-G</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Mean synaptic syntaxin intensity in autaptic cultures (M18WT: 875 ± 35, n = 51; M18S241A: 1058 ± 42, n = 46; M18S241D: 458 ± 19, n=40, ** p &lt; 0.01, ***p&lt;0.001).</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_5-H-I</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 5-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Western Blot of lysates from high-density neuronal cultures from munc18-1 null mutant mice rescued with M18WT, M18S241A or M18S241D. Prior to lysis, cells were treated for 6 h with MG132 (10 M) or DMSO as control. Western Blots were stained for Munc18-1 and tubulin as loading control. (I) Quantification of (H). Munc18-1 levels were normalized to tubulin levels. Effect of proteasome inhibition was quantified as ratio between MG132 and DMSO treatment of each mutant (M18WT: 1.62 ± 0.41; M18S241A: 1.26 ± 0.16; M18S241D: 7.53 ± 1.17, n = 3; **p&lt;0.01).</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_5-J-K</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 5-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>(J) Ubiquitination of different Munc18-1 mutants in HEK293T cells. Western Blot of denatured Munc18-1 immuno-precipitations from cells expressing Munc18-1 mutants and HA-tagged ubiquitin. Prior to lysis, cells were treated for 8 h with MG132 (10 M). Ubiquitin covalently attached to Munc18-1 can be observed as a smear above the characteristic 68 kD Munc18-1 band on Western blots stained for HA-tag. (K) Quantification of immuno-precipitation in (J). Level of Munc18-1 ubiquitination was quantified as ratio of immunoprecipitatedubiquitin and Munc18-1 levels. M18WT was set to 1 (M18WT: 1 ± 0.06; M18S241A: 0.84 ± 0.57; M18S241D: 2.70 ± 0.07, n = 3; **p&lt;0.01). All data are expressed as mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_6-A</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Western blot from whole cell lysate of munc18-1 null mutant neurons rescued with M18WT and incubated with WIN55,212-2 (5 M) for 30 s. Cells were harvested after the indicated time. CB1R activation leads to a rapid and transient increase in pERK activity.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">249</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="64" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_6-B-C-D</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 6-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(B-D) Hippocampal autaptic neurons of munc18-1null mutant mice were rescued with lentiviruses expressing M18WT or M18S241A. CB1R agonist WIN55,212-2 (5 M) was applied at t = 60 s for 30 s. (B) Amplitude of excitatory synapse response normalized to t=0 s. Neurons were stimulated by a single action potential every 30 s for 4 min (M18WTn = 21, M18S241An = 24, *p&lt;0.05). Note the broken y-axis. (C) Ratio of the frequency of spontaneous release events after (t = 180 s) and before (t = 0 s) WIN55,212-2 application (M18WT: 58.0 ± 2.3 %, n = 21; M18S241A: 84.2 ± 5.6 %, n = 24, * p &lt; 0.05). (D) Ratio of amplitude of spontaneous release events after (t=240 s) and before (t=0 s) WIN55,212-2 application (M18WT: 85.0 ± 2.7 %, n = 21; M18S241A: 83.1 ± 2.6 %, n = 24).</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">255</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="6" length="28"/>
        <text>Hippocampal autaptic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_6-E-F-G</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 6-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(E-G) Autaptic neurons of munc18-1null mutant mice rescued with lentiviruses expressing M18WT were superfused with WIN55,212-2 (1 M), WIN55,212-2 (1 M) plus AM251 (1 M) or vehicle only (DMSO). (E) Amplitude of excitatory synapse response normalized to t=0 s. CB1R agonist WIN55,212-2 (1 M) or vehicle only (DMSO) were applied at t=60 s for 30 s. (WT + WIN n = 13; WT + DMSO n = 16, * p &lt; 0.05). Note the broke Y-axis. (F) Paired pulse ratio (20 ms interval) at t = 0 and t = 240 s in M18WTneurons superfused with CB1R agonist WIN55,212-2 (1 M) at t = 60 s for 30 s. WIN55,212-2 application increases PP ratios indicative of a reduction of synaptic release probability (t = 0 s: 0.94 ± 0.1, n = 13; t = 240 s: 1.36 ± 0.2, n = 16, * p &lt; 0.05). (G) Amplitude of excitatory synapse response normalized to t = 0 s. CB1R agonist WIN55,212-2 (1 M) was applied together with the CB1R antagonist AM251 (1 M) at t = 60 s for 30 s. (WT + WIN n = 13, same trace as 6F; WT + WIN + AM251 n = 15, * p &lt; 0.05). Note the broke Y-axis.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">262</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="15" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">273</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="489" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_6-H-I-J</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 6-H-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(H-J) Hippocampal autaptic neurons of munc18-1null mutant mice were rescued with M18WT or M18S241A. mGluR2/3 agonist LY379268 (1 M) was applied by bath-perfusion for 4 min. (H) Ratio of amplitude of evoked release events after (t = 240 s) and before (t = 0 s) LY379268 application (M18WT: 55.0 ± 4.7 %, n = 14; M18S241A: 81.1 ± 3.6 %, n = 16, * p &lt; 0.05). (I) Ratio of frequency of spontaneous release events after (t = 240 s) and before (t = 0 s) LY379268 application (M18WT: 63.0 ± 5.7 %, n = 14; M18S241A: 85.1 ± 3.4 %, n = 16, * p &lt; 0.05). (J) Ratio of the amplitude of spontaneous release events after (t = 240 s) and before (t = 0 s) WIN55,212-2 application (M18WT: 81.0 ± 1.3 %, n = 14; M18S241A: 82.1 ± 3.3 %, n = 16).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">285</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="6" length="28"/>
        <text>Hippocampal autaptic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_7-A-D</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 7-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) DSE duration and amplitude is decreased in CA1pyramidal neurons upon ERK pathway inhibition by a pre-treatment with PD98059 (PD; 10 µM) compared to 0.1% DMSO (control). (A) Average EPSC amplitude during 25 s baseline recording prior to DSE induction shows no significant differences in EPSC amplitude between the DMSO and PD pretreated groups (DMSO: 196.36 +/- 16.51 pA, n = 10; PD: 196.42 +/- 18.61 pA, n = 11, p = 0.9). (B) DSE in neurons of DMSO pre-treated slices, induced by a 10s depolarization to 0 mV (arrow). Inset: example traces of 2 averaged EPSCs before (black) and after depolarization (grey). (C) DSE in slices pre-treated with PD. Insets: example traces of 2 averaged EPSCs before (red) and after depolarization (grey). (D) Comparison of DSE between control and PD. PD pre-treatment limits amplitude and duration of DSE. ** = p &lt; 0.01; unpaired T-test with Welch's correction. Numbers in bars represent the number of neurons in each group.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">296</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="52" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">302</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="439" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">304</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="939" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888233 Figure_7-E-H</id>
    <infon key="sourcedata_document">1611</infon>
    <infon key="doi">10.15252/embj.201592244</infon>
    <infon key="pmc_id">4888233</infon>
    <infon key="figure">Figure 7-E-H</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E-H</infon>
    <passage>
      <offset>0</offset>
      <text>(E-H) ERK-pathway inhibition by pre-treatment with PD98059 (PD; 10 µM) blocks the effect of WIN55,212-2 (WIN; 2 µM) on the amplitude of EPSCs recorded in CA1pyramidal neurons. (E) Average EPSC amplitude during 5 min baseline recording prior to DSE induction shows no significant differences in EPSC amplitude between the DMSO and PD pretreated groups (DMSO: 295.69 +/- 28.73 pA, n = 6; PD: 270.86 +/- 32.14 pA, n = 6, p= 0.6). (F) Effect of WIN application (grey bar, 30 min) on EPSC-amplitude in CA1pyramidal neurons of 0.1% DMSO (control) pre-treated slices. Inset: example traces of averaged EPSCs of baseline (black) and the last 5 min (grey). (G) Effect of WIN application (grey bar, 30 min) on EPSC-amplitude in CA1pyramidal neurons of PD pre-treated slices. Inset: example traces of averaged EPSCs of baseline (red) and the last 5 minutes (grey). (H) Comparison of the effect size of the last 5 minutes in both groups shows a significant difference. * = p &lt; 0.05; unpaired T-test. Numbers in bars represent number of slices in each group.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">307</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="157" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">308</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="500" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">309</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="721" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_1-A</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative micrographs of optic nerve sections collected from mice 8 days after ONC, showing the accumulation of IB-4+ activated myeloid cells in the injury site, which is demarcated by GFAPstaining. Scale bar, 50 µm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0000763</infon>
        <location offset="137" length="13"/>
        <text>myeloid cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_1-B</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative micrograph of the lesion site in optic nerve sections 7 days after crush injury in [Cx3cr1gfp/+ WT] BM chimeric mice, immunostained for GFP (red), to depict monocyte-derived macrophages, and IB-4 (green) to label activated myeloid cells. Scale bar, 100 µm. Inset scale, 20 µm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">11</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="176" length="8"/>
        <text>monocyte</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">10</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="193" length="11"/>
        <text>macrophages</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <infon key="identifier">CL:0000763</infon>
        <location offset="242" length="13"/>
        <text>myeloid cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_1-C</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Representative micrograph of optic nerve section 7 days after crush injury, immunostained for CD3 (red, arrows). Scale bar, 100 µm.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_1-D</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Representative dotplots showing the general gating strategy used in flow cytometry experiments for the analysis of immune cells in the retina. Leukocytes were identified by gating on CD45+ cells, and were further gated on CD11b+ or TCRβ+ to detect monocytes/macrophages and T cells, respectively. Of the CD11b+ cells, infiltrating monocytes were regarded as CD45hi.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">26</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="147" length="10"/>
        <text>Leukocytes</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">32</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="252" length="9"/>
        <text>monocytes</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">33</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="262" length="11"/>
        <text>macrophages</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">34</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="278" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">36</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="335" length="9"/>
        <text>monocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_1-E</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Representative contour plot from [Cx3cr1gfp/+ WT] BM chimeric mouse, verifying that infiltrating blood-derived macrophages (CX3CR1-GFP+) are indeed CD45hi, and showing that they are detectable only in retinas from eyes that underwent ONC, while absent in noninjured controls (red vs. blue line). Cells were pre-gated on CD11b. n = 3-4 per group.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">46</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="115" length="11"/>
        <text>macrophages</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_1-F</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Quantitative analysis of flow cytometry data, showing the induction of an immune response in the retina after ONC, evident by a general increase in leukocytes (CD45+), including CD11b+CD45hi cells (representing infiltrating macrophages) and T cells (TCRβ+). n = 4 per group. Data shown are representative of six independent experiments. Graphs show mean ± SE of each group. *** P &lt; 0.001. FSC - forward scatter; noninj - noninjured control; ONC - optic nerve crush.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">55</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="152" length="10"/>
        <text>leukocytes</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">58</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="228" length="11"/>
        <text>macrophages</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">59</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="245" length="7"/>
        <text>T cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_2-A</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A, C-E) Changes in mRNA transcript levels of an array of adhesion molecules (A) in retinas from ONC eyes compared with contralateral noninjured retinas, 8 hours, and 1, 3 and 7 days after ONC. n = 6-13 per group. Data shown are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_2-B</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative micrographs showing the expression of ICAM-1 and VCAM-1 (red) by the RPE (green) 12 hours after ONC. Scale bar, 20 µm. Bar graphs throughout the figure show mean ± SE of each group. Asterisks above bars indicate significant differences compared with noninjured tissue; significant differences between different time points are indicated by asterisks between bars. *, P &lt; 0.05; **, P &lt; 0.01; *** P &lt; 0.001. noninj - noninjured control; ONC - optic nerve crush.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_2-C-D-E</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 2-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A, C-E) Changes in mRNA transcript levels of an array of chemokines (C, D) and cytokine receptors (E) in retinas from ONC eyes compared with contralateral noninjured retinas, 8 hours, and 1, 3 and 7 days after ONC (optic nerve crush). n = 6-13 per group. Data shown are representative of three independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_3-A-B</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) Quantitative flow cytometry analysis of myeloid cells in the RPE complex (A) and retinas (B) from injured (filled bars) and contralateral noninjured eyes (empty bars), on days 1, 3 and 7 after ONC. Cells were pre-gated on total leukocytes (CD45+), and analyzed for the expression of CD11b. CD11b+ cells were further discriminated based on their expression levels of Ly6C. n = 6-7 per group. Bar graphs throughout the figure show mean ± SE of each group. Asterisks above bars indicate significant differences compared with noninjured tissue; significant differences between different time points are indicated by asterisks between bars. *, P &lt; 0.05; **, P &lt; 0.01; *** P &lt; 0.001. noninj - noninjured control; ONC - optic nerve crush.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">97</infon>
        <infon key="identifier">CL:0000763</infon>
        <location offset="47" length="13"/>
        <text>myeloid cells</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">100</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="235" length="10"/>
        <text>leukocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_4-A</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>Mice were subjected to ONC and i.v.-injected with either an anti-VCAM-1 blocking antibody or an isotype control antibody. Eyes were collected after 2 or 3 days for flow cytometry. (A) Flow cytometry quantification of myeloid cells in retinas from mice that were treated with anti-VCAM-1 antibody, as compared to isotype-treated controls. n = 3 per group. Asterisks above bars indicate significant differences compared with noninjured tissue; significant differences between different antibody treatments are indicated by asterisks between bars.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">111</infon>
        <infon key="identifier">CL:0000763</infon>
        <location offset="217" length="13"/>
        <text>myeloid cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_4-B</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>Mice were subjected to ONC and i.v.-injected with either an anti-VCAM-1 blocking antibody or an isotype control antibody. Eyes were collected after 2 or 3 days for Real-Time PCR analysis, respectively. (B) Expression ratios of Tnf, Il12a and Il1b, compared to Tgfb2, showing that blocking VCAM-1 results in skewing the retina towards a pro-inflammatory milieu after ONC. n = 11-13 per group. Data shown are representative of two independent experiments. Bar graphs throughout the figure show mean ± SE of each group. *, P &lt; 0.05; **, P &lt; 0.01; *** P &lt; 0.001. noninj - noninjured control; ONC - optic nerve crush.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_5-A</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Live cell microscopy imaging of noninjured and ONC eyes, showing the presence of DiR+monocyte clusters in injured eyes only. Some of the cell clusters are co-localized with GFP, indicating monocytes that have crossed the RPE and infiltrated the retina. n = 2-3 per group. Data shown are representative of two independent experiments.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">133</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="89" length="8"/>
        <text>monocyte</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">136</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="193" length="9"/>
        <text>monocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_5-B</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative micrographs of eye sections collected from mice 1 day after ONC, or 29 days after the induction of EAU, stained for β-dystroglycan (red, arrows) and laminin (green), showing a comparable structure of blood vessels in the inner retina of ONC eyes and noninjured controls, which is different from the appearance of blood vessels in EAU retina. Scale bar, 50 µm.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_5-C-D-E</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 5-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(C-E) [Actbegfp/+ WT] BM chimeric mice were generated and subjected to ONC (optic nerve crush). (C) Representative micrographs showing the abundance of GFP+ cells (green) in the RPE (RPE65, red) and retina of the ONC eye compared to noninjured contralateral eye. Retinal layers can be distinguished by Hoechst staining (blue; scale bar, 100 µm). (D) Higher magnification micrographs of ONC eyes, showing the association of blood-derived GFP+ cells (green, arrows) with the RPE (red); Note processes extending from the cells to the RPE (scale bar, 20 µm). (E) Representative micrograph of ONC eye showing GFP+ cells (green) in proximity to the GCL, the site of dying retinal ganglion cells (scale bar, 20 µm). n = 4 per group.</text>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <infon key="identifier">CL:0000740</infon>
        <location offset="666" length="22"/>
        <text>retinal ganglion cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_6-A-B-C-D</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 6-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-D) Changes in mRNA transcript levels of a series of adhesion molecules (A), chemokines (B, C) and cytokine receptors (D) in injured retinas compared with contralateral noninjured retinas, assessed 1 day after GT intoxication. n = 6 per group.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_6-E</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Representative micrographs showing the expression of ICAM-1 and VCAM-1 (red) by the RPE (green) 1 day after GT intoxication. Bar graphs throughout the figure show mean ± SE of each group. *, P &lt; 0.05; **, P &lt; 0.01; *** P &lt; 0.001. GT - glutamate; noninj - noninjured control.</text>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_7-A</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative micrograph of an eye from day 7 after glutamate intoxication, from a mouse that was i.v.-injected with monocytes, showing monocyte localization to the SRS after this mode of application, and indicating a potential homing route for the cells (IL-10, red; CX3CR1-GFP, green).</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">210</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="122" length="9"/>
        <text>monocytes</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">211</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="141" length="8"/>
        <text>monocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_7-B-C</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 7-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B-E) Mice were injected i.v.t. with either monocytes or PBS 1 day after GT intoxication, and ocular sections from 7 days after the injury were analyzed. (B, C) Representative micrographs of noninjured and injured retinas stained for the RGC marker, Brn3a (red; scale bar, 100 µm), and quantification of RGC survival. Arrows indicate Brn3a+ cells. Bar graph shows mean ± SE of each group. *, P &lt; 0.05.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">216</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="44" length="9"/>
        <text>monocytes</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">219</infon>
        <infon key="identifier">CL:0000740</infon>
        <location offset="238" length="3"/>
        <text>RGC</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">221</infon>
        <infon key="identifier">CL:0000740</infon>
        <location offset="304" length="3"/>
        <text>RGC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888238 Figure_7-D-E</id>
    <infon key="sourcedata_document">1641</infon>
    <infon key="doi">10.15252/embj.201694202</infon>
    <infon key="pmc_id">4888238</infon>
    <infon key="figure">Figure 7-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(B-E) Mice were injected i.v.t. with either monocytes or PBS 1 day after GT intoxication, and ocular sections from 7 days after the injury were analyzed. (D, E) Representative micrographs of GT-intoxicated eyes that were i.v.t.-injected with monocytes, showing the expression of an array of cytokines and neurotrophic factors (red) by the injected monocytes (CX3CR1-GFP, green). The injected cells were found in the vitreous and in proximity to injured RGCs (left panels), as well as in the SRS, adjacent to the RPE (right panels). Insets show higher magnification of representative cells (scale bar, 100 µm; inset scale, 20 µm). n = 4-5 per group. GCL - ganglion cell layer; GT - glutamate; mon - monocytes; RGC - retinal ganglion cell; RPE - retinal pigment epithelium; SRS - subretinal space; vit - vitreous.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">227</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="44" length="9"/>
        <text>monocytes</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">242</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="242" length="9"/>
        <text>monocytes</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">243</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="348" length="9"/>
        <text>monocytes</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">231</infon>
        <infon key="identifier">CL:0000740</infon>
        <location offset="453" length="4"/>
        <text>RGCs</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">245</infon>
        <infon key="identifier">CL:0000576</infon>
        <location offset="698" length="9"/>
        <text>monocytes</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">237</infon>
        <infon key="identifier">CL:0000740</infon>
        <location offset="709" length="3"/>
        <text>RGC</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">238</infon>
        <infon key="identifier">CL:0000740</infon>
        <location offset="715" length="21"/>
        <text>retinal ganglion cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_1-A-O</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 1-A-O</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-O</infon>
    <passage>
      <offset>0</offset>
      <text>Male, 12wk wildtype (WT; C57Bl/6J) or obese/diabetic monogenic (db/db; BKS.Cg-m+/+ Lepr DB/J; N = 4/group, A-E), New Zealand Black (NZB) and polygenic obese/prediabetic New Zealand Obese (NZO; n=4/group; F-J), as well as young (i.e. 3 mo) and aged (i.e.22 mo; n = 5/group; K-O), mice were fed ad libitum (fed) or fasted for 24h (fasted). Serumnon-esterified fatty acids (A, F, K), triglycerides (B, G, L) and ketone bodies (C, H, M) were measured. In addition, serumacylcarinitine profiling was conducted and medium-chain (D, I, N) and long-chain (E, J, O) acylcarnitine concentrations are shown.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_1-P-S</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 1-P-S</infon>
    <infon key="sourcedata_figure_dir">Figure_1-P-S</infon>
    <passage>
      <offset>0</offset>
      <text>In another cohort of mice, ex vivo long-chain fatty acid (LCFA) metabolism, including uptake (P), oxidation (Q) and non-oxidative LCFA disposal (NOFAD; R), in precision cut liver slices from fed and fasted WT and db/dbmice (n = 3/ group; 4 slices per mouse), were determined. In addition, in slices from fasted mice, glucose output was determined in the presence of incubation with NEFA (BSA-NEFA) or vehicle (BSA) (S).</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_2-A-I</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 2-A-I</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-I</infon>
    <passage>
      <offset>0</offset>
      <text>Liver mRNA expression of Growth Arrest and DNA Damage inducible 45 alpha (Gadd45a; A, D, G), beta (Gadd45b; B, E, H) and gamma (Gadd45g; C, F, I) was measured in fed and fasted obese/diabetic monogenic (db/db (n=4/group); A,-C), obese/pre-diabetic polygenic New Zealand Obese (NZO (n=4/group; D-F), and aged C57Bl/6J (22mo; n = 5/group; G-I) as well as corresponding lean, young wildtype (WT) mice (n=4/group). Matched controls for the NZO and aged mice were New Zealand Black (NZB) and 12wk old C57Bl/6J (12wk) mice, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_2-J-K-L</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 2-J-K-L</infon>
    <infon key="sourcedata_figure_dir">Figure_2-J-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>LiverGADD45β as well as the housekeeping protein Valosin containing protein (VCP) protein expression was measured from liver samples (J-L). Data are mean ± SEM. Effect of genotype, * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001. Effect of nutritional state: # p &lt; 0.05, ## p &lt; 0.01, ### p &lt; 0.001. The statistical test used and respective p-value outputs can be found in Appendix Table S1.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_3-A-B-C</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 3-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Male, GADD45β+/+ (WT; n=6) or GADD45β-/- mice (KO; n=4) were fed ad libitum (fed) or fasted for 24h (fasted), and subsequently refed for 24h. O2 consumption rate (A), CO2 production rate (B) and respiratory exchange ratio (C) were measured by indirect calorimetry.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_3-D-G</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 3-D-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-G</infon>
    <passage>
      <offset>0</offset>
      <text>In a distinct cohort, male GADD45β+/+ (WT; n=5) or GADD45β-/- mice (KO; n= 8) were fed ad libitum (fed) or fasted for 24h (fasted). Serumnon-esterified fatty acids (D) and ketone bodies (E) as well as serum (F) and liver (G) triglycerides (TG) were measured.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_3-H-I-J</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 3-H-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>SerumTG (H), NEFA (I), and bloodglucose (BG, J) concentrations during an oral lipid tolerance test in overnight fasted GADD45β+/+ (WT; n = 5) or GADD45β-/- (KO; n=5) mice.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_3-K-N</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 3-K-N</infon>
    <infon key="sourcedata_figure_dir">Figure_3-K-N</infon>
    <passage>
      <offset>0</offset>
      <text>Bloodglucose excursion during and intraperitoneal insulin tolerance test (K) as well as fasting bloodglucose (L), seruminsulin (M), and HOMA-IR (N) in GADD45β+/+ (WT; n = 6) or GADD45β-/- mice (KO, n = 9) chronically fed a normal- (NFD) or high (HFD) fat diet. Data are mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Male, GADD45β+/+ (WT) or GADD45β-/- mice (KO) were fed ad libitum (fed) or fasted for 24h (fasted) and ex vivo liver slice long-chain fatty acid (LCFA) metabolism was measured including LCFA uptake (A), oxidation (B) and non-oxidative LCFA disposal (NOFAD) was calculated (C).</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_4-D</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>In addition, glucose production was measured (D) in the presence (BSA-NEFA) or absence (BSA) of extracellular fatty acids (n=4/group with 4 liver slices per mouseliver).</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_4-E</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>Gadd45b mRNA expression was measured from fractionated parenchymal hepatocytes (Hepas) as well as non-parenchymal cells (NP) from C57Bl/6Jmice fed ad libitum (fed) or fasted for 24h (fasted); n=3/group (E).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">135</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="67" length="11"/>
        <text>hepatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_4-F-G</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 4-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>Male, C57Bl/6Jmice with (AAV-G45b miR) or without (AAV-NC miR) liver-hepatocyte-restricted GADD45β silencing were fed or fasted for 24h (n = 6/group) and serum levels of non-esterified fatty acids (NEFA; F) as well as livertriglyceride (TG) concentration (G) were measured.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">146</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="69" length="10"/>
        <text>hepatocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_4-H</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>Male, GADD45β+/+ (WT; n=16) or GADD45β-/- mice (KO; n=15) fasted for 24h (fasted) with (AD-G45b OE) or without (AD-NC) liver-restricted GADD45β over-expression (n = 7-8/group). LiverTG concentration (H) was measured.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_4-I-J-K</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 4-I-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>Male, C57Bl/6Jmice with (AAV-G45b miR; n= 15) or without (AAV-NC miR, n = 13) liver-hepatocyte-restricted GADD45β silencing were chronically fed a normal (NFD) or high (HFD) fat diet (n = 6-8/group). Fasting bloodglucose (I) and seruminsulin (J) were measured from which HOMA-IR was calculated (K).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">172</infon>
        <infon key="identifier">CL:0000182</infon>
        <location offset="84" length="10"/>
        <text>hepatocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_5-A-B-C</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 5-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Male, 12wk wildtype (WT; C57Bl/6J) or obese/diabetic (db/db; BKS.Cg-m+/+ Lepr DB/J) with (AD-G45b OE) or without (AD-NC) prior liver-restricted GADD45β over-expression were fasted and bloodglucose ( A) and seruminsulin (B) were measured from which HOMA-IR was calculated (C) (n = 4-6/group). Data are mean ± SEM. Effect of genotype/viral manipulation, * p &lt; 0.05, ** p &lt; 0.01, *** p &lt; 0.001. Effect of nutritional state: # p &lt; 0.05, ## p &lt; 0.01, ### p &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_5-D</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>LiverGADD45B mRNA expression from men with (T2D) or without (NGT) type 2 diabetes (n = 14-23/group).</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_5-E-F</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 5-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>Scatter plots fasting plasmatriglycerides (E) and glucose (F) in correlation with liver GADD45B mRNA expression (n = 37). Inserts show r2 values and p values from Spearman's correlation test. The statistical test used and respective p-value outputs can be found in Appendix Table S1.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_6-A-B</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 6-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>Male, GADD45β+/+ (WT; n=16) or GADD45β-/- mice (KO; n=15) fasted for 24h (fasted) with (AD-G45b OE) or without (AD-NC) liver-restricted GADD45β over-expression (n = 7-8/group). Liver mRNA expression of Gadd45b (A) as well as fatty acid metabolic genes (B) encompassing transport (Slc28a2, Slc27a5, Cd36), intracellular binding (Fabp1, Dbi) and metabolism (Acly, Dgat1, Atgl, Hsl).</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_6-C-D</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 6-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C: Representative immunoblots of FATP2, CD36, FABP1 and GADD45β from liver whole tissue lysate (W) as well as fractionated organelles/intraceuular structures including nuclei (N), mitochondria (MT), microsomes (MS) and cytoplasm (C), from GADD45β+/+ (WT) and GADD45β-/- (KO) mice. D: Quantified band densities of FABP1 enrichment from fractions in C (n = 4/group).</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_6-E</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E: Liver fraction enrichment of FABP1 from male, GADD45β+/+ (WT) or GADD45β-/- (KO) fasted for 24h with (AD-G45b OE) or without (AD-NC) liver-restricted GADD45β over-expression (n = 4/group). Insert shows a representative FABP1immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_6-F</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F: Liver fraction enrichment of FABP1 from obese/diabetic male db/db mice fasted for 24h with (AD-G45b OE) or without (AD-NC) liver-restricted GADD45β over-expression (n = 4/group). Insert shows a representative FABP1immunoblot.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_6-G</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>G: FABP1 and GADD45Bimmunoblots from Flag-immunoprecipitations (IP-FLAG) or mock IP (IP-HA) from liver input samples from mice with (AD-G45b OE) or without (AD-NC) liver-restricted GADD45β over-expression. Shown is a representative immunoblot from 3 separate experiments using 3 different input samples per condition.</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_6-H</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>H: Liver long chain acyl-CoA (LC-acyl-CoA) concentrations were determined in GADD45β+/+ (WT) or GADD45β-/- (KO) mice (H; n=6/ group) with (AD-G45b OE) or without (AD-NC) liver-restricted GADD45β over-expression (I; n =5/group).</text>
    </passage>
  </document>
  <document>
    <id>4888855 Figure_6-I</id>
    <infon key="sourcedata_document">1803</infon>
    <infon key="doi">10.15252/emmm.201505801</infon>
    <infon key="pmc_id">4888855</infon>
    <infon key="figure">Figure 6-I</infon>
    <infon key="sourcedata_figure_dir">Figure_6-I</infon>
    <passage>
      <offset>0</offset>
      <text>Liver LC-acyl-CoA concentrations were determined in wildtype (WT; C57Bl/6J) or obese/diabetic (db/db; BKS.Cg-m+/+ Lepr DB/J) with (AD-G45b OE) or without (AD-NC) liver-restricted GADD45β over-expression (J; n=4/group).</text>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_1-B-C-D-E</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 1-B-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Representative Iba1 stainings of retinal flat mounts detecting microglia/macrophages in laser spots 3 days after laser coagulation in C57BL6/J controls (B) and Ifnar1-/- (C) mice. Scale bar: 20 µm. D Quantification of amoeboid-shaped mononuclear phagocytes in laser spots. Values show mean ± SD. (n = 11-12 retinas; unpaired Student's t-test: ***p = 0.0004). E Quantification of immune cell morphology in laser spots using a grid image analysis system. Values show mean ± SD. (n = 42-62 cells; unpaired Student's t-test: ***p &lt; 0.0001).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">3</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="68" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="78" length="11"/>
        <text>macrophages</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">9</infon>
        <infon key="identifier">CL:0000113</infon>
        <location offset="239" length="22"/>
        <text>mononuclear phagocytes</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">10</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="384" length="11"/>
        <text>immune cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_1-F-L</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 1-F-L</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-L</infon>
    <passage>
      <offset>0</offset>
      <text>F-K Representative fundus fluoresceinangiography images of C57BL6/J (F-H) and Ifnar1-/- (I-K) mice 3, 7 and 14 days after laser-induced damage. L Quantification of vascular leakage by analyzing pixel intensities at 3, 7 and 14 days after laser-induced retinal damage in C57BL6/J controls versus Ifnar1-/- mice. Values show mean ± SD. (n = 14-22 eyes; One-way ANOVA followed by Tukey's post-test: ***p &lt; 0.0001).</text>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_1-M-Q</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 1-M-Q</infon>
    <infon key="sourcedata_figure_dir">Figure_1-M-Q</infon>
    <passage>
      <offset>0</offset>
      <text>M-P Representative images of lectin stained choroidal flat mounts 7 and 14 days after laser coagulation in C57BL6/J control mice (M, N) and Ifnar1-/- animals (O, P). Dashed lines indicate CNV areas and the asterisk marks the central optic nerve head. Scale bar: 200 µm. Q Quantification of lectin-stained CNV areas with ImageJ software. Bars show mean ± SD. (n = 4-11 RPE/choroidal flat mounts; One-way ANOVA followed by Tukey's post-test: *p = 0.0281).</text>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_2-B-C-D-E</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 2-B-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Representative Iba1 stainings of retinal flat mounts detecting microglia/macrophages in laser spots 3 days after laser coagulation in control mice (B) or IFN-b treated animals (C). Scale bar: 20 µm. D Quantification of amoeboid-shaped mononuclear phagocytes in laser spots. Values show mean ± SD. (n = 7-10 retinas; unpaired Student's t-test: ***p &lt; 0.0001). E Quantification of immune cell morphology in laser spots using a grid image analysis system. Values show mean ± SD. (n = 41-62 cells; unpaired Student's t-test: ***p &lt; 0.0001).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">46</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="68" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">47</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="78" length="11"/>
        <text>macrophages</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <infon key="identifier">CL:0000113</infon>
        <location offset="240" length="22"/>
        <text>mononuclear phagocytes</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">52</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="384" length="11"/>
        <text>immune cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_2-F-L</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 2-F-L</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F-L</infon>
    <passage>
      <offset>0</offset>
      <text>F-K Representative fundus fluoresceinangiography images of control mice (F-H) or IFN-b treated animals (I-K) 3, 7 and 14 days after laser-induced damage. L Quantification of vascular leakage by analyzing pixel intensities at 3, 7 and 14 days after laser-induced retinal damage in control mice and IFN-b treated animals. Values show mean ± SD. (n = 15-22 eyes; One-way ANOVA followed by Tukey's post-test: ***p = 0.0004).</text>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_2-M-Q</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 2-M-Q</infon>
    <infon key="sourcedata_figure_dir">Figure_2-M-Q</infon>
    <passage>
      <offset>0</offset>
      <text>M-P Representative images of lectin stained choroidal flat mounts 7 and 14 days after laser coagulation in control mice (M, N) and IFN-b treated animals (O, P). Dashed lines indicate CNV areas and the asterisk marks the central optic nerve head. Scale bar: 200 µm Q Quantification of lectin-stained CNV areas with ImageJ software. Bars show mean ± SD. (n = 7-12 RPE/choroidal flat mounts; One-way ANOVA followed by Tukey's post-test: **p = 0.0038).</text>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_3-B-F</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 3-B-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-F</infon>
    <passage>
      <offset>0</offset>
      <text>B-D Representative Iba1 staining results of retinal flat mounts detecting microglia/macrophages in laser spot 3 days after laser coagulation in Cx3cr1CreER(B), Ifnar1fl/fl (C) and Cx3cr1CreER:Ifnar1fl/fl (D) mice. Scale bar: 20 µm. E Quantification of amoeboid-shaped mononuclear phagocytes in laser spots. Values show mean ± SD. (n = 17-29 retinas; unpaired Student's t-test: ***p = 0.0003, **p = 0.0044). F Quantification of immune cell morphology in laser spots using a grid image analysis system. Values show mean ± SD. (n = 44-52 cells; unpaired Student's t-test: ***p &lt; 0.0001).</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">91</infon>
        <infon key="identifier">CL:0000129</infon>
        <location offset="74" length="9"/>
        <text>microglia</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">92</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="84" length="11"/>
        <text>macrophages</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">86</infon>
        <infon key="identifier">CL:0000113</infon>
        <location offset="268" length="22"/>
        <text>mononuclear phagocytes</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">97</infon>
        <infon key="identifier">CL:0000738</infon>
        <location offset="427" length="11"/>
        <text>immune cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_3-G-P</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 3-G-P</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G-P</infon>
    <passage>
      <offset>0</offset>
      <text>G-O Representative fundus fluoresceinangiography images of Cx3cr1CreER(G-I), Ifnar1fl/fl (J-L) and Cx3cr1CreER:Ifnar1fl/fl (M-O) mice 3, 7 and 14 days after laser-induced damage. P Quantification of vascular leakage by analyzing pixel intensities at 3, 7 and 14 days after laser-induced retinal damage in Cx3cr1CreER, Ifnar1fl/fl and Cx3cr1CreER:Ifnar1fl/fl mice. Values show mean ± SD. (n = 5-12 eyes; One-way ANOVA followed by Tukey's post-test: **p = 0.0032, *p = 0.0247).</text>
    </passage>
  </document>
  <document>
    <id>4888856 Figure_3-Q-W</id>
    <infon key="sourcedata_document">1703</infon>
    <infon key="doi">10.15252/emmm.201505994</infon>
    <infon key="pmc_id">4888856</infon>
    <infon key="figure">Figure 3-Q-W</infon>
    <infon key="sourcedata_figure_dir">Figure_3-Q-W</infon>
    <passage>
      <offset>0</offset>
      <text>Q-V Representative images of lectin stained choroidal flat mounts 7 and 14 days after laser coagulation in Cx3cr1CreER(Q, R), Ifnar1fl/fl (S, T) and Cx3cr1CreER:Ifnar1fl/fl (U, V) mice. Dashed lines indicate CNV areas and the asterisk marks the central optic nerve head. Scale bar: 200 µm. W Quantification of lectin-stained CNV areas with ImageJ software. Bars show mean ± SD. (n = 4-11 RPE/choroidal flat mounts; One-way ANOVA followed by Tukey's post-test: *p = 0.043, ***p = 0.0007).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_1-B-C</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 1-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Pull-Down of GST-tagged α11.2 segments (top immunoblot; IB) by immobilized MBP-β2AR C-terminus (residues 326-413 of human β2AR). GST fusion proteins were detected by an anti-GST antibody and MBP fusion proteins by an anti-MBP antibody. Middle IB shows that comparable amounts of the various GST fusion proteins had been added to the resin samples and bottom IB illustrates equal loading of all amylose resin samples with MBP-β2AR. (C) Quantification of (B) (***p&lt;0.001, ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_1-D-E</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Pull-Down of GST-CTC but not GST-CTD or GST-CTE (middle IB) by immobilized MBP-β2AR C-terminus (left) but not MBP alone (right), all of which were present at comparable amounts (bottom and top IBs, respectively). GST fusion proteins were detected by an anti-GST antibody and MBP fusion proteins by an anti-MBP antibody. (E) Quantification of (D) (***p&lt;0.001, ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_1-F-G-H-I</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 1-F-G-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>(F) IP of β2AR in the presence of 10 μM GST (Control; Ctr) or GST-tagged C-terminal fragments as indicated. CT4 and CTC specifically displaced α11.2 (top of IB) but not GluA1 (middle of same IB) from β2AR (bottom of same IB). Use of non-specific IgG (left lane in right panels) indicates specificity of IP. (G, H). For quantification of coIPs, α11.2 and GluA1 immunosignals were normalized to β2AR signals (***p&lt;0.001, ANOVA). (I) Representative IB showing amounts of the GST fusion proteins that were added in (F), as detected by anti-GST antibodies.</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_2-A</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Titration of fluorescence polarization of FITC-peptides (100 nM) spanning α11.2 aa 1906-1959 with purified MBP-β2AR C-terminus. Kd value was obtained by fitting a non-linear direct binding curve to Pep2.</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_2-B-C-D</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 2-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(B) IP of β2AR in the absence (Control) or presence of 10 μM peptides, as indicated. Pep2 specifically displaced α11.2 (top of IB) but not GluA1 (middle, same IB) from β2AR (bottom, same IB). Use of non-specific IgG (left lane) indicates specificity of coIPs. (C, D). For quantification, α11.2 and GluA1IB signals were normalized to β2AR signals (***p&lt;0.001, ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_2-E-F</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 2-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E) IP of β2AR in the absence (Control) or presence of 10 μM Pep2 or Pep2 with S1928 being phosphorylated (phPep2), which did not displaced α11.2. (F) α11.2 and GluA1IB signals were normalized to β2AR signals (***p&lt;0.001, ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_3-A-B-C-G-H-I</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 3-A-B-C-G-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B-C-G-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>Forebrain slices from WT (A-F) and S1928A KI mice (G-L) were treated with vehicle (water) or 10 M isoproterenol (ISO) for 0.5 - 10 min before solubilization, ultracentrifugation, IP of α11.2 (A-C, G-I) or β2AR (D-F, J-L), and sequential IB for pS1928, pS1700, and α11.2, for GluA1, or for β2AR, of corresponding regions of the blots, as indicated. All the α11.2IPs in A-C and G-I were from the same samples (which were split in half for parallel IP) as the β2ARIPs in D-F and J-L, respectively (for quantification of coIP of β2AR with α11.2 see Figure EV1F,G). (A-F) In WT, the time-dependent increase in S1928 and S1700 phosphorylation (A-C) paralleled the decrease in coIP of β2AR with α11.2 (A bottom, Figure EV1F) and of α11.2 with β2AR (D-F). (G-L) In S1928A KI mice, ISO induced S1700 phosphorylation (G,I) but did not disrupt the α11.2 - β2AR interaction (G bottom, J-L, Figure EV1G). (B,C,H,I) For quantification of α11.2 phosphorylation, pS1928 and pS1700 signals were normalized to α11.2 (**p&lt;0.01, ***p&lt;0.001, ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_3-D-E-F-J-K-L</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 3-D-E-F-J-K-L</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D-E-F-J-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>Forebrain slices from WT (A-F) and S1928A KI mice (G-L) were treated with vehicle (water) or 10 M isoproterenol (ISO) for 0.5 - 10 min before solubilization, ultracentrifugation, IP of α11.2 (A-C, G-I) or β2AR (D-F, J-L), and sequential IB for pS1928, pS1700, and α11.2, for GluA1, or for β2AR, of corresponding regions of the blots, as indicated. All the α11.2IPs in A-C and G-I were from the same samples (which were split in half for parallel IP) as the β2ARIPs in D-F and J-L, respectively (for quantification of coIP of β2AR with α11.2 see Figure EV1F,G). (A-F) In WT, the time-dependent increase in S1928 and S1700 phosphorylation (A-C) paralleled the decrease in coIP of β2AR with α11.2 (A bottom, Figure EV1F) and of α11.2 with β2AR (D-F). (G-L) In S1928A KI mice, ISO induced S1700 phosphorylation (G,I) but did not disrupt the α11.2 - β2AR interaction (G bottom, J-L, Figure EV1G). (B,C,H,I) For quantification of α11.2 phosphorylation, pS1928 and pS1700 signals were normalized to α11.2 (**p&lt;0.01, ***p&lt;0.001, ANOVA). (E,F,K,L) For quantification of coIP, α11.2 and GluA1 signals were normalized to β2AR (***p&lt;0.001, One Way ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_4-A-B-C</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 4-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Hippocampal cultures were transfected with FLAG-β2AR and α11.2-HA at 6 days in vitro (DIV), treated with vehicle (water) or 1 M isoproterenol (ISO) for 5 min at 18 DIV, fixed and surface labeled for HA and FLAG. (A,B) Representative immunofluorescence microscopy images obtained by wide-field microscopy at lower and higher resolutions (scale bar in A is 5 m). (C) Quantification of distance between centers of HA and FLAG puncta (**p&lt;0.001, Mann-Whitney Rank Sum Test).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_5-A-B-C</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 5-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Forebrain slices from WT mice were treated with vehicle (water; lanes 1,5; numbers on bottom) or 10 M ISO for 5 min, followed, if indicated, by 1, 3, or 20 min wash out of ISO (lanes 3-7) and a second application of ISO for 5 min (lane 6), before solubilization and ultracentrifugation. (A) β2AR was IPed before IB for α11.2 (top part of IB), GluA1 (middle part of IB), and β2AR (bottom part of IB), as indicated. (B,C) For quantification, α11.2 and GluA1IB signals were normalized to β2AR (**p&lt;0.01, ANOVA). ISO-induced displacement of the β2AR from α11.2 (A, lanes 2-6) lasted at least 3 min but not 20 min (compare lanes 6 and 7).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_5-D-H</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 5-D-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D-H</infon>
    <passage>
      <offset>0</offset>
      <text>Forebrain slices from WT mice were treated with vehicle (water; lanes 1,5; numbers on bottom) or 10 M ISO for 5 min, followed, if indicated, by 1, 3, or 20 min wash out of ISO (lanes 3-7) and a second application of ISO for 5 min (lane 6), before solubilization and ultracentrifugation. (D) α11.2 and GluA1 were concurrently IPed from same samples as in (A) by simultaneous addition of anti-α11.2 and -GluA1 antibodies before probing and stripping/re-probing upper part of IB for pS1928, pS1700, and total α11.2 (top three panels) and middle part for pS845, pS831, and total GluA1 (bottom three panels). (E-H) For quantification, pS1928 and pS1700 IB signals were normalized to total α11.2 and pS845 and pS831 signals to total GluA1 (**p&lt;0.01, ANOVA). ISO-induced displacement of the β2AR from α11.2 (see A) rendered α11.2 (but not GluA1) refractory to re-phosphorylation of S1928 and S1700 upon a second ISO application of α11.2 (D, compare lanes 5 and 6).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_6-A-E</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 6-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>Forebrain slices from S1928A KI mice were treated with vehicle (lanes 1,5) or 10 M ISO for 5 min, followed, if indicated, by 1, 3, or 20 min wash out of ISO (lanes 3-7) and a second application of ISO for 5 min (lane 6), before solubilization and ultracentrifugation. (A) α11.2 and GluA1 were concurrently IPed from same samples by simultaneous addition of anti-α11.2 and -GluA1 antibodies before probing and stripping/re-probing upper part of IB for pS1928, pS1700, and total α11.2 and middle part for pS845, pS831, and total GluA1. In S1928A KI mice, S1700 re-phosphorylation after a 3 min wash out of ISO was not blunted (lane 6) in contrast to WT mice but rather augmented (compare to lane 5). (B-E) For quantification, pS1928 (virtually absent) and pS1700 IB signals were normalized to total α11.2 and pS845 and pS831 signals to total GluA1 (**p&lt;0.01, ***p&lt;0.001, ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_7-A</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative single channel recordings from hippocampal neurons at 7-14 DIV with 500 nM BayK-8644, 1 µM ω-conotoxin GVIA, and 1 µM MVIIC in patch pipette upon depolarization from -80 to -30, -20, -10, and 0 mV. The right panel depicts the single-channel current-voltage relationship. Mean amplitude of unitary currents for different membrane potential studied are -2.07 pA (-30 mV), -1.75 (-20 mV), -1.53 (-10 mV) and -1.25 (0 mV; n=5 patches per test potential). Solid line represents best-fit of data using a linear equation (R2=0.92) revealing a slope conductance for these channels of 27 ± 2 pS.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">243</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="50" length="19"/>
        <text>hippocampal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_7-B-C-D</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 7-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(B-D) Representative single channel traces and summary plot upon depolarization from -80 to 0 mV under control conditions and in the presence of ISO in the patch pipette. Cultures were pre-incubated for 15 min with 10 M 11R-PKI if indicated. The patch pipette contained either vehicle for control, nifedipine (nif; 1M), ISO (1M), or ISO plus nifedipine, which blocked all currents. The ISO-induced increase in NPo was prevented by 11R-PKI.</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_7-E-H</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 7-E-H</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E-H</infon>
    <passage>
      <offset>0</offset>
      <text>(E-H) Representative single channel currents upon depolarization from -80 to 0 mV and summary plot after pretreatment of whole cultures with ISO. Cultures were pre-incubated with vehicle (H2O, mock wash, E) or 1 M ISO for 5 min (F,G) and washed for 3 (E,F) or 10 min (G) before forming the cell-attached patch with ISO present in the patch pipette. The upregulation of NPo to ~0.4 (cf. C,D) occurred only if neurons were pretreated with vehicle instead of ISO (E,H; mock wash) or if ISO wash out duration was 10 min (G,H) but not if wash out was only 3 min (F,H).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">263</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="408" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_8-A-B-C</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 8-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-F) Forebrain slices were pre-incubated for 30 min with vehicle (water) or 10 μM Myr-Pep2 or Myr-DSPL. Like Myr-DSPL (Joiner et al., 2010), Pep2 was myristoylated at its N terminus (Myr-Pep2) to make it membrane permeant. Slices were then treated with ISO (10 M, 5 min) or vehicle (water) before solubilization, ultracentrifugation, and IP of β2AR (A-C) or simultaneously α11.2 and GluA1 with a combination of corresponding antibodies within same samples (D-F). (A) Myr-Pep 2 displaced α11.2 (lane 5 vs. 3, top of blot) but not GluA1 (middle, same blot) from β2AR (bottom, same blot); the inverse was true for Myr-DSPL (lane 1 vs. 3). (B,C) For quantification, α11.2 and GluA1 immunosignals were normalized to β2AR signals (**p&lt;0.01, ***p&lt;0.001, One Way ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_8-D-E-F</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 8-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(A-F) Forebrain slices were pre-incubated for 30 min with vehicle (water) or 10 μM Myr-Pep2 or Myr-DSPL. Like Myr-DSPL (Joiner et al., 2010), Pep2 was myristoylated at its N terminus (Myr-Pep2) to make it membrane permeant. Slices were then treated with ISO (10 M, 5 min) or vehicle (water) before solubilization, ultracentrifugation, and IP of β2AR (A-C) or simultaneously α11.2 and GluA1 with a combination of corresponding antibodies within same samples (D-F). (D) Myr-Pep2 blunted ISO-induced phosphorylation of α11.2 S1700 (lane 6 vs. 4, top of blot) but not GluA1 S845 (middle, same blot); the inverse was true for Myr-DSPL (lane 2 vs. 4). (E,F) For quantification, pS1700 and pS845 immunosignals were normalized to α11.2 and GluA1 signals, respectively (***p&lt;0.001, One Way ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_8-G-H</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 8-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_8-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Representative cell-attached recordings from hippocampal neurons as in Figure 7. In interleafed experiments cultures were pre-incubated for 30 min with 10 M Myr-Pep2 or scrambled Myr-Pep2 (Myr-Pep2scr). The patch pipette contained either vehicle (H2O; control) or 1 µM ISO. The ISO induced increase in NPo was prevented by Myr-Pep2 but not Myr-Pep2scr. Arrows indicate the 0-current level (i.e. closed channel). (H) Summary plot for (G). For statistical analysis, the NPo value was determined for each recording and pooled under each condition for comparison (n=10-12 patches; *p&lt;0.05, One Way ANOVA with Tukey post-hoc test).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">303</infon>
        <infon key="identifier">CL:0002608</infon>
        <location offset="49" length="19"/>
        <text>hippocampal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_9-A-F</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 9-A-F</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A-F</infon>
    <passage>
      <offset>0</offset>
      <text>Graphs depict fEPSP initial slopes recorded from hippocampal CA1 before and after either a 5Hz/3 min (A-C) or 100Hz/1sec tetanus (D-F). Arrowheads mark onset of tetani and bars perfusion with 1 µM ISO. Inserts show sample traces immediately before (left) and ~30 min after (right) tetani. (A-C) Litter-matched WT but not conditional Cav1.2 KO mice showed PTT-LTP (**p &lt; 0.001, one-way ANOVA). (D-F) WT as well as Cav1.2 KO mice showed NMDAR-dependent 100 Hz LTP.</text>
    </passage>
  </document>
  <document>
    <id>4910527 Figure_9-G-H-I</id>
    <infon key="sourcedata_document">1645</infon>
    <infon key="doi">10.15252/embj.201593409</infon>
    <infon key="pmc_id">4910527</infon>
    <infon key="figure">Figure 9-G-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_9-G-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>Graphs depict fEPSP initial slopes recorded from hippocampal CA1 before and after either a 5Hz/3 min (A-C, G-I) or 100Hz/1sec tetanus (D-F). Arrowheads mark onset of tetani and bars perfusion with 1 µM ISO and 10 µM of Myr-Pep2 or Myr-Pep2scr. Inserts show sample traces immediately before (left) and ~30 min after (right) tetani.(G-I) Myr-Pep2 but not Myr-Pep2scr blocked PTT-LTP (**p &lt; 0.001, one-way ANOVA).</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_1-A</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Silver staining of proteins extracted from N2Amouse neuronal cells expressing Flag-HA-tagged C9ORF72 and captured through consecutive anti-Flag and anti-HA affinity purification steps.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_1-B</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunoblot analysis of HA-immunoprecipitated proteins and lysate of HEK293 cells co-expressing HA-tagged C9ORF72 and/ or Flag-tagged SMCR8 and/or Flag-tagged WDR41.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_1-C</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Coomassie blue staining of Nickel-NTA affinity purification of HIS-C9ORF72, SMCR8 and WDR41 co-expressed in baculovirus infected insect cells.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_1-D</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblot analysis of HA-immunoprecipitated proteins and lysate of HEK293 cells co-expressing HA-tagged C9ORF72 and HA-tagged SMCR8 with various Flag-tagged Rab GTPases.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_1-E</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Immunoblot against endogenous C9orf72, Wdr41, Rab8a, Rab39b, Rab5 and Rab7 of control (IgG alone) or endogenous Smcr8immunoprecipitated from adult mousebrain.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_1-F</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F)αP32-radiolabelled GDP release from GST-tagged purified RAB8a as a function of increased concentration of either recombinant purified C9ORF72 alone or in complex with SMCR8 and WDR41.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_1-G</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Identical GDP release assay as in (F) but using recombinant purified GST-tagged RAB39b instead of RAB8a. Error bars indicate s.e.m. Experiments were repeated 3 times (n=3).</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_2-A</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Left panel, representative images of organotypic cultures of E18 mouse cortical neurons transfected with GFP-RFP-LC3B and transduced with lentivirus expressing either control shRNA or shRNA targeting C9orf72 mRNA and treated or not with Torin. Right panel, quantification of LC3Bpuncta.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="75" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_2-B</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Upper panel, immunoblot analysis of endogenous LC3B (Map1lc3b), C9orf72 and control Actin of E18 mouse cortical neurons transduced with lentivirus expressing either control shRNA or shRNA targeting C9orf72 mRNA and treated or not with Torin. Lower panel, real time RT-qPCR quantification of endogenous C9orf72 mRNA expression relative to Rplp0 mRNA.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">97</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="107" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_2-C</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Left panel, representative images of immunofluorescence labeling of endogenous P62 (Sqstm1) on organotypic cultures of E18 mouse cortical neurons transduced with lentiviral particles expressing either control shRNA or shRNA targeting C9orf72. Right panel, quantification of P62 aggregates.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">111</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="133" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_2-D</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Left panel, representative images of immunofluorescence labeling of transfected constructs (Green) and endogenous P62 (Sqstm1, red) on GT1-7neuronal cells transfected with siRNA targeting C9orf72 and plasmids expressing control GFP, HA tagged wild type or mutant RAB39b (CA, Q68L or CN, S22N), RAB8a or RAB7. Right panel, quantification of P62 aggregates. Scale bars, 10 µm. Nuclei were counterstained with DAPI. Error bars indicate s.e.m. Student T-test, * indicates p&lt;0.05, *** indicates p&lt;0.001. n=3.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_3-A</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis of HA-immunoprecipitated proteins and lysate of HEK293 cells co-expressing HA-tagged C9ORF72 and HA-tagged SMCR8 with Flag-tagged TBK1, NAP1, TANK or SINTBAD.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_3-B</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) ImmunoprecipitatedHA-tagged C9ORF72, HA-tagged SMCR8 and HA-tagged WDR41 expressed in HEK293 were subjected to in vitro TBK1 kinase assay in the presence of γP32-radiolabelled ATP. Proteins were separated by SDS page migration and phosphorylation was detected by autoradiography (upper panel), while expression was detected by western blotting (lower panel).</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_3-C</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Mass spectrometry identification of SMCR8 phosphorylation sites by in vitro TBK1 kinase assay of HIS-tagged C9ORF72:SMCR8:WDR41 complex purified from baculovirus infected insect cells.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_3-D</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Left panel, representative images of immunofluorescence labeling of transfected constructs (Green) and endogenous P62 (Sqstm1, red) on GT1-7 neuronal cells transfected with siRNA targeting the 3'UTR of Smcr8 mRNA and plasmids expressing control GFP, HA tagged wild type or mutant SMCR8 (TA, S402A and T796A; TD, S402D and T796D; UD, S400D, S492D, S562D and T666D). Right panel, quantification of P62 aggregates.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_3-E</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Left panel, representative images of immunofluorescence labeling of transfected constructs (Green) and endogenous P62 (Sqstm1, red) on GT1-7 neuronal cells transfected with siRNA targeting Tbk1 and plasmids expressing control GFP, HA tagged wild type or mutant SMCR8 or RAB39b. Right panel, quantification of P62 aggregates. Scale bars, 10 µm. Nuclei were counterstained with DAPI. Error bars indicate s.e.m. Student T-test, * indicates p&lt;0.05, *** indicates p&lt;0.001. n=3.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_4-A</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunoblot analysis of endogenous Tdp-43, C9orf72 and control Gapdh of E18 mousecortical neurons transduced with lentivirus expressing either control shRNA or shRNA targeting C9orf72 mRNA.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">207</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="84" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_4-B</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Left panel, representative images of immunofluorescence labeling of endogenous phosphorylated Ser409/410-Tdp-43 on primary cultures of E18 mousecortical neurons transduced with lentiviral particles expressing either control shRNA or shRNA targeting C9orf72. Right panel, quantification of cytoplasmic Tdp-43 aggregates.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">215</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="148" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_4-C</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Left panel, representative images of immunofluorescence labeling of D169G mutant GFP-tagged TDP-43 on primary cultures of E18 mousecortical neurons transfected with either HA-tagged control or HA-C9ORF72 plasmid. Right panel, quantification of cells with cytoplasmic aggregates of TDP-43. Scale bars, 10 µm. Nuclei were counterstained with DAPI. Error bars indicate s.e.m. Student T-test, *** indicates p&lt;0.001. n=3.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">219</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="135" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_5-A</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Left panel, representative images of organotypic cultures of E18 mousecortical neurons co-transfected with HA-tagged ATXN2 with control (Q22x) or intermediate (Q30x) polyQ size and transduced with lentivirus expressing either control shRNA or shRNA targeting C9orf72 mRNA. Right panel, quantification of ATXN2 aggregates. Scale bars, 10 µm. Nuclei were counterstained with DAPI.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">239</infon>
        <infon key="identifier">CL:0002609</infon>
        <location offset="74" length="16"/>
        <text>cortical neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_5-B</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Cell viability (tetrazolium assay) of GT1-7 neuronal cells co-transfected with HA-tagged ATXN2 with control (Q22x) or intermediate (Q30x) polyQ size and control siRNA or siRNA targeting C9orf72 mRNA. Error bars indicate s.e.m. Student T-test, *** indicates p&lt;0.001. n=3.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_5-C-D-E-F</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 5-C-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Tracing of the swimming trajectories of 48 hours post-fertilization zebrafishlarvae following light touch. (D-F) Quantification of the touch-evoked swimming distance (D), average velocity (E), and maximum velocity attained (F) shows significant functional impairment of the zebrafish injected with HA-tagged ATXN2 with intermediate length of polyQ (Q30x) and antisense morpholino oligonucleotides (AMOs) against C9orf72 compared to control HA-tagged ATXN2 (Q22x) or to the sole injection of AMO against C9orf72.</text>
    </passage>
  </document>
  <document>
    <id>4910533 Figure_5-G-H</id>
    <infon key="sourcedata_document">1612</infon>
    <infon key="doi">10.15252/embj.201593350</infon>
    <infon key="pmc_id">4910533</infon>
    <infon key="figure">Figure 5-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Representative images of motor neurons visualized with anti-Sv2immunohistochemistry show severe axonopathy in fish injected with both ATXN2 Q30x and AMO against C9orf72 compared to zebrafish injected with control ATXN2 Q22x or with AMO against C9orf72 alone. (H) Quantification of the motor neuronaxonal length demonstrates a significant decrease of axonal length in 48 hours post-fertilization zebrafishlarvae injected with both ATXN2 Q30x and AMO against C9orf72 compared to controls. Error bars indicate s.e.m. One-way ANOVA, ** indicates p&lt;0.01. n=3.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">258</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="29" length="13"/>
        <text>motor neurons</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">263</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="289" length="12"/>
        <text>motor neuron</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_1-A</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) THP1 cells were infected with the shown strains of HSV-1 (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_1-B</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) THP1 cells were treated with 0.1 μg/ml of acyclovir (ACV) and infected with the KOS HSV-1 and F HSV-1 strains (MOI 3). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_1-C</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) THP1 cells were treated with infectious or UV-inactivated HSV-1 (KOS). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_1-D</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) MDMs were infected with ICP0-deficient or revertant HSV-1 (KOS), MOI 3. Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">35</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="4" length="4"/>
        <text>MDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_1-E</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) THP1-derived cells deficient for cGAS or STING were infected with the shown strains of HSV-1 (MOI 3) or stimulated with poly(I:C) (2 µg/ml). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_2-A</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) MDMs were infected for 18 h with HSV-1 (KOS), MOI 1. Cytosolic viral proteins were detected by mass spectrometry using iTRAQ-labeling. Identified viral proteins are shown.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">57</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="4" length="4"/>
        <text>MDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_2-B</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) MDMs were infected with the KOS or F strains of HSV-1 (MOI 3). Cell lysates were harvested 12 hpi, and levels of ICP27 and β-actin were determined by Western blotting.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">79</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="4" length="4"/>
        <text>MDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_2-C</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) HFFs and MDMs were infected with HSV-1 (KOS) MOI 0.1 and 1.0. Culture medium was replaced 3 hpi, and isolated 24 hpi for viral plaque assay. Data are presented as means of triplicates +/- st.dev.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="13" length="4"/>
        <text>MDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_2-D</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) THP1 cells were infected with the indicated strains of HSV-1 (MOI 3) for 12 hrs. Cell lysates were isolated and levels of ICP27 and β-actin were determined by Western blotting.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_3-A</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) THP1 cells were infected with HSV-1 KOS or an ICP27-deficient mutant (ΔICP27) on KOS genetic background (MOI 3). Supernatants were harvested from untreated cultures or cells infected for 12 or 18 hours for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_3-B</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) MDMs were infected with HSV-1 KOS or ΔICP27 (MOI 3). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <infon key="identifier">CL:0000235</infon>
        <location offset="4" length="4"/>
        <text>MDMs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_3-C</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) THP1-derived cells deficient for cGAS or STING were infected with HSV-1 KOS or ΔICP27 (MOI 3). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_3-D</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) HEK293T cells were transfected with 12 ng STING plasmid DNA, 5 or 25 ng ICP27 plasmid DNA, and reporter gene constructs as indicated (2x104 cells per well). Reporter gene activity was measured in lysates isolated 24 h post transfection.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_3-E</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) THP1 cells were infected with HSV-1 KOS or ΔICP27 (MOI 3) in the presence or absence of acyclovir (ACV). Supernatants were isolated 18 hpi for measurement of type I IFN bioactivity</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_4-A</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) THP1 cells were infected with HSV-1 KOS or ΔICP27 (MOI 3). Cytoplasmic and nuclear extracts were isolated at the indicated time points post infection, and levels of ICP27, RCC1, and GAPDH were determined by Western blotting.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_4-B</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) THP1 cells were infected with HSV-1 KOS or ΔICP27 (MOI 10). The cells were fixed at the indicated time points post infection, and stained with DAPI and an antibody against ICP27, and visualized by confocal microscopy. Scale bar 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_4-C-D</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C, D) THP1 cells were infected with HSV-1 KOS, ΔICP27 or HSV-1 ΔNLS. The localization of the major NLS is illustrated in panel C. Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_4-E-F</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E, F) THP1 cells were infected with HSV-1 KOS or ΔICP27 (MOI 3). Cytoplasmic (E) and nuclear extracts (F) were isolated at the indicated time points post infection. Western blotting was used to determine levels of phospho- and total TBK1 were determined in the cytoplasmic fractions and levels of phospho-IRF3 and RCC1 in the nuclear fractions.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_4-G</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G-I) HEK293T cells were (G) transfected with STING, TBK1, IRF3-5D, and ICP27, together with the reporter gene constructs indicated. Reporter gene activity was measured 24 h post transfection.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_4-H</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>(G-I) HEK293T cells were ((H) transfected with STING and stimulated for 16 h with cGAMP (4 μg/ml) together with the reporter gene constructs indicated. Reporter gene activity was measured 24 h post transfection.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_4-I</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 4-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I</infon>
    <passage>
      <offset>0</offset>
      <text>(G-I) HEK293T cells were (I) transfected with TRIF, MAVS, STING, and ICP27, together with the reporter gene constructs indicated. Reporter gene activity was measured 24 h post transfection.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-A</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Lysates from THP1 cells infected with HSV-1 KOS (MOI 10) were subjected to immunoprecipitation using an anti-STING antibody, and the presence of TBK1, STING, and ICP27 in the precipitates was detected by Western blotting.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-B</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) THP1 cells were infected with HSV-1 KOS (MOI 10) for 6 and 8 h. The cells were fixed and stained with DAPI and anti-ICP27 together with anti-pTBK1 (B). The stainings were visualized by confocal microscopy. Arrowheads, colocalizations between ICP27 and pTBK1. Scale bar 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-C</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) THP1 cells were infected with HSV-1 KOS (MOI 10) for 6 and 8 h. The cells were fixed and stained with DAPI and anti-ICP27 together with anti-STING (C). The stainings were visualized by confocal microscopy. Arrowheads, colocalizations between ICP27 and STING. Scale bar 10 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-D</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) TBK1 was immunoprecipitated from whole cell lysates from HEK293T cells transfected with ICP27 and each of the adaptor proteins TRIF, MAVS, and STING. The precipitates were immunoblotted for TBK1, ICP27, and STING.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-E</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) THP1 control and STING KO cells were infected with HSV-1 KOS (MOI 10) for 6 and 8 h and total lysates were generated. TBK1 was immunoprecipitated, and subjected to Western blotting using antibodies against ICP27, phospho-TBK1 (pTBK1), and TBK1.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-F</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) THP1 control and TBK1 KO cells were infected with HSV-1 KOS (MOI 10) for 8 h and total lysates were generated. STING was immunoprecipitated, and subjected to Western blotting using antibodies against ICP27 and STING.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-G</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) THP1 cells were infected with HSV-1 KOS (MOI 10) for 8 h in the presence or absence of the TBK1 inhibitor BX795 (BX, 200 nM). Total lysates were generated and STING was immunoprecipitated, and subjected to Western blotting using antibodies against ICP27 and STING.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-H</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) THP1 cells were infected with HSV-1 KOS (MOI 10) for 6 and 8 h and total lysates were generated. Phospho-TBK1 was immunoprecipitated, and subjected to Western blotting using antibodies against ICP27 and total TBK1.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_5-I</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>(I) TBK1 was immunoprecipitated from whole cell lysates from HEK293T cells transfected with ICP27 and STING (either WT or S366A). The precipitates were immunoblotted for TBK1, ICP27, and STING.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_6-C</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) THP1 cells were infected with HSV-1 (KOS), HSV-2 (HG52), HSV-1 ΔICP27, or HSV-1 ΔICP27 rescued with HSV-2ICP27 (MOI 3). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_6-D</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) RAW264.7 cells were infected with HSV-1 (KOS), PRV (vBecker3) and the corresponding mutants lacking ICP27 (UL54 in the case of PRV). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_6-F</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) THP1 cells were infected with HSV-1 (KOS), ΔRGG, or ΔICP27 (MOI 3). Supernatants were harvested 18 hpi for measurement of type I IFN bioactivity. ICP27 expression in the infected cells was determined by Western blotting.</text>
    </passage>
  </document>
  <document>
    <id>4931188 Figure_6-G</id>
    <infon key="sourcedata_document">1906</infon>
    <infon key="doi">10.15252/embj.201593458</infon>
    <infon key="pmc_id">4931188</infon>
    <infon key="figure">Figure 6-G</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) THP1 cells were infected with HSV-1 KOS or HSV-1 ΔRGG (MOI 10) for 8 h and total lysates were generated. STING was immunoprecipitated, and subjected to Western blotting using antibodies against ICP27 and STING.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_1-B</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>b) Histograms of GFP expression (x-axis) are presented from A549 cells transduced with the different viral vectors.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_1-C</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>c) Percentage of GFP positive cells from the experiment described in (b).</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_1-D</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>. d) A PCR assay along with primers, as illustrated in Appendix Figure S2a, was used to detect formation of LTR junction and thereby circularization of the vector. The expected size of PCR product is 552 bp from a 1-LTR circle and 1029 bp from a 2-LTR circle.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_1-E</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>. e) Southern Blot analysis to detect integration events in LV- and NILV-S/MAR-transduced single cell clones with DNA probed against the viral genome. A 6.8 kb positive control from a linearized plasmid (lane 3) was included for indication of the size of DNA circles formed by non-integrated NILV-S/MAR vector.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_1-F-G-H</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 1-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>f-h) A padlock probe assay, as illustrated in Appendix Figure S4, was used to demonstrate persistence of proviral DNA either in a circular or integrated form. Representative images show DNA persistence in (f) LV-, (g) NILV- or (h) NILV-S/MAR-transduced cells. Each red dot (Cy3) represents a single DNA molecule and cell nuclei were stained with Hoechst 33342.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_2-C</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>c) Flow cytometry histograms of RFP expression (x-axis) of A549/RFP+Luc+ cells at day 20 and 27 after NILV-S/MAR(GFP, shNT) or NILV-S/MAR(GFP, shRFP) transduction.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_2-D</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>d) Luciferase activity of the A549/RFP+Luc+ cells at day 20 and day 44 after NILV-S/MAR(GFP, shNT)- or NILV-S/MAR(GFP, shRFP)-transduction.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_2-E-F-G-H</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 2-E-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>e-h) Representative fluorescence microscopy images show the expression of RFP from either NILV-S/MAR-transduced or un-transduced A549/RFP+Luc+ cells with cell nuclei stained with Hoechst 33342 (blue). RFP signal (orange) were collected with a fixed exposure time (300 ms) for equal comparison.</text>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_3-C-D-E-F-G-H</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 3-C-D-E-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C-D-E-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>c) Percentage of CD19CAR expression on CD3+ T cells from each independent donor. d) Histograms of CD19CAR expression on T cells form one representative donor before and after expansion. e) CD107a expression on transduced T cells (CD3+) after exposure to CD19+ target cells (Daudi) for 24 h (n=6). f) IFN-γ production in the supernatant was analyzed by ELISA after 24 h of exposure of transduced T cells to target cells (n=6). g) Relative viability of target cells (CD19+ Daudi), as an indication of T cellkilling efficacy, were measured at different effector T cell to target cell ratio (E:T ratio) and normalized to the signal from target cells alone (n=6). h) Transduced T cells were labeled with a fluorescent cell membrane dye and co-cultured with CD19+ Daudi cells for 4 days. Dye dilution upon T cell division was monitored by flow cytometry and representative histograms are shown.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">63</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="44" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">15</infon>
        <infon key="sourcedata_article_annot_id">66</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="120" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">67</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="221" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">23</infon>
        <infon key="sourcedata_article_annot_id">73</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="395" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">58</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="499" length="6"/>
        <text>T cell</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">59</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="559" length="6"/>
        <text>T cell</text>
      </annotation>
      <annotation id="22">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">26</infon>
        <infon key="sourcedata_article_annot_id">77</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="673" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">61</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="800" length="6"/>
        <text>T cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_3-I-J-K-L-M</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 3-I-J-K-L-M</infon>
    <infon key="sourcedata_figure_dir">Figure_3-I-J-K-L-M</infon>
    <passage>
      <offset>0</offset>
      <text>i-m) Mice were treated by intravenous injection of NILV-S/MAR(Mock), LV(CD19CAR) and NILV-S/MAR(CD19CAR)-transduced T cells (8x106 cells/injection) at days 18, 21, 24 after tumor implantation. Tumorgrowth was monitored by caliper measurements. i-k) Tumor volume of individual mice in each treatment groups are presented. l) The average tumor volume of each treatment group is presented and the values on day 37 were statistically compared (n=12 in LV group, n=9 in NILV-S/MAR group and n=11 in Mock control group). m) The survival of mice is shown as Kaplan-Meier curves.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">87</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="116" length="7"/>
        <text>T cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931286 Figure_3-N-O-P-Q</id>
    <infon key="sourcedata_document">1804</infon>
    <infon key="doi">10.15252/emmm.201505869</infon>
    <infon key="pmc_id">4931286</infon>
    <infon key="figure">Figure 3-N-O-P-Q</infon>
    <infon key="sourcedata_figure_dir">Figure_3-N-O-P-Q</infon>
    <passage>
      <offset>0</offset>
      <text>n-p) Representative images showing infiltration of adoptively transferred human T cells into tumors. T cells were visualized by staining for human CD3 (red) and nucleus (blue). q) Quantification of CD3+ T cells from each treatment group is presented (n=5).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="80" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="101" length="7"/>
        <text>T cells</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">110</infon>
        <infon key="identifier">CL:0000084</infon>
        <location offset="203" length="7"/>
        <text>T cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_1-A-B</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) qRT-PCR analysis of TGF ligands, TGF receptors, and TGF target expression in control and FRS2 knockdown HASMCs. (NS: not significant compared to control, *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001 compared to control; unpaired two-tailed Student's t test). -actin was used for sample loading normalization. Histogram of qRT-PCR results are representative of three independent experiments.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">3</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="110" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_1-C</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Left: Immunoblot analysis of TGFRs, phosphorylated Smad2 (p-Smad2), and phosphorylated Smad3 (p-Smad3) in control and FRS2 knockdown HASMCs. Blots are representative of four independent experiments. Right: Band intensities of p-Smad2, p-Smad3, TGFR1, and TGFR2 were normalized to Smad2/3 or GAPDH and expressed as a fraction of a control value. Results are expressed as means ± SD (*p&lt;0.05; ***p&lt;0.001 compared to control; unpaired two-tailed Student's t test).</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">26</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="137" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_2-A</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Left: Immunoblot analysis of smooth muscle marker gene expression in control and FRS2 knockdown HASMCs. Blots are representative of four independent experiments. Right: Band intensities of SM -actin, SM22, and SM-calponin were normalized to -tubulin and expressed as a fraction of a control value. Results are expressed as means ± SD (**p&lt;0.01; ***p&lt;0.001 compared to control; unpaired two-tailed Student's t test).</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">38</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="100" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_2-B</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) qRT-PCR analysis of SMC transcription factor gene expression in control and FRS2 knockdown HASMCs. (*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001 compared to control; unpaired two-tailed Student's t test. N=3). -actin was used for sample loading normalization.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">295</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="24" length="3"/>
        <text>SMC</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">46</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="95" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_2-C</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Collagengel contraction assays were used to determine the contractile ability of control or FRS2 knockdown HASMCs (*p&lt;0.05 compared to control; unpaired two-tailed Student's t test. N=3).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">55</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="111" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_2-D-E-F</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 2-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(D-F) Upper panels: Immunoblots of smooth muscle markers, phosphorylated Smad2 (p-Smad2), and TGFR1 expression in control and FRS2 knockdown HASMCs treated with SB431542 (10 m), TGFR2 or Smad2 shRNA lentiviruses. Blots are representative of three independent experiments. Bottom panels: Band intensities of SM-calponin and p-Smad2 were normalized to -tubulin, HSP90, or Smad2 and expressed as a fraction of a control value.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">66</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="141" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_3-A</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Quantitative real-time PCR analysis of mature let-7 family in control and FRS2 knockdown HASMCs. SNORD47 was used to normalize the variability in template loading. Histogram of qRT-PCR results are three independent experiments.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">79</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="93" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_3-B</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Upper panel: Immunoblots of SM-calponin, phosphorylated Smad2 (p-Smad2), and TGFR1 expression in control and FRS2 knockdown HASMCs transduced with or without let-7b lentiviruses. Blots are representative of three independent experiments. Bottom panels: Band intensities of SM-calponin and p-Smad2 were normalized to GAPDH or Smad2 and expressed as a fraction of a control value.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">87</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="128" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_3-C</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Phase-contrast and immunofluorescencestaining of smooth muscle markers (red) in HASMCs. Nuclei were counterstained with DAPI (blue). Scale bar: 12 m. Images are representative of three independent experiments.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">98</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="84" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_3-D</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) HASMCs were cultured in the growth medium (M231 + SMGS) at day 0 then switched from growth conditions to differentiation medium (M231 + SMDS) for 8 days. Quantitative real-time PCR analysis of mature let-7 family in HASMCs. SNORD47 was used to normalize the variability in template loading. Histogram of qRT-PCR results are three independent experiments.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="4" length="6"/>
        <text>HASMCs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">110</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="220" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_3-E</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Control and FRS2 knockdown HASMCs were cultured in the growth medium (M231 + SMGS) at day 0 then switched from growth conditions to differentiation medium (M231 + SMDS) for 6 days with or without let-7b lentiviruses. Immunoblots of smooth muscle markers, phosphorylated Smad2 (p-Smad2), and TGFR1 expression in control and FRS2 knockdown HASMCs with or without let-7b lentiviruses. Blots are representative of three independent experiments.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">117</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="31" length="6"/>
        <text>HASMCs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">125</infon>
        <infon key="identifier">CL:0002539</infon>
        <location offset="342" length="6"/>
        <text>HASMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_4-A</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Coronary arteries dissected from the humanheart. Left main (LM), left anterior descending (LAD), and left circumflex (LCX) branches. Scale bar: 1 cm.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_4-B</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Elastic-Van Gieson (EVG) staining of humancoronary arteries demonstrating various degrees of atherosclerosis.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_4-C-D</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C-D) Representative images of immunofluorescencestaining for CD31 (green) and SM -actin (red) or SM-MHC (red) in No/mild, moderate, and severe disease human left main coronary arteries. No: no-disease. Nuclei were stained with DAPI (blue). (b)&amp;(d)&amp;(f) are high-magnification view from (a)&amp;(c)&amp;(e). Images are representative of ten No/mild, nine moderate and ten severe disease human left main coronary artery samples. L: lumen. Scale bar: 16 m.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_4-E-G</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 4-E-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-G</infon>
    <passage>
      <offset>0</offset>
      <text>(E&amp;G) Representative images of immunofluorescencestaining for p-FGFR1 (red) or FGFR1 (red) in the same patient cohort. Nuclei were counter-stained with DAPI (blue). Scale bar: 16 m.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_4-F-H</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 4-F-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F-H</infon>
    <passage>
      <offset>0</offset>
      <text>(F&amp;H) Percentage of medial p-FGFR1+SMC and FGFR1+SMC (***p&lt;0.001 compared to No/mild disease, NS: not significant compared to No/mild disease; one-way ANOVA with Newman-Keuls post hoc test for multiple comparison correction).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="35" length="3"/>
        <text>SMC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">172</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="49" length="3"/>
        <text>SMC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_5-A</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>Figure 5. TGFβ signaling activity in smooth muscle cells in human left main coronary arteries with various degrees of atherosclerosis. (A&amp;C&amp;E) Representative images of immunofluorescencestaining for TGF (red), p-Smad2 (red), or p-Smad3 (red) from patients with No/mild, moderate, or severe disease. Nuclei were counter-stained with DAPI (blue). Scale bar: 16 m. (B&amp;D&amp;F) Medial TGF area and percentage of medial p-Smad2, and p-Smad3 positive SMCs (***p&lt;0.001 compared to No/mild disease; one-way ANOVA with Newman-Keuls post hoc test for multiple comparison correction). A full table of p-values for this figure is shown in Appendix Table S1.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">174</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="441" length="4"/>
        <text>SMCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_6-A</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Dissected mouseaorta demonstrating lipid-rich plaques in brachiocephalic artery after 4 months of high fat diet compared to the normal diet in Apoe-/- mice. (b) &amp; (d) Cross-section of brachiocephalic artery from (a) &amp; (c) stained with Oil Red O. L: lumen. Scale bar: 4 mm. 3 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_6-B</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Histological analysis of mouse normal artery or atherosclerotic plaque in brachiocephalic artery with anti-SM -actin, anti-Notch3, and anti-SM-MHC antibodies. Nuclei were counterstained with DAPI (blue). L: lumen. Scale bar: 62 m. 3 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_6-C-D-E-F</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 6-C-D-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C-D-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(C-F) Analysis of brachiocephalic artery of Apoe-/- mice maintained for 4 months on either normal or high fat diet using anti-CD31 (green), anti-p-FGFR1 (red), anti-FGFR1 (red), anti-p-Smad2 (red), and anti-p-Smad3 (red) antibodies. Nuclei counterstained with DAPI (blue). Scale bar: 62 m. L: lumen. M: Media. 6 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_6-G-H-I-J</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 6-G-H-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_6-G-H-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(G-J) Quantification of the number of medial smooth muscle cells expressing p-FGFR1, FGFR1, p-Smad2, and p-Smad3 (***p&lt;0.001 compared to ND, NS: not significant compared to ND; unpaired two-tailed Student's t test.). ND: Normal diet. HFD: High fat diet. A full table of p-values for this figure is shown in Appendix Table S1.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">228</infon>
        <infon key="identifier">CL:0000192</infon>
        <location offset="45" length="19"/>
        <text>smooth muscle cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_7-A</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Representative photomicrographs of Oil Red O-stained atherosclerotic lesions in the aortic arch, of Apoe-/- or Frs2SMCKO/Apoe-/- mice after 16 weeks of high fat diet. 3 mice per group. Scale bar: 5 mm.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_7-B</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) (Left) Microphotographs of aortas (en face) from Apoe-/- and Frs2SMCKO/Apoe-/- mice after 16 weeks of high fat diet after staining with Oil Red O. (Right) Lesion area quantification. All data shown as mean ± SD. (***p&lt;0.001 compared to Apoe-/-; unpaired two-tailed Student's t test). 12 mice per group.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_7-C-D</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C-D) Representative cross-sections of brachiocephalic arteriesApoe-/- and Frs2SMCKO/Apoe-/- mice stained with hematoxylin and eosin (H&amp;E) (C) and Movat (D). (b)&amp;(d) are high-magnification view from (a)&amp;(c). NC: necrotic core. Apoe-/- mice N=9, Frs2SMCKO/Apoe-/- mice N=12.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_7-E</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Histological analysis of atheosclerotic plaque with anti-Ki67 antibody. Nuclei were counterstained with DAPI (blue). (b)&amp;(d) are high-magnification images from (a)&amp;(c). Scale bar: 62 m (low-magnification images); 10 m (high-magnification images). Apoe-/-mice N=9, Frs2SMCKO/Apoe-/-mice N=12.</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_7-F</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 7-F</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Quantification of plaque cellularity; Apoe-/-mice N=9, Frs2SMCKO/Apoe-/-mice N=12 (***p&lt;0.001 compared to Apoe-/-; unpaired two-tailed Student's t test).</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_7-G</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 7-G</infon>
    <infon key="sourcedata_figure_dir">Figure_7-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Quantifications of the extent of fibrous cap and necrotic areas in brachiocephalic artery of Apoe-/- and Frs2SMCKO/Apoe-/-mice. (*p&lt;0.05, **p&lt;0.01 compared to Apoe-/-; unpaired two-tailed Student's t test).</text>
    </passage>
  </document>
  <document>
    <id>4931287 Figure_7-H</id>
    <infon key="sourcedata_document">1801</infon>
    <infon key="doi">10.15252/emmm.201506181</infon>
    <infon key="pmc_id">4931287</infon>
    <infon key="figure">Figure 7-H</infon>
    <infon key="sourcedata_figure_dir">Figure_7-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Measurement of Ki67+ cells (*p&lt;0.05, ***p&lt;0.001 compared to Apoe-/-; unpaired two-tailed Student's t test).</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_1-B</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HeLa cells were infected with x-light ShigellamCherry for 4 h 40 min for quantitative confocal microscopy. IPTG was added 30 min prior to fixation, and then samples were labelled with antibody for SEPT7. The scale bar represents 5 μm. Graph represents mean % ± SEM of Shigella responding to IPTG outside (-) or inside (+) SEPT7 cages from 4 independent experiments. Student's t-test, *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_1-C</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>CHeLa cells were infected with x-light ShigellamCherry for 4 h 40 min for quantitative confocal microscopy. IPTG was added 30 min prior to fixation, and then samples were labelled with antibody for p62. The scale bar represents 5 μm. Graph represents mean % ± SEM of Shigella responding to IPTG without (-) or with (+) p62 from at least 4 independent experiments. Student's t-test, *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_1-D</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Control (CTRL) or isopropanol-treated x-light Shigella GFP were induced with IPTG for 30 min, then labelled with SYTOX Orange for 10 min. The scale bar represents 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_1-E</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E HeLa cells were infected for 1 h 30 min, treated with ethanol (CTRL) or erythromycin (EM) for 2 h prior to fixation, and then labelled with antibody for SEPT7. Graph represents mean % ± SEM of Shigella in SEPT7 cages from 3 independent experiments. Student's t-test, *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_2-B</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HeLa cells stably expressing SEPT6-GFP were infected with S. flexneri AfaI for 4 h, harvested, and then tested with Co-IP. Empty vector and/or uninfected HeLa cells were used in parallel as control. GFP-trap magnetic agarose beads were used to isolate SEPT6-GFP from cells, and extracts were immunoblotted for SEPT6, GFP, SEPT7, or p62. The lysates were immunoblotted for GAPDH as control for cellular protein levels.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_3-A</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HeLa cells were labelled with MitoTracker Red CMXRos, treated with cytochalasin D for 30 min, then fixed and labelled for endogenous SEPT7 for confocal microscopy. The scale bar represents 0.5 μm. See also Fig EV3A.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_3-B</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HeLa cells were infected with S. flexneri for 4 h 40 min, labelled with MitoTracker Red CMXRos, fixed and labelled with antibody for endogenous SEPT7 for quantitative confocal microscopy. The scale bar represents 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_3-C</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C HeLa cells stably expressing SEPT6-GFP were transfected with Mito-BFP for 24 h, infected with Shigella-mCherry for 4 h 40 min, and processed for CLEM. SEPT6 is shown in green, mitochondria in red, and Shigella-mCherry in blue. Septin cages identified by fluorescent light microscopy (FLM) were processed for TEM. The right-most image is enlarged from the boxed region in the TEM image, and shows the bacterium (Sf) surrounded by a double membrane of autophagy (Au) and the mitochondrial membrane (Mt). The scale bar represents 1 μm. See also Fig EV3B.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_3-D</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D HeLa cells stably expressing SEPT6-GFP were transfected with Mito-BFP for 24 h, then infected with Shigella-mCherry for 2 h for live confocal microscopy. Time frame sequence shows a septin cage assembling around Shigella. Mitochondria (circle) support sites of septin ring assembly around the bacterium. Each frame was acquired every 2 min. The scale bar represents 1 μm. See also Movie EV1.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_3-E</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E HeLa cells were treated with control (CTRL), Drp1, or Mfn1 siRNA for 72 h. Whole cell lysates were immunoblotted for Drp1 or Mfn1 to show the efficiency of depletion. GAPDH was used as loading control. siRNA-treated cells were infected with S. flexneri for 4 h 40 min, then fixed for microscopy and stained for endogenous SEPT7 for quantitative confocal microscopy. Graph represents the mean % ± SEM of Shigella inside SEPT7 cages from at least 4 independent experiments per treatment. Student's t-test, ** = p &lt;0.01; *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_4-A</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HeLa cells expressing SEPT6-GFP were stained with MitoTracker Red CMXRos, and fixed for confocal microscopy. Inset image highlights location of septins at sites of mitochondrial fission. The scale bar represents 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_4-B</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HeLa cells were fixed and labelled with antibody against SEPT7 and secondary antibody coupled to HRP, and processed for TEM. The right image is enlarged from the boxed region in the TEM image, and shows a SEPT7 (S7) filament (labelled in black) intersecting with the mitochondrial (Mt) fission site. The scale bar represents 100 nm. See also Fig EV4.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_4-C</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C HeLa cells expressing SEPT6-GFP were stained with MitoTracker Red CMXRos for live SOFI-based super resolution microscopy. Each image was reconstructed from 100 raw TIRF frames using a custom made SOFI-based algorithm. Arrows highlight SEPT6 association with location of mitochondrial fission. The scale bar represents 1 µm. See also Movie EV3.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_4-D</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D HeLa cells expressing SEPT6-GFP were labelled with MitoTracker Red CMXRos, fixed for widefield immunofluorescence microscopy, and labelled with antibodies to Drp1. Arrows highlight one example of Drp1 and SEPT6 association with location of mitochondrial fission. The scale bar represents 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_4-E</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E HeLa cells were transfected with Mito-BFP and ActA-SEPT7-mCherry, fixed and labelled with antibody to Drp1 for widefield immunofluorescence microscopy. The scale bar represents 5 μm. Inset images highlight Drp1 and SEPT7 associated with sites of mitochondrial fission. Pearson's correlation coefficient from 3 independent experiments (mean ± SEM) shows that mitochondria in ActA-SEPT7 transfected cells recruit significantly more Drp1 than control cells (Mito-BFP transfected alone). Student's t-test, * = p&lt;0.05.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_5-A</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HeLa cells were treated with control (CTRL), SEPT7, or Drp1 siRNA for 72 h. Whole cell lysate of siRNA-treated cells were immunoblotted for GAPDH, SEPT7, or Drp1 to show the efficiency of siRNA depletion. GAPDH was used as loading control. siRNA-treated cells were labelled with MitoTracker Red CMXRos, and fixed for confocal microscopy. The scale bar represents 5 μm.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_5-B</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HeLa cells were treated with control (CTRL), SEPT2, SEPT7, SEPT9, Drp1, or SEPT7+ Drp1 siRNA for 72 h, labelled with MitoTracker Red CMXRos, and fixed for quantitative confocal microscopy. Graph represents the distribution in length (μm; whiskers from min to max) of mitochondria in siRNA-treated cells from 3 independent experiments (analysis of at least 100 measurements per biological replicate). Student's t-test, *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_5-C</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C HeLa cells stably expressing SEPT6-GFP were harvested, and then tested with Co-IP. HeLa cells expressing GFP were used in parallel as control. GFP-trap magnetic agarose beads were used to isolate SEPT6-GFP from cells, and extracts were immunoblotted for Drp1, SEPT2, SEPT7, or GFP. The lysates were immunoblotted for GAPDH as control for cellular protein levels.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_5-D</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D HeLa cells were treated with control (CTRL) or SEPT7 siRNA for 72 h, and whole cell lysates were immunoblotted for SEPT7, Drp1, phosphorylated Drp1 (P-Drp1), or Mfn1. GAPDH was used as loading control. Graph represents the mean % ± SEM of the relative amount of Drp1, P-Drp1, Mfn1, or SEPT7 proteins quantified by densitometry from 4 independent experiments. Student's t-test, ns = non-significant; ** = p&lt;0.01, *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_5-E</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E HeLa cells were treated with control (CTRL) or SEPT7 siRNA for 72 h, labelled with MitoTracker Red CMXRos, then fixed and labelled for endogenous P-Drp1 for quantitative confocal microscopy. Representative images shown here. The scale bar represents 1 μm. The recruitment of P-Drp1 to mitochondria was significantly decreased as compared to control cells as measured by Pearson's correlation coefficient from at least 5 independent experiments (mean ± SEM, analysis of at least 250 cells per biological replicate). Student's t-test, * = p&lt;0.05.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_5-F</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F HeLa cells were treated with control (CTRL) or SEPT7 siRNA for 72 h, labelled with MitoTracker Red CMXRos, then fixed and labelled for endogenous Mfn1 for quantitative confocal microscopy. Representative images shown here. The scale bar represents 1 μm. The recruitment of Mfn1 to mitochondria was significantly increased as compared to control cells as measured by Pearson's correlation coefficient from at least 5 independent experiments (mean ± SEM, analysis of at least 250 cells per biological replicate). Student's t-test, * = p&lt;0.05.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_6-A</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A HeLa cells stably expressing SEPT6-GFP were treated with Drp1 siRNA for 72 h, transfected with mito-BFP 24 h, and then infected with S. flexneri-mCherry for 2 h for live confocal microscopy. Representative image shows interplay between two Shigella-septin cages and fused mitochondria. The scale bar represents 1 μm. See also Movie EV3.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_6-B</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B HeLa cells were treated with Drp1 siRNA for 72 h, and then infected with x-light ShigellamCherry for 4 h 40 min for quantitative confocal microscopy. IPTG was added 30 min prior to fixation, and then samples were labelled with antibody for SEPT7. Graph represents mean % ± SEM of Shigella responding to IPTG outside (-) or inside (+) SEPT7 cages from 3 independent experiments. Student's t-test, *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_6-C</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C HeLa cells were infected with S. flexneri M90T for 4 h 40 min, labelled with MitoTracker Red CMXRos, and fixed for quantitative confocal microscopy. Boxplots show the length of mitochondrial (μm; whiskers from min to max) surrounding Shigella outside (-) or inside (+) SEPT7 cages from 3 independent experiments (analysis of at least 130 measurements per biological replicate). Student's t-test; *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4931556 Figure_6-D</id>
    <infon key="sourcedata_document">1938</infon>
    <infon key="doi">10.15252/embr.201541832</infon>
    <infon key="pmc_id">4931556</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D HeLa cells were either kept uninfected as a control or infected with S. flexneri M90T or S. flexneri ΔIcsA for 4 h 40 min. Samples were labelled with MitoTracker Red CMXRos, and fixed for quantitative confocal microscopy. Boxplots show length of mitochondria (μm; whiskers from min to max) in uninfected cells (CTRL), surrounding S. flexneri M90T (+M90T) or S. flexneri ΔIcsA (+ΔIcsA) from 3 independent experiments (analysis of at least 250 measurements per biological replicate). Student's t-test; *** = p&lt;0.001.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_1-A</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Detection of Fstl1protein in ischemic myocardium of WT mice. After MI induction, the heart was harvested at the indicated time points, and separated to ischemic and remote (non-ischemic) areas. Fstl1protein was detected by western blotting (n=3, each time point). Statistical analysis was performed by ordinary one way ANOVA. Post Hoc test was performed by Dunnett test.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_1-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) SerumFstl1 was detected by western blotting at the indicated time points. Ponceau S staining of serum reveals equivalent amount of loaded protein (n=4, each time point). Error bars represent mean ± SEM. Statistical analysis was performed by ordinary one way ANOVA. Post Hoc test was performed by Dunnett test.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_2-A</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) DABimmunohistochemistry staining of Fstl1 with ischemic heart at day 3 after LAD ligation. Arrows indicate a subset of Fstl1 positive cells. Counter staining was performed with hematoxylin. Scale bar indicates 50μm.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_2-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunofluorescent microscopy staining of Fstl1 (green) and sarcomeric actin (red). Fstl1 protein was detected in interstitial areas of the ischemic and border zone but not in cardiomyocytes. Scale bar indicates 100μm.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">26</infon>
        <infon key="identifier">CL:0000746</infon>
        <location offset="179" length="14"/>
        <text>cardiomyocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_2-C</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Immunofluorescent microscopy staining of Fstl1 (green) and S100a4 (red) in the ischemic area. Arrows indicate Fstl1 and S100a4 double positive cells. Scale bar indicates 20μm.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_2-D</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunofluorescent microscopy staining of Fstl1 (green) and α-smooth muscle actin (red). Arrows indicate Fstl1 and α-SMA double positive cells. Scale bar indicates 20μm. Nuclei were stained by DAPI.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_3-A</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Genotypes are indicated as WT for S100a4cre-/- x Fstl1flox+/flox+ mice and cfKO for S100a4cre+/- x Fstl1flox+/flox+. (A) S100a4 expression is induced in the ischemic area (IA). qPCR analysis of mRNA expression of S100a4 in ischemic heart and sham operated heart of WT mice and cfKO mice. Heart samples were harvested at 7 days after the surgery. Statistical analysis was performed by two-way ANOVA. Post Hoc test was performed by Tukey test. Error bars represent mean ± SEM (n=16 and 15 for WT and cfKO sham group, n=15 and 14 for WT and cfKO MI group, respectively).</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_3-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>Genotypes are indicated as WT for S100a4cre-/- x Fstl1flox+/flox+ mice and cfKO for S100a4cre+/- x Fstl1flox+/flox+. (B) qPCR analysis of mRNA expression of Fstl1 and Tgfβ1 in sham and post-MI heart. Error bars represent mean ± SEM (n=16 and 15 for WT and cfKO sham group, n=15 and 14 for WT and cfKO MI group, respectively). Statistical analysis was performed by two-way ANOVA. Post Hoc test was performed by Tukey test.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_3-C</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>Genotypes are indicated as WT for S100a4cre-/- x Fstl1flox+/flox+ mice and cfKO for S100a4cre+/- x Fstl1flox+/flox+. (C) Western blot analysis of Fstl1 protein expression in ischemic and sham-operated hearts at day 7 after the surgery. Quantified values of Fstl1 protein in WT and cfKO mousehearts normalized by GAPDH band intensity are shown. Statistical analysis was performed by two-way ANOVA. Post Hoc test was performed by Tukey test. Error bars represent mean ± SEM (n=5 for each sham group and n=6 for each MI group).</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_3-D</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>Genotypes are indicated as WT for S100a4cre-/- x Fstl1flox+/flox+ mice and cfKO for S100a4cre+/- x Fstl1flox+/flox+. (D) Fstl1 protein expression in isolated cardiac fibroblasts from cfKO and littermate WT neonatal mice. Cell lysate and its media from cells cultured for 24 hours without FBS were assessed by western blotting. Error bars represent mean ± SEM (n=3 per group). Statistical analysis was performed by unpaired t-test (2-tailed). The experiments were performed twice independently.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">79</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="158" length="19"/>
        <text>cardiac fibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_4-A</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Mousesurvival curve after MI and sham surgery. The mortality of the WT and Fstl1-cfKO mice after MI surgery was 27.1% and 46.7%, respectively. Log-rank (Mantel-Cox) test was used for statistical analysis (n=16 for WT sham, n=15 for Fstl1-cfKO sham, n=59 for WT MI and n=30 for Fstl1-cfKO MI).</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_4-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Representative macroscopic images of cardiac rupture. Left; impending LV rupture found in a cfKO mouse post-MI when sampling. Right; evidence of hemothorax that was diagnosed as cardiac rupture in deceased mice.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_4-C</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Representative microscopic images of ruptured heart stained by H&amp;E. Penetrating hematoma due to a tear from the LV endocardium to the epicardium. Left; an image obtained with a low magnification lens. Scale bar indicates 200μm. Right; higher magnification image. Scale bar indicates 100μm. Arrow indicates the tear site. H indicates hematoma.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_5-A</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Transcript mRNA expression of Col1a1 and Fn1 in sham and post-MI hearts. Hearts were obtained at day 7 after surgery. Error bars represent mean ± SEM (n=13-16 for each group). Statistical analysis was performed by two-way ANOVA. Post Hoc test was performed by Tukey test.</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_5-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Protein expression of collagen I, fibronectin and αSMA in the infarcted and sham hearts at day 7 after surgery, as assessed by western blotting. Quantified values of proteins of interest were normalized relative to the tubulin band intensity. Error bars represent mean ± SEM. Statistical analysis was performed by unpaired t-test (2-tailed) for fibronectin and αSMA and non-parametric t-test (2-tailed) for collagen I (fibronectin and collagen I: n=5 per group, αSMA: n=3 and 4 for WT-IA and cfKO-IA, respectively).</text>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_5-C</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) α-smooth muscle actin-positive myofibroblasts (red) were stained in histology sections from infarcted hearts of WT and cfKO mice. Samples were harvested at day 7 after MI. Counter staining was performed by hematoxylin. Scale bar indicates 100μm for top and middle images, 50µm for bottom images. Error bars represent mean ± SEM. Statistical analysis was performed by Mann-Whitney test (n=16 for WT and n=14 for cfKO). (D) Representative images of Picro Sirius Red staining of infarcted heart at 7 days after MI surgery. Images were taken by standard light (top) and polarized light (bottom) microscopes. Scale bar indicates 100μm. Polarized collagen fibers were sorted to orange-red (middle) and green-yellow (bottom) fibers by Image J software. Error bars represent mean ± SEM. Statistical analysis was performed by unpaired t-test (2-tailed) (n=11 for WT and n=13 for cfKO).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">135</infon>
        <infon key="identifier">CL:0000186</infon>
        <location offset="35" length="14"/>
        <text>myofibroblasts</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_6-A</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immunofluorescence microscopy staining of Fst1 (green) and α-SMA (red) in NRCFbs at 24 hours after recombinant TGF-β1 (10ng/ml) stimulation. Nuclei were stained by DAPI. Scale bar indicates 50μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">148</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="78" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_6-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Time course changes of Fstl1 protein expression in NRCFbs after stimulation of recombinant TGF-β1 (10ng/ml). Protein expression of Fstl1 was detected by immunoblotting. Tubulin was used as a loading control (n=3 for each time point). Two independent experiments were performed.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">154</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="55" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_6-C</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Transcript level of Fstl1, S100a4 and Acta2 mRNA in NRCFbs was determined by qPCR analysis. The samples were harvested at 24 hours after stimulation with recombinant TGF-β1 (10ng/ml) or control vehicle. Error bars represent mean ± SEM (Fstl1 and S100a4: n=6 for each group, Acta2: n=3 for each group). Statistical analysis was performed by unpaired t-test (2-tailed) for Fstl1 and S100a4, and non-parametric unpaired t-test (2-tailed) for Acta2. Two independent experiments were performed.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">163</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="56" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_7-A</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NRCFbs at passage 1 were stimulated with recombinant Fstl1 (50ng/ml) or vehicle after cultured in serum-reduced conditions (FBS 0.5%) for 24 hours. The samples were harvested at the indicated time points after stimulation. The expression of ERK1/2 and tubulin were detected by immunoblotting. Error bars represent mean ± SEM. Statistical analysis was performed by one-way ANOVA and Tukey multi comparison test (n=3 for each time point). Three independent experiments were performed.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">173</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="4" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_7-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Fstl1 induced phosphorylation of ERK1/2 was ablated by pretreatment with MEK inhibitor PD98059. NRCFbs were treated by PD98059 (5nM) for 30min and then stimulated with recombinant Fstl1 protein (50ng/ml) for 15min. Error bars represent mean ± SEM. Statistical analysis was performed by one-way ANOVA and Tukey multi comparison test (n=3 for each time point). Two independent experiments were performed.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">184</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="100" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_7-C</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Representative images of NRCFbs scratch assay (left) and quantified cell migration (right). NRCFbs were transfected by Fstl1 siRNA or siRNA non-targeting negative control for 12 hours followed by culturing in 0.5% FBS media for 24 hours. The confluent cell sheet was scratched and cell migration was assessed at 6 hours after the scratch. Scale bar indicates 100µm. Error bars represent mean ± SEM (n=10 for each group). Statistical analysis was performed by unpaired t-test (2-tailed). Two independent experiments were performed.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">189</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="29" length="6"/>
        <text>NRCFbs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="96" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_7-D</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Fstl1-stimulation of cell migration was reversed by PD98059. Endogenous Fstl1 in NRCFbs was ablated by Fstl1 siRNA. Serum-deprived NRCFbs were treated with PD98059 (5nM) for 30 min and then stimulated by Fstl1 (50ng/ml) or vehicle. Cell migration was assessed at 6 hours after Fstl1 stimulation. Error bars represent mean ± SEM (n=7-9 for each group). Statistical analysis was performed by Kruskal-Wallis test and Dunnett's T3 test. Two independent experiments were performed.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">200</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="85" length="6"/>
        <text>NRCFbs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">203</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="135" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_7-E</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Morphological changes of NRCFbs after recombinant Fstl1stimulation was assessed by immunocytochemistry. 24 hours serum starved NRCFbs was stimulated by Fstl1 (50ng/ml) or vehicle for 3 hours. PD98059 (5nM) or DMSO was added 30min prior to Fstl1 stimulation. Cells were stained with Alexa Fluor 488-conjugated phalloidin antibody and nuclei were stained by DAPI. Arrow shows lamellipodium of the cell. Scale bar indicates 50μm.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">211</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="29" length="6"/>
        <text>NRCFbs</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">213</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="131" length="6"/>
        <text>NRCFbs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_8-A-B</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 8-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A, B) Fibroblast proliferation was assessed by Edu incorporation assay. Endogenous Fstl1 was ablated by siRNA. NRCFbs were cultured in 0.5% FBS condition for 48 hours to synchronize the cell cycle. EdU (10μM as the final concentration) was added into media at 4 hours before harvest. Error bars represent mean ± SEM (n=5, each group). Statistical analysis was performed by unpaired t-test (2-tailed). Two independent experiments were performed. (B) Effect of exogenous Fstl1 on cardiac fibroblast proliferation. Cells were cultured in FBS 0.5% media for 24 hours. Recombinant Fstl1 (50ng/ml) or vehicle were added to 2% FBS-containing media and cultured for 48 hours. EdU was added into media at 4 hours before harvest. Error bars represent mean ± SEM (n=7, each group). Statistical analysis was performed by unpaired t-test (2-tailed). Two independent experiments were performed.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">226</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="112" length="6"/>
        <text>NRCFbs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">229</infon>
        <infon key="identifier">CL:0008023</infon>
        <location offset="479" length="18"/>
        <text>cardiac fibroblast</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4967946 Figure_8-C</id>
    <infon key="sourcedata_document">1891</infon>
    <infon key="doi">10.15252/emmm.201506151</infon>
    <infon key="pmc_id">4967946</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Fstl1 promoted fibroblasts proliferation was diminished by PD98059. PD98059 (5nM) was added 30 min prior to recombinant Fstl1 stimulation (50ng/ml). The cells were cultured for 48 hours, and EdU was added into media at 4 hours before harvest. Error bars represent mean ± SEM (n=4-10, per treatment group). Statistical analysis was performed by one-way ANOVA and Tukey multi comparison test. Two independent experiments were performed.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_1-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Location of missense variants of PDIA1 and ERp57 identified in ALS cases. PDI primary structure: catalytic a and a' domains containing the active site motif CXXC sequence (dark purple and dark green), non-catalytic domains b and b' containing ligand binding sites (light purple and light green), and x-linker region (light gray). The constructs used in this study contained a V5-tag (orange) at the C-terminus that was inserted previous to the ER-retention signal (dark gray).</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_1-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Expression of PDI variants in zebrafish. Zebrafish embryos at 1-2 cell stage were injected with sense mRNA coding for the indicated PDIs (PDIA1WT, PDIA1D292N and PDIA1R300H: 200 pg/embryo; ERp57WT, ERp57D217N and ERp57Q481K: 80 pg/embryo). Protein expression was confirmed by Western blot analysis using anti-V5 antibody in total embryo extracts at 24 h post-fertilization (hpf). Actin was used as a loading control. In the left panel 80 µg protein and in the right panel 120 µg protein extract were used.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_1-C</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C and D, Motoneuron defects induced in zebrafishembryos after expression of the indicated ALS-linked PDI mutants and wild-type controls (PDIA1WT and PDIA1R300H: 80 pg mRNA/embryo; ERp57WT, ERp57D217N, ERp57D217N and ERp57Q481K: 30 pgtba mRNA/embryo). The most frequent global phenotypes induced by PDI injection are shown in lateral views of embryos at 24 hpf (left column). Black arrows indicate the presence of curly tail and/or shorter axis phenotypes (see details in Appendix Table S1). Axonmotoneuronmorphology was visualized using confocal microscopy in lateral views of the trunk region in transgenic Tg(Huc:Kaede) zebrafish at 36 hpf (middle and right columns). Images in the right column correspond to magnification views of the rectangular regions depicted in left and middle columns. Asterisks and arrows point to examples of increased axonal branching and reduced axonal length, respectively.</text>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">520</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="9" length="10"/>
        <text>Motoneuron</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">26</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="495" length="10"/>
        <text>motoneuron</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_1-D</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>C and D, Motoneuron defects induced in zebrafishembryos after expression of the indicated ALS-linked PDI mutants and wild-type controls (PDIA1WT and PDIA1R300H: 80 pg mRNA/embryo; ERp57WT, ERp57D217N, ERp57D217N and ERp57Q481K: 30 pgtba mRNA/embryo). The most frequent global phenotypes induced by PDI injection are shown in lateral views of embryos at 24 hpf (left column). Black arrows indicate the presence of curly tail and/or shorter axis phenotypes (see details in Appendix Table S1). Axonmotoneuronmorphology was visualized using confocalmicroscopy in lateral views of the trunk region in transgenic Tg(Huc:Kaede) zebrafish at 36 hpf (middle and right columns). Images in the right column correspond to magnification views of the rectangular regions depicted in left and middle columns. Asterisks and arrows point to examples of increased axonal branching and reduced axonal length, respectively.</text>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">522</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="9" length="10"/>
        <text>Motoneuron</text>
      </annotation>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">62</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="495" length="10"/>
        <text>motoneuron</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_1-E</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E and F Quantification of motoneuronaxon length and axon branching in 36hpf Tg(Huc:Kaede) embryos injected with the indicated PDIA1 (D) and ERp57 (E) mutants.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">71</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="26" length="10"/>
        <text>motoneuron</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_1-F</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>E and F Quantification of motoneuronaxon length and axon branching in 36hpf Tg(Huc:Kaede) embryos injected with the indicated PDIA1 (D) and ERp57 (E) mutants.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="26" length="10"/>
        <text>motoneuron</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_1-G</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Touch-evoked escape responses of 48 hpf zebrafishembryos injected with ALS-linked PDI mutants (Kabashi et al, 2011; Kabashi et al, 2009). The number of touches necessary to evoke an escape response (top) and speed (bottom, in mm/s) of the escape response was determined for each condition. The total number of analyzed embryos is indicated in parenthesis. Experiments of D-F were performed in selected animals sharing normal overall embryomorphology and viability, to avoid unspecific effects of axial shortening or curvature in motoneuronmorphology and/or animal behavior. Statistical analyses were performed using one-way ANOVA and Bonferroni´s post hoc tests. Mean ± SEM with only statistically significant p values are shown: *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001. Abbreviations: A (anterior), D (dorsal), P (posterior), V (ventral). Scale bars represent 500 m (C and D: a,d.g,j), 200 m (C and D: b,e,h,k), 100 m (C and D: c,f,i,l), and 25 µm (G-H).</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">92</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="531" length="10"/>
        <text>motoneuron</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_2-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A NSC34cells were transiently transfected with expression vectors for V5-tagged wild-type and mutant PDIs. After 48 h, overexpressed PDI variants was assessed under reducing conditions in an 8% SDS-PAGE. An antibody detecting total PDIA1 (endogenous mousePDIA1 and exogenous humanV5-tagged PDIA1) (first panel). A second antibody detects only humanPDIA1, therefore only V5-tagged PDIA1 appears (second panel). A mouse and human specific antibody was used to detect total ERp57 (third panel). Anti-V5 was used to detect the exogenous PDI variants. Anti-β-actin was used as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_2-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B and C NSC34cells were transiently transfected with the indicated PDIs constructs together with a GFP expression plasmid. Cell were then differentiated for 24 h in Neurobasal medium containing B27 supplement to induce cell differentiation. Increased neurite outgrowth is indicated with white arrow heads. B Quantification of the average primary neurite lengths was performed, all cells from three independent experiments were compiled. A minimum of 100 cells per experiment was analyzed. In addition, C the percentage of cells with neurites was quantified in the three independent experiments (right panel).</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_2-C</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>B and C NSC34 cells were transiently transfected with the indicated PDIs constructs together with a GFP expression plasmid. Cell were then differentiated for 24 h in Neurobasal medium containing B27 supplement to induce cell differentiation. Increased neurite outgrowth is indicated with white arrow heads. B Quantification of the average primary neurite lengths was performed, all cells from three independent experiments were compiled. A minimum of 100 cells per experiment was analyzed. In addition, C the percentage of cells with neurites was quantified in the three independent experiments (right panel).</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_2-D</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Primary rat ventral spinal cordneurons were prepared and after 4 daysin vitro (DIV) transfected with GFP alone or together with the indicated PDIs constructs. Cells were fixed at 10 DIV and SMI32 staining was performed to identify motoneurons. Images were taken and the total outgrowth of GFP and SMI32 positive cells was quantified. Results are compiled from 3 independent experiments.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">144</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="33" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">146</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="233" length="11"/>
        <text>motoneurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_2-E</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Humanmotoneurons were differentiated from the human embryonic stem cell (ESC) HuESC 3 Hb9::GFP line. Differentiated neurons were transduced with lentivirus expressing GFP alone or together with PDIs-expressing plasmids. Transduced cells were cultured for another 10 days. To identify motoneurons after lentiviral transduction, immunocytochemistry analyses were performed. Quantification of neurite outgrowth in the different experimental conditions of GFP and HB9 positive neurons were obtained. Neurite number and assessment of the length of each neurite was performed in a similar manner as for primary rat motoneurons (see methods). Four independent experiments were performed.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">163</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="7" length="11"/>
        <text>motoneurons</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">156</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="75" length="3"/>
        <text>ESC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">157</infon>
        <infon key="identifier">CL:0002322</infon>
        <location offset="80" length="5"/>
        <text>HuESC</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">167</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="118" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">170</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="286" length="11"/>
        <text>motoneurons</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">160</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="475" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">178</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="611" length="11"/>
        <text>motoneurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_2-F</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F NSC34cell lines stably knocked down for PDIA1 or ERp57 were differentiated for 24 h in Neurobasal medium containing B27 supplement to induce cell differentiation. The percentage of cells with neurites was quantified in the three independent experiments. A minimum of 100 cells per experiment was analyzed. Statistical analyses were performed using one-way ANOVA and Bonferroni´s post hoc tests. Mean ± SEM with only statistically significant p values are shown: *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A PDI mutants form abnormal disulfide-dependent protein complexes. NSC34 cells were transiently transfected with expression vectors for V5-tagged wild-type and mutant PDIA1. After 48 h, differential disulfide-dependent interactions/aggregations of overexpressed PDI variants was assessed under reducing (+DTT) and non-reducing (-DTT) conditions in an 8% SDS-PAGE. Anti-V5 was used for detection in Western blot.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Analysis of the PDIA1 structure to model the effects of the R300H mutation. The close association between Arg300 located to the b' domain of PDIA1 with Trp396 located to the a' domain adjacent to the active site motif CGHC (designated as AS in yellow) is shown in comparison to the mutated version of PDIA1R300H highlighting the same residues. A potential stabilization of the interaction between the b' and a' domain is shown that may be caused by the interaction of the imidazole rings of mutated His300 with Trp396.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-C</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C ALS-linked PDIA1 variants were generated as recombinant proteins and then analyzed by circular dichroism (CD). Averages for CD spectroscopic scans of PDIA1WT and mutants are shown.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-D</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Averages for CD spectroscopic thermal denaturation of recombinant PDIA1WT and mutants.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-E</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Representative electrophoresis analysis of Proteinase K-treated recombinant PDIA1 variants. Mass spectrometric analysis of Proteinase K digested samples from total sample and from in gel trypsin digested protein samples (arrows indicate band 1 and band 2) indicated differences in the removal of the x-linker region. Bottom panel: Ratios of band 1 to band 2 were quantified in 4 independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-F</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Representative fluorescence spectra of recombinant PDIA1b'xWT fragments and the equivalent ALS-linked mutants (n=6). Ratios from the two peak areas and change compared to PDIA1 b'xWT. Both mutants analyzed show a significant shift in peak position compared to wild-type, but in opposite directions, suggesting that PDIA1D292N shifts equilibrium towards the capped version (x region over the binding pocket) and the PDIA1R300H mutant towards the uncapped version (Nguyen et al, 2008).</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-G</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>G The activity of recombinant PDIA1 was measured in vitro using a BPTIrefolding assay following by mass spectrometry analysis. The percentages of different BPTI species was calculated (6H, fully reduced; 1S, one disulfide bond; 2S, two disulfide bonds; 3S, three disulfide bonds) at time point 2.5 min in four independent experiments.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-H</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-H</infon>
    <infon key="sourcedata_figure_dir">Figure_3-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Measurement of H2O2 levels at the ER lumen of living NSC34. Left panel: Reduced PDIs can be oxidized by oxidized ERO1Lα that then transfers electrons to molecular oxygen (O2), generating hydrogen peroxide (H2O2) as a product of PDIs activity. Right panel: NSC34cells were transiently co-transfected with ER luminal HyPer sensor and indicated PDIs. After 48 h the 490/420 nm fluorescence ratio was recorded for 2 min under basal conditions. Means and SEM derived from all cells per condition (n=55-74) monitored in four independent experiments are shown.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_3-I</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 3-I</infon>
    <infon key="sourcedata_figure_dir">Figure_3-I</infon>
    <passage>
      <offset>0</offset>
      <text>I HEK293Tcells were transfected with expression vectors for V5-tagged wild-type and mutant PDIA1, as well as empty vector. After 48 h, V5-tagged proteins were immunoprecipitated and eluted with V5 peptide. The interaction with endogenous ERO1Lα was analyzed by western blot. The inputs and elutions are shown as control. Right panel: Quantification of the degree of interaction is presented.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_4-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A PDI mutants form abnormal disulfide-dependent protein complexes. NSC34cells were transiently transfected with expression vectors for V5-tagged wild-type and mutant ERp57. After 48 h, differential disulfide-dependent interactions/aggregations of overexpressed PDI variants was assessed under reducing (+DTT) and non-reducing (-DTT) conditions in an 8% SDS-PAGE. Anti-V5 was used for detection in Western blot.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_4-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B ALS-linked ERp57 variants were generated as recombinant proteins and then analyzed by circular dichroism (CD). Averages for CD spectroscopic scans of recombinant ERp57WT and mutants are shown.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_4-C</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C A thermal denaturation curve of ERp57WT and mutants was performed.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_4-D</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Representative electrophoresis of Proteinase K treated ERp57 recombinant proteins.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_4-E</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Surface Plasmon Resonance was performed to monitor the affinity of recombinant ERp57 for recombinant CRT P-domain. KD values are expressed as percentage of ERp57WT. Values are derived from four independent experiments. For absolute KD values please see Appendix Table S2.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_4-F</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>FHEK293TNSC34 were transfected with expression vectors for V5-tagged wild-type and mutant ERp57, as well as empty vector. After 48 h, V5-tagged proteins were immunoprecipitated and eluted with V5 peptide. The interaction with endogenous calnexin (CNX) and calreticulin (CRT) was analyzed by Western blot. The inputs and elutions are shown. Right panel: Quantification of the degree of interaction is presented.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_4-G</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G The gain of an N-glycosylation site of ERp57D217N was predicted after the analysis of the protein sequence since the change of Asp217 to an Asn creates the NXT/S consensus sequence. Neuro2a cells were transfected with expression vectors for V5-tagged wild-type and mutant ERp57, as well as empty vector and treated with 1 µg/ml tunicamycin (Tm) for 20 h to inhibit N-glycosylation. Alternatively, protein extracts were digested with PNGase F and the possible removal of the N-glycosylation was analyzed by Western blot using anti-V5 antibody.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A ERp57flox/floxmice were crossed with NestinCre transgenic mice to generate nervous system specific ERp57 deficient animals. The levels of ERp57protein in the spinal cord were monitored by Western blot. ERp57WT (n=4), ERp57Nes+/- (n=5) and ERp57Nes-/- (n=4) mice. HSP90 levels were determined as a loading control. Right panel: Quantification of ERp57 levels was performed relative to Hsp90 levels.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Body weight measurements were performed for indicated time points in ERp57WT (n=50), ERp57Nes+/- (n=32) and ERp57Nes-/- (n=19) mice.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-C</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Rotarod performance was performed ERp57WT (n=20), ERp57Nes+/- (n=15) and ERp57Nes-/- (n=8) mice.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-D</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Hanging test performance was assessed in ERp57WT (n=41), ERp57Nes+/- (n=32) and ERp57Nes-/- (n=12) mice.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-E</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Kaplan-Meier survival curve for ERp57Nes-/- mice (N = 19) that prematurely died or had to be sacrificed because of health reasons between the ages 22 and 73 days. Mean survival of this subgroup of animals was 57 days. ERp57WT (n=50) and ERp57Nes+/- (n=32) mice are shown as a reference.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-F</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Histological analysis of NeuN and GFAP staining was performed in spinal cord tissue from ERp57WT and ERp57Nes-/- mice in three animals per group using indirect immunofluorescence. The nucleus was stained with Hoechst. Representative images from one mouse per group are shown. Scale bar: 50 μm.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-G</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Stereological analysis of the spinal cord from ERp57WT (n = 4), ERp57Nes+/- (n = 4) and ERp57Nes-/- (n = 4) mice. Alternate series of sections from the spinal cord of the mice were either stained for Nissl (top row images) or processed for immunohistochemistry for the cholinergic cell marker Choline Acetyl Transferase (ChAT, bottom row images). The nucleoli of the motoneurons, as stained in the Nissl series, were counted inside the motoneurons pools previously defined using the adjacent ChAT series (contours not shown). Cell densities of the three genotypes are shown on the right plots. No significant differences were found between the genotypes. Scale bar represents 200 μm and 50 μm on large and inset images, respectively.</text>
      <annotation id="12">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">383</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="369" length="11"/>
        <text>motoneurons</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">385</infon>
        <infon key="identifier">CL:0000100</infon>
        <location offset="438" length="11"/>
        <text>motoneurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_5-H</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Representative images of the spinal cord myelination of ERp57WT and ERp57Nes-/- mice.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_6-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative EMG recordings of ERp57WT (n=16), ERp57Nes-/+ (n=12) and ERp57Nes-/- (n=5) mice is presented. The presence of positive sharp waves (PSW) in ERp57Nes+/- and ERp57Nes-/- mice indicated muscle denervation.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_6-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Analysis of NMJ and muscle morphologies were performed from ERp57WT (n=5), ERp57Nes+/- (n=5) and ERp57Nes-/- (n=4). Quantifications of endplate width, measuring the most ventral region of the diaphragms every 134 µm considering both sides of the innervation profile. Twenty to forty measurements per diaphragm were obtained per animal.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_6-C</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Whole-mounted diaphragms from ERp57WT and ERp57Nes-/-mice were co-stained with anti-neurofilament (red) and α-BTX to reveal the postsynaptic densities (green). 3D reconstructions (lower panel) of higher magnification. ERp57WTNMJs are fully innervated pretzel-like, whereas ERp57Nes-/- NMJs display less complex postsynaptic densities and an incomplete or aberrantly distributed innervation pattern (Movies EV4-7).</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_6-D</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Representative 3D reconstructions of z-stacks showing the five categories in which NMJs morphologies were grouped: Pretzel, fragmented, O shaped, C shaped, and dismantled NMJs. Histogram of the distribution frequency of &gt;200 different NMJ per animal is shown.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_6-E</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Quantitative morphometry of &gt;60 NMJs in the different genotypes analyzed.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_7-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A The levels of ERp57protein in the muscle were monitored by Western blot. ERp57WT (n = 4), ERp57Nes+/- (n = 5) and ERp57Nes-/- (n = 4) mice. HSP90 was determined as loading control.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_7-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Tibialis anterior muscles from ERp57WT (n = 5), ERp57Nes+/- (n = 5), and ERp57Nes-/- (n = 4) mice were dissected and cryosectioned (20 µm) for the analysis of several parameters of muscle physiology. Upper panel: hyaluronic acid (HA) staining was performed to assess the gross morphology of the muscle. Middle panel: Bismarck brown staining to monitor skeletal muscles fibrosis. Lower panel: Cryosections were then double stained with wheat germ agglutinin (WGA) to visualize plasmamembrane and nuclei. The absence of central nuclei in all genotypes suggests that ERp57 deficiency does not affect degeneration/regeneration cycles. Images are representative of each genotype and where acquired in the same anatomical region of the TAmuscles.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_7-C</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Tibialis anterior cryosections (20 µm) from ERp57WT, ERp57Nes+/-, and ERp57Nes-/-mice were stained for NADH-TR activity to identify oxidative myofibers (upper panel). Representative micrographs of transversal cryosections show variable proportions of light, intermediate and dark positive staining in the different genotypes: (middle panel) NADH-TR positive (slow-twitch) and negative (fast-twitch) myofibers were quantified as percentage of total for every genotype (lower panel) The mean diameter of slow- and fast-twitch muscle fibers was evaluated at the light microscope using the ImageJ software. Data represent the average ± SEM of &gt;300 fibers per animal. Scale bars represent 50 m in B and C.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_8-A</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A The levels of synaptic proteins SV2, NMDAR2A, PSD95 and Synaptophysin in the cortex were monitored by Western blot. ERp57WT (n = 4), ERp57Nes+/- (n = 5) and ERp57Nes-/- (n = 4) mice. HSP90 and β-Actin were determined as loading controls.</text>
    </passage>
  </document>
  <document>
    <id>4972141 Figure_8-B</id>
    <infon key="sourcedata_document">1381</infon>
    <infon key="doi">10.15252/embj.201592224</infon>
    <infon key="pmc_id">4972141</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Quantification of SV2 monomer (left panel) and SV2 high molecular weight species (right panel). β-Actin was used as the reference.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_1-A</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Maximal IgE-induced beta-hexosaminidase release only releases part of the vesicle pool and is inhibited dose dependently by PKCB inhibitor, Ruboxistaurin (n = 9). Values are mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_1-B</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. PKCB knockout in RBL-2H3 cells, achieved with genome editing using TALENs. Western blot validating complete loss of PKCB protein expression.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_1-C</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. IgE-induced beta-hexosaminidase release was inhibited in PKCB knockout cells and was rescued with stable overexpression of either PKCB1 or PKCB2 (n = 24). Wild type RBL cells in pink and PKCB knockout cells in blue. Values are mean ± SEM; ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_1-D</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Phosphoproteomics analysis of PKCB targets during mast cell secretion. Intensity for each phosphopeptide compared between biological replicas of wild type cells challenged with antigen.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">22</infon>
        <infon key="identifier">CL:0000097</infon>
        <location offset="53" length="9"/>
        <text>mast cell</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_1-F</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Mean intensity for each phosphopeptide with WT compared to PKCB inhibitor versus WT compared to PKCB knockout cells. Dotted line represents threshold for 2-fold change of intensity. The hits (179 phosphopeptides) are highlighted in blue and the 4 phosphopeptides from VAMP8 are highlighted in red: T53 (above both thresholds), T47 (above one threshold), S54 (below both thresholds) and S17 (below both thresholds and site not perfectly conserved in mammals).</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_1-G</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. VAMP8 immunocytochemistry imaged with a spinning disk confocal microscope. VAMP8 localized to vesicles in resting cells and expression was reduced after VAMP8 siRNA knockdown. VAMP8 translocated to the plasma membrane following antigen stimulation (4 minutes) (n = 3, &gt;50 cells per condition). Scale bar 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_2-A</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Crystal structure of VAMP8 in an autophagy SNARE-complex (PDB: 4WY4). Residues T47, T53, S54 and S61 are highlighted in the middle of the SNARE-complex in an orthogonal view.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_3-B</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Ensemble content-mixing assay with v-SNAREvesicles (VAMP8) loaded with dye and unlabeled t-SNAREvesicles (SNAP23 and STX3). Reduced kinetics of content-mixing was observed with VAMP8Glu (T47E, T53E, S54E) compared to wild type VAMP8 (n = 3). As a control (black line), the content-mixing assay was performed by combining v-SNAREvesicles (VAMP8) loaded with dye with unlabeled t-SNAREvesicles prepared without SNAP23 and STX3. The slight steady increase of the control is due to a small amount of content-dye leakage and consequent dequenching of the dyes.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_4-A</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. IgE-induced beta-hexosaminidase release in cells with siRNA knockdown of endogenous VAMP8. Wild type RBL cells in white, VAMP8 in black, VAMP8Ala (T47A, T53A, S54A) in blue and VAMP8Glu (T47E, T53E, S54E) in red. VAMP8 siRNA reduced secretion, which was rescued by VAMP8 overexpression. VAMP8Ala further enhanced secretion, whereas VAMPGlu failed to rescue the siRNA effect (n = 12). Values are mean ± SEM; ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_4-B</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Single-site phosphomimetic mutant of VAMP8 failed to rescue the VAMP8 siRNA effect (n = 11). Values are mean ± SEM.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_4-C-D</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C. Immunocytochemistry of VAMP8 imaged at the plasma membrane using TIRF microscopy, following 4 minutes of antigen stimulation. Endogenous VAMP8 was knocked down with siRNA. Expressed wild type VAMP8 and VAMP8Ala (T47A, T53A, S54A) quickly assumed a uniform plasma membrane stain (due to VAMP8 vesicles fusion), whereas VAMP8Glu (T47E, T53E, S54E) showed a punctate stain, representing vesicles docked at the plasma membrane without fusion. Scale bar 10 µm. D. Identification of puncta in TIRF immunocytochemistry images using MATLAB (see Method). Identified puncta are shown in white in the middle image. Scale bar 10 µm.</text>
    </passage>
  </document>
  <document>
    <id>5010044 Figure_4-E</id>
    <infon key="sourcedata_document">2070</infon>
    <infon key="doi">10.15252/embj.201694071</infon>
    <infon key="pmc_id">5010044</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Quantification of relative puncta density in TIRF immunocytochemistry images (n = 15, in total &gt;400 cells per condition). Values are mean ± SEM; ***P &lt; 0.001.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_1-A</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. The localization of NSUN3 was analysed in HEK293 cells stably expressing NSUN3-GFP (green). NSUN3-GFP and staining with a Mitotracker (red) are shown separately and in an overlay with DAPI to indicate nuclei. The scale bar represents 5 m.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_1-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. To analyse submitochondrial localization of NSUN3, human mitochondria were isolated and either left untreated, swollen in hypotonic buffer (Mitoplasts) or solubilized by sonication (Sonic.) before treatment with different amounts of Proteinase K (PK) where indicated, followed by SDS-PAGE and Western blotting using antibodies against humanTIM44, TIM23, TOM70 or FLAG-tagged NSUN3. Note that TIM44 localises to the matrix, while the N-terminus of TIM23 localises to the intermembrane space and TOM70 is largely exposed on the mitochondrial surface. The asterisk indicates a cross-reaction of the TOM70 antibody.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_2-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. HEK293 cells expressing NSUN3-HisPrcFLAG (NSUN3) or the HisPrcFLAG-tag alone (FLAG) were either not crosslinked (-), UV crosslinked (UV) or treated with 5-azacytidine (5-AzaC). The protein-RNA complexes were affinity purified and the bound RNA was trimmed, end-labelled with 32P phosphate and ligated to linkers. Protein-RNA complexes were separated by SDS-PAGE, transferred to nitrocellulose and exposed to an X-ray film.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_2-G</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. 5-AzaC crosslinking was performed and RNA associated with wildtype NSUN3, the catalytically inactive NSUN3 mutant (C265A) or the FLAG tag alone was isolated as described in (B). The RNA analysed by northern blot using probes against the mt-tRNAMet, mt-tRNAPro and mt-tRNAGlu. Inputs (0.1%) are shown on the left and eluates (50%) on the right.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_3-A</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. In vitro methylation reactions were performed using recombinant His14-MBP-NSUN3 (NSUN3) or the catalytically inactive mutant His14-MBP-NSUN3-C265A (C265A), 3H-labelled S-adenosyl methionine as a methyl group donor and in vitro transcribed mt-tRNAMet, mt-tRNAPro and mt-tRNAGlu. The RNA was then separated on a denaturing polyacrylamide gel, stained with ethidium bromide (EtBr) to indicate inputs and exposed to an X-ray film to analyse methylation (3H-Me).</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_3-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The distribution of Illumina sequence reads along the mt-tRNAMet sequence obtained from CRAC experiments with NSUN3 after UV (light grey) or 5-AzaC crosslinking (dark grey) is given as reads per million mapped reads. The position of the anticodon is indicated by a bar.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_3-D</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. In vitro methylation assays were performed as described in (A) with His14-MBP-NSUN3 and in vitro transcribed wildtype mt-tRNAMet and cytidine mutants of the anticodon stem and loop region indicated in (C). Two exposure times of X-ray films are shown: 16 hours (short), 3 days (long).</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_3-E</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. In vitro methylation assay of in vitro transcribed mt-tRNAMet and chemically synthesized mt-tRNAMet containing an m5C modification at the wobble position. The experiment and analysis were performed as described in (A).</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_4-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. In vitro methylation assays using [3H-methyl]-labelled S-adenosyl methionine, the in vitro transcripts of the mt-tRNAMet mutants described in (A) and recombinant His14-MBP-NSUN3. RNA was then separated on a denaturing polyacrylamide gel, stained with ethidium bromide (EtBr), dried and exposed to an X-ray film to detect methylated transcripts (3H-Me).</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_5-A</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. The localization of ABH1 was analysed by immunofluorescence in HEK293 cells. ABH1 (green) localisation and mitochondria stained with a Mitotracker (red) are shown separately and in an overlay with DAPI to indicate nuclei. The scale bar represents 5 m.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_5-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. HEK293 cells expressing ABH1-HisPrcFLAG (ABH1) or the HisPrcFLAG-tag alone (FLAG) were UV crosslinked (UV) and protein-RNA complexes were affinity purified. Co-precipitated RNA was isolated and analysis by northern blot using probes against the mt-tRNAMet, mt-tRNAPro and mt-tRNAGlu. Inputs (0.1%) are shown on the left and eluates (50%) on the right.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_6-A</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. In vitro transcribed mt-tRNAMet was methylated at C34 using recombinant NSUN3 and 3H-labelled S-adenosyl methionine as a methyl group donor. Radiolabelled mt-tRNAMet was re-extracted and then subjected to oxidation assays without protein (-), with maltose binding protein (MBP), with the dioxygenase FTO or using wildtype (ABH1) or mutant (R338A, D233A) His14-MBP-ABH1. Besides ABH1 controls lacking a-ketoglutarate (KG) or Fe2+ ions, all samples contained a-ketoglutarate and Fe2+ ions. After oxidation, RNA was precipitated and tritium released upon oxidation of radiolabelled mt-tRNAMet was quantified in the supernatant and counts per minute (CPM) are shown for experiments performed in triplicate with error bars indicating ± SD (upper panel). Pelleted RNA was separated on a denaturing polyacrylamide gel and exposed to an X-ray film to analyse the tritium retained (3H-Me).</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_6-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Synthetic anticodon stem loop (ASL) was radioactively labelled and subjected to oxidation assays that were performed and analysed as described in (A) using no protein (-), MBP or wildtype His14-MBP-ABH1 (ABH1). Experiments were performed in triplicate with error bars indicating ± SD.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_6-C</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Anion exchange HPLC analysis was performed on synthetic m5C containing ASL (20nt) before and after oxidation by ABH1. The small shift in retention time indicates formation of f5C modified RNA. The ABH1 oxidation product was then treated with NaBH4 to generate hm5C-modified RNA. All three samples were analysed by ESI-MS and the molecular weight (m.w.) is indicated on the HPLC trace. Only the f5C-containing RNA was labelled efficiently with 1-ethyl-2,3,3-trimethylindoleninium-5-sulfonate (TMI).</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_6-D</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. The different retention times of m5C, hm5C and f5C-modified ASL RNA were confirmed by co-injection of samples shown in (C). HPLC was performed as in C.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_7-A</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. MTIF2-dependent reading of initiation codons AUG, AUA or AUU in the P site of the ribosome by unmodified (unmod.) or C34-modified [14C]Met-tRNAMet. Binding was determined by nitrocellulose filtration and [14C]Met-tRNAMet retrieved on the membrane was quantified by scintillation counting. Binding in the absence of ribosomes (no 70S) or mRNA (no mRNA) served as controls. Data from three independent experiments are presented with error bars indicating ± SEM. The statistical significance of the results was analysed by T-test and is indicated by the asterisks in the graph.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_7-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. TUFM-dependent recognition of A site codons during elongation. Data from three independent experiments are presented with error bars indicating ± SEM and statistical analysis as in (A).</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_8-A</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. HeLa cells were transfected with two different siRNAs against NSUN3 (siNSUN3_1, siNSUN3_2), ABH1 (siABH1_1, siABH1_2) or with nontarget (siNT) siRNA and the knockdown efficiency was analysed by quantitative PCR. The relative abundance of the NSUN3 or ABH1 mRNA was normalized to GAPDH levels. Data are presented as mean ± SD.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_8-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Chemically synthesised f5C modified mt-tRNAMet and total RNA from wild-type (WT) cells or those transfected with siRNAs as in (A) were treated with TMI to specifically label f5C residues. Primer extension, using a radiolabelled antisense primer, was performed under limited dNTP conditions. Products were separated on a denaturing polyacrylamide gel alongside a sequencing ladder and RNAs were detected using a phosphorimager.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_8-C</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Primer extension reactions were performed on total RNA from cells transfected with siRNAs as described in B. Stops corresponding to position C34 in mt-tRNAMet were quantified in three independent experiments and results are shown graphically as mean ± SD.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_8-D</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. RNA from wild-type HeLa cells and cells treated with siRNAs against NSUN3 or ABH1 (as in A) was either first reduced with NaBH4 or directly treated with bisulfite. After deamination and desulfonation, mt-tRNAMetRNAs were reverse transcribed, amplified, cloned and sequenced. The proportions of thymine (grey) generated by bisulfite-conversion or non-converted cytosine (black) at position 34 of mt-tRNAMet are shown. Note that for sequences from non-reduced samples, thymine can originate from unmodified or f5C-containing mt-tRNAMet, while in reduced samples it originates from unmodified cytosine.</text>
    </passage>
  </document>
  <document>
    <id>5048346 Figure_9-A-B</id>
    <infon key="sourcedata_document">2225</infon>
    <infon key="doi">10.15252/embj.201694885</infon>
    <infon key="pmc_id">5048346</infon>
    <infon key="figure">Figure 9-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A. HeLa cells were treated with non-target siRNAs (siNT) or those targeting NSUN3 (siNSUN3_1 or siNSUN3_2) or ABH1 (siABH1_1 or siABH1_2) for 72 h before labelling of mitochondrial translation products with [35S]methionine. Protein samples were separated by SDS-PAGE then transferred to a membrane. Labelled proteins were detected using a phosphorimager and the levels of tubulin were determined by western blotting using an antibody against the endogenous protein for normalisation. B. Mitochondrially-translated proteins that could be clearly detected were quantified in three independent experiments and the results are shown graphically as mean ± SD.</text>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_1-A-E</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 1-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Consecutive in vivo imaging of the same apical dendrites from layer V pyramidal neurons in the somatosensory cortex over 7 weeks reveals formation and elimination of dendritic spines (white and empty arrowheads, respectively) in WT and APP-KO mice. All mice were housed in standard conditions. Scale bar - 10 μm. (B-E) Graphical representations of the relative spine density, spine turnover rate (TOR), elimination and formation over the imaging period. Non-linear regression (F test) has been used for fitting the data points and comparing the difference between groups. N=4 mice per group ** p&lt;0.01.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">3</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="74" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_2-A-B-C</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 2-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Consecutive in vivo imaging of the same apical dendrites from layer V pyramidal neurons in the somatosensory cortex over 46 days reveals formation and elimination of dendritic spines (white and empty arrowheads, respectively) in WT and APP-KO mice. Prior to the exposure to environmental enrichment (EE), all mice were housed in standard conditions. Scale bar - 10 μm. (B-C) Graphical representations of the relative spine density and spine elimination over the period of the exposure of mice to EE. Non-linear regression (F test) has been used for fitting the data points. Repeated one-way ANOVA was performed followed by Dunnett test. WT n=5 mice and APP-KO n=6 mice; * p&lt;0.05, ** p&lt;0.01, NS - no significant difference.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="74" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_3-A-B-C</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 3-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Typical confocal images of apical dendrites with spines (z-projections) from layer V pyramidal neurons in the somatosensory cortex of WT and APP-KO mice (top and bottom) housed in standard and enriched environments (left and right). For classification of spine types, 3D reconstructions by Imaris have been applied. Thin, mushroom and stubby spines are encoded in blue, green and red, respectively. Scale bar represents 2 μm. (B-C) Summary plots of thin and mushroom spine fractions in WT and APP-KO mice exposed to standard (SE) and enriched environments (EE). . Two-tailed Student t-test was used and n=6 mice in all experimental groups; * p&lt;0.05, ** p&lt;0.01, NS - no significant difference.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">35</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="89" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_4-A</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Extracellular D-serine concentrations in cortex were detected by enzyme-based microelectrode biosensors.</text>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_4-B-C</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 4-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) High performance liquid chromatography was performed to quantify total D-serine and L-serine contents in mousebrain of two genotypes. APP-KO mice were fed with D-serine over one month. One-way ANOVA was used for analysis followed by Bonferroni's multiple comparisons test and n&gt;6 mice per group; * p&lt;0.05, ** p&lt;0.01 as compared to WT.</text>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_5-A-G</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 5-A-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-G</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Consecutive in vivo imaging of the same apical dendrites from layer Vpyramidal neurons in the somatosensory cortex of APP-KO mice housed under standard or enriched environment. Note that both groups of mice received D-serine after the second imaging time point (8 d); white and empty arrowheads point to newly formed and eliminated spines, respectively. Scale bar - 10 μm. (B) Spine TOR prior and during continuous D-serine treatment. (C, D) Summary plots of the fraction of spine elimination and formation in APP-KO mice before and after D-serine treatment (8 d and 46 d, respectively). (E) Relative spine densities in D-serine treated APP-KO mice housed under standard and enriched environments. (F, G) Summary plots of the fraction of thin and mushroom spines in control and D-serine treated APP-KO mice. For illustration purpose, the control data from Figure 2 B and C are presented also here. Non-linear regression (F test) has been used for fitting the data points. Two-tailed Student t-test was used in (C-D, F-G) and repeated one-way ANOVA was performed followed by Dunnett test in (B and E). N=5 mice in each group; * p&lt;0.05, ** p&lt;0.01, NS - no significant difference.</text>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <infon key="identifier">CL:0000598</infon>
        <location offset="73" length="17"/>
        <text>pyramidal neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_6-A</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Quantification of total distance that mice traveled for 10 min.</text>
    </passage>
  </document>
  <document>
    <id>5069548 Figure_6-B</id>
    <infon key="sourcedata_document">2247</infon>
    <infon key="doi">10.15252/embj.201694085</infon>
    <infon key="pmc_id">5069548</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) The ratios of mice explored between novel and familiar objects. Lines in boxes indicate mean levels and whiskers represent the data from minimal to maximal range. The box extends from 25% to 75% of values. Wilcoxon signed-rank test was performed to compare data to the hypothetical value 1. N=9-12 mice per group; * p&lt;0.05, ** p&lt;0.01, NS - no significant difference.</text>
    </passage>
  </document>
  <document>
    <id>5069551 Figure_1-A-B-C</id>
    <infon key="sourcedata_document">2262</infon>
    <infon key="doi">10.15252/embj.201695290</infon>
    <infon key="pmc_id">5069551</infon>
    <infon key="figure">Figure 1-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>A. NS1 dimer with one subunit in grey and the other colored by domain (green, β-roll; orange, wing with magenta connector subdomain; blue, central β-ladder). N-linked glycosylation sites are shown in sticks, and the glycans are shown in spheres. B. Topology diagram for the NS1 monomer, colored as the pattern in (A). Glycosylation sites are indicated with red hexagons and disulfide bonds with yellow circles. C. Side views of the NS1 dimer from the wing (left) and the end of the β-ladder (right). The β-roll (green), connector subdomain (orange) and the intertwined loop (yellow) of the wing domain form a discontinuous protrusion on one face of the β-ladder with the spaghetti loop (cyan) on the other face. The wing domain is omitted from the left image for clarity.</text>
    </passage>
  </document>
  <document>
    <id>5069551 Figure_2-A</id>
    <infon key="sourcedata_document">2262</infon>
    <infon key="doi">10.15252/embj.201695290</infon>
    <infon key="pmc_id">5069551</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>The ZIKVNS1 hexamer is modeled by using the full-length DENV2NS1 structure (PDB code: 4O6B) (Akey et al, 2014). Each monomer is colored by domains (green, β-roll; orange, wing; magenta, connector subdomain; blue, central β-ladder). The intertwined loop "spike" of ZIKVNS1 contributing to membrane association is colored in red and indicated by dotted lines.</text>
    </passage>
  </document>
  <document>
    <id>5069551 Figure_3-A-B-C</id>
    <infon key="sourcedata_document">2262</infon>
    <infon key="doi">10.15252/embj.201695290</infon>
    <infon key="pmc_id">5069551</infon>
    <infon key="figure">Figure 3-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>ABC. Electrostatic surface views of NS1 from DENV2 (PDB: 4O6B, A) and WNV (PDB: 4O6C, B) (Akey et al, 2014), as well as ZIKV©, showing diverse characteristics on certain regions. Surfaces are colored by electrostatic potential at neutral pH from -2 kT (red) to +2 kT (blue) using PyMOL (http://pymol.org/).</text>
    </passage>
  </document>
  <document>
    <id>5069551 Figure_4-A</id>
    <infon key="sourcedata_document">2262</infon>
    <infon key="doi">10.15252/embj.201695290</infon>
    <infon key="pmc_id">5069551</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. The NS1 surface is colored using the ConSurf server (Ashkenazy et al, 2016) according to sequence conservation from the most conserved (dark magenta) to the most divergent (dark cyan) based on an alignment of NS1 sequences from 73 flaviviruses.</text>
    </passage>
  </document>
  <document>
    <id>5069551 Figure_4-B</id>
    <infon key="sourcedata_document">2262</infon>
    <infon key="doi">10.15252/embj.201695290</infon>
    <infon key="pmc_id">5069551</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Models of intertwined loop "spike" interacting with the cellular membrane. The disordered "spike" regions are indicated by dash lines in DENV2 and WNVNS1 structures, which consist of hydrophobic or positively charged amino acids.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_1-A</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Immuno-precipitations of extracts from asynchronous S2 cells using 1 μg of the indicated antibodies at 4°C overnight. The control antibody (ab) is a rabbit anti-yeast Mad2.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_1-B</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Single confocal section of a population of S2 cells. Examples of interphase cells are boxed in blue. Mitotic cells positive for the anti-phosphoHistone3 (pH3) are boxed in red.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_1-C</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Single confocal section of a S2 cell. Anti-Incenp, anti-Cid mark the centromeric chromatin and the inner KT, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_1-D-E</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 1-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D-E) Maximal projections of S2 cells imaged by STED microscopy. 7 z-sections for a total of 1.5 um (D) and 4 z-sections for a total of 0.5 um (E) are shown. Anti-CenpC and anti-Spc105R mark the proximal and the distal region of different portions of the outer KT, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_1-F-G</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 1-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F-G) Single confocal sections of S2 cells at the indicated mitotic stages stained to detect Snap29, nuclear pores (WGA), and CyclinB (F), or Snap29, Spc105R, and the nuclear lamina (LaminA) (G). Note the transient perinuclear enrichment of Snap29 in early prophase. WGA stains also cytoplasmic speckles in hemocyte-derived S2 cells (Rizki &amp; Rizki, 1983). High magnification of the insets in C-G shows localization of Snap29 relative to the indicated markers.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">33</infon>
        <infon key="identifier">CL:0000387</infon>
        <location offset="307" length="8"/>
        <text>hemocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_1-H-I-J</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 1-H-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_1-H-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>(H-J) Immuno-gold localization of Snap29 in cryo-sections of S2 cells in pro-metaphase. Pseudo-coloring in red identifies chromosomes (Ch), in yellow membrane organelles and in green MTs. The white arrows in H-I indicate examples of signal in the nucleoplasm that is not associated to membranes, but rather, to electron-dense material. MVB: multivesicular body; NE: nuclear envelope; PM: plasma membrane.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_2-A</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Comparable maximum projections of confocal sections of the dorsal wing pouch portion of third instar larvalimaginal discs. A cartoon of full length Snap29 is shown above the control panel.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_2-B</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Quantification of the Snap29 signal as in panel A, considering &gt; 30 KTs per sample. Relative mRNA expression of the downregulated genes versus control, measured by Q-PCR, is shown above the graph. Note that efficient depletion of Zw10 does not affect Snap29 localization to KTs.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_2-C-D</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Comparable maximum projections of confocal sections of dorsal wing pouches in which Snap29 has been downregulated and the indicated Snap29 form over-expressed. Cartoons of the expressed Snap29 mutant forms are shown above the panels. Anti-pH3 labels mitotic cells and CenpC marks KTs. (D) Quantification of Snap29 as in panel C, considering &gt; 28 KTs per sample. Note that expression of a form of Snap29 lacking the SNARE1 domain does not rescue Snap29 localization to KTs in Snap29 RNAi cells.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_3-A</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Selected frames of time-lapse imaging of control S2 cells or cells treated for 96 hrs with dsRNA against the central portion of Snap29. Note that depleted cell does not display a recognizable metaphase plate, or fail to segregate all chromosomes correctly, or form tripolar spindles or micronuclei (arrowheads; arrowheads in control point to cells dividing normally).</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_3-B</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Western blotting of extract from control cells and cells depleted of Snap29 (dsSnap29) relative to the experiment in a.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_3-C</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Quantification of the mitotic phenotype of control and dsSnap29 depleted cells, based on time-lapse imaging of an average of &gt; 28 individual cells per sample. P value is determined by two-tailed t-test considering all defects together.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_3-D</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Selected frames of time-lapse imaging of control U2OS cells and U2OS cells treated for the indicated time. Note that the depleted cell at 48-66h display altered metaphase plate and chromosome segregation (arrowheads).</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_3-E</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Western blot analysis of extracts relative to the experiments in panel d.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_4-A-B</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Single confocal sections of HeLa cells at metaphase treated for 8 min at 4°C and immunostained to reveal the presence of unattached kinetochores. CENPT labels all KTs, while MAD1 identifies unattached ones. Enlargements of boxed areas displaying both chromosomes aligned and not aligned at the metaphase plate. (B) Quantification of the number of KTs based on attachment, position and MAD1 positivity. Each point per category represents one experiment in which 10 random KTs/cell of 20 cells/sample were counted. P values are obtained by 2-way ANOVA with Dunnett's multiple comparison test. Note that in control cells most of the KT are attached, MAD1-negative and aligned to the metaphase plate, while in SNAP29KD cells half of the KTs that are unattached, MAD1-positive and not aligned to the metaphase plate.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_4-C-D</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 4-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Single confocal sections of HeLa cells. CREST and CENPT were used to label the centromere region and associated KTs, respectively. Enlargements of boxed areas displaying both chromosomes aligned and not aligned at the metaphase plate are shown. (D) Average of the inter KT distance based on in each of which 10 chromosomes/cell and 10 cells/sample were counted. P values are obtained by Kruskal-Wallis test with Dunn's multiple comparison analysis. Note that both aligned and not aligned KTs have a shorter inter KT distance compared to aligned control KTs.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_4-E-F</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 4-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Single confocal sections of HeLa cells at metaphase stained to visualize the mitotic spindle and DNA. (F) Averaged spindle pole length based on &gt;20 cells with bipolar spindles/sample. The P value is obtained by two-tailed paired t-test.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_5-A</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C, E) Max projection of single control and SNAP29 KD HeLa cells treated with 2 mM thymidine for 24 hrs, released in normal medium for 8 hrs and arrested in prometaphase with Nocodazole for 2 hrs.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_5-B</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C, E) Max projection of single control and SNAP29 KD HeLa cells treated with 2 mM thymidine for 24 hrs, released in normal medium for 8 hrs and arrested in prometaphase with Nocodazole for 2 hrs.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_5-C</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C, E) Max projection of single control and SNAP29 KD HeLa cells treated with 2 mM thymidine for 24 hrs, released in normal medium for 8 hrs and arrested in prometaphase with Nocodazole for 2 hrs.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_5-D</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Immunoblotting of HeLa protein extracts, treated as indicated.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_5-E</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C, E) Max projection of single control and SNAP29 KD HeLa cells treated with 2 mM thymidine for 24 hrs, released in normal medium for 8 hrs and arrested in prometaphase with Nocodazole for 2 hrs.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_5-F</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Quantification of 3 independent experiments evaluating the localization of the KT factors shown in A-C, e relative to CREST. 100 KTs from 10 control cells and 200 KTs from 10 SNAP29 KD cells per sample were identified by CREST staining. P values are obtained by 2-way ANOVA with Sidak's multiple comparison analysis relative to localization of HEC1, which is not lost on SNAP29KD cells.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_6-A-D</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 6-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-C) KNL1 localization analysis in control, SNAP29 KD and SNAP29 KD expressing full length human SNAP29, CFP tagged, full length Drosophila Snap29 (CFP-Snap29), or the mutant forms schematized above the panels. Max projections of single cells in prophase are shown. (D) Quantification of 3 independent experiments evaluating the localization of KNL1 relative to CREST. 200 KTs from 10 control cells and 200 KTs from 10 SNAP29 KD cells per sample were identified by CREST staining. P values are obtained by 2-way ANOVA with Dunnett's multiple comparison analysis relative to localization of KNL1 in SNAP29KD cells.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_6-E-F</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 6-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(E-F) Single confocal sections of HeLa cells in interphase overexpressing the indicated constructs. In cells expressing SNAP29 Q1 Q2, SNAP29 and KNL1 accumulate in large compartments that are often positive for p62 (arrows).</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_7-A-B</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 7-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) Confocal sections of wild-type and Snap29 mutant eye-antennal imaginal discs (eye disc portion to the left) of L3 larvae. Discs were labeled with phalloidin and DAPI to visualize the subcortical f-actincytoskeleton and nuclei, respectively. Arrowheads in B point to actin-rich unpolarized cells in apical, medial and basal sections of the same disc.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_7-C</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) High magnification of a single confocal cross-section of wild-type and Snap29 mutant eye disc tissues. Two facing folds of the tissue are separated by the apical lumen. aPKC and Dlg mark the apical and lateral plasma membrane domains, respectively. In Snap29 mutant tissue the apical-basal polarity is disrupted.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_7-D</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Single confocal cross-sections of wild-type and Snap29eye-antennal discs, expressing Puckered-LacZ (Puc-lacZ), a reporter of JNK signaling activation.</text>
    </passage>
  </document>
  <document>
    <id>5069552 Figure_7-E-H</id>
    <infon key="sourcedata_document">2267</infon>
    <infon key="doi">10.15252/embj.201693991</infon>
    <infon key="pmc_id">5069552</infon>
    <infon key="figure">Figure 7-E-H</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E-H</infon>
    <passage>
      <offset>0</offset>
      <text>(E-H) Single confocal cross-sections of wild-type and Snap29eye-antennal discs (E-F), and of otherwise wild-type and Snap29eye-antennal discs expressing the bacterial apoptosis inhibitor p35 (G-H). Anti-activated-Caspase 3 (Casp3) marks apoptotic cells.</text>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_1-A</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Viability analysis of GICs treated with the α-AR antagonists prazosin, ARC 239, doxazosin, BMY 7378, and terazosin. GICs were treated with the antagonists or corresponding vehicles for 72 h, and viability was assayed using WST-1. *P&lt;0.05, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">1</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="25" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">8</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="119" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_1-B</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Quantification of GICsurvival using trypan blue exclusion after 24 h and 72 h of treatment with prazosin. *P=0.0286, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">12</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="21" length="3"/>
        <text>GIC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_1-C</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Viability analysis of patient-derived GICs (TG1, TG16, GBM5, GBM44) and NSCs (NSC24, NSC25, NSC5031, NSC8853) treated with prazosin for 72 h. *P=0.0286, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">29</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="41" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">22</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="75" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_1-D</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Analysis of the sphere-forming capabilities of GICs using the extreme limiting dilution assay. Cells were seeded in presence of vehicle or 30 µM prazosin (PRZ). Sphere formation was scored 10 days post-seeding. Frequency of sphere-forming cells: Control=1/3.88 (lower 8.61, upper 1.95); prazosin 1/248 (lower 1003, upper 62), n=12, p= 1.13 10-10. Overall test for difference in stem cell number between groups.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">34</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="50" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_1-E</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Viability analysis of GICs treated with prazosin after sorting cells according to their expression of EGFR, and the neural stem cell markers CD15 and CD133. Prazosin inhibits cell viability regardless of CD133 or CD15 expression. *P=0.0286, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">44</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="25" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_1-F</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Imunocytochemical staining of NSCs and GICs cultured in media favoring neuronal (ß3-tubulin), astroglial (GFAP) or oligodendroglial (O4) differentiation (Diff media). ß3-tub: ß3-tubulin.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">55</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="33" length="4"/>
        <text>NSCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">56</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="42" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_1-G</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Viability analysis of differentiated NSCs and GICs treated with prazosin for 72 h. Diff: differentiation. *P=0.0286, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">61</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="40" length="4"/>
        <text>NSCs</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">62</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="49" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_2-B-C</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C. In vivo effect of prazosin treatment (1.5mg/Kg) on glioblastoma growth. Tumors were initiated with GBM44GICs (B) or GMB5GICs (C). Left panels: Bioluminescent in vivo images of tumors in mice treated with prazosin (PRZ) or vehicle for 45 days. Middle panels: Quantification of the bioluminescent signals. Fold change in total flux represents the ratio: total flux after treatment/total flux before treatment. *P=0.0002 and *P=0.003 for GBM44 and GBM5 respectively, n=8, two-sided Mann-Whitney U-test. Right panels: Kaplan-Meyer survival curves of mice treated with prazosin (PRZ) or vehicle demonstrating a significant survival benefit of prazosin as compared to vehicle, log-rank Mantel-Cox test. The treatment period is shaded in gray.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">68</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="110" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">69</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="126" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_2-D</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Example of hematoxilin/eosin staining of brain coronal sections from mice sacrificed after 45 days of treatment with prazosin (PRZ) or vehicle. i: tumor infiltration. n: tumor necrosis. Scale bar = 2 mm. GBM44GICs.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">96</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="212" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_2-E</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Left panel: Representative flow cytometry plots depicting the percentage of CD133+glioblastoma cells (GFP+) isolated from mice treated with prazosin (PRZ) or vehicle. Tumors were initiated with GBM44GICs. Right panel: Quantification of flow cytometry analyses of CD133 expression by GFP+-tumor cells isolated from xenografts of three prazosin-treated (PRZ) mice and three vehicle-treated mice. *P=0.0003, n=6, two-sided Mann-Whitney U-test.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="202" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_2-F</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Secondary grafting of tumor cells (GBM44-GFP+) isolated from vehicle or prazosin-treated mice bearing primary tumors. Mice injected with glioblastoma cells isolated from prazosin-treated mice developed tumors at a lower frequency (50% versus 100%). Moreover, mice injected with glioblastoma cells isolated from prazosin-treated mice presented a statistically significant survival benefit. Left Panel: Bioluminescent in vivo images of secondary grafts. Middle panel: Quantification of the bioluminescent signals. *P=0.0004, n=8, two-sided Mann-Whitney U-test. Right panel: Kaplan-Meyer survival curves of mice bearing secondary graft from glioblastoma cells isolated from vehicle- and prazosin-treated mice.</text>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_2-G</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Inhibitory effect of low doses of prazosin (0.15 mg/Kg) on glioblastoma growth in vivo. Left panel: Bioluminescent in vivo images of tumors in mice treated with vehicle or prazosin (PRZ) for 45 days. Tumors were initiated with GBM44GICs (compare with panel B). Middle panel: Quantification of the bioluminescent signals. *P=0.0007, n=8, two-sided Mann-Whitney U-test. Right panel: Kaplan-Meyer survival curves of mice demonstrating a significant survival benefit of a treatment with low doses of prazosin, log-rank Mantel-Cox test. The treatment period is shaded in gray.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">149</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="235" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_3-A</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Viability analysis of GL261 treated with prazosinin vitro. *P=0.0286, n=4, two-sided Mann-Whitney U-test.</text>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_3-C</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Prazosin inhibits in vivo tumorgrowth in an immunocompetent model of glioblastoma. Left panel: Bioluminescent in vivo images of tumors in C57/Bl6mice treated with vehicle or prazosin (PRZ) for 14 days. Middle panel: Quantification of the bioluminescent signals. *P=0.0002, n=8, two-sided Mann-Whitney U-test. Right panel: Kaplan-Meyer survival curves of mice treated with prazosin (PRZ) or vehicle. log-rank Mantel-Cox test. The treatment period is shaded in gray.</text>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_3-D</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Hematoxilin/eosin staining of C57/Bl6micebrain coronal sections sacrificed after 14 days of treatment with prazosin. Scale bar = 2 mm.</text>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_3-E</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Fluorescence imaging of GL261 intra-striatal grafts at 1 and 2 h after an intra-peritoneal injection of BODIPY FL prazosin, the green-fluorescent derivative of prazosin. Scale bar = 2 mm.</text>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-A</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Immunoblotting for pro-caspase-3 (pro-CASP3) and active caspase-3 (CASP3) in GICs treated with prazosin (PRZ) or vehicle (V) demonstrating that prazosin activates caspase-3. ZVAD, a caspase inhibitor, prevents prazosin-induced caspase-3 activation. kDa: kilodaltons.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">197</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="80" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-B</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Immunoblotting for pro-caspase-9 (pro-CASP9) and active caspase-9 (CASP9) in GICs treated with prazosin (PRZ) or vehicle (V) demonstrating that prazosin does not activate caspase-9.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">209</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="80" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-C</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Viability analysis of GICs treated with prazosin for 24h in the presence or absence of ZVAD, a caspase inhibitor. ZVAD counteracts prazosin-induced GIC death. *P=0.0286, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">215</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="25" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">220</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="151" length="3"/>
        <text>GIC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-D</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Prazosin induces glioblastoma cell apoptosis in vivo. GFP+ and GFP- cells were analyzed from tumors in vehicle or prazosin-treated mice. Annexin V / DAPI staining was used to identify apoptotic cells by FACS. Tumors were initiated by GBM44GICs implantation.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">235</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="242" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-E</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Dose-response curve of prazosin on GICsurvival (24h treatment). EC50 was determined with curve fit using nonlinear regression.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">237</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="38" length="3"/>
        <text>GIC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-F</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Viability analysis of GICs treated with prazosin for 24h in the presence or absence of cirazoline, a subtype agonist of the α-ARs. Cirazoline did not alter GICsurvival and counteracted only poorly prazosin-induced GIC death. *P&lt;0.05, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">244</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="25" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">246</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="159" length="3"/>
        <text>GIC</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">249</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="217" length="3"/>
        <text>GIC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-G</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Membrane binding assays demonstrating the absence of prazosin binding sites in GICmembrane preparations. Positive control shows that prazosin binds to membrane preparations of yeast expressing 1-AR. PRZ: prazosin. CRZ: cirazoline.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">256</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="82" length="3"/>
        <text>GIC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-H</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. Immunoblotting for phosphorylated ERK1/2 (P-ERK1/2) and total ERK1/2 following prazosin treatment for 30 min. Prazosin induces ERK1/2 phosphorylation in GICs.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">272</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="156" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-I</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-I</infon>
    <passage>
      <offset>0</offset>
      <text>I. SRE-luciferase reporter activity analysis of GICs treated with prazosin in absence or presence of U0126 (10 μM), an inhibitor of the ERK-activating kinase MEK. U0126 prevented prazosin-induced SRE-luciferase activation in GICs.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">280</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="48" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">286</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="225" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_4-J</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 4-J</infon>
    <infon key="sourcedata_figure_dir">Figure_4-J</infon>
    <passage>
      <offset>0</offset>
      <text>J. Viability analysis of GICs treated with prazosin for 24 h in the presence or absence of U0126 (10 μM), an inhibitor of the ERK-activating kinase MEK. U0126 did not counteract prazosin-induced GIC death. Blockade of prazosin-induced ERK1/2 phosphorylation by U0126 was confirmed by immunoblotting (insert). PRZ: prazosin.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">291</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="25" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">297</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="195" length="3"/>
        <text>GIC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-A</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. PKCδ expression analysis in two patient-derived GICs and NSCs by immunoblotting. GICs express higher levels of PKCδ than NSCs. kDa: kilodaltons.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">307</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="51" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">308</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="60" length="4"/>
        <text>NSCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">310</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="84" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">312</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="124" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-B</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. PKCδ by immunostaining (green). Nuclei were stained with DAPI (blue). Enhanced PKCδ punctate nuclear expression in prazosin-treated (PRZ, 5µM) GICs, as compared to vehicle-treated GICs. PRZ: prazosin. Scale bar: 10 µm.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">321</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="146" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">322</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="183" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-C</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Total PKCδ (PKCδ 78kDa) and cleaved PKCδ (PKCδ 41kDa) expression analysis in GICs by immunoblotting. Prazosin (PRZ) induces PKCδ cleavage into a 41kDa active fragment. 2 µM rottlerin (Rott), a PKCδ inhibitor, inhibits prazosin-induced PKCδ cleavage. V: vehicle. kDa: kilodaltons.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">331</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="80" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-D</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Pro-caspase-3 (Pro-CASP3) and activated caspase-3 (CASP3) expression analysis in GICs by immunoblotting. 2 µM rottlerin (Rott) inhibits prazosin (PRZ)-induced caspase-3 activation. V: vehicle. kDa: kilodaltons.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">343</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="84" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-E</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Inhibition of PKCδ by rottlerin prevents, in a concentration-dependent manner, prazosin-induced GIC death. Viability analysis of GICs treated with prazosin for 72 h in the presence or absence of rottlerin. *P=0.0286, n=4, two-sided Mann-Whitney U-test.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">353</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="99" length="3"/>
        <text>GIC</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">355</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="132" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-F</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Inhibition of PKCδ by the specific anti-PKCδ RACK peptide δV1.1 (10 μM) counteracts prazosin-induced GIC death. Viability analysis of GICs treated with prazosin for 72 h in the presence or absence of δV1.1. *P &lt; 0.005 for Prazosin 1 and 5 µM and P&lt;0.001 for Prazosin 10 µM by two-tailed unpaired Student's t-test, n=4.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">364</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="104" length="3"/>
        <text>GIC</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">366</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="137" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-G</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Decreased PKCδ expression using shRNA counteracts prazosin-induced GIC death. Viability analysis of GICs transduced with scrambled or PKCδ shRNA and treated with prazosin for 72 h. *P &lt; 0.005 by two-tailed unpaired Student's t-test, n=4.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">375</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="70" length="3"/>
        <text>GIC</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">377</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="103" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-H</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. Prazosin inhibits AKT phosphorylation in GICs. LY294002 (LY, 30 µM), an inhibitor of the PI3K/AKT pathway, was used as positive control. Terazosin, which does not affect GIC viability, does not alter AKT phosphorylation (see the corresponding cell viability counting in Fig EV4C). Phosphorylated AKT (P-AKT) and total AKT (AKT) expression analysis in GICs by immunoblotting. V: vehicle. kDa: kilodaltons.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">387</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="44" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">385</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="173" length="3"/>
        <text>GIC</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">388</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="354" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-I</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I</infon>
    <passage>
      <offset>0</offset>
      <text>I. Prazosin (10 µM) does not inhibit AKT phosphorylation in NSCs. Analysis by immunoblotting. V: vehicle. kDa: kilodaltons.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">400</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="60" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-J</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-J</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J</infon>
    <passage>
      <offset>0</offset>
      <text>J. β-catenin expression, a downstream target of AKT, is decreased in prazosin-treated GICs, as opposed to NSCs. Analysis by immunoblotting. V: vehicle. kDa: kilodaltons.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">405</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="86" length="4"/>
        <text>GICs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">406</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="106" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_5-K-L</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 5-K-L</infon>
    <infon key="sourcedata_figure_dir">Figure_5-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>K. L. Inhibition of PKCδ using rottlerin (Rott, 2 µM) or δV1.1 (10 µM) counteracts prazosin inhibition of AKT phosphorylation. Analysis by immunoblotting. V: vehicle. kDa: kilodaltons.</text>
    </passage>
  </document>
  <document>
    <id>5130115 Figure_6-B-C</id>
    <infon key="sourcedata_document">1531</infon>
    <infon key="doi">10.15252/emmm.201505421</infon>
    <infon key="pmc_id">5130115</infon>
    <infon key="figure">Figure 6-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B. Bioluminescent in vivo images of tumors in mice grafted with GICs expressing either scrambled or PKCδ shRNA. All mice were treated with prazosin (PRZ) for 45 days. C. Quantification of the bioluminescent signals showing that decreased expression of PKC counteracts prazosin inhibition of tumor growth. Fold change in total flux represents the ratio: total flux after treatment/total flux prior treatment. *P=0.0007, n=8, two-sided Mann-Whitney U-test.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">420</infon>
        <infon key="identifier">CL:0000125</infon>
        <location offset="64" length="4"/>
        <text>GICs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_1-A-B</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A,B, Immunostaining for CD31+blood vessels in control (ctrl, A) and Gpr124KO (B) forebrains. Note the normal vasculature in the cortical hem (asterisk) of Gpr124KOmice.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_1-C-D-E</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 1-C-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>C,D, Immunostaining for Pax6 in control (C) and Gpr124KO (D) forebrains to reveal the lateral extension of the neocortex (dashed line) between the cortical hem (arrowhead) and the lateral ganglionic eminence (arrow). E, Quantification of the lateral extension of the cortex in control and Gpr124KObrains (mean±SEM; N=10; *** p&lt;0.001).</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_1-F-G-H</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 1-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>F,G Staining for EdU (red) and Ki67 (green) in control (F) and Gpr124KO (G) cortices at E13.5, 24 hours after EdU injection. H, Quantification of Ki67+NPCs in the VZ (blue), SVZ/CP (grey) and of Ki67-neurons (cyan) generated from EdU-labeled NPCs in control and Gpr124KOembryos (mean±SEM; N=4 (control) and N=3 (Gpr124KO); * p&lt;0.05, ** p&lt;0.01). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">31</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="151" length="4"/>
        <text>NPCs</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">63</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="200" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="20">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">506</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="242" length="4"/>
        <text>NPCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_1-I-J-K</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 1-I-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>I,J, Immunostaining for Tbr2 (red) and Pax6 (green ) in control (I) and Gpr124KO (J) cortices. K, Quantification of newborn BPs in the VZ of control and Gpr124KOcortices (mean±SEM; N=4; * p&lt;0.05). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">53</infon>
        <location offset="124" length="3"/>
        <text>BPs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_1-L-M-N-O</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 1-L-M-N-O</infon>
    <infon key="sourcedata_figure_dir">Figure_1-L-M-N-O</infon>
    <passage>
      <offset>0</offset>
      <text>L,M, Immunostaining for Tbr2 (red) and Ngn1 (green) in control (L) and Gpr124KO (M) cortices. N,O Quantification of neurogenic (Ngn1+) RGs and BPs (N) or expanding (Tbr2-Ngn1-) RGs (O) in control and Gpr124KOcortices (mean±SEM; N=4; * p&lt;0.05, *** p&lt;0.001). Note that the fraction of total BPs is significantly reduced (Fig 1K) while the fraction of Ngn1+BPs is insignificantly reduced (Fig 1N), because the proportion of Ngn1+Tbr2+ cells within all BPs is slightly, though statisically insignificantly higher in the Gpr124KObrains (see Fig S2M). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">67</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="135" length="3"/>
        <text>RGs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">72</infon>
        <location offset="143" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">75</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="177" length="3"/>
        <text>RGs</text>
      </annotation>
      <annotation id="14">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">14</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <location offset="289" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">80</infon>
        <location offset="354" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="19">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">19</infon>
        <infon key="sourcedata_article_annot_id">83</infon>
        <location offset="449" length="3"/>
        <text>BPs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_1-P-Q-R-S</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 1-P-Q-R-S</infon>
    <infon key="sourcedata_figure_dir">Figure_1-P-Q-R-S</infon>
    <passage>
      <offset>0</offset>
      <text>P,Q Stainings for Tbr2 (red) and for Tis21-GFP expression (green) in control (P) and Gpr124KO (Q) cortices. R,S Quantification of neurogenic (Tis21-GFP+) RGs and BPs (R) or expanding (Tbr2-Tis21-GFP-) RGs (S) in control and Gpr124KOcortices (mean±SEM; N=4; *** p&lt;0.001). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">98</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="154" length="3"/>
        <text>RGs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">99</infon>
        <location offset="162" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">103</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="201" length="3"/>
        <text>RGs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_2-A-B</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A,B, Staining for Isolectin B4+blood vessels in control (A) and Gpr124ECcKO (B) forebrains. Asterisks mark the lateral ventricles.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_2-C-D</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 2-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C,D, Staining for pimonidazole (PIMO, green) and Isolectin B4+blood vessels (red) in ctrl (C) and Gpr124ECcKO (D) cortices.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_2-E-F-G</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 2-E-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>E,F, Immunostaining for Pax6 in control (E) and Gpr124ECcKO (F) forebrain sections to reveal the lateral extension of the neocortex (dashed line) between the cortical hem (arrowhead) and the lateral ganglionic eminence (arrow). G, Quantification the lateral extension of the cortex in control and Gpr124ECcKObrains (mean±SEM; N=6 for ctrl and N=8 for Gpr124ECcKO; * p&lt;0.05).</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_2-H-I-J</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 2-H-I-J</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H-I-J</infon>
    <passage>
      <offset>0</offset>
      <text>H,I, Staining for EdU (red) and Ki67 (green) in control (H) and Gpr124ECcKO (I) cortices at E13.5, 24 hours after EdU injection. J, Quantification of Ki67+NPCs in the in VZ (blue), SVZ/CP (grey) and of Ki67-neurons (cyan) generated from EdU-labeled NPCs in control and Gpr124ECcKOembryos (mean±SEM; N=4; * p&lt;0.05, ** P&lt;0.01). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">148</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="155" length="4"/>
        <text>NPCs</text>
      </annotation>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">141</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="207" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">153</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="249" length="4"/>
        <text>NPCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_2-K-O</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 2-K-O</infon>
    <infon key="sourcedata_figure_dir">Figure_2-K-O</infon>
    <passage>
      <offset>0</offset>
      <text>K,L, Immunostaining for Tbr2 (red) and Ngn1 (green) in control (K) and Gpr124KO (L) cortices. M-O, Quantification of neurogenic (Ngn1+) RGs and BPs (M), newborn BPs (N) or expanding (Tbr2-Ngn1-) RGs (O) in control and Gpr124ECcKOcortices (mean±SEM; N=4; * p&lt;0.05, ** p&lt;0.01). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">169</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="136" length="3"/>
        <text>RGs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">170</infon>
        <location offset="144" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <location offset="161" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">174</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="195" length="3"/>
        <text>RGs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_3-A</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, qRT-PCR analysis of NSC-specific markers (Fabp7, Hes5) and neuronal markers (Dcx, Tubb3) in the Prom1+ fraction, presented as fold change compared to the Prom1- fraction) from WT cortices at E14.5 (mean±SEM; N=3 for Dcx; N=6 for all other genes).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">185</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="23" length="3"/>
        <text>NSC</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_3-F-G</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 3-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>F, Western blot for HIF-1 (top), HIF-2 (middle) and a-tubulin as loading control (bottom) using forebrain lysates from E13.5 control (left) or Gpr124KOembryos (middle). HIF-1/2-transfected HEK293 cells served as positive control (right). G, Quantification of HIF-1 band intensities shown in panel F (mean±SEM; N=3; ** p&lt;0.01).</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_3-J</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 3-J</infon>
    <infon key="sourcedata_figure_dir">Figure_3-J</infon>
    <passage>
      <offset>0</offset>
      <text>J, qRT-PCR analysis of HIF-1 target gene expression in VZ cells from the cortex of control and Gpr124KO E13.5 embryos (mean±SEM; N=4; *** p&lt;0.001). SVZ, subventricular zone; VZ, ventricular zone.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_4-A-F</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 4-A-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-F</infon>
    <passage>
      <offset>0</offset>
      <text>A-F, Staining for Isolectin B4 (A-C) and oxidized thiols (D-F) in WT cortices at E10.5 (A,D), E11.5 (B,E) and E12.5 (C,F). Panels D-F are pseudocolor conversions of staining intensity (from low [purple] to high [red]). Arrowheads denote the position of the vascular front.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_4-G-H-I</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 4-G-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>G-I, Immunostaining for HIF-1α (red) and DAPI (blue) in WT cortices at E10.5 (G-G''), E11.5 (H-H'') and E12.5 (I-I''). Panels G',G'',H',H'',I' and I'' are magnifications of the boxed areas in their respective original panels. Arrows point to the border of lateral and dorsal cortex.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_4-J-K-L</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 4-J-K-L</infon>
    <infon key="sourcedata_figure_dir">Figure_4-J-K-L</infon>
    <passage>
      <offset>0</offset>
      <text>J-L, Immunostaining for Glut1 of WT cortices at E10.0 (J), E11.5 (K) and E12.5 (L). Dashed lines indicate the apical border of the cortex. Scale bar: 100 µm (D,F,G,H,I, J-L) or 50 µm (I''), respectively.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_5-A</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, qRT-PCR analysis of HIF-1 and HIF-1 target gene expression in cortices from E13.5 WT and HIF-1αCC+/-embryos (mean±SEM; N=8 for WT and N=5 for HIF-1αCC+/-; * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001).</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_5-B-C-D</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 5-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B,C, Staining for EdU (red) and Ki67 (green) in WT (B) and HIF-1αCC+/- (C) cortices at E13.5, 24 hours after EdU injection. D, Quantification of Ki67+NPCs in the in VZ (blue), SVZ/CP (grey) and of Ki67-neurons (cyan) generated from EdU-labeled NPCs in control and HIF-1αCC+/-brains (mean±SEM; N=4; * p&lt;0.05). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">271</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="150" length="4"/>
        <text>NPCs</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">275</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="202" length="7"/>
        <text>neurons</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">287</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="244" length="4"/>
        <text>NPCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_5-E-I</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 5-E-I</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E-I</infon>
    <passage>
      <offset>0</offset>
      <text>E,F, Immunostaining for Tbr2 (red) and Ngn1 (green) in WT (E) or HIF-1αCC+/- (F) cortices at E13.5. G-I Quantification of neurogenic (Ngn1+) RGs and BPs (G), newborn BPs (H) or expanding (Tbr2-Ngn1-) RGs (I) in control and HIF-1αCC+/-cortices at E13.5 (mean±SEM; N=5; * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.001). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">296</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="141" length="3"/>
        <text>RGs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">297</infon>
        <location offset="149" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="13">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">305</infon>
        <location offset="166" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">308</infon>
        <infon key="identifier">CL:0000681</infon>
        <location offset="200" length="3"/>
        <text>RGs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_5-J-K</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 5-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_5-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>J, Whole mount image of brains from WT or HIF-1αCC+/-mice at P5. K Quantification of cortex area in brain sections from P5 WT or HIF-1αCC+/-mice (mean±SEM; N=8 (WT) or N=6 (HIF-1αCC+/-); * p&lt;0.05).</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_5-L-M-N</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 5-L-M-N</infon>
    <infon key="sourcedata_figure_dir">Figure_5-L-M-N</infon>
    <passage>
      <offset>0</offset>
      <text>L,M, Staining with Hoechst 33248 in P5 WT (L) or HIF-1αCC+/- (M) cortices. N, Quantification of cortical thickness of WT and HIF-1αCC+/-cortices. The double arrow denotes the measured thickness of the cortex. N, Quantification of cortical thickness of WT and HIF-1αCC+/-cortices (mean±SEM; N=8 (WT) or N=6 (HIF-1αCC+/-); *** p&lt;0.001).</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_5-O-R</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 5-O-R</infon>
    <infon key="sourcedata_figure_dir">Figure_5-O-R</infon>
    <passage>
      <offset>0</offset>
      <text>O-Q, Epifluorescent images of the E16.5 cortex, 3 days after in utero electroporation (IUE) with EGFP alone (ctrl, O), wild type HIF-1+EGFP (P) or mutant HIF-1ΔC+EGFP (Q). O',P' and Q' are magnifications of the boxed area in their respective original panel. R, Quantification of EGFP+ cells in the cortical zones VZ/SVZ, IZ and CP shown in O-Q (mean±SEM; N=5; ** p&lt; 0.01,* p&lt;0.05). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_5-S-T-U</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 5-S-T-U</infon>
    <infon key="sourcedata_figure_dir">Figure_5-S-T-U</infon>
    <passage>
      <offset>0</offset>
      <text>S-U, qRT-PCR analysis of NSC marker (S; mean±SEM; N=5; * P&lt;0.05), neurogenic markers (T; mean±SEM; N=5; *** p&lt; 0.001, * p&lt;0.05), and HIF target genes (U; mean±SEM; N=5; ** p&lt; 0.01,* p&lt;0.05) in expanding NPCs (eNPCs) and neurogenic NPCs (nNPCs). Gene expression was normalized to the levels in eNPCs.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">353</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="25" length="3"/>
        <text>NSC</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">354</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="203" length="4"/>
        <text>NPCs</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">362</infon>
        <location offset="209" length="5"/>
        <text>eNPCs</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">363</infon>
        <infon key="identifier">CL:0000468</infon>
        <location offset="231" length="4"/>
        <text>NPCs</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">361</infon>
        <location offset="237" length="5"/>
        <text>nNPCs</text>
      </annotation>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">364</infon>
        <location offset="293" length="5"/>
        <text>eNPCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_6-B-E</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 6-B-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-E</infon>
    <passage>
      <offset>0</offset>
      <text>B-E, Staining for pimonodazole (PIMO, green) and Isolectin B4 (IB4,red) in Gpr124KO (B,C) and control (D,E) cortices after exposure of the pregnant dams to 21% O2 (B,D) or 80% O2 (C,E). Compared to the pimonidazole staining in panels B,C, the intensity of this staining is much weaker in panels D,E. For reasons of clarity, the pimonidazole staining in panels D,E was therefore enhanced, equally in both panels.</text>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_7-A</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A, qRT-PCR analysis of glycolytic enzymes in Prom1+ VZ cells and their Prom1- differentiated progeny (BPs and neurons) in WT cortices at E14.5 (mean±SEM; N=3 (Hk2, Gapdh); N=6 (Eno1; Ldha; ** p&lt;0.01).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">444</infon>
        <location offset="102" length="3"/>
        <text>BPs</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">443</infon>
        <infon key="identifier">CL:0000540</infon>
        <location offset="110" length="7"/>
        <text>neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_7-B</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B, Measurement of lactate secretion from proliferating NSCs, and of NSCs differentiating for 3 days (switch to neurogenesis) or for 7 days (fully differentiated), normalized to cellular protein content (mean±SEM; N=6; *** p&lt;0.001).</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">454</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="55" length="4"/>
        <text>NSCs</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">455</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="68" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_7-C</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C, qRT-PCR analysis of Pfkfb3 expression in proliferating NSCs, transduced with scr or Pfkfb3shRNA#1 (mean±SEM; N=4; * p&lt;0.05).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">460</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="58" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_7-D</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>D, Measurement of lactate secretion from proliferating NSCs transduced with scr or Pfkfb3shRNA#1, normalized to cellular protein content (mean±SEM; N=3; * p&lt;0.05).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">464</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="55" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_7-E</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E, Measurement of mitochondrial respiration rate (oxygen consumption rate, OCRMITO; see supplemental methods) in proliferating NSCs, transduced with scr or Pfkfb3shRNA#1, normalized to cellular protein content (mean±SEM; N=3; N.S., not significant).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">471</infon>
        <infon key="identifier">CL:0000047</infon>
        <location offset="127" length="4"/>
        <text>NSCs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5207321 Figure_7-F-N</id>
    <infon key="sourcedata_document">1415</infon>
    <infon key="doi">10.15252/embj.201592372</infon>
    <infon key="pmc_id">5207321</infon>
    <infon key="figure">Figure 7-F-N</infon>
    <infon key="sourcedata_figure_dir">Figure_7-F-N</infon>
    <passage>
      <offset>0</offset>
      <text>F-H, Epifluorescent images of the E15.5 cortex, 3 days after in utero electroporation (IUE) with EGFP + scr shRNA (F), EGFP + Pfkfb3 shRNA#1 (G) or EGFP + Pfkfb3 shRNA#2 (H). J, Quantification of EGFP+ cells in the cortical zones VZ/SVZ, IZ and CP shown in panels F-H (mean±SEM; N=4 for scr and N=5 for Pfkfb3 shRNAs; * p&lt;0.05, ** p&lt; 0.01, *** p&lt; 0.001). K-M, Epifluorescent images of the mouse cortex after in utero electroporation (IUE) with HIF-1α and scr shRNA (K) or with HIF-1α and two different Pfkfb3 shRNAs (L,M) at E16.5, 3 days after transfection. N, Quantification of EGFP+ cells in the cortical zones VZ/SVZ, IZ and CP shown in K-M (mean±SEM; N=5; * p&lt;0.05, ** p&lt; 0.01, *** p&lt; 0.001). Full, dotted and dashed lines indicate basal and apical boundaries of the cortex or boundaries of the cortical zones, respectively. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone. Scale bar: 100 µm</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_1-A</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Representative nuclear spreads of wild-type pachytene and Rec8−/− pachytene-like spermatocytes. Nuclear spreads were immunostained for SYCP3 and ACA. Magnified views are indicated by dashed areas. Schematic representation on magnified chromosomes represents tightly associated sister-AEs (separated for easier representation) in paired wild-type homologs, and the appearance of two distinguishable/separated sister-AEs once REC8-mediated cohesion is lost in Rec8−/− univalents. Bars, 10 μm in spreads and 1 μm on insets.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">5</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="84" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_1-B</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Representative nuclear spread of zygotene-like Stag3 mutant spermatocytes. Nuclear spreads were immunostained for SYCP3 and ACA. Magnified views are indicated by dashed areas. Schematic representation on magnified univalents represents: separation of sister-AEs (centre) and close association of sister-AEs (right). Bellow: graph showing the percentages of axes with: separation of AEs (dark grey area) and closely associated AEs (light grey area). 414 axes analysed, from 11 nuclei. Bars, 10 μm in spreads and 1 μm on insets.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">13</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="63" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_1-C</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Magnified views of zygotene-like Stag3 mutant univalents with LSAEs. Nuclear spreads were immunostained for SYCP3 and ACA. Schematic representation indicates sites of LSAEs. Bellow: graph showing the percentages of axes with: LSAEs (red area), extensive separation of AEs (dark grey area) and closely associated AEs (light grey area). 414 axes analysed, from 11 nuclei. Bars, 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_1-D</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) Representative nuclear spread of zygotene-like Smc1β−/− spermatocytes. Nuclear spreads were immunostained for SYCP3 and ACA. Magnified views are indicated by dashed areas. Schematic representation on magnified univalents represents sites of LSAEs. Bellow: graph showing the percentages of axes with: LSAEs (red area), extensive separation of AEs (dark grey area) and closely associated AEs (light grey area). 404 axes analysed, from 10 nuclei. Bars, 10 μm in spreads and 1 μm on insets.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">31</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="59" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_1-E</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E) STED images of representative zygotene-like Stag3 mutant and Smc1β−/− univalents displaying LSAEs. Nuclear spreads were immunostained for SYCP3. Bars, 1μm.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_1-F</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F) Graph indicating the inter-axis distances measured in wild-type pachytene bivalents; pachytene-like Rec8−/− and zygotene-like Stag3 mutant and Smc1β−/− univalents. Each measurement in wild-type and Rec8−/− corresponds to the median of 3 distances measured along one homolog (n=60). Each measurement in Stag3 mutant and Smc1β−/− mutant axes correspond to 1 distance measured at sites of local separation of AEs (n=40 and n=20, respectively). Horizontal lines indicate median.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_1-G</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G) Graph indicating the inter-axis distances measured at terminally and centrally located sites of LSAEs in zygotene-like Stag3 mutant univalents. Each measurement corresponds to 1 distance measured at terminally (n=20) and centrally (n=20) located sites of local separation of axial elements. Horizontal lines indicate median.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_2-A</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Representative wild-type pachytene bivalents; pachytene-like Rec8−/−, zygotene-like Stag3 mutant and Smc1β−/− univalents. Nuclear spreads were immunostained for SYCP1, SYCP3 and ACA. Filled arrowheads indicate sites of LSAEs with detectable SYCP1. Bars, 1 μm. Bellow: graphs showing the percentages of sites of LSAEs with detectable SC assembly along sister-AEs of Stag3 mutant and Smc1β−/− univalents (n=120 and n=68, respectively).</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_2-B</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Representative zygotene-like Stag3 mutant univalents. Nuclear spreads were immunostained for SYCP3, ACA and: SYCE1, SYCE2 and TEX12. Filled arrowheads indicate SC assembly between sites of LSAEs. Bars, 1 μm</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_2-C</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Quantification of signal distribution within sites of LSAEs, in Stag3 mutant spermatocytes. Signal distribution measured for SYCP3 and: SYCP1, SYCE1, SYCE2 and TEX12. Empty arrowheads indicate signal intensity peaks that correspond to each of the two sister-chromatid axes, filled arrowheads indicate SYCP1 peaks.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="80" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_3-A</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Representative zygotene-like Stag3 mutant and Smc1β−/− univalents. Nuclear spreads were immunostained for SYCP3, SYCE1 and REC8. Bellow: graph showing the percentages of Stag3 mutant axes with sites of LSAEs with and without flanking REC8 foci. 78 axes with LSAEs were analysed. Bars, 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_3-B</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Representative pachytene-like Rec8−/−, zygotene-like Stag3 mutant and Smc1β−/− univalents. Nuclear spreads were immunostained for SYCP3, SYCE1 and RAD21L. Bars, 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_3-C</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Representative zygotene-like Stag3 mutant and Smc1β−/− univalents. Nuclear spreads were immunostained for SYCP3, SYCE1 and RAD21. Bars, 1 μm.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_4-A</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Representative wild-type pachytene sex chromosomes. Nuclear spreads of pachytene spermatocytes were immunostained for SYCP3. Filled arrowheads indicate the PAR. Dashed area indicated in centre panel corresponds to the magnified view on the right panel. Bars, 10 μm in spreads and 1 μm on insets.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">128</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="84" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_4-B</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Graph indicating the inter-axis distances measured at sites of local separation of axial elements in zygotene-like Stag3 mutant univalents and along pachytene wild-type X-chromosomes. Each measurement in the X-chromosomes corresponds to the median of 3 distances (according to the scheme in figure) (n=54). Each measurement in Stag3 mutant corresponds to 1 distance measured at sites with local separation of axial elements (n=40). Horizontal lines indicate median. p &lt; 0.0001, obtained with two-tailed Mann-Whitney test. Bellow: schematic representation of the XY pair: sister-AEs are coloured in black and grey for easier visualization. Filled arrowhead indicates PAR. Purple bars in scheme indicate regions where inter-axis distances are measured.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_4-C</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Representative pachytene wild-type sex chromosomes. Nuclear spreads of pachytene spermatocytes were immunostained for SYCP3 and SYCE2. Dashed area indicated in centre panel corresponds to the magnified view on the right panel. Empty arrowhead indicates two discernable sister-AEs without SYCE2. Bars, 10 μm in spreads and 1 μm on insets.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">141</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="84" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_5-A</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Analysis of REC8 distribution in representative pachytene wild-type sex chromosomes. Nuclear spreads of pachytene spermatocytes were immunostained for SYCP3 and REC8. Bars, 10 μm in spreads and 1 μm on insets. Magnified XY pair is indicated by dashed area. Scatterplot showing the number of REC8 foci per X-chromosome. 225 foci identified in 14 X-chromosomes. Horizontal line indicates the mean, error bars indicate s.d. 3.02.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">151</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="117" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_5-B</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Top: representative computationally straightened pachytene wild-type X-chromosomes. Nuclear spreads were immunostained for SYCP3 and REC8. Chromosomes were aligned at the PAR, and subdivided into 25 regular intervals. Bar, 1 μm. Bellow: histogram showing the distribution of the percentages of REC8 foci (n=225) among 25 regular intervals along 14 X-chromosomes. Dotted line indicates mean.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_5-C</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Histogram showing the relative frequency of inter-REC8 distances along X-chromosomes. 211 inter-REC8 distances from 14 X-chromosomes. Grey area represents 15% of the chromosome axis length. The respective cumulative distribution function is shown.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_5-D</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) Histogram showing the best fit of the observed inter-REC8 distances to the gamma distribution. Green curve indicates the best fit of the observed inter-REC8 distances.  indicates the value for which the best fit was obtained, with estimated standard error 0.27.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_5-E</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E) Graph comparing the median distance of REC8 foci with computationally predicted even and random distributions. Median distances between foci subdivided in three categories (11-14, 15-18 and 19-22 REC8 foci per chromosome). Purple asterisk indicates the median distance of all REC8 foci.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_5-F</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F) Scatterplot comparing inter-REC8 distances along on X-chromosomes with the distances between flanking REC8 foci at sites of LSAEs in the Stag3 mutant. 211 inter-REC8 distances measured along X-chromosomes and 10 distances measured between flanking REC8 foci in Stag3 mutant. Grey area represents 15% of the chromosome axis length. Horizontal lines indicate the median. p &lt; 0.0001, obtained with two-tailed Mann-Whitney test.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_6-A</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A) Representative yet-unsynapsed autosome from wild-type zygotene spermatocytes. Nuclear spreads were immunostained for SYCP3 and SYCE2. Magnified autosome is indicated by dashed area. Filled arrowheads indicate yet-unsynapsed axes regions. Bars, 10 μm in spreads and 1 μm on insets</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">205</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="66" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_6-B</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B) Representative unsynapsed autosome from wild-type zygotene spermatocytes. Nuclear spreads were immunostained for SYCP3, REC8 and ACA. Magnified autosome is indicated by dashed area. Bars, 10 μm in spreads and 1 μm on insets.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">213</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="62" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_6-C</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C) Scatterplot comparing the average number of REC8 foci along zygotene autosomes and X-chromosomes. Number of REC8 foci were quantified along 15 zygotene autosomes and 14 X-chromosomes. Each dot represents the number of REC8 foci on each chromosome. Total number of foci identified: zygotene autosomes (343), X-chromosomes (225). Horizontal lines indicate the mean, error bars indicate s.d.: 7.42 and 3.02 for zygotene autosomes and X-chromosomes, respectively. p = 0.0060, obtained with two-tailed Mann-Whitney test.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_6-D</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D) Histogram showing the relative frequency of inter-REC8 distances along yet-unsynapsed zygotene autosomes. 294 inter-REC8 distances analyzed in 14 chromosomes. Grey area represents 15% of the chromosome axis length. The respective cumulative distribution function is shown.</text>
    </passage>
  </document>
  <document>
    <id>5278604 Figure_6-E</id>
    <infon key="sourcedata_document">1678</infon>
    <infon key="doi">10.15252/embr.201642030</infon>
    <infon key="pmc_id">5278604</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E) Scatterplot comparing the measured inter-REC8 distances on yet-unsynapsed zygotene autosomes, X-chromosomes and sites of LSAEs in Stag3 mutant. Number of inter-REC8 distances for yet-unsynapsed zygotene autosomes, X-chromosomes and sites of local separation of axial elements in Stag3 mutant, n=294, n=211 and n=10, respectively. Horizontal lines indicate the median. p &lt; 0.0001, obtained with two-tailed Mann-Whitney test.</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-A</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Sirt5 deficiency leads to higher ROS levels in MEFs. ROS levels were determined in the indicated MEFs as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments **p&lt;0.01 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-B</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Sirt5 deficiency suppresses GSH production in MEFs. The ratio of [GSH/GSSG] was determined in cell extracts as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments *p&lt;0.05 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-C</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Sirt5 deficiency inhibits NADPH production in MEFs. The ratio of [NADPH/NADP+] was determined in cell extracts as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments ***p&lt;0.001 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-D</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Sirt5 deficiency decreases cell growth. MEF cells were seeded in 6-well plates at a density of 50,000 cells/well, and cell growth rate was carefully monitored every 1-2 days by cell counting for 8 days. The results are average ± SD of 3 independent experiments *p&lt;0.05, ***p&lt;0.001 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-E</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Sirt5 deficiency leads to higher sensitivity of MEFs to Paraquat. The levels of cleaved PARP and Caspase-3 were determined by western blot analysis.</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-F</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Sirt5 protects MEFs from ROS-induced cell death. Wild-type and Sirt5 KO MEFs were treated with Paraquat (500 μM) for 24 hrs, and then cell viability was determined by counting the remaining adherent cells. The results are average ± SD of 3 independent experiments **p&lt;0.01 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-G-H-I</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-G-H-I</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G-H-I</infon>
    <passage>
      <offset>0</offset>
      <text>(G-I) Sirt5 deficiency inhibits the production of NADPH and GSH and increases lipid peroxide in mousebrains after Paraquat injection. Female Sirt5 KO and WT littermates (n=3~5 per group) were intraperitoneally injected with saline or paraquat (10 mg/kg) once a week for 3 consecutive weeks. The ratios of [NADPH/NADP+] and [GSH/GSSG] and the level of lipid peroxide were determined in tissue extracts. The results are average ± SD. *p&lt;0.05, n.s.: not significant (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_1-J-K</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 1-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_1-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>(J-K) Sirt5 KO mice are more sensitive to Paraquat-induced nigrostriatal dopaminergic degeneration. Female Sirt5 KO and WT littermates were treated with paraquat as in (G-I). The brain sections were stained to detect tyrosine hydroxylase (TH) positive dopaminergic neurons in the SNc region, as described in 'Materials and Methods'. Representative immunohistochemistry images (original magnification, 100×; scale bar, 100 μm) and the corresponding quantifications are shown in (J) and (K), respectively. The results are average ± SD. *p&lt;0.05, n.s.: not significant (two-tailed unpaired t-test).</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">69</infon>
        <infon key="identifier">CL:0000700</infon>
        <location offset="252" length="20"/>
        <text>dopaminergic neurons</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_2-A</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A)Knockdown of SIRT5 inhibits NADPH production in HEK293T cells. The ratio of [NADPH/NADP+] was determined in cell extracts as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments **p&lt;0.01, ***p&lt;0.001 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_2-B</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Knockdown of SIRT5 suppresses GSH production in HEK293T cells. The ratio of [GSH/GSSG] was determined in cell extracts as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments **p&lt;0.01 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_2-C</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Knockdown of SIRT5 leads to higher ROS levels in HEK293T cells. ROS levels were determined in the indicated stable cells as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments ***p&lt;0.001 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_2-D</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Knockdown of SIRT5leads to higher sensitivity to Paraquat. The expression levels of PARP and Caspase-3 were determined by western blot analysis.</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_2-E</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) SIRT5 protects HEK293T cells from ROS-induced cell death. The indicated stable HEK293T cells were treated as mentioned above in (D), and then cell viability was determined by counting the remaining adherent cells. The results are average ± SD of 3 independent experiments **p&lt;0.01 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_2-G</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) The activities of G6PD/6PGD and IDH1/2 are reduced in stable HEK293T cells with SIRT5 knockdown. Activities of the indicated endogenous proteins were determined in cell extracts as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, n.s.: not significant (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_2-H</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 2-H</infon>
    <infon key="sourcedata_figure_dir">Figure_2-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) G6PD and IDH2 are activated by SIRT5 in vitro. Upon pre-incubation with SIRT5 in vitro, the activities of the indicated ectopically expressed proteins were determined as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments **p&lt;0.01, n.s.: not significant (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_3-A</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) G6PD activity is not regulated by lysine succinylation. Purified Flag-tagged G6PD was incubated with or without succinyl-CoA (1 mM) at 30°C for 15 mins, followed by measurement of G6PD enzyme activity as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments. n.s.: not significant (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_3-B</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) IDH2 activity is suppressed by lysine succinylation. Purified Flag-tagged IDH2 was incubated with or without succinyl-CoA (1 mM) at 30°C for 15 mins, followed by measurement of IDH2 enzyme activity as described in 'Materials and Methods'. The results are average ± SD of 3 independent experiments *p&lt;0.05 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_3-C</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) SIRT5 knockdown increases G6PD glutarylation and IDH2 succinylation, respectively, and decreases both enzyme activity. Flag-G6PD or Flag-IDH2 was ectopically expressed in the indicated stable HEK293T cells. G6PD/IDH2 proteins were purified by immunoprecipitated with Flag beads and eluted with Flag peptide, followed by determination of their lysine modifications and enzyme activity. The results are average ± SD of 3 independent experiments **p&lt;0.01, ***p&lt;0.001 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_3-D</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) SIRT5 decreases G6PD glutarylation and IDH2 succinylation, and increases both enzyme activity. Flag-G6PD or Flag-IDH2 was co-overexpressed with HA-SIRT5 in HEK293T cells. G6PD and IDH2 proteins were purified by immunoprecipitation with Flag beads and eluted with Flag peptide, followed by determination of their lysine modifications and enzyme activity. The results are average ± SD of 3 independent experiments *p&lt;0.05, **p&lt;0.01 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_3-E</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Cartoon representation of porcine mitochondrial IDH2 structure shows isocitrate binding pocket (PDB ID: 1LWD) [33], made by Pymol (&lt;a href="http://www.pymol.org"&gt;www.pymol.org). The protein is colored in light green and isocitrate in rainbow, with Lys 360 and Lys 413 residues in IDH2 being colored in red.</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_3-F-G</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 3-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>(F-G) K413 in IDH2 may be a key succinylation site that is directly targeted by SIRT5. The indicated Flag-tagged IDH2 proteins were overexpressed in HEK293T cells with stable SIRT5 knockdown or SIRT5 co-overexpression. Wild-type and mutant IDH2 proteins were purified by Flag beads and eluted with Flag peptide, followed by measurement of IDH2 enzyme activity. The results are average ± SD of 3 independent experiments *p&lt;0.05, n.s.: not significant (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_4-A-B</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(A-B) SIRT5 expression is not affected by chemical oxidant treatment. HEK293T cells were treated with Paraquat (A) or H2O2 (B) for the indicated periods. The mRNA and protein expression of endogenous SIRT5 were determined by quantitative real-time PCR and western blot analysis, respectively. The results are average ± SD of 3 independent experiments. n.s.: not significant (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_4-D</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) The desuccinylase activity of SIRT5 is stimulated by oxidative stimuli. Flag-SIRT5 was ectopically expressed in HEK293T cells. The transfected cells were treated with increased concentrations of Paraquat or H2O2 for the indicated periods. Flag-SIRT5 was purified by immunoprecipitation with Flag beads, eluted with Flag peptide, and then subjected to the desuccinylase activity assay as described in 'Materials and Methods'. The SIRT5 desuccinylase activity was normalized against its protein level. The results are average ± SD of 3 independent experiments *p&lt;0.05, ***p&lt;0.001 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_4-E</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) In vitro incubation with chemical oxidants does not affect the desuccinylase activity of SIRT5. Flag-tagged SIRT5 was ectopically expressed in HEK293T cells, and then purified by immunoprecipitation with Flag-beads and eluted with Flag peptide. The purified Flag-SIRT5 was treated with increased concentrations of Paraquat or H2O2 at room temperature for 1 hr, and then subjected to the desuccinylase activity assay as described in 'Materials and Methods'. The SIRT5 desuccinylase activity was normalized against its protein level. The results are average ± SD of 3 independent experiments. n.s.: not significant (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5278614 Figure_4-F</id>
    <infon key="sourcedata_document">1600</infon>
    <infon key="doi">10.15252/embr.201541643</infon>
    <infon key="pmc_id">5278614</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Chemical oxidants enhance the ability of SIRT5 to activate IDH2. Flag-SIRT5 was ectopically expressed in HEK293T cells, and the transfected cells were treated with increased concentrations of Paraquat or H2O2 for the indicated periods. Flag-SIRT5 was purified by immunoprecipitation with Flag beads, eluted with Flag peptide, and then incubated with purified Flag-IDH2in vitro. IDH2 enzyme activity was measured as described in 'Materials and Methods', normalized by its protein level. The results are average ± SD of 3 independent experiments **p&lt;0.01, ***p&lt;0.001 (two-tailed unpaired t-test).</text>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_1-A</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A DNA content of mCFU-E and BaF3-EpoR cells in response to different Epo concentrations. [3H]-Thymidine incorporation was measured after 14 h (mCFU-E) or 38 h (BaF3-EpoR). Data represented as mean ± standard deviation, N=3. Lines represent sigmoidal regression. EC50 values are given.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">285</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="18" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">284</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="144" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_1-B</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Cell doubling with time in response to 50 U/ml Epo. Cell numbers were determined by manual counting using trypan blue exclusion assay. Data represented as mean ± standard deviation, N=3. Lines represent exponential regression. Doubling time is indicated.</text>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_1-C</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Size determinations of mCFU-E and BaF3-EpoR cells. Exemplary fluorescence microscopy pictures upon Hoechst staining for nucleus visualization with 60x objective. The bar respresents 10 µm distance (upper panel). Cell diameter was measured by Imaging flow cytometry. Cytoplasm was stained with Calcein, nuclei were stained with DRAQ5. Probability density function of size distribution with indicated mean diameter of mCFU-E and BaF3EpoR cells. All cells were growth-factor deprived and unstimulated.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">287</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="26" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">288</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="419" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_1-D</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Epo-induced phosphorylation of EpoR, AKT and ERK of mCFU-E and BaF3-EpoR cells. Above each panel the number of growth-factor deprived cells examined per time point is indicated as well as the concentration of Epo applied for stimulation. To the left the position of the molecular weight marker is indicated in kDa and arrowheads indicate the position of the protein of interest. For the detection of the EpoR, 5x106 mCFU-E cells were stimulated with 2.5 U/ml Epo and 5x106 BaF3-EpoR cells were stimulated with 5 U/ml Epo. Cells were lysed, subjected to immunoprecipitation with anti-EpoR and were analyzed by immunoblotting using either anti-pTyr (pEpoR) or anti-EpoR (EpoR) antibodies. For the detection of AKT, mCFU-E cells were stimulated with 2.5 U/ml Epo and BaF3-EpoR cells were stimulated with 5 U/ml Epo. Per time point cellular lysates equivalent to 5x105 mCFU-E cells and 1x106 BaF3-EpoR cells were analyzed by immunoblotting using anti-pAKT and anti-AKT antibodies. For the detection of ERK, cells were stimulated with 50 U/ml Epo. Per time point cellular lysates equivalent to 8x105 cells were analyzed by immunoblotting. Immunoblot detection was performed with chemiluminescence utilizing a CCD camera device (ImageQuant).</text>
      <annotation id="27">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">33</infon>
        <infon key="sourcedata_article_annot_id">289</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="55" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="28">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">34</infon>
        <infon key="sourcedata_article_annot_id">290</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="419" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="29">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">35</infon>
        <infon key="sourcedata_article_annot_id">291</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="716" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="30">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">36</infon>
        <infon key="sourcedata_article_annot_id">292</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="868" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_1-E</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Absolute concentrations of pEpoR, pAKT and ppERK in mCFU-E and BaF3-EpoR cells with time in response to 50 U/ml Epo. Experimental data of a representative experiment is depicted with filled circles, dashed lines represent splines. Error bars indicate standard deviation estimated by an error model.</text>
      <annotation id="7">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">293</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="55" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_1-F</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 1-F</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Expression of cell-cycle indicator genes of mCFU-E and BaF3-EpoR cells in response to 5 U/ml Epo. Genes were selected based on microarray analysis. Experimental data is shown as fold change to unstimulated cells with mean ± standard deviation, N=3. Welch Modified Two-Sample t-Test, * p&lt;0.05.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">294</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="47" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_1-G</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 1-G</infon>
    <infon key="sourcedata_figure_dir">Figure_1-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Fold change of fractions of cells in S/G2/M phase of the cell cycle with respect to 0 U/ml Epo. Growth-factor deprived cells were stimulated with indicated Epo doses for given time. Fractions in sub-G1, G1, S, G2/M were determined by propidium iodide (PI) staining for DNA content. N=3. Welch Modified Two-Sample t-Test, n.s. = not significant, * p &lt; 0.05 , ** p &lt; 0.01 , *** p &lt; 0.005. The percentage of cells in S/G2/M phase in unstimulated cells is additionally indicated.</text>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_2-B-E</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 2-B-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-E</infon>
    <passage>
      <offset>0</offset>
      <text>B-G Model calibration with time-resolved quantitative immunoblot data of mCFU-E cells in blue and BaF3-EpoR cells in black. Growth-factor deprived mCFU-E cells (5x106 cells per condition) and BaF3-EpoR cells (1x107 cells per condition) were stimulated with different Epo doses and absolute concentrations were determined for pEpoR (B), pAKT (C), ppERK (D). The scale for pS6 (E) was estimated in arbitrary units.</text>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">295</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="74" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">296</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="148" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_2-F-G</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 2-F-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F-G</infon>
    <passage>
      <offset>0</offset>
      <text>GTP-Ras (F) and ppERK were determined upon stimulation with indicated, color-coded Epo doses. pEpoR was analyzed by immunoprecipitation followed by immunoblotting, GTP-Ras was analyzed after pulldown using a fusion protein harboring GST fused to the Ras binding domain of Raf1 followed by detection by quantitative immunoblotting. For pAkt and ppERK, cellular lysates were subjected to quantitative immunoblotting. Calibrator proteins were used for EpoR, AKT, GTP-Ras and ERK to facilitate the conversion to nM concentrations. Experimental data represented by filled circles. Error bars represent standard deviation estimated by an error model. Solid lines represent model trajectories.</text>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_3-A</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Model calibration with mCFU-E wild-type cells, and mCFU-E cells overexpressing SHIP1 or PTEN, and BaF3-EpoR wild-type cells. Experimental data represented by filled circles. Error bars represent standard deviation estimated by an error model. Solid lines represent model trajectories.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">297</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="26" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">298</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="54" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_3-B</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Model prediction of pAKT dynamics in BaF3-EpoR cells overexpressing PTEN or SHIP1. Model predictions are represented by solid lines. Experimental validation data obtained by quantitative immunoblotting represented by filled circles. Error bars represent standard deviation estimated by an error model.</text>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_3-D</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Experimental validation of basal DUSP expression in mCFU-E and BaF3-EpoR. Quantitative RT-PCR was performed with all samples on the same plate, allowing a direct comparison of mRNA levels between mCFU-E and BaF3-EpoR cells. Data is normalized to the Rpl32 gene. Ratios of expression in BaF3-EpoR cells compared to mCFU-E cells are shown as box plots. N=10. For details, see Appendix K.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">299</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="55" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="10">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">301</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="199" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">300</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="317" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_4-A</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Model prediction and experimental validation for pAKT, ppERK and pS6 dynamics of 32D-EpoR cells in response to 50 U/ml Epo. Simulations are based on measured, cell-type-specific protein abundance of 32D-EpoR cells and global kinetic rates estimated from mCFUE and BaF3-EpoR cells. Model predictions are represented by solid lines. Experimental validation data obtained by quantitative immunoblotting represented by filled circles. Error bars represent standard deviation estimated by an error model.</text>
      <annotation id="11">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">13</infon>
        <infon key="sourcedata_article_annot_id">302</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="257" length="4"/>
        <text>CFUE</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_4-C</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Model prediction and experimental validation for RSK, AKT, ERK and S6 activation upon RSK overexpression (oe) and 5 U/ml Epo stimulation in 32DEpoR cells. Simulations are based on measured, cell-type-specific protein abundance of 32D-EpoR cells and global kinetic rates estimated from mCFUE and BaF3-EpoR cells. Model predictions are represented by solid lines. Experimental validation data obtained by quantitative immunoblotting represented by filled circles. Error bars represent standard deviation estimated by an error model. Integrated pS6 was significantly higher upon RSK overexpression as compared to 32D-EpoR wild-type (wt) cells, N=4 (lower right panel). Two-Sample t-Test, *** p&lt;0.005.</text>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">20</infon>
        <infon key="sourcedata_article_annot_id">304</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="288" length="4"/>
        <text>CFUE</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_4-D</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Impact of AKT, Ras or PTEN overexpression on BaF3-induced pS6 dynamics in EpoR and BaF3-PTEN cells. Quantitative AKT upon overexpression of PTEN, Ras, a constitutive active BaF3 protein, or the empty vector control in EpoR cells or BaF3-mCFU-E cells. BaF3-factor deprived mCFU-E cells (5x106 cells per condition) and Epo-immunoblotting cells (1x107 cells per condition) were stimulated with 5 U/ml Epo for indicated time points. Cellular lysates were analyzed by S6 employing sequential reprobing anti-pAKT, anti-ppERK, anti-pS6, anti-Epo and to ensure equal loading with anti-beta-actin antibodies. Detection was performed with chemiluminescence using a CCD camera device (ImageQuant). Quantification of pS6 on the right is depicted as fold change to wild-type samples at 30 minutes after Epo stimulation. Error bars represent standard deviation. oe: overexpression. N=3. Welch Modified Two-Sample t-Test, n.s. = not significant, * p &lt; 0.05</text>
      <annotation id="23">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">29</infon>
        <infon key="sourcedata_article_annot_id">305</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="240" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="24">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">30</infon>
        <infon key="sourcedata_article_annot_id">306</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="275" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_5-A</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Epo-induced signaling upon AKT or MEK inhibitor treatment. Growth-factor deprived cells were pretreated for half an hour with AKT VIII or U0126, respectively, and subsequently stimulated with 5 U/ml Epo. PDI served as loading control.</text>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_5-B</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Model calibration with integrated pAKT, ppERK and pS6 data upon inhibitor treatment and 5 U/ml Epo stimulation of mCFU-E, 32D-EpoR and BaF3-EpoR cells. Area under curve from time-resolved, quantitative immunoblotting data was calculated and is represented by filled circles. Error bars represent standard deviation estimated by an error model. Solid lines represent model trajectories.</text>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">12</infon>
        <infon key="sourcedata_article_annot_id">307</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="117" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_5-C</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Analysis of cell-cycle indicator genes upon AKT VIII and U0126 treatment. Growth-factor deprived cells were pretreated for half an hour indicated doses of a single inhibitor, followed by stimulation with 5 U/ml Epo for 0 h and 3 h. The expression of cyclinD2, cyclinG2 and p27 was measured by quantitative RT-PCR and normalized to the Rpl32 gene. Genes were selected based on microarray analysis. Experimental data is shown as fold change to unstimulated cells with mean ± standard deviation, N=3. Welch Modified Two-Sample t-Test, n.s. not significant, * p&lt;0.05, ** p&lt;0.01, *** p&lt;0.005.</text>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_7-B</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>Lower panel: Experimental validation of PTEN and SHIP1 overexpression effects on Epo-dependent proliferation. Proliferation was assessed using [3H]-Thymidine incorporation 14 h (mCFU-E) or 38 h (BaF3-EpoR) after retroviral transduction with PTEN or SHIP1 construct for overexpression. Data represented as mean ± standard deviation, N=3. EC50 values are given.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">308</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="179" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_7-D</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>Lower panel: Experimental validation of proliferation upon combined inhibitor treatment and 5 U/ml Epo stimulation. Proliferation was measured as cell numbers after 14 h (mCFU-E) or 38 h (BaF3-EpoR, 32D-EpoR) with Coulter Counter. Maximum was scaled to 1</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">309</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="172" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_8-A</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Venn diagramm representing overlap of hCFU-E proteome from three independent healthy donors. In total 6,925 proteins were quantified</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">275</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="41" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_8-B</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Size determinations of hCFU-E compared to mCFU-E cells. Cell diameter was measured by Imaging flow cytometry. Cytoplasm was stained with Calcein, nuclei were stained with DRAQ5. Probability density function of size distribution with indicated mean diameter of hCFU-E and mCFU-E cells. All cells were growth-factor deprived and unstimulated.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">283</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="45" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">310</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="263" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">282</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="274" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_8-C</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Cytoplasmic volumes of BaF3-EpoR, 32D-EpoR, mCFU-E and the hCFU-E cells. All volumes were determined using imaging flow cytometry as described in (B).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">311</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="47" length="5"/>
        <text>CFU-E</text>
      </annotation>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">312</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="62" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_8-D</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Correlation between protein molecules per cell for key signaling components determined by quantiative immunoblotting or quantitative mass spectrometry and the "proteomic ruler" method (Wiśniewski et al, 2014) in BaF3-EpoR and mCFU-E cells. Diagonal line as guide to the eye. Spearman's rank-based coefficient of correlation ρ=0.88.</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">320</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="229" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_8-E</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 8-E</infon>
    <infon key="sourcedata_figure_dir">Figure_8-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Protein abundance of key signaling components were determined by mass spectrometry of whole-cell lysates of hCFU-E cells. Copy numbers of proteins per cell were obtained by the "proteomic ruler" method and converted to cytoplasmic concentrations with the volumes calculated from (B) and shown in (C).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">329</infon>
        <infon key="identifier">CL:0000038</infon>
        <location offset="111" length="5"/>
        <text>CFU-E</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5293153 Figure_8-F</id>
    <infon key="sourcedata_document">2666</infon>
    <infon key="doi">10.15252/msb.20167258</infon>
    <infon key="pmc_id">5293153</infon>
    <infon key="figure">Figure 8-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Model prediction and experimental validation of proliferation upon single or combined inhibitor treatment with AKT VIII and U0126 upon 5 U/ml Epo stimulation. Maximum proliferation was scaled to 1. Proliferation was measured as cell numbers, counted with a hemocytometer after 96 hours by trypan blue exclusion assay. Solid lines represent model trajectories. Experimental data is represented as mean ± standard deviation. N=3</text>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_1-A-E</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 1-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>A-E Double-immunolabeling of Sororin (green) and SYCP3 (red) on spread spermatocytes at (A) zygotene (Zyg.), (B) pachytene (Pac.), (C) diplotene (Dip.), (D) late diplotene (L. dip.), and (E) prometaphase I (ProM I).</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">4</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="71" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_1-F-G-H</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 1-F-G-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-F-G-H</infon>
    <passage>
      <offset>0</offset>
      <text>F-H Double-immunolabeling of Sororin (green) and SYCP1 (pseudocoloured in pink) on spread spermatocytes at (F) zygotene, (G) pachytene, and (H) diplotene.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">9</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="90" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_1-I-J-K</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 1-I-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>I-K Double-immunolabeling of Sororin (green) and HORMAD1 (pseudocoloured in blue) on spread spermatocytes at (I) zygotene, (J) pachytene, and (K) diplotene. The sex bivalent (XY) and their pseudoautosomal regions (arrows), as well as the round body (arrowheads) are indicated. Scale bar: 10 µm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">14</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="92" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_2-A-B-C-D</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 2-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>A,C Double-immunolabeling of Sororin (green) and SYCP3 (red) on spread spermatocytes at (A) early zygotene (E. zyg.) and (C) late zygotene (L. zyg.). B,D Double-immunolabeling of SMC3 (pseudocoloured in cyan) and SYCP3 (red) on spread spermatocytes at (B) early zygotene and (D) late zygotene.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">23</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="71" length="13"/>
        <text>spermatocytes</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">26</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="235" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_2-E</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Double-immunolabeling of Sororin (green) and REC8-myc (pseudocoloured in purple) on a spread mid zygotene spermatocyte. The sex univalents (X,Y) are indicated. Scale bar: 10 µm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">30</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="108" length="12"/>
        <text>spermatocyte</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_3-A-E</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 3-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>Double-immunolabeling of Sororin (green) and SYCP3 (red) on spread pachytene-like (Pac.-like) and zygotene-like (Zyg.-like) spermatocytes of different genotypes. Unsynapsed axial elements of sex chromosomes (X,Y) are indicated. Arrowheads indicate nucleolar-associated round bodies. Scale bar: 10 µm.</text>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">41</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="124" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_4-A-L</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 4-A-L</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-L</infon>
    <passage>
      <offset>0</offset>
      <text>Double-immunolabeling of Sororin (green) and SYCP3 (red), and counterstaining of the chromatin with DAPI (blue) on spread spermatocytes at (A) metaphase I (M I), (G) anaphase I (A I), (H) interkinesis (Int.), (I) prophase II (Pro. II), and (J) metaphase II (M II). The sex bivalent (XY) is indicated. Arrows indicate the centriolar area at cell poles. Arrowheads indicate the Sororin labeling at the centromere of Y chromosome. B-F Selected metaphase I autosomal (B and C) and sex (E and F) bivalents. The sex chromosomes (X,Y) are indicated. K,L Enlarged metaphase II centromeres. Scale bar: 10 µm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="122" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_5-A-B-C</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 5-A-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>Double-immunolabeling of Sororin (green) and kinetochores (ACA serum, red), and counterstaining of the chromatin with DAPI (blue) on spread spermatocytes at (A) metaphase I (M I), (B) metaphase II (M II), and (C) anaphase II (A II). Arrowheads indicate the cell poles. The centromere of the Y chromosome and chromatids (Y) is indicated. Scale bar: 10 µm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">69</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="140" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_6-A-B-C-D</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 6-A-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>Double-immunolabeling of Sororin (green) and SYCP3 (red), and counterstaining of the chromatin with DAPI (blue) on spread Sgo2-/- spermatocytes at (A) pachytene (Pac.), (B) diplotene (Dip.), (C) metaphase I (M I), and (D) metaphase II-like (M II-like). The sex bivalent (XY) is indicated. Arrowheads indicate round bodies. Arrows in (A) indicate the pseudoautomal region in the sex bivalent, and the centriolar area at cell poles in (C,D). Scale bar: 10 µm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="130" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341523 Figure_7-A-E</id>
    <infon key="sourcedata_document">1524</infon>
    <infon key="doi">10.15252/embr.201541060</infon>
    <infon key="pmc_id">5341523</infon>
    <infon key="figure">Figure 7-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>Double-immunolabeling of Sororin (green) and SYCP3 (red) on spread cultured wild-type control (WT Control), and okadaic acid treated wild-type (WT + OA) and Smc1β-/- (Smc1β-/- + OA) spermatocytes. A-B WT control cultured spermatocytes in (A) late zygotene (L. zyg.) and (B) metaphase I (M I). Arrows indicate the cell poles. C-D WT cultured spermatocytes treated with okadaic acid in (C) late zygotene (L. zyg.) and (D) metaphase I-like (M I-like). E-F Smc1β-/- cultured spermatocytes treated with okadaic acid in (E) pachytene-like (Pac.-like) and (F) metaphase I-like (M I-like). Arrowheads indicate nucleolar-associated round bodies. The unsynapsed axial elements of the sex chromosomes (X,Y) in prophase I, as well as the sex bivalent (XY) in metaphases I are indicated. Scale bar: 10 µm.</text>
      <annotation id="3">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">101</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="182" length="13"/>
        <text>spermatocytes</text>
      </annotation>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">102</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="221" length="13"/>
        <text>spermatocytes</text>
      </annotation>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">103</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="341" length="13"/>
        <text>spermatocytes</text>
      </annotation>
      <annotation id="6">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <infon key="identifier">CL:0000017</infon>
        <location offset="471" length="13"/>
        <text>spermatocytes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_1-D</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Zygotic grk2i283 mutant at 4dpf compared to wild type (N=80). Arrows indicate the position of swim bladder. Scale bar, 1mm</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_2-A</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Western blot analysis of the different forms of Gli2a in MZgrk2 embryos compared to wild type, shh mRNA and dnPKAmRNA injected wild type and cyclopamine (Cyc(A)) treated wild type 20hpf embryos. Gli2a-FL levels are low relative to Gli2aR levels in wild type embryos, but are elevated in response to pathway activation (shh and dnPKA mRNA injected). Gli2aR levels are increased while Gli2a-FL is undetectable in CycA treated and MZgrk2 mutant embryos. Probing the same blot with rabbit anti-GRK3 (which recognizes the zebrafish Grk2protein) reveals a complete loss of full length Grk2 in MZgrk2 embryos. Probing with anti-γ-tubulin was performed as a loading control. Three biological replicates of this analysis were performed.</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_2-B</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Phenotype of wild type, MZgrk2, and grk2-GFP mRNA injected MZgrk2 embryos at 24hpf (n=20 for each sample). The white lines indicate the shape of the somites (middle panels) and the separation of the eyes (right hand panels). Scale bar, 200μm</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_2-C</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C In situ hybridisation of ptch2, nkx2.2a and olig2 transcripts in wild type, MZgrk2 and grk2-GFP injected MZgrk2 24hpf embryos. Each panel shows a full view of the embryo on the left and a cross sectional view of a somite on the right. (n=30 for each sample). Scale bars, 200μm (whole mounts), 50μm (sections).</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_2-D</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Expression of Prox1a and Engrailedproteins (Eng) in somites of wild-type, MZgrk2 and grk2-GFP mRNA injected MZgrk2 embryos at 30hpf. Each panel shows Prox1a in green, Eng in red and the merge images with DAPIstaining in blue. (n=10 for each sample). Scale bar, 50μm.</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_3-A</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Prox1a and Eng expression in the myotome of 30hpf wild type and MZgrk2 embryos injected with mRNAs encoding Shh, dnPKA or mSmoA1-GFP. Each panel shows Prox1a in green, Eng in red, and the merged images with DAPIstaining in blue. The co-labelling for Prox1a and Eng (orange) is indicative of MP differentiation (n=30 for each sample) Scale bar, 50μm.</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_3-B</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Western blot showing levels of Gli2a-FL and Gli2a-R forms in 20hpf wild type and MZgrk2 embryos injected with mRNA encoding Shh, dnPKA or mSmoA1-GFP, respectively. γ-tubulin was used as loading control. Three biological replicates of this analysis were performed.</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_4-A</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Western blot analysis of GRK2, GLI1, PTCH1, and GLI3 protein levels in Flp-In-3T3 cells with lentiCRISPR of 4 different guide RNAs in presence or absence of SAG. α-tubulin was used as loading control. Guide RNA 2 was found to remove Grk2 efficiently and used for subsequent experiments. GLI3 panel shows both full-length (GLI3FL) and repressor form of GLI3 (GLI3R). (n=3)</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_4-B-C</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 4-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C Hh reporter activity assay for wild type and Grk2-/- cells. Cells were treated with PKA peptide inhibitor (PKI) and mutant form of PKA peptide inhibitor (PKI-M) respectively, in presence or absence of SHH (B) Cells were transfected with mSmoA1-GFP expressing constructs in the presence of SHH or SAG (C). Data represent the mean and ± SD (n=3). Unpaired Students t-test was used for analysis. ***P&lt;0.001; **P&lt;0.01; *P&lt;0.05 and n.s. (not significant).</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_5-A</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Expression of Prox1a (green) and the eng2a:GFP reporter (red) in otherwise wild-type 30hpf embryos injected with mRNA encoding wild type and mutant forms of mouseSmo. Ectopic MPs are indicated by fibres co-labelled with Prox1a and GFP; ectopic MFFs are labeled only with GFP. Images are representative of embryos in the following proportions of each sample: 28/28 (mSmo; mSmoA1; mSmoSD; mSmoKRA); 9/28 (mSmoA1SA); 12/28 (mSmoA1SD). Scale bar, 50μm.</text>
      <annotation id="16">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">16</infon>
        <infon key="sourcedata_article_annot_id">143</infon>
        <infon key="identifier">CL:0007016</infon>
        <location offset="177" length="3"/>
        <text>MPs</text>
      </annotation>
      <annotation id="17">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">17</infon>
        <infon key="sourcedata_article_annot_id">144</infon>
        <infon key="identifier">CL:0000190</infon>
        <location offset="246" length="4"/>
        <text>MFFs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_5-B</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Average number of Prox1a+ve slow fibres in wild type embryos injected with mRNA encoding different forms of mSmo. Prox1 positive cells were quantified in 4 somites in each of 4 embryos for each sample. The error bars indicate SD. Unpaired Student's t-test was used to determine the statistical significance between uninjected embryos and the various Smo mutants (black asterisk); and between mSmoA1 and mSmoA1SA or mSmoA1SD (red asterisk). ***P&lt;0.001; **P&lt;0.01; *P&lt;0.05 and n.s. (not significant).</text>
      <annotation id="1">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">147</infon>
        <infon key="identifier">CL:0000189</infon>
        <location offset="30" length="11"/>
        <text>slow fibres</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_5-C</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Prox1a and Eng expression in smohi1640 mutant embryos injected with mRNA encoding mSmo (n=10), mSmoSA (n=9) and mSmo14SA (n=6). Note the full recovery of SSFs and MPs compared to the un-injected controls. Scale bar, 50μm.</text>
      <annotation id="5">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">161</infon>
        <infon key="identifier">CL:0000189</infon>
        <location offset="156" length="4"/>
        <text>SSFs</text>
      </annotation>
      <annotation id="9">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">165</infon>
        <infon key="identifier">CL:0007016</infon>
        <location offset="165" length="3"/>
        <text>MPs</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_5-D</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>D In situ hybridisation for transcripts of ptch2, olig2 and nkx2.2 in 24hpf smohi1640 mutant embryos injected with mRNA encoding mSmo and mSmoSA (n=6 for each sample). Scale bars, are 100μm (lateral view), 50μm (sections).</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_5-E</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Hh reporter assay of the activity of wild type and mutant forms of mSmo in Smo-/- MEFs in response to Shh or SAG stimulation. Note that mSmoA1 shows constitutive activity in the absence of either Shh or SAG whereas mSmoKRA dose not; all mutants affecting phosphorylation failed to restore the response to Shh or SAG. Data represent the mean and ± SD (n=3). Unpaired Students t-test was used for analysis. ****P&lt;0.0001; **P&lt;0.01; and n.s. (not significant).</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_6-A</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A Wild type 18hpf embryos injected with mRNA encoding GFP-tagged mSmo (green) showing localisation to the PC of myotomal cells labeled with anti-Acetylated tubulin (AcTub; red), stimulated in response to Shh injection (n = 4). Differences in PC distribution are due to morphological changes in the myotome induced by ectopic expression of Shh as revealed by the distribution of nuclei (DAPI stained; blue). Scale bar, 10μm.</text>
      <annotation id="2">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <infon key="identifier">CL:0000187</infon>
        <location offset="112" length="14"/>
        <text>myotomal cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_6-B</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Notochord cells of wild type embryos expressing GFP tagged wild-type and mutant forms of mSmo. Note the localisation to the PC (labeled with anti-AcTub; red) in each case (n=4 for each sample). Scale bar, 10μm.</text>
      <annotation id="4">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">209</infon>
        <infon key="identifier">CL:0007005</infon>
        <location offset="2" length="15"/>
        <text>Notochord cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_6-C</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C MZgrk2 18hpf embryos injected with mRNA encoding GFP-tagged wild type mSmo or mSmoSA (green) showing localisation to the PC (labeled with anti- AcTub; red) in myotomal cells. More Smo is localised to the PC in MZgrk2mutants compared to wild type (panel A). Scale bar, 10μm.</text>
      <annotation id="8">
        <infon key="type">cell_type</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">223</infon>
        <infon key="identifier">CL:0000187</infon>
        <location offset="161" length="14"/>
        <text>myotomal cells</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_7-B</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B Prox1a (green) and Eng (red) expression in the myotome of 30hpf MZgrk2 embryos that were injected with mRNA encoding: Grk2K220R-GFP; Grk2K220M-GFP; Grk2D335N-GFP; Grk2ΔN7aa-GFP and mGrk2L4AV7AL8A-GFP. Merged panels show nuclearstaining with DAPI in blue. (n=20 for each sample). Scale bar, 50μm.</text>
    </passage>
  </document>
  <document>
    <id>5341524 Figure_7-C</id>
    <infon key="sourcedata_document">1578</infon>
    <infon key="doi">10.15252/embr.201541532</infon>
    <infon key="pmc_id">5341524</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Hh reporter activity assay in wild type and Grk2-/- 3T3 cells transfected with the equivalent wild type and mutant kinase domain forms of mouseGrk2, Grk2K220R, Grk2K220M and Grk2D335N after 24h Shh-N and SAG treatment. Data represent the mean and ± SD (n=3). Unpaired Students t-test was used for analysis. ****P&lt;0.0001; **P&lt;0.01; *P&lt;0.05; and n.s. (not significant).</text>
    </passage>
  </document>
</collection>
